Psyllid ID: psy1934

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150
Protein Sequence
MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYVIGRSMLYGHV
Secondary Structure (PSIPRED)
cEEEccEEEcccccccccEEEEEEEcccccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccEEEccccccEEEcccccEEEEccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHccHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
ccccccHHEEEEEccccccEEEEEEEccccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccEEcccccHHHEEEcccccEEEccccccccccccccccccHHHHHHHHHHHcccccHcccccHHHHHHHcccEEHHHHcccc
Coil and Loop (DISEMBL)
MEYLSAAfidkhstphgmhEYLILTELCTGGSLVDVLKErtsalppnivcSILWQTCQAVKhmhgqnppivhrdlKIENLLISsagtvklcdfgsatekvyspdnawsAQQRSMLEDEMArfttpmyrapemvdtwnNYVIGRSMLYGHV
Flexible Loop (DISEMBL)
MEYLSAAfidkhstphgMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSatekvyspdnaWSAQQRSMLEDEMARFTTPmyrapemvdtwnNYVIGRSMLYGHV
Low Complexity Region (SEG)
MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYVIGRSMLYGHV
Disordered region (IsUnstruct)
******AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS*****************ARFTTPMYRAPEMVDTWNNYVIGRSMLY***
Disordered Region (DISOPRED)
MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYVIGRSMLYGHV
Disordered Region (DISEMBL)
MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYVIGRSMLYGHV
Disordered Region (DISPRO)
*EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYVIGRSMLYGHV
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYVIGRSMLYGHV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	150	2.2.26 [Sep-21-2011]
Q99KY4	1305	Cyclin-G-associated kinas	yes	N/A	0.94	0.108	0.541	9e-40
O14976	1311	Cyclin-G-associated kinas	yes	N/A	0.94	0.107	0.534	9e-40
P97874	1305	Cyclin-G-associated kinas	yes	N/A	0.94	0.108	0.534	2e-39
Q54VV7	1126	Probable serine/threonine	yes	N/A	0.853	0.113	0.407	4e-22
Q3UHJ0	959	AP2-associated protein ki	no	N/A	0.786	0.123	0.422	5e-22
P0C1X8	962	AP2-associated protein ki	no	N/A	0.786	0.122	0.422	6e-22
Q86HW6	798	Probable serine/threonine	no	N/A	0.78	0.146	0.432	6e-22
F1MH24	957	AP2-associated protein ki	no	N/A	0.786	0.123	0.422	2e-21
Q2M2I8	961	AP2-associated protein ki	no	N/A	0.786	0.122	0.414	2e-21
O43066	953	Serine/threonine-protein	yes	N/A	0.78	0.122	0.417	8e-21

>sp|Q99KY4|GAK_MOUSE Cyclin-G-associated kinase OS=Mus musculus GN=Gak PE=1 SV=2

 Score =  162 bits (409), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 78/144 (54%), Positives = 106/144 (73%), Gaps = 3/144 (2%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
           +++ SAA I K  +  G  E+L+LTELC G  LV+ LK  E    L  + +  I +QTC+
Sbjct: 99  VQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKRVECKGPLSCDSILKIFYQTCR 157

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+M+E+E
Sbjct: 158 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQKRAMVEEE 217

Query: 119 MARFTTPMYRAPEMVDTWNNYVIG 142
           + R TTPMYR PE+VD ++N+ IG
Sbjct: 218 ITRNTTPMYRTPEIVDLYSNFPIG 241

Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O14976|GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2

 Score =  162 bits (409), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 77/144 (53%), Positives = 106/144 (73%), Gaps = 3/144 (2%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
           +++ SAA I K  +  G  E+L+LTELC G  LV+ LK  E    L  + V  I +QTC+
Sbjct: 99  VQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCR 157

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+++E+E
Sbjct: 158 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 217

Query: 119 MARFTTPMYRAPEMVDTWNNYVIG 142
           + R TTPMYR PE++D ++N+ IG
Sbjct: 218 ITRNTTPMYRTPEIIDLYSNFPIG 241

Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P97874|GAK_RAT Cyclin-G-associated kinase OS=Rattus norvegicus GN=Gak PE=2 SV=1

 Score =  161 bits (407), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/144 (53%), Positives = 106/144 (73%), Gaps = 3/144 (2%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
           +++ SAA I K  +  G  E+L+LTELC G  LV+ L+  E    L  + +  I +QTC+
Sbjct: 99  VQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLRRVECKGPLSCDSILKIFYQTCR 157

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+M+E+E
Sbjct: 158 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQKRAMVEEE 217

Query: 119 MARFTTPMYRAPEMVDTWNNYVIG 142
           + R TTPMYR PE+VD ++N+ IG
Sbjct: 218 ITRNTTPMYRTPEIVDLYSNFPIG 241

Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54VV7|Y0111_DICDI Probable serine/threonine-protein kinase DDB_G0280111 OS=Dictyostelium discoideum GN=DDB_G0280111 PE=3 SV=1

 Score =  103 bits (257), Expect = 4e-22,   Method: Composition-based stats.
 Identities = 57/140 (40%), Positives = 84/140 (60%), Gaps = 12/140 (8%)

Query: 10  DKHSTPHGMHEYLILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQ 66
           DK++T     E  IL E C+GG LV+++++R S+        +  I    C++V +MH Q
Sbjct: 85  DKNNT-----EMFILMEYCSGGHLVEIMQKRLSSGSKFTDQEILKIFQDICESVAYMHSQ 139

Query: 67  NPPIVHRDLKIENLLI-SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTP 125
            P I+HRDLK+EN+L+   +G  KLCDFGSATE++    N    Q     ED+++R TT 
Sbjct: 140 QPLIIHRDLKVENVLLDEESGIYKLCDFGSATEEITRMKNKTEMQNA---EDDISRHTTL 196

Query: 126 MYRAPEMVDTWNNYVIGRSM 145
            YRAPE+VD + + VI   +
Sbjct: 197 QYRAPEIVDFYRSPVINEKI 216

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3UHJ0|AAK1_MOUSE AP2-associated protein kinase 1 OS=Mus musculus GN=Aak1 PE=1 SV=2

 Score =  103 bits (256), Expect = 5e-22,   Method: Composition-based stats.
 Identities = 52/123 (42%), Positives = 76/123 (61%), Gaps = 5/123 (4%)

Query: 20  EYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           E LIL + C GG +V+++ +R  +    N V  I   TC+AV  +H    PI+HRDLK+E
Sbjct: 121 EVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQIFCDTCEAVARLHQCKTPIIHRDLKVE 180

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           N+L+   G   LCDFGSAT K  +P     A+  + +EDE+ ++TT  YRAPEMV+ ++ 
Sbjct: 181 NILLHDRGHYVLCDFGSATNKFQNP----QAEGVNAVEDEIKKYTTLSYRAPEMVNLYSG 236

Query: 139 YVI 141
            +I
Sbjct: 237 KII 239

Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis. Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1. Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes. Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes. Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0C1X8|AAK1_RAT AP2-associated protein kinase 1 OS=Rattus norvegicus GN=Aak1 PE=1 SV=1

 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 52/123 (42%), Positives = 76/123 (61%), Gaps = 5/123 (4%)

Query: 20  EYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           E LIL + C GG +V+++ +R  +    N V  I   TC+AV  +H    PI+HRDLK+E
Sbjct: 121 EVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQIFCDTCEAVARLHQCKTPIIHRDLKVE 180

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           N+L+   G   LCDFGSAT K  +P     A+  + +EDE+ ++TT  YRAPEMV+ ++ 
Sbjct: 181 NILLHDRGHYVLCDFGSATNKFQNP----QAEGVNAVEDEIKKYTTLSYRAPEMVNLYSG 236

Query: 139 YVI 141
            +I
Sbjct: 237 KII 239

Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis. Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes. Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes. Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86HW6|Y6461_DICDI Probable serine/threonine-protein kinase DDB_G0276461 OS=Dictyostelium discoideum GN=DDB_G0276461 PE=3 SV=1

 Score =  102 bits (255), Expect = 6e-22,   Method: Composition-based stats.
 Identities = 54/125 (43%), Positives = 74/125 (59%), Gaps = 8/125 (6%)

Query: 20  EYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           E L+L E C+GGS++D++  R   + L    + +I    C  V  MH Q PPI HRDLKI
Sbjct: 129 EVLMLMEYCSGGSVLDIMNARGEFTRLEEREILAIFSDVCNGVLAMHQQQPPIAHRDLKI 188

Query: 78  ENLL-ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTW 136
           EN+L    +   KLCDFGS+T K ++     +A +R   ED++  FTT  YRAPEMVD +
Sbjct: 189 ENVLYCEHSNRYKLCDFGSSTIKTFN-----TATERGKAEDDINMFTTLFYRAPEMVDLY 243

Query: 137 NNYVI 141
              +I
Sbjct: 244 RGQII 248

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|F1MH24|AAK1_BOVIN AP2-associated protein kinase 1 OS=Bos taurus GN=AAK1 PE=1 SV=2

 Score =  101 bits (252), Expect = 2e-21,   Method: Composition-based stats.
 Identities = 52/123 (42%), Positives = 75/123 (60%), Gaps = 5/123 (4%)

Query: 20  EYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           E LIL + C GG +V+++ +R  +    N V  I   TC+AV  +H    PI+HRDLK+E
Sbjct: 121 EVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQIFCDTCEAVARLHQCKTPIIHRDLKVE 180

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           N+L+   G   LCDFGSAT K  +P      +  + +EDE+ ++TT  YRAPEMV+ ++ 
Sbjct: 181 NILLHDRGHYVLCDFGSATNKFQNP----QTEGVNAVEDEIKKYTTLSYRAPEMVNLYSG 236

Query: 139 YVI 141
            VI
Sbjct: 237 KVI 239

Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis. Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes. Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes. Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2M2I8|AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens GN=AAK1 PE=1 SV=3

 Score =  100 bits (250), Expect = 2e-21,   Method: Composition-based stats.
 Identities = 51/123 (41%), Positives = 75/123 (60%), Gaps = 5/123 (4%)

Query: 20  EYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           E LIL + C GG +V+++ +R  +    N V  I   TC+AV  +H    PI+HRDLK+E
Sbjct: 121 EVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQIFCDTCEAVARLHQCKTPIIHRDLKVE 180

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           N+L+   G   LCDFGSAT K  +P      +  + +EDE+ ++TT  YRAPEMV+ ++ 
Sbjct: 181 NILLHDRGHYVLCDFGSATNKFQNP----QTEGVNAVEDEIKKYTTLSYRAPEMVNLYSG 236

Query: 139 YVI 141
            +I
Sbjct: 237 KII 239

Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis. Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1. Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes. Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes. Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O43066|PPK30_SCHPO Serine/threonine-protein kinase ppk30 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk30 PE=1 SV=1

 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 53/127 (41%), Positives = 71/127 (55%), Gaps = 10/127 (7%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPI 70
           +S     +E  +L E C GG L+D +  R    L    +  IL   C AV  MH  +PP+
Sbjct: 124 YSKSENRYEVYLLMEFCAGGGLIDFMNTRLQHRLTEGEILKILADVCDAVAAMHYLDPPL 183

Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKV---YSPDNAWSAQQRSMLEDEMARFTTPMY 127
           +HRDLKIEN+L+ +  + KLCDFGSA E +    +PD          LE  +A +TTP Y
Sbjct: 184 IHRDLKIENVLLVAPNSYKLCDFGSACEPLAPATTPDTIM------FLEQNIAAYTTPQY 237

Query: 128 RAPEMVD 134
           RAPEM+D
Sbjct: 238 RAPEMID 244

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	150
91090196	1123	PREDICTED: similar to AGAP003715-PA [Tri	0.946	0.126	0.626	8e-51
357625868	1097	hypothetical protein KGM_16646 [Danaus p	0.966	0.132	0.593	4e-50
427779815	1310	Putative cyclin-g-associated kinase [Rhi	0.966	0.110	0.6	5e-48
328717461	1065	PREDICTED: cyclin-G-associated kinase-li	0.966	0.136	0.558	7e-46
443716615	1283	hypothetical protein CAPTEDRAFT_20343 [C	0.926	0.108	0.602	3e-44
390334923	1365	PREDICTED: cyclin-G-associated kinase-li	0.966	0.106	0.531	4e-41
321465608	1214	hypothetical protein DAPPUDRAFT_213883 [	0.92	0.113	0.546	2e-40
348558583	1310	PREDICTED: cyclin-G-associated kinase [C	0.94	0.107	0.562	6e-40
417413691	1248	Putative ark protein kinase family, part	0.94	0.112	0.549	6e-40
432872885	1293	PREDICTED: cyclin-G-associated kinase-li	0.933	0.108	0.566	6e-40

>gi|91090196|ref|XP_967193.1| PREDICTED: similar to AGAP003715-PA [Tribolium castaneum] gi|270013468|gb|EFA09916.1| hypothetical protein TcasGA2_TC012067 [Tribolium castaneum]

 Score =  204 bits (520), Expect = 8e-51,   Method: Compositional matrix adjust.
 Identities = 89/142 (62%), Positives = 112/142 (78%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           ++YLSA+FIDK  T HG  E+L++TELCTGGSL ++L+ R++   P I+  I +QTC+A+
Sbjct: 95  IQYLSASFIDKSQTTHGKAEFLLVTELCTGGSLAEILQARSAPFEPEIITRIFYQTCRAL 154

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
            HMH QNPPI+HRDLK+ENLLIS  GT+KLCDFGSAT +++ PD  WSA Q   LE+ MA
Sbjct: 155 AHMHSQNPPIIHRDLKLENLLISRDGTIKLCDFGSATVEIFRPDLTWSANQHDSLEENMA 214

Query: 121 RFTTPMYRAPEMVDTWNNYVIG 142
             TTPMYRAPEMVDTWNNY +G
Sbjct: 215 HCTTPMYRAPEMVDTWNNYFVG 236

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357625868|gb|EHJ76158.1| hypothetical protein KGM_16646 [Danaus plexippus]

 Score =  202 bits (514), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 86/145 (59%), Positives = 119/145 (82%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           ++Y++A+F+DK  T HGM EYL+LT+LC+GGSL++ L+ R  A P + +  + +QTC+AV
Sbjct: 62  IKYIAASFLDKTKTTHGMGEYLLLTDLCSGGSLMEALQNRGQAFPLSTILRVFYQTCKAV 121

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           +HMH Q PPI HRDLK+EN LIS+ GT+KLCDFGSAT +VYSP+ +WSA QR+MLE+ +A
Sbjct: 122 QHMHAQVPPIAHRDLKLENFLISNEGTIKLCDFGSATTEVYSPNPSWSANQRNMLEENLA 181

Query: 121 RFTTPMYRAPEMVDTWNNYVIGRSM 145
           +FTTPMYRAPEM+DTW+N+ I  ++
Sbjct: 182 QFTTPMYRAPEMLDTWDNHKIDHAV 206

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|427779815|gb|JAA55359.1| Putative cyclin-g-associated kinase [Rhipicephalus pulchellus]

 Score =  195 bits (496), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 87/145 (60%), Positives = 115/145 (79%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           +++++AA I+K  + HG  EYL+LTELC GG LVD+L++RT+ L    V  I +QTC AV
Sbjct: 102 IDFIAAAAIEKGQSGHGKSEYLLLTELCPGGPLVDILQQRTTNLSLAQVLQIFYQTCSAV 161

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           +HMH Q+PPI+HRDLKIENLL+SS GT+KLCDFGS+T K Y PD+ W+A QRS++EDEM 
Sbjct: 162 RHMHSQSPPIIHRDLKIENLLLSSKGTIKLCDFGSSTTKSYKPDSYWTAIQRSLVEDEMC 221

Query: 121 RFTTPMYRAPEMVDTWNNYVIGRSM 145
           + TTPMYR PE++DT+NNY I  +M
Sbjct: 222 KNTTPMYRPPEVLDTYNNYPINEAM 246

Source: Rhipicephalus pulchellus

Species: Rhipicephalus pulchellus

Genus: Rhipicephalus

Family: Ixodidae

Order: Ixodida

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328717461|ref|XP_001947987.2| PREDICTED: cyclin-G-associated kinase-like [Acyrthosiphon pisum]

 Score =  188 bits (477), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 81/145 (55%), Positives = 109/145 (75%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           + ++SAAF  K  +P G +EYLILTE C GG++ ++L  R   L  NIV S+ +Q C A 
Sbjct: 94  IHFISAAFTSKIDSPRGSNEYLILTEFCPGGNVAELLSAREKPLHRNIVTSVFYQMCSAT 153

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           +HMH Q+PP++HRDLKIEN LIS  G +KLCDFGS T KVY PD  W++QQR++LED++ 
Sbjct: 154 RHMHCQSPPLIHRDLKIENFLISDDGKIKLCDFGSCTTKVYKPDENWTSQQRAVLEDKLN 213

Query: 121 RFTTPMYRAPEMVDTWNNYVIGRSM 145
           + TTPMYRAPEM+DTW+N+ IG ++
Sbjct: 214 QCTTPMYRAPEMIDTWSNHEIGTAV 238

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|443716615|gb|ELU08049.1| hypothetical protein CAPTEDRAFT_20343 [Capitella teleta]

 Score =  182 bits (463), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 85/141 (60%), Positives = 107/141 (75%), Gaps = 2/141 (1%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           ++++SAA I K  + HG  E+LILTELCTGG +VDV+  R   L  N V  + +QTC+AV
Sbjct: 94  IQFVSAASISKSESDHGQAEFLILTELCTGGEVVDVV--RNKPLTCNQVLQVFYQTCKAV 151

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           +HMH Q PPI+HRDLK+ENLLIS+   +KLCDFGSAT K Y PD+ WSA QRS+ EDE+A
Sbjct: 152 QHMHKQKPPIIHRDLKVENLLISTRNFIKLCDFGSATTKAYVPDHTWSAVQRSITEDEIA 211

Query: 121 RFTTPMYRAPEMVDTWNNYVI 141
           + TTPMYRAPEM+D + NY I
Sbjct: 212 KNTTPMYRAPEMLDLYQNYPI 232

Source: Capitella teleta

Species: Capitella teleta

Genus: Capitella

Family: Capitellidae

Order: Capitellida

Class: Polychaeta

Phylum: Annelida

Superkingdom: Eukaryota

>gi|390334923|ref|XP_788316.3| PREDICTED: cyclin-G-associated kinase-like [Strongylocentrotus purpuratus]

 Score =  172 bits (436), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 77/145 (53%), Positives = 100/145 (68%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           +++ SAA I K  T HG  EYL+L ELC GG LVD + +R   L  + V    +Q C+ V
Sbjct: 93  VQFFSAASIGKGDTDHGQSEYLLLMELCPGGQLVDAINQRHMPLSCDDVLQTFYQACRGV 152

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           +HMH Q PP+ HRD+K+EN LI S  T+KLCDFGSAT K Y PD++WS+ +RS LEDE A
Sbjct: 153 QHMHKQTPPVTHRDIKLENFLIGSKKTLKLCDFGSATSKSYQPDSSWSSLKRSTLEDEFA 212

Query: 121 RFTTPMYRAPEMVDTWNNYVIGRSM 145
           R TTPMYR PE++D + N+ I  +M
Sbjct: 213 RHTTPMYRPPEILDLYENFPINHAM 237

Source: Strongylocentrotus purpuratus

Species: Strongylocentrotus purpuratus

Genus: Strongylocentrotus

Family: Strongylocentrotidae

Order: Echinoida

Class: Echinoidea

Phylum: Echinodermata

Superkingdom: Eukaryota

>gi|321465608|gb|EFX76608.1| hypothetical protein DAPPUDRAFT_213883 [Daphnia pulex]

 Score =  170 bits (431), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 77/141 (54%), Positives = 103/141 (73%), Gaps = 3/141 (2%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           + ++SA   D+     G  EYL++TELC+GG+L D L+ R S L P  V S+ WQTC+AV
Sbjct: 68  INFISACCNDRGG---GSKEYLVVTELCSGGALFDALRVRNSPLTPEEVSSVFWQTCKAV 124

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           + +H    PI+HRDLKIENLL+++ G +KLCDFGSAT + Y P   W+A QR +LE+EMA
Sbjct: 125 QALHTLEQPIIHRDLKIENLLLTADGVIKLCDFGSATTQQYFPGPDWTASQRGLLEEEMA 184

Query: 121 RFTTPMYRAPEMVDTWNNYVI 141
           + TTP+YRAPEM+DTW+NY I
Sbjct: 185 KHTTPVYRAPEMIDTWSNYPI 205

Source: Daphnia pulex

Species: Daphnia pulex

Genus: Daphnia

Family: Daphniidae

Order: Diplostraca

Class: Branchiopoda

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|348558583|ref|XP_003465097.1| PREDICTED: cyclin-G-associated kinase [Cavia porcellus]

 Score =  168 bits (426), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 81/144 (56%), Positives = 107/144 (74%), Gaps = 3/144 (2%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
           +++ SAA I K  +  G  E+L+LTELC G  LV+ LK  E    LP + V  I +QTC+
Sbjct: 99  VQFCSAASIGKEESDTGQAEFLLLTELCRG-QLVEFLKKIEAKGPLPCDTVLKIFYQTCK 157

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           AV+HMH Q PPI+HRDLK+ENLL+SS GT+KLCDFGSAT   + PD +WSAQ+R+M+E+E
Sbjct: 158 AVQHMHRQKPPIIHRDLKVENLLLSSQGTIKLCDFGSATTISHYPDYSWSAQKRAMVEEE 217

Query: 119 MARFTTPMYRAPEMVDTWNNYVIG 142
           + R TTPMYR PE+VD ++N+ IG
Sbjct: 218 ITRNTTPMYRTPEIVDLYSNFPIG 241

Source: Cavia porcellus

Species: Cavia porcellus

Genus: Cavia

Family: Caviidae

Order: Rodentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|417413691|gb|JAA53163.1| Putative ark protein kinase family, partial [Desmodus rotundus]

 Score =  168 bits (426), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 78/142 (54%), Positives = 106/142 (74%), Gaps = 1/142 (0%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           +++ SAA I K  +  G  E+L+LTELC G  LV+ LK+    LP + V  I +Q C+AV
Sbjct: 51  VQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKSRGLLPCDAVLKIFYQACRAV 109

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           +HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQQR+++E+E+ 
Sbjct: 110 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTVSHFPDYSWSAQQRALVEEEVT 169

Query: 121 RFTTPMYRAPEMVDTWNNYVIG 142
           R TTPMYR PE+VD ++N+ IG
Sbjct: 170 RNTTPMYRTPEIVDLYSNFPIG 191

Source: Desmodus rotundus

Species: Desmodus rotundus

Genus: Desmodus

Family: Phyllostomidae

Order: Chiroptera

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|432872885|ref|XP_004072173.1| PREDICTED: cyclin-G-associated kinase-like [Oryzias latipes]

 Score =  168 bits (426), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 81/143 (56%), Positives = 106/143 (74%), Gaps = 3/143 (2%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
           +++ SAA I K  +  G  E+LILTELC G  LVD +K  E+ + L  + V  + +QTC+
Sbjct: 98  VQFCSAASISKEESDTGQAEFLILTELCKG-QLVDFVKRVEQRAPLSCDTVMKVFYQTCR 156

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           AV+HMH Q PPI+HRDLKIENLLIS+ GT+KLCDFGS+T   + PD +WSAQ+RSM+EDE
Sbjct: 157 AVQHMHKQKPPIIHRDLKIENLLISNQGTIKLCDFGSSTTVSHYPDFSWSAQKRSMVEDE 216

Query: 119 MARFTTPMYRAPEMVDTWNNYVI 141
           + R TTP YR PEM+D ++NY I
Sbjct: 217 ITRNTTPAYRTPEMIDLYSNYPI 239

Source: Oryzias latipes

Species: Oryzias latipes

Genus: Oryzias

Family: Adrianichthyidae

Order: Beloniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	150
UNIPROTKB|F1NC60	1225	Gga.54538 "Uncharacterized pro	0.933	0.114	0.545	8.6e-37
UNIPROTKB|F1NL76	1265	Gga.54538 "Uncharacterized pro	0.933	0.110	0.545	9.2e-37
UNIPROTKB|F1NC57	1266	Gga.54538 "Uncharacterized pro	0.933	0.110	0.545	9.2e-37
UNIPROTKB|F1PGG9	1304	GAK "Uncharacterized protein"	0.94	0.108	0.548	9.7e-37
MGI|MGI:2442153	1305	Gak "cyclin G associated kinas	0.94	0.108	0.541	3.3e-36
UNIPROTKB|O14976	1311	GAK "Cyclin-G-associated kinas	0.94	0.107	0.534	3.3e-36
RGD|621589	1305	Gak "cyclin G associated kinas	0.94	0.108	0.534	6.9e-36
UNIPROTKB|P97874	1305	Gak "Cyclin-G-associated kinas	0.94	0.108	0.534	6.9e-36
ZFIN|ZDB-GENE-041210-358	1318	gak "cyclin G associated kinas	0.933	0.106	0.545	7e-36
UNIPROTKB|F1MIB2	1268	GAK "Uncharacterized protein"	0.94	0.111	0.534	1.1e-35

UNIPROTKB|F1NC60 Gga.54538 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 408 (148.7 bits), Expect = 8.6e-37, P = 8.6e-37
 Identities = 78/143 (54%), Positives = 105/143 (73%)

Query:     1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
             +++ SAA I K  +  G  E+L+LTELC G  LV+ LK  E    +  + V  I +QTC+
Sbjct:    51 VQFCSAASIGKEESDTGQGEFLLLTELCKG-QLVEFLKKVEPKGPISCDTVLKIFYQTCR 109

Query:    59 AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
             AV+HMH Q PPI+HRDLK+ENLLIS+ GT+KLCDFGSAT   Y PD +WSAQ+R+++E+E
Sbjct:   110 AVQHMHKQKPPIIHRDLKVENLLISNQGTIKLCDFGSATTVAYYPDYSWSAQKRALVEEE 169

Query:   119 MARFTTPMYRAPEMVDTWNNYVI 141
             + R TTPMYR PEM+D ++N+ I
Sbjct:   170 ITRNTTPMYRTPEMIDLYSNFPI 192

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1NL76 Gga.54538 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 408 (148.7 bits), Expect = 9.2e-37, P = 9.2e-37
 Identities = 78/143 (54%), Positives = 105/143 (73%)

Query:     1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
             +++ SAA I K  +  G  E+L+LTELC G  LV+ LK  E    +  + V  I +QTC+
Sbjct:    51 VQFCSAASIGKEESDTGQGEFLLLTELCKG-QLVEFLKKVEPKGPISCDTVLKIFYQTCR 109

Query:    59 AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
             AV+HMH Q PPI+HRDLK+ENLLIS+ GT+KLCDFGSAT   Y PD +WSAQ+R+++E+E
Sbjct:   110 AVQHMHKQKPPIIHRDLKVENLLISNQGTIKLCDFGSATTVAYYPDYSWSAQKRALVEEE 169

Query:   119 MARFTTPMYRAPEMVDTWNNYVI 141
             + R TTPMYR PEM+D ++N+ I
Sbjct:   170 ITRNTTPMYRTPEMIDLYSNFPI 192

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1NC57 Gga.54538 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 408 (148.7 bits), Expect = 9.2e-37, P = 9.2e-37
 Identities = 78/143 (54%), Positives = 105/143 (73%)

Query:     1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
             +++ SAA I K  +  G  E+L+LTELC G  LV+ LK  E    +  + V  I +QTC+
Sbjct:    51 VQFCSAASIGKEESDTGQGEFLLLTELCKG-QLVEFLKKVEPKGPISCDTVLKIFYQTCR 109

Query:    59 AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
             AV+HMH Q PPI+HRDLK+ENLLIS+ GT+KLCDFGSAT   Y PD +WSAQ+R+++E+E
Sbjct:   110 AVQHMHKQKPPIIHRDLKVENLLISNQGTIKLCDFGSATTVAYYPDYSWSAQKRALVEEE 169

Query:   119 MARFTTPMYRAPEMVDTWNNYVI 141
             + R TTPMYR PEM+D ++N+ I
Sbjct:   170 ITRNTTPMYRTPEMIDLYSNFPI 192

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005794 "Golgi apparatus" evidence=IEA

UNIPROTKB|F1PGG9 GAK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 408 (148.7 bits), Expect = 9.7e-37, P = 9.7e-37
 Identities = 79/144 (54%), Positives = 106/144 (73%)

Query:     1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
             +++ SAA I K  +  G  E+L+LTELC G  LVD LK  E    L  + V  I +QTC+
Sbjct:    99 VQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVDFLKKIESRGPLSCDTVLKIFYQTCR 157

Query:    59 AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
             AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+++E+E
Sbjct:   158 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 217

Query:   119 MARFTTPMYRAPEMVDTWNNYVIG 142
             + R TTPMYR PE+VD ++N+ IG
Sbjct:   218 ITRNTTPMYRTPEIVDLYSNFPIG 241

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:2442153 Gak "cyclin G associated kinase" [Mus musculus (taxid:10090)]

 Score = 403 (146.9 bits), Expect = 3.3e-36, P = 3.3e-36
 Identities = 78/144 (54%), Positives = 106/144 (73%)

Query:     1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
             +++ SAA I K  +  G  E+L+LTELC G  LV+ LK  E    L  + +  I +QTC+
Sbjct:    99 VQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKRVECKGPLSCDSILKIFYQTCR 157

Query:    59 AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
             AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+M+E+E
Sbjct:   158 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQKRAMVEEE 217

Query:   119 MARFTTPMYRAPEMVDTWNNYVIG 142
             + R TTPMYR PE+VD ++N+ IG
Sbjct:   218 ITRNTTPMYRTPEIVDLYSNFPIG 241

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005794 "Golgi apparatus" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0030332 "cyclin binding" evidence=ISO

UNIPROTKB|O14976 GAK "Cyclin-G-associated kinase" [Homo sapiens (taxid:9606)]

 Score = 403 (146.9 bits), Expect = 3.3e-36, P = 3.3e-36
 Identities = 77/144 (53%), Positives = 107/144 (74%)

Query:     1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNI--VCSILWQTCQ 58
             +++ SAA I K  +  G  E+L+LTELC G  LV+ LK+  S  P +   V  I +QTC+
Sbjct:    99 VQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCR 157

Query:    59 AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
             AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+++E+E
Sbjct:   158 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 217

Query:   119 MARFTTPMYRAPEMVDTWNNYVIG 142
             + R TTPMYR PE++D ++N+ IG
Sbjct:   218 ITRNTTPMYRTPEIIDLYSNFPIG 241

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0005925 "focal adhesion" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0005794 "Golgi apparatus" evidence=IDA

RGD|621589 Gak "cyclin G associated kinase" [Rattus norvegicus (taxid:10116)]

 Score = 400 (145.9 bits), Expect = 6.9e-36, P = 6.9e-36
 Identities = 77/144 (53%), Positives = 106/144 (73%)

Query:     1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
             +++ SAA I K  +  G  E+L+LTELC G  LV+ L+  E    L  + +  I +QTC+
Sbjct:    99 VQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLRRVECKGPLSCDSILKIFYQTCR 157

Query:    59 AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
             AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+M+E+E
Sbjct:   158 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQKRAMVEEE 217

Query:   119 MARFTTPMYRAPEMVDTWNNYVIG 142
             + R TTPMYR PE+VD ++N+ IG
Sbjct:   218 ITRNTTPMYRTPEIVDLYSNFPIG 241

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005794 "Golgi apparatus" evidence=IEA;ISO

GO:0005925 "focal adhesion" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0030332 "cyclin binding" evidence=IDA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

UNIPROTKB|P97874 Gak "Cyclin-G-associated kinase" [Rattus norvegicus (taxid:10116)]

 Score = 400 (145.9 bits), Expect = 6.9e-36, P = 6.9e-36
 Identities = 77/144 (53%), Positives = 106/144 (73%)

Query:     1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
             +++ SAA I K  +  G  E+L+LTELC G  LV+ L+  E    L  + +  I +QTC+
Sbjct:    99 VQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLRRVECKGPLSCDSILKIFYQTCR 157

Query:    59 AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
             AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+M+E+E
Sbjct:   158 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQKRAMVEEE 217

Query:   119 MARFTTPMYRAPEMVDTWNNYVIG 142
             + R TTPMYR PE+VD ++N+ IG
Sbjct:   218 ITRNTTPMYRTPEIVDLYSNFPIG 241

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

ZFIN|ZDB-GENE-041210-358 gak "cyclin G associated kinase" [Danio rerio (taxid:7955)]

 Score = 400 (145.9 bits), Expect = 7.0e-36, P = 7.0e-36
 Identities = 78/143 (54%), Positives = 103/143 (72%)

Query:     1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
             +++ SAA I K  +  G  E+LILTELC G  LVD +K  E+   +  + V  I +Q+C+
Sbjct:    99 VQFCSAASISKEESDTGQAEFLILTELCRG-QLVDFVKKVEQKGPMSCDTVLKIFYQSCR 157

Query:    59 AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
             AV+HMH Q+P ++HRDLKIENLLIS  GT+KLCDFGSAT   + PD +WSA +RSM+EDE
Sbjct:   158 AVQHMHKQSPAVIHRDLKIENLLISHQGTIKLCDFGSATTLAHYPDYSWSAHKRSMVEDE 217

Query:   119 MARFTTPMYRAPEMVDTWNNYVI 141
             + R TTP YR PEM+D ++NY I
Sbjct:   218 ITRNTTPAYRTPEMIDLYSNYPI 240

GO:0004672 "protein kinase activity" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

UNIPROTKB|F1MIB2 GAK "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 398 (145.2 bits), Expect = 1.1e-35, P = 1.1e-35
 Identities = 77/144 (53%), Positives = 105/144 (72%)

Query:     1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
             +++ SAA I K  +  G  E+L+L ELC G  LV+ LK  E    L  + V  I +QTC+
Sbjct:    99 VQFCSAASIGKEESDTGQAEFLLLMELCRG-QLVEFLKKVESKGPLSCDTVLKIFYQTCR 157

Query:    59 AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
             AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+++E+E
Sbjct:   158 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 217

Query:   119 MARFTTPMYRAPEMVDTWNNYVIG 142
             + R TTPMYR PE+VD ++N+ IG
Sbjct:   218 ITRNTTPMYRTPEIVDLYSNFPIG 241

GO:0005794 "Golgi apparatus" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O14976	GAK_HUMAN	2, ., 7, ., 1, 1, ., 1	0.5347	0.94	0.1075	yes	N/A
Q99KY4	GAK_MOUSE	2, ., 7, ., 1, 1, ., 1	0.5416	0.94	0.1080	yes	N/A
P97874	GAK_RAT	2, ., 7, ., 1, 1, ., 1	0.5347	0.94	0.1080	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	150
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-29
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-25
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-25
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-23
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-20
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-17
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-16
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-16
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-15
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-14
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-13
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-12
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-11
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-11
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-10
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-08
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-07
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-07
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-06
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-06
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-06
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-06
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-05
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-05
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-05
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-04
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-04
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-04
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-04
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.001
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	0.001
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	0.002
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	0.002
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	0.002
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	0.002
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.002
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	0.003
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.003
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	0.004
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.004
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	0.004
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  105 bits (265), Expect = 8e-29
 Identities = 45/128 (35%), Positives = 60/128 (46%), Gaps = 32/128 (25%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL++ E C GG L D+LK+R   L  +     L Q   A++++H +   IVHRDLK EN+
Sbjct: 73  YLVM-EYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENI 128

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM----- 132
           L+   G VKL DFG A +                L+      T   TP Y APE+     
Sbjct: 129 LLDEDGHVKLADFGLARQ----------------LDPGEKLTTFVGTPEYMAPEVLLGKG 172

Query: 133 ----VDTW 136
               VD W
Sbjct: 173 YGKAVDIW 180

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 96.2 bits (240), Expect = 2e-25
 Identities = 41/121 (33%), Positives = 60/121 (49%), Gaps = 15/121 (12%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
              ++ E C GGSL D+LKE    L  + +  IL Q  + ++++H     I+HRDLK EN
Sbjct: 65  HLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPEN 122

Query: 80  LLISSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           +L+ S  G VKL DFG +  K+ + D +                 TP Y APE++     
Sbjct: 123 ILLDSDNGKVKLADFGLS--KLLTSDKSLLKTIV----------GTPAYMAPEVLLGKGY 170

Query: 139 Y 139
           Y
Sbjct: 171 Y 171

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 96.9 bits (242), Expect = 2e-25
 Identities = 34/112 (30%), Positives = 50/112 (44%), Gaps = 15/112 (13%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
              ++ E C GG L D L      L  +    I  Q  + ++++H     I+HRDLK EN
Sbjct: 72  HLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPEN 128

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +L+   G VK+ DFG A + + S  +  +               TP Y APE
Sbjct: 129 ILLDENGVVKIADFGLAKKLLKSSSSLTT------------FVGTPWYMAPE 168

Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 2e-23
 Identities = 45/115 (39%), Positives = 63/115 (54%), Gaps = 23/115 (20%)

Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLC 91
           +L+++L+     LPP+ V S +WQ  QA+ + H  N  I+HRD+K EN+L+S +G +KLC
Sbjct: 85  TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLC 142

Query: 92  DFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTW 136
           DFG A         A  A+  S L D +A   T  YRAPE+          VD W
Sbjct: 143 DFGFA--------RALRARPASPLTDYVA---TRWYRAPELLVGDTNYGKPVDVW 186

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 90.7 bits (226), Expect = 4e-23
 Identities = 36/116 (31%), Positives = 53/116 (45%), Gaps = 13/116 (11%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           +   I  E  +GGSL  +LK +   LP  ++     Q  + + ++H     IVHRD+K  
Sbjct: 74  NTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGA 130

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           N+L+ S G VKL DFG A       D        S+         TP + APE++ 
Sbjct: 131 NILVDSDGVVKLADFGCAKRLG---DIETGEGTGSVR-------GTPYWMAPEVIR 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.2 bits (219), Expect = 6e-22
 Identities = 41/132 (31%), Positives = 58/132 (43%), Gaps = 26/132 (19%)

Query: 15  PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
            H    YL+  E      L  ++K+R   LP +++ S L+Q  Q +   H     I+HRD
Sbjct: 68  RHKGDLYLVF-EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRD 123

Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-- 132
           LK ENLLI++ G +KL DFG A  + +                 +    T  YRAPE+  
Sbjct: 124 LKPENLLINTEGVLKLADFGLA--RSFGSPV-------RPYTHYVV---TRWYRAPELLL 171

Query: 133 --------VDTW 136
                   VD W
Sbjct: 172 GDKGYSTPVDIW 183

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.0 bits (211), Expect = 1e-20
 Identities = 43/133 (32%), Positives = 62/133 (46%), Gaps = 25/133 (18%)

Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
            PHG    L++ E      L +VL++    LP   V S +    + V +MH     I+HR
Sbjct: 68  FPHGSGFVLVM-EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHR 123

Query: 74  DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM- 132
           DLK  NLLIS+ G +K+ DFG A  +++S +     + R        +  T  YRAPE+ 
Sbjct: 124 DLKPANLLISADGVLKIADFGLA--RLFSEE-----EPRLYSH----QVATRWYRAPELL 172

Query: 133 ---------VDTW 136
                    VD W
Sbjct: 173 YGARKYDPGVDLW 185

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 82.2 bits (204), Expect = 8e-20
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 26/123 (21%)

Query: 22  LILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            I+ E   GG L   +K++       P   +     Q C A+K++H +   I+HRD+K +
Sbjct: 75  CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQ 132

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMVDT 135
           N+ ++S G VKL DFG +  KV S               ++A+ T   TP Y +PE+   
Sbjct: 133 NIFLTSNGLVKLGDFGIS--KVLSST------------VDLAK-TVVGTPYYLSPEL--- 174

Query: 136 WNN 138
             N
Sbjct: 175 CQN 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 79.2 bits (196), Expect = 9e-19
 Identities = 37/114 (32%), Positives = 59/114 (51%), Gaps = 21/114 (18%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E C+GGSL D+LK     L  + +  +  +  + ++++H     I+HRD+K  N+L+
Sbjct: 74  IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILL 131

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMV 133
           +S G VKL DFG + +                L D  AR T   TP + APE++
Sbjct: 132 TSDGEVKLIDFGLSAQ----------------LSDTKARNTMVGTPYWMAPEVI 169

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 2e-18
 Identities = 36/122 (29%), Positives = 52/122 (42%), Gaps = 48/122 (39%)

Query: 37  LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           L +R   L PN++ SI++Q  + + + H     I+HRDLK +N+LI+  G +KL DFG  
Sbjct: 88  LDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFG-- 143

Query: 97  TEKVYSPDNAWSAQQRSMLEDEMAR-FTTPM-----------YRAPEM----------VD 134
                                 +AR F  P+           YRAPE+          VD
Sbjct: 144 ----------------------LARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVD 181

Query: 135 TW 136
            W
Sbjct: 182 IW 183

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 1e-17
 Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 24/115 (20%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E C GGS +D+LK     L    +  IL +    ++++H +    +HRD+K  N+L+
Sbjct: 76  IIMEYCGGGSCLDLLKPGK--LDETYIAFILREVLLGLEYLHEEGK--IHRDIKAANILL 131

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA-RFT---TPMYRAPEMV 133
           S  G VKL DFG + +                L   M+ R T   TP + APE++
Sbjct: 132 SEEGDVKLADFGVSGQ----------------LTSTMSKRNTFVGTPFWMAPEVI 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 2e-17
 Identities = 38/121 (31%), Positives = 53/121 (43%), Gaps = 34/121 (28%)

Query: 31  GSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G+L  ++K+R       +++ SI++Q  Q + H+H       HRDLK ENLL+S    VK
Sbjct: 82  GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVK 139

Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TPMYRAPEM----------VDT 135
           + DFG A E    P                  +T    T  YRAPE+          VD 
Sbjct: 140 IADFGLAREIRSRPP-----------------YTDYVSTRWYRAPEILLRSTSYSSPVDI 182

Query: 136 W 136
           W
Sbjct: 183 W 183

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 6e-17
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 7/87 (8%)

Query: 16  HGMHE----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
            G  E      I+ E    GSL  ++K +    P ++V   ++Q  Q + ++H Q   ++
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVLQGLAYLHEQG--VI 121

Query: 72  HRDLKIENLLISSAGTVKLCDFGSATE 98
           HRD+K  N+L +  G VKL DFG AT+
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATK 148

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 74.1 bits (183), Expect = 8e-17
 Identities = 43/156 (27%), Positives = 61/156 (39%), Gaps = 33/156 (21%)

Query: 4   LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHM 63
           L  AF  +         YL+L E   GG L   L +               +   A++++
Sbjct: 58  LHYAFQTEE------KLYLVL-EYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYL 109

Query: 64  HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
           H     I++RDLK EN+L+ + G +KL DFG A E         +             F 
Sbjct: 110 HSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-------------FC 154

Query: 124 -TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
            TP Y APE+         VD W+  V+   ML G 
Sbjct: 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 74.2 bits (183), Expect = 1e-16
 Identities = 34/123 (27%), Positives = 58/123 (47%), Gaps = 16/123 (13%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y +L E    G L+  +++  S L          +   A++++H +   I+HRDLK EN+
Sbjct: 78  YFVL-EYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENI 133

Query: 81  LISSAGTVKLCDFGSATEKVYSPDN------AWSAQQRSMLEDEMARFT----TPMYRAP 130
           L+     +K+ DFG+A  KV  P++        +    S +E    RF     T  Y +P
Sbjct: 134 LLDKDMHIKITDFGTA--KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP 191

Query: 131 EMV 133
           E++
Sbjct: 192 ELL 194

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 71.4 bits (176), Expect = 8e-16
 Identities = 23/74 (31%), Positives = 38/74 (51%), Gaps = 2/74 (2%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
             I+TE   GG L+D L++    L    +  +  Q  + ++++  +N   VHRDL   N 
Sbjct: 76  LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN--FVHRDLAARNC 133

Query: 81  LISSAGTVKLCDFG 94
           L++    VK+ DFG
Sbjct: 134 LVTENLVVKISDFG 147

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 70.6 bits (174), Expect = 1e-15
 Identities = 21/74 (28%), Positives = 36/74 (48%), Gaps = 2/74 (2%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
             I+ E   GG L+  L++    L  + + S   Q  + ++++  +N   +HRDL   N 
Sbjct: 76  LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNC 133

Query: 81  LISSAGTVKLCDFG 94
           L+     VK+ DFG
Sbjct: 134 LVGENLVVKISDFG 147

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.9 bits (174), Expect = 2e-15
 Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 24/115 (20%)

Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLC 91
           ++++ L++    +P +++  I+WQT QAV   H  N   +HRD+K EN+LI+  G +KLC
Sbjct: 85  TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLC 142

Query: 92  DFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTW 136
           DFG A  ++ +              D +A   T  YRAPE+          VD W
Sbjct: 143 DFGFA--RILTG-------PGDDYTDYVA---TRWYRAPELLVGDTQYGPPVDVW 185

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 70.0 bits (172), Expect = 3e-15
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 19/114 (16%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  E   GGSL  +LKE    +P  I+  I     + + ++H ++  I+HRD+K  N+L+
Sbjct: 76  ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK-IIHRDVKPSNILV 134

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR-FT-TPMYRAPEMVD 134
           +S G +KLCDFG + +                L + +A+ F  T  Y APE + 
Sbjct: 135 NSRGQIKLCDFGVSGQ----------------LVNSLAKTFVGTSSYMAPERIQ 172

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 70.9 bits (172), Expect = 3e-15
 Identities = 38/114 (33%), Positives = 55/114 (48%), Gaps = 11/114 (9%)

Query: 21  YLILTELCTGGSLVDVLKER--TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
             ++ E   GGSL D+LK+      L  +    IL Q   A++++H +   I+HRD+K E
Sbjct: 73  LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPE 130

Query: 79  NLLISSAGT-VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           N+L+   G  VKL DFG A  K+     + S+              TP Y APE
Sbjct: 131 NILLDRDGRVVKLIDFGLA--KLLPDPGSTSSIPALP----STSVGTPGYMAPE 178

Length = 384

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 7e-15
 Identities = 42/133 (31%), Positives = 68/133 (51%), Gaps = 24/133 (18%)

Query: 7   AFIDKHSTPHGMHEYLILTELCTGGSLVDV---LKERTSALPPNIVCSILWQTCQAVKHM 63
           AFI K+   +    +L++ ELC GGS+ D+   L+++   L    +  IL +T + + ++
Sbjct: 71  AFIKKNPPGNDDQLWLVM-ELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL 129

Query: 64  HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
           H     ++HRD+K +N+L++    VKL DFG             SAQ  S L     R T
Sbjct: 130 HENK--VIHRDIKGQNILLTKNAEVKLVDFGV------------SAQLDSTL---GRRNT 172

Query: 124 ---TPMYRAPEMV 133
              TP + APE++
Sbjct: 173 FIGTPYWMAPEVI 185

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 66.9 bits (164), Expect = 3e-14
 Identities = 36/116 (31%), Positives = 57/116 (49%), Gaps = 22/116 (18%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           +  I+ E C  GS+ D++K     L    + +IL+QT + ++++H      +HRD+K  N
Sbjct: 72  DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGN 129

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA-RFT---TPMYRAPE 131
           +L++  G  KL DFG + +                L D MA R T   TP + APE
Sbjct: 130 ILLNEEGQAKLADFGVSGQ----------------LTDTMAKRNTVIGTPFWMAPE 169

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 67.2 bits (165), Expect = 4e-14
 Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 24/111 (21%)

Query: 36  VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGS 95
           V+K+++  L P  + S +  T + ++++H     I+HRDLK  NLLI+S G +KL DFG 
Sbjct: 91  VIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGL 148

Query: 96  ATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTW 136
           A     SP+   + Q             T  YRAPE+          VD W
Sbjct: 149 ARSFG-SPNRKMTHQ-----------VVTRWYRAPELLFGARHYGVGVDMW 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 5e-14
 Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 14/111 (12%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           IL E C GG+L  ++ E    L    +  +  Q  +A+  +H     ++HRDLK  N+L+
Sbjct: 79  ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILL 136

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +  G VKL DFG       S  N  + Q+R           TP + APE+V
Sbjct: 137 TLDGDVKLADFG------VSAKNKSTLQKRDTF------IGTPYWMAPEVV 175

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.5 bits (163), Expect = 5e-14
 Identities = 45/129 (34%), Positives = 60/129 (46%), Gaps = 39/129 (30%)

Query: 24  LTELCTGGSLVDVLKERTSALPPN------IVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           L E C GG L  +L++R   L         I C +L     A +++H +   I++RDLK 
Sbjct: 71  LMEYCLGGELWTILRDR--GLFDEYTARFYIACVVL-----AFEYLHNRG--IIYRDLKP 121

Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEM---- 132
           ENLL+ S G VKL DFG A +K+ S    W+             F  TP Y APE+    
Sbjct: 122 ENLLLDSNGYVKLVDFGFA-KKLKSGQKTWT-------------FCGTPEYVAPEIILNK 167

Query: 133 -----VDTW 136
                VD W
Sbjct: 168 GYDFSVDYW 176

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 66.2 bits (162), Expect = 8e-14
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 22/128 (17%)

Query: 19  HEYLILTELCTGGSLVDVLKER--TSALPPNIVCSILWQTCQAVK--HMHGQNPPIVHRD 74
            E  ++    +GGSL+D++K       L   I+ ++L +  + ++  H +GQ    +HRD
Sbjct: 72  DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ----IHRD 127

Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPE 131
           +K  N+L+   G+VK+ DFG +         A  A           R T   TP + APE
Sbjct: 128 IKAGNILLGEDGSVKIADFGVS---------ASLADGGDRT--RKVRKTFVGTPCWMAPE 176

Query: 132 MVDTWNNY 139
           +++  + Y
Sbjct: 177 VMEQVHGY 184

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 66.2 bits (162), Expect = 8e-14
 Identities = 34/116 (29%), Positives = 55/116 (47%), Gaps = 15/116 (12%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVK--HMHGQNPPIVHRDLKI 77
           +  I  E C+GG+L ++L+     L  +++     Q  + +   H HG    IVHRD+K 
Sbjct: 73  KVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHG----IVHRDIKP 127

Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
            N+ +   G +KL DFG A   V   +N  +      ++       TP Y APE++
Sbjct: 128 ANIFLDHNGVIKLGDFGCA---VKLKNNTTTM--GEEVQSLAG---TPAYMAPEVI 175

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 66.3 bits (162), Expect = 9e-14
 Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 14/102 (13%)

Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLC 91
           +++D L++  + L  + V   L+Q  + ++  H  N  I+HRD+K EN+L+S +G VKLC
Sbjct: 85  TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLC 142

Query: 92  DFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           DFG A   + +P   ++        D +A   T  YRAPE++
Sbjct: 143 DFGFA-RTLAAPGEVYT--------DYVA---TRWYRAPELL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 65.6 bits (161), Expect = 1e-13
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 3/75 (4%)

Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
            +I+ E   GG L+D L++ R   L  + + S   Q  + ++++  +N   +HRDL   N
Sbjct: 76  LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARN 133

Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 134 CLVGENLVVKISDFG 148

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 65.3 bits (160), Expect = 1e-13
 Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 10/84 (11%)

Query: 19  HEYLILTELCTGGSLVDVLKERT--------SALPPNIVCSILWQTCQAVKHMHGQNPPI 70
               ++ E   GG L+D L++          S L    + S   Q  + ++++  +    
Sbjct: 69  EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--F 126

Query: 71  VHRDLKIENLLISSAGTVKLCDFG 94
           VHRDL   N L+     VK+ DFG
Sbjct: 127 VHRDLAARNCLVGEDLVVKISDFG 150

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 65.2 bits (160), Expect = 3e-13
 Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 11/91 (12%)

Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWS 108
           +   L+Q  + +K++H  N  ++HRDLK  N+L++S   +K+CDFG A       D    
Sbjct: 105 IQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK-- 160

Query: 109 AQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                 L + +    T  YRAPE++ + + Y
Sbjct: 161 ----GFLTEYVV---TRWYRAPELLLSSSRY 184

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.9 bits (159), Expect = 3e-13
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 19/95 (20%)

Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           I++Q  +A+K++H  N  ++HRDLK  N+L++S   VKL DFG A   +   +      +
Sbjct: 112 IMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLA-RSLSELEE---NPE 165

Query: 112 RSMLEDEMARFTTPMYRAPEM----------VDTW 136
             +L D +A   T  YRAPE+          VD W
Sbjct: 166 NPVLTDYVA---TRWYRAPEILLGSTRYTKGVDMW 197

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 63.0 bits (154), Expect = 1e-12
 Identities = 33/120 (27%), Positives = 51/120 (42%), Gaps = 24/120 (20%)

Query: 23  ILTELCTGGSLVDVL---KERTSALPPNIVCSILWQTCQAVKHMHGQNPP---IVHRDLK 76
           I+ E C GG L  ++   K+    +    +  IL Q   A+   H ++ P   ++HRDLK
Sbjct: 78  IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137

Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMV 133
             N+ + +   VKL DFG A               + +  D     T   TP Y +PE +
Sbjct: 138 PANIFLDANNNVKLGDFGLA---------------KILGHDSSFAKTYVGTPYYMSPEQL 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 63.0 bits (154), Expect = 1e-12
 Identities = 25/76 (32%), Positives = 46/76 (60%), Gaps = 2/76 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E   GGSL D++ +    +    +  +  +  Q ++++H QN  ++HRD+K +N+L+
Sbjct: 92  VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILL 149

Query: 83  SSAGTVKLCDFGSATE 98
           S  G+VKL DFG A +
Sbjct: 150 SKDGSVKLADFGFAAQ 165

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 2e-12
 Identities = 38/140 (27%), Positives = 57/140 (40%), Gaps = 29/140 (20%)

Query: 20  EYLILT-ELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           +YL L  E   GG    ++K     LP +     + +    V+ +H +   I+HRD+K E
Sbjct: 70  DYLYLVMEYLNGGDCASLIK-TLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPE 126

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE------- 131
           NLLI   G +KL DFG +   + +                     TP Y APE       
Sbjct: 127 NLLIDQTGHLKLTDFGLSRNGLENKK----------------FVGTPDYLAPETILGVGD 170

Query: 132 --MVDTWNNYVIGRSMLYGH 149
             M D W+   +    L+G+
Sbjct: 171 DKMSDWWSLGCVIFEFLFGY 190

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 62.1 bits (151), Expect = 2e-12
 Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 15/111 (13%)

Query: 23  ILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+ E    G L  +LK +R   LP + V     Q    + H+H +   I+HRD+K  NL 
Sbjct: 76  IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLF 133

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           + +   VK+ D G A  K+ S +  ++    +++        TP Y +PE+
Sbjct: 134 LDAYDNVKIGDLGVA--KLLSDNTNFA---NTIV-------GTPYYLSPEL 172

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-12
 Identities = 37/107 (34%), Positives = 51/107 (47%), Gaps = 30/107 (28%)

Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
             LPP  +  ++ Q  + V  +H     IVHRDLK +N+L++S G VK+ DFG A  ++Y
Sbjct: 102 PGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLA--RIY 157

Query: 102 SPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM---------VDTW 136
           S               EMA  +   T  YRAPE+         VD W
Sbjct: 158 S--------------FEMALTSVVVTLWYRAPEVLLQSSYATPVDMW 190

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 62.1 bits (151), Expect = 2e-12
 Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 15/113 (13%)

Query: 22  LILTELCTGGSLVDVLKERTSAL-PPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI  E   GG+L D +  +   L    +V   L+Q   AV ++H     I+HRD+K  N+
Sbjct: 75  LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNI 132

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
            ++ AG +KL DFG +  K+   +        SM E  +    TP Y +PE+ 
Sbjct: 133 FLTKAGLIKLGDFGIS--KILGSE-------YSMAETVVG---TPYYMSPELC 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 61.5 bits (150), Expect = 3e-12
 Identities = 29/72 (40%), Positives = 44/72 (61%), Gaps = 2/72 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGSL D+LK +   +P  ++  I  Q  + + ++H +   I+HRD+K  NLLI
Sbjct: 76  IVLEYMDGGSLADLLK-KVGKIPEPVLAYIARQILKGLDYLHTKRH-IIHRDIKPSNLLI 133

Query: 83  SSAGTVKLCDFG 94
           +S G VK+ DFG
Sbjct: 134 NSKGEVKIADFG 145

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 4e-12
 Identities = 32/111 (28%), Positives = 56/111 (50%), Gaps = 16/111 (14%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS+  ++K     +    +  I+ +   A+K++H     ++HRD+K  N+L+
Sbjct: 79  IIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILV 134

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           ++ G VKLCDFG A           ++ +RS          TP + APE++
Sbjct: 135 TNTGNVKLCDFGVAALLNQ------NSSKRSTF------VGTPYWMAPEVI 173

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.2 bits (148), Expect = 5e-12
 Identities = 40/119 (33%), Positives = 61/119 (51%), Gaps = 30/119 (25%)

Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLC 91
           +++++L+E  + +PP  V S ++Q  +A+   H  +  IVHRD+K ENLLIS    +KLC
Sbjct: 85  NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLC 142

Query: 92  DFGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TPMYRAPEM---------VDTWN 137
           DFG A               R++ E   A +T    T  YR+PE+         VD W+
Sbjct: 143 DFGFA---------------RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWS 186

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 6e-12
 Identities = 46/178 (25%), Positives = 66/178 (37%), Gaps = 48/178 (26%)

Query: 3   YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKH 62
            L  +F D+       H YL+  E   GG L+++L  R    P       + +   A+  
Sbjct: 65  KLYYSFQDEE------HLYLV-MEYMPGGDLMNLLI-RKDVFPEETARFYIAELVLALDS 116

Query: 63  MHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE---- 118
           +H      +HRD+K +N+LI + G +KL DFG             +  +   L D     
Sbjct: 117 VHKLG--FIHRDIKPDNILIDADGHIKLADFGLCK------KMNKAKDREYYLNDSHNLL 168

Query: 119 -----------------MARFT--TPMYRAPEM---------VDTWNNYVIGRSMLYG 148
                             A  T  TP Y APE+          D W+  VI   MLYG
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 8e-12
 Identities = 24/83 (28%), Positives = 42/83 (50%), Gaps = 2/83 (2%)

Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
               +  I+ E C GGSL D+ +     L    +  +  +T + + ++H      +HRD+
Sbjct: 70  LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDI 127

Query: 76  KIENLLISSAGTVKLCDFGSATE 98
           K  N+L++  G VKL DFG + +
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQ 150

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 60.3 bits (147), Expect = 1e-11
 Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 16/126 (12%)

Query: 7   AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ 66
           +F  K       + YL++ E   GG L  +L E   +L  ++    + +   A++++H  
Sbjct: 61  SFQGKK------NLYLVM-EYLPGGDLASLL-ENVGSLDEDVARIYIAEIVLALEYLHSN 112

Query: 67  NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TP 125
              I+HRDLK +N+LI S G +KL DFG +   +            +  E E  R   TP
Sbjct: 113 G--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR-----RQINLNDDEKEDKRIVGTP 165

Query: 126 MYRAPE 131
            Y APE
Sbjct: 166 DYIAPE 171

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 2e-11
 Identities = 30/106 (28%), Positives = 45/106 (42%), Gaps = 32/106 (30%)

Query: 45  PPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD 104
              I C  + Q  + ++++H     I+HRD+K  N+LI++ G +KL DFG A        
Sbjct: 99  ESQIKC-YMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLA-------- 147

Query: 105 NAWSAQQRSMLEDEMARFT----TPMYRAPEM----------VDTW 136
                  R   +   A +T    T  YR PE+          VD W
Sbjct: 148 -------RPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMW 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 59.9 bits (146), Expect = 2e-11
 Identities = 38/128 (29%), Positives = 55/128 (42%), Gaps = 34/128 (26%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL++ E   GG L   L+ ++   P  +      Q   A++++H  +  IV+RDLK ENL
Sbjct: 77  YLVM-EYVPGGELFSHLR-KSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENL 132

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM----- 132
           L+ S G +K+ DFG A          +               T   TP Y APE+     
Sbjct: 133 LLDSDGYIKITDFGFA---KRVKGRTY---------------TLCGTPEYLAPEIILSKG 174

Query: 133 ----VDTW 136
               VD W
Sbjct: 175 YGKAVDWW 182

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 59.4 bits (144), Expect = 2e-11
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 18/118 (15%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  EL  GGSL  +LK +  + P  ++     Q    ++++H +N   VHRD+K  N+L+
Sbjct: 79  IFLELVPGGSLAKLLK-KYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILV 135

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
            + G VKL DFG A              ++ +       F  +P + APE++     Y
Sbjct: 136 DTNGVVKLADFGMA--------------KQVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 59.6 bits (144), Expect = 2e-11
 Identities = 40/126 (31%), Positives = 62/126 (49%), Gaps = 18/126 (14%)

Query: 11  KHSTPHGMHEYLILTELCTGGSLVDVLK---ERTSALPPNIVCSILWQTCQAVKHMHGQN 67
           K    +G   +L+L ELC GGS+ D++K   +R   +   I+  IL +    ++H+H   
Sbjct: 86  KKDVKNGDQLWLVL-ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--V 142

Query: 68  PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMY 127
              +HRD+K  N+L+++ G VKL DFG             SAQ  S          TP +
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGV------------SAQLTSTRLRRNTSVGTPFW 190

Query: 128 RAPEMV 133
            APE++
Sbjct: 191 MAPEVI 196

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 59.2 bits (144), Expect = 3e-11
 Identities = 26/65 (40%), Positives = 38/65 (58%), Gaps = 3/65 (4%)

Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLC 91
           +L +++K R   LP   V S ++Q  +++ HMH     I HRD+K EN+LI     +KL 
Sbjct: 85  NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLA 141

Query: 92  DFGSA 96
           DFGS 
Sbjct: 142 DFGSC 146

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 5e-11
 Identities = 35/108 (32%), Positives = 48/108 (44%), Gaps = 32/108 (29%)

Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS 102
            L P ++ S L+Q  Q + + H     ++HRDLK +NLLI   G +KL DFG A      
Sbjct: 95  GLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLA------ 146

Query: 103 PDNAWSAQQRSMLEDEMARFT----TPMYRAPEM----------VDTW 136
              A+    R+        +T    T  YRAPE+          VD W
Sbjct: 147 --RAFGVPVRT--------YTHEVVTLWYRAPEILLGSRQYSTPVDIW 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.5 bits (142), Expect = 5e-11
 Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 3/77 (3%)

Query: 19  HEYLILTELCTGGSLVDVL-KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           H  +++TEL   GSL+D L K+       + +C    Q    ++++  +    +HRDL  
Sbjct: 68  HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAA 125

Query: 78  ENLLISSAGTVKLCDFG 94
            N+L++S   VK+ DFG
Sbjct: 126 RNILLASDDKVKIGDFG 142

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 5e-11
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 11/100 (11%)

Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +   L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 99  KTQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLA--R 154

Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           +  P+          L + +A   T  YRAPE++     Y
Sbjct: 155 IADPE----HDHTGFLTEYVA---TRWYRAPEIMLNSKGY 187

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 58.6 bits (142), Expect = 5e-11
 Identities = 45/143 (31%), Positives = 63/143 (44%), Gaps = 35/143 (24%)

Query: 7   AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKE------RTSALP-PNIVCSILWQTCQA 59
           AF+D+ S+  G     I  E C GGSL  + K+      R        I  S+L    + 
Sbjct: 67  AFLDESSSSIG-----IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVL----KG 117

Query: 60  VKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEM 119
           + ++H +   I+HRD+K  N+L++  G VKLCDFG + E V S                 
Sbjct: 118 LSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--------------- 160

Query: 120 ARFT-TPMYRAPEMVDTWNNYVI 141
             FT T  Y APE +     Y I
Sbjct: 161 GTFTGTSFYMAPERI-QGKPYSI 182

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.5 bits (141), Expect = 6e-11
 Identities = 40/126 (31%), Positives = 61/126 (48%), Gaps = 18/126 (14%)

Query: 17  GMHEYLILTELCTGGSLVDVLK---ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           G   +L+L ELC GGS+ +++K        L   ++  IL+     ++H+H  N  I+HR
Sbjct: 96  GGQLWLVL-ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHR 152

Query: 74  DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           D+K  N+L+++ G VKL DFG             SAQ  S          TP + APE++
Sbjct: 153 DVKGNNILLTTEGGVKLVDFGV------------SAQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 134 DTWNNY 139
                Y
Sbjct: 201 ACEQQY 206

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.9 bits (140), Expect = 6e-11
 Identities = 38/121 (31%), Positives = 61/121 (50%), Gaps = 21/121 (17%)

Query: 23  ILTELCTGGSLVDVL-KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+ + C GG L   +  +R    P + +     Q C A+KH+H +   I+HRD+K +N+ 
Sbjct: 76  IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIF 133

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR--FTTPMYRAPEMVDT--WN 137
           ++  GT+KL DFG A  +V +               E+AR    TP Y +PE+ +   +N
Sbjct: 134 LTKDGTIKLGDFGIA--RVLNSTV------------ELARTCIGTPYYLSPEICENRPYN 179

Query: 138 N 138
           N
Sbjct: 180 N 180

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 57.5 bits (139), Expect = 1e-10
 Identities = 30/117 (25%), Positives = 52/117 (44%), Gaps = 17/117 (14%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
             I  E   GGS+   L+         +V     Q  + + ++H +   I+HRDLK +NL
Sbjct: 83  LSIFLEYVPGGSIGSCLR-TYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNL 139

Query: 81  LISSAGTVKLCDFGSA--TEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDT 135
           L+ + G  K+ DFG +  ++ +Y  D   S Q             +  + APE++ +
Sbjct: 140 LVDADGICKISDFGISKKSDDIYDNDQNMSMQ------------GSVFWMAPEVIHS 184

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 57.5 bits (139), Expect = 1e-10
 Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 23/144 (15%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E   GG    +LK    ALP ++      +T  A++++H  N  IVHRDLK +NLLI
Sbjct: 78  MVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLI 134

Query: 83  SSAGTVKLCDFG-------SATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           +S G +KL DFG       S T  +Y        ++     D+     TP Y APE+   
Sbjct: 135 TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE---FLDKQV-CGTPEYIAPEVILR 190

Query: 133 ------VDTWNNYVIGRSMLYGHV 150
                 VD W   +I    L G V
Sbjct: 191 QGYGKPVDWWAMGIILYEFLVGCV 214

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.9 bits (137), Expect = 2e-10
 Identities = 29/79 (36%), Positives = 47/79 (59%), Gaps = 4/79 (5%)

Query: 19  HEYLILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           H Y+++ E C GG L+  +K +R    P + +     Q C  V+H+H +   ++HRD+K 
Sbjct: 72  HLYIVM-EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKS 128

Query: 78  ENLLISSAGTVKLCDFGSA 96
           +N+ ++  G VKL DFGSA
Sbjct: 129 KNIFLTQNGKVKLGDFGSA 147

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 57.0 bits (137), Expect = 2e-10
 Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 14/111 (12%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           IL E C GG++  V+ E    L    +  +  QT +A+ ++H     I+HRDLK  N+L 
Sbjct: 79  ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILF 136

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +  G +KL DFG       S  N  + Q+R           TP + APE+V
Sbjct: 137 TLDGDIKLADFG------VSAKNTRTIQRRDSF------IGTPYWMAPEVV 175

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 4e-10
 Identities = 37/112 (33%), Positives = 51/112 (45%), Gaps = 14/112 (12%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  E   GGS+ D LK    AL   +      Q  + V+++H     IVHRD+K  N+L 
Sbjct: 81  IFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILR 137

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMV 133
            SAG VKL DFG++             Q        M   T TP + +PE++
Sbjct: 138 DSAGNVKLGDFGASKR----------LQTICSSGTGMKSVTGTPYWMSPEVI 179

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 55.4 bits (134), Expect = 6e-10
 Identities = 26/103 (25%), Positives = 42/103 (40%), Gaps = 20/103 (19%)

Query: 45  PPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA---TEKVY 101
              I C  + Q  + + ++H  +  I+HRD+K  N+LI + G +K+ DFG A        
Sbjct: 114 ESQIKC-YMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170

Query: 102 SPDNAWSAQQRSMLEDEMARFTTPM-----YRAPEMVDTWNNY 139
           +P        R           T +     YR PE++     Y
Sbjct: 171 NPKGGGGGGTRKY---------TNLVVTRWYRPPELLLGERRY 204

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.5 bits (134), Expect = 7e-10
 Identities = 34/118 (28%), Positives = 49/118 (41%), Gaps = 15/118 (12%)

Query: 31  GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKL 90
             L  V+  +       + C IL Q    +  +H      +HRDL   N+ I+S G  K+
Sbjct: 104 SDLKKVVDRKIRLTESQVKC-ILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKI 160

Query: 91  CDFGSATEKVYSP-DNAWSAQQRSMLEDEM-ARFTTPMYRAPEM----------VDTW 136
            DFG A    Y P  +  S  +     +EM ++  T  YRAPE+          VD W
Sbjct: 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMW 218

Length = 335

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 55.2 bits (133), Expect = 8e-10
 Identities = 46/164 (28%), Positives = 66/164 (40%), Gaps = 43/164 (26%)

Query: 4   LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHM 63
           L  AF DK       + YL++ E   GG L+ +L         ++    L +   A+  +
Sbjct: 66  LQYAFQDKD------NLYLVM-EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118

Query: 64  HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
           H      VHRD+K EN+LI   G +KL DFGSA                 +  ++M    
Sbjct: 119 HQMG--YVHRDIKPENVLIDRTGHIKLADFGSAAR---------------LTANKMVNSK 161

Query: 124 ----TPMYRAPEMV---------------DTWNNYVIGRSMLYG 148
               TP Y APE++               D W+  VI   M+YG
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG 205

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 54.9 bits (132), Expect = 8e-10
 Identities = 33/112 (29%), Positives = 50/112 (44%), Gaps = 9/112 (8%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  E   GGS+  +L  R   LP  + C    Q    V ++H     +VHRD+K  N+++
Sbjct: 79  IFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVML 135

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
              G +KL DFG A         AW     +      +   TP + APE+++
Sbjct: 136 MPNGIIKLIDFGCARRL------AWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 54.9 bits (133), Expect = 1e-09
 Identities = 33/118 (27%), Positives = 50/118 (42%), Gaps = 32/118 (27%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           L  +++        + V  ++ Q    V H+H  N  I+HRDLK  NLL+++ G +K+CD
Sbjct: 92  LKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH-DNW-ILHRDLKTSNLLLNNRGILKICD 149

Query: 93  FGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TPMYRAPEM----------VDTW 136
           FG A E                    +  +T    T  YRAPE+          +D W
Sbjct: 150 FGLARE----------------YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMW 191

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.3 bits (130), Expect = 1e-09
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 25/138 (18%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GGSL DV+ E  + +    + ++  +  QA++ +H     ++HRD+K +N
Sbjct: 90  ELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDN 145

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L+   G+VKL DFG   +   +P+ +    +RS +        TP + APE+       
Sbjct: 146 VLLGMDGSVKLTDFGFCAQ--ITPEQS----KRSTM------VGTPYWMAPEVVTRKAYG 193

Query: 133 --VDTWNNYVIGRSMLYG 148
             VD W+  ++   M+ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 54.3 bits (131), Expect = 2e-09
 Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 24/98 (24%)

Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWS 108
           V  ++ Q  + ++++H     I+HRDLK+ NLL++  G +K+ DFG A  + Y       
Sbjct: 110 VKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLA--RTYGL----- 160

Query: 109 AQQRSMLEDEMARFTTPMYRAPEM----------VDTW 136
              + M      +  T  YRAPE+          +D W
Sbjct: 161 -PAKPM----TPKVVTLWYRAPELLLGCTTYTTAIDMW 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 53.9 bits (130), Expect = 2e-09
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 10/95 (10%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILW--QTCQAVKHMHGQNPPIVHRDLKIEN 79
            I+TE    GSLVD L+ R  A+   +   + +    C+ ++++  +N   VHRDL   N
Sbjct: 76  YIVTEYMAKGSLVDYLRSRGRAVI-TLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARN 132

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNA-----WSA 109
           +L+S     K+ DFG A E     D+      W+A
Sbjct: 133 VLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTA 167

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.4 bits (131), Expect = 2e-09
 Identities = 33/80 (41%), Positives = 45/80 (56%), Gaps = 4/80 (5%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E  +GG L   L ER      +  C  L +   A++H+H Q   I++RDLK EN+
Sbjct: 76  YLIL-EYLSGGELFMHL-EREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENI 131

Query: 81  LISSAGTVKLCDFGSATEKV 100
           L+ + G VKL DFG   E +
Sbjct: 132 LLDAQGHVKLTDFGLCKESI 151

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.3 bits (130), Expect = 2e-09
 Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 16/98 (16%)

Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVY 101
           ALP  +V    +Q C+A+ ++H +   I HRDLK +NLLI  +  T+KLCDFGSA   + 
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL- 222

Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                  A QRS     ++   +  YRAPE++    NY
Sbjct: 223 -------AGQRS-----VSYICSRFYRAPELMLGATNY 248

Length = 440

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 53.8 bits (129), Expect = 2e-09
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 25/138 (18%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GGSL DV+ E  + +    + ++  +  QA++ +H     ++HRD+K +N
Sbjct: 90  ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDN 145

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L+   G+VKL DFG   +   +P+ +    +RS +        TP + APE+       
Sbjct: 146 ILLGMDGSVKLTDFGFCAQ--ITPEQS----KRSTM------VGTPYWMAPEVVTRKAYG 193

Query: 133 --VDTWNNYVIGRSMLYG 148
             VD W+  ++   M+ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.0 bits (129), Expect = 3e-09
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 25/138 (18%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GGSL DV+ E  + +    + ++  +  QA++ +H     ++HRD+K +N
Sbjct: 91  ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDN 146

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L+   G+VKL DFG   +   +P+ +    +RS     M    TP + APE+       
Sbjct: 147 ILLGMDGSVKLTDFGFCAQ--ITPEQS----KRS----TMV--GTPYWMAPEVVTRKAYG 194

Query: 133 --VDTWNNYVIGRSMLYG 148
             VD W+  ++   M+ G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 53.3 bits (128), Expect = 3e-09
 Identities = 24/74 (32%), Positives = 42/74 (56%), Gaps = 2/74 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+TE    G L++ L++R   L  +++ S+    C+ ++++   +   +HRDL   N L+
Sbjct: 76  IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLV 133

Query: 83  SSAGTVKLCDFGSA 96
           SS G VK+ DFG  
Sbjct: 134 SSTGVVKVSDFGMT 147

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 53.7 bits (129), Expect = 3e-09
 Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 24/106 (22%)

Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           S +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 95  SGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 147

Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWN 137
               A+    R+   +      T  YRAPE+          VD W+
Sbjct: 148 ---RAFGVPVRTYTHE----VVTLWYRAPEILLGCKYYSTAVDIWS 186

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.6 bits (128), Expect = 3e-09
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 18/130 (13%)

Query: 6   AAFIDKHSTPHGMHEYL-ILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHM 63
            AFI K+  P GM + L ++ E C  GS+ D++K  + + L    +  I  +  + + H+
Sbjct: 70  GAFIKKN--PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 64  HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
           H     ++HRD+K +N+L++    VKL DFG             SAQ    +        
Sbjct: 128 HQHK--VIHRDIKGQNVLLTENAEVKLVDFGV------------SAQLDRTVGRRNTFIG 173

Query: 124 TPMYRAPEMV 133
           TP + APE++
Sbjct: 174 TPYWMAPEVI 183

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 53.5 bits (128), Expect = 4e-09
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 14/111 (12%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E C GG++  ++ E    L    +  I  Q  +A++++H     I+HRDLK  N+L+
Sbjct: 86  IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLL 143

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +  G +KL DFG             SA+    L+   +   TP + APE+V
Sbjct: 144 TLDGDIKLADFGV------------SAKNVKTLQRRDSFIGTPYWMAPEVV 182

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.5 bits (129), Expect = 4e-09
 Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 14/87 (16%)

Query: 53  LWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
           L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A           S +  
Sbjct: 114 LYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTT--------SEKGD 163

Query: 113 SMLEDEMARFTTPMYRAPEMVDTWNNY 139
            M E  + R+    YRAPE++   + Y
Sbjct: 164 FMTEYVVTRW----YRAPELLLNCSEY 186

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 53.2 bits (127), Expect = 5e-09
 Identities = 38/138 (27%), Positives = 68/138 (49%), Gaps = 25/138 (18%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GGSL DV+ E  + +    + ++  +  QA+  +H     ++HRD+K +N
Sbjct: 90  ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDN 145

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L+   G+VKL DFG   +   +P+ +    +RS +        TP + APE+       
Sbjct: 146 ILLGMDGSVKLTDFGFCAQ--ITPEQS----KRSTM------VGTPYWMAPEVVTRKAYG 193

Query: 133 --VDTWNNYVIGRSMLYG 148
             VD W+  ++   M+ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 52.7 bits (126), Expect = 6e-09
 Identities = 37/129 (28%), Positives = 62/129 (48%), Gaps = 16/129 (12%)

Query: 6   AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMH 64
            AFI K    H    +L++ E C  GS+ D++K  + +AL  + +  I  +  + + H+H
Sbjct: 80  GAFIKKSPPGHDDQLWLVM-EFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138

Query: 65  GQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTT 124
                ++HRD+K +N+L++    VKL DFG             SAQ    +        T
Sbjct: 139 AHK--VIHRDIKGQNVLLTENAEVKLVDFGV------------SAQLDRTVGRRNTFIGT 184

Query: 125 PMYRAPEMV 133
           P + APE++
Sbjct: 185 PYWMAPEVI 193

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 6e-09
 Identities = 41/146 (28%), Positives = 62/146 (42%), Gaps = 42/146 (28%)

Query: 19  HEYLILTELCTGGSLVDVLKER-----TSAL--PPNIVCSILWQTCQAVKHMHGQNPPIV 71
             Y+++  +  GG L   L+       ++ L     IVC        A++++H +   IV
Sbjct: 75  FLYMLMEYVP-GGELFSYLRNSGRFSNSTGLFYASEIVC--------ALEYLHSKE--IV 123

Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +RDLK EN+L+   G +KL DFG A +     D  W+               TP Y APE
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWTL------------CGTPEYLAPE 168

Query: 132 M---------VDTWNNYVIGRSMLYG 148
           +         VD W   ++   ML G
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.8 bits (127), Expect = 6e-09
 Identities = 29/89 (32%), Positives = 49/89 (55%), Gaps = 10/89 (11%)

Query: 51  SILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQ 110
           S ++Q    +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  + +S +      
Sbjct: 109 SFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLA--RGFSENPG--EN 162

Query: 111 QRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
              M E       T  YRAPE++ ++ +Y
Sbjct: 163 AGFMTE----YVATRWYRAPEIMLSFQSY 187

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 52.4 bits (126), Expect = 7e-09
 Identities = 23/72 (31%), Positives = 35/72 (48%), Gaps = 2/72 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ EL   G L   L+    +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 83  IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLV 140

Query: 83  SSAGTVKLCDFG 94
           SS   VKL DFG
Sbjct: 141 SSPDCVKLGDFG 152

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 52.5 bits (126), Expect = 7e-09
 Identities = 25/54 (46%), Positives = 34/54 (62%), Gaps = 2/54 (3%)

Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           AL PN V S  +Q  + +   H +N  ++HRDLK +NLLI+  G +KL DFG A
Sbjct: 96  ALDPNTVKSFTYQLLKGIAFCH-ENR-VLHRDLKPQNLLINKRGELKLADFGLA 147

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 52.4 bits (126), Expect = 8e-09
 Identities = 23/51 (45%), Positives = 32/51 (62%), Gaps = 2/51 (3%)

Query: 46  PNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           P IV S ++Q  + +   H  N  ++HRDLK +NLLI+  G +KL DFG A
Sbjct: 98  PEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 8e-09
 Identities = 33/111 (29%), Positives = 49/111 (44%), Gaps = 25/111 (22%)

Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA----GTVKLCDFGS 95
           +  ++PP++V S+LWQ    V ++H     ++HRDLK  N+L+       G VK+ D G 
Sbjct: 101 KRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGL 158

Query: 96  ATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTW 136
           A     +P           L D      T  YRAPE+          +D W
Sbjct: 159 A-RLFNAPLKP--------LADLDPVVVTIWYRAPELLLGARHYTKAIDIW 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 52.3 bits (126), Expect = 8e-09
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 10/91 (10%)

Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWS 108
           +   L+Q  + +K++H  N  ++HRDLK  NLL++    +++ DFG A     SP     
Sbjct: 109 IRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE--- 163

Query: 109 AQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
             +  M E       T  YRAPE++ +   Y
Sbjct: 164 -HKYFMTE----YVATRWYRAPELLLSLPEY 189

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 52.1 bits (125), Expect = 8e-09
 Identities = 39/139 (28%), Positives = 62/139 (44%), Gaps = 31/139 (22%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK---ERTSALPPNIVCSILWQTC 57
           ++YL A+FI+ +       E  I+ EL   G L  ++K   ++   +P   +     Q C
Sbjct: 65  IKYL-ASFIENN-------ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 58  QAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLED 117
            A++HMH +   I+HRD+K  N+ I++ G VKL D G                 R     
Sbjct: 117 SALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLG---------------RFFSSK 159

Query: 118 EMARFT---TPMYRAPEMV 133
             A  +   TP Y +PE +
Sbjct: 160 TTAAHSLVGTPYYMSPERI 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (124), Expect = 9e-09
 Identities = 32/74 (43%), Positives = 40/74 (54%), Gaps = 3/74 (4%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  E   GGS+ D LK    AL  N+      Q  Q V ++H     IVHRD+K  N+L 
Sbjct: 83  IFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILR 139

Query: 83  SSAGTVKLCDFGSA 96
            SAG VKL DFG++
Sbjct: 140 DSAGNVKLGDFGAS 153

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 52.1 bits (125), Expect = 1e-08
 Identities = 31/114 (27%), Positives = 49/114 (42%), Gaps = 23/114 (20%)

Query: 23  ILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           I+ E    G L   + +R      +P   +  I  Q  + ++ +H Q   I+HRDLK  N
Sbjct: 76  IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSAN 133

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR--FTTPMYRAPE 131
           +L+ +   VK+ D G +                 +L+  MA+    TP Y APE
Sbjct: 134 ILLVANDLVKIGDLGISK----------------VLKKNMAKTQIGTPHYMAPE 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 51.9 bits (124), Expect = 1e-08
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 24/104 (23%)

Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS 102
            +P   +  +++Q  + +  +H     +VHRDLK +N+L++S+G +KL DFG A  ++YS
Sbjct: 106 GVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA--RIYS 161

Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWN 137
              A ++              T  YRAPE+         VD W+
Sbjct: 162 FQMALTSV-----------VVTLWYRAPEVLLQSSYATPVDLWS 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.1 bits (125), Expect = 1e-08
 Identities = 39/119 (32%), Positives = 55/119 (46%), Gaps = 21/119 (17%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y + TEL  G  L  +L  R   L    +   L+Q  + +K++H     +VHRDLK  N+
Sbjct: 86  YFV-TEL-LGTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNI 139

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           LI+    +K+CDFG A             Q   M        +T  YRAPE++ TW  Y
Sbjct: 140 LINENCDLKICDFGLA-----------RIQDPQM----TGYVSTRYYRAPEIMLTWQKY 183

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 52.1 bits (125), Expect = 1e-08
 Identities = 33/117 (28%), Positives = 57/117 (48%), Gaps = 23/117 (19%)

Query: 19  HEYLILTELCTGGS--LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           H   ++ E C G +  +++V K+    +    +C       Q + ++H      +HRD+K
Sbjct: 88  HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH---GALQGLAYLHSHE--RIHRDIK 142

Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
             N+L++  GTVKL DFGSA+  + SP N++                TP + APE++
Sbjct: 143 AGNILLTEPGTVKLADFGSAS--LVSPANSFVG--------------TPYWMAPEVI 183

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.1 bits (125), Expect = 1e-08
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 23/94 (24%)

Query: 53  LWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
           L+Q  + +K++H     I+HRD+K  NLL++S   +K+CDFG A  +V  PD     + +
Sbjct: 109 LYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLA--RVEEPD-----ESK 159

Query: 113 SMLEDEMARFTTPMYRAPEM----------VDTW 136
            M ++      T  YRAPE+          VD W
Sbjct: 160 HMTQE----VVTQYYRAPEILMGSRHYTSAVDIW 189

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 52.0 bits (124), Expect = 1e-08
 Identities = 35/115 (30%), Positives = 57/115 (49%), Gaps = 19/115 (16%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H   ++ E C G S  D+L+     L    + +I     Q + ++H  N  ++HRD+K  
Sbjct: 98  HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAG 154

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           N+L++  G VKL DFGSA+  + SP N++                TP + APE++
Sbjct: 155 NILLTEPGQVKLADFGSAS--IASPANSFVG--------------TPYWMAPEVI 193

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 51.6 bits (123), Expect = 1e-08
 Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 22/114 (19%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS +D+LK     L    + +IL +  + + ++H +    +HRD+K  N+L+
Sbjct: 79  IIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERK--IHRDIKAANVLL 134

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMV 133
           S  G VKL DFG A +               + + ++ R T   TP + APE++
Sbjct: 135 SEQGDVKLADFGVAGQ---------------LTDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 51.6 bits (123), Expect = 1e-08
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 19/115 (16%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H   ++ E C G S  D+L+     L    + ++     Q + ++H  N  ++HRD+K  
Sbjct: 88  HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAG 144

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           N+L+S  G VKL DFGSA+  + +P N +                TP + APE++
Sbjct: 145 NILLSEPGLVKLGDFGSAS--IMAPANXFVG--------------TPYWMAPEVI 183

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 51.2 bits (122), Expect = 2e-08
 Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 15/110 (13%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  E C GGSL D+    T  L  + +  +  +T Q + ++H +    +HRD+K  N+L+
Sbjct: 83  ICMEFCGGGSLQDIY-HVTGPLSESQIAYVSRETLQGLYYLHSKGK--MHRDIKGANILL 139

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           +  G VKL DFG             SAQ  + +    +   TP + APE+
Sbjct: 140 TDNGHVKLADFGV------------SAQITATIAKRKSFIGTPYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 51.3 bits (123), Expect = 2e-08
 Identities = 33/108 (30%), Positives = 47/108 (43%), Gaps = 34/108 (31%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE----- 98
           +   +V S L+Q  Q +   H +   ++HRDLK +NLLI + G +KL DFG A       
Sbjct: 98  MDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155

Query: 99  KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTW 136
           +VY+ +                   T  YRAPE+          VD W
Sbjct: 156 RVYTHE-----------------VVTLWYRAPEVLLGSPRYSTPVDIW 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 51.2 bits (122), Expect = 2e-08
 Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 19/115 (16%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H   ++ E C G S  D+L+     L    + +I     Q + ++H  N  ++HRD+K  
Sbjct: 94  HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAG 150

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           N+L++  G VKL DFGSA+    SP N++                TP + APE++
Sbjct: 151 NILLTEPGQVKLADFGSAS--KSSPANSFVG--------------TPYWMAPEVI 189

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 50.8 bits (122), Expect = 2e-08
 Identities = 29/110 (26%), Positives = 47/110 (42%), Gaps = 28/110 (25%)

Query: 48  IVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAW 107
            +C I      A++++H +   I+HRD+K +N+L+   G V + DF  AT+         
Sbjct: 105 WICEI----VLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATK--------V 150

Query: 108 SAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYG 148
           +    +      +   TP Y APE+         VD W+  V     L G
Sbjct: 151 TPDTLT---TSTS--GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 50.8 bits (121), Expect = 2e-08
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 5/79 (6%)

Query: 19  HEYLILTELCTGGSLVDVL---KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           +E  I+ EL   G L  ++   K++   +P   V     Q C AV+HMH +   ++HRD+
Sbjct: 75  NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDI 132

Query: 76  KIENLLISSAGTVKLCDFG 94
           K  N+ I++ G VKL D G
Sbjct: 133 KPANVFITATGVVKLGDLG 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 51.4 bits (123), Expect = 2e-08
 Identities = 39/128 (30%), Positives = 54/128 (42%), Gaps = 13/128 (10%)

Query: 7   AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ 66
           A +D    P G+     + E   G +L +VL     ALP      ++ Q   A+   H Q
Sbjct: 42  ALLDSGEAPPGL--LFAVFEYVPGRTLREVLAAD-GALPAGETGRLMLQVLDALACAHNQ 98

Query: 67  NPPIVHRDLKIENLLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
              IVHRDLK +N+++S  G     K+ DFG  T     P    +         E+    
Sbjct: 99  G--IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT---LLPGVRDADVATLTRTTEV--LG 151

Query: 124 TPMYRAPE 131
           TP Y APE
Sbjct: 152 TPTYCAPE 159

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 50.8 bits (122), Expect = 3e-08
 Identities = 27/101 (26%), Positives = 48/101 (47%), Gaps = 19/101 (18%)

Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +   L  + +  +++Q  + +K++H     I+HRDLK  N+ ++    +K+ DFG A   
Sbjct: 111 KCQKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLA--- 165

Query: 100 VYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEMVDTWNNY 139
                           +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHY 193

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 50.6 bits (121), Expect = 3e-08
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 13/96 (13%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I TE   GGSL DV ++    +P +++  I     + + ++      I+HRD+K  N+L+
Sbjct: 76  ICTEFMDGGSL-DVYRK----IPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLV 128

Query: 83  SSAGTVKLCDFGSATE------KVYSPDNAWSAQQR 112
           ++ G VKLCDFG +T+      K Y   NA+ A +R
Sbjct: 129 NTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPER 164

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 50.5 bits (121), Expect = 3e-08
 Identities = 38/114 (33%), Positives = 54/114 (47%), Gaps = 20/114 (17%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P NI+  I     + + ++  +   I+HRD+K  N
Sbjct: 73  EISICMEHMDGGSLDQVLK-KAGRIPENILGKISIAVLRGLTYLR-EKHKIMHRDVKPSN 130

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR-FT-TPMYRAPE 131
           +L++S G +KLCDFG +                  L D MA  F  T  Y +PE
Sbjct: 131 ILVNSRGEIKLCDFGVS----------------GQLIDSMANSFVGTRSYMSPE 168

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 49.6 bits (118), Expect = 8e-08
 Identities = 37/112 (33%), Positives = 51/112 (45%), Gaps = 24/112 (21%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSP 103
           LP   +  ++ Q  + +  +H     IVHRDLK EN+L++S G VKL DFG A  ++YS 
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLA--RIYSC 160

Query: 104 DNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSML 146
             A +               T  YRAPE+         VD W+   I   M 
Sbjct: 161 QMALTPV-----------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 49.2 bits (117), Expect = 9e-08
 Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 8/95 (8%)

Query: 23  ILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD L+ R  S L  + +       C+A++++   N   VHRDL   N+L
Sbjct: 77  IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVL 134

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNA-----WSAQQ 111
           +S     K+ DFG   E   + D       W+A +
Sbjct: 135 VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE 169

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 49.3 bits (117), Expect = 9e-08
 Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 2/100 (2%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLKE    +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 77  EISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSN 134

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEM 119
           +L++S G +KLCDFG + + + S  N++   +  M  + +
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 174

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 49.2 bits (117), Expect = 1e-07
 Identities = 30/102 (29%), Positives = 52/102 (50%), Gaps = 11/102 (10%)

Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNI-VCSILWQTCQAVKHMHGQNPPIVHRD 74
           +G++   I+ EL + G+LV+ L+ R  AL   I +        + ++++  +   +VHRD
Sbjct: 71  NGLY---IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRD 125

Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNA-----WSAQQ 111
           L   N+L+S  G  K+ DFG A       DN+     W+A +
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPE 167

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 49.0 bits (117), Expect = 1e-07
 Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 25/102 (24%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ H+H     I++RDLK EN+L+   G +KL DFG + E +     A+S          
Sbjct: 110 ALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---------- 157

Query: 119 MARFT-TPMYRAPEMV---------DTWNNYVIGRSMLYGHV 150
              F  T  Y APE+V         D W+  V+   ML G +
Sbjct: 158 ---FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSL 196

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 48.9 bits (116), Expect = 1e-07
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 12/92 (13%)

Query: 6   AAFIDKHSTPHGMHEYLILTELCTGGSLVDVL---KERTSALPPNIVCSILWQTCQAVKH 62
           A+FI+ +       E  I+ EL   G L  ++   K++   +P   V     Q C A++H
Sbjct: 69  ASFIEDN-------ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 63  MHGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           MH +   ++HRD+K  N+ I++ G VKL D G
Sbjct: 122 MHSRR--VMHRDIKPANVFITATGVVKLGDLG 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 48.7 bits (116), Expect = 2e-07
 Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 5/85 (5%)

Query: 13  STPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
           +T    H + +  E   GGS+  +L  +  A    ++ +   Q  + + ++H     I+H
Sbjct: 71  ATCEDSH-FNLFVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHENQ--IIH 126

Query: 73  RDLKIENLLISSAGT-VKLCDFGSA 96
           RD+K  NLLI S G  +++ DFG+A
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 48.5 bits (115), Expect = 2e-07
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 2/95 (2%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 77  EISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSN 134

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +L++S G +KLCDFG + + + S  N++   +  M
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 169

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 48.5 bits (115), Expect = 2e-07
 Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 15/116 (12%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  E C GGSL D+    T  L    +  +  +T Q + ++H +    +HRD+K  N+L+
Sbjct: 83  ICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLAYLHSKGK--MHRDIKGANILL 139

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           +  G VKL DFG A +       A  A+++S +        TP + APE+     N
Sbjct: 140 TDNGDVKLADFGVAAKI-----TATIAKRKSFI-------GTPYWMAPEVAAVEKN 183

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 48.1 bits (114), Expect = 2e-07
 Identities = 29/81 (35%), Positives = 40/81 (49%), Gaps = 3/81 (3%)

Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
                  I  E   GGS+ D LK    AL  ++      Q  + + ++H     IVHRD+
Sbjct: 76  RAEKTLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNM--IVHRDI 132

Query: 76  KIENLLISSAGTVKLCDFGSA 96
           K  N+L  SAG VKL DFG++
Sbjct: 133 KGANILRDSAGNVKLGDFGAS 153

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 2e-07
 Identities = 23/58 (39%), Positives = 33/58 (56%), Gaps = 2/58 (3%)

Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
             L  + V   L+Q  + + + H +   ++HRDLK +NLLIS  G +KL DFG A  K
Sbjct: 98  GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAK 153

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 48.3 bits (115), Expect = 2e-07
 Identities = 45/140 (32%), Positives = 62/140 (44%), Gaps = 35/140 (25%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILW-QTCQAVKHMHGQNPPIVHRDLKIENLL 81
            L E   GG L   L  R +   PN V      +   A +++H ++  I++RDLK ENLL
Sbjct: 95  FLLEFVVGGELFTHL--RKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLL 150

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM------ 132
           + + G VK+ DFG A +KV  PD                 FT   TP Y APE+      
Sbjct: 151 LDNKGHVKVTDFGFA-KKV--PDRT---------------FTLCGTPEYLAPEVIQSKGH 192

Query: 133 ---VDTWNNYVIGRSMLYGH 149
              VD W   V+    + G+
Sbjct: 193 GKAVDWWTMGVLLYEFIAGY 212

Length = 329

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 48.1 bits (114), Expect = 3e-07
 Identities = 32/114 (28%), Positives = 56/114 (49%), Gaps = 22/114 (19%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS +D+L  R        + ++L +  + + ++H +    +HRD+K  N+L+
Sbjct: 79  IIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLL 134

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMV 133
           S  G VKL DFG A +               + + ++ R T   TP + APE++
Sbjct: 135 SEQGDVKLADFGVAGQ---------------LTDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 47.9 bits (114), Expect = 3e-07
 Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 23/102 (22%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           MEY+ A  +DK               L  GG         T  +P +++  I +   + +
Sbjct: 78  MEYMDAGSLDK---------------LYAGGV-------ATEGIPEDVLRRITYAVVKGL 115

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS 102
           K +  ++  I+HRD+K  N+L++  G VKLCDFG +   V S
Sbjct: 116 KFLKEEHN-IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 48.1 bits (114), Expect = 3e-07
 Identities = 30/74 (40%), Positives = 39/74 (52%), Gaps = 3/74 (4%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  E   GGS+ D LK    AL  N+      Q  + V ++H     IVHRD+K  N+L 
Sbjct: 83  IFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILR 139

Query: 83  SSAGTVKLCDFGSA 96
            S G VKL DFG++
Sbjct: 140 DSVGNVKLGDFGAS 153

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 48.1 bits (114), Expect = 3e-07
 Identities = 31/114 (27%), Positives = 57/114 (50%), Gaps = 16/114 (14%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  +L E   GG+L D++ +  + L    + ++     QA+ ++H Q   ++HRD+K ++
Sbjct: 92  ELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDS 147

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +L++  G VKL DFG            + AQ    +    +   TP + APE++
Sbjct: 148 ILLTLDGRVKLSDFG------------FCAQISKDVPKRKSLVGTPYWMAPEVI 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 47.8 bits (114), Expect = 3e-07
 Identities = 36/130 (27%), Positives = 58/130 (44%), Gaps = 33/130 (25%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GG+L D++   T      I   +     +A+  +H Q   ++HRD+K ++
Sbjct: 90  ELWVVMEFLEGGALTDIVTH-TRMNEEQIAT-VCLAVLKALSFLHAQG--VIHRDIKSDS 145

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR----FTTPMYRAPEM--- 132
           +L++S G VKL DFG            + AQ    +  E+ R      TP + APE+   
Sbjct: 146 ILLTSDGRVKLSDFG------------FCAQ----VSKEVPRRKSLVGTPYWMAPEVISR 189

Query: 133 ------VDTW 136
                 VD W
Sbjct: 190 LPYGTEVDIW 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 47.9 bits (114), Expect = 3e-07
 Identities = 25/76 (32%), Positives = 41/76 (53%), Gaps = 4/76 (5%)

Query: 20  EYL-ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           ++L I  E   GGS V  L     A    +V + + Q  + + ++H  N  I+HRD+K  
Sbjct: 79  DHLNIFLEYVPGGS-VAALLNNYGAFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGA 135

Query: 79  NLLISSAGTVKLCDFG 94
           N+L+ + G +K+ DFG
Sbjct: 136 NILVDNKGGIKISDFG 151

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 47.9 bits (114), Expect = 3e-07
 Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 19/118 (16%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILW--QTCQAVKHMHGQNPPIVHRDLKIE 78
           + I  E   GGSL  +L+ +   L  N    I +  Q  + +K++H     IVHRD+K +
Sbjct: 80  FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGD 137

Query: 79  NLLISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVD 134
           N+L+++ +G VK+ DFG             ++++ + +      FT T  Y APE++D
Sbjct: 138 NVLVNTYSGVVKISDFG-------------TSKRLAGINPCTETFTGTLQYMAPEVID 182

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 3e-07
 Identities = 26/76 (34%), Positives = 43/76 (56%), Gaps = 3/76 (3%)

Query: 22  LILTELCTGGSLVDVL-KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           L++TE C  G L++ L ++R S L    + S  +Q  + +  +  +N   +HRDL   N+
Sbjct: 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNV 172

Query: 81  LISSAGTVKLCDFGSA 96
           L++    VK+CDFG A
Sbjct: 173 LLTHGKIVKICDFGLA 188

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 47.7 bits (113), Expect = 4e-07
 Identities = 29/78 (37%), Positives = 44/78 (56%), Gaps = 3/78 (3%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           L   + +    L P  V   ++Q  + + ++HGQ+  I+HRDLK +NLLIS  G +KL D
Sbjct: 89  LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLAD 146

Query: 93  FGSATEKVYSPDNAWSAQ 110
           FG A  K   P   +S++
Sbjct: 147 FGLARAKSI-PSQTYSSE 163

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 47.5 bits (113), Expect = 4e-07
 Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 4/75 (5%)

Query: 22  LILTELCTGGSLVDVL-KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           +I+ E   GG+L + + K   S L  + +     Q   A+ H+H +   I+HRDLK +N+
Sbjct: 75  MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNI 132

Query: 81  LISSAGTV-KLCDFG 94
           L+     V K+ DFG
Sbjct: 133 LLDKHKMVVKIGDFG 147

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 47.3 bits (112), Expect = 4e-07
 Identities = 30/132 (22%), Positives = 64/132 (48%), Gaps = 16/132 (12%)

Query: 2   EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVK 61
           +Y     +D +++     E  ++ E   GG+L D++    + +    + ++     +A+ 
Sbjct: 75  DYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALS 132

Query: 62  HMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR 121
           ++H Q   ++HRD+K +++L++S G +KL DFG            + AQ    +    + 
Sbjct: 133 YLHNQG--VIHRDIKSDSILLTSDGRIKLSDFG------------FCAQVSKEVPKRKSL 178

Query: 122 FTTPMYRAPEMV 133
             TP + APE++
Sbjct: 179 VGTPYWMAPEVI 190

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 47.4 bits (112), Expect = 5e-07
 Identities = 32/114 (28%), Positives = 56/114 (49%), Gaps = 22/114 (19%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS +D+L+     L    + +IL +  + + ++H +    +HRD+K  N+L+
Sbjct: 79  IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLL 134

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR---FTTPMYRAPEMV 133
           S  G VKL DFG A +               + + ++ R     TP + APE++
Sbjct: 135 SEHGEVKLADFGVAGQ---------------LTDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 47.3 bits (112), Expect = 5e-07
 Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 22/141 (15%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           + YL++ +   GG L+ +L +    LP ++    + +   A+  +H  +   VHRD+K +
Sbjct: 75  YLYLVM-DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPD 131

Query: 79  NLLISSAGTVKLCDFGS-----------ATEKVYSPDNAWSAQQRSMLEDEMARFTTPMY 127
           N+L+   G ++L DFGS           ++  V +PD   S +    +ED M ++     
Sbjct: 132 NVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI-SPEILQAMEDGMGKY----- 185

Query: 128 RAPEMVDTWNNYVIGRSMLYG 148
             PE  D W+  V    MLYG
Sbjct: 186 -GPE-CDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 47.4 bits (113), Expect = 5e-07
 Identities = 25/77 (32%), Positives = 36/77 (46%), Gaps = 23/77 (29%)

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           K  HG    ++HRD+K  N+L+ ++G VKLCDFG +                  L D  A
Sbjct: 131 KEKHG----VIHRDVKPSNILLDASGNVKLCDFGIS----------------GRLVDSKA 170

Query: 121 RFTT---PMYRAPEMVD 134
           +  +     Y APE +D
Sbjct: 171 KTRSAGCAAYMAPERID 187

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 5e-07
 Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 15/64 (23%)

Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
            +HRDLK EN LI ++G +KL DFG +   V            S++        +P Y A
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIV--------TYANSVV-------GSPDYMA 166

Query: 130 PEMV 133
           PE++
Sbjct: 167 PEVL 170

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 47.3 bits (112), Expect = 6e-07
 Identities = 35/100 (35%), Positives = 46/100 (46%), Gaps = 25/100 (25%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ ++H  N  I++RDLK EN+L+ S G V L DFG   E V               E+ 
Sbjct: 108 AIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-------------EET 152

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYG 148
            + F  TP Y APE+         VD W    +   MLYG
Sbjct: 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.2 bits (112), Expect = 6e-07
 Identities = 23/72 (31%), Positives = 38/72 (52%), Gaps = 2/72 (2%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           L   L +R+  LP +    I  Q  + ++++H Q   I+HRD+K EN+ I+    V + D
Sbjct: 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGD 200

Query: 93  FGSATEKVYSPD 104
            G+A   V +P 
Sbjct: 201 LGAAQFPVVAPA 212

Length = 357

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 47.1 bits (112), Expect = 6e-07
 Identities = 24/72 (33%), Positives = 42/72 (58%), Gaps = 2/72 (2%)

Query: 31  GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKL 90
           GSL  + K+    +P  I+  I     + + +++  +  I+HRD+K  N+L++S G +KL
Sbjct: 88  GSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKL 145

Query: 91  CDFGSATEKVYS 102
           CDFG + E + S
Sbjct: 146 CDFGVSGELINS 157

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.2 bits (112), Expect = 6e-07
 Identities = 19/33 (57%), Positives = 24/33 (72%), Gaps = 4/33 (12%)

Query: 62  HMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           H HG    I+HRDLK +N+LIS+ G +KL DFG
Sbjct: 121 HRHG----IIHRDLKPDNMLISNEGHIKLTDFG 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.1 bits (112), Expect = 6e-07
 Identities = 35/111 (31%), Positives = 54/111 (48%), Gaps = 30/111 (27%)

Query: 53  LWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNA----WS 108
           L+Q  +A+K++H  N  + HRDLK +N+L ++   +K+CDFG A  +V   D      W+
Sbjct: 109 LYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLA--RVAFNDTPTAIFWT 164

Query: 109 AQQRSMLEDEMARFTTPMYRAPEM-----------VDTWNNYVIGRSMLYG 148
                   D +A   T  YRAPE+           +D W+   I   +L G
Sbjct: 165 --------DYVA---TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 46.7 bits (111), Expect = 8e-07
 Identities = 28/100 (28%), Positives = 44/100 (44%), Gaps = 15/100 (15%)

Query: 21  YLILTELCTGGSLVDVLK---ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
             I+TEL   GSL+  L+    +   +   I   +  Q  + + ++  QN   +HRDL  
Sbjct: 77  VYIITELMEKGSLLAFLRSPEGQVLPVASLI--DMACQVAEGMAYLEEQN--SIHRDLAA 132

Query: 78  ENLLISSAGTVKLCDFGSA---TEKVYSPDNA-----WSA 109
            N+L+      K+ DFG A    E VY   +      W+A
Sbjct: 133 RNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA 172

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.5 bits (110), Expect = 8e-07
 Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 25/102 (24%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A++++H ++  +V+RD+K+ENL++   G +K+ DFG   E +                  
Sbjct: 107 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-------------GAT 151

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
           M  F  TP Y APE+         VD W   V+   M+ G +
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 46.3 bits (110), Expect = 8e-07
 Identities = 24/84 (28%), Positives = 40/84 (47%), Gaps = 4/84 (4%)

Query: 19  HEYLILTELCTGGSLVD---VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
               I+ +L  G  L +    LKE+        + +I  Q   A++++H +   IVHRDL
Sbjct: 82  DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-IVHRDL 140

Query: 76  KIENLLISSAGTVKLCDFGSATEK 99
              N+++     V + DFG A +K
Sbjct: 141 TPNNIMLGEDDKVTITDFGLAKQK 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.3 bits (110), Expect = 9e-07
 Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 25/105 (23%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA-GTVKLCDFGSATEKVYS 102
           LP   + S ++Q  + V H H     ++HRDLK +NLL+    G +K+ D G        
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLG------ 158

Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWN 137
              A+S   +S   +      T  YRAPE+          VD W+
Sbjct: 159 --RAFSIPVKSYTHE----IVTLWYRAPEVLLGSTHYSTPVDIWS 197

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.6 bits (111), Expect = 9e-07
 Identities = 38/121 (31%), Positives = 54/121 (44%), Gaps = 32/121 (26%)

Query: 39  ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
           ER S L        L+Q    +KH+H  +  I+HRDLK  N+++ S  T+K+ DFG A  
Sbjct: 118 ERMSYL--------LYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR- 166

Query: 99  KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
                    +A    M+   +    T  YRAPE+         VD W+   I   M+ G 
Sbjct: 167 ---------TAGTSFMMTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Query: 150 V 150
           V
Sbjct: 215 V 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.3 bits (110), Expect = 9e-07
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 25/100 (25%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ ++H  +  +V+RDLK+ENL++   G +K+ DFG   E +                  
Sbjct: 107 ALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT------------- 151

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYG 148
           M  F  TP Y APE+         VD W   V+   M+ G
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 46.2 bits (110), Expect = 1e-06
 Identities = 31/99 (31%), Positives = 42/99 (42%), Gaps = 29/99 (29%)

Query: 62  HMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR 121
           H  G    I++RDLK++N+L+ S G +K+ DFG   E               +L      
Sbjct: 113 HERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKE--------------GILGGVTTS 154

Query: 122 -FT-TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
            F  TP Y APE+         VD W   V+   ML G 
Sbjct: 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 46.3 bits (110), Expect = 1e-06
 Identities = 33/100 (33%), Positives = 44/100 (44%), Gaps = 25/100 (25%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ ++H  N  I++RDLK EN+L+ S G V L DFG   E +                  
Sbjct: 108 ALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-------------SKT 152

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYG 148
            + F  TP Y APE+         VD W    +   MLYG
Sbjct: 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 34/108 (31%), Positives = 50/108 (46%), Gaps = 24/108 (22%)

Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 178

Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+   +    T  YRAPE+         VD W+   I   M+ G V
Sbjct: 179 SFMMTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 1e-06
 Identities = 31/116 (26%), Positives = 43/116 (37%), Gaps = 39/116 (33%)

Query: 71  VHRDLKIENLLISSAGTVKLCDFGSAT--EKV-----------YSPDNAWSAQQRSMLED 117
           +HRD+K +NLL+ + G +KL DFG  T  +K              P N      + M   
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM--S 180

Query: 118 EMARFT---------------TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
              +                 TP Y APE+          D W+  VI   ML G+
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 45.9 bits (109), Expect = 1e-06
 Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 25/100 (25%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
            ++ +H +   I++RDLK++N+L+   G +K+ DFG   E +               E +
Sbjct: 108 GLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN-------------GEGK 152

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYG 148
            + F  TP Y APE+         VD W+  V+   ML G
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 45.9 bits (109), Expect = 1e-06
 Identities = 20/51 (39%), Positives = 33/51 (64%), Gaps = 1/51 (1%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           +P +I+  I     +A++++H     ++HRD+K  N+LI+  G VKLCDFG
Sbjct: 100 IPEDILGKIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFG 149

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 2e-06
 Identities = 18/36 (50%), Positives = 27/36 (75%), Gaps = 2/36 (5%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           A++H+H  +  IV+RDLK EN+L+ + G + LCDFG
Sbjct: 108 ALEHLHKYD--IVYRDLKPENILLDATGHIALCDFG 141

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.0 bits (109), Expect = 2e-06
 Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 16/80 (20%)

Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           Q   AV H+H ++  ++HRD+K  N+L+ S G VKL DFG +  K+Y+          + 
Sbjct: 151 QVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFS--KMYA----------AT 196

Query: 115 LEDEMAR-FT-TPMYRAPEM 132
           + D++ R F  TP Y APE+
Sbjct: 197 VSDDVGRTFCGTPYYVAPEI 216

Length = 496

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.8 bits (108), Expect = 2e-06
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 16/114 (14%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GG+L D++    + +    + ++     +A+  +H Q   ++HRD+K ++
Sbjct: 91  ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDS 146

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +L++  G VKL DFG            + AQ    +    +   TP + APE++
Sbjct: 147 ILLTHDGRVKLSDFG------------FCAQVSKEVPRRKSLVGTPYWMAPELI 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 45.7 bits (108), Expect = 2e-06
 Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 26/124 (20%)

Query: 23  ILTELCTGGSLVD-VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+ E C GG L+  + ++R      + + S   Q    +KH+H +   I+HRD+K +N+ 
Sbjct: 76  IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIF 133

Query: 82  ISSAGTV-KLCDFGSATEKVYSPDNAWSAQQRSMLED--EMAR--FTTPMYRAPEMVDT- 135
           +S  G V KL DFG A                  L D  E+A     TP Y +PE+    
Sbjct: 134 LSKNGMVAKLGDFGIA----------------RQLNDSMELAYTCVGTPYYLSPEICQNR 177

Query: 136 -WNN 138
            +NN
Sbjct: 178 PYNN 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 45.2 bits (107), Expect = 2e-06
 Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 16/115 (13%)

Query: 22  LILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            I+TE    GSLVD LK      L  N +  +  Q  + +  +  +N   +HRDL+  N+
Sbjct: 76  YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANI 133

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPM-YRAPEMVD 134
           L+S     K+ DFG A       DN ++A+       E A+F  P+ + APE ++
Sbjct: 134 LVSETLCCKIADFGLAR---LIEDNEYTAR-------EGAKF--PIKWTAPEAIN 176

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.4 bits (108), Expect = 2e-06
 Identities = 19/51 (37%), Positives = 31/51 (60%), Gaps = 1/51 (1%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           +P  I+  I   T +A+ ++  +   I+HRD+K  N+L+   G +KLCDFG
Sbjct: 104 IPEEILGKIAVATVKALNYLK-EELKIIHRDVKPSNILLDRNGNIKLCDFG 153

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 45.4 bits (107), Expect = 2e-06
 Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 23/115 (20%)

Query: 23  ILTELCTGGSLVDVLKERTSAL-PPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+   C GG L   LKE+   L P N V     Q   A++++H ++  I+HRDLK +N+ 
Sbjct: 77  IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVF 134

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLED--EMAR--FTTPMYRAPEM 132
           ++    +K+ D G A                 +LE+  +MA     TP Y +PE+
Sbjct: 135 LTRTNIIKVGDLGIA----------------RVLENQCDMASTLIGTPYYMSPEL 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 45.1 bits (107), Expect = 2e-06
 Identities = 23/74 (31%), Positives = 37/74 (50%), Gaps = 2/74 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+TE    G L++ L+ER   L    +  +    C+A++++       +HRDL   N L+
Sbjct: 76  IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLV 133

Query: 83  SSAGTVKLCDFGSA 96
                VK+ DFG A
Sbjct: 134 GEDNVVKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 45.2 bits (107), Expect = 3e-06
 Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 11/83 (13%)

Query: 25  TELC------TGGSL---VDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           T+LC       GG L   +  + E     P    C    Q    ++H+H +   I++RDL
Sbjct: 66  TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDL 123

Query: 76  KIENLLISSAGTVKLCDFGSATE 98
           K EN+L+ + G V++ D G A E
Sbjct: 124 KPENVLLDNDGNVRISDLGLAVE 146

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 45.4 bits (107), Expect = 3e-06
 Identities = 20/52 (38%), Positives = 33/52 (63%), Gaps = 2/52 (3%)

Query: 47  NIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
           N++  ++ Q    ++ +H     IVHRD+K ENLL++  G VK+ DFG+A +
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVD 358

Length = 507

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 45.0 bits (107), Expect = 3e-06
 Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 3/75 (4%)

Query: 23  ILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE  + GSL+D LK      L    +  +  Q  + + ++  +N   +HRDL   N+L
Sbjct: 78  IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNIL 135

Query: 82  ISSAGTVKLCDFGSA 96
           +      K+ DFG A
Sbjct: 136 VGENLVCKIADFGLA 150

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 14/101 (13%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           L   + +    L P  V   L+Q  + + ++H +   I+HRDLK +NLLIS  G +KL D
Sbjct: 89  LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLAD 146

Query: 93  FGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           FG A  K   P + +S +             T  YR P+++
Sbjct: 147 FGLARAKSV-PSHTYSNE-----------VVTLWYRPPDVL 175

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 44.8 bits (106), Expect = 3e-06
 Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 11/83 (13%)

Query: 16  HGMHEY----LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           H M ++     +L E   GGSL     E T       +  +  Q    + ++H ++  IV
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHRRH--IV 190

Query: 72  HRDLKIENLLISSAGTVKLCDFG 94
           HRD+K  NLLI+SA  VK+ DFG
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFG 213

Length = 353

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 45.0 bits (106), Expect = 3e-06
 Identities = 28/76 (36%), Positives = 39/76 (51%), Gaps = 4/76 (5%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+L E   GG     L+ R    P ++ C    Q     +++   N  IV+RDLK ENL
Sbjct: 107 YLVL-EFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENL 162

Query: 81  LISSAGTVKLCDFGSA 96
           L+   G +K+ DFG A
Sbjct: 163 LLDKDGFIKMTDFGFA 178

Length = 340

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 44.5 bits (105), Expect = 4e-06
 Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 20/115 (17%)

Query: 21  YLILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           + I+TE C G  L   L+E       L  N VC    Q    V +MH +   I+HRDLK 
Sbjct: 77  FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKA 134

Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPE 131
           +N+ + +   +K+ DFG +   + S D A +             FT TP Y +PE
Sbjct: 135 KNIFLKN-NLLKIGDFGVSRLLMGSCDLATT-------------FTGTPYYMSPE 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 44.7 bits (106), Expect = 4e-06
 Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 8/63 (12%)

Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           I+HRD+K  N+LI+  G +KL DFG A         A+S  + S       R  T  YR 
Sbjct: 140 ILHRDMKAANILITKDGILKLADFGLA--------RAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 130 PEM 132
           PE+
Sbjct: 192 PEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 44.8 bits (106), Expect = 4e-06
 Identities = 25/79 (31%), Positives = 38/79 (48%), Gaps = 15/79 (18%)

Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           Q    ++H+H +   IV+RDLK EN+L+   G V++ D G A E            ++  
Sbjct: 103 QIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVE--------LKGGKKI- 151

Query: 115 LEDEMARFTTPMYRAPEMV 133
                 R  TP Y APE++
Sbjct: 152 ----KGRAGTPGYMAPEVL 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 44.3 bits (105), Expect = 5e-06
 Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 25/102 (24%)

Query: 57  CQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLE 116
              ++++H     IV+RDLK++NLL+ + G VK+ DFG   E            + S   
Sbjct: 111 VLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKE------GMGFGDRTST-- 160

Query: 117 DEMARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYG 148
                F  TP + APE+         VD W   V+   ML G
Sbjct: 161 -----FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 44.2 bits (104), Expect = 5e-06
 Identities = 37/148 (25%), Positives = 59/148 (39%), Gaps = 24/148 (16%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HS    M     + E   GG L+  +++      P+   ++ +    A+      +  I+
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH---AVFYAAEIAIGLFFLHSKGII 123

Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +RDLK++N+++ S G +K+ DFG   E      N W                TP Y APE
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKE------NMWDGVTTKTF------CGTPDYIAPE 171

Query: 132 M---------VDTWNNYVIGRSMLYGHV 150
           +         VD W   V+   ML G  
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQA 199

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 44.2 bits (104), Expect = 6e-06
 Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 25/100 (25%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A++++H  N  +++RDLK EN+L+   G + LCDFG    K+   D+           D+
Sbjct: 105 ALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLC--KLNMKDD-----------DK 149

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYG 148
              F  TP Y APE+         VD W   V+   ML G
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 43.6 bits (103), Expect = 8e-06
 Identities = 21/78 (26%), Positives = 40/78 (51%), Gaps = 2/78 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+ EL  GGSL+  L+++ + L    +  +       ++++  +N   +HRDL   N L
Sbjct: 68  YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCL 125

Query: 82  ISSAGTVKLCDFGSATEK 99
           +     +K+ DFG + E+
Sbjct: 126 VGENNVLKISDFGMSREE 143

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 44.0 bits (104), Expect = 8e-06
 Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 23/89 (25%)

Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYR 128
           I++RDLK++N+++ + G +K+ DFG   E ++      +             F  TP Y 
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-------------FCGTPDYI 168

Query: 129 APEM---------VDTWNNYVIGRSMLYG 148
           APE+         VD W   V+   ML G
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 43.8 bits (103), Expect = 8e-06
 Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 23/90 (25%)

Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYR 128
           I++RDLK++N+++   G +K+ DFG   E V+              ++  + F  TP Y 
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-------------DNRASTFCGTPDYI 163

Query: 129 APEM---------VDTWNNYVIGRSMLYGH 149
           APE+         VD W+  V+   ML G 
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 43.8 bits (103), Expect = 8e-06
 Identities = 44/139 (31%), Positives = 58/139 (41%), Gaps = 29/139 (20%)

Query: 21  YLILTELCTGGSLVDVL-KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           Y +L +   GG L   L +ER+   P         +   A+ ++H  N  IV+RDLK EN
Sbjct: 72  YFVL-DFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSIN--IVYRDLKPEN 126

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEM------ 132
           +L+ S G V L DFG   E +                D    F  TP Y APE+      
Sbjct: 127 ILLDSQGHVVLTDFGLCKEGI-------------AQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 133 ---VDTWNNYVIGRSMLYG 148
              VD W    +   MLYG
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.9 bits (103), Expect = 8e-06
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 19/89 (21%)

Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +++Q  + +K++H  +  I+HRDLK  NL ++    +K+ DFG A               
Sbjct: 125 LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT------------ 170

Query: 112 RSMLEDEMARF-TTPMYRAPEMVDTWNNY 139
               +DEM  +  T  YRAPE++  W +Y
Sbjct: 171 ----DDEMTGYVATRWYRAPEIMLNWMHY 195

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 43.7 bits (103), Expect = 8e-06
 Identities = 21/72 (29%), Positives = 37/72 (51%), Gaps = 2/72 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+TE  + G L++ L+E      P+ +  +    C+ + ++  +    +HRDL   N L+
Sbjct: 76  IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLV 133

Query: 83  SSAGTVKLCDFG 94
              G VK+ DFG
Sbjct: 134 DDQGCVKVSDFG 145

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.7 bits (103), Expect = 8e-06
 Identities = 33/126 (26%), Positives = 55/126 (43%), Gaps = 25/126 (19%)

Query: 16  HGMHE-YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
               + YL++  + T     D+ K     L  + V  +++Q    +K++H     I+HRD
Sbjct: 90  DEFQDFYLVMPYMQT-----DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRD 142

Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEMV 133
           LK  NL ++    +K+ DFG A                   + EM  +  T  YRAPE++
Sbjct: 143 LKPGNLAVNEDCELKILDFGLARHA----------------DAEMTGYVVTRWYRAPEVI 186

Query: 134 DTWNNY 139
             W +Y
Sbjct: 187 LNWMHY 192

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.7 bits (104), Expect = 8e-06
 Identities = 24/66 (36%), Positives = 36/66 (54%), Gaps = 4/66 (6%)

Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA-GTV 88
            G L D+LK+    L    V  I+ Q  +A+  +H  N  I+H D+K+EN+L   A   +
Sbjct: 93  DGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRI 149

Query: 89  KLCDFG 94
            LCD+G
Sbjct: 150 YLCDYG 155

Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 43.6 bits (103), Expect = 9e-06
 Identities = 26/99 (26%), Positives = 48/99 (48%), Gaps = 23/99 (23%)

Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWS 108
           + S + Q  + + + H +N   +HRD+K  N+L+++ G +KL DFG A  ++Y+ +    
Sbjct: 118 IKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLA--RLYNSE---- 169

Query: 109 AQQRSMLEDEMARFTTPMYRAPEM----------VDTWN 137
            + R        +  T  YR PE+          +D W+
Sbjct: 170 -ESRPYTN----KVITLWYRPPELLLGEERYGPAIDVWS 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 9e-06
 Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 6/74 (8%)

Query: 39  ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA-- 96
           +R+  LP     +I  +  +A+ ++HG+   I+HRD+K EN+ +       L DFG+A  
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACK 234

Query: 97  -TEKVYSP-DNAWS 108
                 +P    WS
Sbjct: 235 LDAHPDTPQCYGWS 248

Length = 392

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.5 bits (102), Expect = 1e-05
 Identities = 39/139 (28%), Positives = 65/139 (46%), Gaps = 22/139 (15%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL++ +   GG L+ +L +    LP ++    L +   A+  +H  +   VHRD+K +N+
Sbjct: 77  YLVM-DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNI 133

Query: 81  LISSAGTVKLCDFGS-----------ATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           L+   G ++L DFGS           ++  V +PD   S +    +ED   ++       
Sbjct: 134 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI-SPEILQAMEDGKGKY------G 186

Query: 130 PEMVDTWNNYVIGRSMLYG 148
           PE  D W+  V    MLYG
Sbjct: 187 PE-CDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 43.3 bits (102), Expect = 1e-05
 Identities = 30/103 (29%), Positives = 46/103 (44%), Gaps = 25/103 (24%)

Query: 46  PNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYSPD 104
           P ++ + L+Q  + + + H     ++HRDLK +NLLI      +KL DFG A        
Sbjct: 101 PRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLA-------- 150

Query: 105 NAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWN 137
            A+    R+   +      T  YRAPE+          VD W+
Sbjct: 151 RAFGIPVRTFTHE----VVTLWYRAPEILLGSRHYSTPVDIWS 189

Length = 294

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 1e-05
 Identities = 24/79 (30%), Positives = 37/79 (46%), Gaps = 15/79 (18%)

Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +    ++ +H +   IV+RDLK EN+L+   G +++ D G A E    P+          
Sbjct: 110 EITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVE---IPEG--------- 155

Query: 115 LEDEMARFTTPMYRAPEMV 133
            E    R  T  Y APE+V
Sbjct: 156 -ETIRGRVGTVGYMAPEVV 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.1 bits (101), Expect = 2e-05
 Identities = 33/108 (30%), Positives = 50/108 (46%), Gaps = 24/108 (22%)

Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 128 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TACT 175

Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+   +    T  YRAPE+         VD W+   I   ++ G V
Sbjct: 176 NFMMTPYV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.1 bits (101), Expect = 2e-05
 Identities = 34/104 (32%), Positives = 46/104 (44%), Gaps = 25/104 (24%)

Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A+ ++H  N  IV+RDLK EN+L+ S G + L DFG   E +   +   S      
Sbjct: 104 EIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNGTTST----- 155

Query: 115 LEDEMARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYG 148
                  F  TP Y APE+         VD W    +   MLYG
Sbjct: 156 -------FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 42.7 bits (100), Expect = 2e-05
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 26/147 (17%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HS         ++ E   GG L+  + +R   LP         + C A+  +H +   I+
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHERG--II 118

Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAP 130
           +RDLK++N+L+ + G +KL D+G   E +   D               + F  TP Y AP
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT-------------STFCGTPNYIAP 165

Query: 131 EM---------VDTWNNYVIGRSMLYG 148
           E+         VD W   V+   M+ G
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 42.7 bits (100), Expect = 2e-05
 Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 24/102 (23%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ ++H +   +V+RDLK+ENL++   G +K+ DFG   E +   D A            
Sbjct: 107 ALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGI--KDGA-----------T 152

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
           M  F  TP Y APE+         VD W   V+   M+ G +
Sbjct: 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 42.6 bits (100), Expect = 2e-05
 Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 25/101 (24%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+  +H +   I++RDLK++N+L+   G  KL DFG   E +++                
Sbjct: 108 ALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT------------ 153

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
            + F  TP Y APE+         VD W   V+   ML GH
Sbjct: 154 -STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGH 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.5 bits (100), Expect = 2e-05
 Identities = 40/135 (29%), Positives = 52/135 (38%), Gaps = 43/135 (31%)

Query: 56  TCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT-------EKVY------- 101
           TC A++ +H      +HRD+K +N+LI   G +KL DFG  T        K Y       
Sbjct: 111 TC-AIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167

Query: 102 ----SPDNAWSAQQRSMLED-EMARFT------------TPMYRAPEMV---------DT 135
                P   WS   R  L+  E  R              TP Y APE++         D 
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227

Query: 136 WNNYVIGRSMLYGHV 150
           W+  VI   ML G  
Sbjct: 228 WSVGVILYEMLVGQP 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.3 bits (99), Expect = 2e-05
 Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 22/122 (18%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           +E  ++T L  G  L +++K     L    V  +++Q  + +K++H     I+HRDLK  
Sbjct: 93  NEVYLVTNL-MGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPS 147

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEMVDTWN 137
           N+ ++    +++ DFG A +                 +DEM  +  T  YRAPE++  W 
Sbjct: 148 NVAVNEDCELRILDFGLARQA----------------DDEMTGYVATRWYRAPEIMLNWM 191

Query: 138 NY 139
           +Y
Sbjct: 192 HY 193

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 42.6 bits (100), Expect = 2e-05
 Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 19/89 (21%)

Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +++Q  + +K++H     I+HRDLK  NL ++    +K+ DFG A +             
Sbjct: 123 LVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQT------------ 168

Query: 112 RSMLEDEMARF-TTPMYRAPEMVDTWNNY 139
               + EM  +  T  YRAPE++  W +Y
Sbjct: 169 ----DSEMTGYVVTRWYRAPEVILNWMHY 193

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 3e-05
 Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 30/165 (18%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPI 70
            S     +  L+  + C GG L  +L+ +    L   +      +   A++++H     I
Sbjct: 68  ASFQTETYLCLV-MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--I 124

Query: 71  VHRDLKIENLLISSAGTVKLCDF---------GSATEKVYSPDNAWSAQQRSMLE---DE 118
           V+RDLK EN+L+  +G + L DF              K     +  S+      E   +E
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184

Query: 119 MARFT-----TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
            +  +     T  Y APE+         VD W   ++   MLYG 
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 41.7 bits (98), Expect = 4e-05
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 15/78 (19%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ H+H     I++RD+K+EN+L+ S G V L DFG +  K +  +           E+ 
Sbjct: 117 ALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLS--KEFLAEE----------EER 162

Query: 119 MARFT-TPMYRAPEMVDT 135
              F  T  Y APE++  
Sbjct: 163 AYSFCGTIEYMAPEVIRG 180

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 41.5 bits (97), Expect = 4e-05
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 14/113 (12%)

Query: 23  ILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSL+D LK +  S  P   +     Q  + +  +  +N   +HRDL+  N+L
Sbjct: 77  IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANIL 134

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +S++   K+ DFG A       DN ++A+       E A+F    + APE ++
Sbjct: 135 VSASLVCKIADFGLAR---VIEDNEYTAR-------EGAKFPIK-WTAPEAIN 176

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 41.5 bits (97), Expect = 5e-05
 Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 18/115 (15%)

Query: 23  ILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           I+TE    GSL+D LK        LP  I  S   Q  + + ++  +N   +HRDL+  N
Sbjct: 78  IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA--QIAEGMAYIERKN--YIHRDLRAAN 133

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +L+S +   K+ DFG A  +V   DN ++A+       E A+F    + APE ++
Sbjct: 134 VLVSESLMCKIADFGLA--RVIE-DNEYTAR-------EGAKFPIK-WTAPEAIN 177

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 41.5 bits (97), Expect = 5e-05
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 31/97 (31%)

Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLED-EMARFT-TPMY 127
           IV+RDLK++N+L+ + G +K+ DFG   E              +ML D +   F  TP Y
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKE--------------NMLGDAKTCTFCGTPDY 162

Query: 128 RAPEM---------VDTWN------NYVIGRSMLYGH 149
            APE+         VD W+        +IG+S  +GH
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 41.6 bits (97), Expect = 5e-05
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 15/82 (18%)

Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 124 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 171

Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+   +    T  YRAPE++
Sbjct: 172 SFMMTPYV---VTRYYRAPEVI 190

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 6e-05
 Identities = 21/60 (35%), Positives = 34/60 (56%), Gaps = 2/60 (3%)

Query: 37  LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           L  R   L    V ++  Q   A+ ++HG+   I+HRD+K EN+L++    + L DFG+A
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAA 307

Length = 461

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 41.2 bits (96), Expect = 6e-05
 Identities = 39/147 (26%), Positives = 61/147 (41%), Gaps = 26/147 (17%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HS          + E   GG L+  + +R   LP         +   A+ ++H +   I+
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLHERG--II 118

Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAP 130
           +RDLK++N+L+ S G +KL D+G   E +   D               + F  TP Y AP
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-------------STFCGTPNYIAP 165

Query: 131 EM---------VDTWNNYVIGRSMLYG 148
           E+         VD W   V+   M+ G
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 41.2 bits (96), Expect = 6e-05
 Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 25/106 (23%)

Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A+ ++H     IV+RDLK+ENL++   G +K+ DFG   E +   D A        
Sbjct: 103 EIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGI--TDAA-------- 150

Query: 115 LEDEMARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
               M  F  TP Y APE+         VD W   V+   M+ G +
Sbjct: 151 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.2 bits (96), Expect = 6e-05
 Identities = 18/53 (33%), Positives = 32/53 (60%), Gaps = 9/53 (16%)

Query: 52  ILWQT-------CQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT 97
           +L QT         AV+++H +   ++HRD+K+EN+ ++  G + L DFG+A 
Sbjct: 265 LLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDFGTAM 315

Length = 501

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 7e-05
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 42/167 (25%)

Query: 18  MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           ++ YLI+ E   GG ++ +L ++ + L        + +T  A+  +H      +HRD+K 
Sbjct: 74  LNLYLIM-EFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSIHQLG--FIHRDIKP 129

Query: 78  ENLLISSAGTVKLCDFGSAT--EKVYSPD------------------------NAWSAQQ 111
           +NLL+ S G VKL DFG  T  +K +  +                          W   +
Sbjct: 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189

Query: 112 RSMLEDEMARFTTPMYRAPE---------MVDTWNNYVIGRSMLYGH 149
           R +     +   TP Y APE         + D W+  VI   ML G+
Sbjct: 190 RQL---AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 41.3 bits (97), Expect = 7e-05
 Identities = 25/87 (28%), Positives = 44/87 (50%), Gaps = 8/87 (9%)

Query: 51  SILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDN--AWS 108
           SI  + C  ++++H +   ++HRDLK +N+L+   G V + D+G+A  K    ++     
Sbjct: 117 SIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 109 AQQRSMLEDEMAR----FTTPMYRAPE 131
             +R++    M        TP Y APE
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPE 201

Length = 932

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.1 bits (96), Expect = 7e-05
 Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 21/79 (26%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A++H+H     IV+RD+K+EN+L+ S G V L DFG + E                L +E
Sbjct: 117 ALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKE---------------FLSEE 159

Query: 119 MARF----TTPMYRAPEMV 133
             R      T  Y APE++
Sbjct: 160 KERTYSFCGTIEYMAPEII 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 41.1 bits (96), Expect = 7e-05
 Identities = 20/47 (42%), Positives = 30/47 (63%), Gaps = 2/47 (4%)

Query: 53  LWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           L+Q  + + + H +   ++HRDLK +NLLI+  G +KL DFG A  K
Sbjct: 110 LFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAK 154

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 41.0 bits (96), Expect = 7e-05
 Identities = 23/77 (29%), Positives = 41/77 (53%), Gaps = 3/77 (3%)

Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 77  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 134

Query: 80  LLISSAGTVKLCDFGSA 96
            L+     VK+ DFG +
Sbjct: 135 CLVGENHLVKVADFGLS 151

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.0 bits (96), Expect = 8e-05
 Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 25/104 (24%)

Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A+  +H +   I++RDLK++N+L+ + G +KL D+G   E +   D          
Sbjct: 104 EISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT-------- 153

Query: 115 LEDEMARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYG 148
                + F  TP Y APE+         VD W   V+   M+ G
Sbjct: 154 -----STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 8e-05
 Identities = 38/148 (25%), Positives = 61/148 (41%), Gaps = 36/148 (24%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           + YL++     GG L+ +L +    LP ++    L +   A+  +H      VHRD+K +
Sbjct: 75  NLYLVMDYYV-GGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPD 131

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TPMYRAPEMV- 133
           N+L+   G ++L DFGS                  +L D   +      TP Y +PE++ 
Sbjct: 132 NVLLDKNGHIRLADFGSCLR---------------LLADGTVQSNVAVGTPDYISPEILQ 176

Query: 134 -------------DTWNNYVIGRSMLYG 148
                        D W+  V    MLYG
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 40.7 bits (95), Expect = 8e-05
 Identities = 36/117 (30%), Positives = 53/117 (45%), Gaps = 23/117 (19%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           +LIL +   GG L   L +R        V     +   A++H+H     I++RD+K+EN+
Sbjct: 81  HLIL-DYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENI 136

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF----TTPMYRAPEMV 133
           L+ S G V L DFG + E                 EDE+ R      T  Y AP++V
Sbjct: 137 LLDSNGHVVLTDFGLSKE---------------FHEDEVERAYSFCGTIEYMAPDIV 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 40.8 bits (95), Expect = 8e-05
 Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 25/91 (27%)

Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF--TTPMY 127
           I++RDLK++N+++ S G +K+ DFG   E               M++    R    TP Y
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKE--------------HMVDGVTTRTFCGTPDY 167

Query: 128 RAPEM---------VDTWNNYVIGRSMLYGH 149
            APE+         VD W   V+   ML G 
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.9 bits (96), Expect = 9e-05
 Identities = 26/99 (26%), Positives = 41/99 (41%), Gaps = 5/99 (5%)

Query: 1   MEYLSAAFIDKH---STPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTC 57
           +  L    I K+       G     ++ E    GSL D L+     +    +     Q C
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119

Query: 58  QAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           + + ++  Q    +HRDL   N+L+ S   VK+ DFG A
Sbjct: 120 KGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLA 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 9e-05
 Identities = 42/141 (29%), Positives = 63/141 (44%), Gaps = 26/141 (18%)

Query: 22  LILTELCTGGSLVDVLKERTSALPP---NIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           L++ E  +GG L   +K+R     P     V  + +Q   A+  +H +   ++HRDLK  
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSA 198

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEM----- 132
           N+ +   G +KL DFG +  K YS          S+  D  + F  TP Y APE+     
Sbjct: 199 NIFLMPTGIIKLGDFGFS--KQYSD---------SVSLDVASSFCGTPYYLAPELWERKR 247

Query: 133 ----VDTWNNYVIGRSMLYGH 149
                D W+  VI   +L  H
Sbjct: 248 YSKKADMWSLGVILYELLTLH 268

Length = 478

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 40.5 bits (95), Expect = 1e-04
 Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 10/88 (11%)

Query: 22  LILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            I+TEL   GSL++ L+    R   LP  I   +  Q    + ++  QN   +HRDL   
Sbjct: 77  YIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQN--YIHRDLAAR 132

Query: 79  NLLISSAGTVKLCDFGSA---TEKVYSP 103
           N+L+      K+ DFG A    E +Y  
Sbjct: 133 NVLVGENNICKVADFGLARVIKEDIYEA 160

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 40.5 bits (95), Expect = 1e-04
 Identities = 28/102 (27%), Positives = 48/102 (47%), Gaps = 5/102 (4%)

Query: 15  PHG-MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
            HG +HE+L+     +        +   S+L  +    I  Q    ++++   +   VHR
Sbjct: 91  AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHR 148

Query: 74  DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSML 115
           DL   N L+    TVK+ DFG + + +YS D  +  Q +S+L
Sbjct: 149 DLAARNCLVGEGLTVKISDFGLSRD-IYSAD-YYRVQSKSLL 188

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 40.2 bits (94), Expect = 1e-04
 Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 21/98 (21%)

Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNI--------VCSILWQTCQAVKHMHGQNPPIV 71
           Y+I+ EL  GG L+  L++ R     P +        +C  + + C  ++ MH      +
Sbjct: 75  YIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-----FI 128

Query: 72  HRDLKIENLLISSAG-----TVKLCDFGSATEKVYSPD 104
           HRDL   N L+S  G      VK+ DFG A + +Y  D
Sbjct: 129 HRDLAARNCLVSEKGYDADRVVKIGDFGLARD-IYKSD 165

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 40.4 bits (94), Expect = 1e-04
 Identities = 20/47 (42%), Positives = 30/47 (63%), Gaps = 2/47 (4%)

Query: 53  LWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           L+Q  + + + H +   ++HRDLK +NLLI+  G +KL DFG A  K
Sbjct: 110 LYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAK 154

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 1e-04
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 36/161 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLI+ E   GG ++ +L ++ + L        + +T  A+  +H      +HRD+K +NL
Sbjct: 77  YLIM-EFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNL 132

Query: 81  LISSAGTVKLCDFGSAT------------EKVYSPDNAWSAQ-----------QRSMLED 117
           L+ + G VKL DFG  T               ++P + +S Q           +++  + 
Sbjct: 133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQL 192

Query: 118 EMARFTTPMYRAPE---------MVDTWNNYVIGRSMLYGH 149
             +   TP Y APE         + D W+  VI   ML G+
Sbjct: 193 AYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 40.1 bits (94), Expect = 1e-04
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 12/97 (12%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTV-KLCDFGSATEKVYS 102
           L        ++Q  + +K++H  N  ++HRDLK  N+ I++   V K+ DFG A  ++  
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLA--RIVD 166

Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           P        +  L + +    T  YR+P ++ + NNY
Sbjct: 167 PH----YSHKGYLSEGL---VTKWYRSPRLLLSPNNY 196

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 40.2 bits (94), Expect = 1e-04
 Identities = 30/99 (30%), Positives = 42/99 (42%), Gaps = 29/99 (29%)

Query: 62  HMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR 121
           H HG    +++RDLK++N+L+ + G  KL DFG   E               +L      
Sbjct: 113 HRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKE--------------GILNGVTTT 154

Query: 122 -FT-TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
            F  TP Y APE+         VD W   V+   M+ G 
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 40.0 bits (93), Expect = 1e-04
 Identities = 20/47 (42%), Positives = 30/47 (63%), Gaps = 2/47 (4%)

Query: 53  LWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           ++Q  + + + H +   I+HRDLK +NLLI+  G +KL DFG A  K
Sbjct: 109 MFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAK 153

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 2e-04
 Identities = 16/34 (47%), Positives = 21/34 (61%)

Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD 104
           +HRDL   N+L+S    VK+CDFG A +    PD
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD 229

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.8 bits (93), Expect = 2e-04
 Identities = 16/34 (47%), Positives = 21/34 (61%)

Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD 104
           +HRDL   N+L+S    VK+CDFG A +    PD
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD 228

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 39.6 bits (92), Expect = 2e-04
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 10/92 (10%)

Query: 23  ILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           I+TE  + GSL+D LK+   R   LP N+V  +  Q    + ++   N   +HRDL+  N
Sbjct: 77  IVTEYMSKGSLLDFLKDGEGRALKLP-NLV-DMAAQVAAGMAYIERMN--YIHRDLRSAN 132

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+      K+ DFG A       DN ++A+Q
Sbjct: 133 ILVGDGLVCKIADFGLAR---LIEDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 39.5 bits (92), Expect = 2e-04
 Identities = 21/73 (28%), Positives = 39/73 (53%), Gaps = 2/73 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +++ E+ +GG L   L  +   +  + V  ++ Q    +K++ G+N   VHRDL   N+L
Sbjct: 70  MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVL 127

Query: 82  ISSAGTVKLCDFG 94
           + +    K+ DFG
Sbjct: 128 LVNQHYAKISDFG 140

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 3e-04
 Identities = 16/34 (47%), Positives = 21/34 (61%)

Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD 104
           +HRDL   N+L+S    VK+CDFG A +    PD
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD 234

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.4 bits (92), Expect = 3e-04
 Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 22/89 (24%)

Query: 48  IVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATE-KV---YS 102
           I+ +I+ Q   A+  +H     IVHRD+K +N++ S  +G+ K+ D G+A + +V   Y 
Sbjct: 256 IIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI 313

Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           P        +  L D       P Y APE
Sbjct: 314 P--------KEFLLD-------PRYAAPE 327

Length = 566

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 39.2 bits (91), Expect = 4e-04
 Identities = 20/51 (39%), Positives = 31/51 (60%), Gaps = 5/51 (9%)

Query: 49  VCSILW---QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           +C IL       +A++++H     I+HRD+K EN+ I+  G V L DFG+A
Sbjct: 181 ICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 38.9 bits (90), Expect = 4e-04
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 8/91 (8%)

Query: 23  ILTELCTGGSLVDVLKERTSALP--PNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I+TE  + GSL+D LK         P +V  +  Q    + ++   N   VHRDL+  N+
Sbjct: 77  IVTEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMN--YVHRDLRAANI 133

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           L+      K+ DFG A       DN ++A+Q
Sbjct: 134 LVGENLVCKVADFGLAR---LIEDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 38.8 bits (90), Expect = 5e-04
 Identities = 21/74 (28%), Positives = 41/74 (55%), Gaps = 2/74 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++T+L   GSL+D +++   +L P  + +   Q  + + ++      +VHR+L   N+L+
Sbjct: 85  LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILL 142

Query: 83  SSAGTVKLCDFGSA 96
            S   V++ DFG A
Sbjct: 143 KSDSIVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 38.5 bits (89), Expect = 6e-04
 Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 15/79 (18%)

Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           + C  ++ +H +   IV+RDLK EN+L+   G +++ D G A   V+ P+          
Sbjct: 110 EICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA---VHVPEG--------- 155

Query: 115 LEDEMARFTTPMYRAPEMV 133
            +    R  T  Y APE+V
Sbjct: 156 -QTIKGRVGTVGYMAPEVV 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 38.1 bits (88), Expect = 7e-04
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 10/92 (10%)

Query: 23  ILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           I+TE    GSL+D LKE   +   LP   +  +  Q    + ++   N   +HRDL+  N
Sbjct: 77  IVTEFMGKGSLLDFLKEGDGKYLKLPQ--LVDMAAQIADGMAYIERMN--YIHRDLRAAN 132

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+      K+ DFG A       DN ++A+Q
Sbjct: 133 ILVGDNLVCKIADFGLAR---LIEDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 38.4 bits (89), Expect = 7e-04
 Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 3/90 (3%)

Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           GG ++ +L  R    P ++    + +   AV+ +H      +HRD+K +N+LI   G +K
Sbjct: 85  GGDMMSLLI-RMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIK 141

Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEM 119
           L DFG  T   ++ D+ +      + +D M
Sbjct: 142 LTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 38.0 bits (88), Expect = 7e-04
 Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 3/62 (4%)

Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS 102
           AL    + S  WQ  + ++++      +VHRDL   N+L++    +K+ DFG  +  VY 
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFG-LSRDVYE 179

Query: 103 PD 104
            D
Sbjct: 180 ED 181

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 37.8 bits (88), Expect = 8e-04
 Identities = 22/72 (30%), Positives = 36/72 (50%), Gaps = 2/72 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E    GSL D L++    L    +     Q C+ ++++  +    VHRDL   N+L+
Sbjct: 84  LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILV 141

Query: 83  SSAGTVKLCDFG 94
            S   VK+ DFG
Sbjct: 142 ESENRVKIGDFG 153

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 37.8 bits (88), Expect = 9e-04
 Identities = 24/89 (26%), Positives = 37/89 (41%), Gaps = 11/89 (12%)

Query: 19  HEYLILTELCTGGSLVDVLKER--TSALPPNIVCSILWQTCQAV----KHMHGQNPPIVH 72
               IL EL  GG L   L+E       P ++    L    + V    K++   +   +H
Sbjct: 82  LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIH 139

Query: 73  RDLKIENLLISSAG---TVKLCDFGSATE 98
           RD+   N L++  G     K+ DFG A +
Sbjct: 140 RDIAARNCLLTCKGPGRVAKIADFGMARD 168

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 37.4 bits (87), Expect = 0.001
 Identities = 12/25 (48%), Positives = 20/25 (80%)

Query: 71  VHRDLKIENLLISSAGTVKLCDFGS 95
           +HRD+K +N+L+  +G +KL DFG+
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGT 188

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 37.3 bits (86), Expect = 0.001
 Identities = 23/80 (28%), Positives = 38/80 (47%), Gaps = 15/80 (18%)

Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +    ++ +H +N   V+RDLK EN+L+   G +++ D G A   V  P+          
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA---VKIPEG--------- 155

Query: 115 LEDEMARFTTPMYRAPEMVD 134
            E    R  T  Y APE+++
Sbjct: 156 -ESIRGRVGTVGYMAPEVLN 174

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 37.2 bits (86), Expect = 0.002
 Identities = 15/40 (37%), Positives = 23/40 (57%), Gaps = 2/40 (5%)

Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           Q C+ + ++  +    VHRDL   N+L+ S   VK+ DFG
Sbjct: 117 QICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFG 154

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 11/89 (12%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKH--MHGQNPPIVHRDLKIENL 80
           ++T+L   G L+D + E       NI   +L   C  +    M+ +   +VHRDL   N+
Sbjct: 85  LVTQLMPHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNV 140

Query: 81  LISSAGTVKLCDFGSA-----TEKVYSPD 104
           L+ S   VK+ DFG A      EK Y+ D
Sbjct: 141 LVKSPNHVKITDFGLARLLEGDEKEYNAD 169

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 36.9 bits (86), Expect = 0.002
 Identities = 23/92 (25%), Positives = 39/92 (42%), Gaps = 10/92 (10%)

Query: 6   AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMH 64
            +FI           Y++ + L   GS  D+LK      LP   +  IL     A+ ++H
Sbjct: 66  TSFIVDSEL------YVV-SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH 118

Query: 65  GQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
             +   +HR +K  ++L+S  G V L     +
Sbjct: 119 --SKGFIHRSVKASHILLSGDGKVVLSGLRYS 148

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 37.1 bits (86), Expect = 0.002
 Identities = 16/37 (43%), Positives = 24/37 (64%)

Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAW 107
           +HRD+K +N+LI   G +KL DFG +T      D+A+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 36.6 bits (85), Expect = 0.002
 Identities = 12/27 (44%), Positives = 16/27 (59%)

Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSA 96
            VHRDL   N +++   TVK+ DFG  
Sbjct: 140 FVHRDLAARNCMVAEDLTVKIGDFGMT 166

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 36.9 bits (85), Expect = 0.002
 Identities = 18/58 (31%), Positives = 31/58 (53%), Gaps = 2/58 (3%)

Query: 41  TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
           +  L    + S  +Q  + ++ +  +N   VHRDL   N+L++    VK+CDFG A +
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARD 286

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 36.6 bits (85), Expect = 0.002
 Identities = 19/74 (25%), Positives = 38/74 (51%), Gaps = 2/74 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++T+L   G L+D ++     +    + +   Q  + + ++  +   +VHRDL   N+L+
Sbjct: 85  LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLV 142

Query: 83  SSAGTVKLCDFGSA 96
            +   VK+ DFG A
Sbjct: 143 KTPQHVKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 36.4 bits (84), Expect = 0.002
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 4/75 (5%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            ++ E    GSL D L +    L   ++ +   Q C+ + ++H Q+   +HRDL   N+L
Sbjct: 84  QLIMEYVPLGSLRDYLPKHKLNLAQLLLFA--QQICEGMAYLHSQH--YIHRDLAARNVL 139

Query: 82  ISSAGTVKLCDFGSA 96
           + +   VK+ DFG A
Sbjct: 140 LDNDRLVKIGDFGLA 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 36.5 bits (84), Expect = 0.002
 Identities = 28/117 (23%), Positives = 55/117 (47%), Gaps = 16/117 (13%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           + Y+++ E   GG LV+++      +P         +   A+  +H     ++HRD+K +
Sbjct: 117 YLYMVM-EYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPD 171

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDT 135
           N+L+   G +KL DFG+  +            +  M+  + A   TP Y +PE++ +
Sbjct: 172 NMLLDKHGHLKLADFGTCMK----------MDETGMVRCDTA-VGTPDYISPEVLKS 217

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 36.4 bits (84), Expect = 0.003
 Identities = 21/73 (28%), Positives = 35/73 (47%), Gaps = 2/73 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +I+TE    G+L   L++         +  +L      +K++   N   VHRDL   N+L
Sbjct: 81  MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNIL 138

Query: 82  ISSAGTVKLCDFG 94
           ++S    K+ DFG
Sbjct: 139 VNSNLVCKVSDFG 151

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 36.5 bits (84), Expect = 0.003
 Identities = 21/74 (28%), Positives = 39/74 (52%), Gaps = 2/74 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++T+L   G L+D ++E    +    + +   Q  + + ++  +   +VHRDL   N+L+
Sbjct: 85  LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL--EEVRLVHRDLAARNVLV 142

Query: 83  SSAGTVKLCDFGSA 96
            S   VK+ DFG A
Sbjct: 143 KSPNHVKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 36.1 bits (83), Expect = 0.004
 Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 11/89 (12%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTC-QAVKHM-HGQNPPIVHRDLKIENL 80
           ++T+L   G L+D ++E       NI    L   C Q  K M + +   +VHRDL   N+
Sbjct: 85  LITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNV 140

Query: 81  LISSAGTVKLCDFG-----SATEKVYSPD 104
           L+ +   VK+ DFG      A EK Y  +
Sbjct: 141 LVKTPQHVKITDFGLAKLLGADEKEYHAE 169

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 36.1 bits (83), Expect = 0.004
 Identities = 31/118 (26%), Positives = 51/118 (43%), Gaps = 16/118 (13%)

Query: 21  YLILTELCTGGSLVDVLKERTSA----LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           YL++ E C  G L   L+    A      P  +  +  +    + H+H  N   +H DL 
Sbjct: 70  YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLA 127

Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           + N L+++  TVK+ D+G +  K Y  D   +  Q          +    + APE+VD
Sbjct: 128 LRNCLLTADLTVKIGDYGLSHNK-YKEDYYVTPDQ---------LWVPLRWIAPELVD 175

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 35.8 bits (83), Expect = 0.004
 Identities = 15/34 (44%), Positives = 20/34 (58%), Gaps = 1/34 (2%)

Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD 104
           VHRDL   N L+    T+K+ DFG +   +YS D
Sbjct: 152 VHRDLATRNCLVGKNYTIKIADFGMSRN-LYSSD 184

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 36.1 bits (83), Expect = 0.004
 Identities = 21/67 (31%), Positives = 31/67 (46%), Gaps = 2/67 (2%)

Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
             +  D L   + AL    +    +Q    ++ +  +N   VHRDL   N+LI     VK
Sbjct: 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLVK 279

Query: 90  LCDFGSA 96
           +CDFG A
Sbjct: 280 ICDFGLA 286

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	150
KOG0595|consensus	429		100.0
KOG0598|consensus	357		100.0
KOG0615|consensus	475		99.98
KOG0616|consensus	355		99.97
KOG0575|consensus	592		99.97
KOG0578|consensus	550		99.97
KOG0583|consensus	370		99.97
KOG0198|consensus	313		99.97
KOG0581|consensus	364		99.97
KOG0605|consensus	550		99.97
KOG0592|consensus	604		99.96
KOG0600|consensus	560		99.96
KOG0593|consensus	396		99.96
KOG0192|consensus	362		99.96
KOG0661|consensus	538		99.96
KOG0591|consensus	375		99.96
KOG0588|consensus	786		99.96
KOG1989|consensus	738		99.96
KOG0694|consensus	694		99.96
KOG0599|consensus	411		99.96
KOG4721|consensus	904		99.96
KOG0663|consensus	419		99.95
KOG0612|consensus	1317		99.95
KOG0611|consensus	668		99.95
KOG0597|consensus	808		99.95
KOG0589|consensus	426		99.95
KOG0610|consensus	459		99.95
KOG0582|consensus	516		99.95
KOG0659|consensus	318		99.95
KOG0197|consensus	468		99.95
KOG0594|consensus	323		99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
KOG1187|consensus	361		99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.95
KOG0585|consensus	576		99.94
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.94
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.94
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.94
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.94
KOG0574|consensus	502		99.94
KOG0579|consensus	1187		99.94
KOG0690|consensus	516		99.94
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.94
KOG0986|consensus	591		99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.94
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.94
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.94
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
KOG0604|consensus	400		99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.94
KOG0667|consensus	586		99.94
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.94
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.93
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.93
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.93
KOG0577|consensus	948		99.93
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.93
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.93
KOG0608|consensus	1034		99.93
KOG0696|consensus	683		99.93
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.93
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.93
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.93
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.93
KOG0660|consensus	359		99.93
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.93
PTZ00267	478	NIMA-related protein kinase; Provisional	99.93
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.93
KOG4279|consensus	1226		99.93
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.93
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.93
KOG0658|consensus	364		99.93
KOG4645|consensus	1509		99.93
KOG0201|consensus	467		99.93
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.92
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.92
KOG0194|consensus	474		99.92
KOG0580|consensus	281		99.92
KOG0032|consensus	382		99.92
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.92
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.92
KOG0196|consensus	996		99.92
KOG4717|consensus	864		99.92
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.92
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.92
KOG0607|consensus	463		99.92
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.91
KOG0586|consensus	596		99.91
KOG2345|consensus	302		99.91
KOG0587|consensus	953		99.91
KOG4250|consensus	732		99.91
KOG0033|consensus	355		99.91
KOG3653|consensus	534		99.91
KOG0584|consensus	632		99.91
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.91
PHA03212	391	serine/threonine kinase US3; Provisional	99.91
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.91
KOG0193|consensus	678		99.91
KOG1026|consensus	774		99.91
KOG0614|consensus	732		99.91
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.9
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.9
PHA02988	283	hypothetical protein; Provisional	99.9
PHA03209	357	serine/threonine kinase US3; Provisional	99.9
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.9
KOG1095|consensus	1025		99.9
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.9
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.9
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.9
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.9
KOG2052|consensus	513		99.9
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.9
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.9
PHA03207	392	serine/threonine kinase US3; Provisional	99.9
PHA03211	461	serine/threonine kinase US3; Provisional	99.9
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.9
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.9
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.9
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.9
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.9
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.9
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.9
PTZ00036	440	glycogen synthase kinase; Provisional	99.9
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.9
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.89
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.89
PTZ00283	496	serine/threonine protein kinase; Provisional	99.89
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.89
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.89
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.89
KOG4236|consensus	888		99.89
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.89
KOG0695|consensus	593		99.89
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.89
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.89
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.89
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.89
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.89
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.89
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.89
KOG0666|consensus	438		99.89
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.89
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.89
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.89
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.89
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.89
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.89
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.89
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.89
KOG0984|consensus	282		99.89
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.89
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.89
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.89
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.89
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.88
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.88
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.88
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.88
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.88
KOG0603|consensus	612		99.88
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.88
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.88
PTZ00284	467	protein kinase; Provisional	99.88
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.88
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.88
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.88
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.88
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.88
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.88
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.88
KOG0596|consensus	677		99.88
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.88
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.88
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.88
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.88
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.88
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.88
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.88
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.88
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.88
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.88
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.88
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.88
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.88
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.88
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.88
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.88
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.88
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.88
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.88
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.88
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.88
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.88
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.88
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.88
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.88
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.88
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.88
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.88
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.87
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.87
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.87
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.87
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.87
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.87
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.87
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.87
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.87
KOG0662|consensus	292		99.87
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.87
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.87
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.87
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.87
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.87
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.87
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.87
KOG0983|consensus	391		99.87
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.87
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.87
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.87
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.87
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.87
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.87
KOG1151|consensus	775		99.87
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.87
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.87
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.87
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.87
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.87
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.87
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.87
PHA03210	501	serine/threonine kinase US3; Provisional	99.87
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.87
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.87
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.87
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.87
KOG0671|consensus	415		99.87
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.87
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.87
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.87
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.87
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.87
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.87
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.86
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.86
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.86
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.86
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.86
KOG4257|consensus	974		99.86
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.86
KOG1094|consensus	807		99.86
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.86
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.86
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.86
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.86
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.86
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.86
KOG1152|consensus	772		99.86
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.86
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.86
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.86
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.86
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.86
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.86
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.86
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.86
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.86
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.86
KOG0669|consensus	376		99.86
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.86
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.86
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.86
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.86
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.86
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.86
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.86
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.86
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.86
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.86
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.86
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.86
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.86
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.86
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.85
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.85
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.85
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.85
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.85
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.85
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.85
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.85
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.85
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.85
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.85
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.85
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.85
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.85
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.85
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.85
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.85
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.85
KOG4278|consensus	1157		99.85
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.85
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.85
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.85
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.85
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.85
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.85
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.85
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.85
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.85
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.85
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.85
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.85
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.85
KOG1006|consensus	361		99.84
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.84
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.84
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.84
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.84
KOG0665|consensus	369		99.84
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.84
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.84
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.84
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.84
PLN00009	294	cyclin-dependent kinase A; Provisional	99.84
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.84
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.84
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.84
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.84
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.84
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.84
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.84
KOG0670|consensus	752		99.84
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.84
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.84
PLN00181	793	protein SPA1-RELATED; Provisional	99.84
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.84
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.83
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.83
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.83
KOG1035|consensus	1351		99.83
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.83
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.83
PHA02882	294	putative serine/threonine kinase; Provisional	99.83
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.83
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.83
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.83
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.83
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.83
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.82
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.82
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.82
KOG1345|consensus	378		99.82
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.82
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.82
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.82
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.82
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.82
KOG0200|consensus	609		99.81
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.81
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.81
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.81
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.81
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.81
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.81
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.81
KOG0664|consensus	449		99.81
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.8
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.8
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.8
KOG0576|consensus	829		99.8
KOG0199|consensus	1039		99.79
KOG1027|consensus	903		99.79
KOG1167|consensus	418		99.79
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.79
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.79
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.77
KOG1025|consensus	1177		99.75
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.75
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.72
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.71
KOG0590|consensus	601		99.7
KOG0668|consensus	338		99.67
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.65
PRK09188	365	serine/threonine protein kinase; Provisional	99.64
KOG1165|consensus	449		99.6
KOG0603|consensus	612		99.59
KOG1164|consensus	322		99.53
KOG1024|consensus	563		99.5
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.49
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.47
KOG1163|consensus	341		99.46
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.43
PRK10345	210	hypothetical protein; Provisional	99.39
PRK12274	218	serine/threonine protein kinase; Provisional	99.38
KOG1033|consensus	516		99.37
KOG4158|consensus	598		99.36
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.32
KOG1023|consensus	484		99.3
KOG1166|consensus	974		99.26
PRK14879	211	serine/threonine protein kinase; Provisional	99.26
KOG0195|consensus	448		99.24
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.23
KOG1290|consensus	590		99.19
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.18
KOG0590|consensus	601		99.18
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.16
smart00090	237	RIO RIO-like kinase.	99.16
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.16
KOG1266|consensus	458		99.15
KOG0606|consensus	1205		99.1
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.0
KOG1240|consensus	1431		98.96
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.96
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.91
KOG1243|consensus	690		98.75
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.69
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.69
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.63
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.61
KOG3087|consensus	229		98.54
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.44
KOG0601|consensus	524		98.28
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.22
KOG0606|consensus	1205		98.2
PRK09902	216	hypothetical protein; Provisional	97.96
KOG3741|consensus	655		97.88
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.87
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	97.85
KOG1290|consensus	590		97.83
KOG0601|consensus	524		97.71
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	97.57
KOG2137|consensus	700		97.14
COG0478	304	RIO-like serine/threonine protein kinase fused to	96.96
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.92
KOG1235|consensus	538		96.91
COG0661	517	AarF Predicted unusual protein kinase [General fun	96.83
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	96.62
COG4248	637	Uncharacterized protein with protein kinase and he	95.62
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	95.46
KOG0576|consensus	829		94.04
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	93.64
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	91.24
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	90.54
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	90.16
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	90.09
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	89.17
PRK05231	319	homoserine kinase; Provisional	89.06
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	88.89
PF01636	239	APH: Phosphotransferase enzyme family This family	88.54
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	87.02
KOG2268|consensus	465		86.7
KOG2270|consensus	520		86.66
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	85.87
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	85.74
PRK10271	188	thiK thiamine kinase; Provisional	85.7
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	85.46
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	85.15
COG2334	331	Putative homoserine kinase type II (protein kinase	84.66
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	84.41
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	82.84
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	82.06
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	81.08
PLN02236	344	choline kinase	80.96

>KOG0595|consensus

Probab=100.00  E-value=6.1e-35  Score=206.39  Aligned_cols=131  Identities=29%  Similarity=0.450  Sum_probs=116.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++||.+.+..+..+.+|||||||.||||.++++++ +.+++..++.++.|++.|+++||+++  |+|||+||+|||+
T Consensus        66 l~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLL  142 (429)
T KOG0595|consen   66 LKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILL  142 (429)
T ss_pred             cCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEe
Confidence            45899999999999999999999999999999999876 57999999999999999999999999  9999999999999


Q ss_pred             cCC------CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          83 SSA------GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        83 ~~~------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      ...      ..+||+|||+++.....     .        .--+.+|++.|||||++         |.||.|+++|++++
T Consensus       143 s~~~~~~~~~~LKIADFGfAR~L~~~-----~--------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~  209 (429)
T KOG0595|consen  143 STTARNDTSPVLKIADFGFARFLQPG-----S--------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLT  209 (429)
T ss_pred             ccCCCCCCCceEEecccchhhhCCch-----h--------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHh
Confidence            765      46899999999854311     1        11256899999999996         99999999999999


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       210 g~  211 (429)
T KOG0595|consen  210 GK  211 (429)
T ss_pred             CC
Confidence            86

>KOG0598|consensus

Probab=100.00  E-value=4.3e-34  Score=199.86  Aligned_cols=132  Identities=26%  Similarity=0.376  Sum_probs=117.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      .-||.|+++...+|+..++|+|+||+.||.|+..|.+. +.+++..++.++.+|+.|+.|||+.+  |+|||+||+||++
T Consensus        82 v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILL  158 (357)
T KOG0598|consen   82 IKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILL  158 (357)
T ss_pred             CCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeee
Confidence            45789999999999999999999999999999999764 67999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.+|.+++.|||+++........+            .+.+||+-|||||++         |+||+|+++++|++|.
T Consensus       159 d~~GHi~LtDFgL~k~~~~~~~~t------------~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~  222 (357)
T KOG0598|consen  159 DEQGHIKLTDFGLCKEDLKDGDAT------------RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGK  222 (357)
T ss_pred             cCCCcEEEeccccchhcccCCCcc------------ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCC
Confidence            999999999999998543332211            246899999999994         9999999999999984

>KOG0615|consensus

Probab=99.98  E-value=1.1e-32  Score=195.35  Aligned_cols=134  Identities=27%  Similarity=0.311  Sum_probs=116.1

Q ss_pred             CcccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +++-||+||+.++.++.....|+|+||++||+|.+++-.. ..+.+..-+.++.|++.|+.|+|+.+  |+|||+||+||
T Consensus       231 kkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNI  307 (475)
T KOG0615|consen  231 KKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENI  307 (475)
T ss_pred             HhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceE
Confidence            3567899999999999999999999999999999999754 45777777888999999999999999  99999999999


Q ss_pred             EEcCC---CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEe
Q psy1934          81 LISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSM  145 (150)
Q Consensus        81 l~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~  145 (150)
                      |+..+   -.+|+.|||+++.....             ....+.+|||.|.||||+            |+||+||+++.+
T Consensus       308 Ll~~~~e~~llKItDFGlAK~~g~~-------------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvc  374 (475)
T KOG0615|consen  308 LLSNDAEDCLLKITDFGLAKVSGEG-------------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVC  374 (475)
T ss_pred             EeccCCcceEEEecccchhhccccc-------------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEE
Confidence            99876   57999999999854210             112367899999999994            999999999999


Q ss_pred             eeecC
Q psy1934         146 LYGHV  150 (150)
Q Consensus       146 ~~g~~  150 (150)
                      ++|.+
T Consensus       375 LsG~p  379 (475)
T KOG0615|consen  375 LSGYP  379 (475)
T ss_pred             eccCC
Confidence            99964

>KOG0616|consensus

Probab=99.97  E-value=8e-33  Score=189.16  Aligned_cols=127  Identities=28%  Similarity=0.371  Sum_probs=115.3

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +|.++++...+.+.+.+++||||.+||.|+++|+.. +.++++.++.++.+|+.|++|+|+++  |+.||+||+|+++++
T Consensus       103 ~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~  179 (355)
T KOG0616|consen  103 HPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQ  179 (355)
T ss_pred             CceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeecc
Confidence            578888999999999999999999999999999875 57999999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +|.+|+.|||+++....               +..+.+|||-|+|||++         |+|++|++.+||+.|.
T Consensus       180 ~G~iKitDFGFAK~v~~---------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~  238 (355)
T KOG0616|consen  180 NGHIKITDFGFAKRVSG---------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY  238 (355)
T ss_pred             CCcEEEEeccceEEecC---------------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence            99999999999985421               12356899999999995         9999999999999985

>KOG0575|consensus

Probab=99.97  E-value=4.8e-32  Score=199.45  Aligned_cols=132  Identities=31%  Similarity=0.475  Sum_probs=119.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +=||+||++...+++.+.+|||.|+|+.++|-.+++.+ ..+++++++.++.||+.|+.|||+++  |+|||+|..|+++
T Consensus        75 L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL  151 (592)
T KOG0575|consen   75 LKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFL  151 (592)
T ss_pred             cCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheee
Confidence            45899999999999999999999999999999999854 67999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.+..+||+|||+|........            ++++.+|||.|.||||+         |+||+||++|.++.|+
T Consensus       152 ~~~~~VKIgDFGLAt~le~~~E------------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~  215 (592)
T KOG0575|consen  152 NENMNVKIGDFGLATQLEYDGE------------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGR  215 (592)
T ss_pred             cCcCcEEecccceeeeecCccc------------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCC
Confidence            9999999999999986543222            34577999999999995         9999999999999996

>KOG0578|consensus

Probab=99.97  E-value=1.7e-31  Score=195.09  Aligned_cols=132  Identities=27%  Similarity=0.470  Sum_probs=117.1

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-|++||.+.+.+--++.+|.||||++||+|.+.+...  .+++.++..++++++.|+.|||.++  |+|||+|.+||+
T Consensus       326 ~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnIL  401 (550)
T KOG0578|consen  326 DLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNIL  401 (550)
T ss_pred             hccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeE
Confidence            467899999998888889999999999999999999763  5899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +..++.+|+.|||||........            ...+.+||++|||||++         |+||+|++++||..|.
T Consensus       402 L~~~g~vKltDFGFcaqi~~~~~------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE  466 (550)
T KOG0578|consen  402 LTMDGSVKLTDFGFCAQISEEQS------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE  466 (550)
T ss_pred             eccCCcEEEeeeeeeeccccccC------------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence            99999999999999976533221            22467999999999995         9999999999999885

>KOG0583|consensus

Probab=99.97  E-value=1.3e-31  Score=194.06  Aligned_cols=131  Identities=31%  Similarity=0.451  Sum_probs=117.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+++.++.+..+++++||||+.||+|++++.+ .+.+.+..++.++.|++.|+.|+|+++  ++|||+|++|++++.
T Consensus        79 HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~  155 (370)
T KOG0583|consen   79 HPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDG  155 (370)
T ss_pred             CCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecC
Confidence            78999999999999999999999999999999988 578999999999999999999999999  999999999999999


Q ss_pred             C-CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeeecC
Q psy1934          85 A-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        85 ~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~~  150 (150)
                      + +.+|++|||++.... ....           ...+.+||+.|+|||++           |+||+|++++.|++|.+
T Consensus       156 ~~~~~Kl~DFG~s~~~~-~~~~-----------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~  221 (370)
T KOG0583|consen  156 NEGNLKLSDFGLSAISP-GEDG-----------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRL  221 (370)
T ss_pred             CCCCEEEeccccccccC-CCCC-----------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence            9 999999999998652 1110           01245899999999995           99999999999999964

>KOG0198|consensus

Probab=99.97  E-value=3.7e-30  Score=181.18  Aligned_cols=136  Identities=31%  Similarity=0.453  Sum_probs=113.6

Q ss_pred             ccchhhhcccCCCCCce--EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGMH--EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-||+||+..+......  .+++.|||+++|+|.+++++..+.++++.++.+..|+++|+.|+|+++  ++|+|+|++|+
T Consensus        71 l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~Ni  148 (313)
T KOG0198|consen   71 LNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANI  148 (313)
T ss_pred             CCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceE
Confidence            44789999988644434  699999999999999999876557999999999999999999999999  99999999999


Q ss_pred             EEcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          81 LISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      |++. ++.+|++|||.+.......  ..       ........||+.|||||++          |+||+||++.||++|.
T Consensus       149 Ll~~~~~~~KlaDFG~a~~~~~~~--~~-------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~  219 (313)
T KOG0198|consen  149 LLDPSNGDVKLADFGLAKKLESKG--TK-------SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGK  219 (313)
T ss_pred             EEeCCCCeEEeccCcccccccccc--cc-------ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCC
Confidence            9999 6999999999887543200  00       0112245799999999995          9999999999999984

>KOG0581|consensus

Probab=99.97  E-value=1.8e-31  Score=186.88  Aligned_cols=129  Identities=30%  Similarity=0.419  Sum_probs=113.8

Q ss_pred             cchhhhcccCCCCCce-EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEE
Q psy1934           4 LSAAFIDKHSTPHGMH-EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLL   81 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil   81 (150)
                      -+|+||+..+.+...+ .+.|+||||.+|+|.+.++.. +.+++....+++.++++|+.|||. ++  |+|||+||+|+|
T Consensus       135 ~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlL  211 (364)
T KOG0581|consen  135 QSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLL  211 (364)
T ss_pred             CCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHee
Confidence            4688999999999888 599999999999999999865 568999999999999999999995 77  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.+.|.+|++|||.+.....+              .-.+.+||..|||||.+         |+||+|..+.|++.|+
T Consensus       212 vNskGeVKicDFGVS~~lvnS--------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~Gr  274 (364)
T KOG0581|consen  212 VNSKGEVKICDFGVSGILVNS--------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGR  274 (364)
T ss_pred             eccCCCEEeccccccHHhhhh--------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCC
Confidence            999999999999998754321              11256899999999986         9999999999999885

>KOG0605|consensus

Probab=99.97  E-value=6.1e-31  Score=191.34  Aligned_cols=141  Identities=27%  Similarity=0.377  Sum_probs=115.4

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ++.+|++.+.+++...+||||||++||++..+|... +.|++..++.++.+++.|+..+|+.+  ++||||||+|+|++.
T Consensus       200 s~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~  276 (550)
T KOG0605|consen  200 SPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDA  276 (550)
T ss_pred             CCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecC
Confidence            577999999999999999999999999999999865 67999999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCC---------------------Ccc-----hhH--hh----h---hhhHHhhhcCCCCCccC
Q psy1934          85 AGTVKLCDFGSATEKVYSP---------------------DNA-----WSA--QQ----R---SMLEDEMARFTTPMYRA  129 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~---------------------~~~-----~~~--~~----~---~~~~~~~~~~~~~~y~a  129 (150)
                      .|++|++|||++.-.....                     +..     .+.  ..    +   ....--.+.+|||-|||
T Consensus       277 ~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiA  356 (550)
T KOG0605|consen  277 KGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIA  356 (550)
T ss_pred             CCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccc
Confidence            9999999999986321100                     000     000  00    0   00111234589999999


Q ss_pred             cccc---------cccccceeEEEeeee
Q psy1934         130 PEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus       130 PE~~---------d~~~~g~~~~~~~~g  148 (150)
                      |||+         |+||+||+++||+.|
T Consensus       357 PEVll~kgY~~~cDwWSLG~ImyEmLvG  384 (550)
T KOG0605|consen  357 PEVLLGKGYGKECDWWSLGCIMYEMLVG  384 (550)
T ss_pred             hHHHhcCCCCccccHHHHHHHHHHHHhC
Confidence            9995         999999999999988

>KOG0592|consensus

Probab=99.96  E-value=5e-31  Score=192.20  Aligned_cols=141  Identities=25%  Similarity=0.337  Sum_probs=118.9

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||.|+++..++++...+|+|+||+++|+|.++++.- +.+.+...+.++.+|+.|++|||+++  |||||+||+|||++.
T Consensus       133 hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~  209 (604)
T KOG0592|consen  133 HPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDK  209 (604)
T ss_pred             CCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcC
Confidence            788999999999999999999999999999999864 67999999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCc--chhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDN--AWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++++|.|||.++........  ..... .....+..+.+||-.|++||++         |+|++||++|.|+.|.
T Consensus       210 dmhikITDFGsAK~l~~~~~~~~~~~~~-~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~  284 (604)
T KOG0592|consen  210 DGHIKITDFGSAKILSPSQKSQENPVDP-NQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQ  284 (604)
T ss_pred             CCcEEEeeccccccCChhhccccCccCc-ccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCC
Confidence            999999999999865433221  00000 0000112467999999999996         9999999999999986

>KOG0600|consensus

Probab=99.96  E-value=1.3e-30  Score=188.70  Aligned_cols=134  Identities=23%  Similarity=0.325  Sum_probs=115.9

Q ss_pred             cccchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           2 EYLSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      ++.||+|+++.+-....  +.+|+|+|||+. ||..++.+..-.+++.+++-++.|++.|+.|+|+++  ++|||||.+|
T Consensus       172 ~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SN  248 (560)
T KOG0600|consen  172 RLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSN  248 (560)
T ss_pred             hcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccc
Confidence            46789999988854444  799999999988 999999876567999999999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      ||++.+|.+||+|||+++........           .-++.+-|+||+|||.          +|+||.||++.||+.|+
T Consensus       249 iLidn~G~LKiaDFGLAr~y~~~~~~-----------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk  317 (560)
T KOG0600|consen  249 ILIDNNGVLKIADFGLARFYTPSGSA-----------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK  317 (560)
T ss_pred             eEEcCCCCEEeccccceeeccCCCCc-----------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC
Confidence            99999999999999999865332221           1245678999999998          49999999999999886

>KOG0593|consensus

Probab=99.96  E-value=1.9e-30  Score=178.31  Aligned_cols=133  Identities=29%  Similarity=0.512  Sum_probs=116.7

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      |+-|+++|.+..++.-..+.+||+|||+. ++.+-|.....+++...++.+++|++.|+.|+|+++  ++|||+||+||+
T Consensus        57 qLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENIL  133 (396)
T KOG0593|consen   57 QLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENIL  133 (396)
T ss_pred             hcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheE
Confidence            67799999999999999999999999987 777778777788999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +..++.+|++|||+|+.... +...+           +-.+-|.||+|||.+          |+|+.||+..||+.|.
T Consensus       134 it~~gvvKLCDFGFAR~L~~-pgd~Y-----------TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~  199 (396)
T KOG0593|consen  134 ITQNGVVKLCDFGFARTLSA-PGDNY-----------TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE  199 (396)
T ss_pred             EecCCcEEeccchhhHhhcC-Ccchh-----------hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence            99999999999999985432 11111           233568999999984          9999999999999986

>KOG0192|consensus

Probab=99.96  E-value=7.9e-30  Score=183.74  Aligned_cols=134  Identities=29%  Similarity=0.439  Sum_probs=116.5

Q ss_pred             ccchhhhcccCCCCCce-EEEEEEeccCCCCHHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGMH-EYLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~-~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-||||+.+.++..... ..+|||||+++|+|.+++.. ....++...+..++.+|+.|+.|+|++++ |+|||+|++|+
T Consensus        96 l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~Ni  174 (362)
T KOG0192|consen   96 LRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNI  174 (362)
T ss_pred             CCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhE
Confidence            67899999999888877 79999999999999999987 35679999999999999999999999886 89999999999


Q ss_pred             EEcCCC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeee
Q psy1934          81 LISSAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        81 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g  148 (150)
                      |++.++ ++||+|||+++......            ...+...||+.|||||++           |+||+|+++||+++|
T Consensus       175 Lv~~~~~~~KI~DFGlsr~~~~~~------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~  242 (362)
T KOG0192|consen  175 LVDLKGKTLKIADFGLSREKVISK------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTG  242 (362)
T ss_pred             EEcCCCCEEEECCCccceeecccc------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHC
Confidence            999997 99999999998643221            111235799999999996           799999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       243 ~  243 (362)
T KOG0192|consen  243 E  243 (362)
T ss_pred             C
Confidence            5

>KOG0661|consensus

Probab=99.96  E-value=1.9e-30  Score=186.68  Aligned_cols=126  Identities=29%  Similarity=0.463  Sum_probs=112.2

Q ss_pred             chhhhcccCCCCCce-EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMH-EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      ||+||++.+++.+.+ .+++|||||+- +|+++++.+...+++..++.+++||+.|+.|+|.++  +.|||+||+|||+.
T Consensus        68 hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~  144 (538)
T KOG0661|consen   68 HPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILIS  144 (538)
T ss_pred             CCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEec
Confidence            799999999988888 99999999976 999999988788999999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      ....+||+|||+|+.....+.  +           +..+.|.||+|||++          |+|++||++.|+.
T Consensus       145 ~~~~iKiaDFGLARev~SkpP--Y-----------TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~  204 (538)
T KOG0661|consen  145 GNDVIKIADFGLAREVRSKPP--Y-----------TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELY  204 (538)
T ss_pred             ccceeEecccccccccccCCC--c-----------chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHH
Confidence            999999999999996533221  1           234789999999994          9999999998864

>KOG0591|consensus

Probab=99.96  E-value=8.7e-31  Score=178.51  Aligned_cols=134  Identities=26%  Similarity=0.421  Sum_probs=110.8

Q ss_pred             cccchhhhcccC-CCCCceE-EEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHhcC--CCCeEEec
Q psy1934           2 EYLSAAFIDKHS-TPHGMHE-YLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQ--NPPIVHRD   74 (150)
Q Consensus         2 ~~~~~~~~~~~~-~~~~~~~-~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~--~~~i~h~~   74 (150)
                      |+-|||||++.. .+...++ ++||||+|.+|+|.+.++.   ....+++..+++++.|++.|+.++|..  +..++|||
T Consensus        74 QL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRD  153 (375)
T KOG0591|consen   74 QLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRD  153 (375)
T ss_pred             hcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeecc
Confidence            678999999776 4455555 8999999999999998863   234589999999999999999999983  22399999


Q ss_pred             CCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEe
Q psy1934          75 LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSM  145 (150)
Q Consensus        75 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~  145 (150)
                      +||.||+++.+|.+|+.|||+++.......            .-.+.+|||.||+||++         |+||+||+++||
T Consensus       154 IKPaNIFl~~~gvvKLGDfGL~r~l~s~~t------------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEM  221 (375)
T KOG0591|consen  154 IKPANIFLTANGVVKLGDFGLGRFLSSKTT------------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEM  221 (375)
T ss_pred             CcchheEEcCCCceeeccchhHhHhcchhH------------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence            999999999999999999999986422111            11356899999999996         999999999998


Q ss_pred             ee
Q psy1934         146 LY  147 (150)
Q Consensus       146 ~~  147 (150)
                      ..
T Consensus       222 ca  223 (375)
T KOG0591|consen  222 CA  223 (375)
T ss_pred             Hh
Confidence            63

>KOG0588|consensus

Probab=99.96  E-value=7.7e-30  Score=189.71  Aligned_cols=131  Identities=31%  Similarity=0.435  Sum_probs=117.2

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      .||+++.+.++.+++.++|+|.||+++|.|++++-++ +++++.+...++.||+.|+.|+|..+  |+|||+||+|++++
T Consensus        70 ~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd  146 (786)
T KOG0588|consen   70 EHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLD  146 (786)
T ss_pred             cCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhh
Confidence            4788999999999999999999999999999999876 67888888899999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeecC
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~~  150 (150)
                      .+.++||+|||+|.....+..-             -+.+|+|.|.|||++          |+||.|++++.++.|++
T Consensus       147 ~~~nIKIADFGMAsLe~~gklL-------------eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~L  210 (786)
T KOG0588|consen  147 VKNNIKIADFGMASLEVPGKLL-------------ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKL  210 (786)
T ss_pred             cccCEeeeccceeecccCCccc-------------cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCC
Confidence            9999999999999754322110             145799999999997          99999999999999985

>KOG1989|consensus

Probab=99.96  E-value=1e-29  Score=193.24  Aligned_cols=142  Identities=44%  Similarity=0.764  Sum_probs=119.4

Q ss_pred             chhhhcccC------CCCC-ceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           5 SAAFIDKHS------TPHG-MHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         5 ~~~~~~~~~------~~~~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      |++||.+.+      .... ..++.|.||||+||.|.|+++.+. ..|++.++++++++++.|+.+||...++|||||||
T Consensus        94 h~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLK  173 (738)
T KOG1989|consen   94 HKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLK  173 (738)
T ss_pred             CCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhh
Confidence            567777777      2223 578899999999999999998543 45999999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEE
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRS  144 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~  144 (150)
                      .+|+|++.++..|+||||.+........   ..+.-......+...+|+.|++||++            |||++||++|.
T Consensus       174 iENvLls~~g~~KLCDFGSatt~~~~~~---~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYk  250 (738)
T KOG1989|consen  174 IENVLLSADGNYKLCDFGSATTKILSPT---SAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYK  250 (738)
T ss_pred             hhheEEcCCCCEEeCcccccccccCCCc---cHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHH
Confidence            9999999999999999999876544332   34444556677888999999999996            99999999998


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      ++|..
T Consensus       251 LCy~t  255 (738)
T KOG1989|consen  251 LCYFT  255 (738)
T ss_pred             HHHhC
Confidence            87753

>KOG0694|consensus

Probab=99.96  E-value=2.2e-30  Score=192.97  Aligned_cols=129  Identities=26%  Similarity=0.413  Sum_probs=113.1

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||.+..+..+++..+++|+||||+.||++....+  ...+++..++.+++.|+.|++|+|+++  ||+||+|.+|||++.
T Consensus       428 HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~  503 (694)
T KOG0694|consen  428 HPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDT  503 (694)
T ss_pred             CCeEeecccccccCCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcc
Confidence            7888999999999999999999999999544443  256999999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .|.+||+|||+++...-....            ..+.+|||-|||||++         |+|++||++|||+.|+
T Consensus       504 eGh~kiADFGlcKe~m~~g~~------------TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq  565 (694)
T KOG0694|consen  504 EGHVKIADFGLCKEGMGQGDR------------TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGE  565 (694)
T ss_pred             cCcEEecccccccccCCCCCc------------cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCC
Confidence            999999999999865422221            2356899999999994         9999999999999986

>KOG0599|consensus

Probab=99.96  E-value=3.1e-30  Score=175.60  Aligned_cols=129  Identities=31%  Similarity=0.416  Sum_probs=115.7

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+||++++++++...+++|+|.|+.|.|+|+|.+. -.+++.....++.|+..|+.|+|.++  |+|||+||+|||++.
T Consensus        82 HP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILldd  158 (411)
T KOG0599|consen   82 HPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDD  158 (411)
T ss_pred             CCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeecc
Confidence            788999999999999999999999999999999875 45899999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~~~~g~~~~~~~~g~  149 (150)
                      +.+++++|||+++......             .-...+|||.|.|||++               |.|+.|++++.++.|.
T Consensus       159 n~~i~isDFGFa~~l~~Ge-------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc  225 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGE-------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC  225 (411)
T ss_pred             ccceEEeccceeeccCCch-------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence            9999999999998653221             11246899999999984               9999999999998885

>KOG4721|consensus

Probab=99.96  E-value=8.4e-30  Score=187.51  Aligned_cols=133  Identities=29%  Similarity=0.440  Sum_probs=118.3

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-|+|||.+.+++...-=|||+||||..|.|+.+|+.. ..+....+..|..+|+.|+.|||.++  |||||+|..|||
T Consensus       168 kLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiL  244 (904)
T KOG4721|consen  168 KLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNIL  244 (904)
T ss_pred             hccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceE
Confidence            456899999999999999999999999999999999875 57888888999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeecC
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~~  150 (150)
                      +..+..+||+|||.++...             ....+++..||..|||||++         |+||+|+++|||++|.+
T Consensus       245 Is~~d~VKIsDFGTS~e~~-------------~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~Ei  309 (904)
T KOG4721|consen  245 ISYDDVVKISDFGTSKELS-------------DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEI  309 (904)
T ss_pred             eeccceEEeccccchHhhh-------------hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCC
Confidence            9999999999999876431             11234577899999999995         99999999999998853

>KOG0663|consensus

Probab=99.95  E-value=3.9e-30  Score=178.66  Aligned_cols=133  Identities=29%  Similarity=0.418  Sum_probs=115.4

Q ss_pred             cccchhhhcccC--CCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           2 EYLSAAFIDKHS--TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         2 ~~~~~~~~~~~~--~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +..||||+.+..  ++.+.+.+|+|||||+. +|..++.+...++...+++.++.|++.|+.|||++.  |+|||+|++|
T Consensus       131 ~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SN  207 (419)
T KOG0663|consen  131 KARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSN  207 (419)
T ss_pred             hcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhh
Confidence            456899998777  67778899999999998 999999987778999999999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      +|+...|.+|++|||+|+......            ...+..+-|+||+|||.          +|.||.||++.|++.+.
T Consensus       208 LLm~~~G~lKiaDFGLAR~ygsp~------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k  275 (419)
T KOG0663|consen  208 LLLSHKGILKIADFGLAREYGSPL------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK  275 (419)
T ss_pred             eeeccCCcEEecccchhhhhcCCc------------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC
Confidence            999999999999999998653221            12235678999999998          49999999999988764

>KOG0612|consensus

Probab=99.95  E-value=1.6e-29  Score=196.46  Aligned_cols=130  Identities=27%  Similarity=0.419  Sum_probs=115.0

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~   85 (150)
                      +=|+.+++.+++.+.+|+||||++||+|..++.... .+++.-+++|+..+..|+.-+|+.+  ++|||+||+|+|++..
T Consensus       135 ~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~  211 (1317)
T KOG0612|consen  135 EWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKS  211 (1317)
T ss_pred             HHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEeccc
Confidence            348889999999999999999999999999998764 7999999999999999999999999  9999999999999999


Q ss_pred             CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeeec
Q psy1934          86 GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        86 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g~  149 (150)
                      |+++++|||.|.....++...           ....+|||-|.+||++              |+||+||++|||+||.
T Consensus       212 GHikLADFGsClkm~~dG~V~-----------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~  278 (1317)
T KOG0612|consen  212 GHIKLADFGSCLKMDADGTVR-----------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGE  278 (1317)
T ss_pred             CcEeeccchhHHhcCCCCcEE-----------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCC
Confidence            999999999886554332221           1256899999999994              9999999999999994

>KOG0611|consensus

Probab=99.95  E-value=4.6e-29  Score=177.79  Aligned_cols=131  Identities=28%  Similarity=0.464  Sum_probs=117.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +.||+||.+..++++.+++.|||||..+|.|++++.++ +.+++.+.+.+++||.+|+.|+|.++  ++|||+|.+|||+
T Consensus       110 LNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILL  186 (668)
T KOG0611|consen  110 LNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILL  186 (668)
T ss_pred             cCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheee
Confidence            56899999999999999999999999999999999886 57999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++++|++|||++......  +           --.+.+|++.|-+||++          |.||+|+++|.+.||.
T Consensus       187 D~N~NiKIADFGLSNly~~~--k-----------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGt  250 (668)
T KOG0611|consen  187 DQNNNIKIADFGLSNLYADK--K-----------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGT  250 (668)
T ss_pred             cCCCCeeeeccchhhhhccc--c-----------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcc
Confidence            99999999999998643211  0           11356899999999984          9999999999999884

>KOG0597|consensus

Probab=99.95  E-value=1.7e-29  Score=185.64  Aligned_cols=131  Identities=29%  Similarity=0.482  Sum_probs=116.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|++.+++++..+++|+|+|||.| +|..++... +.++++.++.++.++++|+.|+|+.+  |+|||+||.||++
T Consensus        58 lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl  133 (808)
T KOG0597|consen   58 LKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILL  133 (808)
T ss_pred             cCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeee
Confidence            5689999999999999999999999988 999999764 67999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +..+.+|++|||+++....+-.            ..+...|||.|||||++         |.||+||++||++.|+
T Consensus       134 ~~~~~~KlcdFg~Ar~m~~~t~------------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~  197 (808)
T KOG0597|consen  134 EKGGTLKLCDFGLARAMSTNTS------------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQ  197 (808)
T ss_pred             cCCCceeechhhhhhhcccCce------------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCC
Confidence            9999999999999986532211            11244699999999995         9999999999999986

>KOG0589|consensus

Probab=99.95  E-value=2.8e-29  Score=181.53  Aligned_cols=132  Identities=27%  Similarity=0.400  Sum_probs=115.2

Q ss_pred             cccchhhhcccCCCCCceE-EEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           2 EYLSAAFIDKHSTPHGMHE-YLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~-~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +.+||+||.+.+.+..++. .+|||+||+||++.+.++... ..++++.+..|+.|++.|+.|||+.+  |.|||+|+.|
T Consensus        59 ~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~N  136 (426)
T KOG0589|consen   59 KLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCAN  136 (426)
T ss_pred             hccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhh
Confidence            4689999999998888888 999999999999999998765 45789999999999999999999888  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |++.+++.+++.|||+++......            ..-.+.+||+.||+||++         |+||+||+++||+.
T Consensus       137 ifltk~~~VkLgDfGlaK~l~~~~------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~  201 (426)
T KOG0589|consen  137 IFLTKDKKVKLGDFGLAKILNPED------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT  201 (426)
T ss_pred             hhccccCceeecchhhhhhcCCch------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHh
Confidence            999999999999999998643211            011256899999999996         99999999999863

>KOG0610|consensus

Probab=99.95  E-value=6.7e-29  Score=176.27  Aligned_cols=143  Identities=23%  Similarity=0.274  Sum_probs=115.1

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      ||.+..+...++.....|++||||+||+|..+++.+. ..+++..++.++.+++.|++|||-.+  |+.||+||+|||+.
T Consensus       136 HPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr  213 (459)
T KOG0610|consen  136 HPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR  213 (459)
T ss_pred             CCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe
Confidence            4556668889999999999999999999999887655 45899999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcch------------------------hHhh--------------------hhhhHHhh
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAW------------------------SAQQ--------------------RSMLEDEM  119 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~------------------------~~~~--------------------~~~~~~~~  119 (150)
                      .+|.+.++||.++......+....                        ....                    .......+
T Consensus       214 edGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSn  293 (459)
T KOG0610|consen  214 EDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSN  293 (459)
T ss_pred             cCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccc
Confidence            999999999998875422111000                        0000                    01112344


Q ss_pred             hcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934         120 ARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       120 ~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.+||.-|.|||++         |+|++||++|||+||.
T Consensus       294 SFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~  332 (459)
T KOG0610|consen  294 SFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGT  332 (459)
T ss_pred             ccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCC
Confidence            56899999999995         9999999999999995

>KOG0582|consensus

Probab=99.95  E-value=7.5e-29  Score=177.49  Aligned_cols=138  Identities=29%  Similarity=0.433  Sum_probs=119.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||||+++.-.+.-+..+|+||.||.+|++.+.++..- .++++..+..++.++++|+.|+|+++  -||||+|+.|||
T Consensus        81 ~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnIL  158 (516)
T KOG0582|consen   81 IDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNIL  158 (516)
T ss_pred             cCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEE
Confidence            468999999999999999999999999999999998753 56999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-----------ccccccceeEEEeeeecC
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-----------VDTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-----------~d~~~~g~~~~~~~~g~~  150 (150)
                      ++.+|.++++|||++.......+..        ..+..+.+||++|||||+           .|+||+|+++.|++.|++
T Consensus       159 i~~dG~VkLadFgvsa~l~~~G~R~--------~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~a  230 (516)
T KOG0582|consen  159 IDSDGTVKLADFGVSASLFDSGDRQ--------VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHA  230 (516)
T ss_pred             EcCCCcEEEcCceeeeeecccCcee--------eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCC
Confidence            9999999999999877654432111        011135689999999999           599999999999999985

>KOG0659|consensus

Probab=99.95  E-value=9.7e-29  Score=167.05  Aligned_cols=131  Identities=30%  Similarity=0.355  Sum_probs=115.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++|+.+.+++-..+.+-||+||++. +|+.+++.....++...++.++.++++|+.|+|++.  |+|||+||.|+|++
T Consensus        59 ~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis  135 (318)
T KOG0659|consen   59 KHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS  135 (318)
T ss_pred             cCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc
Confidence            378999999999999999999999988 999999987778999999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      .+|.+|++|||+++.......            ..+..+-|.||+|||.          +|+||.||++.|++-|.
T Consensus       136 ~~g~lKiADFGLAr~f~~p~~------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~  199 (318)
T KOG0659|consen  136 SDGQLKIADFGLARFFGSPNR------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV  199 (318)
T ss_pred             CCCcEEeecccchhccCCCCc------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC
Confidence            999999999999986532211            1123378999999997          49999999999988664

>KOG0197|consensus

Probab=99.95  E-value=1.1e-28  Score=179.27  Aligned_cols=136  Identities=24%  Similarity=0.338  Sum_probs=113.4

Q ss_pred             CcccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      |++-|+++|++.++...+..+||||||++.|+|.++|+.. ...+...+...++.||++|+.||++++  +||||+...|
T Consensus       256 k~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARN  333 (468)
T KOG0197|consen  256 KKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARN  333 (468)
T ss_pred             HhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhh
Confidence            4678999999999999988999999999999999999873 356888888999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee-eec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML-YGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~-~g~  149 (150)
                      ||++.+..+||+|||+++....+   .+....        ...-...|.|||.+         |+||+||+++|++ +|+
T Consensus       334 iLV~~~~~vKIsDFGLAr~~~d~---~Y~~~~--------~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~  402 (468)
T KOG0197|consen  334 ILVDEDLVVKISDFGLARLIGDD---EYTASE--------GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGR  402 (468)
T ss_pred             eeeccCceEEEcccccccccCCC---ceeecC--------CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCC
Confidence            99999999999999999932211   111111        11224569999996         9999999999987 443

>KOG0594|consensus

Probab=99.95  E-value=1.3e-28  Score=171.78  Aligned_cols=131  Identities=31%  Similarity=0.473  Sum_probs=110.9

Q ss_pred             cchh-hhcccCCCCCce------EEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q psy1934           4 LSAA-FIDKHSTPHGMH------EYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHR   73 (150)
Q Consensus         4 ~~~~-~~~~~~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~   73 (150)
                      -|++ |+.+.+..+..+      .+++|+||+.. +|.+++....   .+++...++.+++|++.|+.|||+++  |+||
T Consensus        68 ~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHR  144 (323)
T KOG0594|consen   68 SHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHR  144 (323)
T ss_pred             CCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecc
Confidence            4566 888888777777      89999999977 9999998765   36888889999999999999999999  9999


Q ss_pred             cCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEE
Q psy1934          74 DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGR  143 (150)
Q Consensus        74 ~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~  143 (150)
                      |+||+|++++..|.+|++|||+++... .+...           -+..++|.+|+|||++          |+||+||++.
T Consensus       145 DLKPQNlLi~~~G~lKlaDFGlAra~~-ip~~~-----------yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfa  212 (323)
T KOG0594|consen  145 DLKPQNLLISSSGVLKLADFGLARAFS-IPMRT-----------YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFA  212 (323)
T ss_pred             cCCcceEEECCCCcEeeeccchHHHhc-CCccc-----------ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHH
Confidence            999999999999999999999998431 11111           2355789999999994          9999999999


Q ss_pred             Eeeeec
Q psy1934         144 SMLYGH  149 (150)
Q Consensus       144 ~~~~g~  149 (150)
                      ||+.+.
T Consensus       213 Em~~~~  218 (323)
T KOG0594|consen  213 EMFTRR  218 (323)
T ss_pred             HHHhCC
Confidence            998764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=1.1e-27  Score=171.65  Aligned_cols=132  Identities=24%  Similarity=0.332  Sum_probs=113.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        52 l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll  128 (323)
T cd05571          52 TRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLML  128 (323)
T ss_pred             CCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEE
Confidence            34788999988899999999999999999999998754 46889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       129 ~~~~~~kl~DfG~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~  192 (323)
T cd05571         129 DKDGHIKITDFGLCKEGISDGA------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  192 (323)
T ss_pred             CCCCCEEEeeCCCCcccccCCC------------cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCC
Confidence            9999999999998864221111            01134689999999984         9999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG1187|consensus

Probab=99.95  E-value=3.3e-28  Score=175.92  Aligned_cols=135  Identities=25%  Similarity=0.301  Sum_probs=115.2

Q ss_pred             ccchhhhcccCCCCCce-EEEEEEeccCCCCHHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMH-EYLILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~-~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~n   79 (150)
                      +.|+|++++.+++.+.+ +.+||+||+++|+|.++|..... .++|..+.+++.+++.|+.|||.. .++|+|||+|+.|
T Consensus       128 l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN  207 (361)
T KOG1187|consen  128 LRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN  207 (361)
T ss_pred             CCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence            46999999999999888 59999999999999999987655 899999999999999999999974 4479999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhc-CCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR-FTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ||++.+..+|++|||+++..+.. ....           ... .||..|++||..         |+||+|+++.|+++|+
T Consensus       208 ILLD~~~~aKlsDFGLa~~~~~~-~~~~-----------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr  275 (361)
T KOG1187|consen  208 ILLDEDFNAKLSDFGLAKLGPEG-DTSV-----------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGR  275 (361)
T ss_pred             eeECCCCCEEccCccCcccCCcc-ccce-----------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCC
Confidence            99999999999999999654321 1000           011 589999999985         9999999999998885

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=5e-27  Score=168.26  Aligned_cols=132  Identities=25%  Similarity=0.349  Sum_probs=111.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil   81 (150)
                      +-|++|+...+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+ .+  ++|+|++|+||+
T Consensus        52 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIl  128 (325)
T cd05594          52 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLM  128 (325)
T ss_pred             CCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEE
Confidence            34788899888889999999999999999999988654 468899999999999999999997 67  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++........            ......|++.|+|||++         |+||+|+++++|++|.
T Consensus       129 l~~~~~~kL~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~  193 (325)
T cd05594         129 LDKDGHIKITDFGLCKEGIKDGA------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  193 (325)
T ss_pred             ECCCCCEEEecCCCCeecCCCCc------------ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCC
Confidence            99999999999998864321111            01123589999999984         9999999999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-27  Score=174.84  Aligned_cols=144  Identities=25%  Similarity=0.355  Sum_probs=113.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+|+||||+++|+|.+++... ..+++..++.++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        58 l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll  134 (377)
T cd05629          58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILI  134 (377)
T ss_pred             CCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE
Confidence            45788999999999999999999999999999999754 56888889999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcch--------hHh-------------------h--------hhhhHHhhhcCCCCCc
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAW--------SAQ-------------------Q--------RSMLEDEMARFTTPMY  127 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~--------~~~-------------------~--------~~~~~~~~~~~~~~~y  127 (150)
                      +.++.++++|||+++..........        ...                   .        ..........+||+.|
T Consensus       135 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  214 (377)
T cd05629         135 DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDY  214 (377)
T ss_pred             CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccc
Confidence            9999999999999863211000000        000                   0        0000001124689999


Q ss_pred             cCcccc---------cccccceeEEEeeeec
Q psy1934         128 RAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       128 ~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +|||++         |+||+|+++++|++|.
T Consensus       215 ~aPE~~~~~~~~~~~DiwSlGvil~elltG~  245 (377)
T cd05629         215 IAPEIFLQQGYGQECDWWSLGAIMFECLIGW  245 (377)
T ss_pred             cCHHHHccCCCCCceeeEecchhhhhhhcCC
Confidence            999984         9999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0585|consensus

Probab=99.94  E-value=5.1e-28  Score=174.48  Aligned_cols=138  Identities=27%  Similarity=0.399  Sum_probs=110.3

Q ss_pred             cccchhhhcccCCCC--CceEEEEEEeccCCCCHHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           2 EYLSAAFIDKHSTPH--GMHEYLILTELCTGGSLVDVLKERTSA-LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~--~~~~~~lv~E~~~~g~L~~~l~~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      ++-|+++|++..+..  ..+++|||+|||..|.+...-.  ... +++.+++.+++.+..|+.|||.++  |+||||||+
T Consensus       164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPs  239 (576)
T KOG0585|consen  164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPS  239 (576)
T ss_pred             hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchh
Confidence            355788888777554  3478999999999876654322  133 888999999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-------------ccccccceeEEEe
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-------------VDTWNNYVIGRSM  145 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-------------~d~~~~g~~~~~~  145 (150)
                      |+|++.+|++||+|||.+.............+.       ...+|||.|+|||.             +|+||+|+++|.+
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L-------~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCl  312 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQL-------SRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCL  312 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHH-------hhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHh
Confidence            999999999999999999865444222211111       13689999999998             3999999999999


Q ss_pred             eeecC
Q psy1934         146 LYGHV  150 (150)
Q Consensus       146 ~~g~~  150 (150)
                      ++|++
T Consensus       313 lfG~~  317 (576)
T KOG0585|consen  313 LFGQL  317 (576)
T ss_pred             hhccC
Confidence            99974

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.94  E-value=5.2e-28  Score=175.70  Aligned_cols=143  Identities=27%  Similarity=0.384  Sum_probs=113.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.++..+.+|+||||+++|+|.+++... ..+++..++.++.|++.|+.|+|+.+  ++|||+||+||+++
T Consensus        59 ~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~  135 (363)
T cd05628          59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD  135 (363)
T ss_pred             CCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC
Confidence            4678899888999999999999999999999999764 56899999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchh--------------------Hhh---hhhhHHhhhcCCCCCccCcccc-------
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWS--------------------AQQ---RSMLEDEMARFTTPMYRAPEMV-------  133 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~--------------------~~~---~~~~~~~~~~~~~~~y~aPE~~-------  133 (150)
                      .++.++++|||++............                    ...   ..........+||+.|+|||++       
T Consensus       136 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~  215 (363)
T cd05628         136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK  215 (363)
T ss_pred             CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC
Confidence            9999999999998643211000000                    000   0000001234799999999984       


Q ss_pred             --cccccceeEEEeeeec
Q psy1934         134 --DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       134 --d~~~~g~~~~~~~~g~  149 (150)
                        |+||+|+++++|++|.
T Consensus       216 ~~DvwSlGvil~ell~G~  233 (363)
T cd05628         216 LCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             chhhhhhHHHHHHHHhCC
Confidence              9999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.94  E-value=7.2e-27  Score=167.66  Aligned_cols=133  Identities=29%  Similarity=0.423  Sum_probs=113.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.++..+.+++||||+++|+|.++++.....+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        59 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~  136 (330)
T cd05601          59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID  136 (330)
T ss_pred             CCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC
Confidence            4678888888888889999999999999999999876567899999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------cccccceeEEEeeee
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~~~~g~~~~~~~~g  148 (150)
                      ..+.++++|||++.........           ......||+.|+|||++               |+||+|+++++|++|
T Consensus       137 ~~~~~kL~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g  205 (330)
T cd05601         137 RTGHIKLADFGSAARLTANKMV-----------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG  205 (330)
T ss_pred             CCCCEEeccCCCCeECCCCCce-----------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccC
Confidence            9999999999998753221110           01123588999999973               999999999999998


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       206 ~  206 (330)
T cd05601         206 R  206 (330)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.8e-27  Score=168.19  Aligned_cols=130  Identities=26%  Similarity=0.398  Sum_probs=111.5

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+++.+...++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        55 ~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~  131 (330)
T cd05586          55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDA  131 (330)
T ss_pred             CCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECC
Confidence            778888888888899999999999999999988754 56889999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++.........            .....||+.|+|||++          |+||+|+++++|++|.
T Consensus       132 ~~~~kl~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~  194 (330)
T cd05586         132 TGHIALCDFGLSKANLTDNKT------------TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW  194 (330)
T ss_pred             CCCEEEecCCcCcCCCCCCCC------------ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCC
Confidence            999999999998643211110            1134589999999973          9999999999999985

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.94  E-value=1.6e-27  Score=171.96  Aligned_cols=129  Identities=26%  Similarity=0.372  Sum_probs=113.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|||++|+||++
T Consensus        88 l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl  164 (340)
T PTZ00426         88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLL  164 (340)
T ss_pred             CCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEE
Confidence            34789999999999999999999999999999999764 46888899999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++......               .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       165 ~~~~~ikL~DFG~a~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~  225 (340)
T PTZ00426        165 DKDGFIKMTDFGFAKVVDTR---------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC  225 (340)
T ss_pred             CCCCCEEEecCCCCeecCCC---------------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCC
Confidence            99999999999998643110               1134689999999984         9999999999999986

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.94  E-value=4.2e-27  Score=170.80  Aligned_cols=143  Identities=27%  Similarity=0.397  Sum_probs=113.3

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.++..+.+|+||||+++|+|.+++.+. ..+++..++.++.|++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        59 ~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~  135 (360)
T cd05627          59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD  135 (360)
T ss_pred             CCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC
Confidence            4678888888899999999999999999999999764 46889999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcch------------hHh-----------hhhhhHHhhhcCCCCCccCcccc-------
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAW------------SAQ-----------QRSMLEDEMARFTTPMYRAPEMV-------  133 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~------------~~~-----------~~~~~~~~~~~~~~~~y~aPE~~-------  133 (150)
                      .++.++++|||++...........            +..           ...........+||+.|+|||++       
T Consensus       136 ~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~  215 (360)
T cd05627         136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK  215 (360)
T ss_pred             CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC
Confidence            999999999998764321100000            000           00000001234789999999984       


Q ss_pred             --cccccceeEEEeeeec
Q psy1934         134 --DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       134 --d~~~~g~~~~~~~~g~  149 (150)
                        |+||+|+++++|++|.
T Consensus       216 ~~DiwSlGvilyel~tG~  233 (360)
T cd05627         216 LCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             cceeccccceeeecccCC
Confidence              9999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.94  E-value=5.6e-27  Score=170.95  Aligned_cols=144  Identities=23%  Similarity=0.334  Sum_probs=112.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++++++.+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|+||+||++
T Consensus        58 l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill  134 (376)
T cd05598          58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILI  134 (376)
T ss_pred             CCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEE
Confidence            34778999999999999999999999999999999764 46888888889999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcc---------------------------hhHh----hhhhhHHhhhcCCCCCccCcc
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNA---------------------------WSAQ----QRSMLEDEMARFTTPMYRAPE  131 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~---------------------------~~~~----~~~~~~~~~~~~~~~~y~aPE  131 (150)
                      +.++.++++|||++..........                           ....    ...........+||+.|+|||
T Consensus       135 ~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  214 (376)
T cd05598         135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE  214 (376)
T ss_pred             CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHH
Confidence            999999999999874211000000                           0000    000000011347999999999


Q ss_pred             cc---------cccccceeEEEeeeec
Q psy1934         132 MV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       132 ~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++         |+||+|+++++|++|.
T Consensus       215 ~~~~~~~~~~~DiwSlGvilyell~G~  241 (376)
T cd05598         215 VLLRTGYTQLCDWWSVGVILYEMLVGQ  241 (376)
T ss_pred             HHcCCCCCcceeeeeccceeeehhhCC
Confidence            85         9999999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0574|consensus

Probab=99.94  E-value=5.8e-28  Score=166.73  Aligned_cols=131  Identities=26%  Similarity=0.488  Sum_probs=116.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ++.++++.+.+-....+|||||||..|++.+.++.+...+++.++..++...++|++|||..+  =+|||+|.-|||+..
T Consensus        87 S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT  164 (502)
T KOG0574|consen   87 SKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNT  164 (502)
T ss_pred             CchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcc
Confidence            466888888888889999999999999999999887788999999999999999999999988  899999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +|..|++|||.+....            -+.....+..||++|||||++         |+||+|+++.||+.|+
T Consensus       165 ~G~AKLADFGVAGQLT------------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~  226 (502)
T KOG0574|consen  165 DGIAKLADFGVAGQLT------------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGR  226 (502)
T ss_pred             cchhhhhhccccchhh------------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCC
Confidence            9999999999986432            223344567899999999996         9999999999999986

>KOG0579|consensus

Probab=99.94  E-value=1.5e-27  Score=177.80  Aligned_cols=130  Identities=28%  Similarity=0.458  Sum_probs=116.4

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||.|+++.+.+...+.+||..|||.||.+...+-+....+.+++++.+++|++.|+.|||+++  |||||++..|||+..
T Consensus        88 HP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tl  165 (1187)
T KOG0579|consen   88 HPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTL  165 (1187)
T ss_pred             ChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEe
Confidence            788999999999999999999999999999999887788999999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeee
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g  148 (150)
                      +|.++++|||++-..            .+.....-+..|||+||||||+              |+||+|+++.||+-+
T Consensus       166 dGdirLADFGVSAKn------------~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqi  231 (1187)
T KOG0579|consen  166 DGDIRLADFGVSAKN------------KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQI  231 (1187)
T ss_pred             cCcEeeecccccccc------------hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhcc
Confidence            999999999986421            2233444567899999999995              999999999998765

>KOG0690|consensus

Probab=99.94  E-value=5.5e-28  Score=168.19  Aligned_cols=132  Identities=27%  Similarity=0.383  Sum_probs=117.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      .||.+..+.+.++.++++|+||||..||.|+-+|+.. ..++++..+.+-..|+.|+.|||+++  |+.||+|.+|.+++
T Consensus       226 ~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD  302 (516)
T KOG0690|consen  226 RHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD  302 (516)
T ss_pred             cCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec
Confidence            4777888999999999999999999999999999754 57899998899999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeecC
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~~  150 (150)
                      ++|.+|+.|||+|+..+.....            ..+.+|||-|.|||++         |+|-+|+++|||++|++
T Consensus       303 kDGHIKitDFGLCKE~I~~g~t------------~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRL  366 (516)
T KOG0690|consen  303 KDGHIKITDFGLCKEEIKYGDT------------TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRL  366 (516)
T ss_pred             cCCceEeeecccchhcccccce------------eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccC
Confidence            9999999999999876544332            2256899999999995         99999999999999975

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.94  E-value=1.8e-27  Score=173.41  Aligned_cols=131  Identities=24%  Similarity=0.352  Sum_probs=112.3

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+++++.+.++..+.+|+||||+++|+|.++++..  .+++..+..++.|++.|+.|+|+.+  ++|||+||+||+++
T Consensus       101 ~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~  176 (370)
T cd05621         101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD  176 (370)
T ss_pred             CCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC
Confidence            4788999999999999999999999999999999753  5788888899999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-------------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-------------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-------------~d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.........           ......||+.|+|||+             .|+||+|+++++|++|.
T Consensus       177 ~~~~~kL~DFG~a~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~  244 (370)
T cd05621         177 KHGHLKLADFGTCMKMDETGMV-----------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD  244 (370)
T ss_pred             CCCCEEEEecccceecccCCce-----------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCC
Confidence            9999999999998753211100           0113468999999996             49999999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=4.7e-27  Score=168.74  Aligned_cols=131  Identities=27%  Similarity=0.387  Sum_probs=111.6

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      |++++++.+.++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        64 ~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~  140 (332)
T cd05614          64 SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDS  140 (332)
T ss_pred             CCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECC
Confidence            577888888888899999999999999999999764 46889999999999999999999998  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++.........           ......||+.|+|||++          |+||+|+++++|++|.
T Consensus       141 ~~~~kl~DfG~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~  204 (332)
T cd05614         141 EGHVVLTDFGLSKEFLSEEKE-----------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA  204 (332)
T ss_pred             CCCEEEeeCcCCccccccCCC-----------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence            999999999998643211110           01134689999999973          9999999999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=7e-27  Score=167.50  Aligned_cols=132  Identities=30%  Similarity=0.410  Sum_probs=113.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+++++.+.++..+.+++||||+++|+|..++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        53 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll  129 (325)
T cd05604          53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILL  129 (325)
T ss_pred             CCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE
Confidence            34788999999999999999999999999999988653 56889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......|++.|+|||++         |+||+|+++++|++|.
T Consensus       130 ~~~~~~kL~DfG~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~  193 (325)
T cd05604         130 DSQGHVVLTDFGLCKEGIAQSD------------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGL  193 (325)
T ss_pred             CCCCCEEEeecCCcccCCCCCC------------CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCC
Confidence            9999999999998864221111            01134689999999984         9999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.94  E-value=5.4e-27  Score=168.55  Aligned_cols=133  Identities=26%  Similarity=0.404  Sum_probs=112.3

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++|+.+.+.++..+.+|+||||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++
T Consensus        59 ~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~  136 (331)
T cd05624          59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD  136 (331)
T ss_pred             CCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc
Confidence            3567888888888899999999999999999999875567889999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++..........           .....|++.|+|||++              |+||+|+++++|++|.
T Consensus       137 ~~~~~kl~DfG~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~  205 (331)
T cd05624         137 MNGHIRLADFGSCLKMNQDGTVQ-----------SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE  205 (331)
T ss_pred             CCCCEEEEeccceeeccCCCcee-----------eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCC
Confidence            99999999999986532111100           0123589999999963              9999999999999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0986|consensus

Probab=99.94  E-value=6e-28  Score=173.45  Aligned_cols=132  Identities=24%  Similarity=0.276  Sum_probs=116.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ..++.||.+.+.++..+.+|+|+..|.||+|.-++.+.. ..+++..++.++.+|+.|+++||..+  |+.||+||+|||
T Consensus       242 V~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNIL  319 (591)
T KOG0986|consen  242 VSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENIL  319 (591)
T ss_pred             hccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhhee
Confidence            345668889999999999999999999999998887764 46899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +|..|+++|+|+|+|...+...             .....+||..|||||++         |+|++||++|||+.||
T Consensus       320 LDd~GhvRISDLGLAvei~~g~-------------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~  383 (591)
T KOG0986|consen  320 LDDHGHVRISDLGLAVEIPEGK-------------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGH  383 (591)
T ss_pred             eccCCCeEeeccceEEecCCCC-------------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHccc
Confidence            9999999999999998654321             11245899999999995         9999999999999987

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=1.6e-26  Score=165.13  Aligned_cols=132  Identities=28%  Similarity=0.384  Sum_probs=113.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        55 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~  131 (318)
T cd05582          55 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILL  131 (318)
T ss_pred             CCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEE
Confidence            45889999999999999999999999999999999653 46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......|++.|+|||++         |+||+|+++++|++|.
T Consensus       132 ~~~~~~kL~Dfg~~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~  195 (318)
T cd05582         132 DEEGHIKLTDFGLSKESIDHEK------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGS  195 (318)
T ss_pred             CCCCcEEEeeccCCcccCCCCC------------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCC
Confidence            9999999999998864321111            01134688999999984         9999999999999986

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.94  E-value=5.3e-27  Score=168.40  Aligned_cols=132  Identities=25%  Similarity=0.343  Sum_probs=112.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.++..+.+++||||+++|+|.+.+... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        52 l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll  128 (328)
T cd05593          52 TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLML  128 (328)
T ss_pred             CCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEE
Confidence            34788999989999999999999999999999988654 46889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       129 ~~~~~~kL~DfG~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~  192 (328)
T cd05593         129 DKDGHIKITDFGLCKEGITDAA------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  192 (328)
T ss_pred             CCCCcEEEecCcCCccCCCccc------------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCC
Confidence            9999999999998864221100            01134689999999984         9999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.5e-27  Score=168.51  Aligned_cols=133  Identities=26%  Similarity=0.425  Sum_probs=112.9

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++++.+.+.++..+.+|+||||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++
T Consensus        59 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~  136 (331)
T cd05597          59 DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD  136 (331)
T ss_pred             CCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC
Confidence            3677888888899999999999999999999999865567899999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.........           ......||+.|+|||++              |+||+|+++++|++|.
T Consensus       137 ~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~  205 (331)
T cd05597         137 KNGHIRLADFGSCLRLLADGTV-----------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE  205 (331)
T ss_pred             CCCCEEEEECCceeecCCCCCc-----------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCC
Confidence            9999999999988643211110           00123589999999973              9999999999999986

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.7e-27  Score=171.84  Aligned_cols=143  Identities=25%  Similarity=0.345  Sum_probs=113.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++|++..+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        59 ~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~  135 (364)
T cd05599          59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD  135 (364)
T ss_pred             CCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC
Confidence            4788999999999999999999999999999999764 46899999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHh--------------------------hhhhhHHhhhcCCCCCccCcccc----
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQ--------------------------QRSMLEDEMARFTTPMYRAPEMV----  133 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~y~aPE~~----  133 (150)
                      .++.++++|||++..............                          ...........+||+.|+|||++    
T Consensus       136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  215 (364)
T cd05599         136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG  215 (364)
T ss_pred             CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC
Confidence            999999999998864321110000000                          00000001134689999999984    


Q ss_pred             -----cccccceeEEEeeeec
Q psy1934         134 -----DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       134 -----d~~~~g~~~~~~~~g~  149 (150)
                           |+||+|+++++|++|.
T Consensus       216 ~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         216 YNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             CCCeeeeecchhHHHHhhcCC
Confidence                 9999999999999985

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.94  E-value=2.5e-27  Score=173.18  Aligned_cols=144  Identities=25%  Similarity=0.373  Sum_probs=112.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++++++.+.++..+.+|+||||+++|+|.+++.+. ..+++..++.++.|++.|+.|+|+.+  ++|||+||+||++
T Consensus        58 ~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl  134 (382)
T cd05625          58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILI  134 (382)
T ss_pred             CCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence            34788999999999999999999999999999999764 46888888999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcch---------------------------------h--HhhhhhhHHhhhcCCCCCc
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAW---------------------------------S--AQQRSMLEDEMARFTTPMY  127 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~---------------------------------~--~~~~~~~~~~~~~~~~~~y  127 (150)
                      +.++.++++|||++...........                                 .  .............+||+.|
T Consensus       135 ~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  214 (382)
T cd05625         135 DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNY  214 (382)
T ss_pred             CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCccc
Confidence            9999999999998753210000000                                 0  0000000001234689999


Q ss_pred             cCcccc---------cccccceeEEEeeeec
Q psy1934         128 RAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       128 ~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +|||++         |+||+|+++++|++|.
T Consensus       215 ~aPE~~~~~~~~~~~DiwSlGvil~elltG~  245 (382)
T cd05625         215 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ  245 (382)
T ss_pred             CCHHHhcCCCCCCeeeEEechHHHHHHHhCC
Confidence            999985         9999999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=8.8e-27  Score=166.88  Aligned_cols=132  Identities=28%  Similarity=0.386  Sum_probs=112.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        53 l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll  129 (323)
T cd05575          53 VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILL  129 (323)
T ss_pred             CCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEE
Confidence            44788999988888899999999999999999998753 46888888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       130 ~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~  193 (323)
T cd05575         130 DSQGHVVLTDFGLCKEGIEHSK------------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGL  193 (323)
T ss_pred             CCCCcEEEeccCCCcccccCCC------------ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCC
Confidence            9999999999998764221111            01133589999999984         9999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=6.7e-27  Score=167.61  Aligned_cols=132  Identities=27%  Similarity=0.360  Sum_probs=112.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|++..+.++..+.+++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        53 ~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili  129 (325)
T cd05602          53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL  129 (325)
T ss_pred             CCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE
Confidence            34788999999999999999999999999999999753 45788888889999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       130 ~~~~~~kl~DfG~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  193 (325)
T cd05602         130 DSQGHIVLTDFGLCKENIEHNG------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL  193 (325)
T ss_pred             CCCCCEEEccCCCCcccccCCC------------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCC
Confidence            9999999999999864321111            01134689999999974         9999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=7.4e-27  Score=167.82  Aligned_cols=128  Identities=27%  Similarity=0.368  Sum_probs=112.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++|+++.+.++..+.+|+||||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        59 ~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~  135 (333)
T cd05600          59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID  135 (333)
T ss_pred             CCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC
Confidence            4788999999999999999999999999999999764 46888899999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.....               ......|++.|+|||++         |+||+|+++++|++|.
T Consensus       136 ~~~~~kL~Dfg~a~~~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~  195 (333)
T cd05600         136 ASGHIKLTDFGLSKGIVT---------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGF  195 (333)
T ss_pred             CCCCEEEEeCcCCccccc---------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCC
Confidence            999999999998864321               11234689999999984         9999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0604|consensus

Probab=99.94  E-value=4.3e-27  Score=161.77  Aligned_cols=129  Identities=36%  Similarity=0.484  Sum_probs=108.5

Q ss_pred             chhhhcccCCCC----CceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           5 SAAFIDKHSTPH----GMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         5 ~~~~~~~~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      |++||...++++    +..-+.+|||.++||.|++++.++. ..+++.++..++.||..|+.|||+.+  |.|||+||+|
T Consensus       114 h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpEN  191 (400)
T KOG0604|consen  114 HPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPEN  191 (400)
T ss_pred             CCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhh
Confidence            577888777555    4556799999999999999998765 45899999999999999999999999  9999999999


Q ss_pred             EEEcC---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          80 LLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        80 il~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      +|...   +..+|+.|||+++......             ...+.+-||+|.|||++         |.||+|+++|.|++
T Consensus       192 LLyt~t~~na~lKLtDfGFAK~t~~~~-------------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC  258 (400)
T KOG0604|consen  192 LLYTTTSPNAPLKLTDFGFAKETQEPG-------------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC  258 (400)
T ss_pred             eeeecCCCCcceEecccccccccCCCc-------------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc
Confidence            99965   4579999999998643211             12345779999999995         99999999999999


Q ss_pred             e
Q psy1934         148 G  148 (150)
Q Consensus       148 g  148 (150)
                      |
T Consensus       259 G  259 (400)
T KOG0604|consen  259 G  259 (400)
T ss_pred             C
Confidence            8

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=4e-27  Score=168.27  Aligned_cols=131  Identities=24%  Similarity=0.364  Sum_probs=112.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+|++..+.++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        54 ~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~  130 (316)
T cd05592          54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD  130 (316)
T ss_pred             CCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC
Confidence            4788999999988899999999999999999998764 46888899999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       131 ~~~~~kL~Dfg~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~  193 (316)
T cd05592         131 KDGHIKIADFGMCKENMNGEG------------KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ  193 (316)
T ss_pred             CCCCEEEccCcCCeECCCCCC------------ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCC
Confidence            999999999999864321110            01134689999999984         9999999999999885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=4.7e-27  Score=168.35  Aligned_cols=132  Identities=23%  Similarity=0.338  Sum_probs=112.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        52 l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll  128 (323)
T cd05595          52 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML  128 (323)
T ss_pred             CCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE
Confidence            35788999999999999999999999999999988754 46889999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......|++.|+|||++         |+||+|+++++|++|.
T Consensus       129 ~~~~~~kL~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~  192 (323)
T cd05595         129 DKDGHIKITDFGLCKEGISDGA------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  192 (323)
T ss_pred             cCCCCEEecccHHhccccCCCC------------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCC
Confidence            9999999999998764221110            01124589999999985         9999999999999885

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.3e-27  Score=167.29  Aligned_cols=132  Identities=25%  Similarity=0.354  Sum_probs=113.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|++..+.++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        50 l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili  126 (312)
T cd05585          50 VNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILL  126 (312)
T ss_pred             CCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEE
Confidence            34788999989999999999999999999999999764 46888999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       127 ~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~  190 (312)
T cd05585         127 DYQGHIALCDFGLCKLNMKDDD------------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL  190 (312)
T ss_pred             CCCCcEEEEECcccccCccCCC------------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCC
Confidence            9999999999999864221111            01134689999999984         9999999999999886

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=1.2e-26  Score=166.04  Aligned_cols=132  Identities=28%  Similarity=0.373  Sum_probs=112.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++++++.+.++..+.+|+||||+++++|.+.+... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        53 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll  129 (321)
T cd05603          53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILL  129 (321)
T ss_pred             CCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE
Confidence            34788999999999999999999999999999988653 45788888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......|++.|+|||++         |+||+|+++++|++|.
T Consensus       130 ~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  193 (321)
T cd05603         130 DSQGHVVLTDFGLCKEGVEPEE------------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGL  193 (321)
T ss_pred             CCCCCEEEccCCCCccCCCCCC------------ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCC
Confidence            9999999999998764211100            01133588999999984         9999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.94  E-value=3.8e-27  Score=172.22  Aligned_cols=144  Identities=24%  Similarity=0.367  Sum_probs=113.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      .-|++++++.+.++..+.+|+||||+++|+|.+++.+. ..+++..++.++.|++.|+.|+|+.+  ++|||+||+||++
T Consensus        58 l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili  134 (381)
T cd05626          58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILI  134 (381)
T ss_pred             cCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEE
Confidence            34788999999999999999999999999999999764 46888888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcch-------------------------------hHhhhh----hhHHhhhcCCCCCc
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAW-------------------------------SAQQRS----MLEDEMARFTTPMY  127 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~-------------------------------~~~~~~----~~~~~~~~~~~~~y  127 (150)
                      +..+.++++|||++...........                               ......    ......+.+||+.|
T Consensus       135 ~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  214 (381)
T cd05626         135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNY  214 (381)
T ss_pred             CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccc
Confidence            9999999999998753211000000                               000000    00001234799999


Q ss_pred             cCcccc---------cccccceeEEEeeeec
Q psy1934         128 RAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       128 ~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +|||++         |+||+|+++++|++|.
T Consensus       215 ~aPE~~~~~~~~~~~DiwSlG~il~elltG~  245 (381)
T cd05626         215 IAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ  245 (381)
T ss_pred             cCHHHHcCCCCCCccceeehhhHHHHHHhCC
Confidence            999984         9999999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.2e-27  Score=166.31  Aligned_cols=129  Identities=29%  Similarity=0.378  Sum_probs=112.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|++..+.....+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        58 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli  134 (291)
T cd05612          58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILL  134 (291)
T ss_pred             CCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE
Confidence            45789999999999999999999999999999999764 46888888899999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++......               .....|++.|+|||++         |+||+|+++++|++|.
T Consensus       135 ~~~~~~kl~Dfg~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~  195 (291)
T cd05612         135 DKEGHIKLTDFGFAKKLRDR---------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY  195 (291)
T ss_pred             CCCCCEEEEecCcchhccCC---------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999988643110               1123588999999984         9999999999999885

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=5.3e-27  Score=167.87  Aligned_cols=130  Identities=25%  Similarity=0.399  Sum_probs=112.3

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||++++..+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++.
T Consensus        55 h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~  131 (320)
T cd05590          55 HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDH  131 (320)
T ss_pred             CCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECC
Confidence            788999999999999999999999999999988754 46889999999999999999999998  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       132 ~~~~kL~DfG~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  193 (320)
T cd05590         132 EGHCKLADFGMCKEGIFNGK------------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGH  193 (320)
T ss_pred             CCcEEEeeCCCCeecCcCCC------------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCC
Confidence            99999999998764321111            01134689999999984         9999999999999886

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=1.1e-26  Score=166.48  Aligned_cols=132  Identities=29%  Similarity=0.392  Sum_probs=112.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|++..+.++..+.+|+||||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        57 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~  133 (323)
T cd05584          57 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILL  133 (323)
T ss_pred             CCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE
Confidence            45789999999999999999999999999999999764 45788888889999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....|++.|+|||++         |+||+|+++++|++|.
T Consensus       134 ~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~  197 (323)
T cd05584         134 DAQGHVKLTDFGLCKESIHEGTV------------THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA  197 (323)
T ss_pred             CCCCCEEEeeCcCCeecccCCCc------------ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCC
Confidence            99999999999988643211110            1123589999999984         9999999999999986

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.94  E-value=4.1e-27  Score=169.00  Aligned_cols=129  Identities=27%  Similarity=0.404  Sum_probs=112.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|++..+.++..+.++++|||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        75 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll  151 (329)
T PTZ00263         75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLL  151 (329)
T ss_pred             CCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE
Confidence            45789999999999999999999999999999999764 46888888889999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++......               .....|++.|+|||++         |+||+|+++++|++|.
T Consensus       152 ~~~~~~kl~Dfg~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  212 (329)
T PTZ00263        152 DNKGHVKVTDFGFAKKVPDR---------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY  212 (329)
T ss_pred             CCCCCEEEeeccCceEcCCC---------------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCC
Confidence            99999999999998743210               1134688999999984         9999999999999885

>KOG0667|consensus

Probab=99.94  E-value=4.5e-27  Score=174.45  Aligned_cols=125  Identities=26%  Similarity=0.369  Sum_probs=108.6

Q ss_pred             hhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q psy1934           7 AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         7 ~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~   85 (150)
                      ++|+..+++...++.|||+|.+.. +|+++++... .+++...++.++.||+.|+.+||+.+  |||+|+||+||++-..
T Consensus       249 n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~  325 (586)
T KOG0667|consen  249 NIVRMLDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDP  325 (586)
T ss_pred             eEEEeeeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccC
Confidence            589999999999999999999976 9999999754 57899999999999999999999999  9999999999999654


Q ss_pred             --CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          86 --GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        86 --~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                        ..+|++|||.++.....               ..+.+.+.+|+||||+         |+||+||++.||..|.
T Consensus       326 ~r~~vKVIDFGSSc~~~q~---------------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~  385 (586)
T KOG0667|consen  326 KRSRIKVIDFGSSCFESQR---------------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGE  385 (586)
T ss_pred             CcCceeEEecccccccCCc---------------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCc
Confidence              36999999998753211               1134568899999994         9999999999999985

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.94  E-value=6.2e-27  Score=168.25  Aligned_cols=133  Identities=26%  Similarity=0.420  Sum_probs=112.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++++...+.++..+.+++||||+++|+|.++++.....+++..++.++.|++.|+.|+|+.+  ++|||+||+||+++
T Consensus        59 ~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~  136 (332)
T cd05623          59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD  136 (332)
T ss_pred             CCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC
Confidence            3567888888888889999999999999999999875556888899999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc--------------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~--------------~d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.........           ......||+.|+|||+              .|+||+|+++++|++|.
T Consensus       137 ~~~~~kL~DfG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~  205 (332)
T cd05623         137 MNGHIRLADFGSCLKLMEDGTV-----------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE  205 (332)
T ss_pred             CCCCEEEeecchheecccCCcc-----------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCC
Confidence            9999999999988643211110           0112368999999996              39999999999999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.94  E-value=6.9e-27  Score=170.37  Aligned_cols=131  Identities=24%  Similarity=0.353  Sum_probs=111.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||++++..+.++..+.+++||||+++|+|.++++..  .+++..+..++.|++.|+.|+|+++  ++|||++|+||+++
T Consensus       101 ~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~  176 (371)
T cd05622         101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD  176 (371)
T ss_pred             CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC
Confidence            4788999999999999999999999999999999763  5788888889999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-------------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-------------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-------------~d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........           .......||+.|+|||+             .|+||+|+++++|++|.
T Consensus       177 ~~~~ikL~DfG~a~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~  244 (371)
T cd05622         177 KSGHLKLADFGTCMKMNKEGM-----------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD  244 (371)
T ss_pred             CCCCEEEEeCCceeEcCcCCc-----------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCC
Confidence            999999999999875321110           01123468999999996             39999999999999885

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.93  E-value=1.1e-26  Score=166.33  Aligned_cols=130  Identities=24%  Similarity=0.368  Sum_probs=111.6

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||++++..+.++..+.+|+||||+++++|.+.+... ..+++..+..++.+++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        55 hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~  131 (321)
T cd05591          55 HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDA  131 (321)
T ss_pred             CCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECC
Confidence            678899999999999999999999999999988754 46888888899999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++........            ......|++.|+|||++         |+||+|+++++|++|.
T Consensus       132 ~~~~kL~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~  193 (321)
T cd05591         132 EGHCKLADFGMCKEGILNGV------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ  193 (321)
T ss_pred             CCCEEEeecccceecccCCc------------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCC
Confidence            99999999998864321111            01134588999999984         9999999999999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.93  E-value=7.1e-27  Score=170.23  Aligned_cols=131  Identities=25%  Similarity=0.376  Sum_probs=111.3

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+++++.+.++..+.+++||||+++|+|.++++..  .+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++
T Consensus       101 ~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~  176 (370)
T cd05596         101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD  176 (370)
T ss_pred             CCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc
Confidence            4688999999999999999999999999999999763  5788888889999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-------------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.........           ......||+.|+|||++             |+||+|+++++|++|.
T Consensus       177 ~~~~~kL~DfG~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~  244 (370)
T cd05596         177 KSGHLKLADFGTCMKMDANGMV-----------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD  244 (370)
T ss_pred             CCCCEEEEeccceeeccCCCcc-----------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCC
Confidence            9999999999998743211100           01134689999999963             9999999999999885

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.93  E-value=8e-27  Score=167.52  Aligned_cols=130  Identities=27%  Similarity=0.439  Sum_probs=112.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+++.+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        55 hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~  131 (329)
T cd05588          55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDA  131 (329)
T ss_pred             CCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECC
Confidence            788999999999999999999999999999988654 56899999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++........            ......||+.|+|||++         |+||+|++++++++|.
T Consensus       132 ~~~~kL~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~  193 (329)
T cd05588         132 EGHIKLTDYGMCKEGIRPGD------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR  193 (329)
T ss_pred             CCCEEECcCccccccccCCC------------ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCC
Confidence            99999999998863211110            01134689999999984         9999999999999885

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0577|consensus

Probab=99.93  E-value=1.1e-27  Score=177.07  Aligned_cols=128  Identities=28%  Similarity=0.409  Sum_probs=113.8

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++.||+.|.+.+++=-..+.|||||||-| +..|++..+..++.+..+..+..+.+.|+.|||+.+  .||||+|.-|||
T Consensus        82 ~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNIL  158 (948)
T KOG0577|consen   82 QLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNIL  158 (948)
T ss_pred             hccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceE
Confidence            46799999999999998999999999965 999999888788999999899999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g  148 (150)
                      +..+|.+|++|||.+.....                -.+.+|||+||||||+            |+||+|+++.|++..
T Consensus       159 Lse~g~VKLaDFGSAsi~~P----------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER  221 (948)
T KOG0577|consen  159 LSEPGLVKLADFGSASIMAP----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  221 (948)
T ss_pred             ecCCCeeeeccccchhhcCc----------------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhc
Confidence            99999999999998754311                1256899999999995            999999999987654

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.93  E-value=1.2e-26  Score=166.73  Aligned_cols=130  Identities=28%  Similarity=0.425  Sum_probs=111.9

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+++.+.++..+.+++||||+++|+|.+++... ..+++..+..++.+++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        55 hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~  131 (329)
T cd05618          55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDS  131 (329)
T ss_pred             CCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECC
Confidence            788999999999999999999999999999988654 56889999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       132 ~~~~kL~DfG~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  193 (329)
T cd05618         132 EGHIKLTDYGMCKEGLRPGD------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR  193 (329)
T ss_pred             CCCEEEeeCCccccccCCCC------------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCC
Confidence            99999999998864221111            01134689999999984         9999999999999885

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.2e-26  Score=166.17  Aligned_cols=144  Identities=26%  Similarity=0.407  Sum_probs=115.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      .-|++++++.+.++..+.+|+||||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll  134 (350)
T cd05573          58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILI  134 (350)
T ss_pred             cCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE
Confidence            34788999999999999999999999999999999765 56899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcch-----------------hHhhhhhhHHhhhcCCCCCccCcccc---------ccc
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAW-----------------SAQQRSMLEDEMARFTTPMYRAPEMV---------DTW  136 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~  136 (150)
                      +.++.++++|||++...........                 ...............||+.|+|||++         |+|
T Consensus       135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  214 (350)
T cd05573         135 DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWW  214 (350)
T ss_pred             CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeE
Confidence            9999999999999875432210000                 00000000111234689999999984         999


Q ss_pred             ccceeEEEeeeec
Q psy1934         137 NNYVIGRSMLYGH  149 (150)
Q Consensus       137 ~~g~~~~~~~~g~  149 (150)
                      |+|+++++|++|.
T Consensus       215 SlG~il~ell~g~  227 (350)
T cd05573         215 SLGVILYEMLYGF  227 (350)
T ss_pred             ecchhhhhhccCC
Confidence            9999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0608|consensus

Probab=99.93  E-value=2.1e-26  Score=171.45  Aligned_cols=139  Identities=26%  Similarity=0.425  Sum_probs=112.7

Q ss_pred             hhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc
Q psy1934           8 FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGT   87 (150)
Q Consensus         8 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~   87 (150)
                      +|++.+.+++++.+|+||||++||++-.+|-.. +-+++..+++++.++.+|+++.|..+  +|||||||+|||++.+|.
T Consensus       691 VVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGH  767 (1034)
T KOG0608|consen  691 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGH  767 (1034)
T ss_pred             eEEEEEEeccCCceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCc
Confidence            788889999999999999999999999998765 56888899999999999999999999  999999999999999999


Q ss_pred             EEEeecCceeccc------c--C----------CCcchhH-------------hhhhhhHHhhhcCCCCCccCcccc---
Q psy1934          88 VKLCDFGSATEKV------Y--S----------PDNAWSA-------------QQRSMLEDEMARFTTPMYRAPEMV---  133 (150)
Q Consensus        88 ~~l~dfg~~~~~~------~--~----------~~~~~~~-------------~~~~~~~~~~~~~~~~~y~aPE~~---  133 (150)
                      +|+.|||+|.-.-      +  .          ....+..             .++. ..--...+||+.|+||||+   
T Consensus       768 IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~-r~~ahslvgt~nyiapevl~r~  846 (1034)
T KOG0608|consen  768 IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQ-RILAHSLVGTPNYIAPEVLART  846 (1034)
T ss_pred             eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhh-hhhhhhhcCCCcccChHHhccc
Confidence            9999999987310      0  0          0000100             0110 0111245899999999995   


Q ss_pred             ------cccccceeEEEeeeecC
Q psy1934         134 ------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus       134 ------d~~~~g~~~~~~~~g~~  150 (150)
                            |+|+.|++++||+.|++
T Consensus       847 g~~q~cdwws~gvil~em~~g~~  869 (1034)
T KOG0608|consen  847 GYTQLCDWWSVGVILYEMLVGQP  869 (1034)
T ss_pred             CccccchhhHhhHHHHHHhhCCC
Confidence                  99999999999999975

>KOG0696|consensus

Probab=99.93  E-value=5.1e-27  Score=167.75  Aligned_cols=130  Identities=25%  Similarity=0.444  Sum_probs=114.9

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +|.++.++++++..+++|+||||+.||+|--.+.+- +.+.++.+..++.+|+.|+.+||+++  |+.||+|.+|++++.
T Consensus       409 ppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~  485 (683)
T KOG0696|consen  409 PPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDS  485 (683)
T ss_pred             CchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEecc
Confidence            466788999999999999999999999998888654 56888888899999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .|.+|++|||+++.........            .+.+|||.|+|||++         |+|++|++++||+.|+
T Consensus       486 eGHiKi~DFGmcKEni~~~~TT------------kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQ  547 (683)
T KOG0696|consen  486 EGHIKIADFGMCKENIFDGVTT------------KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ  547 (683)
T ss_pred             CCceEeeecccccccccCCcce------------eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCC
Confidence            9999999999998755433221            246899999999995         9999999999999996

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.93  E-value=1.1e-26  Score=165.96  Aligned_cols=131  Identities=24%  Similarity=0.404  Sum_probs=111.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++
T Consensus        54 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~  130 (316)
T cd05620          54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD  130 (316)
T ss_pred             CCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC
Confidence            4678888888889999999999999999999998764 46888888899999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........            ......|++.|+|||++         |+||+|+++++|++|.
T Consensus       131 ~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~  193 (316)
T cd05620         131 RDGHIKIADFGMCKENVFGDN------------RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ  193 (316)
T ss_pred             CCCCEEeCccCCCeecccCCC------------ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCC
Confidence            999999999998764211110            01234689999999984         9999999999999885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.93  E-value=1.3e-26  Score=166.34  Aligned_cols=130  Identities=28%  Similarity=0.465  Sum_probs=111.3

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      |++++.+.+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        55 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~  131 (327)
T cd05617          55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDA  131 (327)
T ss_pred             CCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeC
Confidence            677888888888889999999999999999988653 46899999999999999999999998  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++.........            .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~  193 (327)
T cd05617         132 DGHIKLTDYGMCKEGLGPGDT------------TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR  193 (327)
T ss_pred             CCCEEEeccccceeccCCCCc------------eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCC
Confidence            999999999988642211110            1134689999999984         9999999999999885

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.93  E-value=1.6e-26  Score=165.53  Aligned_cols=130  Identities=25%  Similarity=0.352  Sum_probs=112.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+|++..+.++..+.+|+||||+++++|...+..  ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        60 ~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~  135 (324)
T cd05589          60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD  135 (324)
T ss_pred             CCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC
Confidence            488999999999999999999999999999988864  46899999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........            ......|++.|+|||++         |+||+|+++++|++|.
T Consensus       136 ~~~~~kL~Dfg~~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~  198 (324)
T cd05589         136 TEGFVKIADFGLCKEGMGFGD------------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE  198 (324)
T ss_pred             CCCcEEeCcccCCccCCCCCC------------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCC
Confidence            999999999998764221110            01134689999999974         9999999999999886

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.93  E-value=1.6e-26  Score=165.53  Aligned_cols=130  Identities=25%  Similarity=0.412  Sum_probs=109.4

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +++++...+.++..+.+++||||+++|+|.+.+... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        60 ~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~  136 (323)
T cd05616          60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDS  136 (323)
T ss_pred             CCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECC
Confidence            455666777888889999999999999999998754 46888999999999999999999998  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       137 ~~~~kL~DfG~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  198 (323)
T cd05616         137 EGHIKIADFGMCKENMWDGV------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ  198 (323)
T ss_pred             CCcEEEccCCCceecCCCCC------------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCC
Confidence            99999999999864321110            01134689999999984         9999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0660|consensus

Probab=99.93  E-value=3.8e-27  Score=164.77  Aligned_cols=133  Identities=28%  Similarity=0.384  Sum_probs=110.8

Q ss_pred             ccchhhhcccCCC-----CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTP-----HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~-----~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +.|++|+.+.+..     ...+.+|+|+|+++. +|.+.+++. ..++...++.+++|++.|+.|+|+.+  ++|||+||
T Consensus        78 ~~HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKP  153 (359)
T KOG0660|consen   78 LRHENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKP  153 (359)
T ss_pred             hcCCCcceEEeecccccccccceeEEehhHHhh-HHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc--ccccccch
Confidence            3478888776644     457889999999965 999999864 34999999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLY  147 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~  147 (150)
                      .|++++.+..+|++|||+++.....          ......+..+-|.||+|||+          +|+||.||++.||+.
T Consensus       154 sNll~n~~c~lKI~DFGLAR~~~~~----------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~  223 (359)
T KOG0660|consen  154 SNLLLNADCDLKICDFGLARYLDKF----------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT  223 (359)
T ss_pred             hheeeccCCCEEeccccceeecccc----------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc
Confidence            9999999999999999999864321          01122345678999999998          499999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       224 gk  225 (359)
T KOG0660|consen  224 GK  225 (359)
T ss_pred             CC
Confidence            85

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.93  E-value=2.6e-26  Score=161.79  Aligned_cols=131  Identities=21%  Similarity=0.291  Sum_probs=111.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+.+...+.+++++||+++|+|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        58 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill  135 (285)
T cd05631          58 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILL  135 (285)
T ss_pred             CCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE
Confidence            36778888888888899999999999999998886533 35888899999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........             .....|++.|+|||++         |+||+|+++++|++|.
T Consensus       136 ~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~  198 (285)
T cd05631         136 DDRGHIRISDLGLAVQIPEGET-------------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ  198 (285)
T ss_pred             CCCCCEEEeeCCCcEEcCCCCe-------------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCC
Confidence            9999999999999875321100             0134689999999984         9999999999999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=1.7e-26  Score=173.15  Aligned_cols=135  Identities=27%  Similarity=0.390  Sum_probs=113.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-||+|++..+.++..+.+|+||||+++|+|.++++..   ..++++..+..++.|++.|+.|+|+++  ++|||+||+|
T Consensus       122 l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~N  199 (478)
T PTZ00267        122 CDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSAN  199 (478)
T ss_pred             CCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHh
Confidence            34789999999999999999999999999999988642   245888888899999999999999998  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      |+++..+.++++|||++.........          .......||+.|+|||++         |+||+|+++++|++|.
T Consensus       200 Ill~~~~~~kL~DFgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~  268 (478)
T PTZ00267        200 IFLMPTGIIKLGDFGFSKQYSDSVSL----------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH  268 (478)
T ss_pred             EEECCCCcEEEEeCcCceecCCcccc----------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCC
Confidence            99999999999999998753211100          011234689999999984         9999999999999885

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.93  E-value=1.8e-26  Score=164.94  Aligned_cols=131  Identities=24%  Similarity=0.366  Sum_probs=112.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||++++..+.++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++
T Consensus        54 ~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~  130 (316)
T cd05619          54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD  130 (316)
T ss_pred             CCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC
Confidence            4788999999999999999999999999999999764 46888888899999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       131 ~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~  193 (316)
T cd05619         131 TDGHIKIADFGMCKENMLGDA------------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ  193 (316)
T ss_pred             CCCCEEEccCCcceECCCCCC------------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCC
Confidence            999999999998864221111            01134588999999984         9999999999999885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG4279|consensus

Probab=99.93  E-value=1.3e-25  Score=168.83  Aligned_cols=134  Identities=25%  Similarity=0.345  Sum_probs=115.9

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSAL--PPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      ++.|.||+++++.....+.+-|.||-.+||+|.++|++..+++  .+++.-.+..||++|+.|+|++.  |+|||+|-+|
T Consensus       628 ~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDN  705 (1226)
T KOG4279|consen  628 TLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDN  705 (1226)
T ss_pred             HHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCc
Confidence            3568899999999999899999999999999999999887888  67888899999999999999999  9999999999


Q ss_pred             EEEcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeee
Q psy1934          80 LLISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLY  147 (150)
Q Consensus        80 il~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~  147 (150)
                      +++.. .|.+||+|||.++..-..  +.          +.-+..||+.|||||++           |+||+||++.||++
T Consensus       706 VLvNTySGvlKISDFGTsKRLAgi--nP----------~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT  773 (1226)
T KOG4279|consen  706 VLVNTYSGVLKISDFGTSKRLAGI--NP----------CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT  773 (1226)
T ss_pred             EEEeeccceEEecccccchhhccC--Cc----------cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc
Confidence            99987 489999999988753211  11          11134689999999997           99999999999999


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |+
T Consensus       774 Gr  775 (1226)
T KOG4279|consen  774 GR  775 (1226)
T ss_pred             CC
Confidence            96

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.93  E-value=3.2e-26  Score=164.07  Aligned_cols=129  Identities=25%  Similarity=0.393  Sum_probs=108.7

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~   85 (150)
                      +.++.+.+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.+
T Consensus        61 ~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~  137 (323)
T cd05615          61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE  137 (323)
T ss_pred             CchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC
Confidence            44666778888889999999999999999998754 46899999999999999999999998  9999999999999999


Q ss_pred             CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          86 GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        86 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       138 ~~ikL~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~  198 (323)
T cd05615         138 GHIKIADFGMCKEHMVDGV------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ  198 (323)
T ss_pred             CCEEEeccccccccCCCCc------------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCC
Confidence            9999999998864221110            01133589999999984         9999999999999885

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.93  E-value=3.2e-26  Score=164.03  Aligned_cols=127  Identities=25%  Similarity=0.437  Sum_probs=107.3

Q ss_pred             hhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc
Q psy1934           8 FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGT   87 (150)
Q Consensus         8 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~   87 (150)
                      ++...+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.++.
T Consensus        63 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~  139 (324)
T cd05587          63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGH  139 (324)
T ss_pred             eeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCC
Confidence            566777778888999999999999999998754 46888889999999999999999998  999999999999999999


Q ss_pred             EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          88 VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        88 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       140 ~kL~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~  198 (324)
T cd05587         140 IKIADFGMCKENIFGGK------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ  198 (324)
T ss_pred             EEEeecCcceecCCCCC------------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCC
Confidence            99999998764221111            01134689999999984         9999999999999885

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0658|consensus

Probab=99.93  E-value=1.4e-27  Score=167.28  Aligned_cols=131  Identities=25%  Similarity=0.408  Sum_probs=105.0

Q ss_pred             cchhhhcccCCCCCc-----eEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           4 LSAAFIDKHSTPHGM-----HEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      =|||||++...+...     -...+||||+|. +|+++++.-   ...++.-.++-+.+|+.+|+.|+|+.+  |+|||+
T Consensus        75 ~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDI  151 (364)
T KOG0658|consen   75 DHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDI  151 (364)
T ss_pred             CCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCC
Confidence            478899877644322     234789999988 999999841   245777778889999999999999988  999999


Q ss_pred             CCCCEEEcCC-CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEE
Q psy1934          76 KIENLLISSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRS  144 (150)
Q Consensus        76 ~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~  144 (150)
                      ||+|+|++.+ +.+|++|||.|+.......+             .+..-|.+|+|||.          +|+||.||++.|
T Consensus       152 KPqNlLvD~~tg~LKicDFGSAK~L~~~epn-------------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE  218 (364)
T KOG0658|consen  152 KPQNLLVDPDTGVLKICDFGSAKVLVKGEPN-------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE  218 (364)
T ss_pred             ChheEEEcCCCCeEEeccCCcceeeccCCCc-------------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence            9999999987 99999999999865432111             12345789999998          499999999999


Q ss_pred             eeeecC
Q psy1934         145 MLYGHV  150 (150)
Q Consensus       145 ~~~g~~  150 (150)
                      |+-|++
T Consensus       219 Ll~g~p  224 (364)
T KOG0658|consen  219 LLKGQP  224 (364)
T ss_pred             HhcCCc
Confidence            998874

>KOG4645|consensus

Probab=99.93  E-value=3.5e-26  Score=179.96  Aligned_cols=135  Identities=27%  Similarity=0.396  Sum_probs=113.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|||++++.++--+...++|.||||++|+|.+++.. .+..++.-.+.+..|++.|+.|||+++  |+|||+||.||+++
T Consensus      1292 nHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld 1368 (1509)
T KOG4645|consen 1292 NHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD 1368 (1509)
T ss_pred             cCccccccCceeecHHHHHHHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee
Confidence            489999999999999999999999999999998864 344666666778889999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      .+|.+|..|||.+......-...   +     .+-....||+.|||||++            |+||+||++.||++|.
T Consensus      1369 ~~g~iK~~DFGsa~ki~~~~~~~---~-----~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1369 FNGLIKYGDFGSAVKIKNNAQTM---P-----GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred             cCCcEEeecccceeEecCchhcC---C-----HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCC
Confidence            99999999999987543221100   0     122245799999999996            9999999999999995

>KOG0201|consensus

Probab=99.93  E-value=7.6e-28  Score=171.85  Aligned_cols=132  Identities=28%  Similarity=0.461  Sum_probs=112.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      .-+++|.++...+-.+..+|++||||.||++.+.|+.. ..+.+..+..++.+++.|+.|+|..+  .+|||++..|+++
T Consensus        68 ~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~  144 (467)
T KOG0201|consen   68 CDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILL  144 (467)
T ss_pred             cCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeE
Confidence            34567888888888899999999999999999999864 34477777778899999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ...+.++++|||++-......            ....+.+||++||||||+         |+||+|++++||+.|.
T Consensus       145 s~~g~vkl~DfgVa~ql~~~~------------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~Ge  208 (467)
T KOG0201|consen  145 SESGDVKLADFGVAGQLTNTV------------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGE  208 (467)
T ss_pred             eccCcEEEEecceeeeeechh------------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCC
Confidence            999999999999987543221            122467899999999996         9999999999999885

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.92  E-value=4.8e-26  Score=162.80  Aligned_cols=130  Identities=25%  Similarity=0.389  Sum_probs=112.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+++++.+.++..+.+|+||||+++|+|.+++.+. ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        55 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~  131 (318)
T cd05570          55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDS  131 (318)
T ss_pred             CCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECC
Confidence            788999999999999999999999999999988764 46899999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++.........            .....|++.|+|||++         |+||+|++++++++|.
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~~~------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~  193 (318)
T cd05570         132 EGHIKIADFGMCKEGILGGVT------------TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ  193 (318)
T ss_pred             CCcEEecccCCCeecCcCCCc------------ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCC
Confidence            999999999988642211110            1123588999999984         9999999999999885

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.92  E-value=4.1e-26  Score=161.98  Aligned_cols=132  Identities=30%  Similarity=0.426  Sum_probs=111.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.++.....++||||++ +++.+++......+++..+..++.|++.|+.|+|+.+  ++|+|+||+||++
T Consensus        60 l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill  136 (303)
T cd07869          60 LKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLI  136 (303)
T ss_pred             CCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE
Confidence            357889999999999999999999996 5888888765566888889999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+++.|+|||++          |+||+|+++++|++|.
T Consensus       137 ~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  201 (303)
T cd07869         137 SDTGELKLADFGLARAKSVPSH------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV  201 (303)
T ss_pred             CCCCCEEECCCCcceeccCCCc------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999998864321110            01123578999999973          9999999999999885

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0194|consensus

Probab=99.92  E-value=1.1e-25  Score=165.43  Aligned_cols=132  Identities=24%  Similarity=0.370  Sum_probs=113.0

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ||-|++|+++.++.....-+++|||+|.||+|.++|+.....++..+...++.+.+.|++|||+.+  ++|||+...|+|
T Consensus       217 ~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL  294 (474)
T KOG0194|consen  217 QLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCL  294 (474)
T ss_pred             hCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHhe
Confidence            577999999999999999999999999999999999876556999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      ++.++.+|++|||+++.........            ....-...|+|||.+         |+||+|+++||++.
T Consensus       295 ~~~~~~vKISDFGLs~~~~~~~~~~------------~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~  357 (474)
T KOG0194|consen  295 YSKKGVVKISDFGLSRAGSQYVMKK------------FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFE  357 (474)
T ss_pred             ecCCCeEEeCccccccCCcceeecc------------ccccCcceecChhhhccCccccccchhheeeeEEeeec
Confidence            9999999999999987542110000            011134679999996         99999999999885

>KOG0580|consensus

Probab=99.92  E-value=2.4e-26  Score=153.40  Aligned_cols=132  Identities=27%  Similarity=0.359  Sum_probs=116.7

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      .+.||||+++..++++...+||++||.+.|+++..|.+.. ..+++.....+..|++.|+.|+|..+  ++|||++|+|+
T Consensus        78 ~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenl  155 (281)
T KOG0580|consen   78 HLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENL  155 (281)
T ss_pred             ccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHh
Confidence            3678999999999999999999999999999999998544 34888888899999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      |++..+.+|++|||.+-..+.              ....+.+||.-|.+||++         |+|++|++++|++.|.
T Consensus       156 Llg~~~~lkiAdfGwsV~~p~--------------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~  219 (281)
T KOG0580|consen  156 LLGSAGELKIADFGWSVHAPS--------------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGL  219 (281)
T ss_pred             ccCCCCCeeccCCCceeecCC--------------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcC
Confidence            999999999999998764321              123467899999999994         9999999999999885

>KOG0032|consensus

Probab=99.92  E-value=3.6e-26  Score=165.98  Aligned_cols=131  Identities=34%  Similarity=0.484  Sum_probs=114.4

Q ss_pred             ccc--chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           2 EYL--SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         2 ~~~--~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +.|  ||+++.+.+.++..+.+++|||+|.||.|++.+...  .+++..+..++.|++.++.|+|+.+  ++|||+||+|
T Consensus        90 ~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN  165 (382)
T KOG0032|consen   90 QQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPEN  165 (382)
T ss_pred             HhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHH
Confidence            445  899999999999999999999999999999999765  3899999999999999999999999  9999999999


Q ss_pred             EEEcCC----CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee
Q psy1934          80 LLISSA----GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML  146 (150)
Q Consensus        80 il~~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~  146 (150)
                      +++...    +.++++|||++.....  .           ......+||+.|+|||++         |+||+|+++|.|+
T Consensus       166 ~L~~~~~~~~~~ik~~DFGla~~~~~--~-----------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL  232 (382)
T KOG0032|consen  166 LLLASKDEGSGRIKLIDFGLAKFIKP--G-----------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILL  232 (382)
T ss_pred             eeeccccCCCCcEEEeeCCCceEccC--C-----------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHh
Confidence            999654    4799999999986432  1           011256899999999995         9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       233 ~G~  235 (382)
T KOG0032|consen  233 SGV  235 (382)
T ss_pred             hCC
Confidence            884

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.92  E-value=8.2e-26  Score=159.45  Aligned_cols=132  Identities=27%  Similarity=0.376  Sum_probs=111.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.....+.+++||||+++ +|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        60 l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~  136 (288)
T cd07871          60 LKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLI  136 (288)
T ss_pred             CCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE
Confidence            4578899999988888999999999976 999998766556788888999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....+++.|+|||++          |+||+|+++++|++|.
T Consensus       137 ~~~~~~kl~DfG~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~  201 (288)
T cd07871         137 NEKGELKLADFGLARAKSVPTKT------------YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR  201 (288)
T ss_pred             CCCCCEEECcCcceeeccCCCcc------------ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999998643211100            1123578899999973          9999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.92  E-value=1.4e-25  Score=157.66  Aligned_cols=132  Identities=23%  Similarity=0.328  Sum_probs=110.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      -|+++++..+.++..+.+++||||+++|+|.+.+...   ...+++..+..++.|++.|+.|+|+.+  ++|+|++|+||
T Consensus        51 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Ni  128 (280)
T cd05608          51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENV  128 (280)
T ss_pred             CCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHE
Confidence            3677888888888889999999999999999887532   245889999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++.........            .....|++.|+|||++         |+||+|+++++|++|.
T Consensus       129 li~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  194 (280)
T cd05608         129 LLDNDGNVRISDLGLAVELKDGQSK------------TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR  194 (280)
T ss_pred             EECCCCCEEEeeCccceecCCCCcc------------ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence            9999999999999988643221110            1123588999999984         9999999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0196|consensus

Probab=99.92  E-value=1.2e-25  Score=170.00  Aligned_cols=136  Identities=24%  Similarity=0.379  Sum_probs=117.9

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ||=|||||++.++-....-++|++|||++|+|..+|+.+++.++.-+...+++.|+.|+.||.+.+  .+|||+...|||
T Consensus       686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNIL  763 (996)
T KOG0196|consen  686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNIL  763 (996)
T ss_pred             cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhhee
Confidence            688999999999999999999999999999999999998888998899999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee-ee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML-YG  148 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~-~g  148 (150)
                      ++++-.+|++|||+++...++....++...         -.-..+|.|||.+         |+||+|+++||.+ ||
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~G---------GKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG  831 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLG---------GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG  831 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccC---------CccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence            999999999999999976554433322110         0113579999997         9999999999976 55

>KOG4717|consensus

Probab=99.92  E-value=1.4e-25  Score=164.04  Aligned_cols=131  Identities=26%  Similarity=0.373  Sum_probs=115.7

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~-   83 (150)
                      ||+|+++..+...+.++||++|.=.+|+|++++-.+..++.+...+++++||+.|+.|+|+..  ++|||+||+|+++. 
T Consensus        76 HpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFE  153 (864)
T KOG4717|consen   76 HPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFE  153 (864)
T ss_pred             CcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEee
Confidence            799999999999999999999999999999999888888999999999999999999999988  99999999998775 


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeecC
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~~  150 (150)
                      +-|.+|+.||||+.......             .-.+.+|++.|.|||++          |+||+|+++|.+.+|+.
T Consensus       154 KlGlVKLTDFGFSNkf~PG~-------------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~  217 (864)
T KOG4717|consen  154 KLGLVKLTDFGFSNKFQPGK-------------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQP  217 (864)
T ss_pred             ecCceEeeeccccccCCCcc-------------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCC
Confidence            55999999999986543221             11356899999999994          99999999999999873

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.92  E-value=3.1e-25  Score=155.75  Aligned_cols=132  Identities=25%  Similarity=0.262  Sum_probs=111.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||++++..+.++..+.++++|||+++++|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+
T Consensus        50 l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nil  127 (277)
T cd05607          50 VNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVL  127 (277)
T ss_pred             cCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEE
Confidence            447889999888999999999999999999999886533 35788888889999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++........             .....+++.|+|||++         |+||+|+++++|++|.
T Consensus       128 i~~~~~~~l~Dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~  191 (277)
T cd05607         128 LDDQGNCRLSDLGLAVELKDGKT-------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR  191 (277)
T ss_pred             EcCCCCEEEeeceeeeecCCCce-------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCC
Confidence            99999999999998864321110             0123578899999984         9999999999999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.92  E-value=2.8e-25  Score=156.38  Aligned_cols=133  Identities=29%  Similarity=0.428  Sum_probs=109.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.++..+.+++||||++++.+..+. .....+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill  133 (287)
T cd07848          57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLI  133 (287)
T ss_pred             CCCccccchhhhEecCCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE
Confidence            45788999999999999999999999986665443 33456888999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........           ......+++.|+|||++         |+||+|+++++|++|.
T Consensus       134 ~~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~  198 (287)
T cd07848         134 SHNDVLKLCDFGFARNLSEGSNA-----------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ  198 (287)
T ss_pred             cCCCcEEEeeccCcccccccccc-----------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCC
Confidence            99999999999998753211110           01123578999999984         9999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0607|consensus

Probab=99.92  E-value=1.4e-25  Score=155.71  Aligned_cols=135  Identities=26%  Similarity=0.393  Sum_probs=111.6

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      |++|+.+.+.+++++.+|||||-+.||+|.+++..+ ..+++.++..+...|+.|+.+||.++  |.|||+||+|||...
T Consensus       135 h~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~  211 (463)
T KOG0607|consen  135 HKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCES  211 (463)
T ss_pred             CccHHHHHHHhcccceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecC
Confidence            678999999999999999999999999999999765 46888888899999999999999999  999999999999977


Q ss_pred             CCc---EEEeecCceeccccCCCc-chhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEee
Q psy1934          85 AGT---VKLCDFGSATEKVYSPDN-AWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSML  146 (150)
Q Consensus        85 ~~~---~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~  146 (150)
                      ...   +|++||.+........+- .-+.      .+-.+.+|+--|||||++              |.||+|+++|.|+
T Consensus       212 pn~vsPvKiCDfDLgSg~k~~~~~spast------P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImL  285 (463)
T KOG0607|consen  212 PNKVSPVKICDFDLGSGIKLNNDCSPAST------PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIML  285 (463)
T ss_pred             CCCcCceeeeccccccccccCCCCCCCCC------ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHH
Confidence            654   789999876543222211 1111      122456888899999994              9999999999999


Q ss_pred             ee
Q psy1934         147 YG  148 (150)
Q Consensus       147 ~g  148 (150)
                      .|
T Consensus       286 sG  287 (463)
T KOG0607|consen  286 SG  287 (463)
T ss_pred             hC
Confidence            87

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.91  E-value=2.8e-25  Score=159.83  Aligned_cols=133  Identities=23%  Similarity=0.410  Sum_probs=104.6

Q ss_pred             chhhhcccCCCCC-ceEEEEEEeccCCCCHHHHHHhhC------------------------------------------
Q psy1934           5 SAAFIDKHSTPHG-MHEYLILTELCTGGSLVDVLKERT------------------------------------------   41 (150)
Q Consensus         5 ~~~~~~~~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------   41 (150)
                      ||+|+++.+.+.. .+.++++|||+++|+|.+++....                                          
T Consensus        70 h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (338)
T cd05102          70 HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRF  149 (338)
T ss_pred             CcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccc
Confidence            7889998876554 446899999999999999987421                                          


Q ss_pred             -------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccC
Q psy1934          42 -------------------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS  102 (150)
Q Consensus        42 -------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~  102 (150)
                                         ..+++..+..++.|++.|+.|+|+++  ++|+|+||+||+++.++.++++|||+++.....
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~  227 (338)
T cd05102         150 QPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKD  227 (338)
T ss_pred             ccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccC
Confidence                               13566777888999999999999998  999999999999999999999999998743221


Q ss_pred             CCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934         103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus       103 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ...          .......+++.|+|||++         |+||+|+++++|++ |.
T Consensus       228 ~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~  274 (338)
T cd05102         228 PDY----------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA  274 (338)
T ss_pred             cch----------hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCC
Confidence            110          001122456789999974         99999999999985 64

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0586|consensus

Probab=99.91  E-value=6.3e-25  Score=162.23  Aligned_cols=132  Identities=29%  Similarity=0.399  Sum_probs=115.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++..+.+....+|+||||+.+|.+++++..+. .+.+..+..++.|+..+++|+|+++  ++|||++.+|+++
T Consensus       112 l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL  188 (596)
T KOG0586|consen  112 LNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILL  188 (596)
T ss_pred             cCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccc
Confidence            568999999999999999999999999999999998763 4666788889999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeecC
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~~  150 (150)
                      +.+..+||+|||++.......             ...+.+|++.|.|||+          +|+|++|++++.+..|.+
T Consensus       189 ~~~mnikIaDfgfS~~~~~~~-------------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsL  253 (596)
T KOG0586|consen  189 DENMNIKIADFGFSTFFDYGL-------------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSL  253 (596)
T ss_pred             ccccceeeeccccceeecccc-------------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccc
Confidence            999999999999987543211             1125679999999999          499999999999999864

>KOG2345|consensus

Probab=99.91  E-value=6.9e-25  Score=147.28  Aligned_cols=144  Identities=28%  Similarity=0.449  Sum_probs=117.2

Q ss_pred             ccchhhhcccC-----CCCCceEEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEec
Q psy1934           3 YLSAAFIDKHS-----TPHGMHEYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD   74 (150)
Q Consensus         3 ~~~~~~~~~~~-----~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~   74 (150)
                      |-+|+++++.+     ........||+++|...|+|.+.+.+..   ..+++.++..++.++++|+.++|+..++..|+|
T Consensus        75 f~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~D  154 (302)
T KOG2345|consen   75 FNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRD  154 (302)
T ss_pred             hCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccC
Confidence            45566666544     2335667899999999999999987643   358999999999999999999999988999999


Q ss_pred             CCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeE
Q psy1934          75 LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIG  142 (150)
Q Consensus        75 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~  142 (150)
                      +||.||+++..+.+.+.|||.+....-...   ...+....++.....-|..|+|||.+            |+||+||++
T Consensus       155 iKP~NILls~~~~~vl~D~GS~~~a~i~i~---~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL  231 (302)
T KOG2345|consen  155 IKPANILLSDSGLPVLMDLGSATQAPIQIE---GSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL  231 (302)
T ss_pred             CCcceeEecCCCceEEEeccCccccceEee---chHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence            999999999999999999998875433222   23344455667777789999999984            999999999


Q ss_pred             EEeeeec
Q psy1934         143 RSMLYGH  149 (150)
Q Consensus       143 ~~~~~g~  149 (150)
                      |.|++|.
T Consensus       232 Ya~mf~~  238 (302)
T KOG2345|consen  232 YAMMFGE  238 (302)
T ss_pred             HHHHHcC
Confidence            9999884

>KOG0587|consensus

Probab=99.91  E-value=1.2e-24  Score=166.06  Aligned_cols=120  Identities=28%  Similarity=0.514  Sum_probs=105.1

Q ss_pred             CCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecC
Q psy1934          16 HGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG   94 (150)
Q Consensus        16 ~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg   94 (150)
                      ..++++|||||||.+|+.-|+++... ..+.|..+..+++.++.|+.+||.+.  ++|||++-.|||+..++.+|++|||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeee
Confidence            56789999999999999999998754 45888888889999999999999998  9999999999999999999999999


Q ss_pred             ceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeeec
Q psy1934          95 SATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g~  149 (150)
                      .+.....            +..+..+.+||+.|||||++              |+||+|+++.||.-|.
T Consensus       169 vSaQlds------------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~  225 (953)
T KOG0587|consen  169 VSAQLDS------------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGA  225 (953)
T ss_pred             eeeeeec------------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCC
Confidence            9865432            22334466899999999996              9999999999999885

>KOG4250|consensus

Probab=99.91  E-value=4.9e-25  Score=165.13  Aligned_cols=133  Identities=29%  Similarity=0.395  Sum_probs=112.3

Q ss_pred             cccchhhhcccCCCCCce------EEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q psy1934           2 EYLSAAFIDKHSTPHGMH------EYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHR   73 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~   73 (150)
                      |+-|+|||+..+..+.+.      ...++||||.+|+|+.+|.+-.  .++++.++..++..+..|+.|||+++  |+||
T Consensus        67 KLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHR  144 (732)
T KOG4250|consen   67 KLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHR  144 (732)
T ss_pred             HcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceec
Confidence            456899999999887765      4599999999999999997533  57999999999999999999999999  9999


Q ss_pred             cCCCCCEEEc--CCC--cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccc
Q psy1934          74 DLKIENLLIS--SAG--TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNY  139 (150)
Q Consensus        74 ~l~~~nil~~--~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g  139 (150)
                      |+||.||++-  .++  ..|++|||.|+...++.             ...+.+||+.|.+||+          +|.||+|
T Consensus       145 DlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s-------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~G  211 (732)
T KOG4250|consen  145 DLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS-------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFG  211 (732)
T ss_pred             cCCCCcEEEeecCCCceEEeeecccccccCCCCC-------------eeeeecCchhhcChHHHhhccCcCceeehhhhh
Confidence            9999999873  333  57999999998654332             1235789999999987          4999999


Q ss_pred             eeEEEeeeec
Q psy1934         140 VIGRSMLYGH  149 (150)
Q Consensus       140 ~~~~~~~~g~  149 (150)
                      +++|+.++|.
T Consensus       212 vtlY~caTG~  221 (732)
T KOG4250|consen  212 VTLYECATGE  221 (732)
T ss_pred             hHHHHHhccC
Confidence            9999999985

>KOG0033|consensus

Probab=99.91  E-value=1.6e-25  Score=150.63  Aligned_cols=132  Identities=31%  Similarity=0.383  Sum_probs=111.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++++..++.+..|+|+|+++|++|..-+-.+ ...++..+..+++|+++++.|+|.++  |+|||++|.|+++
T Consensus        67 LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllL  143 (355)
T KOG0033|consen   67 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLL  143 (355)
T ss_pred             cCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheee
Confidence            45899999999999999999999999999998766543 35788888889999999999999999  9999999999999


Q ss_pred             cCC---CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeecC
Q psy1934          83 SSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        83 ~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~~  150 (150)
                      .+.   .-+|+++||++.... +..            .....+|||.||+||++         |+|+.|++++.++.|.+
T Consensus       144 ASK~~~A~vKL~~FGvAi~l~-~g~------------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~  210 (355)
T KOG0033|consen  144 ASKAKGAAVKLADFGLAIEVN-DGE------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP  210 (355)
T ss_pred             eeccCCCceeecccceEEEeC-Ccc------------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCC
Confidence            654   458999999997543 111            11256899999999995         99999999999888853

>KOG3653|consensus

Probab=99.91  E-value=3.2e-25  Score=159.89  Aligned_cols=132  Identities=28%  Similarity=0.413  Sum_probs=111.9

Q ss_pred             chhhhcccCCCCCce----EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-------CCCCeEEe
Q psy1934           5 SAAFIDKHSTPHGMH----EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-------QNPPIVHR   73 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-------~~~~i~h~   73 (150)
                      |++|+.+...-+.++    .+|||+||.+.|+|.++|+.+  ..+|....+++..++.|+.|||+       .+++|+||
T Consensus       263 h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHR  340 (534)
T KOG3653|consen  263 HENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHR  340 (534)
T ss_pred             chhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccc
Confidence            688888888777766    899999999999999999974  58999999999999999999994       24579999


Q ss_pred             cCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------ccccc
Q psy1934          74 DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DTWNN  138 (150)
Q Consensus        74 ~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~~~~  138 (150)
                      |+|..|+|+..+.++.|+|||++..........          +....+||.+|||||++               |+||.
T Consensus       341 DlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~----------d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYam  410 (534)
T KOG3653|consen  341 DLKSKNVLVKNDLTCCIADFGLALRLEPGKPQG----------DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAM  410 (534)
T ss_pred             cccccceEEccCCcEEeeccceeEEecCCCCCc----------chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHH
Confidence            999999999999999999999998754332211          12246899999999994               99999


Q ss_pred             ceeEEEeeee
Q psy1934         139 YVIGRSMLYG  148 (150)
Q Consensus       139 g~~~~~~~~g  148 (150)
                      |.++||++++
T Consensus       411 gLVLWEi~SR  420 (534)
T KOG3653|consen  411 GLVLWEIASR  420 (534)
T ss_pred             HHHHHHHHhh
Confidence            9999998754

>KOG0584|consensus

Probab=99.91  E-value=1.9e-25  Score=165.30  Aligned_cols=131  Identities=29%  Similarity=0.357  Sum_probs=110.3

Q ss_pred             ccchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|++||++.+.-.+.  ..+-+|+|.+..|+|..|++++ ..+....++.|++||++||.|||++.|||+|||+|.+||
T Consensus        98 L~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNI  176 (632)
T KOG0584|consen   98 LKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNI  176 (632)
T ss_pred             CCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceE
Confidence            4589999977744333  3488999999999999999986 568888999999999999999999999999999999999


Q ss_pred             EEcCC-CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc--------ccccccceeEEEeeee
Q psy1934          81 LISSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------VDTWNNYVIGRSMLYG  148 (150)
Q Consensus        81 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~--------~d~~~~g~~~~~~~~g  148 (150)
                      ++..+ |.+||.|+|+|...-..           ..   ...+|||-|||||+        +|+||+|.++.||.++
T Consensus       177 FinG~~G~VKIGDLGLAtl~r~s-----------~a---ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~  239 (632)
T KOG0584|consen  177 FVNGNLGEVKIGDLGLATLLRKS-----------HA---KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTS  239 (632)
T ss_pred             EEcCCcCceeecchhHHHHhhcc-----------cc---ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhc
Confidence            99765 99999999999753110           00   13579999999998        5999999999999876

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.8e-25  Score=154.93  Aligned_cols=131  Identities=24%  Similarity=0.276  Sum_probs=111.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+.+...+.+++||||+++|+|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        58 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~  135 (285)
T cd05605          58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILL  135 (285)
T ss_pred             CCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEE
Confidence            47889999988888899999999999999999886532 45889999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +..+.++++|||++........             .....|++.|+|||++         |+||+|+++++++.|.
T Consensus       136 ~~~~~~~l~Dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~  198 (285)
T cd05605         136 DDYGHIRISDLGLAVEIPEGET-------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK  198 (285)
T ss_pred             CCCCCEEEeeCCCceecCCCCc-------------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence            9999999999998865321110             0123688999999984         9999999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=3.5e-25  Score=162.38  Aligned_cols=132  Identities=24%  Similarity=0.265  Sum_probs=111.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++.....++++|++. ++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus       140 l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll  215 (391)
T PHA03212        140 INHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFI  215 (391)
T ss_pred             CCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEE
Confidence            458999999999988899999999996 5899888764 46888889999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +..+.++++|||++.........           ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       216 ~~~~~vkL~DFG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  280 (391)
T PHA03212        216 NHPGDVCLGDFGAACFPVDINAN-----------KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH  280 (391)
T ss_pred             cCCCCEEEEeCCccccccccccc-----------ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            99999999999998642111100           11234689999999984         9999999999999885

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.91  E-value=7.1e-25  Score=157.53  Aligned_cols=130  Identities=28%  Similarity=0.391  Sum_probs=111.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.+...+.+++||||+++++|.++++.. ..+++..+..++.+++.|+.|+|+. +  ++|+|++|+||+
T Consensus        60 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil  136 (331)
T cd06649          60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNIL  136 (331)
T ss_pred             CCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEE
Confidence            44788999999888889999999999999999999764 4588888899999999999999975 5  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++.......              .....|++.|+|||++         |+||+|+++++|++|.
T Consensus       137 ~~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~  199 (331)
T cd06649         137 VNSRGEIKLCDFGVSGQLIDSM--------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR  199 (331)
T ss_pred             EcCCCcEEEccCcccccccccc--------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence            9999999999999876432110              0123588999999984         9999999999999885

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0193|consensus

Probab=99.91  E-value=2.6e-25  Score=164.25  Aligned_cols=135  Identities=25%  Similarity=0.324  Sum_probs=114.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      =.|.||+-+.++....+. .||+.+|+|-+|+.+++....++.-....+++.|++.|+.|||.++  |||+|+|..||++
T Consensus       445 TRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl  521 (678)
T KOG0193|consen  445 TRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFL  521 (678)
T ss_pred             cchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEE
Confidence            468899999999988766 9999999999999999876667888888999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeecC
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~~  150 (150)
                      ..+++++|.|||++........       ...   -....|...|||||++            |+||+|+++|||++|.+
T Consensus       522 ~~~~kVkIgDFGLatvk~~w~g-------~~q---~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~l  591 (678)
T KOG0193|consen  522 HEDLKVKIGDFGLATVKTRWSG-------EQQ---LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGEL  591 (678)
T ss_pred             ccCCcEEEecccceeeeeeecc-------ccc---cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcC
Confidence            9999999999999875432210       000   1123477889999996            99999999999999974

>KOG1026|consensus

Probab=99.91  E-value=1.3e-24  Score=165.46  Aligned_cols=135  Identities=21%  Similarity=0.318  Sum_probs=111.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      |=|++||++.++...++-.|+|+||+..|||-++|+.+.             .+++..++..++.||+.|+.||.++.  
T Consensus       546 l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--  623 (774)
T KOG1026|consen  546 LQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--  623 (774)
T ss_pred             ccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--
Confidence            558999999999999999999999999999999997532             12677888999999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|||+.+.|+|++.+..+||+|||+++..... +         ++.......-..+||+||.|         |+||+||
T Consensus       624 FVHRDLATRNCLVge~l~VKIsDfGLsRdiYss-D---------YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GV  693 (774)
T KOG1026|consen  624 FVHRDLATRNCLVGENLVVKISDFGLSRDIYSS-D---------YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGV  693 (774)
T ss_pred             ccccchhhhhceeccceEEEecccccchhhhhh-h---------hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhh
Confidence            999999999999999999999999999854221 1         11111111235689999997         9999999


Q ss_pred             eEEEee-eec
Q psy1934         141 IGRSML-YGH  149 (150)
Q Consensus       141 ~~~~~~-~g~  149 (150)
                      ++||++ +|.
T Consensus       694 vLWEIFsyG~  703 (774)
T KOG1026|consen  694 VLWEIFSYGK  703 (774)
T ss_pred             hhhhhhcccc
Confidence            999988 553

>KOG0614|consensus

Probab=99.91  E-value=8.8e-26  Score=164.48  Aligned_cols=132  Identities=30%  Similarity=0.444  Sum_probs=116.4

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-.+|.|+++..++.+...+|++||-|-||.+...|+.+ +.+...+.+.++..+++|..|||+++  |+.||+||+|++
T Consensus       476 ~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENll  552 (732)
T KOG0614|consen  476 ECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLL  552 (732)
T ss_pred             hcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhhee
Confidence            345678999999999999999999999999999999875 56888888899999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.+|.+|+.|||+++..... .++|            +.+|||-|.|||++         |.|++|++++|++.|.
T Consensus       553 Ld~~Gy~KLVDFGFAKki~~g-~KTw------------TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~  616 (732)
T KOG0614|consen  553 LDNRGYLKLVDFGFAKKIGSG-RKTW------------TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGS  616 (732)
T ss_pred             eccCCceEEeehhhHHHhccC-Ccee------------eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCC
Confidence            999999999999999864322 1221            45899999999995         9999999999999985

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.90  E-value=1.2e-24  Score=153.28  Aligned_cols=130  Identities=25%  Similarity=0.402  Sum_probs=106.9

Q ss_pred             cchhhhcccCCC-----CCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           4 LSAAFIDKHSTP-----HGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         4 ~~~~~~~~~~~~-----~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      -||+|++..+.+     .....+++|+||+++ +|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|++|
T Consensus        62 ~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp  138 (290)
T cd07862          62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKP  138 (290)
T ss_pred             CCCCcceEEEEEecccCCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCH
Confidence            478899887654     245678999999974 9999987543 45888999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +||+++.++.++++|||++.......             ......+++.|+|||++         |+||+|+++++|+.|
T Consensus       139 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  205 (290)
T cd07862         139 QNILVTSSGQIKLADFGLARIYSFQM-------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR  205 (290)
T ss_pred             HHEEEcCCCCEEEccccceEeccCCc-------------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcC
Confidence            99999999999999999987432110             01133578999999985         999999999999987


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       206 ~  206 (290)
T cd07862         206 K  206 (290)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.90  E-value=1e-24  Score=156.87  Aligned_cols=130  Identities=28%  Similarity=0.390  Sum_probs=110.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~nil   81 (150)
                      +-|++|++..+.+...+.+++||||+++++|.++++.. ..+++..+..++.+++.|+.|+|+. +  ++|+|++|+||+
T Consensus        60 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nil  136 (333)
T cd06650          60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNIL  136 (333)
T ss_pred             CCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEE
Confidence            34789999999999999999999999999999999764 4588888889999999999999974 6  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++......              ......++..|+|||++         |+||+|++++++++|.
T Consensus       137 i~~~~~~kL~Dfg~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~  199 (333)
T cd06650         137 VNSRGEIKLCDFGVSGQLIDS--------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR  199 (333)
T ss_pred             EcCCCCEEEeeCCcchhhhhh--------------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            999999999999987643111              01123588899999984         9999999999999885

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA02988 hypothetical protein; Provisional

Probab=99.90  E-value=7.7e-25  Score=154.33  Aligned_cols=130  Identities=15%  Similarity=0.189  Sum_probs=108.1

Q ss_pred             cccchhhhcccCCCCC----ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCC
Q psy1934           2 EYLSAAFIDKHSTPHG----MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLK   76 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~   76 (150)
                      ++-||+|+++.+.+..    ...++++|||+++|+|.+++.+. ..+++.....++.+++.|+.++|+. +  ++|+|++
T Consensus        74 ~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlk  150 (283)
T PHA02988         74 RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLT  150 (283)
T ss_pred             hcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCC
Confidence            3457889998876543    46789999999999999999764 4678888889999999999999974 6  8899999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEe
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSM  145 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~  145 (150)
                      |+|++++.++.++++|||++......               .....++..|+|||++           |+||+|+++++|
T Consensus       151 p~nill~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el  215 (283)
T PHA02988        151 SVSFLVTENYKLKIICHGLEKILSSP---------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEI  215 (283)
T ss_pred             hhhEEECCCCcEEEcccchHhhhccc---------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHH
Confidence            99999999999999999987642110               0123578899999984           999999999999


Q ss_pred             eeec
Q psy1934         146 LYGH  149 (150)
Q Consensus       146 ~~g~  149 (150)
                      ++|.
T Consensus       216 ~~g~  219 (283)
T PHA02988        216 FTGK  219 (283)
T ss_pred             HHCC
Confidence            9986

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=1.4e-24  Score=157.54  Aligned_cols=130  Identities=25%  Similarity=0.318  Sum_probs=110.6

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-|++|+++.+.+...+..++|+|++. ++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus       113 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nil  189 (357)
T PHA03209        113 NVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIF  189 (357)
T ss_pred             hCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEE
Confidence            3458899999999999999999999995 4999998766567899999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      ++..+.++++|||.+........             .....||+.|+|||++         |+||+|+++++|+.
T Consensus       190 l~~~~~~kl~DfG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~  251 (357)
T PHA03209        190 INDVDQVCIGDLGAAQFPVVAPA-------------FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA  251 (357)
T ss_pred             ECCCCCEEEecCccccccccCcc-------------cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHH
Confidence            99999999999998864221110             1133588999999985         99999999999875

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.90  E-value=1.4e-24  Score=156.02  Aligned_cols=134  Identities=28%  Similarity=0.414  Sum_probs=106.5

Q ss_pred             ccchhhhcccCCCC-----CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPH-----GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-||++++..+...     ....+|+||||++ ++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|
T Consensus        56 l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp  131 (338)
T cd07859          56 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKP  131 (338)
T ss_pred             CCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            34788888766432     3346899999996 5899988754 46889999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-----------ccccccceeEEEee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-----------VDTWNNYVIGRSML  146 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-----------~d~~~~g~~~~~~~  146 (150)
                      +||+++.++.++++|||++..........         .......+++.|+|||+           .|+||+|+++++|+
T Consensus       132 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~  202 (338)
T cd07859         132 KNILANADCKLKICDFGLARVAFNDTPTA---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL  202 (338)
T ss_pred             HHeEECCCCcEEEccCccccccccccCcc---------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHH
Confidence            99999999999999999987432111100         00113468999999997           39999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       203 tg~  205 (338)
T cd07859         203 TGK  205 (338)
T ss_pred             cCC
Confidence            885

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG1095|consensus

Probab=99.90  E-value=4.6e-25  Score=172.69  Aligned_cols=134  Identities=22%  Similarity=0.328  Sum_probs=111.5

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER------TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      +|-||||+++.++.-..+.++|++|||++|+|.++|++.      ...++......++.+|++|+.||++++  ++|||+
T Consensus       751 ~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDL  828 (1025)
T KOG1095|consen  751 KFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDL  828 (1025)
T ss_pred             cCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcch
Confidence            578999999999888899999999999999999999876      456788888899999999999999998  999999


Q ss_pred             CCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee
Q psy1934          76 KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML  146 (150)
Q Consensus        76 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~  146 (150)
                      ...|++++.+..+|++|||+|+..... +         .+.......-..+|||||.+         |+||+||++||++
T Consensus       829 AaRNCLL~~~r~VKIaDFGlArDiy~~-~---------yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif  898 (1025)
T KOG1095|consen  829 AARNCLLDERRVVKIADFGLARDIYDK-D---------YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF  898 (1025)
T ss_pred             hhhheeecccCcEEEcccchhHhhhhc-h---------heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence            999999999999999999999832111 1         00000011223579999986         9999999999987


Q ss_pred             e
Q psy1934         147 Y  147 (150)
Q Consensus       147 ~  147 (150)
                      +
T Consensus       899 s  899 (1025)
T KOG1095|consen  899 S  899 (1025)
T ss_pred             h
Confidence            3

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.90  E-value=1.6e-24  Score=151.27  Aligned_cols=134  Identities=19%  Similarity=0.313  Sum_probs=109.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.....+.+++||||+++|+|.+++......+++..+..++.+++.|+.|+|+++  ++|+|++|+|+++
T Consensus        63 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili  140 (266)
T cd05064          63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLV  140 (266)
T ss_pred             CCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEE
Confidence            44889999999888889999999999999999999875557899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee-eec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML-YGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~-~g~  149 (150)
                      +.++.++++|||.+.......  .         .......++..|+|||++         |+||+|+++++++ +|.
T Consensus       141 ~~~~~~~l~dfg~~~~~~~~~--~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~  206 (266)
T cd05064         141 NSDLVCKISGFRRLQEDKSEA--I---------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE  206 (266)
T ss_pred             cCCCcEEECCCcccccccccc--h---------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCC
Confidence            999999999999765321100  0         000122345689999974         9999999999965 464

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.90  E-value=2.5e-24  Score=151.23  Aligned_cols=129  Identities=24%  Similarity=0.289  Sum_probs=110.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      .+++++...+.++..+.+++|+||++|++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        55 ~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~  131 (278)
T cd05606          55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD  131 (278)
T ss_pred             CCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC
Confidence            3577888888888889999999999999999988754 46899999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.......              .....|+..|+|||++          |+||+|+++++|+.|.
T Consensus       132 ~~~~~kl~dfg~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~  193 (278)
T cd05606         132 EHGHVRISDLGLACDFSKKK--------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH  193 (278)
T ss_pred             CCCCEEEccCcCccccCccC--------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCC
Confidence            99999999999876331110              0123588999999973          9999999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.90  E-value=3e-24  Score=151.36  Aligned_cols=131  Identities=24%  Similarity=0.305  Sum_probs=110.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -+++++...+.+...+.+|++|||+++++|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        58 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~  135 (285)
T cd05630          58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILL  135 (285)
T ss_pred             CCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE
Confidence            36778888888888889999999999999999886533 35888889999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........             .....|+..|+|||++         |+||+|+++++|+.|.
T Consensus       136 ~~~~~~~l~Dfg~~~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~  198 (285)
T cd05630         136 DDHGHIRISDLGLAVHVPEGQT-------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ  198 (285)
T ss_pred             CCCCCEEEeeccceeecCCCcc-------------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence            9999999999998864321100             0123588999999985         9999999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.90  E-value=1.3e-24  Score=158.59  Aligned_cols=134  Identities=21%  Similarity=0.365  Sum_probs=108.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC------------------------------------------
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT------------------------------------------   41 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------   41 (150)
                      -|++|++..+.+...+.+++||||+++|+|.+++....                                          
T Consensus       100 ~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (374)
T cd05106         100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSD  179 (374)
T ss_pred             cCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccc
Confidence            37899999999999999999999999999999986421                                          


Q ss_pred             ---------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecC
Q psy1934          42 ---------------------------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG   94 (150)
Q Consensus        42 ---------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg   94 (150)
                                                 ..+++..+..++.|++.|+.|+|+++  ++|||++|+||+++.++.++++|||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfG  257 (374)
T cd05106         180 TYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFG  257 (374)
T ss_pred             cccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeece
Confidence                                       13567778899999999999999998  9999999999999999999999999


Q ss_pred             ceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          95 SATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++..........          ......++..|+|||++         |+||+|+++++|+. |.
T Consensus       258 la~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~  312 (374)
T cd05106         258 LARDIMNDSNYV----------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK  312 (374)
T ss_pred             eeeeccCCccee----------eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence            987532211000          00112345679999974         99999999999985 64

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG2052|consensus

Probab=99.90  E-value=2.5e-24  Score=154.40  Aligned_cols=135  Identities=22%  Similarity=0.327  Sum_probs=108.9

Q ss_pred             ccchhhhcccCCC----CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHh------cCCCCeEE
Q psy1934           3 YLSAAFIDKHSTP----HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMH------GQNPPIVH   72 (150)
Q Consensus         3 ~~~~~~~~~~~~~----~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh------~~~~~i~h   72 (150)
                      +.|+||+.+....    ..-+++|||++|.+.|+|+|+|.+  ..++.+....++..+++|+.|||      +.+|.|.|
T Consensus       262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH  339 (513)
T KOG2052|consen  262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH  339 (513)
T ss_pred             hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence            4678877765532    234688999999999999999987  46888999999999999999999      33456999


Q ss_pred             ecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------cccc
Q psy1934          73 RDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DTWN  137 (150)
Q Consensus        73 ~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~~~  137 (150)
                      ||+|..||++.+++.+.|+|+|++-......+ ...       .....++||.+|||||++               |+||
T Consensus       340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~-~id-------i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa  411 (513)
T KOG2052|consen  340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTD-TID-------IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA  411 (513)
T ss_pred             cccccccEEEccCCcEEEeeceeeEEecccCC-ccc-------CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence            99999999999999999999999986543311 111       122367999999999995               9999


Q ss_pred             cceeEEEeee
Q psy1934         138 NYVIGRSMLY  147 (150)
Q Consensus       138 ~g~~~~~~~~  147 (150)
                      +|.++||++.
T Consensus       412 fgLVlWEiar  421 (513)
T KOG2052|consen  412 FGLVLWEIAR  421 (513)
T ss_pred             HHHHHHHHHH
Confidence            9999998764

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.90  E-value=1.1e-24  Score=157.77  Aligned_cols=127  Identities=28%  Similarity=0.364  Sum_probs=106.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++|++..+.++..+.+++||||+++++|.+..     ..++..+..++.|++.|+.|+|+++  ++|+|++++||+++
T Consensus       130 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~  202 (353)
T PLN00034        130 NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN  202 (353)
T ss_pred             CCCCcceeeeEeccCCeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc
Confidence            4788999999999999999999999999886532     3556777789999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........            ......|+..|+|||++              |+||+|+++++|++|.
T Consensus       203 ~~~~~kL~DfG~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~  270 (353)
T PLN00034        203 SAKNVKIADFGVSRILAQTMD------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR  270 (353)
T ss_pred             CCCCEEEcccccceecccccc------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCC
Confidence            999999999999874321110            01134689999999963              9999999999999885

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.90  E-value=3.8e-24  Score=152.65  Aligned_cols=135  Identities=27%  Similarity=0.362  Sum_probs=105.3

Q ss_pred             ccchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHhhC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q psy1934           3 YLSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKERT--------SALPPNIVCSILWQTCQAVKHMHGQNPPIVH   72 (150)
Q Consensus         3 ~~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h   72 (150)
                      +-||+++++.+.+  +....+|+++||+++ +|.+++....        ..+++..++.++.|++.|+.|+|+.+  ++|
T Consensus        55 l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH  131 (317)
T cd07868          55 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLH  131 (317)
T ss_pred             cCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEc
Confidence            4478899887765  445678999999965 8988876321        24788889999999999999999999  999


Q ss_pred             ecCCCCCEEE----cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------ccccc
Q psy1934          73 RDLKIENLLI----SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNN  138 (150)
Q Consensus        73 ~~l~~~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~  138 (150)
                      +|++|+||++    +..+.++++|||++..........         .......+|+.|+|||++          |+||+
T Consensus       132 rDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  202 (317)
T cd07868         132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL---------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI  202 (317)
T ss_pred             CCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccc---------cccCCccccccccCCHHHcCCCCcCchhhHHHH
Confidence            9999999999    455789999999987532111100         011234678999999973          99999


Q ss_pred             ceeEEEeeeec
Q psy1934         139 YVIGRSMLYGH  149 (150)
Q Consensus       139 g~~~~~~~~g~  149 (150)
                      |+++++|++|.
T Consensus       203 G~il~el~~g~  213 (317)
T cd07868         203 GCIFAELLTSE  213 (317)
T ss_pred             HHHHHHHHhCC
Confidence            99999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=1.9e-24  Score=158.56  Aligned_cols=133  Identities=22%  Similarity=0.296  Sum_probs=111.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++++++.+.++..+.+|++||++. ++|.+++.. ...+++..+..++.|++.|+.|+|+.+  ++|+|+||+||++
T Consensus       143 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill  218 (392)
T PHA03207        143 ISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFL  218 (392)
T ss_pred             cCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE
Confidence            457899999999988899999999996 589998854 356899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +..+.++++|||++.........          .......||+.|+|||++         |+||+|+++++|++|.
T Consensus       219 ~~~~~~~l~DfG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~  284 (392)
T PHA03207        219 DEPENAVLGDFGAACKLDAHPDT----------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN  284 (392)
T ss_pred             cCCCCEEEccCccccccCccccc----------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence            99999999999998643221110          011234689999999984         9999999999998875

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=2.1e-24  Score=160.87  Aligned_cols=133  Identities=23%  Similarity=0.209  Sum_probs=111.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.....+..++++|++. ++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|+||+||++
T Consensus       217 L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl  293 (461)
T PHA03211        217 LSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLV  293 (461)
T ss_pred             CCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEE
Confidence            457899999998888889999999995 5999988765557899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +..+.++++|||+++.........          ......||+.|+|||++         |+||+|++++||+.|
T Consensus       294 ~~~~~vkL~DFGla~~~~~~~~~~----------~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g  358 (461)
T PHA03211        294 NGPEDICLGDFGAACFARGSWSTP----------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVH  358 (461)
T ss_pred             CCCCCEEEcccCCceecccccccc----------cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHc
Confidence            999999999999987432111100          01134689999999984         999999999998765

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.90  E-value=3.4e-24  Score=149.78  Aligned_cols=126  Identities=28%  Similarity=0.431  Sum_probs=110.5

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      |+++++..+.+...+.+|+||||+++++|.+++++. ..+++..+..++.|++.|+.++|+.+  ++|+|++|+||+++.
T Consensus        68 h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~  144 (267)
T PHA03390         68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDR  144 (267)
T ss_pred             CCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeC
Confidence            788999999988889999999999999999999865 37899999999999999999999998  999999999999999


Q ss_pred             CC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .+ .++++|||++......                ....++..|+|||++         |+||+|+++++|+.|.
T Consensus       145 ~~~~~~l~dfg~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~  203 (267)
T PHA03390        145 AKDRIYLCDYGLCKIIGTP----------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK  203 (267)
T ss_pred             CCCeEEEecCccceecCCC----------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence            88 9999999987643211                123478899999984         9999999999999885

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.90  E-value=2e-24  Score=153.40  Aligned_cols=133  Identities=21%  Similarity=0.221  Sum_probs=106.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC------------------CCCCHHHHHHHHHHHHHHHHHHh
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT------------------SALPPNIVCSILWQTCQAVKHMH   64 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------------~~l~~~~~~~~~~~i~~~l~~lh   64 (150)
                      +-|++|++..+.+...+.++++|||+++++|.+++....                  ..+++..+..++.|++.|+.|+|
T Consensus        76 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  155 (304)
T cd05096          76 LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS  155 (304)
T ss_pred             cCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            447889999888888889999999999999999986532                  13566778889999999999999


Q ss_pred             cCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cc
Q psy1934          65 GQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DT  135 (150)
Q Consensus        65 ~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~  135 (150)
                      +.+  ++|+|++|+||+++.++.++++|||++..........          ......++..|+|||++         |+
T Consensus       156 ~~~--ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  223 (304)
T cd05096         156 SLN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR----------IQGRAVLPIRWMAWECILMGKFTTASDV  223 (304)
T ss_pred             HCC--ccccCcchhheEEcCCccEEECCCccceecccCceeE----------ecCcCCCCccccCHHHHhcCCCCchhhh
Confidence            998  9999999999999999999999999886432111000          00122356789999984         99


Q ss_pred             cccceeEEEeee
Q psy1934         136 WNNYVIGRSMLY  147 (150)
Q Consensus       136 ~~~g~~~~~~~~  147 (150)
                      ||+|+++++|++
T Consensus       224 ~slG~~l~el~~  235 (304)
T cd05096         224 WAFGVTLWEILM  235 (304)
T ss_pred             HHHHHHHHHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.90  E-value=3.7e-24  Score=147.17  Aligned_cols=129  Identities=23%  Similarity=0.276  Sum_probs=109.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      ..+|++++..+.++..+.++++|||+++|+|.+++... ..+++..+..++.|++.|+.++|+.+  ++|+|++|+|+++
T Consensus        42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~  118 (237)
T cd05576          42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILL  118 (237)
T ss_pred             cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE
Confidence            35789999999999999999999999999999999764 45889999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+++.|||.+.......               ....++..|++||..         |+||+|+++++++.|.
T Consensus       119 ~~~~~~~l~df~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  179 (237)
T cd05576         119 DDRGHIQLTYFSRWSEVEDSC---------------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGK  179 (237)
T ss_pred             cCCCCEEEecccchhcccccc---------------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCc
Confidence            999999999999765321100               012346679999974         9999999999999875

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.90  E-value=3.3e-24  Score=149.44  Aligned_cols=127  Identities=18%  Similarity=0.220  Sum_probs=107.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+........+++|||+++++|..++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        61 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill  138 (262)
T cd05077          61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILL  138 (262)
T ss_pred             CCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEE
Confidence            45889999999888888999999999999999988765566899999999999999999999998  9999999999999


Q ss_pred             cCCCc-------EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEe
Q psy1934          83 SSAGT-------VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSM  145 (150)
Q Consensus        83 ~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~  145 (150)
                      +..+.       ++++|||.+......                ....++..|+|||++          |+||+|+++++|
T Consensus       139 ~~~~~~~~~~~~~~l~d~g~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el  202 (262)
T cd05077         139 AREGIDGECGPFIKLSDPGIPITVLSR----------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI  202 (262)
T ss_pred             ecCCccCCCCceeEeCCCCCCccccCc----------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHH
Confidence            76653       899999987532110                123467889999974          999999999998


Q ss_pred             ee
Q psy1934         146 LY  147 (150)
Q Consensus       146 ~~  147 (150)
                      ++
T Consensus       203 ~~  204 (262)
T cd05077         203 CY  204 (262)
T ss_pred             Hh
Confidence            74

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.90  E-value=3.3e-24  Score=152.62  Aligned_cols=132  Identities=27%  Similarity=0.380  Sum_probs=110.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+..+..+.+++||||+++ ++.+++......++...+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        61 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill  137 (309)
T cd07872          61 LKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLI  137 (309)
T ss_pred             CCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE
Confidence            4478899999999999999999999976 899888765556888888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....+++.|+|||++          |+||+|+++++|++|.
T Consensus       138 ~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~  202 (309)
T cd07872         138 NERGELKLADFGLARAKSVPTKT------------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR  202 (309)
T ss_pred             CCCCCEEECccccceecCCCccc------------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999988643211110            0123568899999973          9999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.90  E-value=2.8e-24  Score=151.08  Aligned_cols=128  Identities=24%  Similarity=0.306  Sum_probs=108.5

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +++++...+.+...+.+++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++.
T Consensus        56 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~  132 (279)
T cd05633          56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDE  132 (279)
T ss_pred             CCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECC
Confidence            567777777777788999999999999999998754 46899999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++.......              .....|++.|+|||+.          |+||+|+++++++.|+
T Consensus       133 ~~~~~l~dfg~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  193 (279)
T cd05633         133 HGHVRISDLGLACDFSKKK--------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH  193 (279)
T ss_pred             CCCEEEccCCcceeccccC--------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCC
Confidence            9999999999876321110              0123578999999973          9999999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.90  E-value=4.8e-24  Score=148.96  Aligned_cols=134  Identities=22%  Similarity=0.315  Sum_probs=107.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-||++++..+.+.....+++||||+++|+|.+++.+..   ...++..+..++.+++.|+.|+|+.+  ++|+|++|+|
T Consensus        52 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~n  129 (268)
T cd05086          52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRN  129 (268)
T ss_pred             cCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccce
Confidence            457899999998888899999999999999999997542   23556677788999999999999998  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------------ccccccceeEE
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------------VDTWNNYVIGR  143 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------------~d~~~~g~~~~  143 (150)
                      |+++.++.++++|||++........          ........++..|+|||+                .|+||+|++++
T Consensus       130 il~~~~~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~  199 (268)
T cd05086         130 CFLTSDLTVKVGDYGIGPSRYKEDY----------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLW  199 (268)
T ss_pred             EEEcCCccEEecccccccccCcchh----------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHH
Confidence            9999999999999998753211100          001113357788999996                49999999999


Q ss_pred             Eeeee
Q psy1934         144 SMLYG  148 (150)
Q Consensus       144 ~~~~g  148 (150)
                      +|+++
T Consensus       200 el~~~  204 (268)
T cd05086         200 ELFEN  204 (268)
T ss_pred             HHHhC
Confidence            98753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.90  E-value=5.7e-24  Score=158.13  Aligned_cols=131  Identities=31%  Similarity=0.434  Sum_probs=102.8

Q ss_pred             ccchhhhcccCCC--------CCceEEEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy1934           3 YLSAAFIDKHSTP--------HGMHEYLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQNPPIV   71 (150)
Q Consensus         3 ~~~~~~~~~~~~~--------~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~   71 (150)
                      +-|++++++.+.+        +....+++||||+++ ++.+++..   ....+++..++.++.|++.|+.|||+.+  ++
T Consensus       116 l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--Ii  192 (440)
T PTZ00036        116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--IC  192 (440)
T ss_pred             cCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--Ee
Confidence            4478888876543        222357899999976 78777753   2346888899999999999999999999  99


Q ss_pred             EecCCCCCEEEcCCC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccce
Q psy1934          72 HRDLKIENLLISSAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYV  140 (150)
Q Consensus        72 h~~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~  140 (150)
                      |||+||+||+++..+ .++++|||+++.......             .....+|+.|+|||++          |+||+|+
T Consensus       193 HrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv  259 (440)
T PTZ00036        193 HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR-------------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGC  259 (440)
T ss_pred             cCCcCHHHEEEcCCCCceeeeccccchhccCCCC-------------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHH
Confidence            999999999998664 799999999874321110             1134678999999973          9999999


Q ss_pred             eEEEeeeec
Q psy1934         141 IGRSMLYGH  149 (150)
Q Consensus       141 ~~~~~~~g~  149 (150)
                      ++++|++|.
T Consensus       260 il~elltG~  268 (440)
T PTZ00036        260 IIAEMILGY  268 (440)
T ss_pred             HHHHHHhCC
Confidence            999999985

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.90  E-value=8.5e-24  Score=149.29  Aligned_cols=133  Identities=26%  Similarity=0.379  Sum_probs=111.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++||||+++++|..++.+....+++..+..++.|++.++.++|+.+  ++|+|++|+||++
T Consensus        66 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili  143 (292)
T cd06644          66 CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLL  143 (292)
T ss_pred             CCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEE
Confidence            34788899888888889999999999999999988765567899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g  148 (150)
                      +.++.++++|||++........            ......+++.|+|||++              |+||+|+++++|+.|
T Consensus       144 ~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g  211 (292)
T cd06644         144 TLDGDIKLADFGVSAKNVKTLQ------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI  211 (292)
T ss_pred             cCCCCEEEccCccceecccccc------------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcC
Confidence            9999999999998764221110            01123577889999974              999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       212 ~  212 (292)
T cd06644         212 E  212 (292)
T ss_pred             C
Confidence            5

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.89  E-value=3.7e-24  Score=149.42  Aligned_cols=132  Identities=17%  Similarity=0.272  Sum_probs=106.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTS----ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~----~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      -|+++++..+.....+.+++||||+++|+|.+++.....    ..++..+..++.|++.|+.|+|+++  ++|+|++|+|
T Consensus        53 ~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~N  130 (269)
T cd05042          53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRN  130 (269)
T ss_pred             CCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhh
Confidence            378899999888888999999999999999999976432    2356677888999999999999998  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------------ccccccceeEE
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------------VDTWNNYVIGR  143 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------------~d~~~~g~~~~  143 (150)
                      ++++.++.++++|||++.........          .......++..|+|||+                .|+||+|++++
T Consensus       131 ill~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~  200 (269)
T cd05042         131 CQLTADLSVKIGDYGLALEQYPEDYY----------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMW  200 (269)
T ss_pred             eEecCCCcEEEeccccccccccchhe----------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHH
Confidence            99999999999999987643211000          00012235667999996                38999999999


Q ss_pred             Eeee
Q psy1934         144 SMLY  147 (150)
Q Consensus       144 ~~~~  147 (150)
                      +|++
T Consensus       201 el~~  204 (269)
T cd05042         201 ELFT  204 (269)
T ss_pred             HHHh
Confidence            9887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.89  E-value=5.2e-24  Score=155.49  Aligned_cols=131  Identities=22%  Similarity=0.375  Sum_probs=106.7

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-------------------------------------------
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-------------------------------------------   41 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------------------------------------   41 (150)
                      ||+|+++.+.+...+..++||||+++|+|.+++....                                           
T Consensus        98 HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  177 (375)
T cd05104          98 HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSY  177 (375)
T ss_pred             CcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccc
Confidence            7999999999999999999999999999999986421                                           


Q ss_pred             -------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEE
Q psy1934          42 -------------------------------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKL   90 (150)
Q Consensus        42 -------------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l   90 (150)
                                                     ..+++..+..++.+++.|+.|+|+++  ++|+|++|+||+++.++.+++
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl  255 (375)
T cd05104         178 VVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKI  255 (375)
T ss_pred             ccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEE
Confidence                                           13567778889999999999999998  999999999999999999999


Q ss_pred             eecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          91 CDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        91 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      +|||++..........          ......++..|+|||++         |+||+|+++++|++
T Consensus       256 ~DfG~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt  311 (375)
T cd05104         256 CDFGLARDIRNDSNYV----------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS  311 (375)
T ss_pred             ecCccceeccCccccc----------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHh
Confidence            9999987532211100          00112345679999984         99999999999885

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=5.1e-24  Score=160.36  Aligned_cols=118  Identities=27%  Similarity=0.387  Sum_probs=98.2

Q ss_pred             EEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCce
Q psy1934          20 EYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA   96 (150)
Q Consensus        20 ~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~   96 (150)
                      .+++||||+++|+|.++++...   ..+++..+..++.|++.|+.|+|+.+  ++|+|+||+||+++.++.++++|||++
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~DFGls  190 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFS  190 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEecccC
Confidence            4789999999999999997532   35888889999999999999999998  999999999999999999999999998


Q ss_pred             eccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          97 TEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +........          .......||+.|+|||++         |+||+|+++++|++|.
T Consensus       191 ~~~~~~~~~----------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~  242 (496)
T PTZ00283        191 KMYAATVSD----------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK  242 (496)
T ss_pred             eeccccccc----------cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            753211110          001234689999999984         9999999999999885

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.89  E-value=7.4e-24  Score=154.41  Aligned_cols=132  Identities=28%  Similarity=0.440  Sum_probs=108.1

Q ss_pred             ccchhhhcccCCCCCce-----EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPHGMH-----EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-|+++++..+..+..+     ..|+|+||+++ +|.+.+... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|
T Consensus        56 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp  131 (372)
T cd07853          56 FKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKP  131 (372)
T ss_pred             CCCCCcCCHhheecCCCccccceEEEEeecccc-CHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCh
Confidence            34788998888777666     88999999975 888877643 46889999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLY  147 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~  147 (150)
                      +||+++.++.++++|||++.........           ......+++.|+|||++          |+||+|+++++|++
T Consensus       132 ~Nili~~~~~~kL~Dfg~a~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  200 (372)
T cd07853         132 GNLLVNSNCVLKICDFGLARVEEPDESK-----------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG  200 (372)
T ss_pred             HHEEECCCCCEEeccccceeecccCccc-----------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHc
Confidence            9999999999999999998753221110           01123578899999973          99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |+
T Consensus       201 g~  202 (372)
T cd07853         201 RR  202 (372)
T ss_pred             CC
Confidence            86

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.89  E-value=2.8e-23  Score=143.91  Aligned_cols=132  Identities=27%  Similarity=0.438  Sum_probs=111.3

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+.++..+.+++++||+++++|.+++... ...+++..+..++.+++.|+.++|+++  ++|+|++|.||++
T Consensus        56 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili  133 (255)
T cd08219          56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFL  133 (255)
T ss_pred             CCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE
Confidence            4788999999999999999999999999999988653 245788888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+........            ......+++.|+|||+.         |+|++|+++++|+.|.
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~  197 (255)
T cd08219         134 TQNGKVKLGDFGSARLLTSPGA------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK  197 (255)
T ss_pred             CCCCcEEEcccCcceeeccccc------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhcc
Confidence            9999999999998864321110            01123578889999984         9999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.89  E-value=1.3e-23  Score=147.67  Aligned_cols=133  Identities=26%  Similarity=0.377  Sum_probs=112.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+..++|+||+++++|..++......+++..+..++.|++.|+.++|+.+  ++|+|++|+||++
T Consensus        59 l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili  136 (282)
T cd06643          59 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILF  136 (282)
T ss_pred             CCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEE
Confidence            45788999888888889999999999999999988654457899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc--------------ccccccceeEEEeeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------------VDTWNNYVIGRSMLYG  148 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~--------------~d~~~~g~~~~~~~~g  148 (150)
                      +.++.++++|||++........            ......+++.|+|||+              .|+||+|+++++|+.|
T Consensus       137 ~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g  204 (282)
T cd06643         137 TLDGDIKLADFGVSAKNTRTIQ------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQI  204 (282)
T ss_pred             ccCCCEEEcccccccccccccc------------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccC
Confidence            9999999999998764321110            0112357889999996              4999999999999987


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       205 ~  205 (282)
T cd06643         205 E  205 (282)
T ss_pred             C
Confidence            5

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4236|consensus

Probab=99.89  E-value=3.1e-23  Score=152.23  Aligned_cols=132  Identities=32%  Similarity=0.385  Sum_probs=111.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||.|+.+.--++...+++.|||-+.|.-|.=.|.+..+.+++...+.++.||+.|++|||.++  |+|+|+||+|+|+
T Consensus       620 l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLL  697 (888)
T KOG4236|consen  620 LHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLL  697 (888)
T ss_pred             cCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheee
Confidence            45778999999999999999999999775555566655577999988999999999999999999  9999999999999


Q ss_pred             cCC---CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .+.   -.+|++|||+++......             -..+.+|||.|.|||++         |.||.|+++|.-+.|.
T Consensus       698 as~~~FPQvKlCDFGfARiIgEks-------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGT  763 (888)
T KOG4236|consen  698 ASASPFPQVKLCDFGFARIIGEKS-------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGT  763 (888)
T ss_pred             ccCCCCCceeeccccceeecchhh-------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEeccc
Confidence            654   579999999999653211             12256899999999994         9999999999988874

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.89  E-value=1e-23  Score=148.56  Aligned_cols=131  Identities=21%  Similarity=0.266  Sum_probs=110.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|++++...+.+..++..++++||+++++|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+|+++
T Consensus        58 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili  135 (285)
T cd05632          58 NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILL  135 (285)
T ss_pred             CCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE
Confidence            46778888888888899999999999999998886543 45899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +..+.++++|||++........             .....|++.|+|||++         |+||+|++++++++|.
T Consensus       136 ~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  198 (285)
T cd05632         136 DDYGHIRISDLGLAVKIPEGES-------------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ  198 (285)
T ss_pred             CCCCCEEEecCCcceecCCCCc-------------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence            9999999999998864321100             0133688999999984         9999999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0695|consensus

Probab=99.89  E-value=3.2e-24  Score=150.32  Aligned_cols=130  Identities=28%  Similarity=0.457  Sum_probs=114.7

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +|.++-++++++.+..+++|.||.+||+|--.+.+. .+++++.++.+...|+.|+.|+|+++  |+.||+|.+|++++.
T Consensus       310 ~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvllda  386 (593)
T KOG0695|consen  310 NPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDA  386 (593)
T ss_pred             CCeEEehhhhhcccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEcc
Confidence            577888999999999999999999999998777653 68999999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .|.+|+.|+|+++...-..+..            .+.+|||.|.|||++         |+|++|+++.||+.|+
T Consensus       387 eghikltdygmcke~l~~gd~t------------stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagr  448 (593)
T KOG0695|consen  387 EGHIKLTDYGMCKEGLGPGDTT------------STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR  448 (593)
T ss_pred             CCceeecccchhhcCCCCCccc------------ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCC
Confidence            9999999999998654332221            256899999999994         9999999999999885

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.89  E-value=7.9e-24  Score=146.77  Aligned_cols=134  Identities=22%  Similarity=0.387  Sum_probs=110.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.+...+.++++|||+++|+|.+++......+++..+..++.+++.|+.|+|+++  ++|+|++|+|+++
T Consensus        56 l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i  133 (256)
T cd05114          56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLV  133 (256)
T ss_pred             CCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEE
Confidence            35788999998888899999999999999999999765456888889999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||.+.........           ......++..|+|||++         |+||+|++++++++ |.
T Consensus       134 ~~~~~~kl~d~g~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~  199 (256)
T cd05114         134 SSTGVVKVSDFGMTRYVLDDEYT-----------SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK  199 (256)
T ss_pred             cCCCeEEECCCCCccccCCCcee-----------ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence            99999999999987643211000           00112345579999974         99999999999987 54

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.89  E-value=1.7e-23  Score=144.79  Aligned_cols=133  Identities=26%  Similarity=0.342  Sum_probs=112.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.+...+.+++++||+++++|.+++... ...+++..+..++.+++.|+.|+|+.+  ++|+|++++||+
T Consensus        56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nil  133 (256)
T cd08529          56 LDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLF  133 (256)
T ss_pred             cCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEE
Confidence            45788999999999999999999999999999999764 356888888899999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++........            ......+++.|+|||+         .|+|++|+++++|+.|.
T Consensus       134 i~~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  198 (256)
T cd08529         134 LDAYDNVKIGDLGVAKLLSDNTN------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK  198 (256)
T ss_pred             EeCCCCEEEcccccceeccCccc------------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCC
Confidence            99999999999998774322110            0112357788999997         49999999999999885

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.89  E-value=6.9e-24  Score=147.36  Aligned_cols=126  Identities=17%  Similarity=0.194  Sum_probs=106.7

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||++++..+.....+..++||||+++|+|.+++......+++.....++.|++.|+.|+|+.+  ++|+|++|+||+++.
T Consensus        58 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~  135 (258)
T cd05078          58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIR  135 (258)
T ss_pred             CCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEec
Confidence            788999999888888999999999999999999865556888888899999999999999998  999999999999977


Q ss_pred             CCc--------EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          85 AGT--------VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        85 ~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      ++.        ++++|||++.....                .....++..|+|||++          |+||+|+++++++
T Consensus       136 ~~~~~~~~~~~~~l~d~g~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~  199 (258)
T cd05078         136 EEDRKTGNPPFIKLSDPGISITVLP----------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF  199 (258)
T ss_pred             ccccccCCCceEEecccccccccCC----------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHH
Confidence            654        68899987653211                0123467889999973          9999999999998


Q ss_pred             ee
Q psy1934         147 YG  148 (150)
Q Consensus       147 ~g  148 (150)
                      .|
T Consensus       200 ~g  201 (258)
T cd05078         200 SG  201 (258)
T ss_pred             cC
Confidence            87

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.89  E-value=8.6e-24  Score=147.34  Aligned_cols=131  Identities=24%  Similarity=0.392  Sum_probs=111.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||++++..+.....+.+++++||+++++|.+++... ..+++..+..++.+++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        64 ~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~  140 (267)
T cd06645          64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT  140 (267)
T ss_pred             CCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC
Confidence            4788999988888889999999999999999998754 46889999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........            ......|+..|+|||++            |+||+|+++++|+.|.
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~  206 (267)
T cd06645         141 DNGHVKLADFGVSAQITATIA------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ  206 (267)
T ss_pred             CCCCEEECcceeeeEccCccc------------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCC
Confidence            999999999998764321100            01133588899999973            9999999999998774

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.89  E-value=1.2e-23  Score=148.53  Aligned_cols=135  Identities=20%  Similarity=0.219  Sum_probs=110.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQN   67 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~   67 (150)
                      +-|+++++..+.....+..++||||+++++|.+++....               ..+++..+..++.+++.|+.++|+++
T Consensus        64 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  143 (291)
T cd05094          64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH  143 (291)
T ss_pred             CCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            357889999998899999999999999999999997532               23788888999999999999999998


Q ss_pred             CCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------cccccc
Q psy1934          68 PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNN  138 (150)
Q Consensus        68 ~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~  138 (150)
                        ++|+|++|+||+++.++.++++|||++..........          ......++..|+|||+         .|+||+
T Consensus       144 --i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  211 (291)
T cd05094         144 --FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR----------VGGHTMLPIRWMPPESIMYRKFTTESDVWSF  211 (291)
T ss_pred             --eeecccCcceEEEccCCcEEECCCCcccccCCCceee----------cCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence              9999999999999999999999999886432211000          0112345678999997         399999


Q ss_pred             ceeEEEeee-ec
Q psy1934         139 YVIGRSMLY-GH  149 (150)
Q Consensus       139 g~~~~~~~~-g~  149 (150)
                      |+++++|++ |.
T Consensus       212 G~il~el~t~g~  223 (291)
T cd05094         212 GVILWEIFTYGK  223 (291)
T ss_pred             HHHHHHHHhCCC
Confidence            999999986 64

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.89  E-value=1.2e-23  Score=146.06  Aligned_cols=134  Identities=20%  Similarity=0.359  Sum_probs=110.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.+...+.++++|||+++++|.+++......+++..+..++.+++.|+.|+|+.+  ++|+|++|.||++
T Consensus        56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili  133 (256)
T cd05113          56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLV  133 (256)
T ss_pred             CCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEE
Confidence            44788999998888888999999999999999999765456889999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||.+.........           ......++..|++||+.         |+||+|+++++|++ |.
T Consensus       134 ~~~~~~kl~d~g~~~~~~~~~~~-----------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~  199 (256)
T cd05113         134 DDQGCVKVSDFGLSRYVLDDEYT-----------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK  199 (256)
T ss_pred             cCCCCEEECCCccceecCCCcee-----------ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence            99999999999987643221100           00112345679999974         99999999999986 64

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.89  E-value=6.8e-24  Score=166.36  Aligned_cols=145  Identities=23%  Similarity=0.266  Sum_probs=111.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT----------SALPPNIVCSILWQTCQAVKHMHGQNPPIVH   72 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h   72 (150)
                      +-||++++..+.....+..+++|||++|++|.+++.+..          ...+...+..++.+++.|+.|+|+.+  ++|
T Consensus        59 L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIH  136 (932)
T PRK13184         59 LIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLH  136 (932)
T ss_pred             CCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence            457899999988888899999999999999999986421          22445667788999999999999998  999


Q ss_pred             ecCCCCCEEEcCCCcEEEeecCceeccccCCCcchh--Hh----hhhhhHHhhhcCCCCCccCcccc---------cccc
Q psy1934          73 RDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWS--AQ----QRSMLEDEMARFTTPMYRAPEMV---------DTWN  137 (150)
Q Consensus        73 ~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~y~aPE~~---------d~~~  137 (150)
                      ||+||+||+++..+.++++|||++............  ..    ...........+||+.|+|||++         |+||
T Consensus       137 RDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWS  216 (932)
T PRK13184        137 RDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYA  216 (932)
T ss_pred             cCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHH
Confidence            999999999999999999999998754211110000  00    00000011134689999999984         9999


Q ss_pred             cceeEEEeeeec
Q psy1934         138 NYVIGRSMLYGH  149 (150)
Q Consensus       138 ~g~~~~~~~~g~  149 (150)
                      +|+++++|++|.
T Consensus       217 LGVILyELLTG~  228 (932)
T PRK13184        217 LGVILYQMLTLS  228 (932)
T ss_pred             HHHHHHHHHHCC
Confidence            999999999885

>KOG0666|consensus

Probab=99.89  E-value=2.2e-24  Score=149.33  Aligned_cols=133  Identities=28%  Similarity=0.359  Sum_probs=106.9

Q ss_pred             ccchhhhcccCCCCC-ceEEEEEEeccCCCCHHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPHG-MHEYLILTELCTGGSLVDVLKERT----SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-|++++.+..++-. +..+|+++||.+. +|.+.++-+.    ..++...++.++.|++.|+.|||++.  ++|||+||
T Consensus        84 l~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKP  160 (438)
T KOG0666|consen   84 LKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKP  160 (438)
T ss_pred             hcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCc
Confidence            457888887776655 7899999999998 9999887443    34788889999999999999999999  99999999


Q ss_pred             CCEEEcCC----CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEE
Q psy1934          78 ENLLISSA----GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGR  143 (150)
Q Consensus        78 ~nil~~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~  143 (150)
                      .||++..+    |++||+|||+++..-.......         .....+.|.||+|||.          +|+|+.||+..
T Consensus       161 aNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~---------s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfa  231 (438)
T KOG0666|consen  161 ANILVMGDGPERGRVKIADLGLARLFNNPLKPLA---------SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFA  231 (438)
T ss_pred             ceEEEeccCCccCeeEeecccHHHHhhccccccc---------cCCceEEEEEecChHHhcccccccchhhhHHHHHHHH
Confidence            99999766    8999999999985422111110         1113467899999998          49999999998


Q ss_pred             Eeee
Q psy1934         144 SMLY  147 (150)
Q Consensus       144 ~~~~  147 (150)
                      |++.
T Consensus       232 ElLt  235 (438)
T KOG0666|consen  232 ELLT  235 (438)
T ss_pred             HHHc
Confidence            8764

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=9.7e-24  Score=148.06  Aligned_cols=133  Identities=25%  Similarity=0.395  Sum_probs=113.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++||||+++++|.+++......+++..+..++.|++.++.|+|+.+  ++|+|++|+|+++
T Consensus        59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili  136 (280)
T cd06611          59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILL  136 (280)
T ss_pred             CCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE
Confidence            34788999999888899999999999999999999876567899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc--------------ccccccceeEEEeeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------------VDTWNNYVIGRSMLYG  148 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~--------------~d~~~~g~~~~~~~~g  148 (150)
                      +.++.++++|||++........            ......+++.|++||+              .|+||+|+++++|+.|
T Consensus       137 ~~~~~~~l~d~g~~~~~~~~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g  204 (280)
T cd06611         137 TLDGDVKLADFGVSAKNKSTLQ------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQM  204 (280)
T ss_pred             CCCCCEEEccCccchhhccccc------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhC
Confidence            9999999999998754321110            1113357888999997              3999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       205 ~  205 (280)
T cd06611         205 E  205 (280)
T ss_pred             C
Confidence            5

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.8e-23  Score=145.22  Aligned_cols=135  Identities=28%  Similarity=0.354  Sum_probs=112.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+..+....+++++||+++++|.+.+... ..+++..+..++.+++.|+.++|+.+  ++|+|++|+||++
T Consensus        61 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv  137 (263)
T cd06625          61 LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILR  137 (263)
T ss_pred             CCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence            45788999999999999999999999999999999764 45888888999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+..........         .......++..|+|||++         |+||+|+++++++.|+
T Consensus       138 ~~~~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  204 (263)
T cd06625         138 DSAGNVKLGDFGASKRLQTICSSG---------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK  204 (263)
T ss_pred             cCCCCEEEeecccceecccccccc---------ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCC
Confidence            999999999999886432110000         000123467889999984         9999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.89  E-value=1.2e-23  Score=146.91  Aligned_cols=135  Identities=21%  Similarity=0.344  Sum_probs=107.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT----SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      +-||++++..+.......+++||||+++|+|.+++....    ...++..+..++.|++.|+.|+|+.+  ++|+|++|+
T Consensus        52 l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~  129 (269)
T cd05087          52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALR  129 (269)
T ss_pred             CCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcc
Confidence            447889999888888889999999999999999997532    13456677788999999999999998  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------------cccccceeE
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------------DTWNNYVIG  142 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------------d~~~~g~~~  142 (150)
                      |++++.++.++++|||++.........          .......++..|+|||++                |+||+|+++
T Consensus       130 nil~~~~~~~kL~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l  199 (269)
T cd05087         130 NCLLTADLTVKIGDYGLSHNKYKEDYY----------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI  199 (269)
T ss_pred             eEEEcCCCcEEECCccccccccCccee----------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHH
Confidence            999999999999999988643211100          001123467789999963                999999999


Q ss_pred             EEeee-ec
Q psy1934         143 RSMLY-GH  149 (150)
Q Consensus       143 ~~~~~-g~  149 (150)
                      ++++. |.
T Consensus       200 ~el~~~g~  207 (269)
T cd05087         200 WELFELGS  207 (269)
T ss_pred             HHHHhCCC
Confidence            99884 74

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.89  E-value=1.7e-23  Score=147.35  Aligned_cols=130  Identities=28%  Similarity=0.364  Sum_probs=106.0

Q ss_pred             cchhhhcccCCCC-----CceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           4 LSAAFIDKHSTPH-----GMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         4 ~~~~~~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      -|++|++..+.+.     ....+++++||+++ +|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|
T Consensus        60 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp  136 (288)
T cd07863          60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKP  136 (288)
T ss_pred             CCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            3788888877554     24568999999975 8999887543 35889999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +||+++.++.++++|||++........             .....+++.|+|||++         |+||+|+++++|+.|
T Consensus       137 ~Nili~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g  203 (288)
T cd07863         137 ENILVTSGGQVKLADFGLARIYSCQMA-------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR  203 (288)
T ss_pred             HHEEECCCCCEEECccCccccccCccc-------------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhC
Confidence            999999999999999998864321100             1123578899999985         999999999999877


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       204 ~  204 (288)
T cd07863         204 K  204 (288)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.89  E-value=1.6e-23  Score=147.11  Aligned_cols=135  Identities=21%  Similarity=0.249  Sum_probs=109.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQN   67 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~   67 (150)
                      +-|+++++..+.....+..|+++||+++++|.+++....               ..+++..+..++.+++.|+.|+|+++
T Consensus        65 l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~  144 (283)
T cd05048          65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH  144 (283)
T ss_pred             cCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            346888998888888889999999999999999997532               24677788899999999999999998


Q ss_pred             CCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccccc
Q psy1934          68 PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNN  138 (150)
Q Consensus        68 ~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~  138 (150)
                        ++|+|++|+||+++.++.++++|||++.........          .......+++.|+|||++         |+||+
T Consensus       145 --i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl  212 (283)
T cd05048         145 --FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY----------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSF  212 (283)
T ss_pred             --eeccccccceEEEcCCCcEEECCCcceeeccccccc----------cccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence              999999999999999999999999998743211100          001123457789999974         99999


Q ss_pred             ceeEEEeee-ec
Q psy1934         139 YVIGRSMLY-GH  149 (150)
Q Consensus       139 g~~~~~~~~-g~  149 (150)
                      |+++++|+. |.
T Consensus       213 G~il~el~~~g~  224 (283)
T cd05048         213 GVVLWEIFSYGL  224 (283)
T ss_pred             HHHHHHHHcCCC
Confidence            999999985 64

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.89  E-value=1.4e-23  Score=149.14  Aligned_cols=130  Identities=18%  Similarity=0.268  Sum_probs=106.5

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      |+++++..+.....+.+|+++||+++++|.+++....               ..+++..+..++.|++.|+.|+|+++  
T Consensus        67 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--  144 (303)
T cd05088          67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--  144 (303)
T ss_pred             CCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            6889999998898999999999999999999997432               24678889999999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|+|++|+|++++.++.++++|||++......             .......++..|+|||++         |+||+|+
T Consensus       145 i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  211 (303)
T cd05088         145 FIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV  211 (303)
T ss_pred             ccccccchheEEecCCCcEEeCccccCcccchh-------------hhcccCCCcccccCHHHHhccCCcccccchhhhh
Confidence            999999999999999999999999987532100             000111235679999973         9999999


Q ss_pred             eEEEeee-ec
Q psy1934         141 IGRSMLY-GH  149 (150)
Q Consensus       141 ~~~~~~~-g~  149 (150)
                      ++++++. |.
T Consensus       212 il~ellt~g~  221 (303)
T cd05088         212 LLWEIVSLGG  221 (303)
T ss_pred             HHHHHHhcCC
Confidence            9999985 53

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.89  E-value=1.9e-23  Score=146.72  Aligned_cols=134  Identities=23%  Similarity=0.284  Sum_probs=108.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|++..+...+ ...++++||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+|+++
T Consensus        66 l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili  142 (279)
T cd05111          66 LDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILL  142 (279)
T ss_pred             CCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEE
Confidence            347889998877654 5678899999999999999876567899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||.++.........          ......++..|++||++         |+||+|++++++++ |.
T Consensus       143 ~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~  209 (279)
T cd05111         143 KSDSIVQIADFGVADLLYPDDKKY----------FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGA  209 (279)
T ss_pred             cCCCcEEEcCCccceeccCCCccc----------ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCC
Confidence            999999999999987532211100          00122356789999985         99999999999985 64

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.89  E-value=1.4e-23  Score=154.23  Aligned_cols=131  Identities=24%  Similarity=0.413  Sum_probs=106.9

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-------------------------------------------
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-------------------------------------------   41 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------------------------------------   41 (150)
                      ||+|+++.++.+..+.+|+|||||++|+|.+++....                                           
T Consensus       100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (400)
T cd05105         100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMD  179 (400)
T ss_pred             CCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccc
Confidence            8999999999999999999999999999999885421                                           


Q ss_pred             ----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934          42 ----------------------------------------------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus        42 ----------------------------------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                                                                          ..+++..+..++.|++.|+.|+|+.+  
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--  257 (400)
T cd05105         180 MKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--  257 (400)
T ss_pred             cccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence                                                                13566777889999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|+|++|+||+++.++.++++|||++.........          .......+++.|+|||++         |+||+|+
T Consensus       258 ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGv  327 (400)
T cd05105         258 CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY----------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI  327 (400)
T ss_pred             eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccc----------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHH
Confidence            999999999999999999999999998753221110          001123466789999974         9999999


Q ss_pred             eEEEeee
Q psy1934         141 IGRSMLY  147 (150)
Q Consensus       141 ~~~~~~~  147 (150)
                      ++++|+.
T Consensus       328 il~ellt  334 (400)
T cd05105         328 LLWEIFS  334 (400)
T ss_pred             HHHHHHH
Confidence            9999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0984|consensus

Probab=99.89  E-value=2.1e-23  Score=137.20  Aligned_cols=130  Identities=25%  Similarity=0.349  Sum_probs=104.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      .|..+++.+.....+.+||+||.+.. +|..+-+.   +....++..+-+++..+..|+.|||++- .++|||+||.|||
T Consensus       104 CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiL  181 (282)
T KOG0984|consen  104 CPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNIL  181 (282)
T ss_pred             CCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEE
Confidence            35577888888888999999999965 77776553   2345788888889999999999999762 4999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-------------cccccceeEEEeeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------d~~~~g~~~~~~~~g  148 (150)
                      ++..|++|++|||.+.....+.             ..+-..|...|||||.+             |+||+|+++.||+.+
T Consensus       182 In~~GqVKiCDFGIsG~L~dSi-------------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~l  248 (282)
T KOG0984|consen  182 INYDGQVKICDFGISGYLVDSI-------------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAIL  248 (282)
T ss_pred             EccCCcEEEcccccceeehhhh-------------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhc
Confidence            9999999999999886432211             11123477889999985             999999999999876


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      +
T Consensus       249 r  249 (282)
T KOG0984|consen  249 R  249 (282)
T ss_pred             c
Confidence            4

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.89  E-value=4.3e-23  Score=145.18  Aligned_cols=135  Identities=20%  Similarity=0.241  Sum_probs=106.9

Q ss_pred             ccchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|+++++..+.....  ..++++|||+++++|.+++.+....+++..+..++.+++.++.|+|+++  ++|+|++|+||
T Consensus        63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Ni  140 (284)
T cd05079          63 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNV  140 (284)
T ss_pred             CCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheE
Confidence            3467788877755543  5689999999999999999765456888999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeee
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYG  148 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g  148 (150)
                      +++.++.++++|||++..........         .......++..|+|||+         .|+||+|++++++++|
T Consensus       141 l~~~~~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~  208 (284)
T cd05079         141 LVESEHQVKIGDFGLTKAIETDKEYY---------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY  208 (284)
T ss_pred             EEcCCCCEEECCCccccccccCccce---------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcC
Confidence            99999999999999887532211100         00012345667999997         3999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.6e-23  Score=145.30  Aligned_cols=132  Identities=21%  Similarity=0.338  Sum_probs=108.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.....+.+++++||+++++|.+++......+++..+..++.|++.|+.++|+.+  ++|+|++|+||++
T Consensus        56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i  133 (256)
T cd05059          56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLV  133 (256)
T ss_pred             CCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEE
Confidence            45788888888888888999999999999999999765556889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLY  147 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~  147 (150)
                      +.++.++++|||+++........           ......++..|+|||.         .|+||+|+++++++.
T Consensus       134 ~~~~~~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~  196 (256)
T cd05059         134 GEDNVVKVSDFGLARYVLDDQYT-----------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS  196 (256)
T ss_pred             CCCCcEEECCcccceeccccccc-----------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhc
Confidence            99999999999988643211000           0001123457999997         399999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.89  E-value=1.5e-23  Score=152.11  Aligned_cols=128  Identities=27%  Similarity=0.404  Sum_probs=103.2

Q ss_pred             ccchhhhcccCCCCCc------eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGM------HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-|+++++..+.+...      ..+|+||||+++ ++.+.+..   .+++..+..++.|++.|+.|+|+++  ++|+|++
T Consensus        77 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlk  150 (359)
T cd07876          77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK  150 (359)
T ss_pred             CCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence            3478888887765433      457999999976 67766642   4788888889999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+||+++.++.++++|||++.......             ......+|+.|+|||++         |+||+|+++++|++
T Consensus       151 p~NIl~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t  217 (359)
T cd07876         151 PSNIVVKSDCTLKILDFGLARTACTNF-------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK  217 (359)
T ss_pred             HHHEEECCCCCEEEecCCCccccccCc-------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHh
Confidence            999999999999999999986432110             01123578899999984         99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       218 g~  219 (359)
T cd07876         218 GS  219 (359)
T ss_pred             CC
Confidence            86

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.89  E-value=1.7e-23  Score=144.76  Aligned_cols=133  Identities=18%  Similarity=0.306  Sum_probs=108.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++|+||+++++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        50 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~  127 (252)
T cd05084          50 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLV  127 (252)
T ss_pred             CCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEE
Confidence            45788999999999999999999999999999999765456889999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      +.++.++++|||.+..........   .       ......+..|+|||.+         |+||+|+++++++.
T Consensus       128 ~~~~~~kl~dfg~~~~~~~~~~~~---~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~  191 (252)
T cd05084         128 TEKNVLKISDFGMSREEEDGVYAS---T-------GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS  191 (252)
T ss_pred             cCCCcEEECccccCcccccccccc---c-------CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence            999999999999876432110000   0       0001123469999985         99999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.88  E-value=2.6e-23  Score=147.29  Aligned_cols=130  Identities=19%  Similarity=0.259  Sum_probs=106.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      ||++++..+.....+.+++++||+++++|.+++....               ..+++..+..++.|++.|+.++|+++  
T Consensus        62 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--  139 (297)
T cd05089          62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--  139 (297)
T ss_pred             CCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            7889999998888899999999999999999996532               24778888899999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|+|++|+|++++.++.++++|||++........             ......+..|++||+.         |+||+|+
T Consensus       140 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~  206 (297)
T cd05089         140 FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK-------------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGV  206 (297)
T ss_pred             cccCcCCcceEEECCCCeEEECCcCCCccccceec-------------cCCCCcCccccCchhhccCCCCchhhHHHHHH
Confidence            99999999999999999999999998753211000             0011224569999973         9999999


Q ss_pred             eEEEeee-ec
Q psy1934         141 IGRSMLY-GH  149 (150)
Q Consensus       141 ~~~~~~~-g~  149 (150)
                      ++++|+. |.
T Consensus       207 il~el~t~g~  216 (297)
T cd05089         207 LLWEIVSLGG  216 (297)
T ss_pred             HHHHHHcCCC
Confidence            9999985 64

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.88  E-value=2.1e-23  Score=147.13  Aligned_cols=135  Identities=19%  Similarity=0.233  Sum_probs=109.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT------------SALPPNIVCSILWQTCQAVKHMHGQNPPI   70 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i   70 (150)
                      +-|+++++..+.+...+.+++++||+++++|.+++....            ..+++..+..++.|++.++.|+|+++  +
T Consensus        64 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i  141 (288)
T cd05093          64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--F  141 (288)
T ss_pred             CCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence            347889999988888899999999999999999997532            23788899999999999999999998  9


Q ss_pred             EEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccccccee
Q psy1934          71 VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVI  141 (150)
Q Consensus        71 ~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~  141 (150)
                      +|+|++|+||+++.++.++++|||++..........          ......++..|+|||++         |+||+|++
T Consensus       142 ~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~i  211 (288)
T cd05093         142 VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR----------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV  211 (288)
T ss_pred             eecccCcceEEEccCCcEEeccCCccccccCCceee----------cCCCCCccccccCHHHhccCCCCchhhHHHHHHH
Confidence            999999999999999999999999887432111000          00112346789999974         99999999


Q ss_pred             EEEeee-ec
Q psy1934         142 GRSMLY-GH  149 (150)
Q Consensus       142 ~~~~~~-g~  149 (150)
                      +++|+. |.
T Consensus       212 l~~l~t~g~  220 (288)
T cd05093         212 LWEIFTYGK  220 (288)
T ss_pred             HHHHHhCCC
Confidence            999986 64

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.88  E-value=2.2e-23  Score=144.83  Aligned_cols=134  Identities=22%  Similarity=0.282  Sum_probs=109.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.....+..++++||+++++|.++++... ..++...+..++.+++.|+.|+|+.+  ++|+|++|+||+
T Consensus        58 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil  135 (261)
T cd05072          58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVL  135 (261)
T ss_pred             CCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEE
Confidence            347889998888888899999999999999999997643 45788888899999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.+++.|||.+.........           ......++..|+|||++         |+||+|+++++++. |.
T Consensus       136 i~~~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~  202 (261)
T cd05072         136 VSESLMCKIADFGLARVIEDNEYT-----------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK  202 (261)
T ss_pred             ecCCCcEEECCCccceecCCCcee-----------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCC
Confidence            999999999999998753211100           00112345679999974         99999999999986 64

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.88  E-value=1.2e-23  Score=150.93  Aligned_cols=139  Identities=19%  Similarity=0.222  Sum_probs=109.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -||+|++..+.+...+..++|+||+++|+|.+++..+. ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        57 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~  134 (327)
T cd08227          57 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI  134 (327)
T ss_pred             CCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEE
Confidence            47899999999999999999999999999999997543 45889999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+++.||+...............     ........++..|+|||++           |+||+|+++++++.|.
T Consensus       135 ~~~~~~~l~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~  207 (327)
T cd08227         135 SVDGKVYLSGLRSNLSMINHGQRLRVV-----HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH  207 (327)
T ss_pred             ecCCcEEEcccchhhcccccccccccc-----ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCC
Confidence            999999999987544321111000000     0001123456779999973           9999999999999885

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.88  E-value=1.5e-23  Score=145.65  Aligned_cols=135  Identities=21%  Similarity=0.327  Sum_probs=107.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+..+. ..+++||||+++++|.+++......+++..+..++.+++.|+.++|+++  ++|+|++|+||++
T Consensus        52 l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~  128 (257)
T cd05115          52 LDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLL  128 (257)
T ss_pred             cCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEE
Confidence            457888888877654 5789999999999999999765567899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++..........         .......++..|+|||++         |+||+|+++++++. |.
T Consensus       129 ~~~~~~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~  196 (257)
T cd05115         129 VNQHYAKISDFGLSKALGADDSYY---------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQ  196 (257)
T ss_pred             cCCCcEEeccCCccccccCCccce---------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCC
Confidence            999999999999886432111100         000111235679999973         99999999999874 64

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0603|consensus

Probab=99.88  E-value=1.6e-23  Score=155.46  Aligned_cols=128  Identities=30%  Similarity=0.359  Sum_probs=107.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE-
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI-   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~-   82 (150)
                      -|++++++.++.....+.|+|||.+.|+-+.+.+....  ....++..|+++++.++.|||+++  ++|||++|+|||+ 
T Consensus       374 ~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~  449 (612)
T KOG0603|consen  374 DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLD  449 (612)
T ss_pred             CCCcceeecceecCCceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeec
Confidence            37899999999999999999999999987777775532  222666789999999999999988  9999999999999 


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeecC
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~~  150 (150)
                      +..+.++++|||+++.....               ..+.+-|..|.|||+.         |+||+|+++|+|++|+.
T Consensus       450 ~~~g~lrltyFG~a~~~~~~---------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~t  511 (612)
T KOG0603|consen  450 GSAGHLRLTYFGFWSELERS---------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRT  511 (612)
T ss_pred             CCCCcEEEEEechhhhCchh---------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCC
Confidence            68899999999998754221               1233567889999994         99999999999999974

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.88  E-value=3.2e-23  Score=146.31  Aligned_cols=128  Identities=29%  Similarity=0.400  Sum_probs=111.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.....+.++++|||+++++|.+++... ..+++..+..++.|++.|+.++|+.+  ++|+|++|.||+++
T Consensus        59 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~  135 (290)
T cd05580          59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD  135 (290)
T ss_pred             CCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC
Confidence            3788999999999999999999999999999999764 56889999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++......               .....+++.|++||.+         |+|++|+++++|++|.
T Consensus       136 ~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  195 (290)
T cd05580         136 SDGYIKITDFGFAKRVKGR---------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGY  195 (290)
T ss_pred             CCCCEEEeeCCCccccCCC---------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCC
Confidence            9999999999987643211               1123578899999974         9999999999999885

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.88  E-value=1.7e-23  Score=145.85  Aligned_cols=132  Identities=25%  Similarity=0.384  Sum_probs=110.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++|+||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|.|+++
T Consensus        63 ~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill  139 (267)
T cd06646          63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILL  139 (267)
T ss_pred             cCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE
Confidence            45788999888888889999999999999999998754 46888899999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+++.|+|||++            |+||+|+++++|+.|.
T Consensus       140 ~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~  206 (267)
T cd06646         140 TDNGDVKLADFGVAAKITATIA------------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ  206 (267)
T ss_pred             CCCCCEEECcCccceeeccccc------------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCC
Confidence            9999999999999875321110            01123577889999963            9999999999998774

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00284 protein kinase; Provisional

Probab=99.88  E-value=1.7e-23  Score=156.59  Aligned_cols=124  Identities=25%  Similarity=0.441  Sum_probs=98.7

Q ss_pred             hhcccCCCCC-ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEEEcCC
Q psy1934           8 FIDKHSTPHG-MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         8 ~~~~~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil~~~~   85 (150)
                      ++++.++++. .+.+|+|||++ +++|.+++... ..+++..+..++.|++.|+.|+|+ .+  |+|||+||+||+++..
T Consensus       193 i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~  268 (467)
T PTZ00284        193 LMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETS  268 (467)
T ss_pred             eeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecC
Confidence            4444444433 45789999998 66899988764 568899999999999999999997 57  9999999999999866


Q ss_pred             C----------------cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          86 G----------------TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        86 ~----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      +                .+|++|||.+.....               .....+||+.|+|||++         |+||+||
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~---------------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv  333 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH---------------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC  333 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccCcc---------------ccccccCCccccCcHHhhcCCCCcHHHHHHHHH
Confidence            5                489999997653210               01234789999999985         9999999


Q ss_pred             eEEEeeeecC
Q psy1934         141 IGRSMLYGHV  150 (150)
Q Consensus       141 ~~~~~~~g~~  150 (150)
                      +++||++|..
T Consensus       334 il~elltG~~  343 (467)
T PTZ00284        334 IIYELYTGKL  343 (467)
T ss_pred             HHHHHHhCCC
Confidence            9999999863

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.88  E-value=1.8e-23  Score=149.09  Aligned_cols=135  Identities=27%  Similarity=0.360  Sum_probs=104.5

Q ss_pred             ccchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q psy1934           3 YLSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKER--------TSALPPNIVCSILWQTCQAVKHMHGQNPPIVH   72 (150)
Q Consensus         3 ~~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h   72 (150)
                      +-||++++..+.+  .....+++++||+++ ++.+++...        ...+++..+..++.|++.|+.|+|+.+  ++|
T Consensus        55 l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH  131 (317)
T cd07867          55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLH  131 (317)
T ss_pred             CCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEc
Confidence            4478888877754  456788999999975 888877532        124778888899999999999999998  999


Q ss_pred             ecCCCCCEEE----cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------ccccc
Q psy1934          73 RDLKIENLLI----SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNN  138 (150)
Q Consensus        73 ~~l~~~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~  138 (150)
                      +|++|+||++    +..+.++++|||+++.........         .......+|+.|+|||++          |+||+
T Consensus       132 ~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl  202 (317)
T cd07867         132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL---------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI  202 (317)
T ss_pred             CCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccc---------cccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence            9999999999    456789999999987532211100         011234578899999974          99999


Q ss_pred             ceeEEEeeeec
Q psy1934         139 YVIGRSMLYGH  149 (150)
Q Consensus       139 g~~~~~~~~g~  149 (150)
                      |+++++|++|.
T Consensus       203 G~il~el~tg~  213 (317)
T cd07867         203 GCIFAELLTSE  213 (317)
T ss_pred             HHHHHHHHhCC
Confidence            99999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=4.6e-23  Score=145.04  Aligned_cols=131  Identities=27%  Similarity=0.409  Sum_probs=110.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~n   79 (150)
                      +-|+++++..+.+...+.+++|+||+++++|.+++....  ..+++..+..++.+++.++.|+|+ .+  ++|+|++|+|
T Consensus        56 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~n  133 (286)
T cd06622          56 AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTN  133 (286)
T ss_pred             cCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHH
Confidence            457889999999999999999999999999999887631  368899999999999999999996 47  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------cccccceeEEE
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DTWNNYVIGRS  144 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~~~~g~~~~~  144 (150)
                      |+++.++.++++|||++........              ....+++.|++||++               |+||+|+++++
T Consensus       134 il~~~~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~  199 (286)
T cd06622         134 VLVNGNGQVKLCDFGVSGNLVASLA--------------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE  199 (286)
T ss_pred             EEECCCCCEEEeecCCcccccCCcc--------------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHH
Confidence            9999999999999998764321100              123467789999974               99999999999


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      +++|.
T Consensus       200 l~~g~  204 (286)
T cd06622         200 MALGR  204 (286)
T ss_pred             HHhCC
Confidence            99885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.88  E-value=2.1e-23  Score=146.57  Aligned_cols=132  Identities=27%  Similarity=0.403  Sum_probs=109.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++++||+++ +|.+++.+....+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~  132 (284)
T cd07839          56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLI  132 (284)
T ss_pred             cCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE
Confidence            3478899999999999999999999975 888888765566899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+++.|+|||++          |+||+|+++++|++|.
T Consensus       133 ~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~  197 (284)
T cd07839         133 NKNGELKLADFGLARAFGIPVR------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG  197 (284)
T ss_pred             cCCCcEEECccchhhccCCCCC------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence            9999999999998764311100            00123467889999973          9999999999999774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.88  E-value=2.4e-23  Score=145.21  Aligned_cols=136  Identities=21%  Similarity=0.360  Sum_probs=110.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.++++|||+++++|.+++......+++..+..++.+++.|+.++|+.+  ++|+|++|+|+++
T Consensus        63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili  140 (268)
T cd05063          63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILV  140 (268)
T ss_pred             CCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEE
Confidence            34788999999889999999999999999999999875567889999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++............         ......+..|++||++         |+|++|+++++++. |.
T Consensus       141 ~~~~~~kl~dfg~~~~~~~~~~~~~~---------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~  208 (268)
T cd05063         141 NSNLECKVSDFGLSRVLEDDPEGTYT---------TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE  208 (268)
T ss_pred             cCCCcEEECCCccceeccccccccee---------ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCC
Confidence            99999999999988654321111000         0011123569999973         99999999999875 65

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.88  E-value=1.9e-23  Score=148.15  Aligned_cols=132  Identities=27%  Similarity=0.388  Sum_probs=110.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|++..+.++..+.+++|+||+++ +|.+++......+++..+..++.|++.|+.++|+.+  ++|+|++|+||++
T Consensus        61 l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~  137 (301)
T cd07873          61 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLI  137 (301)
T ss_pred             cCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEE
Confidence            4578999999999999999999999975 999988765556888899999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....+++.|+|||++          |+||+|+++++|++|.
T Consensus       138 ~~~~~~kl~dfg~~~~~~~~~~~------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~  202 (301)
T cd07873         138 NERGELKLADFGLARAKSIPTKT------------YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR  202 (301)
T ss_pred             CCCCcEEECcCcchhccCCCCCc------------ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCC
Confidence            99999999999988643211100            0123467889999973          9999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.88  E-value=3.3e-23  Score=146.20  Aligned_cols=133  Identities=21%  Similarity=0.325  Sum_probs=107.6

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      |+++++..+.....+.++++|||+++|+|.+++...               ...+++..+..++.|++.|+.|+|+.+  
T Consensus        75 h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--  152 (293)
T cd05053          75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--  152 (293)
T ss_pred             CCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            788999888888889999999999999999999642               234778888999999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|+|++|+||+++.++.++++|||++.........          .......++..|+|||++         |+||+|+
T Consensus       153 ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  222 (293)
T cd05053         153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY----------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV  222 (293)
T ss_pred             ccccccceeeEEEcCCCeEEeCccccccccccccce----------eccCCCCCCccccCHHHhccCCcCcccceeehhh
Confidence            999999999999999999999999988753211100          000112245679999974         9999999


Q ss_pred             eEEEeee-ec
Q psy1934         141 IGRSMLY-GH  149 (150)
Q Consensus       141 ~~~~~~~-g~  149 (150)
                      ++++++. |.
T Consensus       223 il~el~~~g~  232 (293)
T cd05053         223 LLWEIFTLGG  232 (293)
T ss_pred             HHHHHhcCCC
Confidence            9999875 53

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.88  E-value=3.3e-23  Score=150.60  Aligned_cols=128  Identities=30%  Similarity=0.413  Sum_probs=103.4

Q ss_pred             ccchhhhcccCCCCC------ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHG------MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-|+++++..+.+..      ...+|+||||+++ ++.+.+..   .+++..+..++.|++.|+.|+|+++  ++|+|++
T Consensus        80 l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlk  153 (364)
T cd07875          80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK  153 (364)
T ss_pred             cCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCC
Confidence            346888887765543      3467999999976 77777753   4788888899999999999999998  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+||+++.++.++++|||++.......             ......+++.|+|||++         |+||+|+++++|++
T Consensus       154 p~NIll~~~~~~kL~DfG~a~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~  220 (364)
T cd07875         154 PSNIVVKSDCTLKILDFGLARTAGTSF-------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK  220 (364)
T ss_pred             HHHEEECCCCcEEEEeCCCccccCCCC-------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHh
Confidence            999999999999999999986432110             01123578999999984         99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       221 g~  222 (364)
T cd07875         221 GG  222 (364)
T ss_pred             CC
Confidence            85

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0596|consensus

Probab=99.88  E-value=2.7e-23  Score=152.56  Aligned_cols=130  Identities=28%  Similarity=0.315  Sum_probs=105.5

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~   85 (150)
                      .+||.+.++--.++.+|+||||=+ -+|.+.|+....-.+.-.++.+..|++.++.+.|+.+  |+|.|+||.|+++ ..
T Consensus       420 ~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLl-Vk  495 (677)
T KOG0596|consen  420 DKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLL-VK  495 (677)
T ss_pred             ceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEE-Ee
Confidence            457888888888899999999753 4999999876544443467788899999999999999  9999999999987 45


Q ss_pred             CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------------cccccceeEEEe
Q psy1934          86 GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------------DTWNNYVIGRSM  145 (150)
Q Consensus        86 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------------d~~~~g~~~~~~  145 (150)
                      |.+|++|||++.....+-.+...          -+.+||+.||+||-+                    |+||+||++|.|
T Consensus       496 G~LKLIDFGIA~aI~~DTTsI~k----------dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqM  565 (677)
T KOG0596|consen  496 GRLKLIDFGIANAIQPDTTSIVK----------DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQM  565 (677)
T ss_pred             eeEEeeeechhcccCccccceee----------ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHH
Confidence            78999999999865433222211          245899999999974                    999999999999


Q ss_pred             eeec
Q psy1934         146 LYGH  149 (150)
Q Consensus       146 ~~g~  149 (150)
                      .||.
T Consensus       566 vYgk  569 (677)
T KOG0596|consen  566 VYGK  569 (677)
T ss_pred             HhcC
Confidence            9986

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.88  E-value=2.4e-23  Score=145.54  Aligned_cols=130  Identities=18%  Similarity=0.268  Sum_probs=106.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      ||++++..+.+...+.++++|||+++++|.+++....               ..+++..+..++.+++.|+.|+|+.+  
T Consensus        55 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--  132 (270)
T cd05047          55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--  132 (270)
T ss_pred             CCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            7889999888888899999999999999999997532               23678888899999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|+|++|+|++++.++.++++|||++......             ........+..|+|||++         |+||+|+
T Consensus       133 i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~-------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~  199 (270)
T cd05047         133 FIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV  199 (270)
T ss_pred             EeecccccceEEEcCCCeEEECCCCCccccchh-------------hhccCCCCccccCChHHHccCCCCchhhHHHHHH
Confidence            999999999999999999999999987521100             000111235579999973         9999999


Q ss_pred             eEEEeee-ec
Q psy1934         141 IGRSMLY-GH  149 (150)
Q Consensus       141 ~~~~~~~-g~  149 (150)
                      ++++|+. |.
T Consensus       200 il~el~~~g~  209 (270)
T cd05047         200 LLWEIVSLGG  209 (270)
T ss_pred             HHHHHHcCCC
Confidence            9999985 64

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.88  E-value=3.4e-23  Score=143.52  Aligned_cols=127  Identities=17%  Similarity=0.196  Sum_probs=106.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.... ...++|+||+++|+|.+++......++...+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        58 l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill  134 (259)
T cd05037          58 LSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILV  134 (259)
T ss_pred             CCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEE
Confidence            347889998887766 7789999999999999999875556888888999999999999999998  9999999999999


Q ss_pred             cCCC-------cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-----------ccccccceeEEE
Q psy1934          83 SSAG-------TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-----------VDTWNNYVIGRS  144 (150)
Q Consensus        83 ~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-----------~d~~~~g~~~~~  144 (150)
                      +..+       .++++|||++......                ....++..|+|||+           .|+||+|+++++
T Consensus       135 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~  198 (259)
T cd05037         135 ARYGLNEGYVPFIKLSDPGIPITVLSR----------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLE  198 (259)
T ss_pred             ecCccccCCceeEEeCCCCcccccccc----------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHH
Confidence            8877       7999999988643210                12245677999997           399999999999


Q ss_pred             eeee
Q psy1934         145 MLYG  148 (150)
Q Consensus       145 ~~~g  148 (150)
                      +++|
T Consensus       199 l~~~  202 (259)
T cd05037         199 ICSN  202 (259)
T ss_pred             HHhC
Confidence            8874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.88  E-value=2.4e-23  Score=164.16  Aligned_cols=134  Identities=22%  Similarity=0.347  Sum_probs=106.7

Q ss_pred             ccchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCeEE
Q psy1934           3 YLSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQN-----PPIVH   72 (150)
Q Consensus         3 ~~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~-----~~i~h   72 (150)
                      +-||+|+++.+.+  ...+.+||||||+++++|.+++...   ...+++..++.++.||+.|+.|||+.+     .+|+|
T Consensus        69 L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVH  148 (1021)
T PTZ00266         69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLH  148 (1021)
T ss_pred             cCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCcee
Confidence            4578899988865  4456799999999999999999753   246899999999999999999999743     23999


Q ss_pred             ecCCCCCEEEcC-----------------CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--
Q psy1934          73 RDLKIENLLISS-----------------AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--  133 (150)
Q Consensus        73 ~~l~~~nil~~~-----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--  133 (150)
                      +||+|+||++..                 ...++|+|||++........             .....||+.|+|||++  
T Consensus       149 RDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-------------~~s~vGTp~YmAPEvL~g  215 (1021)
T PTZ00266        149 RDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-------------AHSCVGTPYYWSPELLLH  215 (1021)
T ss_pred             ccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc-------------ccccCCCccccCHHHHhc
Confidence            999999999954                 23489999999864321100             0133689999999974  


Q ss_pred             ---------cccccceeEEEeeeec
Q psy1934         134 ---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       134 ---------d~~~~g~~~~~~~~g~  149 (150)
                               |+||+|+++++|++|.
T Consensus       216 e~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        216 ETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             cCCCCCchhHHHHHHHHHHHHHHCC
Confidence                     9999999999999885

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.88  E-value=3.4e-23  Score=143.02  Aligned_cols=134  Identities=19%  Similarity=0.331  Sum_probs=109.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++||||+++++|.+++......+++..+..++.+++.++.++|+.+  ++|+|++|+||++
T Consensus        49 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili  126 (250)
T cd05085          49 YDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLV  126 (250)
T ss_pred             CCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEE
Confidence            34788999888888889999999999999999999765556788888999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++.........           ......++..|+|||++         |+||+|++++++++ |.
T Consensus       127 ~~~~~~~l~d~g~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~  192 (250)
T cd05085         127 GENNVLKISDFGMSRQEDDGIYS-----------SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGV  192 (250)
T ss_pred             cCCCeEEECCCccceeccccccc-----------cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCC
Confidence            99999999999988643211000           00011235679999973         99999999999886 54

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.88  E-value=3e-23  Score=147.75  Aligned_cols=130  Identities=30%  Similarity=0.398  Sum_probs=111.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil   81 (150)
                      +-||++++..+.+...+.+++++||+++++|.++++.. ..+++..+..++.+++.|+.|+|+ .+  ++|+|++|.|++
T Consensus        56 l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil  132 (308)
T cd06615          56 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNIL  132 (308)
T ss_pred             CCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEE
Confidence            45789999999999999999999999999999999764 568888899999999999999997 47  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++.......              .....++..|++||+.         |+|++|++++++++|.
T Consensus       133 ~~~~~~~~l~dfg~~~~~~~~~--------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~  195 (308)
T cd06615         133 VNSRGEIKLCDFGVSGQLIDSM--------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR  195 (308)
T ss_pred             EecCCcEEEccCCCcccccccc--------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence            9999999999999876432110              0134578899999973         9999999999999885

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.88  E-value=2.6e-23  Score=146.59  Aligned_cols=132  Identities=28%  Similarity=0.389  Sum_probs=110.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+..+..+.+++||||+++ +|.+++......+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~  136 (291)
T cd07844          60 LKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLI  136 (291)
T ss_pred             CCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEE
Confidence            4578899999999999999999999985 999988765567889999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+........            ......++..|+|||++          |+||+|+++++|++|.
T Consensus       137 ~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~  201 (291)
T cd07844         137 SERGELKLADFGLARAKSVPSK------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR  201 (291)
T ss_pred             cCCCCEEECccccccccCCCCc------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999998764211100            00122457789999963          9999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.88  E-value=3.9e-23  Score=149.06  Aligned_cols=127  Identities=27%  Similarity=0.409  Sum_probs=105.2

Q ss_pred             ccchhhhcccCCCCC------ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHG------MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-|++|++..+++..      ...+|+++|++ +++|.++++.  ..+++..+..++.|++.|+.|+|+.+  ++|+|++
T Consensus        71 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdik  145 (343)
T cd07878          71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLK  145 (343)
T ss_pred             cCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCC
Confidence            457888888776542      35679999998 6699988864  46899999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.++++|||++......               .....+++.|+|||++          |+||+|+++++|+
T Consensus       146 p~Nil~~~~~~~kl~Dfg~~~~~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  210 (343)
T cd07878         146 PSNVAVNEDCELRILDFGLARQADDE---------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  210 (343)
T ss_pred             hhhEEECCCCCEEEcCCccceecCCC---------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHH
Confidence            99999999999999999998743211               1134688999999973          9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      .|.
T Consensus       211 ~g~  213 (343)
T cd07878         211 KGK  213 (343)
T ss_pred             HCC
Confidence            885

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.88  E-value=4.3e-23  Score=142.80  Aligned_cols=133  Identities=21%  Similarity=0.265  Sum_probs=111.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER--------TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      -|+++++..+.......+++++||+++++|.+++...        ...+++..+..++.+++.|+.++|+++  ++|+|+
T Consensus        54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di  131 (262)
T cd00192          54 GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDL  131 (262)
T ss_pred             CCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCcc
Confidence            3788999988888899999999999999999999875        356899999999999999999999998  999999


Q ss_pred             CCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee
Q psy1934          76 KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML  146 (150)
Q Consensus        76 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~  146 (150)
                      +|+||+++.++.++++|||.+.........          .......++..|+|||.+         |+||+|+++++++
T Consensus       132 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  201 (262)
T cd00192         132 AARNCLVGEDLVVKISDFGLSRDVYDDDYY----------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF  201 (262)
T ss_pred             CcceEEECCCCcEEEccccccccccccccc----------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHH
Confidence            999999999999999999998754322110          011123467889999974         9999999999988


Q ss_pred             ee
Q psy1934         147 YG  148 (150)
Q Consensus       147 ~g  148 (150)
                      .+
T Consensus       202 ~~  203 (262)
T cd00192         202 TL  203 (262)
T ss_pred             hc
Confidence            63

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.88  E-value=2.3e-23  Score=147.33  Aligned_cols=131  Identities=24%  Similarity=0.470  Sum_probs=110.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+..++++||+++++|.+++..  ..+++..+..++.+++.|+.|+|+.+  ++|+|++|+|+++
T Consensus        76 l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill  151 (292)
T cd06658          76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILL  151 (292)
T ss_pred             CCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE
Confidence            3478899999888889999999999999999998864  35888889999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......++..|+|||+.         |+||+|+++++++.|.
T Consensus       152 ~~~~~~kL~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~  215 (292)
T cd06658         152 TSDGRIKLSDFGFCAQVSKEVP------------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE  215 (292)
T ss_pred             cCCCCEEEccCcchhhcccccc------------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999998764321110            01123578899999984         9999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.88  E-value=5.3e-23  Score=145.07  Aligned_cols=131  Identities=27%  Similarity=0.373  Sum_probs=109.7

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +++++...+.++..+.+++|+||+++++|.+++... ..+++..+..++.|++.|+.++|+.+  ++|+|++|+||+++.
T Consensus        64 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~  140 (290)
T cd05613          64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDS  140 (290)
T ss_pred             CCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECC
Confidence            577888888888889999999999999999999764 46888888888999999999999998  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-----------ccccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-----------~d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++.........           ......++..|++||.           .|+|++|++++++++|.
T Consensus       141 ~~~~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~  205 (290)
T cd05613         141 NGHVVLTDFGLSKEFHEDEVE-----------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA  205 (290)
T ss_pred             CCCEEEeeCccceeccccccc-----------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCC
Confidence            999999999988643211110           0112357888999996           39999999999999885

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.88  E-value=2.6e-23  Score=147.66  Aligned_cols=133  Identities=23%  Similarity=0.396  Sum_probs=109.4

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      |+++++..+.+...+.+++++||+++|+|.++++... ..+++.++..++.+++.|+.|+|+++  ++|+|++|+||+++
T Consensus        98 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~  175 (302)
T cd05055          98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT  175 (302)
T ss_pred             CCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc
Confidence            7899999988888899999999999999999997543 34889999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      .++.++++|||++..........          ......++..|+|||++         |+||+|+++++++. |.
T Consensus       176 ~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~  241 (302)
T cd05055         176 HGKIVKICDFGLARDIMNDSNYV----------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS  241 (302)
T ss_pred             CCCeEEECCCcccccccCCCcee----------ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence            99999999999986432211100          00112356789999974         99999999999886 64

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.88  E-value=3.6e-23  Score=144.23  Aligned_cols=135  Identities=23%  Similarity=0.317  Sum_probs=110.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.....+.++++|||+++++|.+++......+++..+..++.+++.|+.++|+++  ++|+|++|.||++
T Consensus        62 l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili  139 (266)
T cd05033          62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILV  139 (266)
T ss_pred             CCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE
Confidence            34788999988888889999999999999999999875567899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++............          ....++..|++||.+         |+|++|+++++++. |.
T Consensus       140 ~~~~~~~l~dfg~~~~~~~~~~~~~~----------~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~  206 (266)
T cd05033         140 NSNLVCKVSDFGLSRRLEDSEATYTT----------KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE  206 (266)
T ss_pred             cCCCCEEECccchhhcccccccceec----------cCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCC
Confidence            99999999999998754311110000          012345679999974         99999999999774 64

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.88  E-value=2.3e-23  Score=146.05  Aligned_cols=133  Identities=18%  Similarity=0.235  Sum_probs=106.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHR   73 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~   73 (150)
                      +-|+++++..+.....+.+++||||+++++|.+++.+..         ..+++..+..++.+++.|+.|+|+.+  ++|+
T Consensus        66 l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~  143 (277)
T cd05062          66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHR  143 (277)
T ss_pred             CCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccC
Confidence            347889999988888899999999999999999997532         12456777888999999999999998  9999


Q ss_pred             cCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEE
Q psy1934          74 DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRS  144 (150)
Q Consensus        74 ~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~  144 (150)
                      |++|+||+++.++.++++|||++.........          .......++..|+|||++         |+||+|+++++
T Consensus       144 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e  213 (277)
T cd05062         144 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE  213 (277)
T ss_pred             CcchheEEEcCCCCEEECCCCCccccCCccee----------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHH
Confidence            99999999999999999999987643211110          000112356789999984         99999999999


Q ss_pred             eee
Q psy1934         145 MLY  147 (150)
Q Consensus       145 ~~~  147 (150)
                      +++
T Consensus       214 l~~  216 (277)
T cd05062         214 IAT  216 (277)
T ss_pred             HHc
Confidence            987

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.88  E-value=3.7e-23  Score=144.29  Aligned_cols=136  Identities=22%  Similarity=0.338  Sum_probs=109.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.+...+.++++|||+++++|.+++......+++..+..++.+++.|+.++|+.+  ++|+|++|+|+++
T Consensus        62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili  139 (267)
T cd05066          62 FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILV  139 (267)
T ss_pred             CCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEE
Confidence            34789999988888889999999999999999999875556888888999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||.+...........         .......+..|++||++         |+|++|+++++++. |.
T Consensus       140 ~~~~~~~l~dfg~~~~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~  207 (267)
T cd05066         140 NSNLVCKVSDFGLSRVLEDDPEAAY---------TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE  207 (267)
T ss_pred             CCCCeEEeCCCCcccccccccceee---------ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCC
Confidence            9999999999998875422111000         00011234579999974         99999999999764 65

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=3.6e-23  Score=145.10  Aligned_cols=126  Identities=21%  Similarity=0.258  Sum_probs=104.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.....+..++||||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        73 l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill  150 (274)
T cd05076          73 VSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILL  150 (274)
T ss_pred             CCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEE
Confidence            34788999999888888999999999999999999765566888889999999999999999998  9999999999999


Q ss_pred             cCCC-------cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEe
Q psy1934          83 SSAG-------TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSM  145 (150)
Q Consensus        83 ~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~  145 (150)
                      +..+       .++++|||.+......                ....++..|+|||.+          |+||+|++++++
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~----------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el  214 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALSR----------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI  214 (274)
T ss_pred             eccCcccCccceeeecCCccccccccc----------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence            7543       4799999986532110                112467789999953          999999999987


Q ss_pred             e
Q psy1934         146 L  146 (150)
Q Consensus       146 ~  146 (150)
                      +
T Consensus       215 ~  215 (274)
T cd05076         215 C  215 (274)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.88  E-value=3.2e-23  Score=147.98  Aligned_cols=134  Identities=19%  Similarity=0.252  Sum_probs=107.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.... +..++++||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        66 l~h~niv~~~g~~~~-~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill  142 (316)
T cd05108          66 VDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLV  142 (316)
T ss_pred             CCCCCCCeEEEEEcC-CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEe
Confidence            347888888877665 4578999999999999999876556888888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++......... ..         .....++..|++||++         |+||+|++++++++ |.
T Consensus       143 ~~~~~~kl~DfG~a~~~~~~~~~-~~---------~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~  209 (316)
T cd05108         143 KTPQHVKITDFGLAKLLGADEKE-YH---------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS  209 (316)
T ss_pred             cCCCcEEEccccccccccCCCcc-ee---------ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCC
Confidence            99999999999998754221110 00         0011235679999985         99999999999874 53

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.88  E-value=2.4e-23  Score=150.80  Aligned_cols=128  Identities=28%  Similarity=0.394  Sum_probs=103.3

Q ss_pred             ccchhhhcccCCCCC------ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHG------MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-|+++++..+.+..      ...++++|||+++ ++.+.+..   .+++..+..++.|++.|+.|+|+++  ++|+|++
T Consensus        73 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDik  146 (355)
T cd07874          73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK  146 (355)
T ss_pred             hCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence            347888888776543      3467999999976 77776653   4788888899999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+||+++.++.++++|||++........             .....+++.|+|||++         |+||+|+++++|++
T Consensus       147 p~Nill~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  213 (355)
T cd07874         147 PSNIVVKSDCTLKILDFGLARTAGTSFM-------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR  213 (355)
T ss_pred             hHHEEECCCCCEEEeeCcccccCCCccc-------------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999864321100             1123578999999984         99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       214 g~  215 (355)
T cd07874         214 HK  215 (355)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=5.9e-23  Score=142.53  Aligned_cols=133  Identities=23%  Similarity=0.376  Sum_probs=112.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.....+.+|++|||+++++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        57 ~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i  134 (262)
T cd06613          57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILL  134 (262)
T ss_pred             CCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEE
Confidence            44788999888888889999999999999999998765457899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+.......            .......++..|++||++            |+|++|+++++|++|.
T Consensus       135 ~~~~~~~l~d~g~~~~~~~~~------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~  201 (262)
T cd06613         135 TEDGDVKLADFGVSAQLTATI------------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ  201 (262)
T ss_pred             CCCCCEEECccccchhhhhhh------------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCC
Confidence            999999999999876431110            011133577889999973            9999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.88  E-value=4.5e-23  Score=143.63  Aligned_cols=135  Identities=29%  Similarity=0.356  Sum_probs=108.2

Q ss_pred             ccchhhhcccCCCCC--ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHG--MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|+++++..+....  ...+++++||+++++|.+++.+. ..+++..+..++.+++.++.++|+++  ++|+|++|+||
T Consensus        61 l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~ni  137 (265)
T cd06652          61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANI  137 (265)
T ss_pred             cCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHE
Confidence            347888887776544  35788999999999999999765 45788888899999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||.+..........         .......++..|+|||++         |+||+|++++++++|.
T Consensus       138 l~~~~~~~~l~Dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~  206 (265)
T cd06652         138 LRDSVGNVKLGDFGASKRLQTICLSG---------TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK  206 (265)
T ss_pred             EecCCCCEEECcCccccccccccccc---------cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCC
Confidence            99999999999999876432110000         011123578899999984         9999999999999886

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=6.4e-23  Score=142.45  Aligned_cols=127  Identities=28%  Similarity=0.412  Sum_probs=110.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.++..+.+++++||+++++|.++++.. ..+++..+..++.|++.|+.|+|+.+  ++|+|++|.||+++
T Consensus        55 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~  131 (260)
T cd05611          55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID  131 (260)
T ss_pred             CCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC
Confidence            4788999999998889999999999999999999764 46888899999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.....                .....++..|++||..         |+|++|+++++++.|.
T Consensus       132 ~~~~~~l~dfg~~~~~~~----------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~  190 (260)
T cd05611         132 QTGHLKLTDFGLSRNGLE----------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGY  190 (260)
T ss_pred             CCCcEEEeecccceeccc----------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCC
Confidence            999999999998764221                0123467889999973         9999999999998875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.88  E-value=5.3e-23  Score=146.77  Aligned_cols=131  Identities=19%  Similarity=0.288  Sum_probs=106.1

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      |+++++..+.+...+.+++++||+++|+|.+++....               ..+++..+..++.|++.|+.|+|+++  
T Consensus        77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--  154 (314)
T cd05099          77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--  154 (314)
T ss_pred             CCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            8889999988888889999999999999999997532               23677888889999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|+|++|+|++++.++.++++|||+++.........          ......++..|+|||++         |+||+|+
T Consensus       155 i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  224 (314)
T cd05099         155 CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK----------KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI  224 (314)
T ss_pred             eeeccccceeEEEcCCCcEEEcccccccccccccccc----------ccccCCCCccccCHHHHccCCcCccchhhHHHH
Confidence            9999999999999999999999999986432111000          00011234579999974         9999999


Q ss_pred             eEEEeee
Q psy1934         141 IGRSMLY  147 (150)
Q Consensus       141 ~~~~~~~  147 (150)
                      ++++++.
T Consensus       225 ~l~el~~  231 (314)
T cd05099         225 LMWEIFT  231 (314)
T ss_pred             HHHHHHh
Confidence            9999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.88  E-value=5.8e-23  Score=143.99  Aligned_cols=134  Identities=19%  Similarity=0.226  Sum_probs=108.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-------------SALPPNIVCSILWQTCQAVKHMHGQNPPI   70 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i   70 (150)
                      -|+++++..+.....+..+++|||+++++|.+++....             ..+++..+..++.+++.|+.++|+.+  +
T Consensus        66 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i  143 (280)
T cd05049          66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--F  143 (280)
T ss_pred             CCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--e
Confidence            46889999888888899999999999999999997532             23677888899999999999999998  9


Q ss_pred             EEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccccccee
Q psy1934          71 VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVI  141 (150)
Q Consensus        71 ~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~  141 (150)
                      +|+|++|+||+++.++.++++|||++..........          ......+++.|+|||++         |+||+|++
T Consensus       144 ~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  213 (280)
T cd05049         144 VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR----------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV  213 (280)
T ss_pred             eccccccceEEEcCCCeEEECCcccceecccCccee----------cCCCCcccceecChhhhccCCcchhhhHHHHHHH
Confidence            999999999999999999999999886432111000          00122346789999984         99999999


Q ss_pred             EEEeee-ec
Q psy1934         142 GRSMLY-GH  149 (150)
Q Consensus       142 ~~~~~~-g~  149 (150)
                      +++|++ |.
T Consensus       214 l~e~~~~g~  222 (280)
T cd05049         214 LWEIFTYGK  222 (280)
T ss_pred             HHHHHhcCC
Confidence            999986 64

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.88  E-value=8.3e-23  Score=142.58  Aligned_cols=138  Identities=20%  Similarity=0.313  Sum_probs=109.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.....+.+++++||+++++|.+++......+++..+..++.+++.|+.++|+++  ++|+|++|+|+++
T Consensus        62 l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili  139 (269)
T cd05065          62 FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILV  139 (269)
T ss_pred             CCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEE
Confidence            34788999999888989999999999999999999875556888889999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.+++.|||++...........       .........+..|++||++         |+||+|+++++++. |.
T Consensus       140 ~~~~~~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~  209 (269)
T cd05065         140 NSNLVCKVSDFGLSRFLEDDTSDPT-------YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE  209 (269)
T ss_pred             cCCCcEEECCCccccccccCccccc-------cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCC
Confidence            9999999999998764322111000       0000011123579999984         99999999999763 64

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.88  E-value=6.6e-23  Score=142.08  Aligned_cols=135  Identities=25%  Similarity=0.345  Sum_probs=110.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.... +.+++++||+++++|.+++.+.. ..+++..+..++.|++.|+.++|+.+  ++|+|++|+|++
T Consensus        53 l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil  129 (257)
T cd05040          53 LDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNIL  129 (257)
T ss_pred             cCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEE
Confidence            457889998888877 89999999999999999997654 46888999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||++........ .+        .......++..|++||++         |+||+|+++++|+. |+
T Consensus       130 ~~~~~~~kl~dfg~~~~~~~~~~-~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~  198 (257)
T cd05040         130 LASDDKVKIGDFGLMRALPQNED-HY--------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGE  198 (257)
T ss_pred             EecCCEEEecccccccccccccc-ce--------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCC
Confidence            99999999999998875432111 00        000123456789999973         99999999999985 65

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.88  E-value=6e-23  Score=144.23  Aligned_cols=132  Identities=30%  Similarity=0.396  Sum_probs=111.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.....+.+++|+||+ +++|.+++......+++..+..++.+++.++.++|+.+  ++|+|++|+||+++
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~  133 (286)
T cd07832          57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS  133 (286)
T ss_pred             CCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc
Confidence            3788999999888899999999999 88999999765567899999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ..+.++++|||.+..........           .....++..|+|||++          |+|++|++++++++|.
T Consensus       134 ~~~~~~l~dfg~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~  198 (286)
T cd07832         134 ADGVLKIADFGLARLFSEEEPRL-----------YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS  198 (286)
T ss_pred             CCCcEEEeeeeecccccCCCCCc-----------cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence            99999999999886542211100           1123578899999973          9999999999998874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=7.9e-23  Score=143.10  Aligned_cols=135  Identities=19%  Similarity=0.244  Sum_probs=109.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHR   73 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~   73 (150)
                      +-|+++++..+.....+.++++|||+++++|.+++....         ..+++..+..++.+++.|+.|+|+.+  ++|+
T Consensus        66 ~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~  143 (277)
T cd05032          66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHR  143 (277)
T ss_pred             CCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccc
Confidence            347889999998888899999999999999999997532         23567788889999999999999998  9999


Q ss_pred             cCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEE
Q psy1934          74 DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRS  144 (150)
Q Consensus        74 ~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~  144 (150)
                      |++|+|++++.++.++++|||+++........          .......++..|+|||.+         |+|++|+++++
T Consensus       144 di~p~nill~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  213 (277)
T cd05032         144 DLAARNCMVAEDLTVKIGDFGMTRDIYETDYY----------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE  213 (277)
T ss_pred             ccChheEEEcCCCCEEECCcccchhhccCccc----------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHH
Confidence            99999999999999999999987643221100          001122456789999984         99999999999


Q ss_pred             eee-ec
Q psy1934         145 MLY-GH  149 (150)
Q Consensus       145 ~~~-g~  149 (150)
                      +++ |.
T Consensus       214 l~t~g~  219 (277)
T cd05032         214 MATLAE  219 (277)
T ss_pred             hhccCC
Confidence            986 64

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.88  E-value=2.8e-23  Score=147.14  Aligned_cols=130  Identities=27%  Similarity=0.483  Sum_probs=109.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.+......|+|+||+++++|.+++.+  ..+++..+..++.+++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        75 ~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~  150 (296)
T cd06654          75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG  150 (296)
T ss_pred             CCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc
Confidence            478889988888888899999999999999999865  35788888899999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........            ......+++.|+|||.+         |+|++|+++++|++|.
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~  213 (296)
T cd06654         151 MDGSVKLTDFGFCAQITPEQS------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE  213 (296)
T ss_pred             CCCCEEECccccchhcccccc------------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence            999999999998764321100            01123578899999974         9999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.88  E-value=5.7e-23  Score=145.65  Aligned_cols=131  Identities=26%  Similarity=0.449  Sum_probs=111.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.+...+.+++++||+++++|.+++..  ..+++..+..++.|++.|+.++|+.+  ++|+|++++||++
T Consensus        75 l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill  150 (297)
T cd06659          75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILL  150 (297)
T ss_pred             CCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEE
Confidence            4578899999999999999999999999999998865  35888899999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......++..|+|||++         |+||+|+++++|+.|.
T Consensus       151 ~~~~~~kL~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~  214 (297)
T cd06659         151 TLDGRVKLSDFGFCAQISKDVP------------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE  214 (297)
T ss_pred             ccCCcEEEeechhHhhcccccc------------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999998753221100            01123578899999984         9999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.87  E-value=6.6e-23  Score=145.56  Aligned_cols=131  Identities=20%  Similarity=0.298  Sum_probs=106.4

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      |+++++..+.....+.++++|||+++++|.+++.+..               ..++...+..++.|++.|+.|+|+++  
T Consensus        80 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--  157 (304)
T cd05101          80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--  157 (304)
T ss_pred             CCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence            7889999988888899999999999999999997532               23567778888999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|+|++|+||+++.++.++++|||.+..........          ......++..|+|||++         |+||+|+
T Consensus       158 ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  227 (304)
T cd05101         158 CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK----------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV  227 (304)
T ss_pred             eeecccccceEEEcCCCcEEECCCccceecccccccc----------cccCCCCCceeeCchhhccCCCCchhhHHHHHH
Confidence            9999999999999999999999999987532111100          00112345679999974         9999999


Q ss_pred             eEEEeee
Q psy1934         141 IGRSMLY  147 (150)
Q Consensus       141 ~~~~~~~  147 (150)
                      +++++++
T Consensus       228 ~l~el~~  234 (304)
T cd05101         228 LMWEIFT  234 (304)
T ss_pred             HHHHHHc
Confidence            9999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.87  E-value=3.7e-23  Score=147.11  Aligned_cols=131  Identities=20%  Similarity=0.299  Sum_probs=106.5

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      |+++++..+.+...+.+|+|+||+++|+|.+++....               ..+++.++..++.|++.|+.|+|+.+  
T Consensus        83 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--  160 (307)
T cd05098          83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--  160 (307)
T ss_pred             CCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            7889999888888899999999999999999997532               24778888899999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|+|++|+||+++.++.++++|||.+.........          .......+++.|+|||++         |+||+|+
T Consensus       161 i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~  230 (307)
T cd05098         161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV  230 (307)
T ss_pred             cccccccHHheEEcCCCcEEECCCcccccccccchh----------hccccCCCccceeChHHhccCCCCcHHHHHHHHH
Confidence            999999999999999999999999987643211100          000111234679999974         9999999


Q ss_pred             eEEEeee
Q psy1934         141 IGRSMLY  147 (150)
Q Consensus       141 ~~~~~~~  147 (150)
                      ++++|+.
T Consensus       231 ~l~el~~  237 (307)
T cd05098         231 LLWEIFT  237 (307)
T ss_pred             HHHHHHc
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=6.1e-23  Score=146.38  Aligned_cols=143  Identities=24%  Similarity=0.324  Sum_probs=112.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      |+++++..+..+..+..|++|||+++++|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        60 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~  137 (316)
T cd05574          60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH  137 (316)
T ss_pred             CCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc
Confidence            6789999988889999999999999999999987543 45888899999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhh-----------------hhhhHHhhhcCCCCCccCcccc---------cccc
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQ-----------------RSMLEDEMARFTTPMYRAPEMV---------DTWN  137 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~---------d~~~  137 (150)
                      .++.+++.|||++...............                 ...........|+..|+|||+.         |+||
T Consensus       138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s  217 (316)
T cd05574         138 ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT  217 (316)
T ss_pred             CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHH
Confidence            9999999999987643221110000000                 0000001123578889999974         9999


Q ss_pred             cceeEEEeeeec
Q psy1934         138 NYVIGRSMLYGH  149 (150)
Q Consensus       138 ~g~~~~~~~~g~  149 (150)
                      +|++++++++|.
T Consensus       218 lG~ll~~l~~g~  229 (316)
T cd05574         218 LGILLYEMLYGT  229 (316)
T ss_pred             HHHHHHHHhhCC
Confidence            999999999886

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.87  E-value=1.2e-22  Score=142.79  Aligned_cols=131  Identities=26%  Similarity=0.454  Sum_probs=106.6

Q ss_pred             chhhhcccCCC-----CCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           5 SAAFIDKHSTP-----HGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         5 ~~~~~~~~~~~-----~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      |+++++..+.+     +..+.++++|||+++++|.+++...   ...+++..+..++.+++.|+.|+|+.+  ++|+|++
T Consensus        74 h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk  151 (286)
T cd06638          74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVK  151 (286)
T ss_pred             CCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Confidence            67888877754     4556899999999999999987632   245788888899999999999999998  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc--------------ccccccceeE
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------------VDTWNNYVIG  142 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~--------------~d~~~~g~~~  142 (150)
                      |+||+++..+.++++|||++........            ......|++.|+|||+              .|+||+|+++
T Consensus       152 p~nili~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~  219 (286)
T cd06638         152 GNNILLTTEGGVKLVDFGVSAQLTSTRL------------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA  219 (286)
T ss_pred             HHhEEECCCCCEEEccCCceeecccCCC------------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHH
Confidence            9999999999999999999875422111            0112357889999996              3999999999


Q ss_pred             EEeeeec
Q psy1934         143 RSMLYGH  149 (150)
Q Consensus       143 ~~~~~g~  149 (150)
                      ++++.|.
T Consensus       220 ~el~~g~  226 (286)
T cd06638         220 IELGDGD  226 (286)
T ss_pred             HHHhcCC
Confidence            9998875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.87  E-value=6.2e-23  Score=144.17  Aligned_cols=135  Identities=19%  Similarity=0.222  Sum_probs=108.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--------------SALPPNIVCSILWQTCQAVKHMHGQNP   68 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~l~~~~~~~~~~~i~~~l~~lh~~~~   68 (150)
                      +-|+++++..+.....+.+++++||+++++|.+++....              ..+++..+..++.|++.|+.|+|+++ 
T Consensus        64 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-  142 (280)
T cd05092          64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-  142 (280)
T ss_pred             CCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-
Confidence            347888898888888889999999999999999997642              23778888999999999999999998 


Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccc
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNY  139 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g  139 (150)
                       ++|+|++|+||+++.++.++++|||++..........          ......+++.|+|||++         |+||+|
T Consensus       143 -i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  211 (280)
T cd05092         143 -FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----------VGGRTMLPIRWMPPESILYRKFTTESDIWSFG  211 (280)
T ss_pred             -eecccccHhhEEEcCCCCEEECCCCceeEcCCCceee----------cCCCccccccccCHHHhccCCcCchhhHHHHH
Confidence             9999999999999999999999999886432111000          00112345779999973         999999


Q ss_pred             eeEEEeee-ec
Q psy1934         140 VIGRSMLY-GH  149 (150)
Q Consensus       140 ~~~~~~~~-g~  149 (150)
                      ++++++++ |.
T Consensus       212 ~il~el~~~g~  222 (280)
T cd05092         212 VVLWEIFTYGK  222 (280)
T ss_pred             HHHHHHHcCCC
Confidence            99999986 64

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.87  E-value=9e-23  Score=142.05  Aligned_cols=134  Identities=22%  Similarity=0.286  Sum_probs=108.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.....+.++++|||+++++|.+++.... ..+++..+..++.|++.|+.++|+++  ++|+|++|+||+
T Consensus        59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil  136 (263)
T cd05052          59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCL  136 (263)
T ss_pred             CCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEE
Confidence            347889999888888899999999999999999997543 35788888899999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||++........   .        .......+..|+|||+         .|+||+|+++++|+. |.
T Consensus       137 ~~~~~~~kl~df~~~~~~~~~~~---~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~  203 (263)
T cd05052         137 VGENHLVKVADFGLSRLMTGDTY---T--------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM  203 (263)
T ss_pred             EcCCCcEEeCCCcccccccccee---e--------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCC
Confidence            99999999999998864321100   0        0001123557999997         399999999999986 63

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.87  E-value=1.1e-22  Score=144.89  Aligned_cols=140  Identities=19%  Similarity=0.253  Sum_probs=112.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.+...+.++++|||+++++|.+++.... ..+++..+..++.+++.|+.|+|+++  ++|+|++++||+
T Consensus        56 l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nil  133 (314)
T cd08216          56 LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHIL  133 (314)
T ss_pred             cCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEE
Confidence            347889999999999999999999999999999998642 45888888899999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-----------ccccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-----------~d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.+++.||+.+.............     ........++..|+|||+           .|+||+|+++++|+.|.
T Consensus       134 i~~~~~~kl~d~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~  207 (314)
T cd08216         134 LSGDGKVVLSGLRYSVSMIKHGKRQRVV-----HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH  207 (314)
T ss_pred             EecCCceEEecCccceeecccccccccc-----ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCC
Confidence            9999999999999876443211110000     000112346778999996           39999999999998875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.87  E-value=8e-23  Score=142.12  Aligned_cols=131  Identities=30%  Similarity=0.411  Sum_probs=111.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+....++.+++++||+++++|.+++... ..+++..+..++.+++.|+.++|+++  ++|+|++++||++
T Consensus        50 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv  126 (262)
T cd05572          50 CNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLL  126 (262)
T ss_pred             CCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE
Confidence            34788999999888889999999999999999999764 45888889999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.......             ......+++.|++||.+         |+|++|++++++++|.
T Consensus       127 ~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~  189 (262)
T cd05572         127 DSNGYVKLVDFGFAKKLKSGQ-------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR  189 (262)
T ss_pred             cCCCCEEEeeCCcccccCccc-------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCC
Confidence            999999999999886432110             01123578889999984         9999999999999886

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.87  E-value=5.6e-23  Score=144.39  Aligned_cols=132  Identities=27%  Similarity=0.337  Sum_probs=109.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|+++++..+....++.+++|+||++ ++|.+++....  ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||
T Consensus        56 l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~ni  132 (285)
T cd07861          56 LQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNL  132 (285)
T ss_pred             cCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHE
Confidence            347889999999999999999999997 48988886533  45888999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++........            ......+++.|+|||++          |+||+|++++++++|.
T Consensus       133 l~~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~  199 (285)
T cd07861         133 LIDNKGVIKLADFGLARAFGIPVR------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK  199 (285)
T ss_pred             EEcCCCcEEECcccceeecCCCcc------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCC
Confidence            999999999999998864321100            01123467889999973          9999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0662|consensus

Probab=99.87  E-value=1.3e-23  Score=135.99  Aligned_cols=129  Identities=29%  Similarity=0.466  Sum_probs=111.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|-+|++++++.++++++-+|+|||.. +|..+..+..+.+....++.++.|++.|+.++|+++  +.|||+||+|.++
T Consensus        58 lkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnlli  134 (292)
T KOG0662|consen   58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLI  134 (292)
T ss_pred             hhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEe
Confidence            3467899999999999999999999976 999999888778999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSML  146 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~  146 (150)
                      ..+|.+|++|||+++.... +...           -...+.|+||++|.+          +|.||.||+..|+.
T Consensus       135 n~ngelkladfglarafgi-pvrc-----------ysaevvtlwyrppdvlfgakly~tsidmwsagcifaela  196 (292)
T KOG0662|consen  135 NRNGELKLADFGLARAFGI-PVRC-----------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA  196 (292)
T ss_pred             ccCCcEEecccchhhhcCC-ceEe-----------eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHh
Confidence            9999999999999875321 1111           124578999999998          49999999988765

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.87  E-value=8.5e-23  Score=144.71  Aligned_cols=131  Identities=27%  Similarity=0.475  Sum_probs=110.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++|+||+++++|.+++..  ..+++.++..++.+++.++.++|+.+  ++|+|++|+||++
T Consensus        73 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili  148 (296)
T cd06655          73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLL  148 (296)
T ss_pred             cCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE
Confidence            3478899999988888999999999999999998865  35889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....++..|+|||.+         |+||+|++++++++|.
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~  212 (296)
T cd06655         149 GMDGSVKLTDFGFCAQITPEQSK------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE  212 (296)
T ss_pred             CCCCCEEEccCccchhccccccc------------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999987643211100            0123578889999973         9999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.87  E-value=9e-23  Score=141.76  Aligned_cols=136  Identities=17%  Similarity=0.202  Sum_probs=105.5

Q ss_pred             ccchhhhcccCCC-CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTP-HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||++++..+.. ...+..++++||+++++|.+++.......++..+..++.+++.|+.|+|+.+  ++|+|++|+||+
T Consensus        53 l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nil  130 (262)
T cd05058          53 FSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCM  130 (262)
T ss_pred             CCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEE
Confidence            3478888887743 3456689999999999999999765445677777888899999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      ++.++.++++|||++...........        .......++..|+|||..         |+||+|+++++|++|
T Consensus       131 i~~~~~~kl~dfg~~~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~  198 (262)
T cd05058         131 LDESFTVKVADFGLARDIYDKEYYSV--------HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR  198 (262)
T ss_pred             EcCCCcEEECCccccccccCCcceee--------cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcC
Confidence            99999999999998864322110000        001122356679999974         999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.87  E-value=1.2e-22  Score=142.31  Aligned_cols=131  Identities=27%  Similarity=0.417  Sum_probs=111.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++|+||+++++|.+++..  ..+++..+..++.+++.|+.|+|+.+  ++|+|++|+||++
T Consensus        59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i  134 (277)
T cd06642          59 CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLL  134 (277)
T ss_pred             CCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEE
Confidence            3478899999999999999999999999999998864  46888889999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+++.|||++.......            .......++..|++||++         |+||+|++++++++|.
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~  198 (277)
T cd06642         135 SEQGDVKLADFGVAGQLTDTQ------------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE  198 (277)
T ss_pred             eCCCCEEEccccccccccCcc------------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCC
Confidence            999999999999876432110            011123577889999974         9999999999999885

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.87  E-value=1e-22  Score=141.80  Aligned_cols=133  Identities=28%  Similarity=0.385  Sum_probs=110.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-||++++..+.+...+..++++||+++++|.+++...   ...+++..+..++.+++.|+.|+|+++  ++|+|++|+|
T Consensus        59 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~n  136 (267)
T cd08228          59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPAN  136 (267)
T ss_pred             CCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHH
Confidence            35788999999888889999999999999999988642   234788888899999999999999998  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      |+++.++.++++|||++.......            .......+++.|+|||..         |+|++|++++++++|.
T Consensus       137 il~~~~~~~~l~d~g~~~~~~~~~------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~  203 (267)
T cd08228         137 VFITATGVVKLGDLGLGRFFSSKT------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ  203 (267)
T ss_pred             EEEcCCCCEEECccccceeccchh------------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCC
Confidence            999999999999999876432110            011134578899999984         9999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.87  E-value=9.4e-23  Score=143.33  Aligned_cols=135  Identities=21%  Similarity=0.268  Sum_probs=105.7

Q ss_pred             ccchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|+++++..+..  .+...+++|+||+++++|.+++......+++..+..++.+++.|+.|+|+++  ++|+|++|+||
T Consensus        62 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~ni  139 (284)
T cd05081          62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNI  139 (284)
T ss_pred             CCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhE
Confidence            4477888876643  3445789999999999999999765456888999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +++.++.++++|||++...........         ......++..|+|||+.         |+||+|+++++|++|
T Consensus       140 li~~~~~~~l~dfg~~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~  207 (284)
T cd05081         140 LVESENRVKIGDFGLTKVLPQDKEYYK---------VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY  207 (284)
T ss_pred             EECCCCeEEECCCcccccccCCCccee---------ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhc
Confidence            999999999999999875432211000         00011234468999984         999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=4.7e-23  Score=143.55  Aligned_cols=138  Identities=22%  Similarity=0.362  Sum_probs=112.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.....+..++++||+++++|.+++++. ..+++..+..++.+++.|+.++|+.+  ++|+|++|+||++
T Consensus        63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~  139 (267)
T cd06628          63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILV  139 (267)
T ss_pred             cCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEE
Confidence            34788999998888889999999999999999999764 56888888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+.............      .......++..|++||.         .|+|++|+++++++.|.
T Consensus       140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~  209 (267)
T cd06628         140 DNKGGIKISDFGISKKLEANSLSTKTN------GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK  209 (267)
T ss_pred             cCCCCEEecccCCCcccccccccCCcc------ccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCC
Confidence            999999999999887543211100000      00112347788999996         39999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.87  E-value=1.1e-22  Score=141.08  Aligned_cols=129  Identities=26%  Similarity=0.385  Sum_probs=104.3

Q ss_pred             cchhhhcccCC-CCCceEEEEEEeccCCCCHHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           4 LSAAFIDKHST-PHGMHEYLILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         4 ~~~~~~~~~~~-~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      -|+++++..+. .+..+.+++++||+++++|.+++++... .+++..+..++.+++.|+.++|+++  ++|+|++|+||+
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil  134 (256)
T cd05082          57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVL  134 (256)
T ss_pred             CCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEE
Confidence            36777777664 4555778999999999999999976443 4788888999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||++.......               ....++..|+|||+         .|+|++|+++++|++ |.
T Consensus       135 ~~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~  197 (256)
T cd05082         135 VSEDNVAKVSDFGLTKEASSTQ---------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR  197 (256)
T ss_pred             EcCCCcEEecCCccceeccccC---------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCC
Confidence            9999999999999876432110               01123457999997         399999999999985 64

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0983|consensus

Probab=99.87  E-value=1.8e-23  Score=142.73  Aligned_cols=130  Identities=23%  Similarity=0.354  Sum_probs=107.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +|.|++-.+++-....+++.||.+.. .+..+++.-..++++..+-.+...+.+|+.||-.+ ++++|||+||+|||++.
T Consensus       150 cpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe  227 (391)
T KOG0983|consen  150 CPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDE  227 (391)
T ss_pred             CCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEcc
Confidence            46678877888888888999998854 78888877667788887778888999999999754 24999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      .|.+|++|||++.....+.-             ++...|-+.|||||.+            |+||+|+.+.|+++|+
T Consensus       228 ~GniKlCDFGIsGrlvdSkA-------------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~  291 (391)
T KOG0983|consen  228 RGNIKLCDFGISGRLVDSKA-------------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQ  291 (391)
T ss_pred             CCCEEeecccccceeecccc-------------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhccc
Confidence            99999999999876543321             1233578899999985            9999999999999985

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.2e-22  Score=141.30  Aligned_cols=134  Identities=23%  Similarity=0.271  Sum_probs=109.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.....+.+++++||+++++|.+++.... ..+++..+..++.+++.|+.++|+.+  ++|+|++|+||+
T Consensus        58 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil  135 (261)
T cd05068          58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVL  135 (261)
T ss_pred             CCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEE
Confidence            347889998888888899999999999999999997643 45889999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||++.........           .......+..|+|||+         .|+||+|+++++++. |+
T Consensus       136 ~~~~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~  202 (261)
T cd05068         136 VGENNICKVADFGLARVIKEDIYE-----------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR  202 (261)
T ss_pred             EcCCCCEEECCcceEEEccCCccc-----------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCC
Confidence            999999999999988754311000           0001122356999997         399999999999986 64

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.87  E-value=8.5e-23  Score=143.57  Aligned_cols=135  Identities=21%  Similarity=0.234  Sum_probs=108.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHhcC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT----------------SALPPNIVCSILWQTCQAVKHMHGQ   66 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~   66 (150)
                      +-|+++++..+....++..|++|||+++++|.+++....                ..+++..+..++.+++.|+.|+|++
T Consensus        64 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~  143 (283)
T cd05090          64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH  143 (283)
T ss_pred             CCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc
Confidence            347889999988888899999999999999999985321                2367778888999999999999999


Q ss_pred             CCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccc
Q psy1934          67 NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWN  137 (150)
Q Consensus        67 ~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~  137 (150)
                      +  ++|+|++|+|++++.++.++++|||++..........          ......++..|+|||++         |+||
T Consensus       144 ~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  211 (283)
T cd05090         144 F--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR----------VQPKSLLPIRWMPPEAIMYGKFSSDSDIWS  211 (283)
T ss_pred             C--eehhccccceEEEcCCCcEEeccccccccccCCccee----------cccCCCccceecChHHhccCCCCchhhhHH
Confidence            8  9999999999999999999999999987532211100          01122345679999974         9999


Q ss_pred             cceeEEEeee-ec
Q psy1934         138 NYVIGRSMLY-GH  149 (150)
Q Consensus       138 ~g~~~~~~~~-g~  149 (150)
                      +|+++++|++ |.
T Consensus       212 lG~il~el~~~g~  224 (283)
T cd05090         212 FGVVLWEIFSFGL  224 (283)
T ss_pred             HHHHHHHHHcCCC
Confidence            9999999986 53

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.87  E-value=8e-23  Score=142.33  Aligned_cols=137  Identities=26%  Similarity=0.376  Sum_probs=111.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.+...+.+++++||+++++|.+++.+. ..+++..+..++.+++.++.++|+.+  ++|+|++|.|++++
T Consensus        60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~  136 (265)
T cd06631          60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM  136 (265)
T ss_pred             CCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC
Confidence            3678999999988889999999999999999999764 46788888899999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++...........      .........++..|+|||++         |+|++|+++++++.|.
T Consensus       137 ~~~~~~l~dfg~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~  205 (265)
T cd06631         137 PNGIIKLIDFGCARRLAWVGLHGT------HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK  205 (265)
T ss_pred             CCCeEEeccchhhHhhhhcccccc------ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCC
Confidence            999999999998764321111000      00011123578899999984         9999999999999885

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.5e-22  Score=142.07  Aligned_cols=133  Identities=19%  Similarity=0.267  Sum_probs=107.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.... ...++++||+++|+|.+++.+....+++..+..++.|++.|+.|+|+++  ++|+|++|+|++++
T Consensus        67 ~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~  143 (279)
T cd05057          67 DHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK  143 (279)
T ss_pred             CCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc
Confidence            47888888877766 7899999999999999999876556899999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      .++.++++|||.+........ ...         .....++..|++||.+         |+|++|+++++++. |.
T Consensus       144 ~~~~~kL~dfg~~~~~~~~~~-~~~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~  209 (279)
T cd05057         144 TPQHVKITDFGLAKLLDVDEK-EYH---------AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGA  209 (279)
T ss_pred             CCCeEEECCCcccccccCccc-cee---------cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCC
Confidence            999999999998875321111 000         0011234679999974         99999999999886 64

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.87  E-value=2.9e-22  Score=138.77  Aligned_cols=132  Identities=27%  Similarity=0.374  Sum_probs=108.0

Q ss_pred             cchhhhcccCCCC-CceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           4 LSAAFIDKHSTPH-GMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         4 ~~~~~~~~~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      -|+++++..+... ..+.+++++||+++++|.++++... ..+++.++..++.+++.++.++|+.+  ++|+|++|+||+
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil  134 (257)
T cd08223          57 KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVF  134 (257)
T ss_pred             CCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEE
Confidence            4678888777655 3456899999999999999997643 45889999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++..+.++++|||++........            ......+++.|+|||+.         |+||+|+++++++.|.
T Consensus       135 ~~~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~  199 (257)
T cd08223         135 LTRTNIIKVGDLGIARVLENQCD------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK  199 (257)
T ss_pred             EecCCcEEEecccceEEecccCC------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCC
Confidence            99999999999998864321110            01123578899999983         9999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.87  E-value=1.2e-22  Score=144.39  Aligned_cols=144  Identities=29%  Similarity=0.380  Sum_probs=111.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.++..+.++++|||+++++|.++++.. ..+++..+..++.+++.|+.|+|+.+  ++|+|++|.||++
T Consensus        58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll  134 (305)
T cd05609          58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLI  134 (305)
T ss_pred             CCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEE
Confidence            34688899888888889999999999999999999764 46888888889999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcch-h--HhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAW-S--AQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      +..+.++++|||+++.......... .  ..............++..|+|||.         .|+||+|+++++++.|.
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~  213 (305)
T cd05609         135 TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC  213 (305)
T ss_pred             CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999998764211110000 0  000000000112356788999997         49999999999998875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG1151|consensus

Probab=99.87  E-value=2.9e-22  Score=144.75  Aligned_cols=140  Identities=27%  Similarity=0.366  Sum_probs=113.3

Q ss_pred             cchhhhcccCCCC-CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPH-GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      =||.||++.+++. +.+.+|-|+|||+|.+|.-+|+.+ ..+++.+++.++.||+.|+.||....++|||-|+||.|||+
T Consensus       525 DHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL  603 (775)
T KOG1151|consen  525 DHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL  603 (775)
T ss_pred             CcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence            3567888877665 556889999999999999999876 46899999999999999999999999999999999999998


Q ss_pred             cC---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-------------cccccceeEEEee
Q psy1934          83 SS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-------------DTWNNYVIGRSML  146 (150)
Q Consensus        83 ~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------d~~~~g~~~~~~~  146 (150)
                      ..   .|.+||.|||+++.+.........-     +.-.....||.||++||.+             |+||.|++++..+
T Consensus       604 v~GtacGeIKITDFGLSKIMdddSy~~vdG-----meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQCl  678 (775)
T KOG1151|consen  604 VNGTACGEIKITDFGLSKIMDDDSYNSVDG-----MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCL  678 (775)
T ss_pred             ecCcccceeEeeecchhhhccCCccCcccc-----eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhh
Confidence            43   4789999999998765443321110     0011233589999999973             9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      ||+
T Consensus       679 YGr  681 (775)
T KOG1151|consen  679 YGR  681 (775)
T ss_pred             ccC
Confidence            985

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.87  E-value=2.8e-23  Score=144.58  Aligned_cols=133  Identities=26%  Similarity=0.372  Sum_probs=106.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.+.....+..++|+||+++|+|.+++... ...+++..+..++.|++.|+.|+|+++  ++|+++++.||+
T Consensus        58 l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nil  135 (259)
T PF07714_consen   58 LRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNIL  135 (259)
T ss_dssp             HSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccc
Confidence            46889999999888778899999999999999999886 456899999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      ++.++.+|++|||++..........          ..........|+|||.+         |+||+|++++|+++
T Consensus       136 l~~~~~~Kl~~f~~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~  200 (259)
T PF07714_consen  136 LDSNGQVKLSDFGLSRPISEKSKYK----------NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT  200 (259)
T ss_dssp             EETTTEEEEESTTTGEETTTSSSEE----------ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccc----------cccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999887541111100          00122345679999985         99999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.87  E-value=1.3e-22  Score=140.54  Aligned_cols=132  Identities=27%  Similarity=0.349  Sum_probs=111.9

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+.+...+..++++||+++++|.+++... ...+++..+..++.+++.++.++|+.+  ++|+|++|+||++
T Consensus        57 ~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~  134 (256)
T cd08221          57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFL  134 (256)
T ss_pred             CCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEE
Confidence            4788999999999999999999999999999999764 345788899999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+++.|+|||+.         |+||+|+++++|+.|.
T Consensus       135 ~~~~~~kl~d~~~~~~~~~~~~------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~  198 (256)
T cd08221         135 TKAGLIKLGDFGISKILGSEYS------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK  198 (256)
T ss_pred             eCCCCEEECcCcceEEcccccc------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCC
Confidence            9999999999998875422110            01134578899999974         9999999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.87  E-value=1.5e-22  Score=140.04  Aligned_cols=133  Identities=26%  Similarity=0.453  Sum_probs=112.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+.....+|+++||+++++|.+++......+++..+..++.+++.|+.++|+.+  ++|+|++|.||++
T Consensus        55 l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~  132 (256)
T cd06612          55 CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILL  132 (256)
T ss_pred             CCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE
Confidence            35788999999888889999999999999999999765567899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......++..|++||+         .|+|++|+++++|+.|.
T Consensus       133 ~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~  196 (256)
T cd06612         133 NEEGQAKLADFGVSGQLTDTMA------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK  196 (256)
T ss_pred             CCCCcEEEcccccchhcccCcc------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999998764322110            0112346788999997         49999999999998875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.87  E-value=1e-22  Score=142.83  Aligned_cols=133  Identities=21%  Similarity=0.228  Sum_probs=104.4

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.... ...++++||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++
T Consensus        67 ~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~  143 (279)
T cd05109          67 GSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK  143 (279)
T ss_pred             CCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc
Confidence            35667766665544 4578999999999999999865556889999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      .++.++++|||++..........          ......+++.|++||..         |+||+|++++|+++ |.
T Consensus       144 ~~~~~kL~dfG~~~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~  209 (279)
T cd05109         144 SPNHVKITDFGLARLLDIDETEY----------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGA  209 (279)
T ss_pred             CCCcEEECCCCceeeccccccee----------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCC
Confidence            99999999999987542111100          00011245679999985         99999999999875 53

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.87  E-value=1.1e-22  Score=142.62  Aligned_cols=131  Identities=26%  Similarity=0.301  Sum_probs=110.4

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -||++++..+.++..+.+|+|+||+++++|.+++.... ..+++..+..++.|++.|+.++|+.+  ++|+|++|.||++
T Consensus        51 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~  128 (277)
T cd05577          51 SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLL  128 (277)
T ss_pred             CCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE
Confidence            47888998888888899999999999999999987643 35888898999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+.......             ......++..|++||+.         |+|++|++++++++|.
T Consensus       129 ~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~  191 (277)
T cd05577         129 DDHGNVRISDLGLAVELKGGK-------------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR  191 (277)
T ss_pred             CCCCCEEEccCcchhhhccCC-------------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCC
Confidence            999999999999876432110             01123567889999984         9999999999999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.87  E-value=1.8e-22  Score=145.56  Aligned_cols=133  Identities=23%  Similarity=0.392  Sum_probs=105.1

Q ss_pred             chhhhcccCCCC-CceEEEEEEeccCCCCHHHHHHhhC------------------------------------------
Q psy1934           5 SAAFIDKHSTPH-GMHEYLILTELCTGGSLVDVLKERT------------------------------------------   41 (150)
Q Consensus         5 ~~~~~~~~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------   41 (150)
                      |++|++..+.+. .+..+++++||+++++|.+++....                                          
T Consensus        70 h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (337)
T cd05054          70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIE  149 (337)
T ss_pred             CcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccccccccc
Confidence            578888877543 4467899999999999999986421                                          


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCC
Q psy1934          42 ------------------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSP  103 (150)
Q Consensus        42 ------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~  103 (150)
                                        ..+++..+..++.+++.|+.|+|+++  ++|+|++|.||+++.++.++++|||++.......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~  227 (337)
T cd05054         150 DKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDP  227 (337)
T ss_pred             CcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCc
Confidence                              14678888899999999999999998  9999999999999999999999999987532211


Q ss_pred             CcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934         104 DNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus       104 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ..          .......++..|+|||++         |+||+|++++++++ |.
T Consensus       228 ~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~  273 (337)
T cd05054         228 DY----------VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA  273 (337)
T ss_pred             ch----------hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCC
Confidence            00          011123456789999974         99999999999885 64

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.87  E-value=1.6e-22  Score=143.01  Aligned_cols=132  Identities=30%  Similarity=0.380  Sum_probs=110.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+..++||||+ +++|.+++......+++..+..++.|++.|+.++|+++  ++|+|++|+||++
T Consensus        59 ~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill  135 (298)
T cd07841          59 LKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLI  135 (298)
T ss_pred             cCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEE
Confidence            34788999999999999999999999 88999999765346899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....+++.|+|||.          .|+|++|+++++|+.|.
T Consensus       136 ~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~  200 (298)
T cd07841         136 ASDGVLKLADFGLARSFGSPNRK------------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV  200 (298)
T ss_pred             cCCCCEEEccceeeeeccCCCcc------------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence            99999999999988753221110            012245678999996          39999999999998874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=8.6e-23  Score=153.97  Aligned_cols=133  Identities=20%  Similarity=0.282  Sum_probs=106.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT----SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      +-|++|+++.+.++..+..++++|++.+ ++.+++....    .......+..++.|++.|+.|+|+++  ++|||+||+
T Consensus       220 l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~  296 (501)
T PHA03210        220 LNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLE  296 (501)
T ss_pred             CCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence            3588999999999999999999999965 8888775421    11234566778999999999999998  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ||+++.++.++++|||++.........           ......||+.|+|||++         |+||+|+++++|+.|.
T Consensus       297 NILl~~~~~vkL~DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~  365 (501)
T PHA03210        297 NIFLNCDGKIVLGDFGTAMPFEKEREA-----------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD  365 (501)
T ss_pred             HEEECCCCCEEEEeCCCceecCccccc-----------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            999999999999999998753211110           01134689999999984         9999999999998764

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.87  E-value=1.4e-22  Score=141.17  Aligned_cols=135  Identities=24%  Similarity=0.345  Sum_probs=111.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.....+.+++++||+++++|.+++++. ..+++..+..++.|++.|+.++|+++  ++|+|+++.||+++
T Consensus        61 ~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~  137 (268)
T cd06630          61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLID  137 (268)
T ss_pred             CCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc
Confidence            4788999999999999999999999999999999764 46888899999999999999999998  99999999999998


Q ss_pred             CCC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ..+ .++++|||.+...........        .......++..|+|||++         |+|++|++++++++|.
T Consensus       138 ~~~~~~~l~dfg~~~~~~~~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~  205 (268)
T cd06630         138 STGQRLRIADFGAAARLAAKGTGAG--------EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK  205 (268)
T ss_pred             CCCCEEEEcccccccccccccccCC--------ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCC
Confidence            775 699999998865432111000        001123578889999974         9999999999999886

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.87  E-value=1.1e-22  Score=142.81  Aligned_cols=126  Identities=29%  Similarity=0.391  Sum_probs=107.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.+...+.+++|+||+++++|..+.     .+++..+..++.+++.|+.|+|+.+  ++|+|++|+|+++
T Consensus        56 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill  128 (279)
T cd06619          56 CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLV  128 (279)
T ss_pred             CCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEE
Confidence            34788999999999999999999999999886542     4678888889999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.......              .....++..|+|||++         |+||+|+++++|++|.
T Consensus       129 ~~~~~~~l~dfg~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~  190 (279)
T cd06619         129 NTRGQVKLCDFGVSTQLVNSI--------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR  190 (279)
T ss_pred             CCCCCEEEeeCCcceeccccc--------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCC
Confidence            999999999999886432110              1123678899999984         9999999999999885

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.87  E-value=1.5e-22  Score=142.77  Aligned_cols=132  Identities=31%  Similarity=0.445  Sum_probs=108.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.....+..|+++||++ +++.+.+......+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        60 l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~  136 (291)
T cd07870          60 LKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLI  136 (291)
T ss_pred             cCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEE
Confidence            347888998888888899999999996 5888777654456778888889999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....+++.|+|||++          |+||+|++++++++|.
T Consensus       137 ~~~~~~~l~Dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  201 (291)
T cd07870         137 SYLGELKLADFGLARAKSIPSQT------------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ  201 (291)
T ss_pred             cCCCcEEEeccccccccCCCCCC------------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999988643211110            0123467889999974          9999999999999885

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.87  E-value=1.3e-22  Score=141.60  Aligned_cols=131  Identities=24%  Similarity=0.409  Sum_probs=106.9

Q ss_pred             chhhhcccCCCCC------ceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           5 SAAFIDKHSTPHG------MHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         5 ~~~~~~~~~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      |+++++..+.+..      ...+++++||+++++|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|+++
T Consensus        62 h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~  139 (272)
T cd06637          62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKG  139 (272)
T ss_pred             CCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCH
Confidence            6778887765442      357899999999999999998643 45888888899999999999999998  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc--------------ccccccceeEE
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------------VDTWNNYVIGR  143 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~--------------~d~~~~g~~~~  143 (150)
                      +||+++.++.++++|||++........            ......|++.|+|||+              .|+||+|++++
T Consensus       140 ~nili~~~~~~~l~Dfg~~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~  207 (272)
T cd06637         140 QNVLLTENAEVKLVDFGVSAQLDRTVG------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI  207 (272)
T ss_pred             HHEEECCCCCEEEccCCCceecccccc------------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHH
Confidence            999999999999999999864321110            0113357888999995              49999999999


Q ss_pred             Eeeeec
Q psy1934         144 SMLYGH  149 (150)
Q Consensus       144 ~~~~g~  149 (150)
                      +|++|.
T Consensus       208 el~~g~  213 (272)
T cd06637         208 EMAEGA  213 (272)
T ss_pred             HHHhCC
Confidence            999885

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0671|consensus

Probab=99.87  E-value=1.2e-21  Score=138.41  Aligned_cols=124  Identities=31%  Similarity=0.406  Sum_probs=102.8

Q ss_pred             hhcccCCCCCceEEEEEEeccCCCCHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC--
Q psy1934           8 FIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS--   84 (150)
Q Consensus         8 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~--   84 (150)
                      .+...++++-.++.|||+|.+ |.++++++++. ..+++.+.++.+.+|++.++.+||+.+  ++|.|+||+||++-+  
T Consensus       153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSE  229 (415)
T ss_pred             EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccc
Confidence            355667888889999999998 66999999863 367889999999999999999999999  999999999999832  


Q ss_pred             ------------------CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccc
Q psy1934          85 ------------------AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWN  137 (150)
Q Consensus        85 ------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~  137 (150)
                                        .-.+++.|||.+...-               ....+.+.|..|+|||++         |+||
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~---------------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWS  294 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH---------------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWS  294 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceec---------------cCcceeeeccccCCchheeccCcCCccCcee
Confidence                              1236899999886421               112356789999999996         9999


Q ss_pred             cceeEEEeeeec
Q psy1934         138 NYVIGRSMLYGH  149 (150)
Q Consensus       138 ~g~~~~~~~~g~  149 (150)
                      .||++.|+..|.
T Consensus       295 iGCIL~ElytG~  306 (415)
T KOG0671|consen  295 IGCILVELYTGE  306 (415)
T ss_pred             eeeEEEEeeccc
Confidence            999999999884

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.87  E-value=7.1e-22  Score=138.55  Aligned_cols=136  Identities=21%  Similarity=0.251  Sum_probs=108.2

Q ss_pred             ccchhhhcccCCCCC--ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHG--MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|+++++..+....  ....++++||+++++|.+++......+++..+..++.+++.|+.++|+.+  ++|+|++|.||
T Consensus        63 l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni  140 (284)
T cd05038          63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNI  140 (284)
T ss_pred             CCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhE
Confidence            346788887776555  66899999999999999999876556889999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||.+.......... .        ......++..|++||..         |+|++|+++++|++|.
T Consensus       141 l~~~~~~~~l~dfg~~~~~~~~~~~~-~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~  209 (284)
T cd05038         141 LVESEDLVKISDFGLAKVLPEDKDYY-Y--------VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYG  209 (284)
T ss_pred             EEcCCCCEEEcccccccccccCCcce-e--------ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccC
Confidence            99999999999999887543111100 0        00011234568999963         9999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.87  E-value=1.1e-22  Score=142.86  Aligned_cols=135  Identities=19%  Similarity=0.263  Sum_probs=108.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---------------CCCCCHHHHHHHHHHHHHHHHHHhcCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHMHGQN   67 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~~~~~i~~~l~~lh~~~   67 (150)
                      +-|++|++..+..+..+..++++||+++++|.+++...               ...+++..+..++.|++.|+.|+|+++
T Consensus        65 l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g  144 (283)
T cd05091          65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH  144 (283)
T ss_pred             CCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC
Confidence            44789999999888889999999999999999998532               123677778889999999999999998


Q ss_pred             CCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccccc
Q psy1934          68 PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNN  138 (150)
Q Consensus        68 ~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~  138 (150)
                        ++|+|++|+||++..++.++++|||+++........          .......+++.|+|||++         |+||+
T Consensus       145 --i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  212 (283)
T cd05091         145 --VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY----------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY  212 (283)
T ss_pred             --ccccccchhheEecCCCceEecccccccccccchhe----------eeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence              999999999999999999999999987743211100          001122356789999984         99999


Q ss_pred             ceeEEEeee-ec
Q psy1934         139 YVIGRSMLY-GH  149 (150)
Q Consensus       139 g~~~~~~~~-g~  149 (150)
                      |+++++|+. |.
T Consensus       213 G~~l~el~~~g~  224 (283)
T cd05091         213 GVVLWEVFSYGL  224 (283)
T ss_pred             HHHHHHHHcCCC
Confidence            999999986 53

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.87  E-value=2.5e-22  Score=139.33  Aligned_cols=131  Identities=24%  Similarity=0.366  Sum_probs=112.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.++....+++++||+++++|.+++... ..+++..+..++.+++.|+.++|+.+  ++|+|++|+||++
T Consensus        57 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~  133 (258)
T cd05578          57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILL  133 (258)
T ss_pred             CCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEE
Confidence            34788999989999999999999999999999999765 47888999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+........             .....++..|++||++         |+|++|++++++++|.
T Consensus       134 ~~~~~~~l~d~~~~~~~~~~~~-------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  196 (258)
T cd05578         134 DEQGHVHITDFNIATKVTPDTL-------------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK  196 (258)
T ss_pred             cCCCCEEEeecccccccCCCcc-------------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCC
Confidence            9999999999998764322110             1123477789999974         9999999999999885

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.87  E-value=1.2e-22  Score=142.44  Aligned_cols=135  Identities=21%  Similarity=0.311  Sum_probs=105.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-|+++++..+.....+..+++|||+++++|.+++....      ..+++..+..++.+++.|+.|+|+++  ++|+|++
T Consensus        66 l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlk  143 (277)
T cd05036          66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIA  143 (277)
T ss_pred             CCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--Eeecccc
Confidence            446788888888888889999999999999999997642      24788888899999999999999998  9999999


Q ss_pred             CCCEEEcCCC---cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEE
Q psy1934          77 IENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRS  144 (150)
Q Consensus        77 ~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~  144 (150)
                      |+||+++..+   .++++|||+++.........          .......+..|+|||++         |+||+|+++++
T Consensus       144 p~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e  213 (277)
T cd05036         144 ARNCLLTCKGPGRVAKIADFGMARDIYRASYYR----------KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWE  213 (277)
T ss_pred             hheEEEeccCCCcceEeccCccccccCCcccee----------cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHH
Confidence            9999997654   68999999887532110000          00011234579999984         99999999999


Q ss_pred             eee-ec
Q psy1934         145 MLY-GH  149 (150)
Q Consensus       145 ~~~-g~  149 (150)
                      |+. |+
T Consensus       214 l~~~g~  219 (277)
T cd05036         214 IFSLGY  219 (277)
T ss_pred             HHcCCC
Confidence            885 64

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.4e-22  Score=141.96  Aligned_cols=129  Identities=26%  Similarity=0.438  Sum_probs=110.1

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      |+++++..+.+...+.++++|||+++++|.++++.  ..+++..+..++.+++.++.++|+.+  ++|+|++|+||+++.
T Consensus        61 ~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~  136 (277)
T cd06917          61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTN  136 (277)
T ss_pred             CCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcC
Confidence            68899988888888999999999999999999865  36888999999999999999999998  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||.+........            ......++..|+|||.          .|+|++|+++++|++|.
T Consensus       137 ~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~  199 (277)
T cd06917         137 TGNVKLCDFGVAALLNQNSS------------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN  199 (277)
T ss_pred             CCCEEEccCCceeecCCCcc------------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCC
Confidence            99999999998875432110            0112357888999996          39999999999999885

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.87  E-value=2.2e-22  Score=140.19  Aligned_cols=133  Identities=27%  Similarity=0.388  Sum_probs=110.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-|+++++..+.+...+.+++++||+++++|.++++..   ...+++..+..++.+++.|+.|+|+++  ++|+|++|+|
T Consensus        59 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~n  136 (267)
T cd08229          59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPAN  136 (267)
T ss_pred             ccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHH
Confidence            34788999999988889999999999999999988642   235788888999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      |+++.++.++++|||++.........            .....++..|+|||..         |+||+|+++++|++|.
T Consensus       137 ili~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~  203 (267)
T cd08229         137 VFITATGVVKLGDLGLGRFFSSKTTA------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ  203 (267)
T ss_pred             EEEcCCCCEEECcchhhhccccCCcc------------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCC
Confidence            99999999999999987643211100            0123578889999974         9999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.86  E-value=1.8e-22  Score=141.85  Aligned_cols=133  Identities=23%  Similarity=0.283  Sum_probs=105.0

Q ss_pred             cchhhhcccCCCC--CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           4 LSAAFIDKHSTPH--GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         4 ~~~~~~~~~~~~~--~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      -|+++++..+...  ..+.++++|||+++++|.+++..  ..+++..+..++.+++.|+.|+|+++  ++|+|++|+||+
T Consensus        64 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nil  139 (283)
T cd05080          64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVL  139 (283)
T ss_pred             CCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEE
Confidence            3677888776533  34568999999999999999975  35899999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++......... .        .......++..|++||+.         |+||+|+++++|++|.
T Consensus       140 i~~~~~~~l~dfg~~~~~~~~~~~-~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~  207 (283)
T cd05080         140 LDNDRLVKIGDFGLAKAVPEGHEY-Y--------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC  207 (283)
T ss_pred             EcCCCcEEEeecccccccCCcchh-h--------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence            999999999999988643211100 0        000112345679999974         9999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.86  E-value=1.4e-22  Score=142.14  Aligned_cols=131  Identities=25%  Similarity=0.389  Sum_probs=110.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++||||+++++|.+++..  ..+++..+..++.+++.|+.++|+.+  ++|+|++|+||++
T Consensus        59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~  134 (277)
T cd06640          59 CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLL  134 (277)
T ss_pred             CCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEE
Confidence            3478899999988989999999999999999999875  46888888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......++..|+|||+.         |+||+|+++++|++|.
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~  198 (277)
T cd06640         135 SEQGDVKLADFGVAGQLTDTQI------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE  198 (277)
T ss_pred             cCCCCEEEcccccceeccCCcc------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCC
Confidence            9999999999998865322110            01123467889999983         9999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.86  E-value=1.6e-22  Score=140.32  Aligned_cols=133  Identities=20%  Similarity=0.284  Sum_probs=105.4

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+..+. ..++++|||+++++|.+++... ..+++..+..++.|++.|+.++|+++  ++|+|++|.|++++
T Consensus        54 ~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~  129 (257)
T cd05116          54 DNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV  129 (257)
T ss_pred             CCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc
Confidence            46778887776554 5679999999999999999754 46888999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeee-ec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~-g~  149 (150)
                      .++.++++|||++..........         .......++..|+|||.         .|+||+|+++++++. |.
T Consensus       130 ~~~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~  196 (257)
T cd05116         130 TQHYAKISDFGLSKALGADENYY---------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQ  196 (257)
T ss_pred             CCCeEEECCCccccccCCCCCee---------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence            99999999999886532221100         00011234578999996         499999999999985 64

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.86  E-value=2.3e-22  Score=139.52  Aligned_cols=139  Identities=27%  Similarity=0.398  Sum_probs=112.4

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+..+..+.+|+++||+++++|.++++.. ..+++..+..++.|++.|+.++|+.+  ++|+|++++||+++
T Consensus        51 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~  127 (265)
T cd05579          51 QSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID  127 (265)
T ss_pred             CCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc
Confidence            3788999999999999999999999999999999865 36889999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++...........    ...........++..|++||+         .|+|++|+++++++.|.
T Consensus       128 ~~~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~  198 (265)
T cd05579         128 SNGHLKLTDFGLSKVGLVRRQINL----NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGI  198 (265)
T ss_pred             CCCCEEEEecccchhcccCccccc----ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence            999999999998775332211000    000001123356788999996         49999999999998875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=1.8e-22  Score=142.78  Aligned_cols=133  Identities=21%  Similarity=0.202  Sum_probs=106.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-----------SALPPNIVCSILWQTCQAVKHMHGQNPPIV   71 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~   71 (150)
                      +-|+++++..+.+...+..++||||+++++|.+++....           ..+++..+..++.+++.|+.|+|+.+  ++
T Consensus        74 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~  151 (295)
T cd05097          74 LKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FV  151 (295)
T ss_pred             CCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--ee
Confidence            457889999888888999999999999999999986532           12567788889999999999999998  99


Q ss_pred             EecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeE
Q psy1934          72 HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIG  142 (150)
Q Consensus        72 h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~  142 (150)
                      |+|++|+|++++.++.++++|||++.........          .......++..|+|||+         .|+||+|+++
T Consensus       152 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l  221 (295)
T cd05097         152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY----------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL  221 (295)
T ss_pred             ccccChhhEEEcCCCcEEecccccccccccCcce----------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHH
Confidence            9999999999999999999999988643211100          00012234668999997         4999999999


Q ss_pred             EEeee
Q psy1934         143 RSMLY  147 (150)
Q Consensus       143 ~~~~~  147 (150)
                      ++|++
T Consensus       222 ~el~~  226 (295)
T cd05097         222 WEMFT  226 (295)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG4257|consensus

Probab=99.86  E-value=5.5e-23  Score=153.19  Aligned_cols=131  Identities=25%  Similarity=0.342  Sum_probs=111.6

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ||-||+||++.+.... +-.|||||.++.|.|..+|+.....++......+++|++.++.|+|+.+  ++|||+...|||
T Consensus       447 nfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiL  523 (974)
T KOG4257|consen  447 NFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNIL  523 (974)
T ss_pred             hCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhhee
Confidence            6789999999999887 6899999999999999999987778998888899999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML  146 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~  146 (150)
                      +.++..+|++|||+++...+..-          +... ...-...|||||.+         |+|.+|+++||++
T Consensus       524 VsSp~CVKLaDFGLSR~~ed~~y----------YkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl  586 (974)
T KOG4257|consen  524 VSSPQCVKLADFGLSRYLEDDAY----------YKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEIL  586 (974)
T ss_pred             ecCcceeeecccchhhhccccch----------hhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHH
Confidence            99999999999999986533211          1111 01123469999996         9999999999976

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.86  E-value=3.3e-22  Score=139.10  Aligned_cols=132  Identities=27%  Similarity=0.391  Sum_probs=109.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      -|+++++..+.+...+.++++|||+++++|.+++...   ...+++..+..++.+++.|+.++|+.+  ++|+|++|+||
T Consensus        60 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni  137 (267)
T cd08224          60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANV  137 (267)
T ss_pred             CCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhE
Confidence            4678888888888889999999999999999998642   234788899999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++.........            .....++..|+|||++         |+|++|+++++++.|.
T Consensus       138 l~~~~~~~~l~d~~~~~~~~~~~~~------------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~  203 (267)
T cd08224         138 FITATGVVKLGDLGLGRFFSSKTTA------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ  203 (267)
T ss_pred             EECCCCcEEEeccceeeeccCCCcc------------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCC
Confidence            9999999999999987643211100            0123577889999974         9999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG1094|consensus

Probab=99.86  E-value=9.3e-24  Score=156.01  Aligned_cols=134  Identities=20%  Similarity=0.202  Sum_probs=109.8

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSAL-PPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l-~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      |+-||+|+++.+++-.+..+|+++||+++|+|.+++..+..+. ....-..++.||+.|+.||.+.+  ++|||+.+.|+
T Consensus       591 qLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNc  668 (807)
T KOG1094|consen  591 RLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNC  668 (807)
T ss_pred             ccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccce
Confidence            5678999999999999999999999999999999998875443 33344568899999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |++.+.++|++|||+++..... +         .+..+...+-..+|||+|.+         |+|++|+++||+++
T Consensus       669 Lv~~e~~iKiadfgmsR~lysg-~---------yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~  734 (807)
T KOG1094|consen  669 LVDGEFTIKIADFGMSRNLYSG-D---------YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFM  734 (807)
T ss_pred             eecCcccEEecCcccccccccC-C---------ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHH
Confidence            9999999999999999843211 1         01111123456789999986         99999999999864

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.86  E-value=2.4e-22  Score=139.23  Aligned_cols=134  Identities=18%  Similarity=0.312  Sum_probs=109.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+..+....+++++||+++++|.+++......+++..+..++.+++.++.++|+.+  ++|+|++|+|+++
T Consensus        56 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i  133 (256)
T cd05112          56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLV  133 (256)
T ss_pred             CCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEE
Confidence            34678888888888888999999999999999999865556888888999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||.+.........           ......++..|+|||+         .|+||+|+++++++. |.
T Consensus       134 ~~~~~~~l~d~g~~~~~~~~~~~-----------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~  199 (256)
T cd05112         134 GENQVVKVSDFGMTRFVLDDQYT-----------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK  199 (256)
T ss_pred             cCCCeEEECCCcceeecccCccc-----------ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence            99999999999988643211100           0011224567999997         499999999999886 54

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.86  E-value=2.3e-22  Score=139.61  Aligned_cols=133  Identities=24%  Similarity=0.304  Sum_probs=109.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-++++++..+.....+.++++|||+++++|.+++.... ..+++..+..++.+++.|+.|+|+++  ++|+|++++|++
T Consensus        59 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nil  136 (261)
T cd05148          59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNIL  136 (261)
T ss_pred             CCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEE
Confidence            347889999888888899999999999999999997643 45788899999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||.+........   .         .....++..|++||+.         |+|++|+++++++. |+
T Consensus       137 v~~~~~~kl~d~g~~~~~~~~~~---~---------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~  202 (261)
T cd05148         137 VGEDLVCKVADFGLARLIKEDVY---L---------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQ  202 (261)
T ss_pred             EcCCceEEEccccchhhcCCccc---c---------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            99999999999998864321100   0         0012345679999974         99999999999886 54

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.86  E-value=2.6e-22  Score=140.75  Aligned_cols=128  Identities=30%  Similarity=0.424  Sum_probs=106.2

Q ss_pred             chhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           5 SAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         5 ~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      |+++++..+.+...  +.+++|+||+++ ++.+.+......+++..+..++.+++.|+.++|+.+  ++|+|++|+||++
T Consensus        57 h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l  133 (282)
T cd07831          57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILI  133 (282)
T ss_pred             CCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEE
Confidence            67888888877766  889999999975 888888765456899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +. +.++++|||++.........             ....++..|+|||++          |+||+|+++++|+.|.
T Consensus       134 ~~-~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~  196 (282)
T cd07831         134 KD-DILKLADFGSCRGIYSKPPY-------------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF  196 (282)
T ss_pred             cC-CCeEEEecccccccccCCCc-------------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCC
Confidence            99 99999999988643211110             122467889999963          9999999999998874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.86  E-value=4.7e-22  Score=138.75  Aligned_cols=133  Identities=26%  Similarity=0.349  Sum_probs=108.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSAL--PPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|+++++..+.....+.+++++||+++++|.+++......+  ++..+..++.|++.|+.|+|+.+  ++|+|++|.||
T Consensus        62 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~ni  139 (268)
T cd06624          62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNV  139 (268)
T ss_pred             cCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHE
Confidence            347889999998888899999999999999999998653445  77788888999999999999998  99999999999


Q ss_pred             EEcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeee
Q psy1934          81 LISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        81 l~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g  148 (150)
                      +++. .+.++++|||.+.........            .....+++.|+|||++           |+||+|+++++++.|
T Consensus       140 l~~~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g  207 (268)
T cd06624         140 LVNTYSGVVKISDFGTSKRLAGINPC------------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG  207 (268)
T ss_pred             EEcCCCCeEEEecchhheecccCCCc------------cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC
Confidence            9976 578999999987643211100            0122467889999963           999999999999887


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       208 ~  208 (268)
T cd06624         208 K  208 (268)
T ss_pred             C
Confidence            5

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.86  E-value=2.7e-22  Score=139.72  Aligned_cols=131  Identities=24%  Similarity=0.291  Sum_probs=104.5

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      |+++++..+..+. +..+++|||+++++|.+++.... ..+++..+..++.+++.|+.++|+.+  ++|+|++|+||+++
T Consensus        60 ~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~  136 (262)
T cd05071          60 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG  136 (262)
T ss_pred             CCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc
Confidence            6778877665543 56899999999999999997643 35788889999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      .++.++++|||.+..........           .....++..|++||+.         |+||+|++++++++ |+
T Consensus       137 ~~~~~~L~dfg~~~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~  201 (262)
T cd05071         137 ENLVCKVADFGLARLIEDNEYTA-----------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR  201 (262)
T ss_pred             CCCcEEeccCCceeecccccccc-----------ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            99999999999886432111000           0112356679999973         99999999999987 54

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.86  E-value=2.5e-22  Score=141.10  Aligned_cols=132  Identities=32%  Similarity=0.523  Sum_probs=109.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.++..+.+++++||++++.+..+... ...+++..+..++.|++.++.|+|+.+  ++|+|++|+||++
T Consensus        57 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~  133 (286)
T cd07847          57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILI  133 (286)
T ss_pred             CCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEE
Confidence            3478899999989988999999999999888777654 346889999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......++..|++||++          |+||+|+++++|++|.
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~  198 (286)
T cd07847         134 TKQGQIKLCDFGFARILTGPGD------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ  198 (286)
T ss_pred             cCCCcEEECccccceecCCCcc------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence            9999999999998875322110            00122467789999973          9999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG1152|consensus

Probab=99.86  E-value=7.7e-22  Score=145.76  Aligned_cols=128  Identities=30%  Similarity=0.401  Sum_probs=111.2

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccC-CCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCT-GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~-~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      =|+||+++.+-+++.+.|||+||... |-+|++++..+ ..+++.+.+.++.|+..|+.+||+.+  |+|||+|-+|+++
T Consensus       627 sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenviv  703 (772)
T KOG1152|consen  627 SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIV  703 (772)
T ss_pred             CccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC--ceecccccccEEE
Confidence            37999999999999999999999876 45999999765 46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g  148 (150)
                      +.+|.+|+.|||.+......+              .-..+||..|-|||++          |+|++|+++|.+.|.
T Consensus       704 d~~g~~klidfgsaa~~ksgp--------------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyk  765 (772)
T KOG1152|consen  704 DSNGFVKLIDFGSAAYTKSGP--------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYK  765 (772)
T ss_pred             ecCCeEEEeeccchhhhcCCC--------------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEec
Confidence            999999999999875432111              1145799999999996          999999999988764

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.86  E-value=2e-22  Score=141.44  Aligned_cols=129  Identities=26%  Similarity=0.361  Sum_probs=106.7

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCCCE
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIENL   80 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~ni   80 (150)
                      ||++++..+.....+.+++++||+++ +|.+++...   ...+++..+..++.|++.|+.|+|++ +  ++|+|++|+||
T Consensus        59 ~~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~ni  135 (283)
T cd06617          59 CPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNV  135 (283)
T ss_pred             CCCeeeeeEEEecCCcEEEEhhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHE
Confidence            57889988888888999999999974 888887642   23588999999999999999999986 7  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-------------cccccceeEEEeee
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-------------DTWNNYVIGRSMLY  147 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------d~~~~g~~~~~~~~  147 (150)
                      +++.++.++++|||.+.......             ......++..|+|||++             |+|++|+++++|++
T Consensus       136 l~~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~  202 (283)
T cd06617         136 LINRNGQVKLCDFGISGYLVDSV-------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT  202 (283)
T ss_pred             EECCCCCEEEeeccccccccccc-------------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHh
Confidence            99999999999999876432110             01123577889999963             99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       203 g~  204 (283)
T cd06617         203 GR  204 (283)
T ss_pred             CC
Confidence            85

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.86  E-value=3e-22  Score=139.64  Aligned_cols=135  Identities=24%  Similarity=0.334  Sum_probs=108.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||++++..+.+......++++||+++++|.+++....      ..+++..+..++.+++.|+.|+|+.+  ++|+|++
T Consensus        56 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~  133 (269)
T cd05044          56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLA  133 (269)
T ss_pred             cCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence            347889999998888889999999999999999997521      23678888899999999999999998  9999999


Q ss_pred             CCCEEEcCCC-----cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeE
Q psy1934          77 IENLLISSAG-----TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIG  142 (150)
Q Consensus        77 ~~nil~~~~~-----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~  142 (150)
                      |+||+++...     .++++|||++.........          .......++..|+|||++         |+||+|+++
T Consensus       134 p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il  203 (269)
T cd05044         134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY----------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLM  203 (269)
T ss_pred             hheEEEecCCCCCCcceEECCccccccccccccc----------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHH
Confidence            9999998877     8999999988643211000          000122356789999974         999999999


Q ss_pred             EEeee-ec
Q psy1934         143 RSMLY-GH  149 (150)
Q Consensus       143 ~~~~~-g~  149 (150)
                      ++|+. |+
T Consensus       204 ~ellt~g~  211 (269)
T cd05044         204 WEILTLGQ  211 (269)
T ss_pred             HHHHHcCC
Confidence            99985 64

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.86  E-value=3e-22  Score=144.01  Aligned_cols=131  Identities=21%  Similarity=0.307  Sum_probs=105.8

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      |++|++..+.+...+.+++++||+++|+|.+++....               ..++...+..++.|++.|+.|+|+++  
T Consensus        77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--  154 (334)
T cd05100          77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--  154 (334)
T ss_pred             CCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            7889999998888899999999999999999997531               23667778889999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|+|++|+||+++.++.++++|||+++........          .......++..|+|||++         |+||+|+
T Consensus       155 ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  224 (334)
T cd05100         155 CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY----------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV  224 (334)
T ss_pred             eeccccccceEEEcCCCcEEECCcccceeccccccc----------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHH
Confidence            999999999999999999999999988643211000          000112234679999974         9999999


Q ss_pred             eEEEeee
Q psy1934         141 IGRSMLY  147 (150)
Q Consensus       141 ~~~~~~~  147 (150)
                      ++++|+.
T Consensus       225 il~el~~  231 (334)
T cd05100         225 LLWEIFT  231 (334)
T ss_pred             HHHHHHh
Confidence            9999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.86  E-value=2.1e-22  Score=142.28  Aligned_cols=133  Identities=20%  Similarity=0.168  Sum_probs=107.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT----------SALPPNIVCSILWQTCQAVKHMHGQNPPIVH   72 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h   72 (150)
                      +-|+++++..+.+...+.+++++||+++++|.+++....          ..+++..+..++.+++.|+.|+|+++  ++|
T Consensus        76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H  153 (296)
T cd05051          76 LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVH  153 (296)
T ss_pred             cCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccc
Confidence            346788888888888889999999999999999997643          15788889999999999999999998  999


Q ss_pred             ecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEE
Q psy1934          73 RDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGR  143 (150)
Q Consensus        73 ~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~  143 (150)
                      +|++|+||+++..+.++++|||++..........          ......+++.|+|||+         .|+||+|++++
T Consensus       154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~  223 (296)
T cd05051         154 RDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR----------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW  223 (296)
T ss_pred             cccchhceeecCCCceEEccccceeecccCccee----------ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHH
Confidence            9999999999999999999999886432111000          0012245678999997         39999999999


Q ss_pred             Eeee
Q psy1934         144 SMLY  147 (150)
Q Consensus       144 ~~~~  147 (150)
                      ++++
T Consensus       224 el~~  227 (296)
T cd05051         224 EILT  227 (296)
T ss_pred             HHHh
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.86  E-value=1.7e-22  Score=142.70  Aligned_cols=132  Identities=27%  Similarity=0.400  Sum_probs=108.8

Q ss_pred             ccchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-||++++..+.....  +.+++++||+++ +|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||
T Consensus        61 l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~ni  137 (293)
T cd07843          61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNL  137 (293)
T ss_pred             cCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHE
Confidence            4578888887766555  899999999975 999998765556899999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++.........            .....+++.|+|||.+          |+||+|+++++|+.|.
T Consensus       138 li~~~~~~~l~d~g~~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  204 (293)
T cd07843         138 LLNNRGILKICDFGLAREYGSPLKP------------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK  204 (293)
T ss_pred             EECCCCcEEEeecCceeeccCCccc------------cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence            9999999999999988754321110            0123467889999973          9999999999998875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2e-22  Score=140.56  Aligned_cols=131  Identities=25%  Similarity=0.409  Sum_probs=107.0

Q ss_pred             chhhhcccCCCCC------ceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           5 SAAFIDKHSTPHG------MHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         5 ~~~~~~~~~~~~~------~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      |+++++..+.+..      ...+++++||+++++|.+++...   ...+++..+..++.|++.|+.|+|+.+  ++|+|+
T Consensus        62 h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l  139 (275)
T cd06608          62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDI  139 (275)
T ss_pred             CCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCC
Confidence            6788887776533      45689999999999999988653   246888899999999999999999998  999999


Q ss_pred             CCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc--------------cccccccee
Q psy1934          76 KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------------VDTWNNYVI  141 (150)
Q Consensus        76 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~--------------~d~~~~g~~  141 (150)
                      +|+||+++.++.++++|||++.......            .......++..|+|||+              .|+|++|++
T Consensus       140 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i  207 (275)
T cd06608         140 KGQNILLTKNAEVKLVDFGVSAQLDSTL------------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT  207 (275)
T ss_pred             CHHHEEEccCCeEEECCCccceecccch------------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHH
Confidence            9999999999999999999876432110            01123457888999996              399999999


Q ss_pred             EEEeeeec
Q psy1934         142 GRSMLYGH  149 (150)
Q Consensus       142 ~~~~~~g~  149 (150)
                      +++++.|+
T Consensus       208 l~~l~~g~  215 (275)
T cd06608         208 AIELADGK  215 (275)
T ss_pred             HHHHHhCC
Confidence            99999886

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.2e-22  Score=140.83  Aligned_cols=130  Identities=28%  Similarity=0.439  Sum_probs=111.4

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.+.....+++|+||+++++|.+++...  .+++..+..++.|++.++.++|+.+  ++|+|++|+|++++
T Consensus        57 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~  132 (274)
T cd06609          57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS  132 (274)
T ss_pred             CCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC
Confidence            3788999888888889999999999999999999763  6889999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||.+........            ......++..|++||++         |+|++|++++++++|.
T Consensus       133 ~~~~~~l~d~g~~~~~~~~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~  195 (274)
T cd06609         133 EEGDVKLADFGVSGQLTSTMS------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE  195 (274)
T ss_pred             CCCCEEEcccccceeeccccc------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999998875432110            11133577889999974         9999999999999886

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.86  E-value=1.8e-22  Score=143.08  Aligned_cols=130  Identities=27%  Similarity=0.479  Sum_probs=109.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.+...+.+++|+||+++++|.+++.+  ..+++..+..++.+++.++.++|+.+  ++|+|++|+||+++
T Consensus        74 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~  149 (297)
T cd06656          74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG  149 (297)
T ss_pred             CCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC
Confidence            478899998888888999999999999999999865  35788888899999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.........            .....+++.|++||.+         |+|++|+++++++.|.
T Consensus       150 ~~~~~~l~Dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~  212 (297)
T cd06656         150 MDGSVKLTDFGFCAQITPEQSK------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE  212 (297)
T ss_pred             CCCCEEECcCccceEccCCccC------------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999987643211100            0123577889999974         9999999999998875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.86  E-value=1.9e-22  Score=142.32  Aligned_cols=135  Identities=22%  Similarity=0.291  Sum_probs=108.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-----------------------CCCCHHHHHHHHHHHHHH
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-----------------------SALPPNIVCSILWQTCQA   59 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~~~~~i~~~   59 (150)
                      +-||++++..+.++..+..++++||+++++|.+++....                       ..+++..+..++.+++.|
T Consensus        60 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~  139 (290)
T cd05045          60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRG  139 (290)
T ss_pred             CCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHH
Confidence            457889998888888899999999999999999986421                       236778888999999999


Q ss_pred             HHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------
Q psy1934          60 VKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------  133 (150)
Q Consensus        60 l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------  133 (150)
                      +.++|+.+  ++|+|++|+||+++.++.++++|||+++........          .......++..|++||++      
T Consensus       140 l~~LH~~~--ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~apE~~~~~~~~  207 (290)
T cd05045         140 MQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY----------VKRSKGRIPVKWMAIESLFDHIYT  207 (290)
T ss_pred             HHHHHHCC--eehhhhhhheEEEcCCCcEEeccccccccccCccch----------hcccCCCCCccccCHHHHccCCcc
Confidence            99999998  999999999999999999999999998643221110          001112345679999973      


Q ss_pred             ---cccccceeEEEeee-ec
Q psy1934         134 ---DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus       134 ---d~~~~g~~~~~~~~-g~  149 (150)
                         |+||+|+++++|+. |.
T Consensus       208 ~~~Di~slG~~l~el~t~g~  227 (290)
T cd05045         208 TQSDVWSFGVLLWEIVTLGG  227 (290)
T ss_pred             hHhHHHHHHHHHHHHHhcCC
Confidence               99999999999986 64

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.86  E-value=3.6e-22  Score=140.27  Aligned_cols=131  Identities=24%  Similarity=0.418  Sum_probs=106.2

Q ss_pred             chhhhcccCCCC------CceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           5 SAAFIDKHSTPH------GMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         5 ~~~~~~~~~~~~------~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      |+++++..+.+.      ..+.+|++|||+++|+|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|+++
T Consensus        72 h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~  149 (282)
T cd06636          72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKG  149 (282)
T ss_pred             CCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence            677887776653      3568899999999999999997643 44788888889999999999999998  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc--------------ccccccceeEE
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------------VDTWNNYVIGR  143 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~--------------~d~~~~g~~~~  143 (150)
                      +||+++.++.++++|||++........            ......+++.|+|||+              .|+||+|++++
T Consensus       150 ~nili~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~  217 (282)
T cd06636         150 QNVLLTENAEVKLVDFGVSAQLDRTVG------------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAI  217 (282)
T ss_pred             HHEEECCCCCEEEeeCcchhhhhcccc------------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHH
Confidence            999999999999999998764311100            0112357889999996              39999999999


Q ss_pred             Eeeeec
Q psy1934         144 SMLYGH  149 (150)
Q Consensus       144 ~~~~g~  149 (150)
                      +++.|.
T Consensus       218 el~~g~  223 (282)
T cd06636         218 EMAEGA  223 (282)
T ss_pred             HHHhCC
Confidence            999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0669|consensus

Probab=99.86  E-value=3.8e-23  Score=139.81  Aligned_cols=122  Identities=25%  Similarity=0.420  Sum_probs=101.8

Q ss_pred             CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCce
Q psy1934          17 GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA   96 (150)
Q Consensus        17 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~   96 (150)
                      ...++|+|+.+|+. +|+.+|.+....++..+++.++.++..|+.|+|...  |+|||+|+.|++++.++.++++|||++
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccc
Confidence            45679999999988 999999876567899999999999999999999999  999999999999999999999999999


Q ss_pred             eccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          97 TEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +........        ...+-++++.|++|++||.+          |+|..||++.+|+.|.
T Consensus       172 r~fs~~~n~--------~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrs  226 (376)
T KOG0669|consen  172 RAFSTSKNV--------VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRS  226 (376)
T ss_pred             cceeccccc--------CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccC
Confidence            743221111        00112356779999999984          9999999999998764

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.86  E-value=2.1e-22  Score=141.96  Aligned_cols=132  Identities=18%  Similarity=0.218  Sum_probs=104.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEec
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD   74 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~   74 (150)
                      -|+++++..+.....+..+++|||+++|+|.++++...         ...+...+..++.+++.|+.|+|+++  ++|+|
T Consensus        67 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~d  144 (288)
T cd05061          67 TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRD  144 (288)
T ss_pred             CCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCC
Confidence            46788888888888889999999999999999997532         12345667788999999999999998  99999


Q ss_pred             CCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEe
Q psy1934          75 LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSM  145 (150)
Q Consensus        75 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~  145 (150)
                      ++|+||+++.++.++++|||+++........          .......++..|++||..         |+||+|+++++|
T Consensus       145 ikp~nili~~~~~~~L~Dfg~~~~~~~~~~~----------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el  214 (288)
T cd05061         145 LAARNCMVAHDFTVKIGDFGMTRDIYETDYY----------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI  214 (288)
T ss_pred             CChheEEEcCCCcEEECcCCccccccccccc----------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence            9999999999999999999988643211100          001112345679999984         999999999998


Q ss_pred             ee
Q psy1934         146 LY  147 (150)
Q Consensus       146 ~~  147 (150)
                      ++
T Consensus       215 ~~  216 (288)
T cd05061         215 TS  216 (288)
T ss_pred             Hh
Confidence            76

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.86  E-value=4.4e-22  Score=139.02  Aligned_cols=132  Identities=23%  Similarity=0.256  Sum_probs=106.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+..+. +..+++|||+++++|.+++......+++..+..++.+++.|+.++|+++  ++|+|++|+|++++
T Consensus        65 ~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~  141 (270)
T cd05056          65 DHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS  141 (270)
T ss_pred             CCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe
Confidence            46888988887765 5678999999999999999865556889999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ..+.+++.|||++........  .         ......++..|+|||++         |+||+|++++++++ |+
T Consensus       142 ~~~~~~l~d~g~~~~~~~~~~--~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~  206 (270)
T cd05056         142 SPDCVKLGDFGLSRYLEDESY--Y---------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGV  206 (270)
T ss_pred             cCCCeEEccCceeeecccccc--e---------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCC
Confidence            999999999998864321100  0         00011234579999974         99999999999774 64

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.86  E-value=6.7e-22  Score=136.95  Aligned_cols=133  Identities=26%  Similarity=0.444  Sum_probs=111.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.++..+.+++|+||+++++|.+.+.... ..+++..+..++.+++.|+.++|+++  ++|+|++++|++
T Consensus        56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil  133 (256)
T cd08218          56 MKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIF  133 (256)
T ss_pred             CCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEE
Confidence            346889999999999999999999999999999987643 35788888999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||.+........            ......+++.|+|||+.         |+|++|+++++++.|.
T Consensus       134 ~~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~  198 (256)
T cd08218         134 LTKDGTIKLGDFGIARVLNSTVE------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK  198 (256)
T ss_pred             EcCCCCEEEeeccceeecCcchh------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCC
Confidence            99999999999998864321100            01123578889999983         9999999999998885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.86  E-value=2.8e-22  Score=147.49  Aligned_cols=131  Identities=26%  Similarity=0.405  Sum_probs=105.9

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-------------------------------------------
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-------------------------------------------   41 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------------------------------------   41 (150)
                      |++++++.+.....+.+++|+||+++|+|.+++....                                           
T Consensus       100 H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (401)
T cd05107         100 HLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYM  179 (401)
T ss_pred             CCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccc
Confidence            7899999998888899999999999999999996421                                           


Q ss_pred             ------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCC
Q psy1934          42 ------------------------------------------------------SALPPNIVCSILWQTCQAVKHMHGQN   67 (150)
Q Consensus        42 ------------------------------------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~   67 (150)
                                                                            ..+++..+..++.+++.|+.|+|+.+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  259 (401)
T cd05107         180 DMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN  259 (401)
T ss_pred             ccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence                                                                  12455667788899999999999988


Q ss_pred             CCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccccc
Q psy1934          68 PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNN  138 (150)
Q Consensus        68 ~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~  138 (150)
                        ++|+|++|+||+++..+.++++|||++.........          .......++..|++||++         |+|++
T Consensus       260 --ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  327 (401)
T cd05107         260 --CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY----------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF  327 (401)
T ss_pred             --cCcccCCcceEEEeCCCEEEEEecCcceeccccccc----------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHH
Confidence              999999999999999999999999998743221110          001123467789999974         99999


Q ss_pred             ceeEEEeee
Q psy1934         139 YVIGRSMLY  147 (150)
Q Consensus       139 g~~~~~~~~  147 (150)
                      |++++||+.
T Consensus       328 Gvil~e~l~  336 (401)
T cd05107         328 GILLWEIFT  336 (401)
T ss_pred             HHHHHHHHH
Confidence            999999885

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.86  E-value=3.6e-22  Score=140.33  Aligned_cols=132  Identities=30%  Similarity=0.446  Sum_probs=109.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++|+||++++++.++.... ..+++..+..++.+++.++.|+|+.+  ++|+|++|+|+++
T Consensus        57 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~  133 (286)
T cd07846          57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILV  133 (286)
T ss_pred             cCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE
Confidence            34788999999999999999999999998888766543 45889999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........ .           .....++..|+|||+          .|+||+|++++++++|.
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~~-~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~  198 (286)
T cd07846         134 SQSGVVKLCDFGFARTLAAPGE-V-----------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE  198 (286)
T ss_pred             CCCCcEEEEeeeeeeeccCCcc-c-----------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCC
Confidence            9999999999998864321110 0           012346788999996          39999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.86  E-value=3.8e-22  Score=137.86  Aligned_cols=133  Identities=20%  Similarity=0.334  Sum_probs=107.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.....+..++++||+++++|.+++......++...+..++.+++.++.++|+++  ++|+|++|+||++
T Consensus        49 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili  126 (251)
T cd05041          49 YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLV  126 (251)
T ss_pred             CCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEE
Confidence            44678888888888889999999999999999999765556788888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      +.++.++++|||++..........          .......+..|+|||++         |+|++|+++++|++
T Consensus       127 ~~~~~~~l~d~g~~~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t  190 (251)
T cd05041         127 GENNVLKISDFGMSREEEGGIYTV----------SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS  190 (251)
T ss_pred             cCCCcEEEeeccccccccCCccee----------ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence            999999999999886432111000          00011234569999974         99999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.86  E-value=4.7e-22  Score=141.41  Aligned_cols=128  Identities=27%  Similarity=0.409  Sum_probs=108.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+..++|+||+++ ++.+.+......+++..+..++.|++.|+.|+|+.+  ++|+|++|.||++
T Consensus        72 l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~  148 (307)
T cd06607          72 LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILL  148 (307)
T ss_pred             CCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE
Confidence            3478899988888888999999999975 888877655556899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++......                ....++..|+|||++            |+|++|++++++++|.
T Consensus       149 ~~~~~~kL~dfg~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~  211 (307)
T cd06607         149 TEPGTVKLADFGSASLVSPA----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  211 (307)
T ss_pred             CCCCCEEEeecCcceecCCC----------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCC
Confidence            99999999999987643211                123467889999963            9999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.86  E-value=3.9e-22  Score=140.53  Aligned_cols=130  Identities=25%  Similarity=0.456  Sum_probs=109.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.....+..++++||+++++|.+++..  ..+++..+..++.+++.++.++|+.+  ++|+|++|+||+++
T Consensus        74 ~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~  149 (285)
T cd06648          74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT  149 (285)
T ss_pred             CCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc
Confidence            468888888888888999999999999999999876  46888888999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........            ......+++.|++||+.         |+|++|+++++++.|.
T Consensus       150 ~~~~~~l~d~g~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~  212 (285)
T cd06648         150 SDGRVKLSDFGFCAQVSKEVP------------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE  212 (285)
T ss_pred             CCCcEEEcccccchhhccCCc------------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCC
Confidence            999999999997753221100            01123578899999984         9999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.86  E-value=2.5e-22  Score=140.50  Aligned_cols=132  Identities=20%  Similarity=0.217  Sum_probs=107.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEec
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD   74 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~   74 (150)
                      +-|+++++..+.....+..++||||+++++|.+++....        ..+++..+..++.+++.++.|+|+.+  ++|+|
T Consensus        65 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~d  142 (275)
T cd05046          65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRD  142 (275)
T ss_pred             cCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCc
Confidence            347888998888888889999999999999999997543        15788999999999999999999998  99999


Q ss_pred             CCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEe
Q psy1934          75 LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSM  145 (150)
Q Consensus        75 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~  145 (150)
                      ++|+|++++.++.++++|||++........           .......++..|++||.+         |+||+|++++++
T Consensus       143 lkp~Nili~~~~~~~l~~~~~~~~~~~~~~-----------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  211 (275)
T cd05046         143 LAARNCLVSSQREVKVSLLSLSKDVYNSEY-----------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV  211 (275)
T ss_pred             CccceEEEeCCCcEEEcccccccccCcccc-----------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHH
Confidence            999999999999999999998763321100           001122456679999974         999999999998


Q ss_pred             ee
Q psy1934         146 LY  147 (150)
Q Consensus       146 ~~  147 (150)
                      ++
T Consensus       212 ~~  213 (275)
T cd05046         212 FT  213 (275)
T ss_pred             Hh
Confidence            76

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=6.2e-22  Score=138.31  Aligned_cols=133  Identities=26%  Similarity=0.368  Sum_probs=110.3

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.....+.+++|+||+++++|.+++... ..+++..+..++.+++.|+.++|+.+  ++|+|++++||+++
T Consensus        66 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~  142 (272)
T cd06629          66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD  142 (272)
T ss_pred             CCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc
Confidence            3678888888889999999999999999999999765 56888888889999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-----------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-----------~d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++..........          ......++..|++||+           .|+||+|+++++++.|.
T Consensus       143 ~~~~~~l~d~~~~~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  209 (272)
T cd06629         143 ADGICKISDFGISKKSDDIYDND----------QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR  209 (272)
T ss_pred             CCCeEEEeecccccccccccccc----------ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCC
Confidence            99999999999886432111000          0112347788999996           39999999999998875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.86  E-value=4.8e-22  Score=137.93  Aligned_cols=133  Identities=23%  Similarity=0.309  Sum_probs=105.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+..+. +.+++++||+++++|.+++.... .+++..+..++.|++.++.++|.++  ++|+|++|+|++++
T Consensus        54 ~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~  129 (257)
T cd05060          54 DHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV  129 (257)
T ss_pred             CCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc
Confidence            46788888776654 57899999999999999997653 6888999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeee-ec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~-g~  149 (150)
                      .++.++++|||.+..........         .......++..|+|||.         .|+||+|+++++++. |.
T Consensus       130 ~~~~~kl~df~~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~  196 (257)
T cd05060         130 NRHQAKISDFGMSRALGAGSDYY---------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGA  196 (257)
T ss_pred             CCCcEEeccccccceeecCCccc---------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCC
Confidence            99999999999887542221100         00011123457999997         499999999999985 54

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.86  E-value=6.3e-22  Score=137.67  Aligned_cols=130  Identities=30%  Similarity=0.407  Sum_probs=110.9

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil~   82 (150)
                      .|+++++..+.+...+.+++++||+++++|.+++......+++..+..++.+++.++.++|+ .+  ++|+|++++||++
T Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~  134 (265)
T cd06605          57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILV  134 (265)
T ss_pred             CCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEE
Confidence            47889998888888899999999999999999998754678888888999999999999999 88  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+++.|||.+......              ......++..|++||.         .|+|++|++++++++|.
T Consensus       135 ~~~~~~~l~d~g~~~~~~~~--------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~  196 (265)
T cd06605         135 NSRGQIKLCDFGVSGQLVNS--------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR  196 (265)
T ss_pred             CCCCCEEEeecccchhhHHH--------------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999987532100              0011457788999998         39999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.86  E-value=8.8e-22  Score=136.20  Aligned_cols=131  Identities=25%  Similarity=0.372  Sum_probs=108.9

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+.....+.+++|+||+++++|.+++.... ..+++..+..++.+++.++.++|+++  ++|+|++|.||++
T Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~  134 (256)
T cd08220          57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILL  134 (256)
T ss_pred             CCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence            47889998888888899999999999999999997643 35888899999999999999999998  9999999999999


Q ss_pred             cCC-CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.. +.++++|||++........             .....++..|+|||.+         |+||+|+++++++.|.
T Consensus       135 ~~~~~~~~l~d~~~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~  198 (256)
T cd08220         135 DKHKMVVKIGDFGISKILSSKSK-------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLK  198 (256)
T ss_pred             cCCCCEEEEccCCCceecCCCcc-------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCC
Confidence            765 4689999998875421110             0123577889999973         9999999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.86  E-value=3.8e-22  Score=141.74  Aligned_cols=132  Identities=20%  Similarity=0.251  Sum_probs=105.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.... ...++++||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        66 l~h~niv~~~~~~~~-~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill  142 (303)
T cd05110          66 MDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLV  142 (303)
T ss_pred             CCCCCcccEEEEEcC-CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeee
Confidence            347888888876655 3467999999999999999876556888888999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      +.++.++++|||++.........          .......++..|++||++         |+||+|+++++++.
T Consensus       143 ~~~~~~kL~Dfg~~~~~~~~~~~----------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t  206 (303)
T cd05110         143 KSPNHVKITDFGLARLLEGDEKE----------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT  206 (303)
T ss_pred             cCCCceEEccccccccccCcccc----------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence            99999999999998753211110          000112346689999974         99999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.85  E-value=7.4e-22  Score=137.77  Aligned_cols=131  Identities=16%  Similarity=0.177  Sum_probs=101.9

Q ss_pred             chhhhcccCCCCCce------EEEEEEeccCCCCHHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q psy1934           5 SAAFIDKHSTPHGMH------EYLILTELCTGGSLVDVLKERT-----SALPPNIVCSILWQTCQAVKHMHGQNPPIVHR   73 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~   73 (150)
                      |+++++..+......      ..++++||+++|+|.+++....     ..+++..+..++.|++.|+.|+|+.+  ++|+
T Consensus        60 h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~  137 (273)
T cd05035          60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHR  137 (273)
T ss_pred             CCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eecc
Confidence            677777766443333      4799999999999999985431     35788888999999999999999998  9999


Q ss_pred             cCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEE
Q psy1934          74 DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRS  144 (150)
Q Consensus        74 ~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~  144 (150)
                      |++|+||+++.++.++++|||+++.........          .......+..|++||+         .|+||+|++++|
T Consensus       138 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~e  207 (273)
T cd05035         138 DLAARNCMLREDMTVCVADFGLSKKIYSGDYYR----------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE  207 (273)
T ss_pred             ccchheEEECCCCeEEECCccceeecccccccc----------ccccccCCccccCHhhcccCCCCcccchHHHHHHHHH
Confidence            999999999999999999999987543221100          0001124567999997         499999999999


Q ss_pred             eee
Q psy1934         145 MLY  147 (150)
Q Consensus       145 ~~~  147 (150)
                      |+.
T Consensus       208 l~~  210 (273)
T cd05035         208 IAT  210 (273)
T ss_pred             HHh
Confidence            987

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.85  E-value=7.2e-22  Score=141.13  Aligned_cols=128  Identities=27%  Similarity=0.420  Sum_probs=108.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.....+..++|+||+++ ++.+.+......+++..+..++.+++.|+.++|+++  ++|+|++|.||++
T Consensus        82 l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~  158 (317)
T cd06635          82 IKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILL  158 (317)
T ss_pred             CCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEE
Confidence            4478899998888888899999999975 888888765567899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++......                ....+++.|+|||++            |+|++|+++++|++|.
T Consensus       159 ~~~~~~kl~dfg~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~  221 (317)
T cd06635         159 TEPGQVKLADFGSASIASPA----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  221 (317)
T ss_pred             CCCCCEEEecCCCccccCCc----------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCC
Confidence            99999999999987532110                123577889999974            9999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.85  E-value=3.2e-22  Score=143.59  Aligned_cols=140  Identities=16%  Similarity=0.247  Sum_probs=109.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|++|++..+.++.++.+++++||++++++.+++.+.. ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus        56 l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nil  133 (328)
T cd08226          56 FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHIL  133 (328)
T ss_pred             CCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence            458999999999999999999999999999999987643 35888888899999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.+++.||+.+............     .........++..|++||++           |+||+|+++++++.|.
T Consensus       134 l~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~  207 (328)
T cd08226         134 ISGDGLVSLSGLSHLYSLVRNGQKAKV-----VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR  207 (328)
T ss_pred             EeCCCcEEEechHHHhhhhccCccccc-----cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999998754322111100000     00000112345679999974           9999999999998875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.85  E-value=9.2e-22  Score=138.63  Aligned_cols=131  Identities=27%  Similarity=0.405  Sum_probs=109.1

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      |+++++..+.++....+++||||+++++|.+.+... ..+++..+..++.|++.++.++|+.+  ++|+|++|.||+++.
T Consensus        64 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~  140 (288)
T cd05583          64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDS  140 (288)
T ss_pred             CcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECC
Confidence            678888888888889999999999999999998753 46888888889999999999999988  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++.........           ......++..|++||.+           |+|++|+++++|++|.
T Consensus       141 ~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~  205 (288)
T cd05583         141 EGHVVLTDFGLSKEFLAEEEE-----------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA  205 (288)
T ss_pred             CCCEEEEECcccccccccccc-----------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCC
Confidence            999999999987643221110           01123477889999963           9999999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=6.9e-22  Score=136.98  Aligned_cols=129  Identities=25%  Similarity=0.360  Sum_probs=107.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+.....+..++||||+++++|.++++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        58 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili  135 (256)
T cd05039          58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLV  135 (256)
T ss_pred             CCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEE
Confidence            46788888888888899999999999999999997653 25889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.+++.|||.+.......               .....+..|+|||++         |+||+|+++++++. |.
T Consensus       136 ~~~~~~~l~d~g~~~~~~~~~---------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~  197 (256)
T cd05039         136 SEDLVAKVSDFGLAKEASQGQ---------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR  197 (256)
T ss_pred             eCCCCEEEccccccccccccc---------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCC
Confidence            999999999999887531110               011234569999974         99999999999874 54

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.85  E-value=8.4e-22  Score=150.10  Aligned_cols=121  Identities=25%  Similarity=0.384  Sum_probs=93.3

Q ss_pred             CCceEEEEEEeccCCCCHHHHHHhhCCCC-------------------CHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934          16 HGMHEYLILTELCTGGSLVDVLKERTSAL-------------------PPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus        16 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l-------------------~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      .....+++|+||+++++|.+++.......                   ....+..++.|++.|+.|+|+++  |+|||+|
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLK  282 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVK  282 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCC
Confidence            55678999999999999999987532111                   12335578899999999999998  9999999


Q ss_pred             CCCEEEcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------------------
Q psy1934          77 IENLLISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------------------  133 (150)
Q Consensus        77 ~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------------------  133 (150)
                      |+||+++. .+.+|++|||++.........           ......+++.|+|||++                      
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-----------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l  351 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-----------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL  351 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-----------CCcccccCCCccChHHhhccCCCCCCccccccccccchh
Confidence            99999986 578999999998643211100           01134678899999953                      


Q ss_pred             ---------cccccceeEEEeeeec
Q psy1934         134 ---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       134 ---------d~~~~g~~~~~~~~g~  149 (150)
                               |+||+|++++||++|.
T Consensus       352 ~~~~~~~k~DVwSlGviL~el~~~~  376 (566)
T PLN03225        352 WQLNLPDRFDIYSAGLIFLQMAFPN  376 (566)
T ss_pred             ccccCCCCcccHHHHHHHHHHHhCc
Confidence                     9999999999998763

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.85  E-value=1.5e-22  Score=140.29  Aligned_cols=131  Identities=32%  Similarity=0.498  Sum_probs=110.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++|++..+.....+..+++|||+++++|.+++... ..+++..+..++.+++.|+.++|+++  ++|+|++|+||+++
T Consensus        56 ~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~  132 (260)
T PF00069_consen   56 RHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD  132 (260)
T ss_dssp             TBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES
T ss_pred             ccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccc--cccccccccccccc
Confidence            4788999989888899999999999999999999833 56899999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||.+........            ......++..|+|||+.          |+|++|+++++|+.|.
T Consensus       133 ~~~~~~l~Dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~  196 (260)
T PF00069_consen  133 ENGEVKLIDFGSSVKLSENNE------------NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGK  196 (260)
T ss_dssp             TTSEEEESSGTTTEESTSTTS------------EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccccccccccccccccccc------------ccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999998864211000            01133578889999984          9999999999998874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.85  E-value=6.7e-22  Score=137.45  Aligned_cols=132  Identities=23%  Similarity=0.291  Sum_probs=104.4

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+... .+..+++|||+++++|.+++.... ..+++..+..++.+++.|+.|+|+.+  ++|+|++++|+++
T Consensus        59 ~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill  135 (260)
T cd05069          59 RHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILV  135 (260)
T ss_pred             CCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEE
Confidence            3677777766654 356899999999999999997643 34788888999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||.+.........           ......++..|++||+.         |+||+|++++++++ |.
T Consensus       136 ~~~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~  201 (260)
T cd05069         136 GDNLVCKIADFGLARLIEDNEYT-----------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR  201 (260)
T ss_pred             cCCCeEEECCCccceEccCCccc-----------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCC
Confidence            99999999999988643211100           00112345679999974         99999999999987 64

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=6.6e-22  Score=137.34  Aligned_cols=134  Identities=22%  Similarity=0.290  Sum_probs=109.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+..+....+++++||+++++|.+++.... ..+++..+..++.+++.|+.++|+++  ++|+|++|+||+
T Consensus        58 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nil  135 (261)
T cd05034          58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNIL  135 (261)
T ss_pred             CCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEE
Confidence            347889999888888889999999999999999997643 45888999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||.+......   .        .........+..|++||.+         |+||+|++++++++ |+
T Consensus       136 i~~~~~~~l~d~g~~~~~~~~---~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~  202 (261)
T cd05034         136 VGENLVCKIADFGLARLIEDD---E--------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR  202 (261)
T ss_pred             EcCCCCEEECccccceeccch---h--------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence            999999999999987643210   0        0011122345679999974         99999999999986 64

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.85  E-value=5.7e-22  Score=140.28  Aligned_cols=133  Identities=20%  Similarity=0.186  Sum_probs=105.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT----------SALPPNIVCSILWQTCQAVKHMHGQNPPIVH   72 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h   72 (150)
                      +-|+++++..+.+...+.++++|||+++++|.+++....          ..+++..+..++.+++.|+.|+|+.+  ++|
T Consensus        76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H  153 (296)
T cd05095          76 LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVH  153 (296)
T ss_pred             CCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence            347888888888888889999999999999999997532          12566788899999999999999998  999


Q ss_pred             ecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEE
Q psy1934          73 RDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGR  143 (150)
Q Consensus        73 ~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~  143 (150)
                      +|++|+||+++.++.++++|||++..........          ......++..|++||+         .|+||+|++++
T Consensus       154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~  223 (296)
T cd05095         154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR----------IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW  223 (296)
T ss_pred             ccCChheEEEcCCCCEEeccCcccccccCCccee----------ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHH
Confidence            9999999999999999999999986432111000          0011234567999996         49999999999


Q ss_pred             Eeee
Q psy1934         144 SMLY  147 (150)
Q Consensus       144 ~~~~  147 (150)
                      +|+.
T Consensus       224 el~~  227 (296)
T cd05095         224 EILT  227 (296)
T ss_pred             HHHH
Confidence            9875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.85  E-value=7.1e-22  Score=139.37  Aligned_cols=131  Identities=26%  Similarity=0.457  Sum_probs=105.2

Q ss_pred             chhhhcccCCCCC-----ceEEEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           5 SAAFIDKHSTPHG-----MHEYLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         5 ~~~~~~~~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      |+++++..+.+..     .+.+++|+||+++++|.++++.   ....+++..+..++.+++.|+.++|+++  ++|+|++
T Consensus        78 h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlk  155 (291)
T cd06639          78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVK  155 (291)
T ss_pred             CCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCC
Confidence            5778887765432     3468999999999999998864   2345888899999999999999999998  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc--------------ccccccceeE
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------------VDTWNNYVIG  142 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~--------------~d~~~~g~~~  142 (150)
                      |+|++++.++.++++|||++........            ......++..|+|||+              .|+||+|+++
T Consensus       156 p~nili~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~  223 (291)
T cd06639         156 GNNILLTTEGGVKLVDFGVSAQLTSTRL------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITA  223 (291)
T ss_pred             HHHEEEcCCCCEEEeecccchhcccccc------------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHH
Confidence            9999999999999999998764321110            0012357788999996              3999999999


Q ss_pred             EEeeeec
Q psy1934         143 RSMLYGH  149 (150)
Q Consensus       143 ~~~~~g~  149 (150)
                      ++|+.|.
T Consensus       224 ~el~~g~  230 (291)
T cd06639         224 IELGDGD  230 (291)
T ss_pred             HHHhhCC
Confidence            9999885

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.85  E-value=5e-22  Score=141.42  Aligned_cols=135  Identities=27%  Similarity=0.364  Sum_probs=107.6

Q ss_pred             ccchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERT----SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||++++..+.+...  +.+++|+||+++ ++.+.+....    ..+++..+..++.|++.|+.|+|+.+  ++|+|++
T Consensus        59 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlk  135 (316)
T cd07842          59 LKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLK  135 (316)
T ss_pred             cCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCC
Confidence            4578899988888777  889999999976 7887775432    25788889999999999999999998  9999999


Q ss_pred             CCCEEEcC----CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeE
Q psy1934          77 IENLLISS----AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIG  142 (150)
Q Consensus        77 ~~nil~~~----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~  142 (150)
                      |+||+++.    .+.++++|||++..........         .......++..|+|||++          |+||+|+++
T Consensus       136 p~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l  206 (316)
T cd07842         136 PANILVMGEGPERGVVKIGDLGLARLFNAPLKPL---------ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIF  206 (316)
T ss_pred             HHHEEEcCCCCccceEEECCCccccccCCCcccc---------cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence            99999999    8999999999887532211100         011123567889999963          999999999


Q ss_pred             EEeeeec
Q psy1934         143 RSMLYGH  149 (150)
Q Consensus       143 ~~~~~g~  149 (150)
                      ++|++|.
T Consensus       207 ~~l~~~~  213 (316)
T cd07842         207 AELLTLE  213 (316)
T ss_pred             HHHHhcC
Confidence            9998875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.85  E-value=7.6e-22  Score=139.61  Aligned_cols=131  Identities=27%  Similarity=0.466  Sum_probs=110.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.+...+.+|+|+||+++++|.+++.+.  .+++..+..++.+++.|+.++|+++  ++|+|++|.|+++
T Consensus        73 l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili  148 (293)
T cd06647          73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL  148 (293)
T ss_pred             cCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEE
Confidence            34788999999988889999999999999999999753  5788888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+++.|++||.+         |+|++|++++++++|.
T Consensus       149 ~~~~~~kL~dfg~~~~~~~~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~  212 (293)
T cd06647         149 GMDGSVKLTDFGFCAQITPEQS------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE  212 (293)
T ss_pred             cCCCCEEEccCcceeccccccc------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999998764322111            00123577889999973         9999999999998875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.85  E-value=8e-22  Score=136.48  Aligned_cols=130  Identities=29%  Similarity=0.420  Sum_probs=110.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.......+++++||+++++|.+++.+. ..+++..+..++.+++.|+.++|+.+  ++|+|++++||+++
T Consensus        60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~  136 (258)
T cd06632          60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD  136 (258)
T ss_pred             CCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC
Confidence            4688999999888989999999999999999999764 45788888889999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||.+.......             ......++..|++||.          .|+|++|+++++++.|.
T Consensus       137 ~~~~~kl~d~~~~~~~~~~~-------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~  199 (258)
T cd06632         137 TNGVVKLADFGMAKQVVEFS-------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK  199 (258)
T ss_pred             CCCCEEEccCccceeccccc-------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCC
Confidence            99999999999876432211             0112357788999985          39999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.85  E-value=8.6e-22  Score=138.39  Aligned_cols=132  Identities=27%  Similarity=0.402  Sum_probs=109.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+..+..+.++++|||+. ++|.+++.... ..+++..+..++.+++.|+.|+|+.+  ++|+|++|+||+
T Consensus        56 l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nil  132 (284)
T cd07860          56 LNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLL  132 (284)
T ss_pred             cCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEE
Confidence            357899999999999999999999996 58998886533 45888999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++.........            .....+++.|+|||++          |+|++|++++++++|.
T Consensus       133 l~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~  198 (284)
T cd07860         133 INTEGAIKLADFGLARAFGVPVRT------------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR  198 (284)
T ss_pred             ECCCCCEEEeeccchhhcccCccc------------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            999999999999987643211100            0122457789999963          9999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.85  E-value=6.3e-22  Score=139.28  Aligned_cols=130  Identities=25%  Similarity=0.383  Sum_probs=109.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.....+.+++|+||+++++|.+++... ..+++..+..++.+++.++.|+|+ .+  ++|+|++|+|++
T Consensus        60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil  136 (284)
T cd06620          60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNIL  136 (284)
T ss_pred             cCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEE
Confidence            34688999999999999999999999999999988764 468888999999999999999996 46  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++.......              .....++..|++||++         |+||+|++++++++|.
T Consensus       137 ~~~~~~~~l~d~gl~~~~~~~~--------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~  199 (284)
T cd06620         137 VNSRGQIKLCDFGVSGELINSI--------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK  199 (284)
T ss_pred             ECCCCcEEEccCCcccchhhhc--------------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCC
Confidence            9999999999999875321110              0123578899999984         9999999999998875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.85  E-value=6e-22  Score=137.65  Aligned_cols=133  Identities=23%  Similarity=0.296  Sum_probs=105.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+... .+..+++|||+++++|.+++.... ..+++..+..++.+++.|+.|+|+.+  ++|+|++|.|++
T Consensus        58 l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nil  134 (260)
T cd05070          58 LRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANIL  134 (260)
T ss_pred             cCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEE
Confidence            34677888776654 356899999999999999997643 35788899999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||.+.........           ......++..|+|||+         .|+||+|++++++++ |.
T Consensus       135 i~~~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~  201 (260)
T cd05070         135 VGDGLVCKIADFGLARLIEDNEYT-----------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR  201 (260)
T ss_pred             EeCCceEEeCCceeeeeccCcccc-----------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCC
Confidence            999999999999998753221100           0011234567999997         499999999999987 54

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.85  E-value=1.1e-21  Score=136.17  Aligned_cols=132  Identities=24%  Similarity=0.359  Sum_probs=108.3

Q ss_pred             cchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCeEEe
Q psy1934           4 LSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMH-----GQNPPIVHR   73 (150)
Q Consensus         4 ~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh-----~~~~~i~h~   73 (150)
                      -|+++++..+..  ..+..+++++||+++++|.+++...   ...+++..+..++.+++.|+.++|     +.+  ++|+
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~  134 (265)
T cd08217          57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHR  134 (265)
T ss_pred             CCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceec
Confidence            467888877744  4556789999999999999999754   356888899999999999999999     777  9999


Q ss_pred             cCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEE
Q psy1934          74 DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRS  144 (150)
Q Consensus        74 ~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~  144 (150)
                      |++|+||+++.++.++++|||++........            ......+++.|++||++         |+|++|+++++
T Consensus       135 dl~p~nili~~~~~~kl~d~g~~~~~~~~~~------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~  202 (265)
T cd08217         135 DLKPANIFLDANNNVKLGDFGLAKILGHDSS------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE  202 (265)
T ss_pred             CCCHHHEEEecCCCEEEecccccccccCCcc------------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHH
Confidence            9999999999999999999998875422111            01123578899999984         99999999999


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      |+.|.
T Consensus       203 l~~g~  207 (265)
T cd08217         203 LCALS  207 (265)
T ss_pred             HHHCC
Confidence            99875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4278|consensus

Probab=99.85  E-value=1.7e-22  Score=150.92  Aligned_cols=134  Identities=24%  Similarity=0.357  Sum_probs=110.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+++++++++..+--+||++|||.+|+|.++|+++.. .++.-....++.||.+|+.||..++  +||||+...|+|
T Consensus       320 ikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCL  397 (1157)
T KOG4278|consen  320 IKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCL  397 (1157)
T ss_pred             hcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcc
Confidence            4578999999999999999999999999999999998753 3555556678889999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee-eec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML-YGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~-~g~  149 (150)
                      ++.+..+|++|||+++.+..+   .+.++        ....-...|.|||.+         |+|++|+++||++ ||+
T Consensus       398 VgEnhiVKvADFGLsRlMtgD---TYTAH--------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGM  464 (1157)
T KOG4278|consen  398 VGENHIVKVADFGLSRLMTGD---TYTAH--------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGM  464 (1157)
T ss_pred             ccccceEEeeccchhhhhcCC---ceecc--------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCC
Confidence            999999999999999875322   11111        111234469999985         9999999999987 553

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.85  E-value=1.2e-21  Score=137.51  Aligned_cols=129  Identities=30%  Similarity=0.467  Sum_probs=109.1

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      |+++++..+.+...+..++||||+ ++++.+.+.... ..+++..+..++.+++.++.++|+++  ++|+|+++.||+++
T Consensus        57 h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~  133 (283)
T cd07830          57 HPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS  133 (283)
T ss_pred             CCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc
Confidence            688899888888899999999999 779999987653 46789999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........             .....++..|+|||++          |+||+|+++++++.|.
T Consensus       134 ~~~~~~l~d~~~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~  196 (283)
T cd07830         134 GPEVVKIADFGLAREIRSRPP-------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR  196 (283)
T ss_pred             CCCCEEEeecccceeccCCCC-------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC
Confidence            999999999998864321110             0123467889999963          9999999999998875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.85  E-value=1.2e-21  Score=136.71  Aligned_cols=132  Identities=23%  Similarity=0.334  Sum_probs=110.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIE   78 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~   78 (150)
                      .-|+++++..+.+...+..++++||+++++|.+++..   ....+++..+..++.+++.++.++|+ .+  ++|+|+++.
T Consensus        66 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~  143 (269)
T cd08528          66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPN  143 (269)
T ss_pred             CCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHH
Confidence            3478899999999999999999999999999998854   23458888899999999999999996 56  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ||+++.++.++++|||.+.......             ......++..|++||++         |+|++|+++++++.|.
T Consensus       144 nil~~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~  210 (269)
T cd08528         144 NIMLGEDDKVTITDFGLAKQKQPES-------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ  210 (269)
T ss_pred             HEEECCCCcEEEecccceeeccccc-------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999987532111             11234578889999974         9999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.85  E-value=6.6e-22  Score=137.51  Aligned_cols=136  Identities=24%  Similarity=0.409  Sum_probs=111.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      -|+++++........+.+++++|++++++|.+++....  ..+++..+..++.|++.|+.++|+.+  ++|+|++|+||+
T Consensus        57 ~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~  134 (267)
T cd06610          57 NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNIL  134 (267)
T ss_pred             CCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEE
Confidence            36778888888888899999999999999999997642  45888899999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++...........        .......++..|++||++          |+|++|+++++|+.|.
T Consensus       135 ~~~~~~~~l~df~~~~~~~~~~~~~~--------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~  204 (267)
T cd06610         135 LGEDGSVKIADFGVSASLADGGDRTR--------KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA  204 (267)
T ss_pred             EcCCCCEEEcccchHHHhccCccccc--------cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCC
Confidence            99999999999998865433221100        011233578889999973          9999999999999885

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.85  E-value=8.2e-22  Score=137.43  Aligned_cols=134  Identities=28%  Similarity=0.342  Sum_probs=106.5

Q ss_pred             cchhhhcccCCCCC--ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           4 LSAAFIDKHSTPHG--MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         4 ~~~~~~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      -|+++++..+....  .+.+++++||+++++|.+++... ..+++.....++.|++.|+.++|+++  ++|+|++|+||+
T Consensus        62 ~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil  138 (266)
T cd06651          62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANIL  138 (266)
T ss_pred             CCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEE
Confidence            46778887765443  46789999999999999999764 35788888899999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++..........         .......++..|+|||++         |+||+|++++++++|.
T Consensus       139 ~~~~~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~  206 (266)
T cd06651         139 RDSAGNVKLGDFGASKRLQTICMSG---------TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK  206 (266)
T ss_pred             ECCCCCEEEccCCCccccccccccC---------CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCC
Confidence            9999999999999876432110000         000123477889999974         9999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=7.2e-22  Score=137.58  Aligned_cols=135  Identities=30%  Similarity=0.363  Sum_probs=107.4

Q ss_pred             ccchhhhcccCCCCC--ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHG--MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|+++++..+....  .+.+++++||+++++|.+++.+. ..+++..+..++.+++.|+.++|+++  ++|+|++|+||
T Consensus        61 l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni  137 (264)
T cd06653          61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANI  137 (264)
T ss_pred             cCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHE
Confidence            346778887765443  35789999999999999998764 35788888899999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++..........         .......++..|+|||++         |+|++|++++++++|.
T Consensus       138 ~i~~~~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  206 (264)
T cd06653         138 LRDSAGNVKLGDFGASKRIQTICMSG---------TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK  206 (264)
T ss_pred             EEcCCCCEEECccccccccccccccC---------ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCC
Confidence            99999999999999887432110000         001123578889999984         9999999999999886

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.85  E-value=1.3e-21  Score=136.02  Aligned_cols=133  Identities=24%  Similarity=0.349  Sum_probs=106.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.... ..+++++||+++++|.+++.... ..+++..+..++.+++.|+.++|+++  ++|+|++|+|++
T Consensus        58 l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~  134 (260)
T cd05073          58 LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANIL  134 (260)
T ss_pred             cCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEE
Confidence            346778888777666 77899999999999999997532 44778888889999999999999988  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++..+.+++.|||.+.........           ......++..|++||++         |+|++|+++++++. |+
T Consensus       135 i~~~~~~~l~d~~~~~~~~~~~~~-----------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~  201 (260)
T cd05073         135 VSASLVCKIADFGLARVIEDNEYT-----------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR  201 (260)
T ss_pred             EcCCCcEEECCCcceeeccCCCcc-----------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCC
Confidence            999999999999988643211100           00112345679999974         99999999999986 65

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.85  E-value=1.2e-21  Score=139.84  Aligned_cols=128  Identities=27%  Similarity=0.432  Sum_probs=108.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.++.....|+++||+.+ ++.+.+......+++..+..++.+++.++.|+|+++  ++|+|++|+||++
T Consensus        78 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili  154 (313)
T cd06633          78 LKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILL  154 (313)
T ss_pred             CCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEE
Confidence            3478899999988888999999999965 888888765567888898899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.....                .....++..|+|||++            |+||+|+++++|++|.
T Consensus       155 ~~~~~~kL~dfg~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~  217 (313)
T cd06633         155 TEPGQVKLADFGSASKSSP----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  217 (313)
T ss_pred             CCCCCEEEeecCCCcccCC----------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999998753211                0123577889999974            9999999999998875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.85  E-value=1.4e-21  Score=135.39  Aligned_cols=128  Identities=23%  Similarity=0.368  Sum_probs=103.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+.... +.+++++||+++++|.+++.... ..+++..+..++.|++.|+.++|+.+  ++|+|++|+|+++
T Consensus        57 ~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili  133 (254)
T cd05083          57 HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILV  133 (254)
T ss_pred             CCCCcCeEEEEEcC-CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEE
Confidence            46778887777655 45799999999999999997643 35788888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++........               ....+..|+|||.+         |+||+|++++++++ |+
T Consensus       134 ~~~~~~kl~Dfg~~~~~~~~~~---------------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~  195 (254)
T cd05083         134 SEDGVAKVSDFGLARVGSMGVD---------------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR  195 (254)
T ss_pred             cCCCcEEECCCccceeccccCC---------------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999998864321100               11234569999974         99999999999885 64

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.85  E-value=5.4e-22  Score=139.79  Aligned_cols=132  Identities=20%  Similarity=0.208  Sum_probs=105.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------------CCCCHHHHHHHHHHHHHHHHH
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------------SALPPNIVCSILWQTCQAVKH   62 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------------~~l~~~~~~~~~~~i~~~l~~   62 (150)
                      -|+++++..+..+.+..+++++||+++++|.+++....                     ..+++..+..++.+++.|+.+
T Consensus        66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~  145 (288)
T cd05050          66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAY  145 (288)
T ss_pred             CCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            47889998888888889999999999999999997431                     136677788999999999999


Q ss_pred             HhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------c
Q psy1934          63 MHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------V  133 (150)
Q Consensus        63 lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~  133 (150)
                      +|+++  ++|+|++|.|++++.++.++++|||++.........          ........+..|+|||+         .
T Consensus       146 lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~  213 (288)
T cd05050         146 LSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----------KASENDAIPIRWMPPESIFYNRYTTES  213 (288)
T ss_pred             HHhCC--eecccccHhheEecCCCceEECccccceecccCccc----------cccCCCccChhhcCHHHHhcCCCCchh
Confidence            99998  999999999999999999999999987643211100          00011224567999997         3


Q ss_pred             cccccceeEEEeee
Q psy1934         134 DTWNNYVIGRSMLY  147 (150)
Q Consensus       134 d~~~~g~~~~~~~~  147 (150)
                      |+||+|+++++|+.
T Consensus       214 Dv~slG~il~el~~  227 (288)
T cd05050         214 DVWAYGVVLWEIFS  227 (288)
T ss_pred             HHHHHHHHHHHHHh
Confidence            99999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.85  E-value=9.8e-22  Score=138.36  Aligned_cols=132  Identities=28%  Similarity=0.453  Sum_probs=110.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.+...+..++++||+++++|.+++......+++..+..++.+++.|+.++|+.+  ++|+|++|.||+++
T Consensus        73 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~  150 (286)
T cd06614          73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS  150 (286)
T ss_pred             CCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc
Confidence            4678888888888889999999999999999999876446888999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.......            .......++..|++||+         .|+|++|+++++++.|.
T Consensus       151 ~~~~~~l~d~~~~~~~~~~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~  213 (286)
T cd06614         151 KDGSVKLADFGFAAQLTKEK------------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE  213 (286)
T ss_pred             CCCCEEECccchhhhhccch------------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCC
Confidence            99999999999865322110            01113346788999997         39999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.85  E-value=1.1e-21  Score=138.84  Aligned_cols=131  Identities=24%  Similarity=0.457  Sum_probs=109.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+..+++|||+++++|.+++..  ..+++..+..++.+++.++.++|+.+  ++|+|++|.||++
T Consensus        74 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv  149 (292)
T cd06657          74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILL  149 (292)
T ss_pred             cCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE
Confidence            3478899999988889999999999999999998764  35788888999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+++.|++||++         |+|++|+++++++.|.
T Consensus       150 ~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~  213 (292)
T cd06657         150 THDGRVKLSDFGFCAQVSKEVP------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE  213 (292)
T ss_pred             CCCCCEEEcccccceecccccc------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999998764321110            01123578889999974         9999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.85  E-value=1.4e-21  Score=137.44  Aligned_cols=132  Identities=32%  Similarity=0.494  Sum_probs=107.9

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.+...+.+++++||++++.+..+... ...+++..+..++.+++.|+.++|+.+  ++|+|+++.||+++
T Consensus        58 ~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~  134 (288)
T cd07833          58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS  134 (288)
T ss_pred             CCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC
Confidence            378899999998888999999999998666655543 356889999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++..........           .....++..|+|||++          |+||+|+++++++.|.
T Consensus       135 ~~~~~kl~d~g~~~~~~~~~~~~-----------~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  199 (288)
T cd07833         135 ESGVLKLCDFGFARALRARPASP-----------LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE  199 (288)
T ss_pred             CCCCEEEEeeecccccCCCcccc-----------ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence            99999999999876542211100           0123567889999973          9999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.85  E-value=1.1e-21  Score=137.77  Aligned_cols=132  Identities=29%  Similarity=0.436  Sum_probs=109.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|+++++..+.+...+.+++|+||+++ +|.+++....  ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||
T Consensus        55 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni  131 (284)
T cd07836          55 LKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNL  131 (284)
T ss_pred             hcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHE
Confidence            3478899999999999999999999986 8998887543  45889999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||.+........            ......++..|++||++          |+|++|++++++++|.
T Consensus       132 ~~~~~~~~~l~d~g~~~~~~~~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  198 (284)
T cd07836         132 LINKRGELKLADFGLARAFGIPVN------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR  198 (284)
T ss_pred             EECCCCcEEEeecchhhhhcCCcc------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999998764321100            01123467889999963          9999999999999885

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG1006|consensus

Probab=99.84  E-value=7.1e-22  Score=134.33  Aligned_cols=130  Identities=28%  Similarity=0.384  Sum_probs=102.8

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKE----RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      .|+|+++.+..-.++.-|++||.+.- ++..+-+.    ....++++.+-.+......|+.||-.. ..|+|||+||+||
T Consensus       122 cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNI  199 (361)
T KOG1006|consen  122 CPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNI  199 (361)
T ss_pred             CcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhhe
Confidence            47899998888888999999999965 66665542    224577877767777778999999643 2399999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~  149 (150)
                      |++..|.+|++|||++.....+             -..+--.|-..|||||.+           |+||+|++++|.++|.
T Consensus       200 Lldr~G~vKLCDFGIcGqLv~S-------------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~  266 (361)
T KOG1006|consen  200 LLDRHGDVKLCDFGICGQLVDS-------------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGN  266 (361)
T ss_pred             EEecCCCEeeecccchHhHHHH-------------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCC
Confidence            9999999999999998643211             112234688899999986           9999999999999985

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.84  E-value=1.2e-21  Score=137.35  Aligned_cols=131  Identities=27%  Similarity=0.409  Sum_probs=110.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++|+||+++++|.+++..  ..+++..+..++.+++.++.++|+.+  ++|+|++|.|+++
T Consensus        59 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i  134 (277)
T cd06641          59 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL  134 (277)
T ss_pred             cCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEE
Confidence            4578899998888888999999999999999999865  35888888999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.......            .......++..|++||.+         |+||+|+++++++.|.
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~  198 (277)
T cd06641         135 SEHGEVKLADFGVAGQLTDTQ------------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE  198 (277)
T ss_pred             CCCCCEEEeecccceecccch------------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCC
Confidence            999999999999876432110            011123577889999974         9999999999998885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.84  E-value=1.2e-21  Score=139.32  Aligned_cols=132  Identities=25%  Similarity=0.440  Sum_probs=106.4

Q ss_pred             ccchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|+++++..+...+.  +.+++|+||+++ +|.+++......+++..+..++.|++.|+.++|+.+  ++|+|++|+||
T Consensus        63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~ni  139 (309)
T cd07845          63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNL  139 (309)
T ss_pred             CCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence            4577888877765433  578999999975 899888765456899999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +++..+.++++|||.+.........            .....+++.|+|||++          |+|++|+++++|+.|.
T Consensus       140 l~~~~~~~kL~dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  206 (309)
T cd07845         140 LLTDKGCLKIADFGLARTYGLPAKP------------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK  206 (309)
T ss_pred             EECCCCCEEECccceeeecCCccCC------------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCC
Confidence            9999999999999988754221100            0112356789999974          9999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.84  E-value=2.4e-21  Score=139.96  Aligned_cols=131  Identities=22%  Similarity=0.384  Sum_probs=101.3

Q ss_pred             chhhhcccCCCC-CceEEEEEEeccCCCCHHHHHHhhC------------------------------------------
Q psy1934           5 SAAFIDKHSTPH-GMHEYLILTELCTGGSLVDVLKERT------------------------------------------   41 (150)
Q Consensus         5 ~~~~~~~~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------   41 (150)
                      |+++++..+... .++.++++|||+++|+|.+++....                                          
T Consensus        70 h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (343)
T cd05103          70 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSAS  149 (343)
T ss_pred             CccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccc
Confidence            578888877554 4456899999999999999986421                                          


Q ss_pred             ------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCcee
Q psy1934          42 ------------------------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT   97 (150)
Q Consensus        42 ------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   97 (150)
                                              ..+++..+..++.|++.|+.|+|+++  ++|+|++|.||+++.++.++++|||++.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~  227 (343)
T cd05103         150 SGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLAR  227 (343)
T ss_pred             ccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEeccccc
Confidence                                    12456677788999999999999998  9999999999999999999999999886


Q ss_pred             ccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          98 EKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      ........          .......++..|+|||++         |+|++|+++++++.
T Consensus       228 ~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  276 (343)
T cd05103         228 DIYKDPDY----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  276 (343)
T ss_pred             ccccCcch----------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence            53221110          000112345679999974         99999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.84  E-value=1e-21  Score=139.45  Aligned_cols=136  Identities=23%  Similarity=0.373  Sum_probs=105.6

Q ss_pred             ccchhhhcccCCCCC--------ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEec
Q psy1934           3 YLSAAFIDKHSTPHG--------MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD   74 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~   74 (150)
                      +-||++++..+....        .+..++|+||+++ ++.+.+......+++..+..++.|++.|+.|+|+++  ++|+|
T Consensus        68 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~d  144 (310)
T cd07865          68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRD  144 (310)
T ss_pred             CCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccC
Confidence            347788887765332        3466999999975 888888765456899999999999999999999998  99999


Q ss_pred             CCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEE
Q psy1934          75 LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRS  144 (150)
Q Consensus        75 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~  144 (150)
                      ++|+||+++.++.++++|||++..........        ........++..|+|||++          |+||+|+++++
T Consensus       145 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~e  216 (310)
T cd07865         145 MKAANILITKDGILKLADFGLARAFSLSKNSK--------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAE  216 (310)
T ss_pred             CCHHHEEECCCCcEEECcCCCcccccCCcccC--------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHH
Confidence            99999999999999999999887542211100        0001123567889999963          99999999999


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      +++|.
T Consensus       217 l~t~~  221 (310)
T cd07865         217 MWTRS  221 (310)
T ss_pred             HHhCC
Confidence            98774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0665|consensus

Probab=99.84  E-value=2e-22  Score=139.61  Aligned_cols=128  Identities=30%  Similarity=0.436  Sum_probs=104.2

Q ss_pred             cchhhhcccCCCC------CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           4 LSAAFIDKHSTPH------GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         4 ~~~~~~~~~~~~~------~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      -|+++++....+.      ....+|+|||++.. +|.+....   .+...++..+++|++.|++|+|+.+  |+|||+||
T Consensus        73 ~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkP  146 (369)
T KOG0665|consen   73 NHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKP  146 (369)
T ss_pred             cccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCc
Confidence            3566777666544      45667999999965 88887763   4777888899999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +||++..+..+|+.|||+++....+             ...+..+.|..|+|||++         |+||.||++.||..|
T Consensus       147 snivv~~~~~lKi~dfg~ar~e~~~-------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~  213 (369)
T KOG0665|consen  147 SNIVVNSDCTLKILDFGLARTEDTD-------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILG  213 (369)
T ss_pred             ccceecchhheeeccchhhcccCcc-------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhc
Confidence            9999999999999999998753221             112234678899999984         999999999999988


Q ss_pred             cC
Q psy1934         149 HV  150 (150)
Q Consensus       149 ~~  150 (150)
                      +|
T Consensus       214 ~V  215 (369)
T KOG0665|consen  214 TV  215 (369)
T ss_pred             eE
Confidence            75

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.84  E-value=2.2e-21  Score=134.16  Aligned_cols=131  Identities=21%  Similarity=0.297  Sum_probs=108.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSA-LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+.....+.++++|||+++++|.+++...... +++..+..++.|++.++.++|+.+  ++|+|++|+||++
T Consensus        59 ~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~  136 (258)
T smart00219       59 DHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLV  136 (258)
T ss_pred             CCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEE
Confidence            4778899888888889999999999999999999764433 899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      +..+.++++|||++.........  .        . ....+++.|++||..         |+|++|+++++|+.
T Consensus       137 ~~~~~~~l~dfg~~~~~~~~~~~--~--------~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~  199 (258)
T smart00219      137 GENLVVKISDFGLSRDLYDDDYY--K--------K-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFT  199 (258)
T ss_pred             ccCCeEEEcccCCceeccccccc--c--------c-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHh
Confidence            99999999999998754321100  0        0 011256789999974         99999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.84  E-value=2.4e-21  Score=136.75  Aligned_cols=130  Identities=25%  Similarity=0.389  Sum_probs=103.2

Q ss_pred             chhhhcccCCCCCceE-----EEEEEeccCCCCHHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           5 SAAFIDKHSTPHGMHE-----YLILTELCTGGSLVDVLKERT----SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~-----~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      |+++++..+.......     .+++|||+++ ++.+++....    ..+++..+..++.|++.|+.|+|+.+  ++|+|+
T Consensus        60 ~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl  136 (295)
T cd07837          60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDL  136 (295)
T ss_pred             CCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCC
Confidence            3678887776665554     8999999986 8988886432    34788999999999999999999998  999999


Q ss_pred             CCCCEEEcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEE
Q psy1934          76 KIENLLISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRS  144 (150)
Q Consensus        76 ~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~  144 (150)
                      +|+||+++. .+.++++|||++........ .           .....+++.|+|||++          |+|++|+++++
T Consensus       137 ~~~nil~~~~~~~~kl~dfg~~~~~~~~~~-~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~  204 (295)
T cd07837         137 KPQNLLVDKQKGLLKIADLGLGRAFSIPVK-S-----------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAE  204 (295)
T ss_pred             ChHHEEEecCCCeEEEeecccceecCCCcc-c-----------cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHH
Confidence            999999998 78999999998864321100 0           0112457789999963          99999999999


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      |+.|.
T Consensus       205 l~~g~  209 (295)
T cd07837         205 MSRKQ  209 (295)
T ss_pred             HHcCC
Confidence            99885

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.84  E-value=1.8e-21  Score=137.85  Aligned_cols=133  Identities=21%  Similarity=0.369  Sum_probs=106.0

Q ss_pred             ccchhhhcccCCCCCce----------EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q psy1934           3 YLSAAFIDKHSTPHGMH----------EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH   72 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~----------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h   72 (150)
                      +-||++++..+......          .+++++||+++ ++.+.+.+....+++..+..++.|++.|+.|+|+.+  ++|
T Consensus        63 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H  139 (302)
T cd07864          63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLH  139 (302)
T ss_pred             CCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence            34788888777665544          89999999986 788888765456889999999999999999999998  999


Q ss_pred             ecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeE
Q psy1934          73 RDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIG  142 (150)
Q Consensus        73 ~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~  142 (150)
                      +|+++.||+++.++.++++|||.+...........           ....++..|++||++          |+|++|+++
T Consensus       140 ~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~-----------~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~  208 (302)
T cd07864         140 RDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY-----------TNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL  208 (302)
T ss_pred             CCCCHHHEEECCCCcEEeCcccccccccCCccccc-----------ccceeccCccChHHhcCCCCCCchhHHHHHHHHH
Confidence            99999999999999999999998865422211000           012346779999963          999999999


Q ss_pred             EEeeeec
Q psy1934         143 RSMLYGH  149 (150)
Q Consensus       143 ~~~~~g~  149 (150)
                      ++++.|+
T Consensus       209 ~el~~g~  215 (302)
T cd07864         209 GELFTKK  215 (302)
T ss_pred             HHHHhCC
Confidence            9998875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.84  E-value=1.7e-21  Score=136.07  Aligned_cols=133  Identities=15%  Similarity=0.209  Sum_probs=101.7

Q ss_pred             ccchhhhcccCCC------CCceEEEEEEeccCCCCHHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy1934           3 YLSAAFIDKHSTP------HGMHEYLILTELCTGGSLVDVLKER-----TSALPPNIVCSILWQTCQAVKHMHGQNPPIV   71 (150)
Q Consensus         3 ~~~~~~~~~~~~~------~~~~~~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~   71 (150)
                      +-|+++++..+..      ......++++||+++|+|.+++...     ...+++..+..++.|++.|+.|+|+++  ++
T Consensus        57 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~  134 (272)
T cd05075          57 FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FI  134 (272)
T ss_pred             CCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence            3467888876532      1233579999999999999987432     134788888999999999999999998  99


Q ss_pred             EecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeE
Q psy1934          72 HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIG  142 (150)
Q Consensus        72 h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~  142 (150)
                      |+|++|+||+++.++.++++|||++.........          .......+++.|++||+.         |+||+|+++
T Consensus       135 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il  204 (272)
T cd05075         135 HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY----------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTM  204 (272)
T ss_pred             ccccchhheEEcCCCCEEECCCCcccccCcccce----------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHH
Confidence            9999999999999999999999998753221100          000112355679999983         999999999


Q ss_pred             EEeee
Q psy1934         143 RSMLY  147 (150)
Q Consensus       143 ~~~~~  147 (150)
                      +++++
T Consensus       205 ~el~~  209 (272)
T cd05075         205 WEIAT  209 (272)
T ss_pred             HHHHc
Confidence            99987

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.84  E-value=2.5e-21  Score=136.82  Aligned_cols=132  Identities=25%  Similarity=0.357  Sum_probs=105.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.....+.+++|+||+++ ++.+.+.... ..+++..+..++.+++.|+.++|+++  ++|+|++|+||+
T Consensus        58 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nil  134 (294)
T PLN00009         58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLL  134 (294)
T ss_pred             ccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEE
Confidence            4478899999999999999999999965 8888876543 23577788889999999999999998  999999999999


Q ss_pred             EcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          82 ISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++. .+.++++|||++.........            .....+++.|++||++          |+|++|++++++++|.
T Consensus       135 l~~~~~~~kl~dfg~~~~~~~~~~~------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~  201 (294)
T PLN00009        135 IDRRTNALKLADFGLARAFGIPVRT------------FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK  201 (294)
T ss_pred             EECCCCEEEEcccccccccCCCccc------------cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            985 467899999988643211110            0123467889999963          8999999999999885

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.84  E-value=3e-21  Score=134.10  Aligned_cols=136  Identities=25%  Similarity=0.421  Sum_probs=110.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.....+.+++++||+++++|.+++... ..+++..+..++.+++.|+.++|+.+  ++|+|+++.||++
T Consensus        56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~  132 (264)
T cd06626          56 LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFL  132 (264)
T ss_pred             CCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE
Confidence            34688999888888889999999999999999999764 34788888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      +..+.++++|||.+............        ......++..|++||++            |+|++|+++++++.|.
T Consensus       133 ~~~~~~kl~d~g~~~~~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~  203 (264)
T cd06626         133 DHNGVIKLGDFGCAVKLKNNTTTMGE--------EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK  203 (264)
T ss_pred             CCCCCEEEcccccccccCCCCCcccc--------cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCC
Confidence            99999999999988754322111000        00123467789999963            9999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.84  E-value=2e-21  Score=134.85  Aligned_cols=131  Identities=30%  Similarity=0.391  Sum_probs=111.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+.....+.+++++||+++++|.+++... ..+++..+..++.+++.++.++|+ .+  ++|+|++|+||++
T Consensus        57 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~  133 (264)
T cd06623          57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLI  133 (264)
T ss_pred             CCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEE
Confidence            3788888888888889999999999999999999765 568999999999999999999999 88  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....++..|++||.+         |+|++|++++++++|.
T Consensus       134 ~~~~~~~l~df~~~~~~~~~~~~------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~  197 (264)
T cd06623         134 NSKGEVKIADFGISKVLENTLDQ------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK  197 (264)
T ss_pred             CCCCCEEEccCccceecccCCCc------------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999987643221110            0123467889999973         9999999999999885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.84  E-value=3.2e-21  Score=135.45  Aligned_cols=132  Identities=27%  Similarity=0.392  Sum_probs=109.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.....+..++++||++ ++|.+++.... ..+++..+..++.+++.|+.++|+.+  ++|+|++|+||+
T Consensus        55 l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil  131 (283)
T cd07835          55 LNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLL  131 (283)
T ss_pred             cCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEE
Confidence            347889999999999999999999995 58999987643 35889999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||.+........            ......++..|+|||++          |+||+|++++++++|.
T Consensus       132 ~~~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  197 (283)
T cd07835         132 IDREGALKLADFGLARAFGVPVR------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR  197 (283)
T ss_pred             EcCCCcEEEeecccccccCCCcc------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999998864321100            00122457889999963          9999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.84  E-value=2.6e-21  Score=137.80  Aligned_cols=127  Identities=28%  Similarity=0.405  Sum_probs=106.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.....+..++|+||+. |++.+.+......+++..+..++.+++.|+.++|+++  ++|+|++|.||+++
T Consensus        73 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~  149 (308)
T cd06634          73 RHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS  149 (308)
T ss_pred             CCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC
Confidence            36778888888888889999999996 5888877655556888888899999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++......                ....+++.|+|||++            |+||+|+++++++.|.
T Consensus       150 ~~~~~kl~dfg~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  211 (308)
T cd06634         150 EPGLVKLGDFGSASIMAPA----------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  211 (308)
T ss_pred             CCCcEEECCcccceeecCc----------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCC
Confidence            9999999999987643110                123477889999963            9999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.84  E-value=3e-21  Score=139.83  Aligned_cols=127  Identities=29%  Similarity=0.421  Sum_probs=102.3

Q ss_pred             cchhhhcccCCCC------CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           4 LSAAFIDKHSTPH------GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         4 ~~~~~~~~~~~~~------~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      -|+++++..+.+.      +...+|+|+||+.+ +|.+.+..   .+++..+..++.|++.|+.++|+++  ++|+|++|
T Consensus        73 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp  146 (353)
T cd07850          73 NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKP  146 (353)
T ss_pred             CCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCH
Confidence            4677877766543      23467999999965 88888764   2888888899999999999999998  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +||+++.++.++++|||++........             .....++..|+|||++         |+||+|+++++|+.|
T Consensus       147 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g  213 (353)
T cd07850         147 SNIVVKSDCTLKILDFGLARTAGTSFM-------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG  213 (353)
T ss_pred             HHEEECCCCCEEEccCccceeCCCCCC-------------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHC
Confidence            999999999999999999874321100             1123467889999984         999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       214 ~  214 (353)
T cd07850         214 T  214 (353)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.84  E-value=2.4e-21  Score=135.98  Aligned_cols=134  Identities=16%  Similarity=0.170  Sum_probs=105.4

Q ss_pred             cchhhhcccCC-CCCceEEEEEEeccCCCCHHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           4 LSAAFIDKHST-PHGMHEYLILTELCTGGSLVDVLKERT-------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         4 ~~~~~~~~~~~-~~~~~~~~lv~E~~~~g~L~~~l~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      -|+++++..+. .+.....++++||+++++|.+++....       ..+++..+..++.+++.|+.|+|+.+  ++|+|+
T Consensus        66 ~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di  143 (280)
T cd05043          66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDI  143 (280)
T ss_pred             CCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--Eeeccc
Confidence            46888887664 344577899999999999999997532       34788889999999999999999998  999999


Q ss_pred             CCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee
Q psy1934          76 KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML  146 (150)
Q Consensus        76 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~  146 (150)
                      +|+|++++.++.++++|||+++..........          .....++..|+|||+.         |+||+|+++++++
T Consensus       144 ~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~----------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~  213 (280)
T cd05043         144 AARNCVIDEELQVKITDNALSRDLFPMDYHCL----------GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM  213 (280)
T ss_pred             CHhhEEEcCCCcEEECCCCCcccccCCceEEe----------CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHh
Confidence            99999999999999999999874322111000          0112346679999974         9999999999998


Q ss_pred             e-ec
Q psy1934         147 Y-GH  149 (150)
Q Consensus       147 ~-g~  149 (150)
                      . |.
T Consensus       214 ~~g~  217 (280)
T cd05043         214 TLGQ  217 (280)
T ss_pred             cCCC
Confidence            6 64

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.84  E-value=3.1e-21  Score=134.07  Aligned_cols=132  Identities=24%  Similarity=0.328  Sum_probs=104.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|+++++..+... .+.+++++||+++++|.+++.... ..+++..+..++.+++.|+.++|+.+  ++|+|++|+|+++
T Consensus        59 ~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i  135 (260)
T cd05067          59 QHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILV  135 (260)
T ss_pred             CCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEE
Confidence            3677777776654 467899999999999999987533 45788888899999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.+++.|||.+.........           ......++..|++||++         |+||+|++++++++ |.
T Consensus       136 ~~~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~  201 (260)
T cd05067         136 SETLCCKIADFGLARLIEDNEYT-----------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR  201 (260)
T ss_pred             cCCCCEEEccCcceeecCCCCcc-----------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCC
Confidence            99999999999988643211000           00112345679999974         99999999999987 65

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0670|consensus

Probab=99.84  E-value=9e-21  Score=138.92  Aligned_cols=126  Identities=26%  Similarity=0.359  Sum_probs=103.8

Q ss_pred             hhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q psy1934           8 FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         8 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~   85 (150)
                      .+++...+...+++|||+|.+.- +|.++|+.-+  -+|....+..++.|+..|+.+|-.++  ++|.||||+|||+...
T Consensus       496 clrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccC
Confidence            45666778889999999999976 9999998643  35788899999999999999999999  9999999999999876


Q ss_pred             -CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeecC
Q psy1934          86 -GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        86 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~~  150 (150)
                       ..+|+||||.|........              +....+.+|.|||++         |+||.||++||+.+|.+
T Consensus       573 k~iLKLCDfGSA~~~~enei--------------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkI  633 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEI--------------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKI  633 (752)
T ss_pred             cceeeeccCccccccccccc--------------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccce
Confidence             5689999998864322111              112346789999994         99999999999999975

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.84  E-value=2e-21  Score=139.88  Aligned_cols=133  Identities=29%  Similarity=0.425  Sum_probs=104.9

Q ss_pred             ccchhhhcccCCCC-----CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPH-----GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-|+++++..+...     .....++++||+++ ++.+.++.  ..+++..+..++.|++.|+.++|+.+  ++|+|++|
T Consensus        60 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp  134 (336)
T cd07849          60 FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKP  134 (336)
T ss_pred             CCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCH
Confidence            34677888776433     33568999999975 88888865  46889999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLY  147 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~  147 (150)
                      +||+++..+.++++|||++...........         ......+++.|+|||++          |+||+|+++++|++
T Consensus       135 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~  205 (336)
T cd07849         135 SNLLLNTNCDLKICDFGLARIADPEHDHTG---------FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS  205 (336)
T ss_pred             HHEEECCCCCEEECcccceeeccccccccC---------CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            999999999999999998875322111000         01123578899999973          99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |+
T Consensus       206 G~  207 (336)
T cd07849         206 NR  207 (336)
T ss_pred             CC
Confidence            86

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.84  E-value=6e-21  Score=131.61  Aligned_cols=132  Identities=28%  Similarity=0.367  Sum_probs=111.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+..+..+.++++|||+++++|.+++... ..+++..+..++.|++.++.++|+.+  ++|+|++|.||++
T Consensus        50 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~  126 (250)
T cd05123          50 INHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILL  126 (250)
T ss_pred             cCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEE
Confidence            34788899888999999999999999999999999764 35888999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+........            ......++..|++||.         .|+|++|++++++++|.
T Consensus       127 ~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~  190 (250)
T cd05123         127 DADGHIKLTDFGLAKELSSEGS------------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK  190 (250)
T ss_pred             cCCCcEEEeecCcceecccCCC------------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCC
Confidence            9999999999998765322110            0112346778999997         49999999999998875

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.84  E-value=9.8e-22  Score=155.14  Aligned_cols=128  Identities=16%  Similarity=0.162  Sum_probs=89.8

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeec-----
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDF-----   93 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~df-----   93 (150)
                      ..++.++|++ +++|.++++.....+++..++.++.|++.|+.|+|+++  |+|||+||+||+++..+.++++||     
T Consensus        53 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~  129 (793)
T PLN00181         53 DSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCSD  129 (793)
T ss_pred             chhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccCc
Confidence            4678889988 44999999765456899999999999999999999999  999999999999976555555555     


Q ss_pred             --------------CceeccccCCCcchhH---hh-hhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee
Q psy1934          94 --------------GSATEKVYSPDNAWSA---QQ-RSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML  146 (150)
Q Consensus        94 --------------g~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~  146 (150)
                                    |+++............   .. ...........||++|||||++         |+||+||+++||+
T Consensus       130 ~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl  209 (793)
T PLN00181        130 SGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELF  209 (793)
T ss_pred             ccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHh
Confidence                          4443211000000000   00 0000011224689999999985         9999999999998


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       210 ~~~  212 (793)
T PLN00181        210 CPV  212 (793)
T ss_pred             hCC
Confidence            764

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.84  E-value=2.6e-21  Score=135.77  Aligned_cols=132  Identities=24%  Similarity=0.371  Sum_probs=108.7

Q ss_pred             cchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           4 LSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      -|+++++..+.....  +..++|+||+++ +|.+++......+++..+..++.+++.|+.++|+.+  ++|+|++|.||+
T Consensus        56 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil  132 (287)
T cd07840          56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNIL  132 (287)
T ss_pred             cCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeE
Confidence            368888888887776  899999999975 899988765456889999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||.+.........           ......++..|+|||.          .|+|++|++++++++|.
T Consensus       133 ~~~~~~~~l~d~g~~~~~~~~~~~-----------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~  199 (287)
T cd07840         133 INNDGVLKLADFGLARPYTKRNSA-----------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK  199 (287)
T ss_pred             EcCCCCEEEccccceeeccCCCcc-----------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCC
Confidence            999999999999988754322110           0112346778999995          39999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.83  E-value=3.7e-21  Score=135.61  Aligned_cols=131  Identities=28%  Similarity=0.404  Sum_probs=105.7

Q ss_pred             ccchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-|++|++..+.+  ...+.+++||||+++++|.+++..   ....+++..+..++.+++.++.|+|+.+  ++|+|+++
T Consensus        56 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~  133 (287)
T cd06621          56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKP  133 (287)
T ss_pred             CCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCH
Confidence            3477888877754  344578999999999999988753   2345788888999999999999999998  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYG  148 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g  148 (150)
                      .|++++.++.++++|||++........              ....++..|++||.         .|+|++|+++++|++|
T Consensus       134 ~nil~~~~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g  199 (287)
T cd06621         134 SNILLTRKGQVKLCDFGVSGELVNSLA--------------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN  199 (287)
T ss_pred             HHEEEecCCeEEEeecccccccccccc--------------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999999999998764321110              01246778999996         3999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       200 ~  200 (287)
T cd06621         200 R  200 (287)
T ss_pred             C
Confidence            5

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.83  E-value=4.8e-21  Score=135.57  Aligned_cols=129  Identities=25%  Similarity=0.384  Sum_probs=107.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil~~   83 (150)
                      |+++++..+.+...+.++++|||+++ ++.++.......+++..+..++.+++.|+.|+|+ .+  ++|+|++|+||+++
T Consensus        73 ~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~  149 (296)
T cd06618          73 CPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD  149 (296)
T ss_pred             CCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc
Confidence            68899999999999999999999865 8888777655678899888999999999999997 47  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-------------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------d~~~~g~~~~~~~~g~  149 (150)
                      .++.+++.|||++........             .....++..|+|||.+             |+||+|+++++|++|.
T Consensus       150 ~~~~~kL~dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~  215 (296)
T cd06618         150 ASGNVKLCDFGISGRLVDSKA-------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ  215 (296)
T ss_pred             CCCCEEECccccchhccCCCc-------------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCC
Confidence            999999999998764321100             0122467789999963             9999999999999885

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.83  E-value=2.9e-21  Score=138.96  Aligned_cols=134  Identities=25%  Similarity=0.380  Sum_probs=105.5

Q ss_pred             cchhhhcccCCCC----CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           4 LSAAFIDKHSTPH----GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         4 ~~~~~~~~~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      -|+++++..+.+.    ....+++|+||++ ++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+|
T Consensus        62 ~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~N  137 (334)
T cd07855          62 KHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSN  137 (334)
T ss_pred             CCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHH
Confidence            3677887766543    4467899999996 4899988654 45899999999999999999999998  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      |+++.++.++++|||++...........        .......++..|++||+          .|+|++|+++++|+.|.
T Consensus       138 il~~~~~~~kl~dfg~~~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~  209 (334)
T cd07855         138 LLVNEDCELRIGDFGMARGLSSSPTEHK--------YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR  209 (334)
T ss_pred             EEEcCCCcEEecccccceeecccCcCCC--------cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCC
Confidence            9999999999999999875432211100        00112357888999996          39999999999998775

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1035|consensus

Probab=99.83  E-value=1.1e-21  Score=154.23  Aligned_cols=127  Identities=26%  Similarity=0.359  Sum_probs=97.7

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      ..+||-||||+...+.+++++....-..+...+++++|++|+.|+|+.+  ++|||+||.||+++.+..+||.|||++..
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchh
Confidence            5679999999997777777653211146778899999999999999999  99999999999999999999999999986


Q ss_pred             ccc------CCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeee
Q psy1934          99 KVY------SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLY  147 (150)
Q Consensus        99 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~  147 (150)
                      ...      .....+...........++.+||-.|+|||++            |+||+|+++.||++
T Consensus       747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc
Confidence            211      01111111111222345678999999999984            99999999999875

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.83  E-value=5.8e-21  Score=134.12  Aligned_cols=130  Identities=28%  Similarity=0.440  Sum_probs=106.3

Q ss_pred             cchhhhcccCCCCCceE-----EEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           4 LSAAFIDKHSTPHGMHE-----YLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~-----~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      -|+++++..+.+.....     +++++||+++ +|.+++.... ..+++..+..++.+++.|+.++|+.+  ++|+|+++
T Consensus        59 ~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~  135 (287)
T cd07838          59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKP  135 (287)
T ss_pred             CCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCh
Confidence            37888888887766665     9999999975 8999887643 35889999999999999999999998  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +|++++.++.++++|||++........             .....++..|++||++         |+||+|+++++|+.|
T Consensus       136 ~nili~~~~~~~l~dfg~~~~~~~~~~-------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~  202 (287)
T cd07838         136 QNILVTSDGQVKIADFGLARIYSFEMA-------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRR  202 (287)
T ss_pred             hhEEEccCCCEEEeccCcceeccCCcc-------------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhC
Confidence            999999999999999998865321100             0122467789999974         999999999999877


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      +
T Consensus       203 ~  203 (287)
T cd07838         203 R  203 (287)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.83  E-value=5.4e-21  Score=137.63  Aligned_cols=134  Identities=28%  Similarity=0.363  Sum_probs=106.2

Q ss_pred             cchhhhcccCCCCC--ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           4 LSAAFIDKHSTPHG--MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         4 ~~~~~~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      -|+++++..+.+..  ...+++|+||+++ +|.+++...  .+++.....++.+++.|+.++|+.+  ++|+|++|+||+
T Consensus        65 ~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nil  139 (337)
T cd07852          65 DHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNIL  139 (337)
T ss_pred             CCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEE
Confidence            47888888886543  3468999999975 999988753  6788888889999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||.+..........       .........++..|+|||++          |+||+|++++++++|.
T Consensus       140 l~~~~~~kl~d~g~~~~~~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~  210 (337)
T cd07852         140 LNSDCRVKLADFGLARSLSELEENP-------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK  210 (337)
T ss_pred             EcCCCcEEEeeccchhccccccccc-------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCC
Confidence            9999999999999887543221110       00011123578899999963          9999999999999885

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.83  E-value=5.3e-21  Score=135.42  Aligned_cols=121  Identities=16%  Similarity=0.119  Sum_probs=92.0

Q ss_pred             EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceecc
Q psy1934          20 EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK   99 (150)
Q Consensus        20 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   99 (150)
                      ..++++|++.. ++.+.++.. ...++..+..++.|++.|+.|+|+.+  ++|||+||+||+++.++.++++|||+++..
T Consensus       101 ~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~~~~l~DFGla~~~  176 (294)
T PHA02882        101 YRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNNRGYIIDYGIASHF  176 (294)
T ss_pred             EEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCcEEEEEcCCceee
Confidence            34788888754 777776543 33577788889999999999999998  999999999999999999999999998754


Q ss_pred             ccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934         100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ..........     ........||+.|+|||+.         |+||+|+++++|++|.
T Consensus       177 ~~~~~~~~~~-----~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~  230 (294)
T PHA02882        177 IIHGKHIEYS-----KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIK  230 (294)
T ss_pred             ccCCcccccc-----cccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            3221110000     0011123589999999974         9999999999999885

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.83  E-value=5.7e-21  Score=131.93  Aligned_cols=132  Identities=27%  Similarity=0.404  Sum_probs=110.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      -++++++..+.......+++++||+++++|.+++.+..   ..+++..+..++.+++.|+.++|+.+  ++|+|++++|+
T Consensus        57 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~ni  134 (258)
T cd08215          57 NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNI  134 (258)
T ss_pred             CCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHe
Confidence            36888888888888899999999999999999998652   56899999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++........            ......+++.|++||.         .|+|++|+++++++.|.
T Consensus       135 l~~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~  200 (258)
T cd08215         135 FLTSNGLVKLGDFGISKVLSSTVD------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK  200 (258)
T ss_pred             EEcCCCcEEECCccceeecccCcc------------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCC
Confidence            999999999999998864322110            0012357788999997         49999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.83  E-value=5.3e-21  Score=131.51  Aligned_cols=131  Identities=27%  Similarity=0.477  Sum_probs=110.8

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -++++++..+.+...+..++++||+++++|.+++......+++..+..++.+++.++.++|+.+  ++|+|++|.||+++
T Consensus        55 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~  132 (253)
T cd05122          55 KHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT  132 (253)
T ss_pred             CCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc
Confidence            3677888888888889999999999999999999775457899999999999999999999988  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.+++.|||.+........             .....++..|++||++         |+|++|++++++++|.
T Consensus       133 ~~~~~~l~d~~~~~~~~~~~~-------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~  194 (253)
T cd05122         133 SDGEVKLIDFGLSAQLSDTKA-------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK  194 (253)
T ss_pred             cCCeEEEeecccccccccccc-------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCC
Confidence            999999999998764322110             1133577889999973         9999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.83  E-value=5.8e-21  Score=133.89  Aligned_cols=131  Identities=31%  Similarity=0.430  Sum_probs=109.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -++++++..+.....+.+++++||+++ ++.+.+......+++..+..++.+++.|+.++|+.+  ++|+|++|+||+++
T Consensus        56 ~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~  132 (283)
T cd05118          56 NHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN  132 (283)
T ss_pred             cCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC
Confidence            367888888888888999999999976 899988775567899999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||.+........            ......++..|++||.+          |+|++|++++++++|+
T Consensus       133 ~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~  196 (283)
T cd05118         133 TEGVLKLADFGLARSFGSPVR------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR  196 (283)
T ss_pred             CCCcEEEeeeeeeEecCCCcc------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence            999999999998865422110            00123467789999973          9999999999999885

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.83  E-value=4.5e-21  Score=137.89  Aligned_cols=143  Identities=25%  Similarity=0.347  Sum_probs=110.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.++++|||+++ +|.+++... ..+++.....++.|++.|+.++|+.+  ++|+|+++.||++
T Consensus        77 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill  152 (335)
T PTZ00024         77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFI  152 (335)
T ss_pred             CCCcceeeeeEEEecCCcEEEEEecccc-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEE
Confidence            3478899999998888999999999974 999998753 45888889999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcch-hHhhh-hhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAW-SAQQR-SMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+........... ..... ..........+++.|+|||++          |+||+|+++++|++|.
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999998875431110000 00000 000011123467889999964          9999999999999885

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.83  E-value=6.5e-21  Score=131.92  Aligned_cols=133  Identities=25%  Similarity=0.406  Sum_probs=109.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+..+..+.+++++||+++++|.+++.... ..+++..+..++.+++.|+.++|+.+  ++|+|++|.||+
T Consensus        56 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil  133 (257)
T cd08225          56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIF  133 (257)
T ss_pred             CCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEE
Confidence            347889999999999999999999999999999997543 34788899999999999999999998  999999999999


Q ss_pred             EcCCC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++ .++++|||.+.........            .....+++.|+|||+.         |+|++|+++++++.|.
T Consensus       134 ~~~~~~~~~l~d~~~~~~~~~~~~~------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~  199 (257)
T cd08225         134 LSKNGMVAKLGDFGIARQLNDSMEL------------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK  199 (257)
T ss_pred             EcCCCCeEEecccccchhccCCccc------------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            98875 5699999987643211100            0122478889999973         9999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.82  E-value=7.1e-21  Score=133.17  Aligned_cols=142  Identities=23%  Similarity=0.286  Sum_probs=112.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ++++++..+.+...+.++++||++++++|.+++... ..+++..+..++.+++.|+.++|+.+  ++|+|++++||+++.
T Consensus        61 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~  137 (280)
T cd05581          61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDK  137 (280)
T ss_pred             CCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECC
Confidence            788999999999999999999999999999999764 46899999999999999999999998  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchh--------HhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeee
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWS--------AQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLY  147 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~  147 (150)
                      ++.++++|||.+............        ..............++..|++||+         .|+|++|+++++++.
T Consensus       138 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~  217 (280)
T cd05581         138 DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT  217 (280)
T ss_pred             CCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHh
Confidence            999999999987643221100000        000000011123356788999997         499999999999988


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       218 g~  219 (280)
T cd05581         218 GK  219 (280)
T ss_pred             CC
Confidence            74

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.82  E-value=1.3e-20  Score=132.05  Aligned_cols=131  Identities=31%  Similarity=0.477  Sum_probs=109.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|+++++..+.....+.+++|+||+++ +|.+++.+....+++..+..++.+++.|+.++|+++  ++|+|++++||+++
T Consensus        56 ~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~  132 (282)
T cd07829          56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN  132 (282)
T ss_pred             CCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc
Confidence            378899999988888999999999985 999999875456899999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||.+........            ......++..|+|||.          .|+|++|+++++++.|.
T Consensus       133 ~~~~~~l~d~g~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~  196 (282)
T cd07829         133 RDGVLKLADFGLARAFGIPLR------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK  196 (282)
T ss_pred             CCCCEEEecCCcccccCCCcc------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence            999999999998764321110            0012235677999996          39999999999998874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=1.1e-20  Score=130.49  Aligned_cols=132  Identities=27%  Similarity=0.457  Sum_probs=110.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-++++++..+.....+.+++++||+++++|.+++... ..+++..+..++.+++.++.++|+.+  ++|+|++|.||++
T Consensus        56 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i  132 (254)
T cd06627          56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILT  132 (254)
T ss_pred             CCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE
Confidence            34678888888888889999999999999999999765 56899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+.........            .....++..|++||.         .|+|++|++++++++|.
T Consensus       133 ~~~~~~~l~d~~~~~~~~~~~~~------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~  196 (254)
T cd06627         133 TKDGVVKLADFGVATKLNDVSKD------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN  196 (254)
T ss_pred             CCCCCEEEeccccceecCCCccc------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCC
Confidence            99999999999988754322110            012346778999997         49999999999998875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG1345|consensus

Probab=99.82  E-value=3.6e-20  Score=126.51  Aligned_cols=127  Identities=30%  Similarity=0.406  Sum_probs=99.7

Q ss_pred             chhhhc-ccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFID-KHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~-~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      |.+|++ +.-.++..+.+.+++||+|.|+|.+-+..  .++.+..-+.++.|+++|+.|||+.+  ++|||+|.+|||+-
T Consensus        80 H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif  155 (378)
T KOG1345|consen   80 HQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIF  155 (378)
T ss_pred             chhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEe
Confidence            344666 44477888899999999999999987754  56778877889999999999999999  99999999999995


Q ss_pred             CC--CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeee
Q psy1934          84 SA--GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLY  147 (150)
Q Consensus        84 ~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~  147 (150)
                      ..  .++|++|||..+.....-.               ...-+..|-+||+.              |+|.+|++++..+.
T Consensus       156 ~~df~rvKlcDFG~t~k~g~tV~---------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt  220 (378)
T KOG1345|consen  156 DADFYRVKLCDFGLTRKVGTTVK---------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT  220 (378)
T ss_pred             cCCccEEEeeecccccccCceeh---------------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeec
Confidence            43  5899999998764321100               01124457888873              99999999999999


Q ss_pred             ecC
Q psy1934         148 GHV  150 (150)
Q Consensus       148 g~~  150 (150)
                      |..
T Consensus       221 G~~  223 (378)
T KOG1345|consen  221 GKF  223 (378)
T ss_pred             CCC
Confidence            963

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.82  E-value=7.1e-21  Score=135.16  Aligned_cols=142  Identities=21%  Similarity=0.303  Sum_probs=105.6

Q ss_pred             cchhhhcccCCC--------CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           4 LSAAFIDKHSTP--------HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         4 ~~~~~~~~~~~~--------~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      -|+++++..+..        +....+++++||+++ ++.+.+......+++..+..++.|++.|+.|+|+.+  ++|+|+
T Consensus        65 ~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl  141 (311)
T cd07866          65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDI  141 (311)
T ss_pred             CCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence            467777776644        334467999999976 787777654456899999999999999999999998  999999


Q ss_pred             CCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEe
Q psy1934          76 KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSM  145 (150)
Q Consensus        76 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~  145 (150)
                      +|+||+++.++.++++|||++............ .............+++.|+|||++          |+||+|+++++|
T Consensus       142 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el  220 (311)
T cd07866         142 KAANILIDNQGILKIADFGLARPYDGPPPNPKG-GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM  220 (311)
T ss_pred             CHHHEEECCCCCEEECcCccchhccCCCccccc-CCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHH
Confidence            999999999999999999988743222111000 000000111234567889999963          999999999999


Q ss_pred             eeec
Q psy1934         146 LYGH  149 (150)
Q Consensus       146 ~~g~  149 (150)
                      +.|.
T Consensus       221 ~~g~  224 (311)
T cd07866         221 FTRR  224 (311)
T ss_pred             HhCC
Confidence            9885

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.82  E-value=1.6e-20  Score=129.76  Aligned_cols=130  Identities=25%  Similarity=0.332  Sum_probs=109.9

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      -|+++++..+.+...+.+++++||+++++|.+++...   ...+++..+..++.+++.|+.++|+.+  ++|+|+++.||
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni  134 (256)
T cd08530          57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANI  134 (256)
T ss_pred             CCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceE
Confidence            3688999999989999999999999999999998652   245788888999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.+++.|||++.......              .....+++.|++||.         .|+|++|+++++++.|+
T Consensus       135 ~~~~~~~~kl~d~g~~~~~~~~~--------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~  198 (256)
T cd08530         135 LLVANDLVKIGDLGISKVLKKNM--------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA  198 (256)
T ss_pred             EEecCCcEEEeeccchhhhccCC--------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999886542210              012346788999997         49999999999998875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.82  E-value=7.3e-21  Score=152.92  Aligned_cols=127  Identities=19%  Similarity=0.248  Sum_probs=103.3

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCCCE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIENL   80 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~ni   80 (150)
                      ++-||+|+++.+++...+..++||||+++|+|.++++.    +++..+..++.+++.|+.|+|.. .++++|+|++|+||
T Consensus       739 ~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Ni  814 (968)
T PLN00113        739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI  814 (968)
T ss_pred             hCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhE
Confidence            35689999999999988999999999999999999963    78888899999999999999943 22399999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++..+..++. ++.......                .....+++.|+|||++         |+||+|++++||++|.
T Consensus       815 l~~~~~~~~~~-~~~~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~  875 (968)
T PLN00113        815 IIDGKDEPHLR-LSLPGLLCT----------------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK  875 (968)
T ss_pred             EECCCCceEEE-ecccccccc----------------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCC
Confidence            99988777664 443321100                0123578899999984         9999999999999885

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.82  E-value=3.5e-20  Score=139.01  Aligned_cols=119  Identities=25%  Similarity=0.393  Sum_probs=92.5

Q ss_pred             ceEEEEEEeccCCCCHHHHHHhhCC-----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEEec
Q psy1934          18 MHEYLILTELCTGGSLVDVLKERTS-----------------------ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD   74 (150)
Q Consensus        18 ~~~~~lv~E~~~~g~L~~~l~~~~~-----------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~   74 (150)
                      ++..|+|+||+++++|.++++....                       .+++..+..++.+++.++.|+|+.+  ++|+|
T Consensus       257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrD  334 (507)
T PLN03224        257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRD  334 (507)
T ss_pred             CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCC
Confidence            4578999999999999999864211                       1345567788999999999999998  99999


Q ss_pred             CCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------------------
Q psy1934          75 LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------------------  132 (150)
Q Consensus        75 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------------------  132 (150)
                      ++|+||+++.++.++++|||++.........           ......+++.|++||+                      
T Consensus       335 LKp~NILl~~~~~~kL~DFGla~~~~~~~~~-----------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~  403 (507)
T PLN03224        335 IKPENLLVTVDGQVKIIDFGAAVDMCTGINF-----------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPF  403 (507)
T ss_pred             CchHhEEECCCCcEEEEeCcCccccccCCcc-----------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhh
Confidence            9999999999999999999998643211000           0011234778999996                      


Q ss_pred             ---------ccccccceeEEEeeeec
Q psy1934         133 ---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus       133 ---------~d~~~~g~~~~~~~~g~  149 (150)
                               +|+||+|+++++|+.|.
T Consensus       404 ~~~yg~~~~~DvwSlGvil~em~~~~  429 (507)
T PLN03224        404 AWLYGRPDLFDSYTAGVLLMQMCVPE  429 (507)
T ss_pred             HHhcCCCCccchhhHHHHHHHHHhCC
Confidence                     39999999999998764

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.82  E-value=1.5e-20  Score=130.57  Aligned_cols=131  Identities=31%  Similarity=0.391  Sum_probs=107.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      -||++++..+.......+++++||+++++|.+++...   ...+++..+..++.+++.|+.++|+.+  ++|+|++|+|+
T Consensus        60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~ni  137 (260)
T cd08222          60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNI  137 (260)
T ss_pred             CCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhhe
Confidence            4788999988888889999999999999999988642   245889999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      +++. +.++++|||++.........            .....+++.|++||.         .|+|++|++++++++|.
T Consensus       138 li~~-~~~~l~d~g~~~~~~~~~~~------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~  202 (260)
T cd08222         138 FLKN-NLLKIGDFGVSRLLMGSCDL------------ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA  202 (260)
T ss_pred             Eeec-CCEeecccCceeecCCCccc------------ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            9975 56999999988653221110            112346788999997         49999999999988775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0200|consensus

Probab=99.81  E-value=2.3e-20  Score=143.40  Aligned_cols=130  Identities=20%  Similarity=0.335  Sum_probs=107.4

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      |++++.+.++....+.+++|+||++.|+|.++|+...               ..++......++.||+.|++||++..  
T Consensus       361 H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--  438 (609)
T KOG0200|consen  361 HPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--  438 (609)
T ss_pred             CcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--
Confidence            7889999998888999999999999999999998754               23777788899999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCC--CCCccCcccc---------ccccc
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAPEMV---------DTWNN  138 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~y~aPE~~---------d~~~~  138 (150)
                      ++|||+...||++..+..+|++|||+++........  ...         ...+  ...|||||.+         |+||+
T Consensus       439 ~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y--~~~---------~~~~~LP~kWmApEsl~~~~ft~kSDVWSf  507 (609)
T KOG0200|consen  439 CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYY--RTK---------SSAGTLPVKWMAPESLFDRVFTSKSDVWSF  507 (609)
T ss_pred             ccchhhhhhhEEecCCCEEEEccccceeccCCCCce--Eec---------CCCCccceeecCHHHhccCcccccchhhHH
Confidence            999999999999999999999999999853322111  000         0011  2359999986         99999


Q ss_pred             ceeEEEeee
Q psy1934         139 YVIGRSMLY  147 (150)
Q Consensus       139 g~~~~~~~~  147 (150)
                      |+++||++.
T Consensus       508 GI~L~Eifs  516 (609)
T KOG0200|consen  508 GILLWEIFT  516 (609)
T ss_pred             HHHHHHHhh
Confidence            999999873

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.81  E-value=1.5e-20  Score=135.41  Aligned_cols=130  Identities=28%  Similarity=0.397  Sum_probs=104.5

Q ss_pred             cchhhhcccCCCCCc-----eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           4 LSAAFIDKHSTPHGM-----HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      -|+++++..+.....     ..+++++||+. ++|.++++.. ..+++..+..++.|++.|+.++|+.+  ++|+|++|+
T Consensus        62 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~  137 (337)
T cd07858          62 DHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPS  137 (337)
T ss_pred             CCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHH
Confidence            467788877755433     35899999996 5899888754 46889999999999999999999998  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeee
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g  148 (150)
                      ||+++.++.++++|||++........            ......++..|+|||++          |+|++|+++++|+.|
T Consensus       138 Nil~~~~~~~kL~Dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g  205 (337)
T cd07858         138 NLLLNANCDLKICDFGLARTTSEKGD------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR  205 (337)
T ss_pred             HEEEcCCCCEEECcCccccccCCCcc------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcC
Confidence            99999999999999998874321100            01123567889999963          999999999999887


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       206 ~  206 (337)
T cd07858         206 K  206 (337)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.81  E-value=1.6e-20  Score=134.95  Aligned_cols=133  Identities=26%  Similarity=0.388  Sum_probs=104.1

Q ss_pred             chhhhcccCCC----CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           5 SAAFIDKHSTP----HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         5 ~~~~~~~~~~~----~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      |++|++..+..    .....+++++||++ ++|.+.+... ..+++..++.++.|++.|+.|+|+.+  ++|+|++|+||
T Consensus        61 h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Ni  136 (332)
T cd07857          61 HKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNL  136 (332)
T ss_pred             CCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHe
Confidence            67888877642    33356789999986 4899988653 46889999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||.+..........        ........|++.|+|||+.          |+||+|+++++++.|.
T Consensus       137 li~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~  207 (332)
T cd07857         137 LVNADCELKICDFGLARGFSENPGEN--------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK  207 (332)
T ss_pred             EEcCCCCEEeCcCCCceecccccccc--------cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999999987532211100        0001124688899999963          9999999999988774

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.81  E-value=2.1e-20  Score=135.03  Aligned_cols=127  Identities=27%  Similarity=0.397  Sum_probs=103.8

Q ss_pred             ccchhhhcccCCCCCce------EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGMH------EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-|+++++..+.+....      .+++|+||+ +++|.+++..  ..+++..+..++.|++.|+.++|+.+  ++|+|++
T Consensus        71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlk  145 (343)
T cd07880          71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLK  145 (343)
T ss_pred             cCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCC
Confidence            34678888877665433      569999999 6699988864  46889999999999999999999998  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.++++|||++......               .....+++.|++||+          .|+|++|+++++++
T Consensus       146 p~Nill~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~  210 (343)
T cd07880         146 PGNLAVNEDCELKILDFGLARQTDSE---------------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML  210 (343)
T ss_pred             HHHEEEcCCCCEEEeecccccccccC---------------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            99999999999999999988643211               012346788999996          39999999999998


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      .|.
T Consensus       211 ~g~  213 (343)
T cd07880         211 TGK  213 (343)
T ss_pred             hCC
Confidence            875

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.81  E-value=2e-20  Score=129.15  Aligned_cols=132  Identities=30%  Similarity=0.415  Sum_probs=110.2

Q ss_pred             chhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           5 SAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         5 ~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      |+++++..+.....  +.+++++||+++++|.+++.+.. .+++..+..++.+++.++.++|+.+  ++|+|++|+||++
T Consensus        58 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i  134 (260)
T cd06606          58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILV  134 (260)
T ss_pred             CCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE
Confidence            67888888877777  89999999999999999998653 7889999999999999999999988  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+.........          .......++..|++||..         |+|++|+++++++.|.
T Consensus       135 ~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~  200 (260)
T cd06606         135 DSDGVVKLADFGCAKRLGDIETG----------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK  200 (260)
T ss_pred             cCCCCEEEcccccEEeccccccc----------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999988754322110          001133577889999974         9999999999998875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.81  E-value=2e-20  Score=131.70  Aligned_cols=129  Identities=28%  Similarity=0.369  Sum_probs=103.3

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHH---h-hCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK---E-RTSALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIEN   79 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~---~-~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~n   79 (150)
                      |+++++..+.....+..++++||++. ++.++..   . ....+++..+..++.+++.|+.|+|+. +  ++|+|++|+|
T Consensus        62 ~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~N  138 (288)
T cd06616          62 CPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSN  138 (288)
T ss_pred             CCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHH
Confidence            68899988888888899999999865 6655432   1 224688899999999999999999974 7  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc------------ccccccceeEEEeee
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------------VDTWNNYVIGRSMLY  147 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~------------~d~~~~g~~~~~~~~  147 (150)
                      |+++.++.++++|||++........             .....+++.|+|||+            .|+||+|++++++++
T Consensus       139 il~~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  205 (288)
T cd06616         139 ILLDRNGNIKLCDFGISGQLVDSIA-------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT  205 (288)
T ss_pred             EEEccCCcEEEeecchhHHhccCCc-------------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHh
Confidence            9999999999999998764321100             012347788999996            399999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       206 g~  207 (288)
T cd06616         206 GK  207 (288)
T ss_pred             CC
Confidence            85

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.81  E-value=3e-20  Score=134.29  Aligned_cols=127  Identities=28%  Similarity=0.427  Sum_probs=103.1

Q ss_pred             ccchhhhcccCCCC------CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPH------GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~------~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-|+++++..+.+.      ..+.++++++++ +++|.+.++.  ..+++..+..++.|++.|+.|+|+.+  ++|+|++
T Consensus        73 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlk  147 (345)
T cd07877          73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLK  147 (345)
T ss_pred             cCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCC
Confidence            45778888777553      234578899887 6799888764  35888999999999999999999998  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.++++|||++......               .....++..|+|||+          .|+||+|+++++++
T Consensus       148 p~NIll~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  212 (345)
T cd07877         148 PSNLAVNEDCELKILDFGLARHTDDE---------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  212 (345)
T ss_pred             hHHEEEcCCCCEEEeccccccccccc---------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH
Confidence            99999999999999999987643111               012357888999996          39999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      .|.
T Consensus       213 ~g~  215 (345)
T cd07877         213 TGR  215 (345)
T ss_pred             hCC
Confidence            885

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.81  E-value=1.7e-20  Score=134.57  Aligned_cols=133  Identities=29%  Similarity=0.406  Sum_probs=107.2

Q ss_pred             cchhhhcccCCCCCce-----EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           4 LSAAFIDKHSTPHGMH-----EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      -|+++++..+.....+     .+++++||+++ +|.+++.+. ..+++..+..++.+++.|+.++|+.+  ++|+|++|.
T Consensus        57 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~  132 (330)
T cd07834          57 RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPS  132 (330)
T ss_pred             CCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence            3677888877666554     88999999985 899988754 37889999999999999999999998  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeee
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g  148 (150)
                      ||+++.++.++++|||.+..........         .......+++.|+|||++          |+|++|+++++|++|
T Consensus       133 nili~~~~~~~L~dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g  203 (330)
T cd07834         133 NILVNSNCDLKICDFGLARGVDPDEDEK---------GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR  203 (330)
T ss_pred             HEEEcCCCCEEEcccCceEeeccccccc---------ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcC
Confidence            9999999999999999887543221100         001123578889999973          999999999999887


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       204 ~  204 (330)
T cd07834         204 K  204 (330)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0664|consensus

Probab=99.81  E-value=1.9e-22  Score=138.00  Aligned_cols=115  Identities=35%  Similarity=0.522  Sum_probs=92.6

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      +++|.++|.+.. +|-+.+-+ ...++.+.++.+++||+.|+.|+|+.+  |.|||+||.|.++.++-.+|++|||+++.
T Consensus       130 qEiYV~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  130 QELYVLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccc
Confidence            355788888865 66666543 356889999999999999999999999  99999999999999999999999999985


Q ss_pred             cccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeee
Q psy1934          99 KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYG  148 (150)
Q Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g  148 (150)
                      ....        +   ....+..+.|.+|+|||+          +|+||.||++.|++-.
T Consensus       206 ee~d--------~---~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgR  254 (449)
T KOG0664|consen  206 WDQR--------D---RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQR  254 (449)
T ss_pred             cchh--------h---hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhh
Confidence            3211        1   122345567889999998          4999999999887643

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.80  E-value=2.5e-20  Score=134.57  Aligned_cols=126  Identities=27%  Similarity=0.403  Sum_probs=103.2

Q ss_pred             cchhhhcccCCCCCce------EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           4 LSAAFIDKHSTPHGMH------EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      -|+++++..+.+...+      .+++|+||+ +++|.+++..  ..+++..+..++.+++.|+.++|+.+  ++|+|++|
T Consensus        72 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp  146 (343)
T cd07851          72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKP  146 (343)
T ss_pred             cCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            3677777766555444      489999999 5599998875  46889999999999999999999998  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLY  147 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~  147 (150)
                      +|++++.++.++++|||++......               .....++..|+|||+          .|+||+|+++++++.
T Consensus       147 ~Nill~~~~~~kL~dfg~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt  211 (343)
T cd07851         147 SNIAVNEDCELKILDFGLARHTDDE---------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT  211 (343)
T ss_pred             HHeEECCCCCEEEcccccccccccc---------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHh
Confidence            9999999999999999988643211               012346788999996          399999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       212 g~  213 (343)
T cd07851         212 GK  213 (343)
T ss_pred             CC
Confidence            85

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.80  E-value=4.4e-20  Score=132.65  Aligned_cols=127  Identities=31%  Similarity=0.467  Sum_probs=104.0

Q ss_pred             ccchhhhcccCCCCC-ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHG-MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||++++..+.+.. .+.+++++||+ +++|.++++.  ..+++..+..++.|++.|+.++|+.+  ++|+|++|.|++
T Consensus        66 l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nil  140 (328)
T cd07856          66 LRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNIL  140 (328)
T ss_pred             cCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEe
Confidence            457889998887754 56789999998 4589988864  35777888888999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||.+......               .....+++.|++||++          |+|++|+++++++.|.
T Consensus       141 i~~~~~~~l~dfg~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~  203 (328)
T cd07856         141 INENCDLKICDFGLARIQDPQ---------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK  203 (328)
T ss_pred             ECCCCCEEeCccccccccCCC---------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999987632110               0123467789999963          9999999999999885

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.80  E-value=5.2e-20  Score=132.88  Aligned_cols=126  Identities=25%  Similarity=0.382  Sum_probs=101.5

Q ss_pred             ccchhhhcccCCCCCc------eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGM------HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-|+++++..+.+...      ..+++++||+.. ++.+...   ..+++..+..++.+++.|+.++|+.+  ++|+|++
T Consensus        71 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlk  144 (342)
T cd07879          71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLK  144 (342)
T ss_pred             cCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCC
Confidence            3478888887765533      457999999965 7776553   35888888899999999999999998  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.++++|||++......               .....++..|+|||++          |+||+|+++++++
T Consensus       145 p~NIll~~~~~~kL~dfg~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~  209 (342)
T cd07879         145 PGNLAVNEDCELKILDFGLARHADAE---------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML  209 (342)
T ss_pred             HHHEEECCCCCEEEeeCCCCcCCCCC---------------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence            99999999999999999987643111               0123467889999973          9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      .|.
T Consensus       210 ~g~  212 (342)
T cd07879         210 TGK  212 (342)
T ss_pred             hCC
Confidence            886

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0576|consensus

Probab=99.80  E-value=3.3e-20  Score=138.95  Aligned_cols=128  Identities=27%  Similarity=0.430  Sum_probs=109.9

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      .||+|+-+.+.+--..+.|++||||.+|+|.+.-... +++++.++....+..+.|+.|+|+.+  =+|||+|-.||++.
T Consensus        70 ~h~nivay~gsylr~dklwicMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt  146 (829)
T KOG0576|consen   70 RHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT  146 (829)
T ss_pred             CCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec
Confidence            4788999988888889999999999999999966543 67899898888899999999999998  89999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc------------ccccccceeEEEee
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------------VDTWNNYVIGRSML  146 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~------------~d~~~~g~~~~~~~  146 (150)
                      ..+.+|++|||.+-...            ..........||++|||||+            .|+|+.|+.+.|+.
T Consensus       147 d~gDvklaDfgvsaqit------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~  209 (829)
T KOG0576|consen  147 DEGDVKLADFGVSAQIT------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELG  209 (829)
T ss_pred             ccCceeecccCchhhhh------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhh
Confidence            99999999999875432            23334456789999999998            49999999988753

>KOG0199|consensus

Probab=99.79  E-value=1.5e-20  Score=141.79  Aligned_cols=135  Identities=27%  Similarity=0.397  Sum_probs=110.4

Q ss_pred             CcccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           1 MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +++-|+++|++.++--+ ...++|+|.++.|+|.++|+. ....+-......++.||+.|+.||.+++  ++|||+...|
T Consensus       166 ~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARN  242 (1039)
T KOG0199|consen  166 LKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARN  242 (1039)
T ss_pred             HhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhh
Confidence            35678999999887776 788999999999999999986 4456778889999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      +++.+...+||+|||+.+......+. +....        ...-...|.|||.+         |+|++|+++|||++
T Consensus       243 lllasprtVKI~DFGLmRaLg~ned~-Yvm~p--------~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt  310 (1039)
T KOG0199|consen  243 LLLASPRTVKICDFGLMRALGENEDM-YVMAP--------QRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT  310 (1039)
T ss_pred             heecccceeeeecccceeccCCCCcc-eEecC--------CCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence            99999999999999998865433221 11100        11234569999986         99999999999994

>KOG1027|consensus

Probab=99.79  E-value=1.7e-19  Score=137.73  Aligned_cols=132  Identities=27%  Similarity=0.329  Sum_probs=104.3

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh--CCCCCH-HHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER--TSALPP-NIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~-~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ||++|++...-++.+..||+.|.|.- +|.++++..  ...... -.....+.|+.+|+.|||+.+  |+|||+||+|||
T Consensus       562 H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNIL  638 (903)
T KOG1027|consen  562 HPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNIL  638 (903)
T ss_pred             CCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEE
Confidence            78999999999999999999999965 999999873  111111 233566789999999999999  999999999999


Q ss_pred             EcC---C--CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          82 ISS---A--GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        82 ~~~---~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      +..   +  .+++|+|||+++........ .        ....+..||-.|+|||++         |++++||+++-.+.
T Consensus       639 I~~~~~~~~~ra~iSDfglsKkl~~~~sS-~--------~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvlt  709 (903)
T KOG1027|consen  639 ISVPSADGTLRAKISDFGLSKKLAGGKSS-F--------SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLT  709 (903)
T ss_pred             EEccCCCcceeEEecccccccccCCCcch-h--------hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEec
Confidence            977   2  46899999999865332221 1        112344689999999995         99999999999887


Q ss_pred             e
Q psy1934         148 G  148 (150)
Q Consensus       148 g  148 (150)
                      |
T Consensus       710 g  710 (903)
T KOG1027|consen  710 G  710 (903)
T ss_pred             C
Confidence            6

>KOG1167|consensus

Probab=99.79  E-value=2.7e-19  Score=127.67  Aligned_cols=138  Identities=25%  Similarity=0.306  Sum_probs=107.8

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~   85 (150)
                      .++++........+++++|+||++..+..++...    ++...++.+++.++.|+.++|.++  |+|||+||.|++.+..
T Consensus        95 ~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~  168 (418)
T KOG1167|consen   95 DNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRR  168 (418)
T ss_pred             hhhhcchhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccc
Confidence            4688899999999999999999999888887753    667888899999999999999999  9999999999999876


Q ss_pred             -CcEEEeecCceeccccCCCc-------------------------------chhH-hhhhhhHHhhhcCCCCCccCccc
Q psy1934          86 -GTVKLCDFGSATEKVYSPDN-------------------------------AWSA-QQRSMLEDEMARFTTPMYRAPEM  132 (150)
Q Consensus        86 -~~~~l~dfg~~~~~~~~~~~-------------------------------~~~~-~~~~~~~~~~~~~~~~~y~aPE~  132 (150)
                       ++-.+.|||++.........                               .+.. ...+.........||+.|+|||+
T Consensus       169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv  248 (418)
T KOG1167|consen  169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV  248 (418)
T ss_pred             cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence             77889999999821100000                               0000 01111223445679999999999


Q ss_pred             ----------ccccccceeEEEeeeec
Q psy1934         133 ----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus       133 ----------~d~~~~g~~~~~~~~g~  149 (150)
                                +|+||.|+++..++.++
T Consensus       249 L~k~~~QttaiDiws~GVI~Lslls~~  275 (418)
T KOG1167|consen  249 LFRCPRQTTAIDIWSAGVILLSLLSRR  275 (418)
T ss_pred             HhhccCcCCccceeeccceeehhhccc
Confidence                      49999999999988764

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.79  E-value=1.5e-19  Score=126.30  Aligned_cols=133  Identities=17%  Similarity=0.199  Sum_probs=100.0

Q ss_pred             ccchhhhcccCCCCCc------eEEEEEEeccCCCCHHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy1934           3 YLSAAFIDKHSTPHGM------HEYLILTELCTGGSLVDVLKERT-----SALPPNIVCSILWQTCQAVKHMHGQNPPIV   71 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~   71 (150)
                      +-||++++..+.....      ...++++||+++|+|.+++....     ..++...+..++.+++.|+.|+|+.+  ++
T Consensus        58 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~  135 (273)
T cd05074          58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FI  135 (273)
T ss_pred             CCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--Ee
Confidence            3467787777644322      23478999999999998875321     24678888999999999999999998  99


Q ss_pred             EecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeE
Q psy1934          72 HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIG  142 (150)
Q Consensus        72 h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~  142 (150)
                      |+|++|+||+++.++.++++|||+++.........          ......+++.|++||.         .|+||+|+++
T Consensus       136 H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il  205 (273)
T cd05074         136 HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR----------QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTM  205 (273)
T ss_pred             ecccchhhEEEcCCCCEEECcccccccccCCccee----------cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHH
Confidence            99999999999999999999999887532211000          0011234567899997         3999999999


Q ss_pred             EEeee
Q psy1934         143 RSMLY  147 (150)
Q Consensus       143 ~~~~~  147 (150)
                      ++++.
T Consensus       206 ~el~~  210 (273)
T cd05074         206 WEIMT  210 (273)
T ss_pred             HHHhh
Confidence            99886

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.79  E-value=9.6e-20  Score=131.50  Aligned_cols=132  Identities=24%  Similarity=0.345  Sum_probs=100.2

Q ss_pred             cchhhhcccCCCCC--------------ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           4 LSAAFIDKHSTPHG--------------MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         4 ~~~~~~~~~~~~~~--------------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      -|+++++..+....              ....++++||+++ +|.+++..  ..+++..++.++.|++.|+.|+|+.+  
T Consensus        60 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--  134 (342)
T cd07854          60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN--  134 (342)
T ss_pred             CCCcchhhHhhhcccccccccccccccccceEEEEeecccc-cHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            35677776654333              2468999999975 89888864  45889999999999999999999998  


Q ss_pred             eEEecCCCCCEEEcCC-CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------cccccc
Q psy1934          70 IVHRDLKIENLLISSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNN  138 (150)
Q Consensus        70 i~h~~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~  138 (150)
                      ++|+|++++|++++.. +.++++|||.+..........         .......++..|+|||+          .|+||+
T Consensus       135 ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl  205 (342)
T cd07854         135 VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK---------GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA  205 (342)
T ss_pred             cccCCCCHHHEEEcCCCceEEECCcccceecCCccccc---------cccccccccccccCHHHHhCccccCchhhHHHH
Confidence            9999999999999754 578999999886431110000         00012246788999996          399999


Q ss_pred             ceeEEEeeeec
Q psy1934         139 YVIGRSMLYGH  149 (150)
Q Consensus       139 g~~~~~~~~g~  149 (150)
                      |+++++|++|.
T Consensus       206 Gvil~el~~g~  216 (342)
T cd07854         206 GCIFAEMLTGK  216 (342)
T ss_pred             HHHHHHHHhCC
Confidence            99999999885

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.77  E-value=2e-18  Score=134.19  Aligned_cols=114  Identities=25%  Similarity=0.377  Sum_probs=95.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++|+++....+..+.+|+||||+++++|.+++... ..+++..++.++.|++.|+.|||.++  |+|+|++|+||+++
T Consensus        62 ~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~  138 (669)
T cd05610          62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS  138 (669)
T ss_pred             CCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc
Confidence            4678899888888889999999999999999999754 46788888999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM  132 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  132 (150)
                      .++.++++|||+++.......            ......+|+.|++||.
T Consensus       139 ~~g~vkL~DFGls~~~~~~~~------------~~~~~~~t~~~~~pe~  175 (669)
T cd05610         139 NEGHIKLTDFGLSKVTLNREL------------NMMDILTTPSMAKPKN  175 (669)
T ss_pred             CCCCEEEEeCCCCccccCCcc------------cccccccCccccCccc
Confidence            999999999999875322111            1123467888899986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1025|consensus

Probab=99.75  E-value=1.2e-19  Score=138.85  Aligned_cols=131  Identities=23%  Similarity=0.289  Sum_probs=108.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++++++.... .+.||++|++.|+|.++++.+...+......-|.+||++|+.|+|+++  ++|||+...|+|+
T Consensus       755 ldHpnl~RLLgvc~~s-~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLV  831 (1177)
T KOG1025|consen  755 LDHPNLLRLLGVCMLS-TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLV  831 (1177)
T ss_pred             CCCchHHHHhhhcccc-hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheee
Confidence            4578999999988874 499999999999999999988788888888899999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML  146 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~  146 (150)
                      .+...+|+.|||+++....+.. .+.+..         ......|||-|.+         |+|++|+++||++
T Consensus       832 ksP~hvkitdfgla~ll~~d~~-ey~~~~---------gK~pikwmale~i~~~~~thqSDVWsfGVtiWElm  894 (1177)
T KOG1025|consen  832 KSPNHVKITDFGLAKLLAPDEK-EYSAPG---------GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELM  894 (1177)
T ss_pred             cCCCeEEEEecchhhccCcccc-cccccc---------cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHH
Confidence            9999999999999986433222 222111         0123457777764         9999999999987

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.75  E-value=1.6e-18  Score=118.36  Aligned_cols=130  Identities=33%  Similarity=0.460  Sum_probs=108.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -++++++..+........++++||+++++|.+++.... .++...+..++.+++.++.++|+.+  ++|+|+++.|++++
T Consensus        45 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~  121 (244)
T smart00220       45 KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLD  121 (244)
T ss_pred             CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEEC
Confidence            46778888888888889999999999999999997642 3788888899999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||.+.......             ......++..|++||.         .|+|++|+++++++.|.
T Consensus       122 ~~~~~~l~d~~~~~~~~~~~-------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~  183 (244)
T smart00220      122 EDGHVKLADFGLARQLDPGG-------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGK  183 (244)
T ss_pred             CCCcEEEccccceeeecccc-------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999887543211             0113357788999997         49999999999988774

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.72  E-value=4.4e-18  Score=111.93  Aligned_cols=92  Identities=27%  Similarity=0.331  Sum_probs=78.4

Q ss_pred             CCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHh
Q psy1934          31 GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQ  110 (150)
Q Consensus        31 g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  110 (150)
                      |+|.++++.....+++..+..++.|++.|+.|+|+.+        ||+||+++.++.+++  ||++......        
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~--------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE--------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc--------
Confidence            6899999876567999999999999999999999864        999999999999998  9987643211        


Q ss_pred             hhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934         111 QRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       111 ~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                               ...|++.|||||++         |+||+|+++++|++|.
T Consensus        63 ---------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~  101 (176)
T smart00750       63 ---------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYE  101 (176)
T ss_pred             ---------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCC
Confidence                     12578999999985         9999999999999885

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.71  E-value=1.6e-17  Score=112.55  Aligned_cols=133  Identities=32%  Similarity=0.433  Sum_probs=108.2

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -++++++..+.....+.+++++|++++++|.+++......+++..+..++.+++.++.++|+.+  +.|+|+++.|++++
T Consensus        55 ~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~  132 (225)
T smart00221       55 KHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG  132 (225)
T ss_pred             CCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc
Confidence            3567888888777778999999999999999999864322788888899999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~~~~g~  149 (150)
                      ..+.++++|||.+.........           ......++..|++||.          .|+|++|+++++++.|.
T Consensus       133 ~~~~~~l~d~g~~~~~~~~~~~-----------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~  197 (225)
T smart00221      133 MDGLVKLADFGLARFIHRDLAA-----------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGP  197 (225)
T ss_pred             CCCCEEEeeCceeeEecCcccc-----------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCC
Confidence            9999999999988754322100           0012346677999996          49999999999998875

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0590|consensus

Probab=99.70  E-value=2.8e-17  Score=125.75  Aligned_cols=135  Identities=27%  Similarity=0.427  Sum_probs=104.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++.....+......-.||||++ +|+.++.+. ..+....+..++.|++.|++|+|+.+  +.|||+|++|+++
T Consensus       378 l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~  453 (601)
T KOG0590|consen  378 LSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLV  453 (601)
T ss_pred             ccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEE
Confidence            3456666655544444444444999999 999999763 35777788888999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ...+.+|++|||.+.......+.        ........+|+..|+|||++          |+|+.|++...|..|+
T Consensus       454 ~~~g~lki~Dfg~~~vf~~~~e~--------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~  522 (601)
T KOG0590|consen  454 TENGILKIIDFGAASVFRYPWEK--------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR  522 (601)
T ss_pred             ecCCceEEeecCcceeeccCcch--------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence            99999999999987643221111        11233456899999999994          9999999999998875

>KOG0668|consensus

Probab=99.67  E-value=9.2e-18  Score=112.50  Aligned_cols=124  Identities=19%  Similarity=0.327  Sum_probs=97.3

Q ss_pred             chhhhcccCCCC--CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           5 SAAFIDKHSTPH--GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         5 ~~~~~~~~~~~~--~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +|+|+++.+.-.  ......|++||..+.+...+-.    .++...++.++.++++|+.|+|+.+  |+|||+||.|+.+
T Consensus        92 g~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmI  165 (338)
T KOG0668|consen   92 GPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMI  165 (338)
T ss_pred             CCCeeehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeee
Confidence            678888888433  4456789999999877766553    4777788899999999999999999  9999999999999


Q ss_pred             cCC-CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeee
Q psy1934          83 SSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLY  147 (150)
Q Consensus        83 ~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~  147 (150)
                      +.. ..+++.|+|++...-...  .+.           -++-+..|..||.+          |+||+||.+.+|.+
T Consensus       166 dh~~rkLrlIDWGLAEFYHp~~--eYn-----------VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miF  228 (338)
T KOG0668|consen  166 DHELRKLRLIDWGLAEFYHPGK--EYN-----------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF  228 (338)
T ss_pred             chhhceeeeeecchHhhcCCCc--eee-----------eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHh
Confidence            876 679999999997543221  111           23456778999984          99999998877654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.65  E-value=5.1e-16  Score=103.54  Aligned_cols=126  Identities=33%  Similarity=0.489  Sum_probs=101.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +++++...+........++++|++++++|.+++......++...+..++.+++.++.++|+.+  ++|+|+++.||+++.
T Consensus        50 ~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~  127 (215)
T cd00180          50 HPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDS  127 (215)
T ss_pred             CCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeC
Confidence            467777888888778999999999989999999865346888888999999999999999998  999999999999999


Q ss_pred             -CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc----------ccccccceeEEE
Q psy1934          85 -AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRS  144 (150)
Q Consensus        85 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~----------~d~~~~g~~~~~  144 (150)
                       .+.+++.||+.+........            ......+...|++||.          .|+|++|+++++
T Consensus       128 ~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~  186 (215)
T cd00180         128 DNGKVKLADFGLSKLLTSDKS------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE  186 (215)
T ss_pred             CCCcEEEecCCceEEccCCcc------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHH
Confidence             89999999998864422110            0112345677888876          388999987654

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.64  E-value=9.5e-16  Score=111.08  Aligned_cols=112  Identities=17%  Similarity=0.156  Sum_probs=78.4

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC-CCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL-KIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l-~~~nil~~   83 (150)
                      |++++.....   .+..++||||++|++|.. ..    ....   ..++.+++.++.++|+.+  ++|||+ ||+||+++
T Consensus        80 h~~iv~~l~~---~~~~~LVmE~~~G~~L~~-~~----~~~~---~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~  146 (365)
T PRK09188         80 GIGVVPQLLA---TGKDGLVRGWTEGVPLHL-AR----PHGD---PAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG  146 (365)
T ss_pred             CCCCCcEEEE---cCCcEEEEEccCCCCHHH-hC----ccch---HHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc
Confidence            5566642221   245799999999999973 21    1111   356788999999999998  999999 99999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV  133 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  133 (150)
                      .++.++++|||++..........    .-....+-.+..+++.|++||.+
T Consensus       147 ~~~~ikLiDFGlA~~~~~~~~~~----~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        147 PDGEAAVIDFQLASVFRRRGALY----RIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             CCCCEEEEECccceecccCcchh----hhhhhhhhhhhhccCccCCcccC
Confidence            88999999999998653221110    00011222356788899999985

>KOG1165|consensus

Probab=99.60  E-value=1.6e-15  Score=106.56  Aligned_cols=134  Identities=20%  Similarity=0.199  Sum_probs=109.2

Q ss_pred             hhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-
Q psy1934           8 FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAG-   86 (150)
Q Consensus         8 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~-   86 (150)
                      |-...+.++++-+-.||+|.+ |.+|+|++.-+...++..++..++.|++.-++++|++.  +|.||+||+|+|++..+ 
T Consensus        86 IP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~  162 (449)
T KOG1165|consen   86 IPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGT  162 (449)
T ss_pred             CCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCC
Confidence            555666778888889999998 77999999988889999999999999999999999999  99999999999998754 


Q ss_pred             ----cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          87 ----TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        87 ----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                          .+.++|||+++...+..     ..++..+.++.+..||-+||+-..         -|.-++|=++--.+.|.
T Consensus       163 k~~n~IhiiDFGmAK~YrDp~-----TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGs  233 (449)
T KOG1165|consen  163 KDANVIHIIDFGMAKEYRDPK-----TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS  233 (449)
T ss_pred             CCCceEEEEeccchhhhcCcc-----ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCC
Confidence                47899999998754322     344566777778889999998754         27777776666555554

>KOG0603|consensus

Probab=99.59  E-value=9e-17  Score=119.98  Aligned_cols=127  Identities=29%  Similarity=0.422  Sum_probs=109.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +|.+++++..++..++.+++.+|..||++...+... ....+.....+...++-++.++|+.+  ++++|+|++||+++.
T Consensus        56 ~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~  132 (612)
T KOG0603|consen   56 TPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLL  132 (612)
T ss_pred             CCceeeeeeeeccccchhHhhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecc
Confidence            577899999999999999999999999999988754 33556666777888999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-------cccccceeEEEeeeecC
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------d~~~~g~~~~~~~~g~~  150 (150)
                      .|.+++.|||.++....                ....+||.-|||||++       |+|++|+++.+|+.|.+
T Consensus       133 ~Ghi~~tdfglske~v~----------------~~~~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~  189 (612)
T KOG0603|consen  133 EGHIKLTDFGLSKEAVK----------------EKIACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTL  189 (612)
T ss_pred             cCccccCCchhhhHhHh----------------hhhcccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCC
Confidence            99999999998875321                1122789999999996       89999999999999863

>KOG1164|consensus

Probab=99.53  E-value=9e-15  Score=105.04  Aligned_cols=137  Identities=23%  Similarity=0.244  Sum_probs=101.5

Q ss_pred             hhhcccCCC-CCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           7 AFIDKHSTP-HGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         7 ~~~~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      .|..+.+.+ ......++||+.+ |.+|.++.+... ..++..++..++.|++.++.++|+.+  ++|||+||+|+.++.
T Consensus        81 ~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~  157 (322)
T KOG1164|consen   81 HFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQ  157 (322)
T ss_pred             CCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecC
Confidence            466666667 5777889999988 669999887655 67899999999999999999999999  999999999999986


Q ss_pred             C-----CcEEEeecCceeccccCCCcchhHhhhhhhHH-hhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          85 A-----GTVKLCDFGSATEKVYSPDNAWSAQQRSMLED-EMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~-----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                      .     ..+.+.|||+++...........   ...... .....||..|.++.+         -|.||++.++.++..|.
T Consensus       158 ~~~~~~~~~~llDfGlar~~~~~~~~~~~---~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~  234 (322)
T KOG1164|consen  158 SSRSEVRTLYLLDFGLARRFKYVGDSGGN---LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS  234 (322)
T ss_pred             CCCcccceEEEEecCCCccccccCCCCcc---cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence            5     46899999999832221111000   000001 123458999999876         39999888777776663

>KOG1024|consensus

Probab=99.50  E-value=8.4e-15  Score=104.89  Aligned_cols=131  Identities=15%  Similarity=0.183  Sum_probs=98.6

Q ss_pred             chhhhcccCC-CCCceEEEEEEeccCCCCHHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           5 SAAFIDKHST-PHGMHEYLILTELCTGGSLVDVLKERT-------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         5 ~~~~~~~~~~-~~~~~~~~lv~E~~~~g~L~~~l~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      |+++.....+ .+...+.+.++.+..-|+|..+|..+.       ..++..+...++.|+..|+.|+|.++  ++|.|+.
T Consensus       346 H~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiA  423 (563)
T KOG1024|consen  346 HPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIA  423 (563)
T ss_pred             CCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhh
Confidence            5666665553 445566788889998899999998432       12444556678899999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      ..|++++..-++|++|=++++..+...-...          .-+..-...||+||-+         |+||+|+++||+++
T Consensus       424 aRNCvIdd~LqVkltDsaLSRDLFP~DYhcL----------GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmt  493 (563)
T KOG1024|consen  424 ARNCVIDDQLQVKLTDSALSRDLFPGDYHCL----------GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMT  493 (563)
T ss_pred             hhcceehhheeEEeccchhccccCccccccc----------CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHh
Confidence            9999999999999999988875443221100          0012235679999985         99999999999873

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.49  E-value=8.5e-14  Score=92.94  Aligned_cols=73  Identities=19%  Similarity=0.274  Sum_probs=62.1

Q ss_pred             EEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          22 LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHM-HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        22 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      +|||||++++++...... ...++...+..++.|++.++.++ |+.+  ++|+|++|.||+++ ++.+++.|||++..
T Consensus        93 ~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~v~LiDFG~a~~  166 (190)
T cd05147          93 VLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGKLYIIDVSQSVE  166 (190)
T ss_pred             EEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence            899999998777654322 24688888899999999999999 6888  99999999999998 47899999999863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.47  E-value=2.9e-13  Score=90.41  Aligned_cols=74  Identities=20%  Similarity=0.250  Sum_probs=62.5

Q ss_pred             EEEEEeccCCCCHHH-HHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          21 YLILTELCTGGSLVD-VLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        21 ~~lv~E~~~~g~L~~-~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++||||++|+++.. .+..  ..++......++.+++.++.++|+ .+  ++|+|++|.||+++ ++.++++|||++..
T Consensus        92 ~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~~~~liDFG~a~~  166 (190)
T cd05145          92 NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DGKPYIIDVSQAVE  166 (190)
T ss_pred             CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CCCEEEEEccccee
Confidence            389999999875443 3433  457777888899999999999999 88  99999999999998 78999999999875


Q ss_pred             c
Q psy1934          99 K   99 (150)
Q Consensus        99 ~   99 (150)
                      .
T Consensus       167 ~  167 (190)
T cd05145         167 L  167 (190)
T ss_pred             c
Confidence            4

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1163|consensus

Probab=99.46  E-value=2.9e-13  Score=91.65  Aligned_cols=134  Identities=19%  Similarity=0.161  Sum_probs=100.0

Q ss_pred             hhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC--
Q psy1934           8 FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA--   85 (150)
Q Consensus         8 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~--   85 (150)
                      |.+....+.++..-.+|||.+ |++|.+++.-+...++-.++..++-|++.-++|+|.++  ++|||+||+|++.+..  
T Consensus        73 iP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh  149 (341)
T KOG1163|consen   73 IPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRH  149 (341)
T ss_pred             Cchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccc
Confidence            344445666777789999998 77999999877777888999999999999999999999  9999999999999754  


Q ss_pred             -CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------ccccccceeEEEeeeec
Q psy1934          86 -GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        86 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------~d~~~~g~~~~~~~~g~  149 (150)
                       ..+.++|||+++..-+...     ..+-.+.+.....||.+|-+-.-         -|.-|.|.++--..-|.
T Consensus       150 ~~kl~LIDFGLaKky~d~~t-----~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~  218 (341)
T KOG1163|consen  150 CNKLYLIDFGLAKKYRDIRT-----RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGS  218 (341)
T ss_pred             cceEEEEeccchhhhccccc-----cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCC
Confidence             4678999999986533321     22333445556678888855432         27777776665554443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.43  E-value=1.4e-13  Score=97.03  Aligned_cols=134  Identities=30%  Similarity=0.387  Sum_probs=99.3

Q ss_pred             hhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           7 AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         7 ~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ++++..+.+......+++++++.++++.+++....  ..++......+..+++.++.++|+.+  ++|||++|+|++++.
T Consensus        59 ~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~  136 (384)
T COG0515          59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDR  136 (384)
T ss_pred             ceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecC
Confidence            46666666666667899999999999997776543  25888888999999999999999999  999999999999999


Q ss_pred             CC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeee
Q psy1934          85 AG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        85 ~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g  148 (150)
                      .. .+++.|||.+.............      .......++..|++||++            |+|++|+..++++.|
T Consensus       137 ~~~~~~l~dfg~~~~~~~~~~~~~~~------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~  207 (384)
T COG0515         137 DGRVVKLIDFGLAKLLPDPGSTSSIP------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG  207 (384)
T ss_pred             CCCeEEEeccCcceecCCCCcccccc------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhC
Confidence            88 79999999887332211100000      011245689999999943            777777555544433

>PRK10345 hypothetical protein; Provisional

Probab=99.39  E-value=1.3e-12  Score=88.44  Aligned_cols=87  Identities=17%  Similarity=0.209  Sum_probs=67.8

Q ss_pred             chhhhcccCCCCCc---eE-EEEEEec--cCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCeEEecCCC
Q psy1934           5 SAAFIDKHSTPHGM---HE-YLILTEL--CTGGSLVDVLKERTSALPPNIVCSILWQTCQAV-KHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         5 ~~~~~~~~~~~~~~---~~-~~lv~E~--~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l-~~lh~~~~~i~h~~l~~   77 (150)
                      +|+|+++.++.+..   +. +.+|+||  +++++|.+++++.  .+++.  ..++.+++.++ .|+|+++  |+|||+||
T Consensus        60 h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp  133 (210)
T PRK10345         60 WSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKP  133 (210)
T ss_pred             CcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCH
Confidence            68899999887775   34 4489999  5579999999763  35555  24567777777 8999999  99999999


Q ss_pred             CCEEEcCC----CcEEEee-cCcee
Q psy1934          78 ENLLISSA----GTVKLCD-FGSAT   97 (150)
Q Consensus        78 ~nil~~~~----~~~~l~d-fg~~~   97 (150)
                      +||+++..    ..++++| ||...
T Consensus       134 ~NILl~~~~~~~~~~~LiDg~G~~~  158 (210)
T PRK10345        134 QNILCQRISESEVIPVVCDNIGEST  158 (210)
T ss_pred             HHEEEeccCCCCCcEEEEECCCCcc
Confidence            99999743    4799999 55433

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.38  E-value=7.9e-13  Score=88.80  Aligned_cols=117  Identities=15%  Similarity=0.139  Sum_probs=77.7

Q ss_pred             EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC-CCCCEEEcCCCcEEEeecCceec
Q psy1934          20 EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL-KIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        20 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l-~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      ..+++|||++|.+|.+....     .   ...++.++..++.++|+++  ++|+|+ +|.||+++.++.++++|||++..
T Consensus        72 ~~~lvmeyI~G~~L~~~~~~-----~---~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         72 GRHLDRSYLAGAAMYQRPPR-----G---DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             CEEEEEeeecCccHHhhhhh-----h---hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            45999999999888764421     1   1245678899999999999  999999 79999999999999999999974


Q ss_pred             cccCCCcchhH----hhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeeec
Q psy1934          99 KVYSPDNAWSA----QQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        99 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~  149 (150)
                      ...  ......    ..-.+.... -...++.++.|+--           ++.+.|..++++.+|.
T Consensus       142 ~~~--~~~~~r~L~~rDl~~llk~-~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~  204 (218)
T PRK12274        142 GNP--RARWMRLLAREDLRHLLKH-KRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRR  204 (218)
T ss_pred             cCC--cchHHHHHHHHHHHHHHHH-HHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhcc
Confidence            321  111000    000111111 12256667777542           4447777777766654

>KOG1033|consensus

Probab=99.37  E-value=1.9e-14  Score=105.84  Aligned_cols=118  Identities=26%  Similarity=0.372  Sum_probs=93.1

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCce
Q psy1934          19 HEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA   96 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~   96 (150)
                      ..++|.|++|...+|.+++....  ...+......++.|+..++.|   ++  .+|+|++|.||+...+..+++.|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence            45799999999999999996432  234556667888999999999   67  999999999999999999999999987


Q ss_pred             eccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          97 TEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      ..........      .....++..+||++||+||.+         |++++|++++|++.
T Consensus       404 ts~~~~~~~~------~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVA------PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCccc------chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            6543322111      112345677999999999985         99999999988764

>KOG4158|consensus

Probab=99.36  E-value=1.8e-12  Score=93.52  Aligned_cols=117  Identities=24%  Similarity=0.331  Sum_probs=85.5

Q ss_pred             ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC----CcEEEeec
Q psy1934          18 MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA----GTVKLCDF   93 (150)
Q Consensus        18 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~----~~~~l~df   93 (150)
                      ..+.|+||.-.+. +|.+++-..  ..+......++.|+++|+.|+|+++  +.|||+|.+||++..+    -.+.++||
T Consensus       315 ~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  315 PKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             CceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEccc
Confidence            3578999987755 999999653  4566666778899999999999999  9999999999999543    35789999


Q ss_pred             CceeccccCC-CcchhHhhhhhhHHhhhcCCCCCccCcccc---------------cccccceeEEEee
Q psy1934          94 GSATEKVYSP-DNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DTWNNYVIGRSML  146 (150)
Q Consensus        94 g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~~~~g~~~~~~~  146 (150)
                      |.+....... ...+.       ......-|.-..||||+.               |.|+.|.++||++
T Consensus       390 GCcLAd~~hGlqlpy~-------S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIf  451 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPYE-------SDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIF  451 (598)
T ss_pred             ceeeeccccccccccc-------cccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHh
Confidence            9875321110 01111       111223355668999983               9999999999976

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.32  E-value=3.9e-12  Score=86.81  Aligned_cols=68  Identities=21%  Similarity=0.419  Sum_probs=56.7

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      +..+|+|||++|.+|.+...     +++.    ...++..++..+|+.+  ++|+|++|.|++++..+ +++.|||....
T Consensus       116 ~~~~lvmEyi~G~tL~~~~~-----~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~liDfg~~~~  183 (232)
T PRK10359        116 HTYIMLIEYIEGVELNDMPE-----ISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRIIDLSGKRC  183 (232)
T ss_pred             CCeEEEEEEECCccHHHhhh-----ccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEEEECCCccc
Confidence            46899999999999987632     2332    3458889999999999  99999999999999888 99999997654

>KOG1023|consensus

Probab=99.30  E-value=8.6e-13  Score=98.09  Aligned_cols=136  Identities=21%  Similarity=0.283  Sum_probs=105.6

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++.|.|+.++.+..-.+...++|.+||+.|+|.|.+......+++.....+...+++|+.|+|... -..|..++..|++
T Consensus         3 ~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~nCl   81 (484)
T KOG1023|consen    3 QLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSSNCL   81 (484)
T ss_pred             ccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeeccccce
Confidence            567889999988888889999999999999999999886667887777788899999999999775 2399999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------------cccccceeEEEe
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------------DTWNNYVIGRSM  145 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------------d~~~~g~~~~~~  145 (150)
                      ++..+.+|+.|||+..........  ...        ....-...|.|||.+                |++|+|++++|+
T Consensus        82 vd~~w~lklt~~Gl~~~~~~~~~~--~~~--------~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   82 VDSRWVLKLTDFGLNSLLEETAEP--EAH--------HPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeeEEEEechhhhcccccccccc--ccc--------chhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            999999999999987654321000  000        000122457888874                888888888887


Q ss_pred             eee
Q psy1934         146 LYG  148 (150)
Q Consensus       146 ~~g  148 (150)
                      ++.
T Consensus       152 ~~r  154 (484)
T KOG1023|consen  152 LFR  154 (484)
T ss_pred             Hhc
Confidence            654

>KOG1166|consensus

Probab=99.26  E-value=1.9e-12  Score=102.61  Aligned_cols=130  Identities=23%  Similarity=0.357  Sum_probs=98.2

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~   85 (150)
                      +.|+++.+.....+.-++|+||.+.|+|.+++. ....+++..++.+..+++.-+.++|..+  |||.||||+|+++...
T Consensus       754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~  830 (974)
T KOG1166|consen  754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRRE  830 (974)
T ss_pred             cchHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecc
Confidence            557777777777778899999999999999997 3456889999999999999999999999  9999999999999542


Q ss_pred             -------CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          86 -------GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        86 -------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                             .-++|+|||.+-......++..          -...++|-.+-|+|+.         |.+-+..+++.|++|
T Consensus       831 ~~~~~~~~~l~lIDfG~siDm~lfp~~~~----------F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG  899 (974)
T KOG1166|consen  831 ICADSDSKGLYLIDFGRSIDMKLFPDGTK----------FKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFG  899 (974)
T ss_pred             cCCCCcccceEEEecccceeeeEcCCCcE----------EeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHH
Confidence                   3589999998765443333211          1133566677788874         555555555566665

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.26  E-value=1.5e-11  Score=83.15  Aligned_cols=74  Identities=26%  Similarity=0.432  Sum_probs=63.7

Q ss_pred             CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCce
Q psy1934          17 GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA   96 (150)
Q Consensus        17 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~   96 (150)
                      ..+..+++|||++|++|.+.+....    . ....++.++..++.++|+.+  ++|+|++|.|++++ .+.++++|||.+
T Consensus        70 ~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a  141 (211)
T PRK14879         70 DPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLA  141 (211)
T ss_pred             eCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcc
Confidence            4456789999999999999986531    2 66678889999999999998  99999999999998 788999999988


Q ss_pred             ec
Q psy1934          97 TE   98 (150)
Q Consensus        97 ~~   98 (150)
                      ..
T Consensus       142 ~~  143 (211)
T PRK14879        142 EF  143 (211)
T ss_pred             cC
Confidence            74

>KOG0195|consensus

Probab=99.24  E-value=3.2e-12  Score=88.24  Aligned_cols=129  Identities=18%  Similarity=0.285  Sum_probs=98.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSA-LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      |-||+|....+..+......++..|++.|+|+.+|.+..+. ....++.+++..++.|+.|+|+..+-|..-.+....+.
T Consensus       244 fshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvm  323 (448)
T KOG0195|consen  244 FSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVM  323 (448)
T ss_pred             ecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEE
Confidence            45899999999999999999999999999999999875332 46677888999999999999988754555567777888


Q ss_pred             EcCCCcEE--EeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeee
Q psy1934          82 ISSAGTVK--LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLY  147 (150)
Q Consensus        82 ~~~~~~~~--l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~  147 (150)
                      ++.+-+.+  .+|--++...                   ....-+|.||+||.+            |.||+.+++||+.+
T Consensus       324 idedltarismad~kfsfqe-------------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t  384 (448)
T KOG0195|consen  324 IDEDLTARISMADTKFSFQE-------------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT  384 (448)
T ss_pred             ecchhhhheecccceeeeec-------------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc
Confidence            88775544  4443333211                   022346889999974            99999999999876


Q ss_pred             ecC
Q psy1934         148 GHV  150 (150)
Q Consensus       148 g~~  150 (150)
                      ..|
T Consensus       385 rev  387 (448)
T KOG0195|consen  385 REV  387 (448)
T ss_pred             ccc
Confidence            543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.23  E-value=1.5e-11  Score=93.96  Aligned_cols=70  Identities=29%  Similarity=0.384  Sum_probs=60.7

Q ss_pred             ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCcee
Q psy1934          18 MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT   97 (150)
Q Consensus        18 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   97 (150)
                      ....++||||++|++|.+++.         ....++.+++.++.++|+.+  ++|+|++|.||++ .++.++++|||+++
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            345689999999999999885         23457789999999999999  9999999999999 57789999999987


Q ss_pred             cc
Q psy1934          98 EK   99 (150)
Q Consensus        98 ~~   99 (150)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            54

>KOG1290|consensus

Probab=99.19  E-value=5.4e-11  Score=87.47  Aligned_cols=73  Identities=25%  Similarity=0.345  Sum_probs=61.9

Q ss_pred             hhcccC----CCCCceEEEEEEeccCCCCHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEE
Q psy1934           8 FIDKHS----TPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLL   81 (150)
Q Consensus         8 ~~~~~~----~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil   81 (150)
                      +|++.+    .+-++.++|+|+|++ |.+|..+++.. ..+++...++.+++|++.|+.|||. ++  |||.|+||+|+|
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvL  220 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVL  220 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceee
Confidence            555555    556788999999999 66999988754 4779999999999999999999994 56  999999999999


Q ss_pred             Ec
Q psy1934          82 IS   83 (150)
Q Consensus        82 ~~   83 (150)
                      +-
T Consensus       221 l~  222 (590)
T KOG1290|consen  221 LC  222 (590)
T ss_pred             ee
Confidence            84

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.18  E-value=4e-11  Score=80.37  Aligned_cols=71  Identities=28%  Similarity=0.414  Sum_probs=60.4

Q ss_pred             ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCcee
Q psy1934          18 MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT   97 (150)
Q Consensus        18 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   97 (150)
                      .+..+++|||++|++|.+.+....  .      .++.+++.++.++|+.+  ++|+|++|.|++++ .+.+++.|||.+.
T Consensus        69 ~~~~~lv~e~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~  137 (199)
T TIGR03724        69 PDNKTIVMEYIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGK  137 (199)
T ss_pred             CCCCEEEEEEECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCc
Confidence            345689999999999999875421  1      56788999999999998  99999999999999 7889999999887


Q ss_pred             cc
Q psy1934          98 EK   99 (150)
Q Consensus        98 ~~   99 (150)
                      ..
T Consensus       138 ~~  139 (199)
T TIGR03724       138 YS  139 (199)
T ss_pred             CC
Confidence            53

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590|consensus

Probab=99.18  E-value=4.9e-12  Score=97.26  Aligned_cols=134  Identities=25%  Similarity=0.393  Sum_probs=108.6

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHH-HhhCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEE
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVL-KERTSALPPNIVCSILWQTCQAVKHMH-GQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l-~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~i~h~~l~~~nil~   82 (150)
                      |.++++..+.....+..++.+||..++++++.. .......+......++.|+..++.|+| ..+  +.|+|++|+|.++
T Consensus        80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l  157 (601)
T KOG0590|consen   80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLL  157 (601)
T ss_pred             cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchh
Confidence            667888888889999999999999999999988 433225666677788999999999999 887  9999999999999


Q ss_pred             cCCC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCC-CCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +..+ .++.+|||++............         ....+| ++.|+|||..          |+|+.|++...++.|.
T Consensus       158 ~~s~~~l~~~df~~At~~~~~~g~~~~---------~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~  227 (601)
T KOG0590|consen  158 DESGSALKIADFGLATAYRNKNGAERS---------LKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGE  227 (601)
T ss_pred             ccCCCcccCCCchhhccccccCCccee---------eecccCCCCCCCCcccccchhhcCCCcccccccccccccccCC
Confidence            9998 9999999999865442111111         123457 8999999983          9999999999988875

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.16  E-value=2.1e-10  Score=79.24  Aligned_cols=71  Identities=28%  Similarity=0.400  Sum_probs=59.8

Q ss_pred             EEEEEeccCC-CCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceecc
Q psy1934          21 YLILTELCTG-GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK   99 (150)
Q Consensus        21 ~~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   99 (150)
                      .++|+|+++| .+|.+++..  ..++...    +.+++.++.++|+.+  ++|+|++|.||+++.++.++++|||.+...
T Consensus       121 ~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        121 ADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             eeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            3699999997 699998864  3455443    467889999999999  999999999999998889999999988754

>smart00090 RIO RIO-like kinase

Probab=99.16  E-value=9.1e-11  Score=80.94  Aligned_cols=76  Identities=17%  Similarity=0.245  Sum_probs=61.6

Q ss_pred             EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          20 EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        20 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      ..++||||++|+++....... ..+.......++.+++.++.++|+.+ .++|+|++|+||+++ .+.+++.|||.+..
T Consensus       122 ~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      122 RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            358999999998877654222 23555566788899999999999875 399999999999998 78899999998874

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.16  E-value=9.2e-11  Score=78.75  Aligned_cols=71  Identities=17%  Similarity=0.191  Sum_probs=59.1

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      +..+++|||++|++|.+....       .....++.+++.++.++|+.+  ++|+|++|.|++++.++.+++.|||.+..
T Consensus       104 ~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         104 NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence            345899999999888765321       223456788999999999988  99999999999999999999999998854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1266|consensus

Probab=99.15  E-value=5.2e-11  Score=84.16  Aligned_cols=139  Identities=22%  Similarity=0.296  Sum_probs=100.3

Q ss_pred             cccchhhhcccCC-----CCCceEEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q psy1934           2 EYLSAAFIDKHST-----PHGMHEYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHR   73 (150)
Q Consensus         2 ~~~~~~~~~~~~~-----~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~   73 (150)
                      |+.|.++++++.+     +++..+..+++||+..|++.++|++..   ..+......+|+.||+.|+.|||++.|+++|.
T Consensus       123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg  202 (458)
T KOG1266|consen  123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG  202 (458)
T ss_pred             HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence            5667888887763     345566899999999999999998642   33666777899999999999999999999999


Q ss_pred             cCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhh-hcCCCCCccCccc---------ccccccceeEE
Q psy1934          74 DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEM-ARFTTPMYRAPEM---------VDTWNNYVIGR  143 (150)
Q Consensus        74 ~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~y~aPE~---------~d~~~~g~~~~  143 (150)
                      ++..+.+++..++.+|+..-.......       +.  .+...... -..+.+.|.+||.         .|++++|..+.
T Consensus       203 nlTc~tifiq~ngLIkig~~ap~s~h~-------s~--~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  203 NLTCDTIFIQHNGLIKIGSVAPDSTHP-------SV--NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             CcchhheeecCCceEEecccCccccch-------hh--hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence            999999999988888875432211100       00  11111111 1235667888887         59999998888


Q ss_pred             Eeeeec
Q psy1934         144 SMLYGH  149 (150)
Q Consensus       144 ~~~~g~  149 (150)
                      +|..|.
T Consensus       274 emailE  279 (458)
T KOG1266|consen  274 EMAILE  279 (458)
T ss_pred             HHHHhe
Confidence            876553

>KOG0606|consensus

Probab=99.10  E-value=1.7e-11  Score=96.87  Aligned_cols=92  Identities=37%  Similarity=0.506  Sum_probs=68.8

Q ss_pred             HHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCc-chh--HhhhhhhHHhhhcCCCCCccCcccc
Q psy1934          57 CQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDN-AWS--AQQRSMLEDEMARFTTPMYRAPEMV  133 (150)
Q Consensus        57 ~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~y~aPE~~  133 (150)
                      +.+++|+|..+  |+|||++++|.++..-|+.|+.|||+.+...-.... .+.  ...-...-.....+||+.|.||||+
T Consensus       153 vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi  230 (1205)
T KOG0606|consen  153 VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI  230 (1205)
T ss_pred             hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence            56899999999  999999999999999999999999998854322211 000  0000111112245899999999995


Q ss_pred             ---------cccccceeEEEeeeecC
Q psy1934         134 ---------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus       134 ---------d~~~~g~~~~~~~~g~~  150 (150)
                               |+|++|++.||.+.|.|
T Consensus       231 lrqgygkpvdwwamGiIlyeFLVgcv  256 (1205)
T KOG0606|consen  231 LRQGYGKPVDWWAMGIILYEFLVGCV  256 (1205)
T ss_pred             hhhccCCCccHHHHHHHHHHHheeee
Confidence                     99999999999998875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.00  E-value=1.3e-09  Score=72.35  Aligned_cols=74  Identities=23%  Similarity=0.290  Sum_probs=57.4

Q ss_pred             EEEEEEeccCCCCHHH-HHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEEEcCCCcEEEeecCcee
Q psy1934          20 EYLILTELCTGGSLVD-VLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLLISSAGTVKLCDFGSAT   97 (150)
Q Consensus        20 ~~~lv~E~~~~g~L~~-~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   97 (150)
                      ..+++|||++++++.. .+....  .. .....++.+++.++.++|. .+  ++|+|++|+|++++ ++.+++.|||.+.
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~~~~liDfg~a~  162 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DGKVYIIDVPQAV  162 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CCcEEEEECcccc
Confidence            4589999999854322 222211  11 4566788999999999998 88  99999999999999 8899999999886


Q ss_pred             cc
Q psy1934          98 EK   99 (150)
Q Consensus        98 ~~   99 (150)
                      ..
T Consensus       163 ~~  164 (187)
T cd05119         163 EI  164 (187)
T ss_pred             cc
Confidence            43

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1240|consensus

Probab=98.96  E-value=9.4e-12  Score=98.83  Aligned_cols=88  Identities=24%  Similarity=0.220  Sum_probs=70.8

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~   85 (150)
                      |+.+.+..+......-|||=+|... +|+|++..+ ..+..-+.+-++.|++.|+.-+|..+  ++|+|+|.+||++.+.
T Consensus        81 pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSW  156 (1431)
T KOG1240|consen   81 PNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSW  156 (1431)
T ss_pred             CcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeee
Confidence            4445555555555556777788866 999999764 34666677778899999999999999  9999999999999999


Q ss_pred             CcEEEeecCcee
Q psy1934          86 GTVKLCDFGSAT   97 (150)
Q Consensus        86 ~~~~l~dfg~~~   97 (150)
                      .++.+.||+.-+
T Consensus       157 NW~~LtDFAsFK  168 (1431)
T KOG1240|consen  157 NWLYLTDFASFK  168 (1431)
T ss_pred             chhhhhcccccC
Confidence            999999998554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.96  E-value=2.1e-10  Score=80.62  Aligned_cols=111  Identities=26%  Similarity=0.392  Sum_probs=70.5

Q ss_pred             EEEEeccCCCCHHHHHHh---hCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCc
Q psy1934          22 LILTELCTGGSLVDVLKE---RTSA---LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGS   95 (150)
Q Consensus        22 ~lv~E~~~~g~L~~~l~~---~~~~---l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~   95 (150)
                      +++|+-+.+ +|.+++..   ....   +.-.....+..|++..+.++|..+  ++|.|++++|++++.+|.+.+.||+.
T Consensus       115 ~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~~~G~v~Lg~F~~  191 (288)
T PF14531_consen  115 FLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDIKPENFLLDQDGGVFLGDFSS  191 (288)
T ss_dssp             EEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE-TTS-EEE--GGG
T ss_pred             hhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecccceeeEEEcCCCCEEEcChHH
Confidence            677777755 88887653   2211   112223445578899999999999  99999999999999999999999986


Q ss_pred             eeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-----------------ccccccceeEEEeeeecC
Q psy1934          96 ATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-----------------VDTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-----------------~d~~~~g~~~~~~~~g~~  150 (150)
                      .......    ...           ...+..|.+||.                 .|.|++|++++.+++|.+
T Consensus       192 ~~r~g~~----~~~-----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  192 LVRAGTR----YRC-----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             EEETTEE----EEG-----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             HeecCce----eec-----------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            6532110    000           112345666664                 399999999999988753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.91  E-value=4.2e-09  Score=66.85  Aligned_cols=84  Identities=18%  Similarity=0.161  Sum_probs=64.1

Q ss_pred             hhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCeEEecCCCCCEEEcCC
Q psy1934           7 AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQN-PPIVHRDLKIENLLISSA   85 (150)
Q Consensus         7 ~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-~~i~h~~l~~~nil~~~~   85 (150)
                      ++.+........+..++++||++++++..+        +.......+.++..++..+|... .+++|+|+++.|++++..
T Consensus        54 ~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~  125 (155)
T cd05120          54 PVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG  125 (155)
T ss_pred             CCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence            344444555555789999999988766543        33444566788899999999741 139999999999999988


Q ss_pred             CcEEEeecCceec
Q psy1934          86 GTVKLCDFGSATE   98 (150)
Q Consensus        86 ~~~~l~dfg~~~~   98 (150)
                      +.+++.||+.+..
T Consensus       126 ~~~~l~Df~~~~~  138 (155)
T cd05120         126 KILGIIDWEYAGY  138 (155)
T ss_pred             cEEEEEecccccC
Confidence            8999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243|consensus

Probab=98.75  E-value=1.5e-08  Score=77.43  Aligned_cols=127  Identities=20%  Similarity=0.293  Sum_probs=94.6

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMH-GQNPPIVHRDLKIENL   80 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~i~h~~l~~~ni   80 (150)
                      -+.||+|+++.+..+..+..|||+|-+.  .|..++++.    ....+.--+.||+.|+.+|| +++  ++|.++.-+++
T Consensus        65 tlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SV  136 (690)
T KOG1243|consen   65 TLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSV  136 (690)
T ss_pred             hccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeE
Confidence            4689999999999999999999999885  677788763    34555556789999999997 666  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcc-------cccccccceeEEEeeee
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE-------MVDTWNNYVIGRSMLYG  148 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE-------~~d~~~~g~~~~~~~~g  148 (150)
                      ++...|.-++.+|...........   ..+         ....--.|..|+       .+|.|-+|++.++++.|
T Consensus       137 fVn~~GeWkLggle~v~~~~~~~~---~~~---------~~~~~~s~~~P~~~~~s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  137 FVNESGEWKLGGLELVSKASGFNA---PAK---------SLYLIESFDDPEEIDPSEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             EEcCCCcEEEeeeEEEeccccCCc---ccc---------cchhhhcccChhhcCccccchhhhhHHHHHHHHhCc
Confidence            999999999999876653322211   000         000011133343       36999999999988877

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.69  E-value=6.6e-08  Score=72.37  Aligned_cols=76  Identities=18%  Similarity=0.271  Sum_probs=57.0

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHH-HHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCcee
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQ-AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT   97 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~-~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   97 (150)
                      +..+|||||++|+++.+............   .++..++. .+..+|..+  ++|+|++|.|+++..++.+++.|||++.
T Consensus       231 ~~~vLvmE~i~G~~L~~~~~~~~~~~~~~---~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~  305 (437)
T TIGR01982       231 SERVLTMEWIDGIPLSDIAALDEAGLDRK---ALAENLARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVG  305 (437)
T ss_pred             CCceEEEEeECCcccccHHHHHhcCCCHH---HHHHHHHHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCee
Confidence            34589999999999988775432223222   23344433 356778888  9999999999999999999999999987


Q ss_pred             cc
Q psy1934          98 EK   99 (150)
Q Consensus        98 ~~   99 (150)
                      ..
T Consensus       306 ~l  307 (437)
T TIGR01982       306 RL  307 (437)
T ss_pred             EC
Confidence            53

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.69  E-value=8.4e-08  Score=64.26  Aligned_cols=75  Identities=21%  Similarity=0.309  Sum_probs=55.9

Q ss_pred             eEEEEEEeccCCCCHH-HHHHhhCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEEecCCCCCEEEcCCCcEEEeecCce
Q psy1934          19 HEYLILTELCTGGSLV-DVLKERTSALPPNIVCSILWQTCQAVKHM-HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA   96 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~-~~l~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~   96 (150)
                      +.-+|||||+.++.+. ..+++  ..++......+..+++.++..+ |..+  ++|+|+++.||++. ++.+.++|||-+
T Consensus        97 ~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~NIL~~-~~~v~iIDF~qa  171 (197)
T cd05146          97 KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYNMLWH-DGKVWFIDVSQS  171 (197)
T ss_pred             cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEE-CCcEEEEECCCc
Confidence            3458999999764332 23332  2344455566678899999888 8888  99999999999996 467999999976


Q ss_pred             ec
Q psy1934          97 TE   98 (150)
Q Consensus        97 ~~   98 (150)
                      -.
T Consensus       172 v~  173 (197)
T cd05146         172 VE  173 (197)
T ss_pred             ee
Confidence            53

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.63  E-value=3.2e-07  Score=64.43  Aligned_cols=78  Identities=23%  Similarity=0.272  Sum_probs=63.0

Q ss_pred             eEEEEEEeccCCC-CHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-------CCcEE
Q psy1934          19 HEYLILTELCTGG-SLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS-------AGTVK   89 (150)
Q Consensus        19 ~~~~lv~E~~~~g-~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~-------~~~~~   89 (150)
                      ..-++|||++++. +|.+++.... ...+......++.++...+..||..+  ++|+|+++.||+++.       ...+.
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEE
Confidence            4568999999986 8999886432 33445566678889999999999999  999999999999975       35789


Q ss_pred             EeecCceec
Q psy1934          90 LCDFGSATE   98 (150)
Q Consensus        90 l~dfg~~~~   98 (150)
                      ++||+.+..
T Consensus       186 LIDl~r~~~  194 (268)
T PRK15123        186 VIDLHRAQI  194 (268)
T ss_pred             EEECCcccc
Confidence            999997753

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.61  E-value=2.2e-07  Score=61.17  Aligned_cols=68  Identities=31%  Similarity=0.441  Sum_probs=55.1

Q ss_pred             EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          20 EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        20 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      ...|+|||.+|..|.+.+...    .    ..++..+-.-+.-||..+  ++|.|+.++|+++...+ +.+.|||++..
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            446999999998888888753    1    234556666778899999  99999999999997766 88999999874

>KOG3087|consensus

Probab=98.54  E-value=7.3e-07  Score=58.86  Aligned_cols=76  Identities=24%  Similarity=0.393  Sum_probs=57.9

Q ss_pred             EEEEEeccCC-CCHHHHHHhhCCCCCHHH-HHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC---cEEEeecCc
Q psy1934          21 YLILTELCTG-GSLVDVLKERTSALPPNI-VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAG---TVKLCDFGS   95 (150)
Q Consensus        21 ~~lv~E~~~~-g~L~~~l~~~~~~l~~~~-~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~---~~~l~dfg~   95 (150)
                      -.|+|||.+| .++.+++.+....-..+. ...++..+-..+.-||...  ++|.|+.++||++..++   .+.+.|||+
T Consensus        85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecc
Confidence            3699999987 488888876533322222 2566777888899999999  99999999999997664   357899998


Q ss_pred             eec
Q psy1934          96 ATE   98 (150)
Q Consensus        96 ~~~   98 (150)
                      +..
T Consensus       163 s~~  165 (229)
T KOG3087|consen  163 SSV  165 (229)
T ss_pred             hhc
Confidence            764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.51  E-value=9.4e-07  Score=59.82  Aligned_cols=78  Identities=23%  Similarity=0.363  Sum_probs=64.3

Q ss_pred             eEEEEEEeccCCC-CHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC---cEEEeecC
Q psy1934          19 HEYLILTELCTGG-SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAG---TVKLCDFG   94 (150)
Q Consensus        19 ~~~~lv~E~~~~g-~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~---~~~l~dfg   94 (150)
                      ..-++++|++++. +|.+++..... .+......++.++...+.-||..+  +.|+|+++.||++....   .+.++||+
T Consensus        90 ~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld  166 (206)
T PF06293_consen   90 YRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLD  166 (206)
T ss_pred             eeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcch
Confidence            4568999999975 79998876322 555566678889999999999999  99999999999998887   78899998


Q ss_pred             ceecc
Q psy1934          95 SATEK   99 (150)
Q Consensus        95 ~~~~~   99 (150)
                      -++..
T Consensus       167 ~~~~~  171 (206)
T PF06293_consen  167 RMRFR  171 (206)
T ss_pred             hceeC
Confidence            76643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.48  E-value=3.4e-07  Score=59.66  Aligned_cols=68  Identities=24%  Similarity=0.299  Sum_probs=51.4

Q ss_pred             EEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCC---CeEEecCCCCCEEEcCCCcEEEeecCcee
Q psy1934          21 YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNP---PIVHRDLKIENLLISSAGTVKLCDFGSAT   97 (150)
Q Consensus        21 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~---~i~h~~l~~~nil~~~~~~~~l~dfg~~~   97 (150)
                      .++|||+++|.++.+.      ....   ...+.++..++..+|+.+.   .++|+|+++.|++++ .+.+++.||+.+.
T Consensus        66 ~~lv~e~i~G~~l~~~------~~~~---~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          66 GVLITEFIEGSELLTE------DFSD---PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CeEEEEecCCCccccc------cccC---HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            4799999999776543      0111   2335678889999998761   149999999999998 6679999999876


Q ss_pred             c
Q psy1934          98 E   98 (150)
Q Consensus        98 ~   98 (150)
                      .
T Consensus       136 ~  136 (170)
T cd05151         136 M  136 (170)
T ss_pred             C
Confidence            4

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.44  E-value=4.7e-07  Score=69.15  Aligned_cols=72  Identities=22%  Similarity=0.229  Sum_probs=50.6

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCC-----CCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC----cEE
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSA-----LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAG----TVK   89 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~-----l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~----~~~   89 (150)
                      ++.+|||||++|+++.+.-.-...+     +.+..+..++.|+.       ..+  ++|+|++|.||+++.++    +++
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~  304 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG--FFHADMHPGNIFVSYDPPENPRYI  304 (537)
T ss_pred             CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC--eeeCCCChHHeEEecCCCCCCeEE
Confidence            3456999999999998743211122     33333333344443       456  99999999999999887    999


Q ss_pred             EeecCceecc
Q psy1934          90 LCDFGSATEK   99 (150)
Q Consensus        90 l~dfg~~~~~   99 (150)
                      +.|||+....
T Consensus       305 llDFGivg~l  314 (537)
T PRK04750        305 ALDFGIVGSL  314 (537)
T ss_pred             EEecceEEEC
Confidence            9999988753

>KOG0601|consensus

Probab=98.28  E-value=4.3e-07  Score=68.52  Aligned_cols=130  Identities=25%  Similarity=0.288  Sum_probs=95.3

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCeEEecCCCCCE
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQ----AVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~----~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      |.+.++.....++.+..++-+|.|. .++.++.......++.+..+..+.+...    |+.++|..+  ++|.++++.|+
T Consensus       177 ~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i  253 (524)
T KOG0601|consen  177 HENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANI  253 (524)
T ss_pred             cccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhhe
Confidence            4455666677788889999999995 5888888776555788888877777777    999999998  99999999999


Q ss_pred             EEcCC-CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEE
Q psy1934          81 LISSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRS  144 (150)
Q Consensus        81 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~  144 (150)
                      +...+ ..+++.||++........... ..      ......-|...|++||+.        |++++|.+..+
T Consensus       254 ~~~~~~~s~~~~df~~v~~i~~~~~~~-~~------~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~  319 (524)
T KOG0601|consen  254 FTTSDWTSCKLTDFGLVSKISDGNFSS-VF------KVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILE  319 (524)
T ss_pred             ecccccceeecCCcceeEEccCCcccc-ce------eeeecCCCCceEeChhhhccccchHhhhcchhhhhHh
Confidence            99998 788999999876543322111 00      011122466679999985        77777765443

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.22  E-value=2.3e-06  Score=57.02  Aligned_cols=72  Identities=28%  Similarity=0.406  Sum_probs=46.0

Q ss_pred             EEEEEeccC--CCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCeEEecCCCCCEEEcCCCcEEEeecCcee
Q psy1934          21 YLILTELCT--GGSLVDVLKERTSALPPNIVCSILWQTCQAVKH-MHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT   97 (150)
Q Consensus        21 ~~lv~E~~~--~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~-lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   97 (150)
                      -+|||||++  |..+..+....   ++......++.+++..+.. +|..+  ++|+|+++.||+++.. .+.+.|||-+.
T Consensus        81 ~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             TEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             CEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEecCcce
Confidence            379999998  54554433321   2133344556667664544 57888  9999999999999877 89999999776


Q ss_pred             c
Q psy1934          98 E   98 (150)
Q Consensus        98 ~   98 (150)
                      .
T Consensus       155 ~  155 (188)
T PF01163_consen  155 D  155 (188)
T ss_dssp             E
T ss_pred             e
Confidence            4

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606|consensus

Probab=98.20  E-value=4.8e-07  Score=72.54  Aligned_cols=142  Identities=27%  Similarity=0.318  Sum_probs=101.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +|..+.....+....-.+|+++|..++++...|++.. ..+.+-...+...+..+.+++|...  +.|++.++.+.+...
T Consensus       863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~  939 (1205)
T KOG0606|consen  863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAY  939 (1205)
T ss_pred             CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch--hhcccccccchhhcc
Confidence            3555555556667778899999999999999998643 4555555566677778899999987  999999999999999


Q ss_pred             CCcEEEeecCceeccccC-C---C-------------cchhHhhhh--hhHHhhhcCCCCCccCcccc---------ccc
Q psy1934          85 AGTVKLCDFGSATEKVYS-P---D-------------NAWSAQQRS--MLEDEMARFTTPMYRAPEMV---------DTW  136 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~-~---~-------------~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~---------d~~  136 (150)
                      .+..++.+|+........ .   .             ......+..  ........++|+-|.+||..         |+|
T Consensus       940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen  940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred             cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence            999999998733321110 0   0             000000000  11224456789999999984         999


Q ss_pred             ccceeEEEeeeec
Q psy1934         137 NNYVIGRSMLYGH  149 (150)
Q Consensus       137 ~~g~~~~~~~~g~  149 (150)
                      +.|+.+.+.+.|.
T Consensus      1020 ~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGI 1032 (1205)
T ss_pred             hhhhhhhhhhcCC
Confidence            9999999998885

>PRK09902 hypothetical protein; Provisional

Probab=97.96  E-value=0.0001  Score=50.02  Aligned_cols=79  Identities=20%  Similarity=0.261  Sum_probs=63.3

Q ss_pred             ceEEEEEEeccCC-CCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc--EEEeec
Q psy1934          18 MHEYLILTELCTG-GSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGT--VKLCDF   93 (150)
Q Consensus        18 ~~~~~lv~E~~~~-g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~--~~l~df   93 (150)
                      ..+-.||+|-++| -+|.+++.+.. ...+......+..++...+.-||+.+  +.|+|+-+.||+++..+.  +++.||
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEh
Confidence            3456899998874 38999886542 23456666678889999999999999  999999999999987666  889999


Q ss_pred             Cceec
Q psy1934          94 GSATE   98 (150)
Q Consensus        94 g~~~~   98 (150)
                      .-++.
T Consensus       175 Ek~r~  179 (216)
T PRK09902        175 EKSRR  179 (216)
T ss_pred             hccch
Confidence            76654

>KOG3741|consensus

Probab=97.88  E-value=0.00014  Score=55.22  Aligned_cols=96  Identities=11%  Similarity=0.217  Sum_probs=76.3

Q ss_pred             cccchhhhcccCCCC----CceEEEEEEeccCC-CCHHHHHHh--------------hCCCCCHHHHHHHHHHHHHHHHH
Q psy1934           2 EYLSAAFIDKHSTPH----GMHEYLILTELCTG-GSLVDVLKE--------------RTSALPPNIVCSILWQTCQAVKH   62 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~----~~~~~~lv~E~~~~-g~L~~~l~~--------------~~~~l~~~~~~~~~~~i~~~l~~   62 (150)
                      |+-|+++|.+.+++.    +...+++|++|.|+ ++|.++--.              ...+.++..++.++.|+..|+.+
T Consensus       329 kl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~s  408 (655)
T KOG3741|consen  329 KLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYS  408 (655)
T ss_pred             HhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHH
Confidence            456888999888777    55778999999985 588885521              11235678889999999999999


Q ss_pred             HhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceecc
Q psy1934          63 MHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK   99 (150)
Q Consensus        63 lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   99 (150)
                      +|+.+  +..+-+.+.+|++..+.+++++..|+....
T Consensus       409 IHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  409 IHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHhcC--ceeecccHhHeEeeCcceEEEecccceeee
Confidence            99999  888999999999988888888776665543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.87  E-value=4.2e-05  Score=52.09  Aligned_cols=68  Identities=24%  Similarity=0.427  Sum_probs=51.1

Q ss_pred             ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCcee
Q psy1934          18 MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT   97 (150)
Q Consensus        18 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   97 (150)
                      ....+++|||++|-.|.+...     +++.    ....+..++.-+|+.+  +.|.|..|.|+++..++ +++.||+..+
T Consensus       115 ~~~~~ll~EYIeG~~l~d~~~-----i~e~----~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  115 TSSYVLLMEYIEGVELNDIED-----IDED----LAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             eeEEEEEEEEecCeecccchh-----cCHH----HHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEEEECcccc
Confidence            356689999999976665432     2222    2344567789999999  99999999999988555 8899997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=97.85  E-value=6.1e-05  Score=50.92  Aligned_cols=29  Identities=31%  Similarity=0.492  Sum_probs=24.9

Q ss_pred             CeEEecCCCCCEEEcC--CCcEEEeecCcee
Q psy1934          69 PIVHRDLKIENLLISS--AGTVKLCDFGSAT   97 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~--~~~~~l~dfg~~~   97 (150)
                      .++|+|+.+.|++++.  .+...+.||+.+.
T Consensus       175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             EEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence            4899999999999988  5667899998765

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1290|consensus

Probab=97.83  E-value=1.9e-06  Score=64.17  Aligned_cols=50  Identities=28%  Similarity=0.432  Sum_probs=38.3

Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++||+|||-++...    .           .-+.-..|..|+||||+         |+||+.|+++|+++|-
T Consensus       390 di~vKIaDlGNACW~~----k-----------hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGD  448 (590)
T KOG1290|consen  390 DIRVKIADLGNACWVH----K-----------HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGD  448 (590)
T ss_pred             ceeEEEeeccchhhhh----h-----------hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCc
Confidence            3579999999987521    0           11123468889999996         9999999999999984

>KOG0601|consensus

Probab=97.71  E-value=2.6e-05  Score=59.17  Aligned_cols=89  Identities=29%  Similarity=0.293  Sum_probs=68.5

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~   85 (150)
                      .+.+.+...-....+.++-.|||+++++...... ...+.+...+++..+++.++.++|+..  ++|.|+++.||++..+
T Consensus       326 ~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~  402 (524)
T KOG0601|consen  326 LPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISND  402 (524)
T ss_pred             cccCCCCCCccccccccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccc
Confidence            3444433433334555699999999887776632 234777888889999999999999988  9999999999999886


Q ss_pred             -CcEEEeecCcee
Q psy1934          86 -GTVKLCDFGSAT   97 (150)
Q Consensus        86 -~~~~l~dfg~~~   97 (150)
                       +..++.||+.+.
T Consensus       403 ~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  403 GFFSKLGDFGCWT  415 (524)
T ss_pred             hhhhhcccccccc
Confidence             677888888775

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=97.57  E-value=7e-06  Score=64.75  Aligned_cols=61  Identities=21%  Similarity=0.200  Sum_probs=39.8

Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      |+++......++.+|+.+........ .         ......+||+.|||||++         |+||+|++++||++|.
T Consensus       508 ~~~~~p~~~~~~~~~~~~~~~~~g~~-~---------~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~  577 (669)
T cd05610         508 NLYQTPKQVKIGTPYRTPKSVRRGAA-P---------VEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGI  577 (669)
T ss_pred             ceeECCccccccccCCCchhhhcccc-c---------ccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            44554445556677776653211100 0         011234789999999984         9999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG2137|consensus

Probab=97.14  E-value=0.00074  Score=52.67  Aligned_cols=87  Identities=15%  Similarity=0.242  Sum_probs=60.8

Q ss_pred             HHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCC---cchhHhhhhhhHHhhhcCCCCCccCc
Q psy1934          54 WQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD---NAWSAQQRSMLEDEMARFTTPMYRAP  130 (150)
Q Consensus        54 ~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~y~aP  130 (150)
                      .++..|+.++|..- .++|+++.|+++.+...+.-|++.|+++........   ..++.....      -..-...|.||
T Consensus       106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~------~~~~~~~f~ap  178 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPL------LLQPHLNFLAP  178 (700)
T ss_pred             hcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCCh------hhccCcccccc
Confidence            34568899999653 499999999999999999999999987654322100   111111111      11234579999


Q ss_pred             ccc---------cccccceeEEEeee
Q psy1934         131 EMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus       131 E~~---------d~~~~g~~~~~~~~  147 (150)
                      |++         |.+|+|+..+-+..
T Consensus       179 E~~~~~~~~~~sd~fSlG~li~~i~~  204 (700)
T KOG2137|consen  179 EYLLGTTNTPASDVFSLGVLIYTIYN  204 (700)
T ss_pred             hhhccccccccccceeeeeEEEEEec
Confidence            985         99999999998773

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=96.96  E-value=0.0024  Score=45.01  Aligned_cols=71  Identities=24%  Similarity=0.287  Sum_probs=47.8

Q ss_pred             ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCce
Q psy1934          18 MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA   96 (150)
Q Consensus        18 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~   96 (150)
                      .+.-.+|||+.+|-.|...-      +.......++..|+..+.-.=..+  ++|+|+++-||+++.++.+.+.||.=+
T Consensus       179 ~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~~~vIDwPQ~  249 (304)
T COG0478         179 WNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGDIVVIDWPQA  249 (304)
T ss_pred             cccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCCEEEEeCccc
Confidence            35558999999986655422      112222233344444443333566  999999999999999999999999643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.92  E-value=0.0038  Score=41.71  Aligned_cols=86  Identities=17%  Similarity=0.177  Sum_probs=60.8

Q ss_pred             hhhcccCCCCCceEEEEEEeccCCCCHHHH---HHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEEecCCCCCEEE
Q psy1934           7 AFIDKHSTPHGMHEYLILTELCTGGSLVDV---LKERTSALPPNIVCSILWQTCQAVKHMHGQNP-PIVHRDLKIENLLI   82 (150)
Q Consensus         7 ~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~---l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~-~i~h~~l~~~nil~   82 (150)
                      ++.++.+..-.    ..++||.+.+++...   +.. ...-+|..+.+++.+++..+.+++.... .+.-.|++++|+.+
T Consensus        21 ~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv   95 (188)
T PF12260_consen   21 PFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGV   95 (188)
T ss_pred             CCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEE
Confidence            44555444322    568999987655421   111 1235788888999999999999975311 27779999999999


Q ss_pred             cCCCcEEEeecCcee
Q psy1934          83 SSAGTVKLCDFGSAT   97 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~   97 (150)
                      ..++++++.|.....
T Consensus        96 ~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   96 NDDGRLKLIDLDDVF  110 (188)
T ss_pred             eCCCcEEEEechhcc
Confidence            999999999987544

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235|consensus

Probab=96.91  E-value=0.0045  Score=47.69  Aligned_cols=77  Identities=16%  Similarity=0.225  Sum_probs=51.9

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC----CCcEEEeecC
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS----AGTVKLCDFG   94 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~----~~~~~l~dfg   94 (150)
                      +...|+|||++|..+.|.-.=...+.+...+...+.+..  ...+-..+  ++|+|-.|-|+++..    +..+.+.|||
T Consensus       275 t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhG  350 (538)
T KOG1235|consen  275 TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHG  350 (538)
T ss_pred             cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcC--CccCCCCCCcEEEecCCCCCccEEEEccc
Confidence            466899999999866665432224566655433333221  12233456  999999999999984    4678899999


Q ss_pred             ceecc
Q psy1934          95 SATEK   99 (150)
Q Consensus        95 ~~~~~   99 (150)
                      +....
T Consensus       351 l~~~i  355 (538)
T KOG1235|consen  351 LYAVI  355 (538)
T ss_pred             ccccc
Confidence            87754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=96.83  E-value=0.0049  Score=47.40  Aligned_cols=76  Identities=18%  Similarity=0.343  Sum_probs=52.0

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      +.-.|+|||++|-.+.+...-...+.+...+.....++.  +..+-..+  +.|.|..|-|+++..++++...|||+...
T Consensus       239 ~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~  314 (517)
T COG0661         239 TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGR  314 (517)
T ss_pred             CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC--ccccCCCccceEEecCCcEEEEcCcceec
Confidence            456899999999888887433224455333322222211  12222345  99999999999999999999999998764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=96.62  E-value=0.0055  Score=42.68  Aligned_cols=73  Identities=18%  Similarity=0.237  Sum_probs=50.0

Q ss_pred             EEEEEEeccCCC-CHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEEEcCCCcEEEeecCcee
Q psy1934          20 EYLILTELCTGG-SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLLISSAGTVKLCDFGSAT   97 (150)
Q Consensus        20 ~~~lv~E~~~~g-~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~   97 (150)
                      ...|||||+... .-.-.|+.  -+++......+..+++..+.-|=. .+  ++|.|++.-|||+. ++.+.++|++=+-
T Consensus       140 ~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV  214 (268)
T COG1718         140 NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAV  214 (268)
T ss_pred             CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CCeEEEEECcccc
Confidence            347999998642 22223332  123333455556677777766654 77  99999999999999 8889999998654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=95.62  E-value=0.013  Score=44.03  Aligned_cols=113  Identities=16%  Similarity=0.210  Sum_probs=73.9

Q ss_pred             EEEEEeccCCC-CHHHHHH---h--hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecC
Q psy1934          21 YLILTELCTGG-SLVDVLK---E--RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG   94 (150)
Q Consensus        21 ~~lv~E~~~~g-~L~~~l~---~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg   94 (150)
                      .=+.|...+|. .+..+.+   +  +.....|+-..+..+.++.+-.-+|..+  -.-.|+.++|++++..+.+.+.|-.
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEccc
Confidence            44556666543 2333332   1  1123567788888899999999999988  7779999999999999999888733


Q ss_pred             ceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeee
Q psy1934          95 SATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g  148 (150)
                      .-...  ..+.           .....+|..-|.+||..              |.+-++++..++++|
T Consensus       163 sfqi~--~ng~-----------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g  217 (637)
T COG4248         163 SFQIN--ANGT-----------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG  217 (637)
T ss_pred             ceeec--cCCc-----------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence            21111  1110           01134678889999974              666666666666655

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=95.46  E-value=0.14  Score=35.24  Aligned_cols=29  Identities=31%  Similarity=0.459  Sum_probs=25.4

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|.|+.+.|++++..+ +.+.||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            489999999999998877 89999987753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576|consensus

Probab=94.04  E-value=0.015  Score=45.78  Aligned_cols=123  Identities=24%  Similarity=0.238  Sum_probs=68.2

Q ss_pred             cchh-hhcccCCCCCceEEEEEEeccCCC-CHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           4 LSAA-FIDKHSTPHGMHEYLILTELCTGG-SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         4 ~~~~-~~~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      -+|+ .+...+-.+.+...++.++++.++ +...........+..-++....+.-.+++.++|+.-  =.|+|    |++
T Consensus       291 n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l  364 (829)
T KOG0576|consen  291 NNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NIL  364 (829)
T ss_pred             cCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccc
Confidence            3455 666667777888889999999876 222111110011111122222333445667777543  34555    444


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSML  146 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~  146 (150)
                      . .....+..+|+.........             ...+..+++.+++||++         |.|+.+.-..++.
T Consensus       365 ~-s~~~~~~~~~~v~~~L~~~~-------------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~a  424 (829)
T KOG0576|consen  365 G-SEEEVKLLDFAVPPQLTRTM-------------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMA  424 (829)
T ss_pred             c-cccccccccccCCcccCccc-------------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcC
Confidence            3 33567778887654322111             11244688999999974         8888876444443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=93.64  E-value=0.28  Score=36.57  Aligned_cols=75  Identities=23%  Similarity=0.311  Sum_probs=48.6

Q ss_pred             CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCce
Q psy1934          17 GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA   96 (150)
Q Consensus        17 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~   96 (150)
                      +.-..|++|++. |+++.. ++    .-.++++..++.+.+.- .+.-+.+-+.-||++...||+++ .|.+.++||.++
T Consensus       297 e~~y~yl~~kdh-gt~is~-ik----~~~~~e~lsff~s~~si-l~~lekkf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISI-IK----ADRSEEELSFFWSCISI-LDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             CceEEEEEEecC-Cceeee-ee----cccHHHHHHHHHHHHHH-HhhhhhcCCcccccccccceeee-cCceEEEEeeee
Confidence            334557788876 334332 11    12345555566554433 33333333488999999999999 999999999999


Q ss_pred             ecc
Q psy1934          97 TEK   99 (150)
Q Consensus        97 ~~~   99 (150)
                      +..
T Consensus       369 Rl~  371 (488)
T COG5072         369 RLS  371 (488)
T ss_pred             ecc
Confidence            854

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=91.24  E-value=0.29  Score=34.08  Aligned_cols=38  Identities=24%  Similarity=0.359  Sum_probs=32.5

Q ss_pred             HHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecC
Q psy1934          57 CQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG   94 (150)
Q Consensus        57 ~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg   94 (150)
                      ++++.-.|+.++..+|.|..|+||.-++.|.+|+.|=+
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence            35677778666679999999999999999999999965

The function of this family is unknown.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=90.54  E-value=0.34  Score=33.32  Aligned_cols=30  Identities=30%  Similarity=0.376  Sum_probs=25.2

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|.|+.+.|++++..+...+.||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            389999999999998766567999997753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=90.16  E-value=2.3  Score=28.74  Aligned_cols=82  Identities=22%  Similarity=0.215  Sum_probs=51.9

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCC------CCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTG------GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~------g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      .+|.+..+..++.-..=+|+|...+      .+|.+++++  ..+++ .....+.   .-..++-+..  |+.+|++|.|
T Consensus        77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~N  148 (199)
T PF10707_consen   77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQALD---EFKRYLLDHH--IVIRDLNPHN  148 (199)
T ss_pred             cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHHHH---HHHHHHHHcC--CeecCCCccc
Confidence            3455566666666666788886442      378888864  34555 3333333   3345666666  9999999999


Q ss_pred             EEEcCCC----cEEEee-cCc
Q psy1934          80 LLISSAG----TVKLCD-FGS   95 (150)
Q Consensus        80 il~~~~~----~~~l~d-fg~   95 (150)
                      |++....    .+.++| ||.
T Consensus       149 Iv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  149 IVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EEEEecCCCceEEEEEeCCCC
Confidence            9996542    466777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=90.09  E-value=1.4  Score=31.51  Aligned_cols=30  Identities=30%  Similarity=0.411  Sum_probs=26.3

Q ss_pred             CeEEecCCCCCEEEcCC----CcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSA----GTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~----~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.||+++.+    +.+.+.||..+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            48999999999999874    7899999988764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=89.17  E-value=0.42  Score=32.96  Aligned_cols=30  Identities=17%  Similarity=0.308  Sum_probs=26.2

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++..+...+.||+.+..
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            489999999999999877778999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK05231 homoserine kinase; Provisional

Probab=89.06  E-value=0.35  Score=34.83  Aligned_cols=30  Identities=27%  Similarity=0.344  Sum_probs=25.5

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++.+....+.||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            399999999999998666567999998763

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=88.89  E-value=0.52  Score=32.23  Aligned_cols=30  Identities=27%  Similarity=0.379  Sum_probs=26.0

Q ss_pred             CeEEecCCCCCEEEcC-CCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISS-AGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++. ++.+.+.||..+..
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            4999999999999997 57799999987754

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=88.54  E-value=0.38  Score=32.44  Aligned_cols=30  Identities=33%  Similarity=0.552  Sum_probs=20.8

Q ss_pred             CeEEecCCCCCEEEc-CCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLIS-SAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~-~~~~~~l~dfg~~~~   98 (150)
                      .++|.|+.+.|++++ .++.+.+.||+.+..
T Consensus       167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  167 VLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             EEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             EEEEeccccccceeeeccceeEEEecccceE
Confidence            499999999999999 556668999987764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=87.02  E-value=1.4  Score=31.59  Aligned_cols=30  Identities=27%  Similarity=0.354  Sum_probs=26.1

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|.|+.+.|++++.++...+.||+.+..
T Consensus       188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       188 GVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             ccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            499999999999998887678999988753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268|consensus

Probab=86.70  E-value=0.77  Score=33.96  Aligned_cols=68  Identities=16%  Similarity=0.259  Sum_probs=47.2

Q ss_pred             ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecC
Q psy1934          18 MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG   94 (150)
Q Consensus        18 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg   94 (150)
                      .+.=|+|||+..|-.|.+.-+-    ..++++.   ..+..-+.-+..++  +||+|..--|+++..++.++++||-
T Consensus       180 ~~RH~Vvmelv~g~Pl~~v~~v----~d~~~ly---~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd~~i~vIDFP  247 (465)
T KOG2268|consen  180 HNRHCVVMELVDGYPLRQVRHV----EDPPTLY---DDLMGLIVRLANHG--LIHGDFNEFNIMVKDDDKIVVIDFP  247 (465)
T ss_pred             ccceeeHHHhhcccceeeeeec----CChHHHH---HHHHHHHHHHHHcC--ceecccchheeEEecCCCEEEeech
Confidence            3566899999988777664321    2233332   22223344455667  9999999999999999999999995

>KOG2270|consensus

Probab=86.66  E-value=1.7  Score=32.76  Aligned_cols=70  Identities=21%  Similarity=0.333  Sum_probs=44.9

Q ss_pred             EEEEeccCC-CCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEEecCCCCCEEEcCCCcEEEeecCce
Q psy1934          22 LILTELCTG-GSLVDVLKERTSALPPNIVCSILWQTCQAVKHM-HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA   96 (150)
Q Consensus        22 ~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~   96 (150)
                      .|||+|+.. |-..-.|+.  ..++...+..+-.+++.-++.| +.++  ++|.|++--|+|+.. |.+.++|.+=+
T Consensus       240 VLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd-G~lyiIDVSQS  311 (520)
T KOG2270|consen  240 VLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD-GKLYIIDVSQS  311 (520)
T ss_pred             eEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC-CEEEEEEcccc
Confidence            799999963 222334432  3466555555545555545443 6777  999999999998754 56777786543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=85.87  E-value=0.65  Score=32.98  Aligned_cols=30  Identities=27%  Similarity=0.336  Sum_probs=26.0

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++.++...+.||..+..
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            399999999999999877778999987653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=85.74  E-value=0.71  Score=31.15  Aligned_cols=30  Identities=43%  Similarity=0.562  Sum_probs=21.1

Q ss_pred             CeEEecCCCCCEEE-cCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLI-SSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~-~~~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.||++ ...+.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            38999999999999 7889999999987764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK10271 thiK thiamine kinase; Provisional

Probab=85.70  E-value=0.96  Score=30.34  Aligned_cols=29  Identities=31%  Similarity=0.515  Sum_probs=24.7

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      ..+|.|+.|.|+++...+ ++++|++.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            379999999999987766 88999987764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=85.46  E-value=3.4  Score=29.46  Aligned_cols=28  Identities=29%  Similarity=0.478  Sum_probs=24.0

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCcee
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSAT   97 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~   97 (150)
                      .++|+|+.+.|++++. +.+.+.||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            3899999999999987 567899998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=85.15  E-value=0.9  Score=31.64  Aligned_cols=29  Identities=31%  Similarity=0.558  Sum_probs=24.8

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++.++ +.+.||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            489999999999998776 78999987764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=84.66  E-value=1.1  Score=32.74  Aligned_cols=29  Identities=31%  Similarity=0.477  Sum_probs=25.7

Q ss_pred             eEEecCCCCCEEEcCCCc-EEEeecCceec
Q psy1934          70 IVHRDLKIENLLISSAGT-VKLCDFGSATE   98 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~-~~l~dfg~~~~   98 (150)
                      ++|.|+.+.|++++.... ..+.||+.+..
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            899999999999998874 88999998764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=84.41  E-value=5.9  Score=27.04  Aligned_cols=57  Identities=28%  Similarity=0.302  Sum_probs=39.5

Q ss_pred             ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCc
Q psy1934          18 MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGS   95 (150)
Q Consensus        18 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~   95 (150)
                      ....-||.||.+...          .++...    +.++.+-+..+|..+  |+-+|+++.|..     .-+++|||.
T Consensus       149 ~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~  205 (207)
T PF13095_consen  149 LPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKILHKLG--IVPRDVKPRNYR-----GGKLVDFSS  205 (207)
T ss_pred             CccEEEEEeecCCcc----------ccchhH----HHHHHHHHHHHHHCC--eeeccCcccccc-----CCEEEeccc
Confidence            344567777766532          223333    456777888899999  999999999975     346888874

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=82.84  E-value=4.2  Score=28.86  Aligned_cols=29  Identities=34%  Similarity=0.426  Sum_probs=26.3

Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      ++|.|+.+.|++....+.+.++||.-+..
T Consensus       155 ~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         155 PCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             eecCCCCccceEEcCCCcEEEEecccCCC
Confidence            89999999999999989999999976653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=82.06  E-value=1.5  Score=31.12  Aligned_cols=30  Identities=30%  Similarity=0.421  Sum_probs=24.8

Q ss_pred             CeEEecCCCCCEEEcCCCc-EEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGT-VKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~-~~l~dfg~~~~   98 (150)
                      .++|.|+.+.|++++.++. .-+.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987454 56999988764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=81.08  E-value=2.1  Score=31.29  Aligned_cols=30  Identities=30%  Similarity=0.392  Sum_probs=27.0

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      +++|.|..+.|++++..+-.-+.||+.+..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            599999999999999888888999998764

>PLN02236 choline kinase

Probab=80.96  E-value=1.9  Score=31.71  Aligned_cols=30  Identities=23%  Similarity=0.466  Sum_probs=25.7

Q ss_pred             CeEEecCCCCCEEEcC-CCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISS-AGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++. ++.+.+.||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            4899999999999976 46799999987764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	150
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-41
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-08
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-07
3soa_A	444	Full-Length Human Camkii Length = 444		8e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-06
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-06
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-05
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-05
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-05
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-05
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-05
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-05
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-05
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-05
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-05
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-05
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-05
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-04
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-04
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-04
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-04
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-04
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-04
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-04
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-04
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-04
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-04
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-04
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-04
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-04
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-04
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-04
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-04
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-04
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-04
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-04
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-04
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-04
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-04
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-04
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-04
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-04
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-04
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-04
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-04
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-04
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-04
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-04
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-04
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-04
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-04
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-04
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-04
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-04
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-04
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-04
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-04
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-04
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-04
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-04
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-04
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-04
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-04
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-04

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score =  164 bits (414), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 77/144 (53%), Positives = 106/144 (73%), Gaps = 3/144 (2%)
Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQ 58
           +++ SAA I K  +  G  E+L+LTELC G  LV+ LK  E    L  + V  I +QTC+
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+++E+E
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 119 MARFTTPMYRAPEMVDTWNNYVIG 142
           + R TTPMYR PE++D ++N+ IG
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIG 231

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 59/101 (58%), Gaps = 8/101 (7%)
Query: 41  TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA--TE 98
           T  L  + +   ++QT +AVK +HG N  ++HRDLK  NLLI+S   +K+CDFG A   +
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 99  KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           +  + ++  + QQ  M+E    R+    YRAPE++ T   Y
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRW----YRAPEVMLTSAKY 200

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 58/101 (57%), Gaps = 8/101 (7%)
Query: 41  TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA--TE 98
           T  L  + +   ++QT +AVK +HG N  ++HRDLK  NLLI+S   +K+CDFG A   +
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 99  KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           +  + ++  + QQ  M E    R+    YRAPE++ T   Y
Sbjct: 164 ESAADNSEPTGQQSGMTEXVATRW----YRAPEVMLTSAKY 200

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 14/97 (14%)
Query: 37  LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           L      +P ++V SI WQT QAV   H  N   +HRD+K EN+LI+    +KLCDFG A
Sbjct: 92  LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFA 149
Query: 97  TEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
              +  P + +        +DE+A   T  YR+PE++
Sbjct: 150 -RLLTGPSDYY--------DDEVA---TRWYRSPELL 174

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 58/101 (57%), Gaps = 8/101 (7%)
Query: 41  TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA--TE 98
           T  L  + +   ++QT +AVK +HG N  ++HRDLK  NLLI+S   +K+CDFG A   +
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 99  KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           +  + ++  + QQ  M E    R+    YRAPE++ T   Y
Sbjct: 164 ESAADNSEPTGQQSGMTEYVATRW----YRAPEVMLTSAKY 200

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 30/154 (19%)
Query: 8   FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQN 67
            I+ H      +E +++ E  +GG L D +      +    V + + Q C+ +KHMH  +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 68  PPIVHRDLKIENLL--ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTP 125
             IVH D+K EN++     A +VK+ DFG AT+               +  DE+ + TT 
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATK---------------LNPDEIVKVTTA 212
Query: 126 M--YRAPEMVDT---------WNNYVIGRSMLYG 148
              + APE+VD          W   V+G  +L G
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/74 (40%), Positives = 44/74 (59%), Gaps = 2/74 (2%)
Query: 23  ILTELCTGGSLVDVLKERTS--ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I+TE  + GSL  +L +  +   L      S+ +   + + ++H +NPPIVHRDLK  NL
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNL 170
Query: 81  LISSAGTVKLCDFG 94
           L+    TVK+CDFG
Sbjct: 171 LVDKKYTVKVCDFG 184

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 58/115 (50%), Gaps = 22/115 (19%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E C  GS+ D+++ R   L  + + +IL  T + ++++H      +HRD+K  N+L+
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK--IHRDIKAGNILL 158
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR----FTTPMYRAPEMV 133
           ++ G  KL DFG A +                L D MA+      TP + APE++
Sbjct: 159 NTEGHAKLADFGVAGQ----------------LTDXMAKRNXVIGTPFWMAPEVI 197

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 14/111 (12%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           IL E C GG++  V+ E    L  + +  +  QT  A+ ++H     I+HRDLK  N+L 
Sbjct: 111 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILF 168
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +  G +KL DFG       S  N  + Q+R           TP + APE+V
Sbjct: 169 TLDGDIKLADFG------VSAKNTRTIQRRDSF------IGTPYWMAPEVV 207

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 14/102 (13%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLC 91
           +++D L+   + L   +V   L+Q    +   H  N  I+HRD+K EN+L+S +G VKLC
Sbjct: 109 TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLC 166
Query: 92  DFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           DFG A   + +P   +        +DE+A   T  YRAPE++
Sbjct: 167 DFGFA-RTLAAPGEVY--------DDEVA---TRWYRAPELL 196

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 14/111 (12%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           IL E C GG++  V+ E    L  + +  +  QT  A+ ++H     I+HRDLK  N+L 
Sbjct: 111 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILF 168
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +  G +KL DFG       S  N    Q+R           TP + APE+V
Sbjct: 169 TLDGDIKLADFG------VSAKNTRXIQRRDXF------IGTPYWMAPEVV 207

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 66/122 (54%), Gaps = 14/122 (11%)
Query: 18  MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           M +  ++T L  G  L  +LK  T  L  + +C  L+Q  + +K++H  N  ++HRDLK 
Sbjct: 118 MKDVYLVTHL-MGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKP 172
Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWN 137
            NLL+++   +K+CDFG A  +V  PD+  +      L + +A   T  YRAPE++    
Sbjct: 173 SNLLLNTTXDLKICDFGLA--RVADPDHDHTG----FLTEYVA---TRWYRAPEIMLNSK 223
Query: 138 NY 139
            Y
Sbjct: 224 GY 225

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 14/111 (12%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           IL E C GG++  V+ E    L  + +  +  QT  A+ ++H     I+HRDLK  N+L 
Sbjct: 111 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILF 168
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +  G +KL DFG       S  N    Q+R           TP + APE+V
Sbjct: 169 TLDGDIKLADFG------VSAKNTRXIQRRDSF------IGTPYWMAPEVV 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 2/89 (2%)
Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
            ST  G    +++TEL T G+L   LK R       ++ S   Q  + ++ +H + PPI+
Sbjct: 95  ESTVKGKKCIVLVTELXTSGTLKTYLK-RFKVXKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 72  HRDLKIENLLISS-AGTVKLCDFGSATEK 99
           HRDLK +N+ I+   G+VK+ D G AT K
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLK 182

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 29/74 (39%), Positives = 44/74 (59%), Gaps = 2/74 (2%)
Query: 23  ILTELCTGGSLVDVLKERTS--ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I+TE  + GSL  +L +  +   L      S+ +   + + ++H +NPPIVHR+LK  NL
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170
Query: 81  LISSAGTVKLCDFG 94
           L+    TVK+CDFG
Sbjct: 171 LVDKKYTVKVCDFG 184

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 59/121 (48%), Gaps = 24/121 (19%)
Query: 39  ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA-GTVKLCDFGSAT 97
            R  A PP ++   L+Q  +++  +H  +  + HRD+K  N+L++ A GT+KLCDFGSA 
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA- 179
Query: 98  EKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVIGRSMLY 147
            K  SP            E  +A   +  YRAPE+          VD W+   I   M+ 
Sbjct: 180 -KKLSPS-----------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 148 G 148
           G
Sbjct: 228 G 228

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 119 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLA--R 174
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 175 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 201

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLA--R 176
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 177 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 203

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLA--R 172
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 173 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 199

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLA--R 176
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 177 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 203

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 176
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 177 VADPDHDHTG----FLXEXVA---TRWYRAPEIM 203

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 122 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 177
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 178 VADPDHDHTG----FLXEXVA---TRWYRAPEIM 204

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLA--R 172
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 173 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 199

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 18/130 (13%)
Query: 6   AAFIDKHSTPHGMHEYL-ILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHM 63
            AFI K+  P GM + L ++ E C  GS+ D++K  + + L    +  I  +  + + H+
Sbjct: 88  GAFIKKN--PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 64  HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
           H     ++HRD+K +N+L++    VKL DFG             SAQ    +        
Sbjct: 146 HQHK--VIHRDIKGQNVLLTENAEVKLVDFGV------------SAQLDRTVGRRNTFIG 191
Query: 124 TPMYRAPEMV 133
           TP + APE++
Sbjct: 192 TPYWMAPEVI 201

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 65/139 (46%), Gaps = 27/139 (19%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           + I+ EL TGG L D + +R      +    I+ Q    + +MH  N  IVHRDLK EN+
Sbjct: 96  FYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENI 152
Query: 81  LISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---- 133
           L+ S      +K+ DFG +T            QQ + ++D   R  T  Y APE++    
Sbjct: 153 LLESKEKDCDIKIIDFGLST----------CFQQNTKMKD---RIGTAYYIAPEVLRGTY 199
Query: 134 ----DTWNNYVIGRSMLYG 148
               D W+  VI   +L G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 65/139 (46%), Gaps = 27/139 (19%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           + I+ EL TGG L D + +R      +    I+ Q    + +MH  N  IVHRDLK EN+
Sbjct: 96  FYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENI 152
Query: 81  LISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---- 133
           L+ S      +K+ DFG +T            QQ + ++D   R  T  Y APE++    
Sbjct: 153 LLESKEKDCDIKIIDFGLST----------CFQQNTKMKD---RIGTAYYIAPEVLRGTY 199
Query: 134 ----DTWNNYVIGRSMLYG 148
               D W+  VI   +L G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 125 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 180
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 181 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 207

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 172
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 173 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 199

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 122 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 177
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 178 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 204

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 123 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 178
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 179 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 205

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 114 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 169
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 170 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 196

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 176
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 177 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 203

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 172
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 173 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 199

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 119 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 174
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 175 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 201

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 115 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 170
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 171 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 197

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 176
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 177 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 203

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 137 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 192
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 193 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 219

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 115 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 170
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 171 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 197

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 119 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 174
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 175 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 201

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 69/131 (52%), Gaps = 14/131 (10%)
Query: 9   IDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNP 68
           I + ST   M +  I+ +L     L  +LK  +  L  + +C  L+Q  + +K++H  N 
Sbjct: 109 ILRASTLEAMRDVYIVQDLMET-DLYKLLK--SQQLSNDHICYFLYQILRGLKYIHSAN- 164
Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYR 128
            ++HRDLK  NLLI++   +K+CDFG A  ++  P++  +      L + +A   T  YR
Sbjct: 165 -VLHRDLKPSNLLINTTCDLKICDFGLA--RIADPEHDHTG----FLTEXVA---TRWYR 214
Query: 129 APEMVDTWNNY 139
           APE++     Y
Sbjct: 215 APEIMLNSKGY 225

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 30/147 (20%)
Query: 16  HGMHE-----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPI 70
           HG  E     Y++L E+C   SL+++ K R +   P      + QT Q V+++H  N  +
Sbjct: 108 HGFFEDDDFVYVVL-EICRRRSLLELHKRRKAVTEPE-ARYFMRQTIQGVQYLH--NNRV 163
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
           +HRDLK+ NL ++    VK+ DFG AT+        +  +++  L        TP Y AP
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATK------IEFDGERKKXL------CGTPNYIAP 211
Query: 131 EM---------VDTWNNYVIGRSMLYG 148
           E+         VD W+   I  ++L G
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVG 238

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 30/147 (20%)
Query: 16  HGMHE-----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPI 70
           HG  E     Y++L E+C   SL+++ K R +   P      + QT Q V+++H  N  +
Sbjct: 108 HGFFEDDDFVYVVL-EICRRRSLLELHKRRKAVTEPE-ARYFMRQTIQGVQYLH--NNRV 163
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
           +HRDLK+ NL ++    VK+ DFG AT+        +  +++  L        TP Y AP
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATK------IEFDGERKKTL------CGTPNYIAP 211
Query: 131 EM---------VDTWNNYVIGRSMLYG 148
           E+         VD W+   I  ++L G
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVG 238

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 25/139 (17%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GGSL DV+ E  + +    + ++  +  QA++ +H     ++HRD+K +N
Sbjct: 92  ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDN 147
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L+   G+VKL DFG   +   +P+ +    +RS +        TP + APE+       
Sbjct: 148 ILLGMDGSVKLTDFGFCAQ--ITPEQS----KRSXM------VGTPYWMAPEVVTRKAYG 195
Query: 133 --VDTWNNYVIGRSMLYGH 149
             VD W+  ++   M+ G 
Sbjct: 196 PKVDIWSLGIMAIEMIEGE 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 25/139 (17%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GGSL DV+ E  + +    + ++  +  QA++ +H     ++HRD+K +N
Sbjct: 91  ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDN 146
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L+   G+VKL DFG   +   +P+ +    +RS +        TP + APE+       
Sbjct: 147 ILLGMDGSVKLTDFGFCAQ--ITPEQS----KRSXM------VGTPYWMAPEVVTRKAYG 194
Query: 133 --VDTWNNYVIGRSMLYGH 149
             VD W+  ++   M+ G 
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 12/116 (10%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L  + +      +  I  QT Q + ++H +N  I+HRD+K  N+ +
Sbjct: 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFL 165
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
               TVK+ DFG AT K     + WS  Q+  +E       + ++ APE++   +N
Sbjct: 166 HEGLTVKIGDFGLATVK-----SRWSGSQQ--VEQPTG---SVLWMAPEVIRMQDN 211

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 25/139 (17%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GGSL DV+ E  + +    + ++  +  QA++ +H     ++HRD+K +N
Sbjct: 91  ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDN 146
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L+   G+VKL DFG   +   +P+ +    +RS +        TP + APE+       
Sbjct: 147 ILLGMDGSVKLTDFGFCAQ--ITPEQS----KRSTM------VGTPYWMAPEVVTRKAYG 194
Query: 133 --VDTWNNYVIGRSMLYGH 149
             VD W+  ++   M+ G 
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 43/77 (55%), Gaps = 4/77 (5%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           LIL  +     L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+L
Sbjct: 90  LILERMEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENIL 146
Query: 82  IS-SAGTVKLCDFGSAT 97
           I  + G +KL DFGS  
Sbjct: 147 IDLNRGELKLIDFGSGA 163

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 45/139 (32%), Positives = 65/139 (46%), Gaps = 27/139 (19%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           + I+ EL TGG L D + +R      +    I+ Q    + +MH  N  IVHRDLK EN+
Sbjct: 96  FYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENI 152
Query: 81  LISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---- 133
           L+ S      +K+ DFG +T            QQ + ++D   R  T  Y APE++    
Sbjct: 153 LLESKEKDCDIKIIDFGLST----------CFQQNTKMKD---RIGTAYYIAPEVLRGTY 199
Query: 134 ----DTWNNYVIGRSMLYG 148
               D W+  VI   +L G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 14/110 (12%)
Query: 36  VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGS 95
           ++K+ +  L P+ + + +  T Q ++++H     I+HRDLK  NLL+   G +KL DFG 
Sbjct: 101 IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGL 158
Query: 96  ATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYVIGRSM 145
           A +   SP+ A+  Q             T  YRAPE++     Y +G  M
Sbjct: 159 A-KSFGSPNRAYXHQ-----------VVTRWYRAPELLFGARMYGVGVDM 196

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 51/85 (60%), Gaps = 11/85 (12%)
Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWS 108
           +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +V  PD+  +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--RVADPDHDHT 185
Query: 109 AQQRSMLEDEMARFTTPMYRAPEMV 133
                 L + +A   T  YRAPE++
Sbjct: 186 G----FLTEYVA---TRWYRAPEIM 203

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 25/139 (17%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GGSL DV+ E  + +    + ++  +  QA++ +H     ++HRD+K +N
Sbjct: 91  ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDN 146
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L+   G+VKL DFG   +   +P+ +    +RS +        TP + APE+       
Sbjct: 147 ILLGMDGSVKLTDFGFCAQ--ITPEQS----KRSEM------VGTPYWMAPEVVTRKAYG 194
Query: 133 --VDTWNNYVIGRSMLYGH 149
             VD W+  ++   M+ G 
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 30/147 (20%)
Query: 16  HGMHE-----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPI 70
           HG  E     Y++L E+C   SL+++ K R +   P      + QT Q V+++H  N  +
Sbjct: 92  HGFFEDDDFVYVVL-EICRRRSLLELHKRRKAVTEPE-ARYFMRQTIQGVQYLH--NNRV 147
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
           +HRDLK+ NL ++    VK+ DFG AT+        +  +++  L        TP Y AP
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATK------IEFDGERKKDL------CGTPNYIAP 195
Query: 131 EM---------VDTWNNYVIGRSMLYG 148
           E+         VD W+   I  ++L G
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVG 222

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMX--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMX--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 76  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 131
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 132 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMX--GTLPYVAPELLKR 181
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 60/119 (50%), Gaps = 17/119 (14%)
Query: 23  ILTELCTGGSLVDVLKERTSAL-PPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+ + C GG L   +  +   L   + +     Q C A+KH+H +   I+HRD+K +N+ 
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIF 157
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDT--WNN 138
           ++  GTV+L DFG A  +V +          S +E   A   TP Y +PE+ +   +NN
Sbjct: 158 LTKDGTVQLGDFGIA--RVLN----------STVELARACIGTPYYLSPEICENKPYNN 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 76  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 131
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 132 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 181
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 76  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 131
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 132 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 181
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 76  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 131
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 132 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 181
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 76  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 131
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 132 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 181
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 23  ILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD L+ R  S L  + +       C+A++++ G N   VHRDL   N+L
Sbjct: 92  IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVL 149
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNA-----WSAQQRSMLEDEMARFTTPMYRAPEMVDTW 136
           +S     K+ DFG   E   + D       W+A + ++ E    +F+T        +  W
Sbjct: 150 VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE-ALRE---KKFSTKSDVWSFGILLW 205
Query: 137 NNYVIGR 143
             Y  GR
Sbjct: 206 EIYSFGR 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMX--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMX--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 30/147 (20%)
Query: 16  HGMHE-----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPI 70
           HG  E     Y++L E+C   SL+++ K R +   P      + QT Q V+++H  N  +
Sbjct: 108 HGFFEDDDFVYVVL-EICRRRSLLELHKRRKAVTEPE-ARYFMRQTIQGVQYLH--NNRV 163
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
           +HRDLK+ NL ++    VK+ DFG AT+        +  +++  L        TP Y AP
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATK------IEFDGERKKDL------CGTPNYIAP 211
Query: 131 EM---------VDTWNNYVIGRSMLYG 148
           E+         VD W+   I  ++L G
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVG 238

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 74  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 129
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 130 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 179
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGEL 204

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 16/92 (17%)
Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA-GTVKLCDFGSATEKVY 101
           ++P N++   ++Q  +AV  +H     I HRD+K +NLL++S   T+KLCDFGSA + + 
Sbjct: 137 SIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP 194
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           S             E  +A   +  YRAPE++
Sbjct: 195 S-------------EPSVAXICSRFYRAPELM 213

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 23  ILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD L+ R  S L  + +       C+A++++ G N   VHRDL   N+L
Sbjct: 83  IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVL 140
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNA-----WSAQQRSMLEDEMARFTTPMYRAPEMVDTW 136
           +S     K+ DFG   E   + D       W+A + ++ E   A F+T        +  W
Sbjct: 141 VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE-ALRE---AAFSTKSDVWSFGILLW 196
Query: 137 NNYVIGR 143
             Y  GR
Sbjct: 197 EIYSFGR 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 65/145 (44%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 76  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 131
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT   Y+         R  L ++M    T  Y APE+   
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYN--------NRERLLNKMC--GTLPYVAPELLKR 181
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 76  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 131
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 132 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 181
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 76  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 131
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 132 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 181
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGEL 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT  V+  +N      R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLAT--VFRYNN------RERLLNKMC--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 58/124 (46%), Gaps = 20/124 (16%)
Query: 13  STPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILW-QTCQAVKHMHGQNPPIV 71
            T     +  ++ +   GG L  +L  R S   PN V      + C A++++H ++  I+
Sbjct: 73  GTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALEYLHSKD--II 128
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +RDLK EN+L+   G +K+ DFG A    Y PD  +                TP Y APE
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYXL------------CGTPDYIAPE 173
Query: 132 MVDT 135
           +V T
Sbjct: 174 VVST 177

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 23  ILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD L+ R  S L  + +       C+A++++ G N   VHRDL   N+L
Sbjct: 77  IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVL 134
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNA-----WSAQQRSMLEDEMARFTTPMYRAPEMVDTW 136
           +S     K+ DFG   E   + D       W+A + ++ E    +F+T        +  W
Sbjct: 135 VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE-ALRE---KKFSTKSDVWSFGILLW 190
Query: 137 NNYVIGR 143
             Y  GR
Sbjct: 191 EIYSFGR 197

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 65/145 (44%), Gaps = 24/145 (16%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            G  +YL L E C+GG L D + E    +P         Q    V ++HG    I HRD+
Sbjct: 75  EGNIQYLFL-EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDI 130
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           K ENLL+     +K+ DFG AT   Y+         R  L ++M    T  Y APE+   
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYN--------NRERLLNKMC--GTLPYVAPELLKR 180
Query: 133 -------VDTWNNYVIGRSMLYGHV 150
                  VD W+  ++  +ML G +
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGEL 205

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 23  ILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD L+ R  S L  + +       C+A++++ G N   VHRDL   N+L
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVL 321
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNA-----WSAQQRSMLEDEMARFTTPMYRAPEMVDTW 136
           +S     K+ DFG   E   + D       W+A + ++ E    +F+T        +  W
Sbjct: 322 VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE-ALRE---KKFSTKSDVWSFGILLW 377
Query: 137 NNYVIGR 143
             Y  GR
Sbjct: 378 EIYSFGR 384

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 14/111 (12%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E C GG++  ++ E    L    +  +  Q  +A+  +H +   I+HRDLK  N+L+
Sbjct: 93  IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLM 150
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +  G ++L DFG       S  N  + Q+R           TP + APE+V
Sbjct: 151 TLEGDIRLADFG------VSAKNLKTLQKRDSF------IGTPYWMAPEVV 189

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 14/111 (12%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E C GG++  ++ E    L    +  +  Q  +A+  +H +   I+HRDLK  N+L+
Sbjct: 85  IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLM 142
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +  G ++L DFG             SA+    L+   +   TP + APE+V
Sbjct: 143 TLEGDIRLADFGV------------SAKNLKTLQKRDSFIGTPYWMAPEVV 181

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 96  DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NXGVLHRDIKDENILIDLNRGELKL 152
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 153 IDFGSGALLKDTVYTDFDGTRVYSP 177

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT + + ++H ++  I+HRDLK  N+ +
Sbjct: 96  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL 153
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG ATEK
Sbjct: 154 HEDNTVKIGDFGLATEK 170

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT + + ++H ++  I+HRDLK  N+ +
Sbjct: 96  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL 153
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG ATEK
Sbjct: 154 HEDNTVKIGDFGLATEK 170

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 2/100 (2%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLKE    +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 88  EISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSN 145
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEM 119
           +L++S G +KLCDFG + + + S  N++   +  M  + +
Sbjct: 146 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERL 185

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 26/154 (16%)
Query: 6   AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG 65
           A  I  +      ++ +++ E   GG L D + + +  L        + Q C+ ++HMH 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 66  QNPPIVHRDLKIENLLI--SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
               I+H DLK EN+L     A  +K+ DFG A  + Y P        R  L+     F 
Sbjct: 206 MY--ILHLDLKPENILCVNRDAKQIKIIDFGLA--RRYKP--------REKLK---VNFG 250
Query: 124 TPMYRAPEMV---------DTWNNYVIGRSMLYG 148
           TP + APE+V         D W+  VI   +L G
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 99  DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 155
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 156 IDFGSGALLKDTVYTDFDGTRVYSP 180

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 96  DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 152
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 153 IDFGSGALLKDTVYTDFDGTRVYSP 177

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 96  DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 152
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 153 IDFGSGALLKDTVYTDFDGTRVYSP 177

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 43/76 (56%), Gaps = 4/76 (5%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS +D+LK     L    + +IL +  + + ++H +    +HRD+K  N+L+
Sbjct: 94  IIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERK--IHRDIKAANVLL 149
Query: 83  SSAGTVKLCDFGSATE 98
           S  G VKL DFG A +
Sbjct: 150 SEQGDVKLADFGVAGQ 165

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/66 (43%), Positives = 39/66 (59%), Gaps = 4/66 (6%)
Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLC 91
           L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL 
Sbjct: 102 LFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLI 158
Query: 92  DFGSAT 97
           DFGS  
Sbjct: 159 DFGSGA 164

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 69/139 (49%), Gaps = 25/139 (17%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GGSL DV+ E  + +    + ++  +  QA++ +H     ++HR++K +N
Sbjct: 92  ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRNIKSDN 147
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L+   G+VKL DFG   +   +P+ +    +RS +        TP + APE+       
Sbjct: 148 ILLGMDGSVKLTDFGFCAQ--ITPEQS----KRSTM------VGTPYWMAPEVVTRKAYG 195
Query: 133 --VDTWNNYVIGRSMLYGH 149
             VD W+  ++   M+ G 
Sbjct: 196 PKVDIWSLGIMAIEMIEGE 214

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 53/112 (47%), Gaps = 30/112 (26%)
Query: 38  KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT 97
           K     LP   +  ++ Q  + +  +H     IVHRDLK EN+L++S GTVKL DFG A 
Sbjct: 103 KAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA- 159
Query: 98  EKVYSPDNAWSAQQRSMLEDEMARF---TTPMYRAPEM---------VDTWN 137
            ++YS               +MA F    T  YRAPE+         VD W+
Sbjct: 160 -RIYS--------------YQMALFPVVVTLWYRAPEVLLQSTYATPVDMWS 196

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 101 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 157
Query: 91  CDFGSAT 97
            DFGS  
Sbjct: 158 IDFGSGA 164

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 101 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 157
Query: 91  CDFGSAT 97
            DFGS  
Sbjct: 158 IDFGSGA 164

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 123 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 179
Query: 91  CDFGSAT 97
            DFGS  
Sbjct: 180 IDFGSGA 186

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/143 (34%), Positives = 62/143 (43%), Gaps = 28/143 (19%)
Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H YLI  +L TGG L + +  R      +     + Q  +AV H H     +VHRDLK E
Sbjct: 95  HHYLIF-DLVTGGELFEDIVAREYYSEAD-ASHCIQQILEAVLHCHQMG--VVHRDLKPE 150
Query: 79  NLLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           NLL++S      VKL DFG A E V     AW                TP Y +PE+   
Sbjct: 151 NLLLASKLKGAAVKLADFGLAIE-VEGEQQAW-----------FGFAGTPGYLSPEVLRK 198
Query: 133 ------VDTWNNYVIGRSMLYGH 149
                 VD W   VI   +L G+
Sbjct: 199 DPYGKPVDLWACGVILYILLVGY 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 65/145 (44%), Gaps = 29/145 (20%)
Query: 17  GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           G H YL+  +L TGG L + +  R      +     + Q  ++V H+H  +  IVHRDLK
Sbjct: 103 GFH-YLVF-DLVTGGELFEDIVAREYYSEAD-ASHCIHQILESVNHIHQHD--IVHRDLK 157
Query: 77  IENLLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM- 132
            ENLL++S      VKL DFG A E V     AW                TP Y +PE+ 
Sbjct: 158 PENLLLASKCKGAAVKLADFGLAIE-VQGEQQAW-----------FGFAGTPGYLSPEVL 205
Query: 133 --------VDTWNNYVIGRSMLYGH 149
                   VD W   VI   +L G+
Sbjct: 206 RKDPYGKPVDIWACGVILYILLVGY 230

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 100 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 156
Query: 91  CDFGSAT 97
            DFGS  
Sbjct: 157 IDFGSGA 163

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 2/95 (2%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P  I+  +     + + ++  +   I+HRD+K  N
Sbjct: 97  EISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSN 154
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +L++S G +KLCDFG + + + S  N++   +  M
Sbjct: 155 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 189

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 44/84 (52%), Gaps = 16/84 (19%)
Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLC 91
           L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL 
Sbjct: 144 LFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLI 200
Query: 92  DFGSAT------------EKVYSP 103
           DFGS               +VYSP
Sbjct: 201 DFGSGALLKDTVYTDFDGTRVYSP 224

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 116 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 172
Query: 91  CDFGSAT 97
            DFGS  
Sbjct: 173 IDFGSGA 179

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 116 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 172
Query: 91  CDFGSAT 97
            DFGS  
Sbjct: 173 IDFGSGA 179

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 135 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 191
Query: 91  CDFGSAT 97
            DFGS  
Sbjct: 192 IDFGSGA 198

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 11/94 (11%)
Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+ DFG A  +
Sbjct: 117 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLA--R 172
Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           V  PD+  +      L + +A   T  YRAPE++
Sbjct: 173 VADPDHDHTG----FLTEYVA---TRWYRAPEIM 199

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 44/84 (52%), Gaps = 16/84 (19%)
Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLC 91
           L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL 
Sbjct: 130 LFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLI 186
Query: 92  DFGSAT------------EKVYSP 103
           DFGS               +VYSP
Sbjct: 187 DFGSGALLKDTVYTDFDGTRVYSP 210

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 116 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 172
Query: 91  CDFGSAT 97
            DFGS  
Sbjct: 173 IDFGSGA 179

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 128 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 184
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 185 IDFGSGALLKDTVYTDFDGTRVYSP 209

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 129 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 185
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 186 IDFGSGALLKDTVYTDFDGTRVYSP 210

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 148 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 204
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 205 IDFGSGALLKDTVYTDFDGTRVYSP 229

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 2/95 (2%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 78  EISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSN 135
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +L++S G +KLCDFG + + + S  N++   +  M
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 2/95 (2%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 78  EISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSN 135
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +L++S G +KLCDFG + + + S  N++   +  M
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 128 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 184
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 185 IDFGSGALLKDTVYTDFDGTRVYSP 209

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 115 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 171
Query: 91  CDFGSAT 97
            DFGS  
Sbjct: 172 IDFGSGA 178

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 143 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 199
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 200 IDFGSGALLKDTVYTDFDGTRVYSP 224

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 44/84 (52%), Gaps = 16/84 (19%)
Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLC 91
           L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL 
Sbjct: 130 LFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLI 186
Query: 92  DFGSAT------------EKVYSP 103
           DFGS               +VYSP
Sbjct: 187 DFGSGALLKDTVYTDFDGTRVYSP 210

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 2/95 (2%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 78  EISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSN 135
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +L++S G +KLCDFG + + + S  N++   +  M
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 129 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 185
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 186 IDFGSGALLKDTVYTDFDGTRVYSP 210

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 128 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 184
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 185 IDFGSGALLKDTVYTDFDGTRVYSP 209

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 44/85 (51%), Gaps = 16/85 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 128 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 184
Query: 91  CDFGSAT------------EKVYSP 103
            DFGS               +VYSP
Sbjct: 185 IDFGSGALLKDTVYTDFDGTRVYSP 209

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 2/95 (2%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 78  EISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSN 135
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +L++S G +KLCDFG + + + S  N++   +  M
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKL 90
            L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+LI  + G +KL
Sbjct: 115 DLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL 171
Query: 91  CDFGSAT 97
            DFGS  
Sbjct: 172 IDFGSGA 178

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 2/95 (2%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 105 EISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSN 162
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +L++S G +KLCDFG + + + S  N++   +  M
Sbjct: 163 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 197

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 47/95 (49%), Gaps = 16/95 (16%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           LIL        L D + ER  AL   +  S  WQ  +AV+H H  N  ++HRD+K EN+L
Sbjct: 133 LILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENIL 189
Query: 82  IS-SAGTVKLCDFGSAT------------EKVYSP 103
           I  + G +KL DFGS               +VYSP
Sbjct: 190 IDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSP 224

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/127 (22%), Positives = 65/127 (51%), Gaps = 16/127 (12%)
Query: 20  EYLILTELCTGGSLVDVLKE-------RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
           E  ++ +L +GGS++D++K        ++  L  + + +IL +  + ++++H      +H
Sbjct: 82  ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IH 139
Query: 73  RDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           RD+K  N+L+   G+V++ DFG +       D   +  +++ +        TP + APE+
Sbjct: 140 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-------GTPCWMAPEV 192
Query: 133 VDTWNNY 139
           ++    Y
Sbjct: 193 MEQVRGY 199

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 51/109 (46%), Gaps = 24/109 (22%)
Query: 38  KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT 97
           K     LP   +  ++ Q  + +  +H     IVHRDLK EN+L++S GTVKL DFG A 
Sbjct: 103 KAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA- 159
Query: 98  EKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWN 137
            ++YS   A +               T  YRAPE+         VD W+
Sbjct: 160 -RIYSYQMALAPV-----------VVTLWYRAPEVLLQSTYATPVDMWS 196

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/65 (41%), Positives = 38/65 (58%), Gaps = 4/65 (6%)
Query: 38  KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT 97
           K     LP   +  ++ Q  + +  +H     IVHRDLK EN+L++S GTVKL DFG A 
Sbjct: 103 KAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA- 159
Query: 98  EKVYS 102
            ++YS
Sbjct: 160 -RIYS 163

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 2/95 (2%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 78  EISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSN 135
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +L++S G +KLCDFG + + + S  N++   +  M
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 51/109 (46%), Gaps = 24/109 (22%)
Query: 38  KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT 97
           K     LP   +  ++ Q  + +  +H     IVHRDLK EN+L++S GTVKL DFG A 
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA- 167
Query: 98  EKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWN 137
            ++YS   A +               T  YRAPE+         VD W+
Sbjct: 168 -RIYSYQMALTPV-----------VVTLWYRAPEVLLQSTYATPVDMWS 204

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/127 (22%), Positives = 65/127 (51%), Gaps = 16/127 (12%)
Query: 20  EYLILTELCTGGSLVDVLKE-------RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
           E  ++ +L +GGS++D++K        ++  L  + + +IL +  + ++++H      +H
Sbjct: 87  ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ--IH 144
Query: 73  RDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           RD+K  N+L+   G+V++ DFG +       D   +  +++ +        TP + APE+
Sbjct: 145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-------GTPCWMAPEV 197
Query: 133 VDTWNNY 139
           ++    Y
Sbjct: 198 MEQVRGY 204

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/82 (37%), Positives = 45/82 (54%), Gaps = 4/82 (4%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E  +GG L   L ER      +  C  L +   A+ H+H +   I++RDLK EN+
Sbjct: 97  YLIL-EYLSGGELFMQL-EREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENI 152
Query: 81  LISSAGTVKLCDFGSATEKVYS 102
           +++  G VKL DFG   E ++ 
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHD 174

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 45/81 (55%), Gaps = 4/81 (4%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E  +GG L   L ER      +  C  L +   A+ H+H +   I++RDLK EN+
Sbjct: 97  YLIL-EYLSGGELFMQL-EREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENI 152
Query: 81  LISSAGTVKLCDFGSATEKVY 101
           +++  G VKL DFG   E ++
Sbjct: 153 MLNHQGHVKLTDFGLCKESIH 173

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 57/127 (44%), Gaps = 24/127 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLC 91
            L  VL E  + L  + +   L+Q  + V H H     I+HRDLK +NLLI+S G +KL 
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLA 161
Query: 92  DFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVI 141
           DFG A         A+    RS   +      T  YRAP++          VD W+   I
Sbjct: 162 DFGLA--------RAFGIPVRSYTHE----VVTLWYRAPDVLMGSKKYSTSVDIWSIGCI 209
Query: 142 GRSMLYG 148
              M+ G
Sbjct: 210 FAEMITG 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 19/115 (16%)
Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H   ++ E C G S  D+L+     L    + ++     Q + ++H  N  ++HRD+K  
Sbjct: 127 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAG 183
Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           N+L+S  G VKL DFGSA+  + +P N +                TP + APE++
Sbjct: 184 NILLSEPGLVKLGDFGSAS--IMAPANXFVG--------------TPYWMAPEVI 222

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 57/127 (44%), Gaps = 24/127 (18%)
Query: 32  SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLC 91
            L  VL E  + L  + +   L+Q  + V H H     I+HRDLK +NLLI+S G +KL 
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLA 161
Query: 92  DFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTWNNYVI 141
           DFG A         A+    RS   +      T  YRAP++          VD W+   I
Sbjct: 162 DFGLA--------RAFGIPVRSYTHE----VVTLWYRAPDVLMGSKKYSTSVDIWSIGCI 209
Query: 142 GRSMLYG 148
              M+ G
Sbjct: 210 FAEMITG 216

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 2/95 (2%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 140 EISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSN 197
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +L++S G +KLCDFG + + + S  N++   +  M
Sbjct: 198 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 232

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 51/107 (47%), Gaps = 19/107 (17%)
Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWS 108
           + ++L+     VK++H     I+HRDLK  N L++   +VK+CDFG A    Y P+N  S
Sbjct: 158 IKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY-PENGNS 214
Query: 109 AQQRSMLEDEMARFTTPM----------------YRAPEMVDTWNNY 139
               S  ED+M   T P                 YRAPE++    NY
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY 261

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 19/115 (16%)
Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H   ++ E C G S  D+L+     L    + ++     Q + ++H  N  ++HRD+K  
Sbjct: 88  HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAG 144
Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           N+L+S  G VKL DFGSA+  + +P N +                TP + APE++
Sbjct: 145 NILLSEPGLVKLGDFGSAS--IMAPANXFVG--------------TPYWMAPEVI 183

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           H   H   +  ++ E C    L          L P IV S L+Q  + +   H +N  ++
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VL 123
Query: 72  HRDLKIENLLISSAGTVKLCDFGSA 96
           HRDLK +NLLI+  G +KL DFG A
Sbjct: 124 HRDLKPQNLLINRNGELKLADFGLA 148

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 56/114 (49%), Gaps = 22/114 (19%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS +D+L  R        + ++L +  + + ++H +    +HRD+K  N+L+
Sbjct: 98  IIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLL 153
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMV 133
           S  G VKL DFG A +               + + ++ R T   TP + APE++
Sbjct: 154 SEQGDVKLADFGVAGQ---------------LTDTQIKRNTFVGTPFWMAPEVI 192

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 68/145 (46%), Gaps = 29/145 (20%)
Query: 17  GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           G H YLI+ +L +GG L D + E+      +    +++Q   AVK++H  +  IVHRDLK
Sbjct: 88  GGHLYLIM-QLVSGGELFDRIVEKGFYTERD-ASRLIFQVLDAVKYLH--DLGIVHRDLK 143
Query: 77  IENLL---ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM- 132
            ENLL   +     + + DFG +  K+  P +  S               TP Y APE+ 
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLS--KMEDPGSVLSTA-----------CGTPGYVAPEVL 190
Query: 133 --------VDTWNNYVIGRSMLYGH 149
                   VD W+  VI   +L G+
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGY 215

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 22/114 (19%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS +D+L+     L    + +IL +  + + ++H +    +HRD+K  N+L+
Sbjct: 82  IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLL 137
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMV 133
           S  G VKL DFG A +               + + ++ R T   TP + APE++
Sbjct: 138 SEHGEVKLADFGVAGQ---------------LTDTQIKRNTFVGTPFWMAPEVI 176

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 68/145 (46%), Gaps = 29/145 (20%)
Query: 17  GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           G H YLI+ +L +GG L D + E+      +    +++Q   AVK++H  +  IVHRDLK
Sbjct: 88  GGHLYLIM-QLVSGGELFDRIVEKGFYTERD-ASRLIFQVLDAVKYLH--DLGIVHRDLK 143
Query: 77  IENLL---ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM- 132
            ENLL   +     + + DFG +  K+  P +  S               TP Y APE+ 
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLS--KMEDPGSVLSTA-----------CGTPGYVAPEVL 190
Query: 133 --------VDTWNNYVIGRSMLYGH 149
                   VD W+  VI   +L G+
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGY 215

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 22/114 (19%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS +D+L+     L    + +IL +  + + ++H +    +HRD+K  N+L+
Sbjct: 102 IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLL 157
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMV 133
           S  G VKL DFG A +               + + ++ R T   TP + APE++
Sbjct: 158 SEHGEVKLADFGVAGQ---------------LTDTQIKRNTFVGTPFWMAPEVI 196

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 68/145 (46%), Gaps = 29/145 (20%)
Query: 17  GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           G H YLI+ +L +GG L D + E+      +    +++Q   AVK++H  +  IVHRDLK
Sbjct: 88  GGHLYLIM-QLVSGGELFDRIVEKGFYTERD-ASRLIFQVLDAVKYLH--DLGIVHRDLK 143
Query: 77  IENLL---ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM- 132
            ENLL   +     + + DFG +  K+  P +  S               TP Y APE+ 
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLS--KMEDPGSVLSTA-----------CGTPGYVAPEVL 190
Query: 133 --------VDTWNNYVIGRSMLYGH 149
                   VD W+  VI   +L G+
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGY 215

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 19  HEYLILTELCTGGSL---VDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           +E  I+ EL   G L   +   K++   +P   V     Q C A++HMH +   ++HRD+
Sbjct: 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDI 162
Query: 76  KIENLLISSAGTVKLCDFG 94
           K  N+ I++ G VKL D G
Sbjct: 163 KPANVFITATGVVKLGDLG 181

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 36/149 (24%)
Query: 18  MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           +H +L++ EL  GG L + +K++           I+ +   AV HMH  +  +VHRDLK 
Sbjct: 79  LHTFLVM-ELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVSHMH--DVGVVHRDLKP 134
Query: 78  ENLLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPM----YRAP 130
           ENLL +       +K+ DFG A  ++  PDN                  TP     Y AP
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFA--RLKPPDN--------------QPLKTPCFTLHYAAP 178
Query: 131 EMV---------DTWNNYVIGRSMLYGHV 150
           E++         D W+  VI  +ML G V
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQV 207

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK ENLLI++ G +KL DFG A     
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLA----- 151
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 152 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 176

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK ENLLI++ G +KL DFG A     
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLA----- 153
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 154 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 178

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 68/145 (46%), Gaps = 29/145 (20%)
Query: 17  GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           G H YLI+ +L +GG L D + E+      +    +++Q   AVK++H  +  IVHRDLK
Sbjct: 88  GGHLYLIM-QLVSGGELFDRIVEKGFYTERD-ASRLIFQVLDAVKYLH--DLGIVHRDLK 143
Query: 77  IENLL---ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM- 132
            ENLL   +     + + DFG +  K+  P +  S               TP Y APE+ 
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLS--KMEDPGSVLSTA-----------CGTPGYVAPEVL 190
Query: 133 --------VDTWNNYVIGRSMLYGH 149
                   VD W+  VI   +L G+
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGY 215

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK ENLLI++ G +KL DFG A     
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLA----- 152
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 153 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 177

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK ENLLI++ G +KL DFG A     
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLA----- 151
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 152 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 176

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK ENLLI++ G +KL DFG A     
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLA----- 150
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 151 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 175

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 14/92 (15%)
Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS 102
            +P  I+  I   T +A+ H+  +N  I+HRD+K  N+L+  +G +KLCDFG + + V S
Sbjct: 121 VIPEEILGKITLATVKALNHLK-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
                 A  R              Y APE +D
Sbjct: 180 IAKTRDAGCRP-------------YMAPERID 198

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 66/144 (45%), Gaps = 29/144 (20%)
Query: 19  HEYLILTELCTGGSLVDVL---KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           H   I+ E C GG L++ +   + R  AL    V  ++ Q   A+ + H Q+  +VH+DL
Sbjct: 93  HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDL 150
Query: 76  KIENLLI---SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           K EN+L    S    +K+ DFG A E   S +++ +A              T +Y APE+
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLA-ELFKSDEHSTNAA------------GTALYMAPEV 197
Query: 133 V--------DTWNNYVIGRSMLYG 148
                    D W+  V+   +L G
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 67/136 (49%), Gaps = 20/136 (14%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  EL  GGSL  ++KE+   LP +     L Q  + ++++H +   I+H D+K +N+L+
Sbjct: 162 IFMELLEGGSLGQLVKEQ-GCLPEDRALYYLGQALEGLEYLHSRR--ILHGDVKADNVLL 218
Query: 83  SSAGT-VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------- 132
           SS G+   LCDFG A      PD       +S+L  +    T   + APE+         
Sbjct: 219 SSDGSHAALCDFGHAV--CLQPDGL----GKSLLTGDYIPGTE-THMAPEVVLGRSCDAK 271
Query: 133 VDTWNNYVIGRSMLYG 148
           VD W++  +   ML G
Sbjct: 272 VDVWSSCCMMLHMLNG 287

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  N+ +
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 137
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG ATEK
Sbjct: 138 HEDLTVKIGDFGLATEK 154

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  N+ +
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 165
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG ATEK
Sbjct: 166 HEDLTVKIGDFGLATEK 182

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  N+ +
Sbjct: 100 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 157
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG ATEK
Sbjct: 158 HEDLTVKIGDFGLATEK 174

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 64/148 (43%), Gaps = 29/148 (19%)
Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           +  G H YL+  +L TGG L + +  R      +     + Q  +AV H H     +VHR
Sbjct: 73  SEEGFH-YLVF-DLVTGGELFEDIVAREYYSEAD-ASHCIQQILEAVLHCHQMG--VVHR 127
Query: 74  DLKIENLLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
           DLK ENLL++S      VKL DFG A E V     AW                TP Y +P
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIE-VQGDQQAW-----------FGFAGTPGYLSP 175
Query: 131 EM---------VDTWNNYVIGRSMLYGH 149
           E+         VD W   VI   +L G+
Sbjct: 176 EVLRKEAYGKPVDIWACGVILYILLVGY 203

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT + + ++H ++  I+HRDLK  N+ +
Sbjct: 84  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL 141
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG AT K
Sbjct: 142 HEDNTVKIGDFGLATVK 158

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 62/143 (43%), Gaps = 28/143 (19%)
Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H YLI  +L TGG L + +  R      +     + Q  +AV H H     +VHR+LK E
Sbjct: 84  HHYLIF-DLVTGGELFEDIVAREYYSEAD-ASHCIQQILEAVLHCHQMG--VVHRNLKPE 139
Query: 79  NLLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           NLL++S      VKL DFG A E V     AW                TP Y +PE+   
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIE-VEGEQQAW-----------FGFAGTPGYLSPEVLRK 187
Query: 133 ------VDTWNNYVIGRSMLYGH 149
                 VD W   VI   +L G+
Sbjct: 188 DPYGKPVDLWACGVILYILLVGY 210

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 24/104 (23%)
Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS 102
            +P   +  +++Q  + +  +H     +VHRDLK +N+L++S+G +KL DFG A  ++YS
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA--RIYS 171
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWN 137
              A ++              T  YRAPE+         VD W+
Sbjct: 172 FQMALTSV-----------VVTLWYRAPEVLLQSSYATPVDLWS 204

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 64/148 (43%), Gaps = 29/148 (19%)
Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           +  G H YL+  +L TGG L + +  R      +     + Q  ++V H H     IVHR
Sbjct: 73  SEEGFH-YLVF-DLVTGGELFEDIVAREYYSEAD-ASHCIQQILESVNHCHLNG--IVHR 127
Query: 74  DLKIENLLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
           DLK ENLL++S      VKL DFG A E V     AW                TP Y +P
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIE-VQGDQQAW-----------FGFAGTPGYLSP 175
Query: 131 EM---------VDTWNNYVIGRSMLYGH 149
           E+         VD W   VI   +L G+
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVGY 203

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 28/151 (18%)
Query: 9   IDKHSTPHGMHEYLILTELCTGGSLVDV-LKERTSALPPNIVCSILWQTCQAVKHMHGQN 67
           I+ H       E +++ E   GG +  + L E    +  N V  ++ Q  + V ++H  N
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 68  PPIVHRDLKIENLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTT 124
             IVH DLK +N+L+SS    G +K+ DFG  + K+       + + R ++        T
Sbjct: 152 --IVHLDLKPQNILLSSIYPLGDIKIVDFG-MSRKI-----GHACELREIM-------GT 196
Query: 125 PMYRAPEMV---------DTWNNYVIGRSML 146
           P Y APE++         D WN  +I   +L
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLL 227

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 64/148 (43%), Gaps = 29/148 (19%)
Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           +  G H YL+  +L TGG L + +  R      +     + Q  ++V H H     IVHR
Sbjct: 73  SEEGFH-YLVF-DLVTGGELFEDIVAREYYSEAD-ASHCIQQILESVNHCHLNG--IVHR 127
Query: 74  DLKIENLLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
           DLK ENLL++S      VKL DFG A E V     AW                TP Y +P
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIE-VQGDQQAW-----------FGFAGTPGYLSP 175
Query: 131 EM---------VDTWNNYVIGRSMLYGH 149
           E+         VD W   VI   +L G+
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVGY 203

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 2/95 (2%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  I  E   GGSL  VLK +   +P  I+  +     + + ++  ++  I+HRD+K  N
Sbjct: 81  EISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSN 138
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +L++S G +KLCDFG + + +    N +   +  M
Sbjct: 139 ILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYM 173

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 28/146 (19%)
Query: 16  HGMHE----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HG  E      ++ ELC   SL+++ K R +   P      L Q     +++H     ++
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-ARYYLRQIVLGCQYLHRNR--VI 137
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           HRDLK+ NL ++    VK+ DFG AT+  Y        +++ +L        TP Y APE
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEY------DGERKKVL------CGTPNYIAPE 185
Query: 132 M---------VDTWNNYVIGRSMLYG 148
           +         VD W+   I  ++L G
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVG 211

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 15/91 (16%)
Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS 102
            +P   +  +++Q  + +  +H     +VHRDLK +N+L++S+G +KL DFG A  ++YS
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA--RIYS 171
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
              A ++              T  YRAPE++
Sbjct: 172 FQMALTSV-----------VVTLWYRAPEVL 191

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 28/146 (19%)
Query: 16  HGMHE----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HG  E      ++ ELC   SL+++ K R +   P      L Q     +++H     ++
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-ARYYLRQIVLGCQYLHRNR--VI 161
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           HRDLK+ NL ++    VK+ DFG AT+  Y        +++ +L        TP Y APE
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEY------DGERKKVL------CGTPNYIAPE 209
Query: 132 M---------VDTWNNYVIGRSMLYG 148
           +         VD W+   I  ++L G
Sbjct: 210 VLSKKGHSFEVDVWSIGCIMYTLLVG 235

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           TP G   Y+++ E   G +L D++      + P     ++   CQA+   H QN  I+HR
Sbjct: 85  TPAGPLPYIVM-EYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH-QNG-IIHR 140
Query: 74  DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           D+K  N+LIS+   VK+ DFG A       D+  S  Q + +        T  Y +PE  
Sbjct: 141 DVKPANILISATNAVKVVDFGIARAIA---DSGNSVXQTAAV------IGTAQYLSPEQ- 190
Query: 134 DTWNNYVIGRSMLY 147
               + V  RS +Y
Sbjct: 191 -ARGDSVDARSDVY 203

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 45/76 (59%), Gaps = 4/76 (5%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  EL  GGSL  ++KE+   LP +     L Q  + ++++H +   I+H D+K +N+L+
Sbjct: 143 IFMELLEGGSLGQLVKEQ-GCLPEDRALYYLGQALEGLEYLHSRR--ILHGDVKADNVLL 199
Query: 83  SSAGT-VKLCDFGSAT 97
           SS G+   LCDFG A 
Sbjct: 200 SSDGSHAALCDFGHAV 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 43/76 (56%), Gaps = 4/76 (5%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS +D+L+     L    + +IL +  + + ++H +    +HRD+K  N+L+
Sbjct: 97  IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLL 152
Query: 83  SSAGTVKLCDFGSATE 98
           S  G VKL DFG A +
Sbjct: 153 SEHGEVKLADFGVAGQ 168

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 28/146 (19%)
Query: 16  HGMHE----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HG  E      ++ ELC   SL+++ K R +   P      L Q     +++H     ++
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-ARYYLRQIVLGCQYLHRNR--VI 163
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           HRDLK+ NL ++    VK+ DFG AT+  Y        +++ +L        TP Y APE
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEY------DGERKKVL------CGTPNYIAPE 211
Query: 132 M---------VDTWNNYVIGRSMLYG 148
           +         VD W+   I  ++L G
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVG 237

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 56/114 (49%), Gaps = 22/114 (19%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS +D+L+     L    + +IL +  + + ++H +    +HRD+K  N+L+
Sbjct: 82  IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLL 137
Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR---FTTPMYRAPEMV 133
           S  G VKL DFG A +               + + ++ R     TP + APE++
Sbjct: 138 SEHGEVKLADFGVAGQ---------------LTDTQIKRNXFVGTPFWMAPEVI 176

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 15/91 (16%)
Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS 102
            +P   +  +++Q  + +  +H     +VHRDLK +N+L++S+G +KL DFG A  ++YS
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA--RIYS 171
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
              A ++              T  YRAPE++
Sbjct: 172 FQMALTSV-----------VVTLWYRAPEVL 191

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 19  HEYLILTELCTGGSL---VDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           HE  +L      G+L   ++ LK++ + L  + +  +L   C+ ++ +H +     HRDL
Sbjct: 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDL 160
Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDT 135
           K  N+L+   G   L D GS  +     +    ++Q   L+D  A+  T  YRAPE+   
Sbjct: 161 KPTNILLGDEGQPVLMDLGSMNQACIHVE---GSRQALTLQDWAAQRCTISYRAPELFSV 217
Query: 136 WNNYVI 141
            ++ VI
Sbjct: 218 QSHCVI 223

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEMA F  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMAGFVATRWYRAPEIMLNWMHY 200

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEMA F  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMAGFVATRWYRAPEIMLNWMHY 200

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 63/140 (45%), Gaps = 25/140 (17%)
Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            E  +L E   GG+L D++ +    L    + ++     QA+ ++H Q   ++HRD+K +
Sbjct: 115 EELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSD 170
Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           ++L++  G VKL DFG            + AQ    +        TP + APE+      
Sbjct: 171 SILLTLDGRVKLSDFG------------FCAQISKDVPKRKXLVGTPYWMAPEVISRSLY 218
Query: 133 ---VDTWNNYVIGRSMLYGH 149
              VD W+  ++   M+ G 
Sbjct: 219 ATEVDIWSLGIMVIEMVDGE 238

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/73 (38%), Positives = 39/73 (53%), Gaps = 3/73 (4%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            ++ +L   G L D L E+  AL      SI+    +AV  +H  N  IVHRDLK EN+L
Sbjct: 176 FLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENIL 232
Query: 82  ISSAGTVKLCDFG 94
           +     ++L DFG
Sbjct: 233 LDDNMQIRLSDFG 245

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILW--QTCQAVKHMHGQNP-PIVHRDLKIEN 79
           ++ E   GGSL +VL             ++ W  Q  Q V ++H   P  ++HRDLK  N
Sbjct: 77  LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 136
Query: 80  LLISSAGTV-KLCDFGSATE 98
           LL+ + GTV K+CDFG+A +
Sbjct: 137 LLLVAGGTVLKICDFGTACD 156

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 106 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 161
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEMA F  T  YRAPE++  W +Y
Sbjct: 162 ILDFGLARHT----------------DDEMAGFVATRWYRAPEIMLNWMHY 196

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 152
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 153 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 177

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILW--QTCQAVKHMHGQNP-PIVHRDLKIEN 79
           ++ E   GGSL +VL             ++ W  Q  Q V ++H   P  ++HRDLK  N
Sbjct: 76  LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135
Query: 80  LLISSAGTV-KLCDFGSATE 98
           LL+ + GTV K+CDFG+A +
Sbjct: 136 LLLVAGGTVLKICDFGTACD 155

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 153
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 154 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 178

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 153
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 154 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 178

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 153
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 154 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 178

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 152
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 153 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 177

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 151
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 152 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 176

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 102 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 154
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 155 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 179

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 150
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 151 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 175

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 153
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 154 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 178

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 149
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 150 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 174

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 152
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 153 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 177

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 151
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 152 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 176

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 149
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 150 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 174

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 150
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 151 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 175

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 98  TGIPLPLIKSYLFQLLQGLSFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 150
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 151 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 175

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 150
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 151 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 175

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/149 (23%), Positives = 69/149 (46%), Gaps = 25/149 (16%)
Query: 9   IDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNP 68
           +D +S+     E  ++ E   GG+L D++    + +    + ++     +A+ ++H Q  
Sbjct: 105 VDMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG- 161
Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYR 128
            ++HRD+K +++L++S G +KL DFG            + AQ    +        TP + 
Sbjct: 162 -VIHRDIKSDSILLTSDGRIKLSDFG------------FCAQVSKEVPKRKXLVGTPYWM 208
Query: 129 APEM---------VDTWNNYVIGRSMLYG 148
           APE+         VD W+  ++   M+ G
Sbjct: 209 APEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           H   H   +  ++ E C    L          L P IV S L+Q  + +   H +N  ++
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VL 123
Query: 72  HRDLKIENLLISSAGTVKLCDFGSA 96
           HRDLK +NLLI+  G +KL +FG A
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLA 148

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 150
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 151 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 175

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 150
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 151 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 175

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 105 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 157
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 158 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 182

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 153
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 154 ---RAFGVPVRTYXHE----VVTLWYRAPEIL 178

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 150
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 151 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 175

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 151
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 152 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 176

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 149
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 150 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 174

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 150
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 151 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 175

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 102 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 154
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 155 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 179

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 149
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 150 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 174

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 105 TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 157
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 158 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 182

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 149
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 150 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 174

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 150
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 151 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 175

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 14/92 (15%)
Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
           + +P  ++ S L+Q  Q +   H     ++HRDLK +NLLI++ G +KL DFG A     
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA----- 149
Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
               A+    R+   +      T  YRAPE++
Sbjct: 150 ---RAFGVPVRTYTHE----VVTLWYRAPEIL 174

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 28/146 (19%)
Query: 16  HGMHE----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HG  E      ++ ELC   SL+++ K R +   P      L Q     +++H     ++
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-ARYYLRQIVLGCQYLHRNR--VI 139
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           HRDLK+ NL ++    VK+ DFG AT+  Y        +++  L        TP Y APE
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEY------DGERKKTL------CGTPNYIAPE 187
Query: 132 M---------VDTWNNYVIGRSMLYG 148
           +         VD W+   I  ++L G
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVG 213

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 28/146 (19%)
Query: 16  HGMHE----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HG  E      ++ ELC   SL+++ K R +   P      L Q     +++H     ++
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-ARYYLRQIVLGCQYLHRNR--VI 139
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           HRDLK+ NL ++    VK+ DFG AT+  Y        +++  L        TP Y APE
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEY------DGERKKTL------CGTPNYIAPE 187
Query: 132 M---------VDTWNNYVIGRSMLYG 148
           +         VD W+   I  ++L G
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVG 213

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 28/146 (19%)
Query: 16  HGMHE----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HG  E      ++ ELC   SL+++ K R +   P      L Q     +++H     ++
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-ARYYLRQIVLGCQYLHRNR--VI 143
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           HRDLK+ NL ++    VK+ DFG AT+  Y        +++  L        TP Y APE
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEY------DGERKKTL------CGTPNYIAPE 191
Query: 132 M---------VDTWNNYVIGRSMLYG 148
           +         VD W+   I  ++L G
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVG 217

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 61/146 (41%), Gaps = 29/146 (19%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           HG    LI+ E   GG L   ++ER   A        I+     A++ +H  N  I HRD
Sbjct: 96  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRD 153
Query: 75  LKIENLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +K ENLL +S      +KL DFG A E   +  NA                 TP Y APE
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQTP-----------CYTPYYVAPE 199
Query: 132 MV---------DTWNNYVIGRSMLYG 148
           ++         D W+  VI   +L G
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCG 225

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 20/56 (35%), Positives = 37/56 (66%), Gaps = 1/56 (1%)
Query: 39  ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           ++   +P +I+  I     +A++H+H +   ++HRD+K  N+LI++ G VK+CDFG
Sbjct: 101 DKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFG 155

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 3/78 (3%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+L E+C  G +   LK R      N     + Q    + ++H     I+HRDL + NL
Sbjct: 87  YLVL-EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNL 143
Query: 81  LISSAGTVKLCDFGSATE 98
           L++    +K+ DFG AT+
Sbjct: 144 LLTRNMNIKIADFGLATQ 161

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 18/118 (15%)
Query: 23  ILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNP---PIVHRDLK 76
           I+ E C GG L  V+ + T     L    V  ++ Q   A+K  H ++     ++HRDLK
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
             N+ +     VKL DFG A  ++ + D +++           A   TP Y +PE ++
Sbjct: 144 PANVFLDGKQNVKLGDFGLA--RILNHDTSFAK----------AFVGTPYYMSPEQMN 189

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 20/56 (35%), Positives = 37/56 (66%), Gaps = 1/56 (1%)
Query: 39  ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           ++   +P +I+  I     +A++H+H +   ++HRD+K  N+LI++ G VK+CDFG
Sbjct: 145 DKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFG 199

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 61/146 (41%), Gaps = 29/146 (19%)
Query: 16  HGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           HG    LI+ E   GG L   ++ER   A        I+     A++ +H  N  I HRD
Sbjct: 77  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRD 134
Query: 75  LKIENLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +K ENLL +S      +KL DFG A E   +  NA                 TP Y APE
Sbjct: 135 VKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQTP-----------CYTPYYVAPE 180
Query: 132 MV---------DTWNNYVIGRSMLYG 148
           ++         D W+  VI   +L G
Sbjct: 181 VLGPEKYDKSCDMWSLGVIMYILLCG 206

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLVGIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+        T  YRAPE+         VD W+  VI   M+ G V
Sbjct: 179 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGV 223

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLVGIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+        T  YRAPE+         VD W+  VI   M+ G V
Sbjct: 179 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGV 223

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 36/144 (25%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL- 81
           ++TEL  GG L+D +  R          ++L+   + V+++H Q   +VHRDLK  N+L 
Sbjct: 93  VVTELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILY 149
Query: 82  ISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYR----APEMV- 133
           +  +G   ++++CDFG A +                L  E     TP Y     APE++ 
Sbjct: 150 VDESGNPESIRICDFGFAKQ----------------LRAENGLLMTPCYTANFVAPEVLE 193
Query: 134 --------DTWNNYVIGRSMLYGH 149
                   D W+  V+  +ML G+
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGY 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 45/83 (54%), Gaps = 4/83 (4%)
Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           TP G   Y+++ E   G +L D++      + P     ++   CQA+   H QN  I+HR
Sbjct: 85  TPAGPLPYIVM-EYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH-QNG-IIHR 140
Query: 74  DLKIENLLISSAGTVKLCDFGSA 96
           D+K  N++IS+   VK+ DFG A
Sbjct: 141 DVKPANIMISATNAVKVMDFGIA 163

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 45/83 (54%), Gaps = 4/83 (4%)
Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           TP G   Y+++ E   G +L D++      + P     ++   CQA+   H QN  I+HR
Sbjct: 85  TPAGPLPYIVM-EYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH-QNG-IIHR 140
Query: 74  DLKIENLLISSAGTVKLCDFGSA 96
           D+K  N++IS+   VK+ DFG A
Sbjct: 141 DVKPANIMISATNAVKVMDFGIA 163

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 45/83 (54%), Gaps = 4/83 (4%)
Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           TP G   Y+++ E   G +L D++      + P     ++   CQA+   H QN  I+HR
Sbjct: 85  TPAGPLPYIVM-EYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH-QNG-IIHR 140
Query: 74  DLKIENLLISSAGTVKLCDFGSA 96
           D+K  N++IS+   VK+ DFG A
Sbjct: 141 DVKPANIMISATNAVKVMDFGIA 163

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 45/83 (54%), Gaps = 4/83 (4%)
Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           TP G   Y+++ E   G +L D++      + P     ++   CQA+   H QN  I+HR
Sbjct: 85  TPAGPLPYIVM-EYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH-QNG-IIHR 140
Query: 74  DLKIENLLISSAGTVKLCDFGSA 96
           D+K  N++IS+   VK+ DFG A
Sbjct: 141 DVKPANIMISATNAVKVMDFGIA 163

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           TP G   Y+++ E   G +L D++      + P     ++   CQA+   H QN  I+HR
Sbjct: 102 TPAGPLPYIVM-EYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH-QNG-IIHR 157
Query: 74  DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           D+K  N++IS+   VK+ DFG A       D+  S  Q +      A   T  Y +PE  
Sbjct: 158 DVKPANIMISATNAVKVMDFGIARAIA---DSGNSVTQTA------AVIGTAQYLSPEQ- 207
Query: 134 DTWNNYVIGRSMLY 147
               + V  RS +Y
Sbjct: 208 -ARGDSVDARSDVY 220

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 31/141 (21%)
Query: 21  YLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           + ++ E+ TGG L D  + ++R S +       I+ Q    + +MH     IVHRDLK E
Sbjct: 101 FYLVGEVYTGGELFDEIISRKRFSEVDA---ARIIRQVLSGITYMH--KNKIVHRDLKPE 155
Query: 79  NLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-- 133
           NLL+ S      +++ DFG +T         + A ++  ++D++    T  Y APE++  
Sbjct: 156 NLLLESKSKDANIRIIDFGLSTH--------FEASKK--MKDKIG---TAYYIAPEVLHG 202
Query: 134 ------DTWNNYVIGRSMLYG 148
                 D W+  VI   +L G
Sbjct: 203 TYDEKCDVWSTGVILYILLSG 223

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 31/141 (21%)
Query: 21  YLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           + ++ E+ TGG L D  + ++R S +       I+ Q    + +MH     IVHRDLK E
Sbjct: 124 FYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMH--KNKIVHRDLKPE 178
Query: 79  NLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-- 133
           NLL+ S      +++ DFG +T         + A ++  ++D++    T  Y APE++  
Sbjct: 179 NLLLESKSKDANIRIIDFGLSTH--------FEASKK--MKDKIG---TAYYIAPEVLHG 225
Query: 134 ------DTWNNYVIGRSMLYG 148
                 D W+  VI   +L G
Sbjct: 226 TYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 31/141 (21%)
Query: 21  YLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           + ++ E+ TGG L D  + ++R S +       I+ Q    + +MH     IVHRDLK E
Sbjct: 125 FYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMH--KNKIVHRDLKPE 179
Query: 79  NLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-- 133
           NLL+ S      +++ DFG +T         + A ++  ++D++    T  Y APE++  
Sbjct: 180 NLLLESKSKDANIRIIDFGLSTH--------FEASKK--MKDKIG---TAYYIAPEVLHG 226
Query: 134 ------DTWNNYVIGRSMLYG 148
                 D W+  VI   +L G
Sbjct: 227 TYDEKCDVWSTGVILYILLSG 247

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 31/141 (21%)
Query: 21  YLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           + ++ E+ TGG L D  + ++R S +       I+ Q    + +MH     IVHRDLK E
Sbjct: 107 FYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMH--KNKIVHRDLKPE 161
Query: 79  NLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-- 133
           NLL+ S      +++ DFG +T         + A ++  ++D++    T  Y APE++  
Sbjct: 162 NLLLESKSKDANIRIIDFGLSTH--------FEASKK--MKDKIG---TAYYIAPEVLHG 208
Query: 134 ------DTWNNYVIGRSMLYG 148
                 D W+  VI   +L G
Sbjct: 209 TYDEKCDVWSTGVILYILLSG 229

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+E E+    T  YRAPE++
Sbjct: 179 SFMMEPEV---VTRYYRAPEVI 197

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+E E+    T  YRAPE++
Sbjct: 179 SFMMEPEV---VTRYYRAPEVI 197

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K +   L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVKXQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 116 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELK 171
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 172 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 206

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 20/56 (35%), Positives = 36/56 (64%), Gaps = 1/56 (1%)
Query: 39  ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           ++   +P +I+  I     +A++H+H +   ++HRD+K  N+LI++ G VK CDFG
Sbjct: 128 DKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKXCDFG 182

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 46/80 (57%), Gaps = 7/80 (8%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL- 81
           ++TEL  GG L+D +  R          ++L+   + V+++H Q   +VHRDLK  N+L 
Sbjct: 93  VVTELXKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILY 149
Query: 82  ISSAG---TVKLCDFGSATE 98
           +  +G   ++++CDFG A +
Sbjct: 150 VDESGNPESIRICDFGFAKQ 169

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 4/75 (5%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  EL  GGSL  ++K+    LP +     L Q  + ++++H +   I+H D+K +N+L+
Sbjct: 141 IFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLL 197
Query: 83  SSAGT-VKLCDFGSA 96
           SS G+   LCDFG A
Sbjct: 198 SSDGSRAALCDFGHA 212

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 22/141 (15%)
Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H YL++ +   GG L+ +L +    LP ++    + +   A+  +H  +   VHRD+K +
Sbjct: 148 HLYLVM-DYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH--YVHRDIKPD 204
Query: 79  NLLISSAGTVKLCDFGS-----------ATEKVYSPDNAWSAQQRSMLEDEMARFTTPMY 127
           N+L+   G ++L DFGS           ++  V +PD   S +    +ED M ++     
Sbjct: 205 NVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYI-SPEILQAMEDGMGKY----- 258
Query: 128 RAPEMVDTWNNYVIGRSMLYG 148
             PE  D W+  V    MLYG
Sbjct: 259 -GPE-CDWWSLGVCMYEMLYG 277

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 20/136 (14%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  EL  GGSL  ++K+    LP +     L Q  + ++++H +   I+H D+K +N+L+
Sbjct: 143 IFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLL 199
Query: 83  SSAGT-VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------- 132
           SS G+   LCDFG A      PD       +S+L  +     T  + APE+         
Sbjct: 200 SSDGSRAALCDFGHAL--CLQPDGL----GKSLLTGDYIP-GTETHMAPEVVMGKPCDAK 252
Query: 133 VDTWNNYVIGRSMLYG 148
           VD W++  +   ML G
Sbjct: 253 VDIWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 20/136 (14%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  EL  GGSL  ++K+    LP +     L Q  + ++++H +   I+H D+K +N+L+
Sbjct: 127 IFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLL 183
Query: 83  SSAGT-VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--------- 132
           SS G+   LCDFG A      PD       +S+L  +     T  + APE+         
Sbjct: 184 SSDGSRAALCDFGHAL--CLQPDGL----GKSLLTGDYIP-GTETHMAPEVVMGKPCDAK 236
Query: 133 VDTWNNYVIGRSMLYG 148
           VD W++  +   ML G
Sbjct: 237 VDIWSSCCMMLHMLNG 252

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  N+ +
Sbjct: 107 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 164
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG AT K
Sbjct: 165 HEDLTVKIGDFGLATVK 181

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 21/119 (17%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+ T    G  L +++K  + AL    V  +++Q  + +K++H     I+HRDLK  N+
Sbjct: 109 YLVTT--LMGADLNNIVK--SQALSDEHVQFLVYQLLRGLKYIHSAG--IIHRDLKPSNV 162
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
            ++    +++ DFG A               R   E+      T  YRAPE++  W +Y
Sbjct: 163 AVNEDSELRILDFGLA---------------RQADEEMTGYVATRWYRAPEIMLNWMHY 206

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 112 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELK 167
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 168 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 202

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  N+ +
Sbjct: 82  IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 139
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG AT K
Sbjct: 140 HEDLTVKIGDFGLATVK 156

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  N+ +
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 165
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG AT K
Sbjct: 166 HEDLTVKIGDFGLATVK 182

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  N+ +
Sbjct: 85  IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 142
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG AT K
Sbjct: 143 HEDLTVKIGDFGLATVK 159

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 22/141 (15%)
Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H YL++ +   GG L+ +L +    LP ++    + +   A+  +H  +   VHRD+K +
Sbjct: 164 HLYLVM-DYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH--YVHRDIKPD 220
Query: 79  NLLISSAGTVKLCDFGS-----------ATEKVYSPDNAWSAQQRSMLEDEMARFTTPMY 127
           N+L+   G ++L DFGS           ++  V +PD   S +    +ED M ++     
Sbjct: 221 NVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYI-SPEILQAMEDGMGKY----- 274
Query: 128 RAPEMVDTWNNYVIGRSMLYG 148
             PE  D W+  V    MLYG
Sbjct: 275 -GPE-CDWWSLGVCMYEMLYG 293

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 14/91 (15%)
Query: 43  ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYS 102
            L  N+V    WQ  Q +   H     I+HRDLK +NLLI+  G +KL DFG A      
Sbjct: 104 GLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGI 160
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           P N +S++             T  YRAP+++
Sbjct: 161 PVNTFSSE-----------VVTLWYRAPDVL 180

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  N+ +
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 137
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG AT K
Sbjct: 138 HEDLTVKIGDFGLATVK 154

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  N+ +
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 137
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG AT K
Sbjct: 138 HEDLTVKIGDFGLATVK 154

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 4/120 (3%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I  E C  G+L D++         +    +  Q  +A+ ++H Q   I+HRDLK  N+ 
Sbjct: 91  FIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIF 148
Query: 82  ISSAGTVKLCDFGSATEKVYSPDN-AWSAQQRSMLEDEM-ARFTTPMYRAPEMVDTWNNY 139
           I  +  VK+ DFG A     S D     +Q      D + +   T MY A E++D   +Y
Sbjct: 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 25/138 (18%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GG+L D++    + +    + ++     QA+  +H Q   ++HRD+K ++
Sbjct: 95  ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDS 150
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L++  G VKL DFG            + AQ    +        TP + APE+       
Sbjct: 151 ILLTHDGRVKLSDFG------------FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 198
Query: 133 --VDTWNNYVIGRSMLYG 148
             VD W+  ++   M+ G
Sbjct: 199 PEVDIWSLGIMVIEMVDG 216

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 54/119 (45%), Gaps = 20/119 (16%)
Query: 23  ILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNP---PIVHRDLK 76
           I+ E C GG L  V+ + T     L    V  ++ Q   A+K  H ++     ++HRDLK
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVD 134
             N+ +     VKL DFG A  ++ + D           ED    F  TP Y +PE ++
Sbjct: 144 PANVFLDGKQNVKLGDFGLA--RILNHD-----------EDFAKEFVGTPYYMSPEQMN 189

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  N+ +
Sbjct: 85  IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL 142
Query: 83  SSAGTVKLCDFGSATEK 99
               TVK+ DFG AT K
Sbjct: 143 HEDLTVKIGDFGLATVK 159

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 62/139 (44%), Gaps = 25/139 (17%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GG+L D++    + +    + ++     QA+  +H Q   ++HRD+K ++
Sbjct: 102 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDS 157
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L++  G VKL DFG            + AQ    +        TP + APE+       
Sbjct: 158 ILLTHDGRVKLSDFG------------FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 205
Query: 133 --VDTWNNYVIGRSMLYGH 149
             VD W+  ++   M+ G 
Sbjct: 206 PEVDIWSLGIMVIEMVDGE 224

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 51/108 (47%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+  E+    T  YRAPE+         VD W+   I   M+ G V
Sbjct: 179 SFMMTPEV---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 62/139 (44%), Gaps = 25/139 (17%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GG+L D++    + +    + ++     QA+  +H Q   ++HRD+K ++
Sbjct: 91  ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDS 146
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L++  G VKL DFG            + AQ    +        TP + APE+       
Sbjct: 147 ILLTHDGRVKLSDFG------------FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 194
Query: 133 --VDTWNNYVIGRSMLYGH 149
             VD W+  ++   M+ G 
Sbjct: 195 PEVDIWSLGIMVIEMVDGE 213

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 10/91 (10%)
Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWS 108
           V   L+Q  + +K+MH     ++HRDLK  NLL++    +K+ DFG A     SP     
Sbjct: 160 VRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP----- 212
Query: 109 AQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           A+ +  + + +A   T  YRAPE++ + + Y
Sbjct: 213 AEHQYFMTEYVA---TRWYRAPELMLSLHEY 240

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 54/118 (45%), Gaps = 18/118 (15%)
Query: 23  ILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNP---PIVHRDLK 76
           I+ E C GG L  V+ + T     L    V  ++ Q   A+K  H ++     ++HRDLK
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
             N+ +     VKL DFG A  ++ + D +++               TP Y +PE ++
Sbjct: 144 PANVFLDGKQNVKLGDFGLA--RILNHDTSFAK----------TFVGTPYYMSPEQMN 189

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 62/139 (44%), Gaps = 25/139 (17%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GG+L D++    + +    + ++     QA+  +H Q   ++HRD+K ++
Sbjct: 100 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDS 155
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L++  G VKL DFG            + AQ    +        TP + APE+       
Sbjct: 156 ILLTHDGRVKLSDFG------------FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 203
Query: 133 --VDTWNNYVIGRSMLYGH 149
             VD W+  ++   M+ G 
Sbjct: 204 PEVDIWSLGIMVIEMVDGE 222

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K +   L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVKXQ--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 115 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELK 170
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 171 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 205

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 115 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELK 170
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 171 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 205

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL +   GG L   L +       + V   L +   A+ H+H     I++RDLK EN+
Sbjct: 102 YLIL-DFLRGGDLFTRLSKEVMFTEED-VKFYLAELALALDHLHSLG--IIYRDLKPENI 157
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWS 108
           L+   G +KL DFG + E +     A+S
Sbjct: 158 LLDEEGHIKLTDFGLSKESIDHEKKAYS 185

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 121 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELK 176
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 177 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 211

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K   + L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 106 GADLNNIVK--CAKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 161
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 162 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 196

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 44/140 (31%), Positives = 61/140 (43%), Gaps = 27/140 (19%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y ++ E   GG L D +  R      +    I+ Q    V ++H  N  IVHRDLK ENL
Sbjct: 111 YYLVMECYKGGELFDEIIHRMKFNEVD-AAVIIKQVLSGVTYLHKHN--IVHRDLKPENL 167
Query: 81  LISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---- 133
           L+ S      +K+ DFG +         A    Q+ M E    R  T  Y APE++    
Sbjct: 168 LLESKEKDALIKIVDFGLS---------AVFENQKKMKE----RLGTAYYIAPEVLRKKY 214
Query: 134 ----DTWNNYVIGRSMLYGH 149
               D W+  VI   +L G+
Sbjct: 215 DEKCDVWSIGVILFILLAGY 234

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/114 (25%), Positives = 54/114 (47%), Gaps = 16/114 (14%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GG+L D++    + +    + ++     QA+  +H Q   ++HRD+K ++
Sbjct: 145 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDS 200
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +L++  G VKL DFG            + AQ    +        TP + APE++
Sbjct: 201 ILLTHDGRVKLSDFG------------FCAQVSKEVPRRKXLVGTPYWMAPELI 242

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 10/88 (11%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
            L+Q  + +K+MH     ++HRDLK  NLL++    +K+ DFG A     SP     A+ 
Sbjct: 164 FLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP-----AEH 216
Query: 112 RSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           +  + + +A   T  YRAPE++ + + Y
Sbjct: 217 QYFMTEYVA---TRWYRAPELMLSLHEY 241

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 59/137 (43%), Gaps = 25/137 (18%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL +   GG L   L +       + V   L +   A+ H+H     I++RDLK EN+
Sbjct: 103 YLIL-DFLRGGDLFTRLSKEVMFTEED-VKFYLAELALALDHLHSLG--IIYRDLKPENI 158
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------- 133
           L+   G +KL DFG + E +     A+S               T  Y APE+V       
Sbjct: 159 LLDEEGHIKLTDFGLSKESIDHEKKAYSF------------CGTVEYMAPEVVNRRGHTQ 206
Query: 134 --DTWNNYVIGRSMLYG 148
             D W+  V+   ML G
Sbjct: 207 SADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 59/137 (43%), Gaps = 25/137 (18%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL +   GG L   L +       + V   L +   A+ H+H     I++RDLK EN+
Sbjct: 102 YLIL-DFLRGGDLFTRLSKEVMFTEED-VKFYLAELALALDHLHSLG--IIYRDLKPENI 157
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------- 133
           L+   G +KL DFG + E +     A+S               T  Y APE+V       
Sbjct: 158 LLDEEGHIKLTDFGLSKESIDHEKKAYSF------------CGTVEYMAPEVVNRRGHTQ 205
Query: 134 --DTWNNYVIGRSMLYG 148
             D W+  V+   ML G
Sbjct: 206 SADWWSFGVLMFEMLTG 222

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 62/139 (44%), Gaps = 25/139 (17%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ E   GG+L D++    + +    + ++     QA+  +H Q   ++HRD+K ++
Sbjct: 222 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDS 277
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L++  G VKL DFG            + AQ    +        TP + APE+       
Sbjct: 278 ILLTHDGRVKLSDFG------------FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYG 325
Query: 133 --VDTWNNYVIGRSMLYGH 149
             VD W+  ++   M+ G 
Sbjct: 326 PEVDIWSLGIMVIEMVDGE 344

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 53/118 (44%), Gaps = 12/118 (10%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
            +TE   GG+L  ++K   S  P +   S        + ++H  N  I+HRDL   N L+
Sbjct: 84  FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLV 141
Query: 83  SSAGTVKLCDFGSA---TEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMVD 134
                V + DFG A    ++   P+   S ++     D   R+T    P + APEM++
Sbjct: 142 RENKNVVVADFGLARLMVDEKTQPEGLRSLKK----PDRKKRYTVVGNPYWMAPEMIN 195

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 60/147 (40%), Gaps = 24/147 (16%)
Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HS    M     + E   GG L+  +++      P+   ++ +    A+     Q+  I+
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH---AVFYAAEIAIGLFFLQSKGII 143
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +RDLK++N+++ S G +K+ DFG   E      N W                TP Y APE
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMCKE------NIWDGVTTKXF------CGTPDYIAPE 191
Query: 132 M---------VDTWNNYVIGRSMLYGH 149
           +         VD W   V+   ML G 
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 24/89 (26%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 8   FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQN 67
            ++ H      +E +++ E  +GG L + + +  + +  +     + Q C+ + HMH  N
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 68  PPIVHRDLKIENLLISS--AGTVKLCDFG 94
              VH DLK EN++ ++  +  +KL DFG
Sbjct: 170 --YVHLDLKPENIMFTTKRSNELKLIDFG 196

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 116 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 171
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 172 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 206

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/85 (27%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E    G L   L ++   +  ++   ++      +++M  QNPPIVHRDL+  N+ +
Sbjct: 98  MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL 157
Query: 83  SSAGT-----VKLCDFGSATEKVYS 102
            S         K+ DFG++ + V+S
Sbjct: 158 QSLDENAPVCAKVADFGTSQQSVHS 182

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 46/104 (44%), Gaps = 13/104 (12%)
Query: 22  LILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHM------------HGQNP 68
           +++TE C  G+L   L+ +R   +P  +    L++    ++H+               + 
Sbjct: 99  MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 158
Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
             +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 116 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 171
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 172 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 206

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 63/141 (44%), Gaps = 28/141 (19%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 146
Query: 81  LISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---- 133
           L +S      +KL DFG A E         +    S+ E       TP Y APE++    
Sbjct: 147 LYTSKRPNAILKLTDFGFAKE---------TTSHNSLTEP----CYTPYYVAPEVLGPEK 193
Query: 134 -----DTWNNYVIGRSMLYGH 149
                D W+  VI   +L G+
Sbjct: 194 YDKSCDMWSLGVIMYILLCGY 214

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K  +  L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--SQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG                     +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLCRHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 115 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 170
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 171 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 205

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 106 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 161
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 162 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 196

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 130 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 185
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 186 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 129 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 184
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 185 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 219

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 120 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 175
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 176 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 210

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 115 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 170
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 171 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 205

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 107 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 162
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 163 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 197

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 122 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 177
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 178 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 212

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/89 (26%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 8   FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQN 67
            ++ H      +E +++ E  +GG L + + +  + +  +     + Q C+ + HMH  N
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 68  PPIVHRDLKIENLLISS--AGTVKLCDFG 94
              VH DLK EN++ ++  +  +KL DFG
Sbjct: 276 --YVHLDLKPENIMFTTKRSNELKLIDFG 302

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 109 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 164
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 165 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 199

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 122 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 177
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 178 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 212

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 117 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 172
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 173 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 207

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 108 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 163
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 164 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 198

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 129 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 184
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 185 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 219

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 116 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 171
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 172 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 206

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 112 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 167
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 168 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 202

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 122 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 177
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 178 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 212

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 133 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 188
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 189 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 223

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLVGIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+        T  YRAPE+         VD W+   I   M+ G V
Sbjct: 179 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 46/104 (44%), Gaps = 13/104 (12%)
Query: 22  LILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHM------------HGQNP 68
           +++TE C  G+L   L+ +R   +P  +    L++    ++H+               + 
Sbjct: 99  MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 158
Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
             +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 112 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 167
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 168 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 202

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 139 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 194
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 195 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 130 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 185
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 186 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 106 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 161
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 162 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 196

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 107 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 162
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 163 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 197

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 133 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 188
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 189 ILDFGLARHT----------------DDEMXGYVATRWYRAPEIMLNWMHY 223

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 46/104 (44%), Gaps = 13/104 (12%)
Query: 22  LILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHM------------HGQNP 68
           +++TE C  G+L   L+ +R   +P  +    L++    ++H+               + 
Sbjct: 99  MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 158
Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
             +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 121 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 176
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 177 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 211

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 44/84 (52%), Gaps = 16/84 (19%)
Query: 21  YLILTELCTGGSLVDVL------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YLI+ E  +GG + D L      KE+ +        S   Q   AV++ H +   IVHRD
Sbjct: 87  YLIM-EYASGGEVFDYLVAHGRMKEKEAR-------SKFRQIVSAVQYCHQKR--IVHRD 136
Query: 75  LKIENLLISSAGTVKLCDFGSATE 98
           LK ENLL+ +   +K+ DFG + E
Sbjct: 137 LKAENLLLDADMNIKIADFGFSNE 160

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 11/98 (11%)
Query: 6   AAFI--DKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHM 63
           A FI  D+  T  G  EYL++ E    GSL   L   TS    +  C +     + + ++
Sbjct: 70  ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSS--CRLAHSVTRGLAYL 127
Query: 64  HGQ-------NPPIVHRDLKIENLLISSAGTVKLCDFG 94
           H +        P I HRDL   N+L+ + GT  + DFG
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 112 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 167
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 168 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 202

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 62/143 (43%), Gaps = 30/143 (20%)
Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H YL++ +L +GG L D + ER           ++ Q   AVK++H     IVHRDLK E
Sbjct: 80  HYYLVM-QLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPE 135
Query: 79  NLLI---SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           NLL         + + DFG +             +Q  ++        TP Y APE+   
Sbjct: 136 NLLYLTPEENSKIMITDFGLS-----------KMEQNGIMSTACG---TPGYVAPEVLAQ 181
Query: 133 ------VDTWNNYVIGRSMLYGH 149
                 VD W+  VI   +L G+
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGY 204

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 41/145 (28%)
Query: 21  YLILTELCTGGSLVDVL------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YL++ E  +GG + D L      KE+ +        +   Q   AV++ H +   IVHRD
Sbjct: 89  YLVM-EYASGGEVFDYLVAHGRMKEKEAR-------AKFRQIVSAVQYCHQKF--IVHRD 138
Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEM- 132
           LK ENLL+ +   +K+ DFG + E  +               +++  F  +P Y APE+ 
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFG--------------NKLDEFCGSPPYAAPELF 184
Query: 133 ---------VDTWNNYVIGRSMLYG 148
                    VD W+  VI  +++ G
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 65/147 (44%), Gaps = 41/147 (27%)
Query: 21  YLILTELCTGGSLVDVL------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YLI+ E  +GG + D L      KE+ +        S   Q   AV++ H +   IVHRD
Sbjct: 90  YLIM-EYASGGEVFDYLVAHGRMKEKEAR-------SKFRQIVSAVQYCHQKR--IVHRD 139
Query: 75  LKIENLLISSAGTVKLCDFGSATE-KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM- 132
           LK ENLL+ +   +K+ DFG + E  V    +A+                 P Y APE+ 
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG--------------APPYAAPELF 185
Query: 133 ---------VDTWNNYVIGRSMLYGHV 150
                    VD W+  VI  +++ G +
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSL 212

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 37/150 (24%)
Query: 17  GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           G H YL+ TEL  GG L+D +  R           +L    + V+++H Q   +VHRDLK
Sbjct: 93  GKHVYLV-TELMRGGELLDKIL-RQKFFSEREASFVLHTIGKTVEYLHSQG--VVHRDLK 148
Query: 77  IENLL-ISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYR---- 128
             N+L +  +G    +++CDFG A +                L  E     TP Y     
Sbjct: 149 PSNILYVDESGNPECLRICDFGFAKQ----------------LRAENGLLMTPCYTANFV 192
Query: 129 APEMV---------DTWNNYVIGRSMLYGH 149
           APE++         D W+  ++  +ML G+
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGY 222

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 55/119 (46%), Gaps = 21/119 (17%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+ T    G  L +++K    AL    V  +++Q  + +K++H     I+HRDLK  N+
Sbjct: 109 YLVTT--LMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSAG--IIHRDLKPSNV 162
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
            ++    +++ DFG A               R   E+      T  YRAPE++  W +Y
Sbjct: 163 AVNEDSELRILDFGLA---------------RQADEEMTGYVATRWYRAPEIMLNWMHY 206

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 37/150 (24%)
Query: 17  GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           G H YL+ TEL  GG L+D +  R           +L    + V+++H Q   +VHRDLK
Sbjct: 93  GKHVYLV-TELMRGGELLDKIL-RQKFFSEREASFVLHTIGKTVEYLHSQG--VVHRDLK 148
Query: 77  IENLL-ISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYR---- 128
             N+L +  +G    +++CDFG A +                L  E     TP Y     
Sbjct: 149 PSNILYVDESGNPECLRICDFGFAKQ----------------LRAENGLLMTPCYTANFV 192
Query: 129 APEMV---------DTWNNYVIGRSMLYGH 149
           APE++         D W+  ++  +ML G+
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGY 222

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 79  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 136
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +S   + K+ DFG A       DN ++A+       E A+F    + APE ++
Sbjct: 137 VSDTLSCKIADFGLAR---LIEDNEYTAR-------EGAKFPIK-WTAPEAIN 178

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 18/132 (13%)
Query: 23  ILTELCTGGSLVDVL------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           ++ E  +GG + D L      KE+ +        +   Q   AV++ H +   IVHRDLK
Sbjct: 90  LVXEYASGGEVFDYLVAHGRXKEKEAR-------AKFRQIVSAVQYCHQKF--IVHRDLK 140
Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTW 136
            ENLL+ +   +K+ DFG + E  ++  N   A   +        F    Y  PE VD W
Sbjct: 141 AENLLLDADXNIKIADFGFSNE--FTFGNKLDAFCGAPPYAAPELFQGKKYDGPE-VDVW 197
Query: 137 NNYVIGRSMLYG 148
           +  VI  +++ G
Sbjct: 198 SLGVILYTLVSG 209

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 61/143 (42%), Gaps = 31/143 (21%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           + ++ +L   G L D L E+ + L       I+    + +  +H  N  IVHRDLK EN+
Sbjct: 99  FFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENI 155
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-------- 132
           L+     +KL DFG      +S       + RS+         TP Y APE+        
Sbjct: 156 LLDDDMNIKLTDFG------FSCQLDPGEKLRSVC-------GTPSYLAPEIIECSMNDN 202
Query: 133 -------VDTWNNYVIGRSMLYG 148
                  VD W+  VI  ++L G
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 117 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 172
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                    DEM  +  T  YRAPE++  W +Y
Sbjct: 173 ILDFGLARHTA----------------DEMTGYVATRWYRAPEIMLNWMHY 207

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 10/79 (12%)
Query: 21  YLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           Y ++ E+  GG L D  +L+++ S +   +   I+ Q      ++H  N  IVHRDLK E
Sbjct: 96  YYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTYLHKHN--IVHRDLKPE 150
Query: 79  NLLISSA---GTVKLCDFG 94
           NLL+ S      +K+ DFG
Sbjct: 151 NLLLESKSRDALIKIVDFG 169

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 117 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 172
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                    DEM  +  T  YRAPE++  W +Y
Sbjct: 173 ILDFGLARHTA----------------DEMTGYVATRWYRAPEIMLNWMHY 207

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 117 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 172
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DFG A                    DEM  +  T  YRAPE++  W +Y
Sbjct: 173 ILDFGLARHTA----------------DEMTGYVATRWYRAPEIMLNWMHY 207

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+        T  YRAPE+         VD W+   I   M+ G V
Sbjct: 179 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+        T  YRAPE+         VD W+   I   M+ G V
Sbjct: 179 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 141
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +S   + K+ DFG A       DN ++A+       E A+F    + APE ++
Sbjct: 142 VSDTLSCKIADFGLAR---LIEDNEYTAR-------EGAKFPIK-WTAPEAIN 183

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 10/79 (12%)
Query: 21  YLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           Y ++ E+  GG L D  +L+++ S +   +   I+ Q      ++H  N  IVHRDLK E
Sbjct: 79  YYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTYLHKHN--IVHRDLKPE 133
Query: 79  NLLISSA---GTVKLCDFG 94
           NLL+ S      +K+ DFG
Sbjct: 134 NLLLESKSRDALIKIVDFG 152

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 19/134 (14%)
Query: 21  YLILTELCTGGSLVDVL------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YL++ E  +GG + D L      KE+ +        +   Q   AV++ H +   IVHRD
Sbjct: 89  YLVM-EYASGGEVFDYLVAHGRMKEKEAR-------AKFRQIVSAVQYCHQKF--IVHRD 138
Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           LK ENLL+ +   +K+ DFG + E  ++  N   A   +        F    Y  PE VD
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNE--FTFGNKLDAFCGAPPYAAPELFQGKKYDGPE-VD 195
Query: 135 TWNNYVIGRSMLYG 148
            W+  VI  +++ G
Sbjct: 196 VWSLGVILYTLVSG 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 41/145 (28%)
Query: 21  YLILTELCTGGSLVDVL------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YL++ E  +GG + D L      KE+ +        +   Q   AV++ H +   IVHRD
Sbjct: 89  YLVM-EYASGGEVFDYLVAHGRMKEKEAR-------AKFRQIVSAVQYCHQKF--IVHRD 138
Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEM- 132
           LK ENLL+ +   +K+ DFG + E  +               +++  F  +P Y APE+ 
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFG--------------NKLDTFCGSPPYAAPELF 184
Query: 133 ---------VDTWNNYVIGRSMLYG 148
                    VD W+  VI  +++ G
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 524
Query: 83  SSAGTVKLCDFG 94
           SS   VKL DFG
Sbjct: 525 SSNDCVKLGDFG 536

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 23  ILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSL+D LK +  S  P   +     Q  + +  +  +N   +HRDL+  N+L
Sbjct: 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANIL 316
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +S++   K+ DFG A       DN ++A+       E A+F    + APE ++
Sbjct: 317 VSASLVCKIADFGLAR---VIEDNEYTAR-------EGAKFPIK-WTAPEAIN 358

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 130 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 185
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEM-ARFTTPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM     T  YRAPE++  W +Y
Sbjct: 186 ILDFGLARHT----------------DDEMXGXVATRWYRAPEIMLNWMHY 220

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 14/113 (12%)
Query: 23  ILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSL+D LK +  S  P   +     Q  + +  +  +N   +HRDL+  N+L
Sbjct: 86  IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANIL 143
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +S++   K+ DFG A  +V   DN ++A+       E A+F    + APE ++
Sbjct: 144 VSASLVCKIADFGLA--RVIE-DNEYTAR-------EGAKFPI-KWTAPEAIN 185

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 57/114 (50%), Gaps = 16/114 (14%)
Query: 23  ILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I+TE    GSL+D LK  E    L P ++     Q  + + ++  +N   +HRDL+  N+
Sbjct: 84  IITEFMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKN--YIHRDLRAANV 140
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           L+S +   K+ DFG A       DN ++A+       E A+F    + APE ++
Sbjct: 141 LVSESLMCKIADFGLAR---VIEDNEYTAR-------EGAKFPIK-WTAPEAIN 183

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 60/148 (40%), Gaps = 24/148 (16%)
Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HS    M     + E   GG L+  +++      P+   ++ +    A+     Q+  I+
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH---AVFYAAEIAIGLFFLQSKGII 464
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +RDLK++N+++ S G +K+ DFG   E      N W                TP Y APE
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGMCKE------NIWDGVTTKXF------CGTPDYIAPE 512
Query: 132 M---------VDTWNNYVIGRSMLYGHV 150
           +         VD W   V+   ML G  
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQA 540

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 18/114 (15%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 110 YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 165
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           L+ SAG +K+ DFG            WS    S   D++    T  Y  PEM++
Sbjct: 166 LLGSAGELKIADFG------------WSVHAPSSRRDDLC--GTLDYLPPEMIE 205

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEM-ARFTTPMYRAPEMVDTWNNY 139
           + DFG A                   +DEM     T  YRAPE++  W +Y
Sbjct: 166 ILDFGLARHT----------------DDEMTGXVATRWYRAPEIMLNWMHY 200

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 147
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +S   + K+ DFG A       DN ++A+       E A+F    + APE ++
Sbjct: 148 VSDTLSCKIADFGLAR---LIEDNEYTAR-------EGAKFPIK-WTAPEAIN 189

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 94  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 151
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +S   + K+ DFG A       DN ++A+       E A+F    + APE ++
Sbjct: 152 VSDTLSCKIADFGLAR---LIEDNEYTAR-------EGAKFPI-KWTAPEAIN 193

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 89  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 146
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +S   + K+ DFG A       DN ++A+       E A+F    + APE ++
Sbjct: 147 VSDTLSCKIADFGLAR---LIEDNEYTAR-------EGAKFPIK-WTAPEAIN 188

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 41/145 (28%)
Query: 21  YLILTELCTGGSLVDVL------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YL++ E  +GG + D L      KE+ +        +   Q   AV++ H +   IVHRD
Sbjct: 89  YLVM-EYASGGEVFDYLVAHGRMKEKEAR-------AKFRQIVSAVQYCHQKF--IVHRD 138
Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEM- 132
           LK ENLL+ +   +K+ DFG + E  +               +++  F  +P Y APE+ 
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFG--------------NKLDTFCGSPPYAAPELF 184
Query: 133 ---------VDTWNNYVIGRSMLYG 148
                    VD W+  VI  +++ G
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 41/145 (28%)
Query: 21  YLILTELCTGGSLVDVL------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YL++ E  +GG + D L      KE+ +        +   Q   AV++ H +   IVHRD
Sbjct: 89  YLVM-EYASGGEVFDYLVAHGRMKEKEAR-------AKFRQIVSAVQYCHQKF--IVHRD 138
Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEM- 132
           LK ENLL+ +   +K+ DFG + E  +               +++  F  +P Y APE+ 
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFG--------------NKLDTFCGSPPYAAPELF 184
Query: 133 ---------VDTWNNYVIGRSMLYG 148
                    VD W+  VI  +++ G
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 18/114 (15%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 87  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 142
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           L+ SAG +K+ DFG            WS    S   D++    T  Y  PEM++
Sbjct: 143 LLGSAGELKIADFG------------WSVHAPSSRRDDLC--GTLDYLPPEMIE 182

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 115 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 172
Query: 83  SSAGTVKLCDFG 94
           SS   VKL DFG
Sbjct: 173 SSNDCVKLGDFG 184

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/73 (28%), Positives = 38/73 (52%), Gaps = 2/73 (2%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+TE    G L++ L+E         +  +    C+A++++  ++   +HRDL   N L
Sbjct: 80  FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCL 137
Query: 82  ISSAGTVKLCDFG 94
           ++  G VK+ DFG
Sbjct: 138 VNDQGVVKVSDFG 150

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 41/145 (28%)
Query: 21  YLILTELCTGGSLVDVL------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YL++ E  +GG + D L      KE+ +        +   Q   AV++ H +   IVHRD
Sbjct: 82  YLVM-EYASGGEVFDYLVAHGWMKEKEAR-------AKFRQIVSAVQYCHQKF--IVHRD 131
Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEM- 132
           LK ENLL+ +   +K+ DFG + E  +               +++  F  +P Y APE+ 
Sbjct: 132 LKAENLLLDADMNIKIADFGFSNEFTFG--------------NKLDTFCGSPPYAAPELF 177
Query: 133 ---------VDTWNNYVIGRSMLYG 148
                    VD W+  VI  +++ G
Sbjct: 178 QGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/73 (28%), Positives = 37/73 (50%), Gaps = 2/73 (2%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+TE    G L++ L+E         +  +    C+A++++  +    +HRDL   N L
Sbjct: 75  FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCL 132
Query: 82  ISSAGTVKLCDFG 94
           ++  G VK+ DFG
Sbjct: 133 VNDQGVVKVSDFG 145

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+TE    G L++ L+E         +  +    C+A++++  ++   +HRDL   N L
Sbjct: 80  FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCL 137
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRS 113
           ++  G VK+ DFG +    Y  D+ +++ + S
Sbjct: 138 VNDQGVVKVSDFGLSR---YVLDDEYTSSRGS 166

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/103 (24%), Positives = 46/103 (44%), Gaps = 15/103 (14%)
Query: 22  LILTELCTGGSLVDVLKERTSALPP------------NIVCSILWQTCQAVKHMHGQNPP 69
           +++ E C  G+L   L+ + +   P            +++C   +Q  + ++ +  +   
Sbjct: 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIC-YSFQVAKGMEFLASRK-- 164
Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
            +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 165 XIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 148
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 149 LYTSKRPNAILKLTDFGFAKE 169

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 84  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 141
Query: 83  SSAGTVKLCDFG 94
           SS   VKL DFG
Sbjct: 142 SSNDCVKLGDFG 153

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 148
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 149 LYTSKRPNAILKLTDFGFAKE 169

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 192
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 193 LYTSKRPNAILKLTDFGFAKE 213

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E    G L   L ++   +  ++   ++      +++M  QNPPIVHRDL+  N+ +
Sbjct: 98  MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL 157
Query: 83  SSAGT-----VKLCDFGSATEKVYS 102
            S         K+ DFG + + V+S
Sbjct: 158 QSLDENAPVCAKVADFGLSQQSVHS 182

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 153
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 154 LYTSKRPNAILKLTDFGFAKE 174

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 198
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 199 LYTSKRPNAILKLTDFGFAKE 219

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 47/79 (59%), Gaps = 12/79 (15%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 138 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARA- 189
Query: 115 LEDEMARFTTPMYRAPEMV 133
                A   T  Y +PE++
Sbjct: 190 ----NAFVGTAQYVSPELL 204

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 21/73 (28%), Positives = 38/73 (52%), Gaps = 2/73 (2%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+TE    G L++ L+E         +  +    C+A++++  ++   +HRDL   N L
Sbjct: 86  FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCL 143
Query: 82  ISSAGTVKLCDFG 94
           ++  G VK+ DFG
Sbjct: 144 VNDQGVVKVSDFG 156

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 87  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 144
Query: 83  SSAGTVKLCDFG 94
           SS   VKL DFG
Sbjct: 145 SSNDCVKLGDFG 156

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 162
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 163 LYTSKRPNAILKLTDFGFAKE 183

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL +   GG L   L +       + V   L +    + H+H     I++RDLK EN+
Sbjct: 106 YLIL-DFLRGGDLFTRLSKEVMFTEED-VKFYLAELALGLDHLHSLG--IIYRDLKPENI 161
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWS 108
           L+   G +KL DFG + E +     A+S
Sbjct: 162 LLDEEGHIKLTDFGLSKEAIDHEKKAYS 189

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 152
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 153 LYTSKRPNAILKLTDFGFAKE 173

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 92  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 149
Query: 83  SSAGTVKLCDFG 94
           SS   VKL DFG
Sbjct: 150 SSNDCVKLGDFG 161

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 90  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 147
Query: 83  SSAGTVKLCDFG 94
           SS   VKL DFG
Sbjct: 148 SSNDCVKLGDFG 159

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 87  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 144
Query: 83  SSAGTVKLCDFG 94
           SS   VKL DFG
Sbjct: 145 SSNDCVKLGDFG 156

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 21/73 (28%), Positives = 37/73 (50%), Gaps = 2/73 (2%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+TE    G L++ L+E         +  +    C+A++++  +    +HRDL   N L
Sbjct: 79  FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCL 136
Query: 82  ISSAGTVKLCDFG 94
           ++  G VK+ DFG
Sbjct: 137 VNDQGVVKVSDFG 149

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 89  IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 146
Query: 83  SSAGTVKLCDFG 94
           SS   VKL DFG
Sbjct: 147 SSNDCVKLGDFG 158

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 12/103 (11%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHM------------HGQNPP 69
           +++ E C  G+L   L+ + +   P      L++    ++H+               +  
Sbjct: 109 MVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
            +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 154
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 155 LYTSKRPNAILKLTDFGFAKE 175

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 147
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 148 LYTSKRPNAILKLTDFGFAKE 168

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 146
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 147 LYTSKRPNAILKLTDFGFAKE 167

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 43/152 (28%)
Query: 19  HEYLILTELCTGGSLVDV------LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
            +Y I+ EL  GG L D       LKE T  L         +Q   AV+++H     I+H
Sbjct: 87  EDYYIVLELMEGGELFDKVVGNKRLKEATCKL-------YFYQMLLAVQYLHENG--IIH 137
Query: 73  RDLKIENLLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           RDLK EN+L+SS      +K+ DFG      +S     ++  R++         TP Y A
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFG------HSKILGETSLMRTLC-------GTPTYLA 184
Query: 130 PEM------------VDTWNNYVIGRSMLYGH 149
           PE+            VD W+  VI    L G+
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 21/73 (28%), Positives = 37/73 (50%), Gaps = 2/73 (2%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+TE    G L++ L+E         +  +    C+A++++  +    +HRDL   N L
Sbjct: 95  FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCL 152
Query: 82  ISSAGTVKLCDFG 94
           ++  G VK+ DFG
Sbjct: 153 VNDQGVVKVSDFG 165

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 43/152 (28%)
Query: 19  HEYLILTELCTGGSLVDV------LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
            +Y I+ EL  GG L D       LKE T  L         +Q   AV+++H     I+H
Sbjct: 87  EDYYIVLELMEGGELFDKVVGNKRLKEATCKL-------YFYQMLLAVQYLHENG--IIH 137
Query: 73  RDLKIENLLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           RDLK EN+L+SS      +K+ DFG      +S     ++  R++         TP Y A
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFG------HSKILGETSLMRTLC-------GTPTYLA 184
Query: 130 PEM------------VDTWNNYVIGRSMLYGH 149
           PE+            VD W+  VI    L G+
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I+    +A++++H  N  I HRD+K ENL
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENL 148
Query: 81  LISSA---GTVKLCDFGSATE 98
           L +S      +KL DFG A E
Sbjct: 149 LYTSKRPNAILKLTDFGFAKE 169

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 43/152 (28%)
Query: 19  HEYLILTELCTGGSLVDV------LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
            +Y I+ EL  GG L D       LKE T  L         +Q   AV+++H     I+H
Sbjct: 87  EDYYIVLELMEGGELFDKVVGNKRLKEATCKL-------YFYQMLLAVQYLHENG--IIH 137
Query: 73  RDLKIENLLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           RDLK EN+L+SS      +K+ DFG      +S     ++  R++         TP Y A
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFG------HSKILGETSLMRTLC-------GTPTYLA 184
Query: 130 PEM------------VDTWNNYVIGRSMLYGH 149
           PE+            VD W+  VI    L G+
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 43/152 (28%)
Query: 19  HEYLILTELCTGGSLVDV------LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
            +Y I+ EL  GG L D       LKE T  L         +Q   AV+++H     I+H
Sbjct: 86  EDYYIVLELMEGGELFDKVVGNKRLKEATCKL-------YFYQMLLAVQYLHENG--IIH 136
Query: 73  RDLKIENLLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           RDLK EN+L+SS      +K+ DFG      +S     ++  R++         TP Y A
Sbjct: 137 RDLKPENVLLSSQEEDCLIKITDFG------HSKILGETSLMRTLC-------GTPTYLA 183
Query: 130 PEM------------VDTWNNYVIGRSMLYGH 149
           PE+            VD W+  VI    L G+
Sbjct: 184 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 215

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 21/73 (28%), Positives = 37/73 (50%), Gaps = 2/73 (2%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+TE    G L++ L+E         +  +    C+A++++  +    +HRDL   N L
Sbjct: 95  FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCL 152
Query: 82  ISSAGTVKLCDFG 94
           ++  G VK+ DFG
Sbjct: 153 VNDQGVVKVSDFG 165

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 87  IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 144
Query: 83  SSAGTVKLCDFG 94
           SS   VKL DFG
Sbjct: 145 SSNDCVKLGDFG 156

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 43/152 (28%)
Query: 19  HEYLILTELCTGGSLVDV------LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
            +Y I+ EL  GG L D       LKE T  L         +Q   AV+++H     I+H
Sbjct: 93  EDYYIVLELMEGGELFDKVVGNKRLKEATCKL-------YFYQMLLAVQYLHENG--IIH 143
Query: 73  RDLKIENLLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           RDLK EN+L+SS      +K+ DFG      +S     ++  R++         TP Y A
Sbjct: 144 RDLKPENVLLSSQEEDCLIKITDFG------HSKILGETSLMRTLC-------GTPTYLA 190
Query: 130 PEM------------VDTWNNYVIGRSMLYGH 149
           PE+            VD W+  VI    L G+
Sbjct: 191 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 222

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 524
Query: 83  SSAGTVKLCDFG 94
           S+   VKL DFG
Sbjct: 525 SATDCVKLGDFG 536

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + D+G A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDYGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 13/104 (12%)
Query: 22  LILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHM------------HGQNP 68
           +++ E C  G+L   L+ +R   +P  +    L++    ++H+               + 
Sbjct: 99  MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 158
Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
             +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 159 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 61/134 (45%), Gaps = 19/134 (14%)
Query: 21  YLILTELCTGGSLVDVL------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YL++ E  +GG + D L      KE+ +        +   Q   AV++ H +   IVHRD
Sbjct: 90  YLVM-EYASGGEVFDYLVAHGRMKEKEAR-------AKFRQIVSAVQYCHQKY--IVHRD 139
Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           LK ENLL+     +K+ DFG + E  ++  N       S        F    Y  PE VD
Sbjct: 140 LKAENLLLDGDMNIKIADFGFSNE--FTVGNKLDTFCGSPPYAAPELFQGKKYDGPE-VD 196
Query: 135 TWNNYVIGRSMLYG 148
            W+  VI  +++ G
Sbjct: 197 VWSLGVILYTLVSG 210

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 19/45 (42%), Positives = 29/45 (64%), Gaps = 2/45 (4%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A
Sbjct: 131 LLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLA 173

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 55/119 (46%), Gaps = 21/119 (17%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+ T    G  L +++K    AL    V  +++Q  + +K++H     I+HRDLK  N+
Sbjct: 101 YLVTT--LMGADLNNIVK--CQALSDEHVQFLVYQLLRGLKYIHSAG--IIHRDLKPSNV 154
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
            ++    +++ DFG A               R   E+      T  YRAPE++  W +Y
Sbjct: 155 AVNEDCELRILDFGLA---------------RQADEEMTGYVATRWYRAPEIMLNWMHY 198

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 140 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 192
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 193 XFVGTAQYVSP 203

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 13/104 (12%)
Query: 22  LILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHM------------HGQNP 68
           +++ E C  G+L   L+ +R   +P  +    L++    ++H+               + 
Sbjct: 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 167
Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
             +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 50/108 (46%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 133 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 180
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+   +    T  YRAPE+         VD W+   I   M+ G V
Sbjct: 181 SFMM---VPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 225

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 137 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 189
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 190 XFVGTAQYVSP 200

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 143 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 195
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 196 XFVGTAQYVSP 206

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 58/124 (46%), Gaps = 31/124 (25%)
Query: 19  HEYLILTELCTGGSLVDV------LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
            +Y I+ EL  GG L D       LKE T  L         +Q   AV+++H     I+H
Sbjct: 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKL-------YFYQMLLAVQYLHENG--IIH 262
Query: 73  RDLKIENLLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           RDLK EN+L+SS      +K+ DFG      +S     ++  R++         TP Y A
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFG------HSKILGETSLMRTLC-------GTPTYLA 309
Query: 130 PEMV 133
           PE++
Sbjct: 310 PEVL 313

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 13/104 (12%)
Query: 22  LILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHM------------HGQNP 68
           +++ E C  G+L   L+ +R   +P  +    L++    ++H+               + 
Sbjct: 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 167
Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
             +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 138 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 190
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 191 XFVGTAQYVSP 201

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 140 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 192
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 193 XFVGTAQYVSP 203

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 58/124 (46%), Gaps = 31/124 (25%)
Query: 19  HEYLILTELCTGGSLVDV------LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
            +Y I+ EL  GG L D       LKE T  L         +Q   AV+++H     I+H
Sbjct: 226 EDYYIVLELMEGGELFDKVVGNKRLKEATCKL-------YFYQMLLAVQYLHENG--IIH 276
Query: 73  RDLKIENLLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           RDLK EN+L+SS      +K+ DFG      +S     ++  R++         TP Y A
Sbjct: 277 RDLKPENVLLSSQEEDCLIKITDFG------HSKILGETSLMRTLC-------GTPTYLA 323
Query: 130 PEMV 133
           PE++
Sbjct: 324 PEVL 327

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 140 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 192
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 193 XFVGTAQYVSP 203

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 140 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 192
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 193 XFVGTAQYVSP 203

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 138 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 190
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 191 XFVGTAQYVSP 201

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 141 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 193
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 194 XFVGTAQYVSP 204

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 140 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 192
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 193 XFVGTAQYVSP 203

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 138 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 190
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 191 XFVGTAQYVSP 201

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 5/77 (6%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPN--IVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I  E   GGSL  +L+ +   L  N   +     Q  + +K++H     IVHRD+K +N+
Sbjct: 82  IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNV 139
Query: 81  LISS-AGTVKLCDFGSA 96
           LI++ +G +K+ DFG++
Sbjct: 140 LINTYSGVLKISDFGTS 156

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 118 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 170
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 171 XFVGTAQYVSP 181

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 122 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 174
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 175 XFVGTAQYVSP 185

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 115 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 167
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 168 XFVGTAQYVSP 178

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/45 (42%), Positives = 29/45 (64%), Gaps = 2/45 (4%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A
Sbjct: 131 LLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLA 173

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L+
Sbjct: 87  IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV 144
Query: 83  SSAGTVKLCDFG 94
           S+   VKL DFG
Sbjct: 145 SATDCVKLGDFG 156

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 116 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 168
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 169 XFVGTAQYVSP 179

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 141
Query: 82  ISSAGTVKLCDFGSA 96
           +S   + K+ DFG A
Sbjct: 142 VSDTLSCKIADFGLA 156

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 117 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 169
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 170 XFVGTAQYVSP 180

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 93  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 150
Query: 82  ISSAGTVKLCDFGSA 96
           +S   + K+ DFG A
Sbjct: 151 VSDTLSCKIADFGLA 165

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/45 (42%), Positives = 29/45 (64%), Gaps = 2/45 (4%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A
Sbjct: 124 LLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLA 166

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 23  ILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSL+D LK +  S  P   +     Q  + +  +  +N   +HRDL+  N+L
Sbjct: 253 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANIL 310
Query: 82  ISSAGTVKLCDFGSA 96
           +S++   K+ DFG A
Sbjct: 311 VSASLVCKIADFGLA 325

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 141
Query: 82  ISSAGTVKLCDFGSA 96
           +S   + K+ DFG A
Sbjct: 142 VSDTLSCKIADFGLA 156

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 145 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 197
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 198 XFVGTAQYVSP 208

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL++ E   GG L+ +L +    +P  +    L +   A+  +H      VHRD+K +N+
Sbjct: 137 YLVM-EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNI 193
Query: 81  LISSAGTVKLCDFGS 95
           L+   G ++L DFGS
Sbjct: 194 LLDRCGHIRLADFGS 208

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 141
Query: 82  ISSAGTVKLCDFGSA 96
           +S   + K+ DFG A
Sbjct: 142 VSDTLSCKIADFGLA 156

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 92  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 149
Query: 82  ISSAGTVKLCDFGSA 96
           +S   + K+ DFG A
Sbjct: 150 VSDTLSCKIADFGLA 164

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 147
Query: 82  ISSAGTVKLCDFGSA 96
           +S   + K+ DFG A
Sbjct: 148 VSDTLSCKIADFGLA 162

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 85  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 142
Query: 82  ISSAGTVKLCDFGSA 96
           +S   + K+ DFG A
Sbjct: 143 VSDTLSCKIADFGLA 157

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 132 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 179
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+        T  YRAPE+         VD W+   I   M+ G V
Sbjct: 180 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+L
Sbjct: 86  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL 143
Query: 82  ISSAGTVKLCDFGSA 96
           +S   + K+ DFG A
Sbjct: 144 VSDTLSCKIADFGLA 158

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/104 (25%), Positives = 46/104 (44%), Gaps = 13/104 (12%)
Query: 22  LILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHMHGQNPPI---------- 70
           +++ E C  G+L   L+ +R   +P  +    L++    ++H+   +  +          
Sbjct: 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 167
Query: 71  --VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
             +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 13/104 (12%)
Query: 22  LILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHM------------HGQNP 68
           +++ E C  G+L   L+ +R   +P  +    L++    ++H+               + 
Sbjct: 145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 204
Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
             +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 5/77 (6%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPN--IVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I  E   GGSL  +L+ +   L  N   +     Q  + +K++H     IVHRD+K +N+
Sbjct: 96  IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNV 153
Query: 81  LISS-AGTVKLCDFGSA 96
           LI++ +G +K+ DFG++
Sbjct: 154 LINTYSGVLKISDFGTS 170

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+        T  YRAPE+         VD W+   I   M+ G V
Sbjct: 179 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 57/114 (50%), Gaps = 16/114 (14%)
Query: 23  ILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I+TE    GSL+D LK  E    L P ++     Q  + + ++  +N   +HRDL+  N+
Sbjct: 85  IITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKN--YIHRDLRAANV 141
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           L+S +   K+ DFG A       DN ++A+       E A+F    + APE ++
Sbjct: 142 LVSESLMCKIADFGLAR---VIEDNEYTAR-------EGAKFPIK-WTAPEAIN 184

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+        T  YRAPE+         VD W+   I   M+ G V
Sbjct: 179 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+        T  YRAPE+         VD W+   I   M+ G V
Sbjct: 179 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 61/141 (43%), Gaps = 28/141 (19%)
Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           LI+ E   GG L   +++R   A        I     +A++++H  N  I HRD+K ENL
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSIN--IAHRDVKPENL 192
Query: 81  LISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---- 133
           L +S      +KL DFG A E         +    S+         TP Y APE++    
Sbjct: 193 LYTSKRPNAILKLTDFGFAKE---------TTSHNSL----TTPCYTPYYVAPEVLGPEK 239
Query: 134 -----DTWNNYVIGRSMLYGH 149
                D W+  VI   +L G+
Sbjct: 240 YDKSCDXWSLGVIXYILLCGY 260

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 60/143 (41%), Gaps = 31/143 (21%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           + ++ +L   G L D L E+ + L       I+    + +  +H  N  IVHRDLK EN+
Sbjct: 99  FFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENI 155
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-------- 132
           L+     +KL DFG      +S       + R +         TP Y APE+        
Sbjct: 156 LLDDDMNIKLTDFG------FSCQLDPGEKLREVC-------GTPSYLAPEIIECSMNDN 202
Query: 133 -------VDTWNNYVIGRSMLYG 148
                  VD W+  VI  ++L G
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 15/104 (14%)
Query: 22  LILTELCTGGSLVDVLKERTSAL----PPNIVCSIL---------WQTCQAVKHMHGQNP 68
           +++ E C  G+L   L+ + +      P ++    L         +Q  + ++ +  +  
Sbjct: 110 MVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK- 168
Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
             +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 169 -XIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 18/114 (15%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 85  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 140
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           L+ SAG +K+ DFG            WS    S   D +    T  Y  PEM++
Sbjct: 141 LLGSAGELKIADFG------------WSVHAPSSRRDTLC--GTLDYLPPEMIE 180

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 60/143 (41%), Gaps = 31/143 (21%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           + ++ +L   G L D L E+ + L       I+    + +  +H  N  IVHRDLK EN+
Sbjct: 86  FFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENI 142
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-------- 132
           L+     +KL DFG      +S       + R +         TP Y APE+        
Sbjct: 143 LLDDDMNIKLTDFG------FSCQLDPGEKLREVC-------GTPSYLAPEIIECSMNDN 189
Query: 133 -------VDTWNNYVIGRSMLYG 148
                  VD W+  VI  ++L G
Sbjct: 190 HPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 47/79 (59%), Gaps = 12/79 (15%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 137 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARA- 188
Query: 115 LEDEMARFTTPMYRAPEMV 133
                +   T  Y +PE++
Sbjct: 189 ----NSFVGTAQYVSPELL 203

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 40/74 (54%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G +   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 89  YLIL-EYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 144
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 145 LLGSAGELKIADFG 158

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 141 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 193
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 194 SFVGTAQYVSP 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 3/76 (3%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y ++ E   G +L + + E    L  +   +   Q    +KH H     IVHRD+K +N+
Sbjct: 86  YYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNI 142
Query: 81  LISSAGTVKLCDFGSA 96
           LI S  T+K+ DFG A
Sbjct: 143 LIDSNKTLKIFDFGIA 158

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++HG+   I+HRDLK EN+L++    +++ DFG+A  KV SP+   S Q R+ 
Sbjct: 140 EIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA--KVLSPE---SKQARAN 192
Query: 115 LEDEMARFTTP 125
                A++ +P
Sbjct: 193 SFVGTAQYVSP 203

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 48  IVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGT--VKLCDFGSATEKVYSPDN 105
           ++ +I+ Q   A+ ++H Q   I HRD+K EN L S+  +  +KL DFG + E  Y  +N
Sbjct: 169 LISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKE-FYKLNN 225
Query: 106 AWSAQQRSMLEDEMARFTTPMYRAPEMVDTWN 137
                  +       +  TP + APE+++T N
Sbjct: 226 GEYYGMTT-------KAGTPYFVAPEVLNTTN 250

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 53/120 (44%), Gaps = 4/120 (3%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I  E C   +L D++         +    +  Q  +A+ ++H Q   I+HRDLK  N+ 
Sbjct: 91  FIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIF 148
Query: 82  ISSAGTVKLCDFGSATEKVYSPDN-AWSAQQRSMLEDEM-ARFTTPMYRAPEMVDTWNNY 139
           I  +  VK+ DFG A     S D     +Q      D + +   T MY A E++D   +Y
Sbjct: 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 10/92 (10%)
Query: 23  ILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           I+TE    GSL+D LK  T     LP  +  S   Q    + ++   N   VHRDL+  N
Sbjct: 86  IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA--QIASGMAYVERMN--YVHRDLRAAN 141
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+      K+ DFG A       DN W+A+Q
Sbjct: 142 ILVGENLVCKVADFGLAR---LIEDNEWTARQ 170

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 23  ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HR+L+  N+L
Sbjct: 80  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRNLRAANIL 137
Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +S   + K+ DFG A       DN ++A+       E A+F    + APE ++
Sbjct: 138 VSDTLSCKIADFGLAR---LIEDNEYTAR-------EGAKFPIK-WTAPEAIN 179

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 31/51 (60%), Gaps = 2/51 (3%)
Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           V   L+Q  + + + H Q   ++HRDLK +NLLI+  G +KL DFG A  K
Sbjct: 102 VKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAK 150

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 40/74 (54%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G +   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 89  YLIL-EYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 144
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 145 LLGSAGELKIADFG 158

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 123 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 180
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 181 -------------EPNVSXICSRYYRAPELIFGATDY 204

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 177 -------------EPNVSXICSRYYRAPELIFGATDY 200

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 24/108 (22%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 129 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAST 176
Query: 112 RSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGHV 150
             M+        T  YRAPE+         VD W+   I   ++ G V
Sbjct: 177 NFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 177 -------------EPNVSXICSRYYRAPELIFGATDY 200

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 177 -------------EPNVSXICSRYYRAPELIFGATDY 200

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 18/114 (15%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 84  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 139
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           L+ SAG +K+ DFG            WS    S    E+    T  Y  PEM++
Sbjct: 140 LLGSAGELKIADFG------------WSVHAPSSRRTELC--GTLDYLPPEMIE 179

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 177 -------------EPNVSXICSRYYRAPELIFGATDY 200

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 11/85 (12%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQN-PPIVHRDLKIENLL 81
           ++ E   GG L  VL  +   +PP+I+ +   Q  + + ++H +   PI+HRDLK  N+L
Sbjct: 83  LVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140
Query: 82  I--------SSAGTVKLCDFGSATE 98
           I         S   +K+ DFG A E
Sbjct: 141 ILQKVENGDLSNKILKITDFGLARE 165

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 120 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 177
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 178 -------------EPNVSXICSRYYRAPELIFGATDY 201

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 131 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 189 -------------EPNVSXICSRYYRAPELIFGATDY 212

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 52/124 (41%), Gaps = 28/124 (22%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NPPIVHRDLK 76
           ++T+    GSL D LK  T  L    +  + + +   + H+H +       P I HRDLK
Sbjct: 112 LITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 77  IENLLISSAGTVKLCDFG------SATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
            +N+L+   GT  + D G      S T +V  P N               R  T  Y  P
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN--------------TRVGTKRYMPP 215
Query: 131 EMVD 134
           E++D
Sbjct: 216 EVLD 219

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 138 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 195
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 196 -------------EPNVSXICSRYYRAPELIFGATDY 219

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 131 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 189 -------------EPNVSXICSRYYRAPELIFGATDY 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 46/110 (41%), Gaps = 16/110 (14%)
Query: 31  GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NPPIVHRDLKIENLLISS 84
           GSL D L   T  +   I  ++   T   + H+H +       P I HRDLK +N+L+  
Sbjct: 86  GSLFDYLNRYTVTVEGMIKLAL--STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143
Query: 85  AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
            GT  + D G A     + D    A           R  T  Y APE++D
Sbjct: 144 NGTCCIADLGLAVRHDSATDTIDIAPNH--------RVGTKRYMAPEVLD 185

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 46/110 (41%), Gaps = 16/110 (14%)
Query: 31  GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NPPIVHRDLKIENLLISS 84
           GSL D L   T  +   I  ++   T   + H+H +       P I HRDLK +N+L+  
Sbjct: 92  GSLFDYLNRYTVTVEGMIKLAL--STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 149
Query: 85  AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
            GT  + D G A     + D    A           R  T  Y APE++D
Sbjct: 150 NGTCCIADLGLAVRHDSATDTIDIAPNH--------RVGTKRYMAPEVLD 191

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 127 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 184
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 185 -------------EPNVSXICSRYYRAPELIFGATDY 208

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 46/110 (41%), Gaps = 16/110 (14%)
Query: 31  GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NPPIVHRDLKIENLLISS 84
           GSL D L   T  +   I  ++   T   + H+H +       P I HRDLK +N+L+  
Sbjct: 112 GSLFDYLNRYTVTVEGMIKLAL--STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 169
Query: 85  AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
            GT  + D G A     + D    A           R  T  Y APE++D
Sbjct: 170 NGTCCIADLGLAVRHDSATDTIDIAPNH--------RVGTKRYMAPEVLD 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 46/110 (41%), Gaps = 16/110 (14%)
Query: 31  GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NPPIVHRDLKIENLLISS 84
           GSL D L   T  +   I  ++   T   + H+H +       P I HRDLK +N+L+  
Sbjct: 89  GSLFDYLNRYTVTVEGMIKLAL--STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 146
Query: 85  AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
            GT  + D G A     + D    A           R  T  Y APE++D
Sbjct: 147 NGTCCIADLGLAVRHDSATDTIDIAPNH--------RVGTKRYMAPEVLD 188

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 177 -------------EPNVSYICSRYYRAPELIFGATDY 200

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 46/110 (41%), Gaps = 16/110 (14%)
Query: 31  GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NPPIVHRDLKIENLLISS 84
           GSL D L   T  +   I  ++   T   + H+H +       P I HRDLK +N+L+  
Sbjct: 87  GSLFDYLNRYTVTVEGMIKLAL--STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 144
Query: 85  AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
            GT  + D G A     + D    A           R  T  Y APE++D
Sbjct: 145 NGTCCIADLGLAVRHDSATDTIDIAPNH--------RVGTKRYMAPEVLD 186

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 54/129 (41%), Gaps = 21/129 (16%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMH---------GQNPPI 70
           E  ++T     GSL D LK   + +  N +C +     + + ++H         G  P I
Sbjct: 87  ELWLITAFHDKGSLTDYLK--GNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSI 144
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
            HRD K +N+L+ S  T  L DFG A    + P             D   +  T  Y AP
Sbjct: 145 AHRDFKSKNVLLKSDLTAVLADFGLAVR--FEPGKPPG--------DTHGQVGTRRYMAP 194
Query: 131 EMVDTWNNY 139
           E+++   N+
Sbjct: 195 EVLEGAINF 203

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 177 -------------EPNVSYICSRYYRAPELIFGATDY 200

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 110 YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 165
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 166 LLGSAGELKIADFG 179

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 177 -------------EPNVSYICSRYYRAPELIFGATDY 200

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 211 -------------EPNVSXICSRYYRAPELIFGATDY 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 19/92 (20%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++H ++  +V+RD+K+ENL++   G +K+ DFG   E +   D A        
Sbjct: 113 EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGA-------- 160
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 161 ---TMKXFCGTPEYLAPEVLED-NDY--GRAV 186

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 85  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 140
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 141 LLGSAGELKIADFG 154

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 46/110 (41%), Gaps = 16/110 (14%)
Query: 31  GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NPPIVHRDLKIENLLISS 84
           GSL D L   T  +   I  ++   T   + H+H +       P I HRDLK +N+L+  
Sbjct: 125 GSLFDYLNRYTVTVEGMIKLAL--STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182
Query: 85  AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
            GT  + D G A     + D    A           R  T  Y APE++D
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNH--------RVGTKRYMAPEVLD 224

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/107 (23%), Positives = 46/107 (42%), Gaps = 19/107 (17%)
Query: 22  LILTELCTGGSLVDVLKERTSALPP----------------NIVCSILWQTCQAVKHMHG 65
           +++ E C  G+L   L+ + +   P                +++C   +Q  + ++ +  
Sbjct: 110 MVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC-YSFQVAKGMEFLAS 168
Query: 66  QNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
           +    +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 169 RK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 19/92 (20%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++H ++  +V+RD+K+ENL++   G +K+ DFG   E +   D A        
Sbjct: 113 EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGA-------- 160
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 161 ---TMKXFCGTPEYLAPEVLED-NDY--GRAV 186

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 19/92 (20%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++H ++  +V+RD+K+ENL++   G +K+ DFG   E +   D A        
Sbjct: 118 EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGA-------- 165
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 166 ---TMKXFCGTPEYLAPEVLED-NDY--GRAV 191

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           +  FG A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILGFGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 101 YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 156
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 157 LLGSAGELKIADFG 170

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 19/92 (20%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++H ++  +V+RD+K+ENL++   G +K+ DFG   E +   D A        
Sbjct: 113 EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGA-------- 160
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 161 ---TMKXFCGTPEYLAPEVLED-NDY--GRAV 186

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 31/155 (20%)
Query: 7   AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ 66
           A  D + +P+  H YL++ +L +GG L D + E+      +   +++ Q   AV ++H  
Sbjct: 84  ALEDIYESPN--HLYLVM-QLVSGGELFDRIVEKGFYTEKD-ASTLIRQVLDAVYYLHRM 139
Query: 67  NPPIVHRDLKIENLLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
              IVHRDLK ENLL  S      + + DFG +  K+    +  S               
Sbjct: 140 G--IVHRDLKPENLLYYSQDEESKIMISDFGLS--KMEGKGDVMSTA-----------CG 184
Query: 124 TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
           TP Y APE+         VD W+  VI   +L G+
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 179 SFMM---TPYVVTRYYRAPEVI 197

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 61/141 (43%), Gaps = 29/141 (20%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+  +L TGG L + +  R      +     + Q  +++ + H     IVHR+LK ENL
Sbjct: 81  YLVF-DLVTGGELFEDIVAREFYSEAD-ASHCIQQILESIAYCHSNG--IVHRNLKPENL 136
Query: 81  LISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           L++S      VKL DFG A E   +   AW                TP Y +PE+     
Sbjct: 137 LLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-----------GTPGYLSPEVLKKDP 183
Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W   VI   +L G+
Sbjct: 184 YSKPVDIWACGVILYILLVGY 204

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 124 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 181
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 182 -------------EPNVSYICSRYYRAPELIFGATDY 205

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/77 (29%), Positives = 36/77 (46%), Gaps = 3/77 (3%)
Query: 22  LILTELCTGGSLVD-VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            I  E C  G+L   + K R   L   +   +  Q  + V ++H +   ++HRDLK  N+
Sbjct: 110 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK--KLIHRDLKPSNI 167
Query: 81  LISSAGTVKLCDFGSAT 97
            +     VK+ DFG  T
Sbjct: 168 FLVDTKQVKIGDFGLVT 184

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 132 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 189
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 190 -------------EPNVSYICSRYYRAPELIFGATDY 213

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 198 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 255
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 256 -------------EPNVSYICSRYYRAPELIFGATDY 279

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 61/141 (43%), Gaps = 29/141 (20%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+  +L TGG L + +  R      +     + Q  +++ + H     IVHR+LK ENL
Sbjct: 81  YLVF-DLVTGGELFEDIVAREFYSEAD-ASHCIQQILESIAYCHSNG--IVHRNLKPENL 136
Query: 81  LISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           L++S      VKL DFG A E   +   AW                TP Y +PE+     
Sbjct: 137 LLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-----------GTPGYLSPEVLKKDP 183
Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W   VI   +L G+
Sbjct: 184 YSKPVDIWACGVILYILLVGY 204

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 179 SFMM---TPYVVTRYYRAPEVI 197

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 84  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKK--VIHRDIKPENL 139
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 140 LLGSAGELKIADFG 153

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 84  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 139
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSA 109
           L+ SAG +K+ DFG +   V++P +  +A
Sbjct: 140 LLGSAGELKIADFGWS---VHAPSSRRAA 165

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 49/108 (45%), Gaps = 21/108 (19%)
Query: 31  GSLVDVLKERTSA-LPPNIVCSILWQTCQAV---KHMHGQNPPIVHRDLKIENLLISSAG 86
           G+  + LK+R    +P  I+  +     +A+   K  HG    ++HRD+K  N+L+   G
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERG 162
Query: 87  TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
            +KLCDFG +   V        A+ RS             Y APE +D
Sbjct: 163 QIKLCDFGISGRLVDD-----KAKDRSA--------GCAAYMAPERID 197

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 89  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 144
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 145 LLGSAGELKIADFG 158

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 61/141 (43%), Gaps = 29/141 (20%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+  +L TGG L + +  R      +     + Q  +++ + H     IVHR+LK ENL
Sbjct: 80  YLVF-DLVTGGELFEDIVAREFYSEAD-ASHCIQQILESIAYCHSNG--IVHRNLKPENL 135
Query: 81  LISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           L++S      VKL DFG A E   +   AW                TP Y +PE+     
Sbjct: 136 LLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-----------GTPGYLSPEVLKKDP 182
Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W   VI   +L G+
Sbjct: 183 YSKPVDIWACGVILYILLVGY 203

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 87  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 142
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 143 LLGSAGELKIADFG 156

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 19/92 (20%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++H ++  +V+RD+K+ENL++   G +K+ DFG   E +   D A        
Sbjct: 113 EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGA-------- 160
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 161 ---TMKTFCGTPEYLAPEVLED-NDY--GRAV 186

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 87  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 142
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 143 LLGSAGELKIADFG 156

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 44/88 (50%), Gaps = 16/88 (18%)
Query: 53  LWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V           
Sbjct: 166 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--------- 214
Query: 112 RSMLEDEMARFTTPMYRAPEMVDTWNNY 139
               E  ++   +  YRAPE++    +Y
Sbjct: 215 ----EPNVSYICSRYYRAPELIFGATDY 238

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 83  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 138
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 139 LLGSAGELKIADFG 152

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 146
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 147 CLVGENHLVKVADFG 161

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 87  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 142
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 143 LLGSAGELKIADFG 156

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 86  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 141
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 142 LLGSAGELKIADFG 155

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 19/92 (20%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++H ++  +V+RD+K+ENL++   G +K+ DFG   E +   D A        
Sbjct: 113 EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGA-------- 160
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 161 ---TMKTFCGTPEYLAPEVLED-NDY--GRAV 186

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 211 -------------EPNVSYICSRYYRAPELIFGATDY 234

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 84  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 139
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 140 LLGSAGELKIADFG 153

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 44/88 (50%), Gaps = 16/88 (18%)
Query: 53  LWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V           
Sbjct: 164 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--------- 212
Query: 112 RSMLEDEMARFTTPMYRAPEMVDTWNNY 139
               E  ++   +  YRAPE++    +Y
Sbjct: 213 ----EPNVSYICSRYYRAPELIFGATDY 236

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 58/130 (44%), Gaps = 31/130 (23%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEM----------VDTWNN 138
           + DFG A                   +DEM  +  T  YRAPE+          VD W+ 
Sbjct: 166 ILDFGLARHT----------------DDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSV 209
Query: 139 YVIGRSMLYG 148
             I   +L G
Sbjct: 210 GCIMAELLTG 219

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 16/97 (16%)
Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA + V  
Sbjct: 147 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 204
Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                        E  ++   +  YRAPE++    +Y
Sbjct: 205 -------------EPNVSYICSRYYRAPELIFGATDY 228

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+TE  + G L++ L+     L P+ +  + +  C+ +  +       +HRDL   N L+
Sbjct: 80  IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLV 137
Query: 83  SSAGTVKLCDFG 94
                VK+ DFG
Sbjct: 138 DRDLCVKVSDFG 149

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 89  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 144
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 145 LLGSAGELKIADFG 158

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 88  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 143
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 144 LLGSAGELKIADFG 157

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 141
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 142 CLVGENHLVKVADFG 156

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 19/92 (20%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A++++H ++  +V+RD+K+ENL++   G +K+ DFG   E +   D A        
Sbjct: 116 EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGA-------- 163
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 164 ---TMKTFCGTPEYLAPEVLED-NDY--GRAV 189

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 84  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 139
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 140 LLGSAGELKIADFG 153

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 84  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 139
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 140 LLGSAGELKIADFG 153

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 141
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 142 CLVGENHLVKVADFG 156

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 85  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 140
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 141 LLGSAGELKIADFG 154

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 87  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 142
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 143 LLGSAGELKIADFG 156

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 84  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 139
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 140 LLGSAGELKIADFG 153

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 82  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 139
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 140 CLVGENHLVKVADFG 154

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 89  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 144
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 145 LLGSAGELKIADFG 158

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + DF  A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDFYLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 61/141 (43%), Gaps = 29/141 (20%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+  +L TGG L + +  R      +     + Q  +++ + H     IVHR+LK ENL
Sbjct: 104 YLVF-DLVTGGELFEDIVAREFYSEAD-ASHCIQQILESIAYCHSNG--IVHRNLKPENL 159
Query: 81  LISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           L++S      VKL DFG A E   +   AW                TP Y +PE+     
Sbjct: 160 LLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-----------GTPGYLSPEVLKKDP 206
Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W   VI   +L G+
Sbjct: 207 YSKPVDIWACGVILYILLVGY 227

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 81  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 136
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 137 LLGSAGELKIADFG 150

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 84  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 139
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ DFG
Sbjct: 140 LLGSAGELKIADFG 153

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 18/92 (19%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A+ ++H +   +V+RDLK+ENL++   G +K+ DFG   E +   D A        
Sbjct: 116 EIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGI--KDGA-------- 164
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 165 ---TMKXFCGTPEYLAPEVLED-NDY--GRAV 190

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/69 (36%), Positives = 39/69 (56%), Gaps = 4/69 (5%)
Query: 31  GSLVDVLK--ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTV 88
           GS +D+    +R   L   +   I  Q   AV ++  ++  I+HRD+K EN++I+   T+
Sbjct: 112 GSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTI 169
Query: 89  KLCDFGSAT 97
           KL DFGSA 
Sbjct: 170 KLIDFGSAA 178

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 82  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 139
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 140 CLVGENHLVKVADFG 154

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 125 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 172
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 173 SFMM---TPYVVTRYYRAPEVI 191

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 169 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 216
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 217 SFMM---TPYVVTRYYRAPEVI 235

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 97  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 154
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 155 CLVGENHLVKVADFG 169

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 136 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 183
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 184 SFMM---TPYVVTRYYRAPEVI 202

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 169 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 216
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 217 SFMM---TPYVVTRYYRAPEVI 235

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 18/92 (19%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A+ ++H +   +V+RDLK+ENL++   G +K+ DFG   E +   D A        
Sbjct: 117 EIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGI--KDGA-------- 165
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 166 ---TMKXFCGTPEYLAPEVLED-NDY--GRAV 191

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/70 (35%), Positives = 35/70 (50%), Gaps = 8/70 (11%)
Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           I+HRD+K  N+LI+  G +KL DFG A         A+S  + S       R  T  YR 
Sbjct: 145 ILHRDMKAANVLITRDGVLKLADFGLA--------RAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 130 PEMVDTWNNY 139
           PE++    +Y
Sbjct: 197 PELLLGERDY 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 60/148 (40%), Gaps = 26/148 (17%)
Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HS          + E   GG L+    +R   LP         +   A+ ++H +   I+
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLM-FHMQRQRKLPEEHARFYSAEISLALNYLHERG--II 128
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAP 130
           +RDLK++N+L+ S G +KL D+G   E +   D               + F  TP Y AP
Sbjct: 129 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-------------SXFCGTPNYIAP 175
Query: 131 EM---------VDTWNNYVIGRSMLYGH 149
           E+         VD W   V+   M+ G 
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 88  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 145
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 146 CLVGENHLVKVADFG 160

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 146
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 147 CLVGENHLVKVADFG 161

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 141
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 142 CLVGENHLVKVADFG 156

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 132 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 179
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 180 SFMM---TPYVVTRYYRAPEVI 198

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 130 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 177
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 178 SFMM---TPYVVTRYYRAPEVI 196

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/70 (35%), Positives = 35/70 (50%), Gaps = 8/70 (11%)
Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           I+HRD+K  N+LI+  G +KL DFG A         A+S  + S       R  T  YR 
Sbjct: 146 ILHRDMKAANVLITRDGVLKLADFGLA--------RAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 130 PEMVDTWNNY 139
           PE++    +Y
Sbjct: 198 PELLLGERDY 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 18/92 (19%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A+ ++H +   +V+RDLK+ENL++   G +K+ DFG   E +   D A        
Sbjct: 118 EIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGI--KDGA-------- 166
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 167 ---TMKXFCGTPEYLAPEVLED-NDY--GRAV 192

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + D G A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDAGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/70 (35%), Positives = 35/70 (50%), Gaps = 8/70 (11%)
Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           I+HRD+K  N+LI+  G +KL DFG A         A+S  + S       R  T  YR 
Sbjct: 146 ILHRDMKAANVLITRDGVLKLADFGLA--------RAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 130 PEMVDTWNNY 139
           PE++    +Y
Sbjct: 198 PELLLGERDY 207

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/70 (35%), Positives = 35/70 (50%), Gaps = 8/70 (11%)
Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
           I+HRD+K  N+LI+  G +KL DFG A         A+S  + S       R  T  YR 
Sbjct: 146 ILHRDMKAANVLITRDGVLKLADFGLA--------RAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 130 PEMVDTWNNY 139
           PE++    +Y
Sbjct: 198 PELLLGERDY 207

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 179 SFMM---TPYVVTRYYRAPEVI 197

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 132 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 179
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 180 SFMM---TPYVVTRYYRAPEVI 198

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 146
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 147 CLVGENHLVKVADFG 161

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 124 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 171
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 172 SFMM---TPYVVTRYYRAPEVI 190

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 125 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 172
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 173 SFMM---TPYVVTRYYRAPEVI 191

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 125 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 172
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 173 SFMM---TPYVVTRYYRAPEVI 191

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 143
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 144 CLVGENHLVKVADFG 158

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/123 (26%), Positives = 53/123 (43%), Gaps = 17/123 (13%)
Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HS          + E   GG L+    +R   LP         +   A+ ++H +   I+
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLM-FHMQRQRKLPEEHARFYSAEISLALNYLHERG--II 132
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAP 130
           +RDLK++N+L+ S G +KL D+G   E +   D               + F  TP Y AP
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-------------SXFCGTPNYIAP 179
Query: 131 EMV 133
           E++
Sbjct: 180 EIL 182

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 143
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 144 CLVGENHLVKVADFG 158

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 85  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 142
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 143 CLVGENHLVKVADFG 157

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 60/148 (40%), Gaps = 26/148 (17%)
Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HS          + E   GG L+    +R   LP         +   A+ ++H +   I+
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLM-FHMQRQRKLPEEHARFYSAEISLALNYLHERG--II 143
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAP 130
           +RDLK++N+L+ S G +KL D+G   E +   D               + F  TP Y AP
Sbjct: 144 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-------------SXFCGTPNYIAP 190
Query: 131 EM---------VDTWNNYVIGRSMLYGH 149
           E+         VD W   V+   M+ G 
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 15/82 (18%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +A  
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------TAGT 178
Query: 112 RSMLEDEMARFTTPMYRAPEMV 133
             M+        T  YRAPE++
Sbjct: 179 SFMM---TPYVVTRYYRAPEVI 197

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/85 (25%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E    G L   L ++   +  ++   ++      +++M  QNPPIVHRDL+  N+ +
Sbjct: 98  MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL 157
Query: 83  SSAGT-----VKLCDFGSATEKVYS 102
            S         K+ DF  + + V+S
Sbjct: 158 QSLDENAPVCAKVADFSLSQQSVHS 182

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + D G A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDRGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 86  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 143
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 144 CLVGENHLVKVADFG 158

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/73 (30%), Positives = 38/73 (52%), Gaps = 2/73 (2%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +++ E+  GG L   L  +   +P + V  +L Q    +K++  +N   VHRDL   N+L
Sbjct: 85  MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVL 142
Query: 82  ISSAGTVKLCDFG 94
           + +    K+ DFG
Sbjct: 143 LVNRHYAKISDFG 155

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 141
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 142 CLVGENHLVKVADFG 156

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 89  FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 146
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 147 CLVGENHLVKVADFG 161

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 59/147 (40%), Gaps = 24/147 (16%)
Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           HS          + E   GG L+    +R   LP         +   A+ ++H +   I+
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLM-FHMQRQRKLPEEHARFYSAEISLALNYLHERG--II 175
Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +RDLK++N+L+ S G +KL D+G   E +   D   +               TP Y APE
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------------CGTPNYIAPE 223
Query: 132 M---------VDTWNNYVIGRSMLYGH 149
           +         VD W   V+   M+ G 
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 31/141 (21%)
Query: 21  YLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           + ++ E+ TGG L D  + ++R S +       I+ Q    + + H     IVHRDLK E
Sbjct: 101 FYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYXHKNK--IVHRDLKPE 155
Query: 79  NLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-- 133
           NLL+ S      +++ DFG +T         + A ++   +D++    T  Y APE++  
Sbjct: 156 NLLLESKSKDANIRIIDFGLSTH--------FEASKKX--KDKIG---TAYYIAPEVLHG 202
Query: 134 ------DTWNNYVIGRSMLYG 148
                 D W+  VI   +L G
Sbjct: 203 TYDEKCDVWSTGVILYILLSG 223

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 5/100 (5%)
Query: 1   MEYLSAAFIDKH---STPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTC 57
           ++ L + FI K+   S   G  E  ++ E    G L D L+   + L  + +     Q C
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 121
Query: 58  QAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSAT 97
           + ++++  +    VHRDL   N+L+ S   VK+ DFG A 
Sbjct: 122 KGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK 159

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 30  GGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVK 89
           G  L +++K     L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K
Sbjct: 110 GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELK 165
Query: 90  LCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
           + D G A                   +DEM  +  T  YRAPE++  W +Y
Sbjct: 166 ILDGGLARHT----------------DDEMTGYVATRWYRAPEIMLNWMHY 200

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 64/146 (43%), Gaps = 40/146 (27%)
Query: 21  YLILTELCTGGSLVD------VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YL++ ELCTGG L +      V +E  +A        I+     AV + H  N  + HRD
Sbjct: 99  YLVM-ELCTGGELFERVVHKRVFRESDAA-------RIMKDVLSAVAYCHKLN--VAHRD 148
Query: 75  LKIENLLI---SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           LK EN L    S    +KL DFG A    + P          M+  ++    TP Y +P+
Sbjct: 149 LKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGK--------MMRTKVG---TPYYVSPQ 195
Query: 132 MV--------DTWNNYVIGRSMLYGH 149
           ++        D W+  V+   +L G+
Sbjct: 196 VLEGLYGPECDEWSAGVMMYVLLCGY 221

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 18/92 (19%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A+ ++H +   +V+RDLK+ENL++   G +K+ DFG   E +   D A        
Sbjct: 259 EIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGI--KDGA-------- 307
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 308 ---TMKTFCGTPEYLAPEVLED-NDY--GRAV 333

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 64/146 (43%), Gaps = 40/146 (27%)
Query: 21  YLILTELCTGGSLVD------VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           YL++ ELCTGG L +      V +E  +A        I+     AV + H  N  + HRD
Sbjct: 82  YLVM-ELCTGGELFERVVHKRVFRESDAA-------RIMKDVLSAVAYCHKLN--VAHRD 131
Query: 75  LKIENLLI---SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           LK EN L    S    +KL DFG A    + P          M+  ++    TP Y +P+
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGK--------MMRTKVG---TPYYVSPQ 178
Query: 132 MV--------DTWNNYVIGRSMLYGH 149
           ++        D W+  V+   +L G+
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGY 204

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/45 (42%), Positives = 29/45 (64%), Gaps = 2/45 (4%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A
Sbjct: 131 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 18/92 (19%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSM 114
           +   A+ ++H +   +V+RDLK+ENL++   G +K+ DFG   E +   D A        
Sbjct: 256 EIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGI--KDGA-------- 304
Query: 115 LEDEMARF-TTPMYRAPEMVDTWNNYVIGRSM 145
               M  F  TP Y APE+++  N+Y  GR++
Sbjct: 305 ---TMKTFCGTPEYLAPEVLED-NDY--GRAV 330

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 38/76 (50%), Gaps = 3/76 (3%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           + TELC G SL    +   ++LP   V   L  T  A+ H+H Q   +VH D+K  N+ +
Sbjct: 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL 190
Query: 83  SSAGTVKLCDFGSATE 98
              G  KL DFG   E
Sbjct: 191 GPRGRCKLGDFGLLVE 206

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 57/138 (41%), Gaps = 28/138 (20%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E  +GG L + +         +       Q    V + H     I HRDLK+EN L+
Sbjct: 93  IIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLL 149
Query: 83  --SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------- 133
             S A  +K+CDFG      YS  +   +Q +S +        TP Y APE++       
Sbjct: 150 DGSPAPRLKICDFG------YSKSSVLHSQPKSTV-------GTPAYIAPEVLLRQEYDG 196
Query: 134 ---DTWNNYVIGRSMLYG 148
              D W+  V    ML G
Sbjct: 197 KIADVWSCGVTLYVMLVG 214

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 57/138 (41%), Gaps = 28/138 (20%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E  +GG L + +         +       Q    V + H     + HRDLK+EN L+
Sbjct: 91  IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLL 147
Query: 83  --SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------- 133
             S A  +K+CDFG      YS  +   +Q +S +        TP Y APE++       
Sbjct: 148 DGSPAPRLKICDFG------YSKSSVLHSQPKSTV-------GTPAYIAPEVLLKKEYDG 194
Query: 134 ---DTWNNYVIGRSMLYG 148
              D W+  V    ML G
Sbjct: 195 KVADVWSCGVTLYVMLVG 212

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 27/140 (19%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           + ++TE   GG L + +  R          +I+ Q    + ++H  N  IVHRD+K EN+
Sbjct: 121 FYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENI 177
Query: 81  LISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---- 133
           L+ +  +   +K+ DFG ++   +S D          L D   R  T  Y APE++    
Sbjct: 178 LLENKNSLLNIKIVDFGLSS--FFSKDYK--------LRD---RLGTAYYIAPEVLKKKY 224
Query: 134 ----DTWNNYVIGRSMLYGH 149
               D W+  VI   +L G+
Sbjct: 225 NEKCDVWSCGVIMYILLCGY 244

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 36/147 (24%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL++ +   GG L+ +L +    LP  +    L +   A+  +H  +   VHRD+K +N+
Sbjct: 150 YLVM-DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNI 206
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TPMYRAPEMV--- 133
           L+   G ++L DFGS  +               ++ED   + +    TP Y +PE++   
Sbjct: 207 LMDMNGHIRLADFGSCLK---------------LMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 134 -----------DTWNNYVIGRSMLYGH 149
                      D W+  V    MLYG 
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 63/144 (43%), Gaps = 34/144 (23%)
Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           E  ++ EL TGG L D + E+            + Q  +AV ++H     IVHRDLK EN
Sbjct: 122 EISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPEN 178
Query: 80  LLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM- 132
           LL ++      +K+ DFG +                 ++E ++   T   TP Y APE+ 
Sbjct: 179 LLYATPAPDAPLKIADFGLS----------------KIVEHQVLMKTVCGTPGYCAPEIL 222
Query: 133 --------VDTWNNYVIGRSMLYG 148
                   VD W+  +I   +L G
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 57/138 (41%), Gaps = 28/138 (20%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E  +GG L + +         +       Q    V + H     + HRDLK+EN L+
Sbjct: 92  IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLL 148
Query: 83  --SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------- 133
             S A  +K+CDFG      YS  +   +Q +S +        TP Y APE++       
Sbjct: 149 DGSPAPRLKICDFG------YSKSSVLHSQPKSTV-------GTPAYIAPEVLLKKEYDG 195
Query: 134 ---DTWNNYVIGRSMLYG 148
              D W+  V    ML G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           +LIL +   GG L   L +R      + V   + +   A++H+H     I++RD+K+EN+
Sbjct: 135 HLIL-DYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENI 190
Query: 81  LISSAGTVKLCDFGSATEKV 100
           L+ S G V L DFG + E V
Sbjct: 191 LLDSNGHVVLTDFGLSKEFV 210

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 56/137 (40%), Gaps = 25/137 (18%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y +L +   GG L   L+     L P        +   A+ ++H  N  IV+RDLK EN+
Sbjct: 115 YFVL-DYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLN--IVYRDLKPENI 170
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-------- 132
           L+ S G + L DFG   E +         +  S          TP Y APE+        
Sbjct: 171 LLDSQGHIVLTDFGLCKENI---------EHNSTTSTFCG---TPEYLAPEVLHKQPYDR 218
Query: 133 -VDTWNNYVIGRSMLYG 148
            VD W    +   MLYG
Sbjct: 219 TVDWWCLGAVLYEMLYG 235

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 44/88 (50%), Gaps = 16/88 (18%)
Query: 53  LWQTCQAVKHMHGQNPPIVHRDLKIENLLISS-AGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           ++Q  +++ ++H     I HRD+K +NLL+   +G +KL DFGSA   +           
Sbjct: 147 MYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--------- 195
Query: 112 RSMLEDEMARFTTPMYRAPEMVDTWNNY 139
               E  ++   +  YRAPE++    NY
Sbjct: 196 ----EPNVSXICSRYYRAPELIFGATNY 219

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 36/75 (48%), Gaps = 2/75 (2%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I  E C   +L D++         +    +  Q  +A+ ++H Q   I+HR+LK  N+ 
Sbjct: 91  FIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRNLKPXNIF 148
Query: 82  ISSAGTVKLCDFGSA 96
           I  +  VK+ DFG A
Sbjct: 149 IDESRNVKIGDFGLA 163

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 18/114 (15%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 88  YLIL-EYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 143
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           L+ S G +K+ DFG            WS    S   D +    T  Y  PEM++
Sbjct: 144 LLGSNGELKIADFG------------WSVHAPSSRRDTLC--GTLDYLPPEMIE 183

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/123 (22%), Positives = 50/123 (40%), Gaps = 16/123 (13%)
Query: 17  GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
            MH+  ++TEL     L  V+ ++   + P  +   ++     +  +H     +VHRDL 
Sbjct: 105 AMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLH 161
Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTW 136
             N+L++    + +CDF  A E     +       R              YRAPE+V  +
Sbjct: 162 PGNILLADNNDITICDFNLAREDTADANKTHYVTHR-------------WYRAPELVMQF 208
Query: 137 NNY 139
             +
Sbjct: 209 KGF 211

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 12/89 (13%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTV-KLCDFGSATEKVYSPDNAWSAQ 110
            ++Q  + +K++H  N  ++HRDLK  NL I++   V K+ DFG A  ++  P  +    
Sbjct: 125 FMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLA--RIMDPHYSHKGH 180
Query: 111 QRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
               L        T  YR+P ++ + NNY
Sbjct: 181 LSEGL-------VTKWYRSPRLLLSPNNY 202

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/123 (22%), Positives = 50/123 (40%), Gaps = 16/123 (13%)
Query: 17  GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
            MH+  ++TEL     L  V+ ++   + P  +   ++     +  +H     +VHRDL 
Sbjct: 105 AMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLH 161
Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTW 136
             N+L++    + +CDF  A E     +       R              YRAPE+V  +
Sbjct: 162 PGNILLADNNDITICDFNLAREDTADANKTHYVTHR-------------WYRAPELVMQF 208
Query: 137 NNY 139
             +
Sbjct: 209 KGF 211

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 56/125 (44%), Gaps = 20/125 (16%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMH--------GQNPPIVHRD 74
           ++T     GSL D LK   + +  N +C I     + + ++H        G  P I HRD
Sbjct: 99  LITAFHEKGSLSDFLK--ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRD 156
Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +K +N+L+ +  T  + DFG A  K  +  +A          D   +  T  Y APE+++
Sbjct: 157 IKSKNVLLKNNLTACIADFGLAL-KFEAGKSA---------GDTHGQVGTRRYMAPEVLE 206
Query: 135 TWNNY 139
              N+
Sbjct: 207 GAINF 211

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 19/89 (21%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +++Q  + +K++H     +VHRDLK  NL ++    +K+ DFG A               
Sbjct: 149 LVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHA------------ 194
Query: 112 RSMLEDEMARF-TTPMYRAPEMVDTWNNY 139
               + EM  +  T  YRAPE++ +W +Y
Sbjct: 195 ----DAEMTGYVVTRWYRAPEVILSWMHY 219

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 62/148 (41%), Gaps = 33/148 (22%)
Query: 13  STPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
           STP  +    ++ E  +GG L D +  +   L       +  Q    V + H     +VH
Sbjct: 86  STPSDI---FMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHRHM--VVH 139
Query: 73  RDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAP 130
           RDLK EN+L+ +    K+ DFG +                 M + E  R +  +P Y AP
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSN---------------MMSDGEFLRXSCGSPNYAAP 184
Query: 131 EM----------VDTWNNYVIGRSMLYG 148
           E+          VD W++ VI  ++L G
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 19/89 (21%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +++Q  + +K++H     +VHRDLK  NL ++    +K+ DFG A               
Sbjct: 131 LVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHA------------ 176
Query: 112 RSMLEDEMARF-TTPMYRAPEMVDTWNNY 139
               + EM  +  T  YRAPE++ +W +Y
Sbjct: 177 ----DAEMTGYVVTRWYRAPEVILSWMHY 201

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 26/108 (24%)
Query: 53  LWQTCQAVKHMHGQNPPIVHRDLKIENLLISS---AGTVKLCDFGSATEKVYSPDNAWSA 109
           + Q  +A+++ H  N  I+HRD+K EN+L++S   +  VKL DFG A +   S   A   
Sbjct: 136 MRQILEALRYCHDNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAG-- 191
Query: 110 QQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYG 148
                      R  TP + APE+         VD W   VI   +L G
Sbjct: 192 ----------GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HR+L   N
Sbjct: 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARN 348
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 349 CLVGENHLVKVADFG 363

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 17/88 (19%)
Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +++Q  + ++++H     I+HRDLK  NL ++    +K+ DFG A               
Sbjct: 133 LVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA--------------- 175
Query: 112 RSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           R    +      T  YRAPE++  W  Y
Sbjct: 176 RQADSEMXGXVVTRWYRAPEVILNWMRY 203

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 5/99 (5%)
Query: 1   MEYLSAAFIDKH---STPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTC 57
           ++ L + FI K+   S   G     ++ E    G L D L+   + L  + +     Q C
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 58  QAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           + ++++  +    VHRDL   N+L+ S   VK+ DFG A
Sbjct: 138 KGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLA 174

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 5/99 (5%)
Query: 1   MEYLSAAFIDKH---STPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTC 57
           ++ L + FI K+   S   G     ++ E    G L D L+   + L  + +     Q C
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 124
Query: 58  QAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           + ++++  +    VHRDL   N+L+ S   VK+ DFG A
Sbjct: 125 KGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLA 161

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 86  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 141
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ +FG
Sbjct: 142 LLGSAGELKIANFG 155

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 2/44 (4%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
           Q    ++H+H +N  I++RDLK EN+L+   G V++ D G A E
Sbjct: 297 QIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE 338

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 2/44 (4%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
           Q    ++H+H +N  I++RDLK EN+L+   G V++ D G A E
Sbjct: 297 QIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE 338

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 5/99 (5%)
Query: 1   MEYLSAAFIDKH---STPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTC 57
           ++ L + FI K+   S   G     ++ E    G L D L+   + L  + +     Q C
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 125
Query: 58  QAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           + ++++  +    VHRDL   N+L+ S   VK+ DFG A
Sbjct: 126 KGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLA 162

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 2/44 (4%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
           Q    ++H+H +N  I++RDLK EN+L+   G V++ D G A E
Sbjct: 297 QIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE 338

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 2/44 (4%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
           Q    ++H+H +N  I++RDLK EN+L+   G V++ D G A E
Sbjct: 297 QIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE 338

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 87  YLIL-EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 142
Query: 81  LISSAGTVKLCDFG 94
           L+ SAG +K+ +FG
Sbjct: 143 LLGSAGELKIANFG 156

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 19/94 (20%)
Query: 22  LILTELCTGGSLVDVLKERT-----SALPPNIVC------------SILWQTCQAVKHMH 64
           L++TE C  G L++ L+ +      S   P I+             S  +Q  + +  + 
Sbjct: 126 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 185
Query: 65  GQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
            +N   +HRDL   N+L++     K+CDFG A +
Sbjct: 186 SKN--CIHRDLAARNILLTHGRITKICDFGLARD 217

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 19/94 (20%)
Query: 22  LILTELCTGGSLVDVLKER-----TSALPPNIVC------------SILWQTCQAVKHMH 64
           L++TE C  G L++ L+ +      S   P I+             S  +Q  + +  + 
Sbjct: 121 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 180
Query: 65  GQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
            +N   +HRDL   N+L++     K+CDFG A +
Sbjct: 181 SKN--CIHRDLAARNILLTHGRITKICDFGLARD 212

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 19/94 (20%)
Query: 22  LILTELCTGGSLVDVLKER-----TSALPPNIVC------------SILWQTCQAVKHMH 64
           L++TE C  G L++ L+ +      S   P I+             S  +Q  + +  + 
Sbjct: 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162
Query: 65  GQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
            +N   +HRDL   N+L++     K+CDFG A +
Sbjct: 163 SKN--CIHRDLAARNILLTHGRITKICDFGLARD 194

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 12/101 (11%)
Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA----TEKVYSPD 104
           + +IL+        +H     I+HRDLK  N L++   +VK+CDFG A    +EK  +  
Sbjct: 131 IKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 105 NAWSAQQ------RSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           N     +      +++ +   +   T  YRAPE++    NY
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 8/91 (8%)
Query: 23  ILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I+TE    GSL+D LK  E  +   PN+V  +  Q    + ++   N   +HRDL+  N+
Sbjct: 80  IVTEYMNKGSLLDFLKDGEGRALKLPNLV-DMAAQVAAGMAYIERMN--YIHRDLRSANI 136
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           L+ +    K+ DFG A       DN  +A+Q
Sbjct: 137 LVGNGLICKIADFGLAR---LIEDNEXTARQ 164

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+ E  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 84  FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 141
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 142 CLVGENHLVKVADFG 156

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 8/91 (8%)
Query: 23  ILTELCTGGSLVDVLKERTSALP--PNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I+TE  + GSL+D LK  T      P +V  +  Q    + ++   N   VHRDL+  N+
Sbjct: 82  IVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMN--YVHRDLRAANI 138
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           L+      K+ DFG A       DN ++A+Q
Sbjct: 139 LVGENLVCKVADFGLAR---LIEDNEYTARQ 166

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 51  SILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           S L Q    + + H +   ++HRDLK +NLLI+  G +K+ DFG A
Sbjct: 104 SFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLA 147

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/59 (32%), Positives = 31/59 (52%), Gaps = 1/59 (1%)
Query: 38  KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           K  T  +P  ++  I+     +  ++H +   I HRD+K  N+L+   G VKL DFG +
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNE-KNICHRDVKPSNILMDKNGRVKLSDFGES 199

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 51  SILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           S L Q    + + H +   ++HRDLK +NLLI+  G +K+ DFG A
Sbjct: 104 SFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLA 147

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 59/131 (45%), Gaps = 17/131 (12%)
Query: 15  PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           P+  H Y++  EL   G +++V       L  +          + ++++H Q   I+HRD
Sbjct: 108 PNEDHLYMVF-ELVNQGPVMEV--PTLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRD 162
Query: 75  LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           +K  NLL+   G +K+ DFG + E   S          ++L + +    TP + APE + 
Sbjct: 163 IKPSNLLVGEDGHIKIADFGVSNEFKGS---------DALLSNTVG---TPAFMAPESLS 210
Query: 135 TWNNYVIGRSM 145
                  G+++
Sbjct: 211 ETRKIFSGKAL 221

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/46 (41%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 51  SILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           S L Q    + + H +   ++HRDLK +NLLI+  G +K+ DFG A
Sbjct: 104 SFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLA 147

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+ E  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 84  FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 141
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 142 CLVGENHLVKVADFG 156

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 8/91 (8%)
Query: 23  ILTELCTGGSLVDVLKERTSALP--PNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I+TE  + GSL+D LK  T      P +V  +  Q    + ++   N   VHRDL+  N+
Sbjct: 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMN--YVHRDLRAANI 311
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           L+      K+ DFG A       DN ++A+Q
Sbjct: 312 LVGENLVCKVADFGLAR---LIEDNEYTARQ 339

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 21/73 (28%), Positives = 38/73 (52%), Gaps = 2/73 (2%)
Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +++ E+  GG L   L  +   +P + V  +L Q    +K++  +N   VHR+L   N+L
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVL 468
Query: 82  ISSAGTVKLCDFG 94
           + +    K+ DFG
Sbjct: 469 LVNRHYAKISDFG 481

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 19/92 (20%)
Query: 22  LILTELCTGGSLVDVLKERT-----SALPPNIVC------------SILWQTCQAVKHMH 64
           L++TE C  G L++ L+ +      S   P I+             S  +Q  + +  + 
Sbjct: 126 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 185
Query: 65  GQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
            +N   +HRDL   N+L++     K+CDFG A
Sbjct: 186 SKN--CIHRDLAARNILLTHGRITKICDFGLA 215

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 8/91 (8%)
Query: 23  ILTELCTGGSLVDVLKERTSALP--PNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I+TE  + GSL+D LK  T      P +V  +  Q    + ++   N   VHRDL+  N+
Sbjct: 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMN--YVHRDLRAANI 311
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           L+      K+ DFG A       DN ++A+Q
Sbjct: 312 LVGENLVCKVADFGLAR---LIEDNEYTARQ 339

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 52/122 (42%), Gaps = 6/122 (4%)
Query: 29  TGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTV 88
            GG L D + E+   +  +       Q   A+++ H     IVHRDLK ENLL+     V
Sbjct: 91  AGGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNV 147
Query: 89  KLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYVIGRSMLYG 148
           K+ DFG +   + +  N       S            +Y  PE VD W+  ++   ML G
Sbjct: 148 KIADFGLSN--IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE-VDVWSCGIVLYVMLVG 204
Query: 149 HV 150
            +
Sbjct: 205 RL 206

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+ E  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 82  FYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 139
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 140 CLVGENHLVKVADFG 154

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ EL   G L   L+   ++L    +     Q C+A+ ++   N   VHRD+ + N+L+
Sbjct: 101 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV 158
Query: 83  SSAGTVKLCDFG 94
           +S   VKL DFG
Sbjct: 159 ASPECVKLGDFG 170

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/94 (25%), Positives = 43/94 (45%), Gaps = 19/94 (20%)
Query: 22  LILTELCTGGSLVDVLKERTSAL-----PPNIVC------------SILWQTCQAVKHMH 64
           L++TE C  G L++ L+ +  +       P I+             S  +Q  + +  + 
Sbjct: 119 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 178
Query: 65  GQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
            +N   +HRDL   N+L++     K+CDFG A +
Sbjct: 179 SKN--CIHRDLAARNILLTHGRITKICDFGLARD 210

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ EL   G L   L+   ++L    +     Q C+A+ ++   N   VHRD+ + N+L+
Sbjct: 85  IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV 142
Query: 83  SSAGTVKLCDFG 94
           +S   VKL DFG
Sbjct: 143 ASPECVKLGDFG 154

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HR+L   N
Sbjct: 330 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRNLAARN 387
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 388 CLVGENHLVKVADFG 402

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 40.0 bits (92), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 22/72 (30%), Positives = 39/72 (54%), Gaps = 3/72 (4%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T LC G +L  V+++    L  N    I  +  + + ++H +   I+H+DLK +N+  
Sbjct: 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFY 163
Query: 83  SSAGTVKLCDFG 94
            + G V + DFG
Sbjct: 164 DN-GKVVITDFG 174

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 40.0 bits (92), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 17/42 (40%), Positives = 22/42 (52%)
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
           +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 261

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 40.0 bits (92), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ EL   G L   L+   ++L    +     Q C+A+ ++   N   VHRD+ + N+L+
Sbjct: 89  IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV 146
Query: 83  SSAGTVKLCDFG 94
           +S   VKL DFG
Sbjct: 147 ASPECVKLGDFG 158

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 17/42 (40%), Positives = 22/42 (52%)
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
           +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+ E  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 89  FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 146
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 147 CLVGENHLVKVADFG 161

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 17/42 (40%), Positives = 22/42 (52%)
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
           +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 254

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 47/85 (55%), Gaps = 8/85 (9%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHM--HGQNPPIVHRDLKIENL 80
           ++T+    GSL+D +++   AL P ++ +   Q  + + ++  HG    +VHR+L   N+
Sbjct: 109 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG----MVHRNLAARNV 164
Query: 81  LISSAGTVKLCDFGSATEKVYSPDN 105
           L+ S   V++ DFG A   +  PD+
Sbjct: 165 LLKSPSQVQVADFGVAD--LLPPDD 187

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 17/42 (40%), Positives = 22/42 (52%)
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
           +HRDL   N+L+S    VK+CDFG A +    PD       R
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 263

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 61/143 (42%), Gaps = 34/143 (23%)
Query: 20  EYLILTELCTGGSLVDVLKE--RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           ++ ++ E  +GG L D + +  R   +       +  Q   AV + H     +VHRDLK 
Sbjct: 85  DFFMVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVDYCHRHM--VVHRDLKP 139
Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAPEM--- 132
           EN+L+ +    K+ DFG +                 M + E  R +  +P Y APE+   
Sbjct: 140 ENVLLDAHMNAKIADFGLSN---------------MMSDGEFLRTSCGSPNYAAPEVISG 184
Query: 133 -------VDTWNNYVIGRSMLYG 148
                  VD W+  VI  ++L G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCG 207

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 47/85 (55%), Gaps = 8/85 (9%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHM--HGQNPPIVHRDLKIENL 80
           ++T+    GSL+D +++   AL P ++ +   Q  + + ++  HG    +VHR+L   N+
Sbjct: 91  LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG----MVHRNLAARNV 146
Query: 81  LISSAGTVKLCDFGSATEKVYSPDN 105
           L+ S   V++ DFG A   +  PD+
Sbjct: 147 LLKSPSQVQVADFGVA--DLLPPDD 169

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 39.7 bits (91), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 22/77 (28%), Positives = 36/77 (46%), Gaps = 3/77 (3%)
Query: 22  LILTELCTGGSLVD-VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            I  E C  G+L   + K R   L   +   +  Q  + V ++H +   +++RDLK  N+
Sbjct: 96  FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK--KLINRDLKPSNI 153
Query: 81  LISSAGTVKLCDFGSAT 97
            +     VK+ DFG  T
Sbjct: 154 FLVDTKQVKIGDFGLVT 170

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 10/92 (10%)
Query: 23  ILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           I+TE    GSL+D LK  T     LP  +  S   Q    + ++   N   VHRDL+  N
Sbjct: 86  IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA--QIASGMAYVERMN--YVHRDLRAAN 141
Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           +L+      K+ DFG A       DN ++A+Q
Sbjct: 142 ILVGENLVCKVADFGLAR---LIEDNEYTARQ 170

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 21  YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           + I+ E  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N
Sbjct: 85  FYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARN 142
Query: 80  LLISSAGTVKLCDFG 94
            L+     VK+ DFG
Sbjct: 143 CLVGENHLVKVADFG 157

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 41/91 (45%), Gaps = 25/91 (27%)
Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF--TTPMY 127
           IV+RDLK++N+L+   G +K+ DFG   E              +ML D        TP Y
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKE--------------NMLGDAKTNXFCGTPDY 184
Query: 128 RAPEM---------VDTWNNYVIGRSMLYGH 149
            APE+         VD W+  V+   ML G 
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 55/127 (43%), Gaps = 21/127 (16%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPN--IVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I  +LC   +L D +  R S       +   I  Q  +AV+ +H +   ++HRDLK  N+
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNI 195
Query: 81  LISSAGTVKLCDFGSAT--------EKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
             +    VK+ DFG  T        + V +P  A++            +  T +Y +PE 
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH--------XGQVGTKLYMSPEQ 247
Query: 133 VDTWNNY 139
           +   NNY
Sbjct: 248 IHG-NNY 253

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/70 (37%), Positives = 33/70 (47%), Gaps = 15/70 (21%)
Query: 55  QTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLCDFGSAT------------EKVY 101
           Q   A++H H +   +VHRD+K EN+LI    G  KL DFGS               +VY
Sbjct: 147 QVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVY 204
Query: 102 SPDNAWSAQQ 111
           SP    S  Q
Sbjct: 205 SPPEWISRHQ 214

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 30/141 (21%)
Query: 20  EYLILTELCTGGSLVDVLKE--RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           ++ ++ E  +GG L D + +  R   +       +  Q   AV + H     +VHRDLK 
Sbjct: 85  DFFMVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVDYCHRHM--VVHRDLKP 139
Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           EN+L+ +    K+ DFG +        N  S  +   L D      +P Y APE+     
Sbjct: 140 ENVLLDAHMNAKIADFGLS--------NMMSDGE--FLRDSCG---SPNYAAPEVISGRL 186
Query: 133 -----VDTWNNYVIGRSMLYG 148
                VD W+  VI  ++L G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 8/91 (8%)
Query: 23  ILTELCTGGSLVDVLKERTSALP--PNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           I+TE  + GSL+D LK  T      P +V  +  Q    + ++   N   VHRDL+  N+
Sbjct: 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMN--YVHRDLRAANI 394
Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQ 111
           L+      K+ DFG A       DN ++A+Q
Sbjct: 395 LVGENLVCKVADFGLAR---LIEDNEYTARQ 422

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 44/104 (42%), Gaps = 15/104 (14%)
Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD---- 104
           V +IL+      K +H     I+HRDLK  N L++   +VK+CDFG A       D    
Sbjct: 133 VKTILYNLLLGEKFIHESG--IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIV 190
Query: 105 ---------NAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                           +++ +   +   T  YRAPE++    NY
Sbjct: 191 NDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 234

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 40/74 (54%), Gaps = 4/74 (5%)
Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L ++ S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 88  YLIL-EYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 143
Query: 81  LISSAGTVKLCDFG 94
           L+ S G +K+ DFG
Sbjct: 144 LLGSNGELKIADFG 157

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 39.3 bits (90), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/102 (23%), Positives = 44/102 (43%), Gaps = 13/102 (12%)
Query: 22  LILTELCTGGSLVDVLKERTSALPP--NIVCSIL---------WQTCQAVKHMHGQNPPI 70
           +++ E C  G+L   L+ + +   P  ++    L         +Q  + ++ +  +    
Sbjct: 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK--X 165
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
           +HRDL   N+L+S    VK+ DFG A +    PD       R
Sbjct: 166 IHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 17/42 (40%), Positives = 23/42 (54%)
Query: 71  VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQR 112
           +HRDL   N+L+S    VK+CDFG A +   +PD       R
Sbjct: 221 IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTR 262

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 39.3 bits (90), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 21/72 (29%), Positives = 37/72 (51%), Gaps = 2/72 (2%)
Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++TEL   GSL+D L++         +     Q  + + ++  +    +HRDL   NLL+
Sbjct: 97  MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL 154
Query: 83  SSAGTVKLCDFG 94
           ++   VK+ DFG
Sbjct: 155 ATRDLVKIGDFG 166

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	150
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-58
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-46
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-24
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-24
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-24
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-23
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-23
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-22
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-22
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-22
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-22
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-22
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-22
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-22
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-21
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-21
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-21
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-21
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-21
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-21
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-21
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-20
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-18
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-18
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-18
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-18
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-18
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-18
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-17
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-17
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-17
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-17
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-17
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-17
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-16
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-16
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-16
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-16
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-16
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-15
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-15
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-13
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-12
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-12
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-11
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-11
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-11
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-11
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-11
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-11
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-11
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-11
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-11
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-11
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-11
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-11
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-10
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-10
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-10
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-10
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-10
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-10
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-10
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-10
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-10
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-10
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-10
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-10
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-10
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-09
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-09
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-09
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-09
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-09
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-09
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-08
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-08
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-07
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-07
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-07
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-06
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-06
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-06
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-06
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-06
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-06
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-06
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-06
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-05
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-04
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-04
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-04

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  183 bits (467), Expect = 2e-58
 Identities = 77/144 (53%), Positives = 107/144 (74%), Gaps = 3/144 (2%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSA--LPPNIVCSILWQTCQ 58
           +++ SAA I K  +  G  E+L+LTELC  G LV+ LK+  S   L  + V  I +QTC+
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           AV+HMH Q PPI+HRDLK+ENLL+S+ GT+KLCDFGSAT   + PD +WSAQ+R+++E+E
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 119 MARFTTPMYRAPEMVDTWNNYVIG 142
           + R TTPMYR PE++D ++N+ IG
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIG 231

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  152 bits (387), Expect = 1e-46
 Identities = 34/140 (24%), Positives = 59/140 (42%), Gaps = 11/140 (7%)

Query: 6   AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKH 62
           A  + +       HE  +L      G+L + ++        L  + +  +L   C+ ++ 
Sbjct: 93  AYCLRERG---AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 63  MHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF 122
           +H       HRDLK  N+L+   G   L D GS  +     +    ++Q   L+D  A+ 
Sbjct: 150 IH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG---SRQALTLQDWAAQR 204

Query: 123 TTPMYRAPEMVDTWNNYVIG 142
            T  YRAPE+    ++ VI 
Sbjct: 205 CTISYRAPELFSVQSHCVID 224

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  104 bits (261), Expect = 4e-28
 Identities = 34/146 (23%), Positives = 57/146 (39%), Gaps = 18/146 (12%)

Query: 7   AFIDK----HSTPHGMHEYL-ILTELCTGGSLVDVLKERTSALPP--NIVCSILWQTCQA 59
           A+++K       P     YL I  +LC   +L D +  R +      ++   I  Q  +A
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 60  VKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEM 119
           V+ +H +   ++HRDLK  N+  +    VK+ DFG  T      +               
Sbjct: 131 VEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 120 ARFTTPMYRAPEM---------VDTW 136
            +  T +Y +PE          VD +
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIF 214

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  102 bits (257), Expect = 1e-27
 Identities = 38/141 (26%), Positives = 57/141 (40%), Gaps = 7/141 (4%)

Query: 3   YLSAAFIDKHSTPHGMHEYL-ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVK 61
           +L      K  T       L I  E C  G+L D++         +    +  Q  +A+ 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130

Query: 62  HMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR 121
           ++H Q   I+HRDLK  N+ I  +  VK+ DFG A     S D      Q      +   
Sbjct: 131 YIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN-L 187

Query: 122 FT---TPMYRAPEMVDTWNNY 139
            +   T MY A E++D   +Y
Sbjct: 188 TSAIGTAMYVATEVLDGTGHY 208

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  100 bits (252), Expect = 5e-27
 Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 22/115 (19%)

Query: 23  ILTELCTGGSLVDVLKERTSA-LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I  E C  G+L   +++R    L   +   +  Q  + V ++H +   +++RDLK  N+ 
Sbjct: 97  IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIF 154

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMV 133
           +     VK+ DFG  T                 L+++  R     T  Y +PE +
Sbjct: 155 LVDTKQVKIGDFGLVT----------------SLKNDGKRTRSKGTLRYMSPEQI 193

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =   99 bits (249), Expect = 3e-26
 Identities = 33/136 (24%), Positives = 51/136 (37%), Gaps = 5/136 (3%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYL-ILTELCTGGSLVDVLKERTSALPPNI--VCSILWQTC 57
           M+  S         P     YL I  +LC   +L D +  R S           I  Q  
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174

Query: 58  QAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLED 117
           +AV+ +H +   ++HRDLK  N+  +    VK+ DFG  T      +             
Sbjct: 175 EAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232

Query: 118 EMARFTTPMYRAPEMV 133
              +  T +Y +PE +
Sbjct: 233 HTGQVGTKLYMSPEQI 248

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 96.2 bits (240), Expect = 6e-25
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 14/114 (12%)

Query: 21  YLILTELCTGGSLVDVL--KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
             I+TE  + GSL  +L        L      S+ +   + + ++H +NPPIVHR+LK  
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           NLL+    TVK+CDFG +  K  +  ++             +   TP + APE+
Sbjct: 169 NLLVDKKYTVKVCDFGLSRLKASTFLSS------------KSAAGTPEWMAPEV 210

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 95.5 bits (238), Expect = 1e-24
 Identities = 35/114 (30%), Positives = 47/114 (41%), Gaps = 22/114 (19%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           + TELC G SL    +   ++LP   V   L  T  A+ H+H Q   +VH D+K  N+ +
Sbjct: 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL 190

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMV 133
              G  KL DFG   E                L    A       P Y APE++
Sbjct: 191 GPRGRCKLGDFGLLVE----------------LGTAGAGEVQEGDPRYMAPELL 228

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 93.8 bits (234), Expect = 2e-24
 Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 30/128 (23%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+L E+C  G +   LK R      N     + Q    + ++H     I+HRDL + NL
Sbjct: 87  YLVL-EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNL 143

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM----- 132
           L++    +K+ DFG             + Q +         +T   TP Y +PE+     
Sbjct: 144 LLTRNMNIKIADFG------------LATQLKM---PHEKHYTLCGTPNYISPEIATRSA 188

Query: 133 ----VDTW 136
                D W
Sbjct: 189 HGLESDVW 196

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 93.5 bits (233), Expect = 3e-24
 Identities = 26/116 (22%), Positives = 48/116 (41%), Gaps = 22/116 (18%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E    G L   L ++   +  ++   ++      +++M  QNPPIVHRDL+  N+ +
Sbjct: 98  MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL 157

Query: 83  SSAG-----TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEM 132
            S         K+ DFG + + V+S                ++       + APE 
Sbjct: 158 QSLDENAPVCAKVADFGLSQQSVHS----------------VSGLLGNFQWMAPET 197

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 94.1 bits (234), Expect = 4e-24
 Identities = 33/129 (25%), Positives = 47/129 (36%), Gaps = 28/129 (21%)

Query: 14  TPHGMHEYLILTELCTGGSLVDVL--KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
                H+ LI  E C  GSL  VL        LP +    +L      + H+      IV
Sbjct: 78  ETTTRHKVLI-MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IV 134

Query: 72  HRDLKIENLLISSA----GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---T 124
           HR++K  N++           KL DFG+A               R + +DE    +   T
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAA---------------RELEDDEQFV-SLYGT 178

Query: 125 PMYRAPEMV 133
             Y  P+M 
Sbjct: 179 EEYLHPDMY 187

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 93.5 bits (233), Expect = 4e-24
 Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 29/136 (21%)

Query: 7   AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHM 63
             ID+ +         I+ E C GG L  V+ + T     L    V  ++ Q   A+K  
Sbjct: 73  RIIDRTN-----TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 64  HGQNPP---IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           H ++     ++HRDLK  N+ +     VKL DFG A  ++ + D               A
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA--RILNHDT------------SFA 173

Query: 121 RFT---TPMYRAPEMV 133
           + T   TP Y +PE +
Sbjct: 174 K-TFVGTPYYMSPEQM 188

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 92.4 bits (230), Expect = 1e-23
 Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 17/129 (13%)

Query: 8   FIDKHSTPHGMHEYL-ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ 66
           F D   +     + + ++TEL T G+L   LK R   +   ++ S   Q  + ++ +H +
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 67  NPPIVHRDLKIENLLISSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTP 125
            PPI+HRDLK +N+ I+   G+VK+ D G AT K  S         ++++        TP
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-------FAKAVIG-------TP 194

Query: 126 MYRAPEMVD 134
            + APEM +
Sbjct: 195 EFMAPEMYE 203

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 93.4 bits (232), Expect = 2e-23
 Identities = 33/130 (25%), Positives = 49/130 (37%), Gaps = 28/130 (21%)

Query: 14  TPHGMHEYLILTELCTGGSLVDVL--KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
                H+ LI+ E C  GSL  VL        LP +    +L      + H+      IV
Sbjct: 78  ETTTRHKVLIM-EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IV 134

Query: 72  HRDLKIENLLISSA----GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---T 124
           HR++K  N++           KL DFG+A               R + +DE    +   T
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAA---------------RELEDDEQFV-SLYGT 178

Query: 125 PMYRAPEMVD 134
             Y  P+M +
Sbjct: 179 EEYLHPDMYE 188

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 91.6 bits (228), Expect = 2e-23
 Identities = 32/112 (28%), Positives = 54/112 (48%), Gaps = 14/112 (12%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+T+ C G SL   L    +      +  I  QT + + ++H ++  I+HRDLK  N+ +
Sbjct: 96  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL 153

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMV 133
               TVK+ DFG ATEK            R     +  + + + ++ APE++
Sbjct: 154 HEDNTVKIGDFGLATEK-----------SRWSGSHQFEQLSGSILWMAPEVI 194

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 91.7 bits (228), Expect = 4e-23
 Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 15/112 (13%)

Query: 23  ILTELCTGGSLVDVLKERTSA-LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+ + C GG L   +  +       + +     Q C A+KH+H +   I+HRD+K +N+ 
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIF 157

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           ++  GTV+L DFG A     + + A +               TP Y +PE+ 
Sbjct: 158 LTKDGTVQLGDFGIARVLNSTVELARACI------------GTPYYLSPEIC 197

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 92.1 bits (228), Expect = 9e-23
 Identities = 35/159 (22%), Positives = 56/159 (35%), Gaps = 35/159 (22%)

Query: 8   FIDKHSTPHGMHEYLILTELCTGGSLVDVL--KERTSALPPNIVCSILWQTCQAVKHMHG 65
             D           L+  E C GG L   L   E    L    + ++L     A++++H 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139

Query: 66  QNPPIVHRDLKIENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF 122
               I+HRDLK EN+++         K+ D G A               + + + E+   
Sbjct: 140 NR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYA---------------KELDQGELCT- 181

Query: 123 T---TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
               T  Y APE+         VD W+   +    + G 
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 89.6 bits (223), Expect = 2e-22
 Identities = 38/141 (26%), Positives = 60/141 (42%), Gaps = 31/141 (21%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           +++L ELC   SL+++ K R  AL        L Q     +++H     ++HRDLK+ NL
Sbjct: 91  FVVL-ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNL 146

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM----- 132
            ++    VK+ DFG             + +      D   +     TP Y APE+     
Sbjct: 147 FLNEDLEVKIGDFG------------LATKVEY---DGERKKVLCGTPNYIAPEVLSKKG 191

Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W+   I  ++L G 
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 89.7 bits (223), Expect = 2e-22
 Identities = 38/141 (26%), Positives = 60/141 (42%), Gaps = 31/141 (21%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           +++L ELC   SL+++ K R  AL        L Q     +++H     ++HRDLK+ NL
Sbjct: 117 FVVL-ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNL 172

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM----- 132
            ++    VK+ DFG             + +      D   +     TP Y APE+     
Sbjct: 173 FLNEDLEVKIGDFG------------LATKVEY---DGERKKVLCGTPNYIAPEVLSKKG 217

Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W+   I  ++L G 
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 89.3 bits (222), Expect = 2e-22
 Identities = 28/130 (21%), Positives = 54/130 (41%), Gaps = 12/130 (9%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
             I+T LC G +L  V+++    L  N    I  +  + + ++H +   I+H+DLK +N+
Sbjct: 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNV 161

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEMVDTWNNY 139
              + G V + DFG  +             Q    ED++        + APE++   +  
Sbjct: 162 FYDN-GKVVITDFGLFSIS--------GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 140 VIGRSMLYGH 149
                + +  
Sbjct: 213 TEEDKLPFSK 222

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 89.0 bits (221), Expect = 2e-22
 Identities = 33/127 (25%), Positives = 49/127 (38%), Gaps = 16/127 (12%)

Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------N 67
           + H   +  ++T     GSL D L+  T  L       I+      + H+H +       
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131

Query: 68  PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMY 127
           P I HRDLK +N+L+   G   + D G A     S +                R  T  Y
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN--------NPRVGTKRY 183

Query: 128 RAPEMVD 134
            APE++D
Sbjct: 184 MAPEVLD 190

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 88.5 bits (220), Expect = 4e-22
 Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 21/120 (17%)

Query: 18  MHEYLILTELCTGGSLVDVL--KERTSALPPNIVCSILWQTCQAVKHMHGQNP-PIVHRD 74
           ++   ++ E   GGSL +VL   E           S   Q  Q V ++H   P  ++HRD
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 75  LKIENLLISSAGTV-KLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEM 132
           LK  NLL+ + GTV K+CDFG+A +                 +  M     +  + APE+
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDI----------------QTHMTNNKGSAAWMAPEV 174

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 88.5 bits (220), Expect = 4e-22
 Identities = 34/132 (25%), Positives = 49/132 (37%), Gaps = 22/132 (16%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y+++ E C    L   LK++ S + P    S      +AV  +H     IVH DLK  N 
Sbjct: 104 YMVM-E-CGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANF 158

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMVDTWN 137
           LI   G +KL DFG A      PD              + + +   T  Y  PE +   +
Sbjct: 159 LIVD-GMLKLIDFGIA--NQMQPD-----------TTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 138 NYVIGRSMLYGH 149
           +           
Sbjct: 205 SSRENGKSKSKI 216

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 88.6 bits (220), Expect = 6e-22
 Identities = 35/113 (30%), Positives = 48/113 (42%), Gaps = 16/113 (14%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y+++ E C    L   LK++ S + P    S      +AV  +H     IVH DLK  N 
Sbjct: 85  YMVM-E-CGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANF 139

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           LI   G +KL DFG A        N       S+++D      T  Y  PE +
Sbjct: 140 LIVD-GMLKLIDFGIA--------NQMQPDTTSVVKDSQV--GTVNYMPPEAI 181

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 88.3 bits (219), Expect = 8e-22
 Identities = 33/136 (24%), Positives = 54/136 (39%), Gaps = 16/136 (11%)

Query: 15  PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NP 68
                +  ++T+    GSL D LK  T  L    +  + + +   + H+H +       P
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP 161

Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYR 128
            I HRDLK +N+L+   GT  + D G A + +   +                R  T  Y 
Sbjct: 162 AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP--------NTRVGTKRYM 213

Query: 129 APEMVDTWNNYVIGRS 144
            PE++D   N    +S
Sbjct: 214 PPEVLDESLNRNHFQS 229

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 86.6 bits (215), Expect = 2e-21
 Identities = 33/117 (28%), Positives = 51/117 (43%), Gaps = 23/117 (19%)

Query: 23  ILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           I+ EL   G L  ++K        +P   V     Q C A++HMH +   ++HRD+K  N
Sbjct: 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPAN 166

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMV 133
           + I++ G VKL D G    + +S                 A  +   TP Y +PE +
Sbjct: 167 VFITATGVVKLGDLGLG--RFFSSKT------------TAAH-SLVGTPYYMSPERI 208

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 86.1 bits (214), Expect = 2e-21
 Identities = 17/113 (15%), Positives = 32/113 (28%), Gaps = 18/113 (15%)

Query: 21  YLILTELCTGGSLVDVL-KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
             ++T     GSL +VL +     +  +          + +  +H   P I    L   +
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS 143

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           ++I    T ++                              R   P + APE 
Sbjct: 144 VMIDEDMTARISMADVKFSF-----------------QSPGRMYAPAWVAPEA 179

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 87.6 bits (217), Expect = 2e-21
 Identities = 34/113 (30%), Positives = 47/113 (41%), Gaps = 16/113 (14%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y+++ E C    L   LK++ S + P    S      +AV  +H     IVH DLK  N 
Sbjct: 132 YMVM-E-CGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANF 186

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           LI   G +KL DFG A        N       S+++D         Y  PE +
Sbjct: 187 LIVD-GMLKLIDFGIA--------NQMQPDTTSVVKDSQV--GAVNYMPPEAI 228

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 85.0 bits (211), Expect = 6e-21
 Identities = 40/141 (28%), Positives = 58/141 (41%), Gaps = 33/141 (23%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLIL E    G++   L+ + S        + + +   A+ + H +   ++HRD+K ENL
Sbjct: 85  YLIL-EYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 140

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM----- 132
           L+ SAG +K+ DFG            WS    S       R     T  Y  PEM     
Sbjct: 141 LLGSAGELKIADFG------------WSVHAPSSR-----RTDLCGTLDYLPPEMIEGRM 183

Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W+  V+    L G 
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGK 204

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 85.7 bits (212), Expect = 8e-21
 Identities = 34/136 (25%), Positives = 56/136 (41%), Gaps = 15/136 (11%)

Query: 8   FI--DKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG 65
           FI  D+  T  G  EYL++ E    GSL   L   T        C +     + + ++H 
Sbjct: 72  FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHT 129

Query: 66  Q-------NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           +        P I HRDL   N+L+ + GT  + DFG +     +       +  +     
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA---- 185

Query: 119 MARFTTPMYRAPEMVD 134
           ++   T  Y APE+++
Sbjct: 186 ISEVGTIRYMAPEVLE 201

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 85.8 bits (212), Expect = 8e-21
 Identities = 26/161 (16%), Positives = 59/161 (36%), Gaps = 40/161 (24%)

Query: 16  HGMHEY----LILTELCTGGSLVDVLKERTSA----LPPNIVCSILWQTCQAVKHMHGQN 67
           +  H +    +++ EL + G+L++ +    +     +P  +V S   +    ++ +H   
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE 192

Query: 68  PPIVHRDLKIENLLISSA-----------GTVKLCDFGSATEKVYSPDNAWSAQQRSMLE 116
             I+H D+K +N ++ +              + L D G + +    P         +   
Sbjct: 193 --IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG----TIFT--- 243

Query: 117 DEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYG 148
              A+  T  ++  EM         +D +        ML+G
Sbjct: 244 ---AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 85.1 bits (211), Expect = 8e-21
 Identities = 29/112 (25%), Positives = 44/112 (39%), Gaps = 4/112 (3%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
            +TE   GG+L  ++K   S  P +   S        + ++H  N  I+HRDL   N L+
Sbjct: 84  FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLV 141

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQ--RSMLEDEMARFTTPMYRAPEM 132
                V + DFG A   V         +   +   +        P + APEM
Sbjct: 142 RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 86.0 bits (213), Expect = 9e-21
 Identities = 33/119 (27%), Positives = 50/119 (42%), Gaps = 18/119 (15%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y+ + ELC   +L + ++++  A       ++L QT   + H+H  N  IVHRDLK  N+
Sbjct: 94  YIAI-ELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNI 149

Query: 81  LISSAGT-----VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVD 134
           LIS           + DFG    K  +         R           T  + APEM+ 
Sbjct: 150 LISMPNAHGKIKAMISDFGLC--KKLAVG-------RHSFSRRSGVPGTEGWIAPEMLS 199

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 84.4 bits (209), Expect = 2e-20
 Identities = 31/132 (23%), Positives = 50/132 (37%), Gaps = 18/132 (13%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NPPIVHR 73
           +  ++++    GSL D L   T  +    +  +   T   + H+H +       P I HR
Sbjct: 114 QLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171

Query: 74  DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYRAPEM 132
           DLK +N+L+   GT  + D G A                  ++        T  Y APE+
Sbjct: 172 DLKSKNILVKKNGTCCIADLGLAVRH---------DSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 133 VDTWNNYVIGRS 144
           +D   N     S
Sbjct: 223 LDDSINMKHFES 234

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 83.8 bits (208), Expect = 2e-20
 Identities = 40/115 (34%), Positives = 57/115 (49%), Gaps = 26/115 (22%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           ++  L      +P ++V SI WQT QAV   H  N   +HRD+K EN+LI+    +KLCD
Sbjct: 88  VLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCD 145

Query: 93  FGSATEKVY-SPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTW 136
           FG A  ++   P + +         DE+A   T  YR+PE+          VD W
Sbjct: 146 FGFA--RLLTGPSDYYD--------DEVA---TRWYRSPELLVGDTQYGPPVDVW 187

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 83.1 bits (206), Expect = 2e-20
 Identities = 31/121 (25%), Positives = 52/121 (42%), Gaps = 25/121 (20%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNP-PIVHRDLKIEN 79
             ++ E   GG L  VL  +   +PP+I+ +   Q  + + ++H +   PI+HRDLK  N
Sbjct: 81  LCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138

Query: 80  LLISSAG--------TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +LI             +K+ DFG A E   +               +M+      + APE
Sbjct: 139 ILILQKVENGDLSNKILKITDFGLAREWHRT--------------TKMSAAGAYAWMAPE 184

Query: 132 M 132
           +
Sbjct: 185 V 185

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 83.0 bits (206), Expect = 6e-20
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 24/114 (21%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           ++D L+   + L   +V   L+Q    +   H  N  I+HRD+K EN+L+S +G VKLCD
Sbjct: 110 ILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCD 167

Query: 93  FGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTW 136
           FG A     +P   +         DE+A   T  YRAPE+          VD W
Sbjct: 168 FGFARTLA-APGEVYD--------DEVA---TRWYRAPELLVGDVKYGKAVDVW 209

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 83.3 bits (206), Expect = 1e-19
 Identities = 32/132 (24%), Positives = 52/132 (39%), Gaps = 24/132 (18%)

Query: 4   LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHM 63
           L  AF D +         +I  E  +GG L + + +  + +  +     + Q C+ + HM
Sbjct: 219 LHDAFEDDNEM------VMIY-EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 64  HGQNPPIVHRDLKIENLLISSAG--TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR 121
           H  N   VH DLK EN++ ++     +KL DFG        P  +               
Sbjct: 272 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLT--AHLDPKQSVK-----------VT 316

Query: 122 FTTPMYRAPEMV 133
             T  + APE+ 
Sbjct: 317 TGTAEFAAPEVA 328

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 82.5 bits (204), Expect = 1e-19
 Identities = 37/132 (28%), Positives = 55/132 (41%), Gaps = 27/132 (20%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            LIL E  +GG L D +      +    V + + Q C+ +KHMH  +  IVH D+K EN+
Sbjct: 124 VLIL-EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENI 180

Query: 81  LISSAG--TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           +  +    +VK+ DFG A     +PD                   T  + APE+      
Sbjct: 181 MCETKKASSVKIIDFGLA--TKLNPDEIVK-----------VTTATAEFAAPEIVDREPV 227

Query: 133 ---VDTWNNYVI 141
               D W   V+
Sbjct: 228 GFYTDMWAIGVL 239

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 81.1 bits (201), Expect = 2e-19
 Identities = 38/141 (26%), Positives = 55/141 (39%), Gaps = 33/141 (23%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+L E    G L   L++           + + +   A+ + H +   ++HRD+K ENL
Sbjct: 90  YLML-EFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHERK--VIHRDIKPENL 145

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM----- 132
           L+   G +K+ DFG            WS    S+      R T   T  Y  PEM     
Sbjct: 146 LMGYKGELKIADFG------------WSVHAPSLR-----RRTMCGTLDYLPPEMIEGKT 188

Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W   V+    L G 
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGM 209

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 81.6 bits (201), Expect = 3e-19
 Identities = 19/144 (13%), Positives = 37/144 (25%), Gaps = 28/144 (19%)

Query: 4   LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHM 63
           LS    D     + +       +L    S +D +           +  +  Q  +   ++
Sbjct: 151 LSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210

Query: 64  HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
             +   +VH     +NL I   G + L D  +                  +     A   
Sbjct: 211 QSKG--LVHGHFTPDNLFIMPDGRLMLGDVSAL---------------WKVGTRGPASSV 253

Query: 124 TPMYRAPEM-----------VDTW 136
              Y   E            ++ W
Sbjct: 254 PVTYAPREFLNASTATFTHALNAW 277

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 80.9 bits (200), Expect = 3e-19
 Identities = 32/133 (24%), Positives = 54/133 (40%), Gaps = 20/133 (15%)

Query: 15  PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMH--------GQ 66
                +  ++T     GSL D LK     +  N +C I     + + ++H        G 
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGH 148

Query: 67  NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPM 126
            P I HRD+K +N+L+ +  T  + DFG A    +    +          D   +  T  
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLA--LKFEAGKS--------AGDTHGQVGTRR 198

Query: 127 YRAPEMVDTWNNY 139
           Y APE+++   N+
Sbjct: 199 YMAPEVLEGAINF 211

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 80.9 bits (200), Expect = 5e-19
 Identities = 34/115 (29%), Positives = 51/115 (44%), Gaps = 18/115 (15%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            L++ E   GG L D + + +  L        + Q C+ ++HMH     I+H DLK EN+
Sbjct: 162 VLVM-EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENI 218

Query: 81  LISSAGT--VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           L  +     +K+ DFG A  + Y P                  F TP + APE+V
Sbjct: 219 LCVNRDAKQIKIIDFGLA--RRYKPREKLK-----------VNFGTPEFLAPEVV 260

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 80.5 bits (199), Expect = 8e-19
 Identities = 42/140 (30%), Positives = 56/140 (40%), Gaps = 28/140 (20%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+  E   GG L D +  R           I+ Q    V ++H  N  IVHRDLK ENL
Sbjct: 112 YLV-MECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENL 167

Query: 81  LISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           L+ S      +K+ DFG +   V+                   R  T  Y APE+     
Sbjct: 168 LLESKEKDALIKIVDFGLS--AVFENQKKMK-----------ERLGTAYYIAPEVLRKKY 214

Query: 133 ---VDTWNNYVIGRSMLYGH 149
               D W+  VI   +L G+
Sbjct: 215 DEKCDVWSIGVILFILLAGY 234

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 79.6 bits (197), Expect = 1e-18
 Identities = 28/113 (24%), Positives = 51/113 (45%), Gaps = 18/113 (15%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            +I  E  +G  + + +      L    + S + Q C+A++ +H  N  I H D++ EN+
Sbjct: 77  VMIF-EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENI 133

Query: 81  LISS--AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +  +  + T+K+ +FG A  +   P + +              FT P Y APE
Sbjct: 134 IYQTRRSSTIKIIEFGQA--RQLKPGDNFR-----------LLFTAPEYYAPE 173

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 79.3 bits (196), Expect = 1e-18
 Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 22/115 (19%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E C GG++  ++ E    L    +  +  Q  +A+  +H +   I+HRDLK  N+L+
Sbjct: 93  IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLM 150

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA-RFT---TPMYRAPEMV 133
           +  G ++L DFG             SA+        +  R +   TP + APE+V
Sbjct: 151 TLEGDIRLADFGV------------SAK----NLKTLQKRDSFIGTPYWMAPEVV 189

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 79.3 bits (196), Expect = 1e-18
 Identities = 39/134 (29%), Positives = 54/134 (40%), Gaps = 30/134 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            LIL EL +GG L D L ++ S L      S + Q    V ++H +   I H DLK EN+
Sbjct: 91  VLIL-ELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENI 146

Query: 81  LISS----AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---- 132
           ++         +KL DFG A          +              F TP + APE+    
Sbjct: 147 MLLDKNIPIPHIKLIDFGLA--HEIEDGVEFK-----------NIFGTPEFVAPEIVNYE 193

Query: 133 -----VDTWNNYVI 141
                 D W+  VI
Sbjct: 194 PLGLEADMWSIGVI 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 78.8 bits (195), Expect = 2e-18
 Identities = 39/134 (29%), Positives = 54/134 (40%), Gaps = 30/134 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            LIL EL +GG L D L ++ S L      S + Q    V ++H +   I H DLK EN+
Sbjct: 91  VLIL-ELVSGGELFDFLAQKES-LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENI 146

Query: 81  LISS----AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---- 132
           ++         +KL DFG A          +              F TP + APE+    
Sbjct: 147 MLLDKNIPIPHIKLIDFGLA--HEIEDGVEFK-----------NIFGTPEFVAPEIVNYE 193

Query: 133 -----VDTWNNYVI 141
                 D W+  VI
Sbjct: 194 PLGLEADMWSIGVI 207

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 79.7 bits (197), Expect = 2e-18
 Identities = 37/127 (29%), Positives = 53/127 (41%), Gaps = 28/127 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y++  EL TGG L D + +R      +    I+ Q    + +MH  N  IVHRDLK EN+
Sbjct: 97  YIV-GELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENI 152

Query: 81  LISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           L+ S      +K+ DFG +    +  +                R  T  Y APE+     
Sbjct: 153 LLESKEKDCDIKIIDFGLS--TCFQQNTKMK-----------DRIGTAYYIAPEVLRGTY 199

Query: 133 ---VDTW 136
               D W
Sbjct: 200 DEKCDVW 206

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 79.3 bits (195), Expect = 2e-18
 Identities = 19/127 (14%), Positives = 37/127 (29%), Gaps = 18/127 (14%)

Query: 12  HSTPHGMHEYLILTEL--CTGGSLVDVLKERTS---ALPPNIVCSILWQTCQAVKHMHGQ 66
                 +     L         +  +VL   +S   +L  +    +  Q  + +  +H  
Sbjct: 171 DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230

Query: 67  NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPM 126
              +VH  L+  ++++   G V L  F                   S +      F  P 
Sbjct: 231 G--LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----------RDGASAVSPIGRGFAPPE 277

Query: 127 YRAPEMV 133
             A  M+
Sbjct: 278 TTAERML 284

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 78.9 bits (195), Expect = 2e-18
 Identities = 32/131 (24%), Positives = 51/131 (38%), Gaps = 30/131 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPP---NIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           Y++  E   G  L   + +R  A       +    + Q  +A+++ H  N  I+HRD+K 
Sbjct: 102 YMV-FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKP 158

Query: 78  ENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-- 132
             +L++S      VKL  FG A  ++                    R  TP + APE+  
Sbjct: 159 HCVLLASKENSAPVKLGGFGVAI-QLGESGLVAG-----------GRVGTPHFMAPEVVK 206

Query: 133 -------VDTW 136
                  VD W
Sbjct: 207 REPYGKPVDVW 217

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 79.0 bits (195), Expect = 3e-18
 Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 16/97 (16%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI-SSAGTVKLCDFGSATEKVYS 102
           LP   V   ++Q  +++ ++H     I HRD+K +NLL+      +KLCDFGSA  K   
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA--KQLV 208

Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
                       +    +R+    YRAPE++    +Y
Sbjct: 209 RGEP-------NVSYICSRY----YRAPELIFGATDY 234

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 78.1 bits (193), Expect = 3e-18
 Identities = 39/134 (29%), Positives = 55/134 (41%), Gaps = 29/134 (21%)

Query: 21  YLILTELCTGGSLVD-VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
            LIL E   GG +    L E    +  N V  ++ Q  + V ++H  N  IVH DLK +N
Sbjct: 105 ILIL-EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQN 161

Query: 80  LLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---- 132
           +L+SS    G +K+ DFG +  +                        TP Y APE+    
Sbjct: 162 ILLSSIYPLGDIKIVDFGMS--RKIGHACELR-----------EIMGTPEYLAPEILNYD 208

Query: 133 -----VDTWNNYVI 141
                 D WN  +I
Sbjct: 209 PITTATDMWNIGII 222

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 79.0 bits (195), Expect = 3e-18
 Identities = 37/132 (28%), Positives = 52/132 (39%), Gaps = 28/132 (21%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+  E+ TGG L D +  R           I+ Q    + +MH     IVHRDLK ENL
Sbjct: 102 YLV-GEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENL 157

Query: 81  LISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           L+ S      +++ DFG +    +                   +  T  Y APE+     
Sbjct: 158 LLESKSKDANIRIIDFGLS--THFEASKKMK-----------DKIGTAYYIAPEVLHGTY 204

Query: 133 ---VDTWNNYVI 141
               D W+  VI
Sbjct: 205 DEKCDVWSTGVI 216

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 77.8 bits (192), Expect = 4e-18
 Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 22/115 (19%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E C  GS+ D+++ R   L  + + +IL  T + ++++H      +HRD+K  N+L+
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILL 158

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA-RFT---TPMYRAPEMV 133
           ++ G  KL DFG             + Q    L D MA R T   TP + APE++
Sbjct: 159 NTEGHAKLADFGV------------AGQ----LTDTMAKRNTVIGTPFWMAPEVI 197

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 78.5 bits (194), Expect = 4e-18
 Identities = 28/108 (25%), Positives = 50/108 (46%), Gaps = 16/108 (14%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI-SSAGTVKLC 91
                 +    +P  ++   ++Q  +++ ++H     I HRD+K +NLL+   +G +KL 
Sbjct: 127 ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLI 184

Query: 92  DFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           DFGSA  K+              +    +R+    YRAPE++    NY
Sbjct: 185 DFGSA--KILIAG-------EPNVSYICSRY----YRAPELIFGATNY 219

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 78.1 bits (193), Expect = 4e-18
 Identities = 40/143 (27%), Positives = 61/143 (42%), Gaps = 33/143 (23%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YLI+ E  +GG + D L      +      S   Q   AV++ H +   IVHRDLK ENL
Sbjct: 90  YLIM-EYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENL 145

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM----- 132
           L+ +   +K+ DFG +    ++            L+           P Y APE+     
Sbjct: 146 LLDADMNIKIADFGFSN--EFTVGG--------KLD------AFCGAPPYAAPELFQGKK 189

Query: 133 -----VDTWNNYVIGRSMLYGHV 150
                VD W+  VI  +++ G +
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSL 212

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 77.2 bits (191), Expect = 5e-18
 Identities = 41/134 (30%), Positives = 55/134 (41%), Gaps = 30/134 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            LIL EL +GG L D L E+ S L  +     L Q    V ++H +   I H DLK EN+
Sbjct: 84  VLIL-ELVSGGELFDFLAEKES-LTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENI 139

Query: 81  LISS----AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---- 132
           ++         +KL DFG A        N +              F TP + APE+    
Sbjct: 140 MLLDKNVPNPRIKLIDFGIA--HKIEAGNEFK-----------NIFGTPEFVAPEIVNYE 186

Query: 133 -----VDTWNNYVI 141
                 D W+  VI
Sbjct: 187 PLGLEADMWSIGVI 200

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 78.2 bits (193), Expect = 5e-18
 Identities = 35/127 (27%), Positives = 52/127 (40%), Gaps = 28/127 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+ TE   GG L + +  R          +I+ Q    + ++H  N  IVHRD+K EN+
Sbjct: 122 YLV-TEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLHKHN--IVHRDIKPENI 177

Query: 81  LISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           L+ +      +K+ DFG +    +S D                R  T  Y APE+     
Sbjct: 178 LLENKNSLLNIKIVDFGLS--SFFSKDYKLR-----------DRLGTAYYIAPEVLKKKY 224

Query: 133 ---VDTW 136
               D W
Sbjct: 225 NEKCDVW 231

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 78.0 bits (192), Expect = 6e-18
 Identities = 35/111 (31%), Positives = 54/111 (48%), Gaps = 20/111 (18%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  E   GGSL  VLK +   +P  I+  +     + + ++  ++  I+HRD+K  N+L+
Sbjct: 108 ICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILV 165

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR-FT-TPMYRAPE 131
           +S G +KLCDFG + +                L D MA  F  T  Y +PE
Sbjct: 166 NSRGEIKLCDFGVSGQ----------------LIDSMANSFVGTRSYMSPE 200

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 77.0 bits (190), Expect = 7e-18
 Identities = 26/133 (19%), Positives = 43/133 (32%), Gaps = 40/133 (30%)

Query: 23  ILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           I  E C GGSL D + E     S      +  +L Q  + ++++H  +  +VH D+K  N
Sbjct: 88  IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSN 145

Query: 80  LLISSAG-------------------TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           + IS                        K+ D G  T                 +     
Sbjct: 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT----------------RISSPQV 189

Query: 121 RFTTPMYRAPEMV 133
                 + A E++
Sbjct: 190 EEGDSRFLANEVL 202

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 76.9 bits (190), Expect = 7e-18
 Identities = 31/126 (24%), Positives = 50/126 (39%), Gaps = 22/126 (17%)

Query: 21  YLILTELCTGGSLVDVLKERTS-----ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           YL+  E   GGS++  + +R       A        ++     A+  +H +   I HRDL
Sbjct: 87  YLV-FEKMRGGSILSHIHKRRHFNELEA------SVVVQDVASALDFLHNKG--IAHRDL 137

Query: 76  KIENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           K EN+L         VK+CDF          +   S      L   +    +  Y APE+
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLG--SGIKLNGDCSPISTPEL---LTPCGSAEYMAPEV 192

Query: 133 VDTWNN 138
           V+ ++ 
Sbjct: 193 VEAFSE 198

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 77.3 bits (191), Expect = 8e-18
 Identities = 42/151 (27%), Positives = 56/151 (37%), Gaps = 36/151 (23%)

Query: 4   LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHM 63
           L   + +K          LIL EL  GG L D L E+ S L        L Q    V ++
Sbjct: 79  LHEVYENKTDV------ILIL-ELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYL 130

Query: 64  HGQNPPIVHRDLKIENLLISS----AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEM 119
           H     I H DLK EN+++         +K+ DFG A        N +            
Sbjct: 131 HSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFGNEFK----------- 175

Query: 120 ARFTTPMYRAPEM---------VDTWNNYVI 141
             F TP + APE+          D W+  VI
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 76.9 bits (190), Expect = 8e-18
 Identities = 35/151 (23%), Positives = 60/151 (39%), Gaps = 33/151 (21%)

Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
            P+  H Y++  EL   G +++V   +   L  +          + ++++H Q   I+HR
Sbjct: 107 DPNEDHLYMVF-ELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLHYQK--IIHR 161

Query: 74  DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAPE 131
           D+K  NLL+   G +K+ DFG             S + +    D +   T  TP + APE
Sbjct: 162 DIKPSNLLVGEDGHIKIADFG------------VSNEFKG--SDALLSNTVGTPAFMAPE 207

Query: 132 M------------VDTWNNYVIGRSMLYGHV 150
                        +D W   V     ++G  
Sbjct: 208 SLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 76.9 bits (190), Expect = 8e-18
 Identities = 33/111 (29%), Positives = 46/111 (41%), Gaps = 17/111 (15%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           +L+  +L   G L D L E+ + L       I+    + +  +H  N  IVHRDLK EN+
Sbjct: 100 FLVF-DLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENI 155

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           L+     +KL DFG +      P                    TP Y APE
Sbjct: 156 LLDDDMNIKLTDFGFS--CQLDPGEKLR-----------EVCGTPSYLAPE 193

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 77.0 bits (190), Expect = 9e-18
 Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 23/128 (17%)

Query: 11  KHSTPHGMHEYLILTELCTGGSLVDVLK-ERTSALPPNIVCSILWQTCQAVKHMHGQNPP 69
           K + P    +  ++ E C  GS+ D++K  + + L    +  I  +  + + H+H     
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-- 149

Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TP 125
           ++HRD+K +N+L++    VKL DFG             SAQ    L+  + R      TP
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGV------------SAQ----LDRTVGRRNTFIGTP 193

Query: 126 MYRAPEMV 133
            + APE++
Sbjct: 194 YWMAPEVI 201

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.5 bits (191), Expect = 9e-18
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 16/97 (16%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI-SSAGTVKLCDFGSATEKVYS 102
           +P N++   ++Q  +AV  +H     I HRD+K +NLL+ S   T+KLCDFGSA  K   
Sbjct: 138 IPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSA--KKLI 193

Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           P           +    +RF    YRAPE++     Y
Sbjct: 194 PSEP-------SVAYICSRF----YRAPELMLGATEY 219

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 77.1 bits (190), Expect = 1e-17
 Identities = 28/129 (21%), Positives = 45/129 (34%), Gaps = 29/129 (22%)

Query: 21  YLILTELCTGGSLVDVL-------KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           Y+I  E     S++          K  T  +P  ++  I+     +  ++H +   I HR
Sbjct: 119 YIIY-EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHR 176

Query: 74  DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAP 130
           D+K  N+L+   G VKL DFG             S                  T  +  P
Sbjct: 177 DVKPSNILMDKNGRVKLSDFG------------ESEYMVDKK-----IKGSRGTYEFMPP 219

Query: 131 EMVDTWNNY 139
           E     ++Y
Sbjct: 220 EFFSNESSY 228

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 76.7 bits (189), Expect = 1e-17
 Identities = 32/142 (22%), Positives = 59/142 (41%), Gaps = 32/142 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            L++ +  +G  L   +      L   +   I  Q   AV ++  ++  I+HRD+K EN+
Sbjct: 105 QLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENI 161

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM----- 132
           +I+   T+KL DFGSA             ++  +        T   T  Y APE+     
Sbjct: 162 VIAEDFTIKLIDFGSAAY----------LERGKLFY------TFCGTIEYCAPEVLMGNP 205

Query: 133 -----VDTWNNYVIGRSMLYGH 149
                ++ W+  V   ++++  
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEE 227

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 76.1 bits (188), Expect = 1e-17
 Identities = 36/132 (27%), Positives = 53/132 (40%), Gaps = 28/132 (21%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL+  ELCTGG L + +  +      +    I+     AV + H  N  + HRDLK EN 
Sbjct: 82  YLV-MELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENF 137

Query: 81  LISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           L  +      +KL DFG A    + P                 +  TP Y +P++     
Sbjct: 138 LFLTDSPDSPLKLIDFGLA--ARFKPGKMMR-----------TKVGTPYYVSPQVLEGLY 184

Query: 133 ---VDTWNNYVI 141
               D W+  V+
Sbjct: 185 GPECDEWSAGVM 196

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 77.5 bits (191), Expect = 1e-17
 Identities = 32/132 (24%), Positives = 53/132 (40%), Gaps = 33/132 (25%)

Query: 21  YLILTELCTGGSLVDVLKER------TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           Y+ L ELC   +L D+++ +                S+L Q    V H+H     I+HRD
Sbjct: 85  YIAL-ELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRD 140

Query: 75  LKIENLLISSAG-------------TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR 121
           LK +N+L+S++               + + DFG    K            +S     +  
Sbjct: 141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLC--KKLDSG-------QSSFRTNLNN 191

Query: 122 FT-TPMYRAPEM 132
            + T  +RAPE+
Sbjct: 192 PSGTSGWRAPEL 203

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 76.9 bits (190), Expect = 1e-17
 Identities = 35/134 (26%), Positives = 57/134 (42%), Gaps = 39/134 (29%)

Query: 21  YLILTELCTGGSLVDVLKERTS-----ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           Y++ TEL  GG L+D +  +       A       ++L+   + V+++H Q   +VHRDL
Sbjct: 92  YVV-TELMKGGELLDKILRQKFFSEREA------SAVLFTITKTVEYLHAQG--VVHRDL 142

Query: 76  KIENLLISS----AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           K  N+L         ++++CDFG A  K    +N        +L        T  + APE
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFA--KQLRAEN-------GLLMT---PCYTANFVAPE 190

Query: 132 M---------VDTW 136
           +          D W
Sbjct: 191 VLERQGYDAACDIW 204

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 76.0 bits (188), Expect = 1e-17
 Identities = 33/126 (26%), Positives = 48/126 (38%), Gaps = 48/126 (38%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           L          L P IV S L+Q  + +   H +N  ++HRDLK +NLLI+  G +KL +
Sbjct: 87  LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLAN 144

Query: 93  FGSATEKVYSPDNAWSAQQRSMLEDEMAR-FTTPM-----------YRAPEM-------- 132
           FG                        +AR F  P+           YR P++        
Sbjct: 145 FG------------------------LARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 133 --VDTW 136
             +D W
Sbjct: 181 TSIDMW 186

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 76.4 bits (189), Expect = 1e-17
 Identities = 38/126 (30%), Positives = 51/126 (40%), Gaps = 48/126 (38%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           L  VL E  + L  + +   L+Q  + V H H     I+HRDLK +NLLI+S G +KL D
Sbjct: 105 LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLAD 162

Query: 93  FGSATEKVYSPDNAWSAQQRSMLEDEMAR-FTTPM-----------YRAPEM-------- 132
           FG                        +AR F  P+           YRAP++        
Sbjct: 163 FG------------------------LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198

Query: 133 --VDTW 136
             VD W
Sbjct: 199 TSVDIW 204

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.6 bits (189), Expect = 2e-17
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 14/97 (14%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA-GTVKLCDFGSATEKVYS 102
            PP ++   L+Q  +++  +H  +  + HRD+K  N+L++ A GT+KLCDFGSA  K  S
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA--KKLS 183

Query: 103 PDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           P           +    +R+    YRAPE++    +Y
Sbjct: 184 PS-------EPNVAYICSRY----YRAPELIFGNQHY 209

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 75.8 bits (187), Expect = 2e-17
 Identities = 34/115 (29%), Positives = 55/115 (47%), Gaps = 24/115 (20%)

Query: 23  ILTELCTGGSLVDVLK---ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           I  EL    SL    K   ++   +P +I+  I     +A++H+H +   ++HRD+K  N
Sbjct: 83  ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSN 140

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPE 131
           +LI++ G VK+CDFG     +       S      L D++A+        Y APE
Sbjct: 141 VLINALGQVKMCDFG-----I-------SGY----LVDDVAKDIDAGCKPYMAPE 179

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 75.7 bits (187), Expect = 2e-17
 Identities = 41/138 (29%), Positives = 56/138 (40%), Gaps = 39/138 (28%)

Query: 21  YLILTELCTGGSLVDVLKERTS-----ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           YL+  +L TGG L + +  R       A         + Q  +++ + H     IVHR+L
Sbjct: 81  YLV-FDLVTGGELFEDIVAREFYSEADA------SHCIQQILESIAYCHSNG--IVHRNL 131

Query: 76  KIENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           K ENLL++S      VKL DFG A     +   AW                TP Y +PE+
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-----------GFAGTPGYLSPEV 178

Query: 133 ---------VDTWNNYVI 141
                    VD W   VI
Sbjct: 179 LKKDPYSKPVDIWACGVI 196

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 75.6 bits (187), Expect = 2e-17
 Identities = 31/126 (24%), Positives = 46/126 (36%), Gaps = 48/126 (38%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           L  +L      L      S L Q    + + H +   ++HRDLK +NLLI+  G +K+ D
Sbjct: 86  LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIAD 143

Query: 93  FGSATEKVYSPDNAWSAQQRSMLEDEMAR-FTTPM-----------YRAPEM-------- 132
           FG                        +AR F  P+           YRAP++        
Sbjct: 144 FG------------------------LARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 133 --VDTW 136
             +D W
Sbjct: 180 TTIDIW 185

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 75.7 bits (187), Expect = 2e-17
 Identities = 39/132 (29%), Positives = 56/132 (42%), Gaps = 28/132 (21%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y++  EL TGG L D + +R      +    I+ Q    + +MH  N  IVHRDLK EN+
Sbjct: 97  YIV-GELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENI 152

Query: 81  LISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           L+ S      +K+ DFG +    +  +                R  T  Y APE+     
Sbjct: 153 LLESKEKDCDIKIIDFGLS--TCFQQNTKMK-----------DRIGTAYYIAPEVLRGTY 199

Query: 133 ---VDTWNNYVI 141
               D W+  VI
Sbjct: 200 DEKCDVWSAGVI 211

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 76.3 bits (188), Expect = 2e-17
 Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 11/112 (9%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  EL  GGSL  ++K +   LP +     L Q  + ++++H +   I+H D+K +N+L+
Sbjct: 127 IFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLL 183

Query: 83  SSAGT-VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           SS G+   LCDFG A                 +         T  + APE+V
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP-------GTETHMAPEVV 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 75.9 bits (187), Expect = 2e-17
 Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 21/115 (18%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I  EL  G     + K     +P  I+  +     +A+ ++  ++  ++HRD+K  N+L+
Sbjct: 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILL 158

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEMVD 134
              G +KLCDFG     +       S +    L D+ A+        Y APE +D
Sbjct: 159 DERGQIKLCDFG-----I-------SGR----LVDDKAKDRSAGCAAYMAPERID 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 76.2 bits (188), Expect = 2e-17
 Identities = 39/133 (29%), Positives = 54/133 (40%), Gaps = 39/133 (29%)

Query: 21  YLILTELCTGGSLVDVLKERTS-----ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           YL+  +L TGG L + +  R       A         + Q  +++ + H     IVHR+L
Sbjct: 104 YLV-FDLVTGGELFEDIVAREFYSEADA------SHCIQQILESIAYCHSNG--IVHRNL 154

Query: 76  KIENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           K ENLL++S      VKL DFG A     +   AW                TP Y +PE+
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-----------GFAGTPGYLSPEV 201

Query: 133 ---------VDTW 136
                    VD W
Sbjct: 202 LKKDPYSKPVDIW 214

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 75.7 bits (187), Expect = 2e-17
 Identities = 34/113 (30%), Positives = 47/113 (41%), Gaps = 46/113 (40%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSP 103
           LP   +  ++ Q  + +  +H     IVHRDLK EN+L++S GTVKL DFG         
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFG--------- 165

Query: 104 DNAWSAQQRSMLEDEMAR-FTTPM----------YRAPEM---------VDTW 136
                          +AR ++  M          YRAPE+         VD W
Sbjct: 166 ---------------LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMW 203

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 75.4 bits (186), Expect = 2e-17
 Identities = 28/124 (22%), Positives = 64/124 (51%), Gaps = 16/124 (12%)

Query: 23  ILTELCTGGSLVDVLKE-------RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           ++ +L +GGS++D++K        ++  L  + + +IL +  + ++++H      +HRD+
Sbjct: 90  LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDV 147

Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDT 135
           K  N+L+   G+V++ DFG +       D   +  +++ +        TP + APE+++ 
Sbjct: 148 KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG-------TPCWMAPEVMEQ 200

Query: 136 WNNY 139
              Y
Sbjct: 201 VRGY 204

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 75.7 bits (187), Expect = 2e-17
 Identities = 29/113 (25%), Positives = 48/113 (42%), Gaps = 46/113 (40%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSP 103
           +P   +  +++Q  + +  +H     +VHRDLK +N+L++S+G +KL DFG         
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFG--------- 165

Query: 104 DNAWSAQQRSMLEDEMAR-FTTPM----------YRAPEM---------VDTW 136
                          +AR ++  M          YRAPE+         VD W
Sbjct: 166 ---------------LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLW 203

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 76.3 bits (188), Expect = 2e-17
 Identities = 39/134 (29%), Positives = 55/134 (41%), Gaps = 38/134 (28%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y++L EL  GG L D +      L         +Q   AV+++H     I+HRDLK EN+
Sbjct: 215 YIVL-ELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENV 270

Query: 81  LISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM-- 132
           L+SS      +K+ DFG +  K+    +                 T   TP Y APE+  
Sbjct: 271 LLSSQEEDCLIKITDFGHS--KILGETSLM--------------RTLCGTPTYLAPEVLV 314

Query: 133 ----------VDTW 136
                     VD W
Sbjct: 315 SVGTAGYNRAVDCW 328

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 75.0 bits (185), Expect = 3e-17
 Identities = 34/135 (25%), Positives = 58/135 (42%), Gaps = 30/135 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSA---LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           Y++  E C GG L++ +    +    L    V  ++ Q   A+ + H Q+  +VH+DLK 
Sbjct: 96  YIV-METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKP 152

Query: 78  ENLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-- 132
           EN+L         +K+ DFG A  +++  D   +               T +Y APE+  
Sbjct: 153 ENILFQDTSPHSPIKIIDFGLA--ELFKSDEHST-----------NAAGTALYMAPEVFK 199

Query: 133 ------VDTWNNYVI 141
                  D W+  V+
Sbjct: 200 RDVTFKCDIWSAGVV 214

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.1 bits (185), Expect = 4e-17
 Identities = 38/161 (23%), Positives = 62/161 (38%), Gaps = 40/161 (24%)

Query: 11  KHSTPH--GMHE-------YLILTELCTG-GSLVDVLKERTSALPPNIVCSILWQTCQAV 60
                    + +       ++++ E       L D + ER  AL   +  S  WQ  +AV
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAV 162

Query: 61  KHMHGQNPPIVHRDLKIENLLI-SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEM 119
           +H H     ++HRD+K EN+LI  + G +KL DFGS               + ++  D  
Sbjct: 163 RHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL-----------LKDTVYTD-- 207

Query: 120 ARFT-TPMYRAPEM----------VDTWNNYVIGRSMLYGH 149
             F  T +Y  PE              W+  ++   M+ G 
Sbjct: 208 --FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 76.0 bits (187), Expect = 4e-17
 Identities = 29/120 (24%), Positives = 50/120 (41%), Gaps = 22/120 (18%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           H+  HG     I+ E   G SL     ++   LP     + L +   A+ ++H     +V
Sbjct: 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSIG--LV 204

Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           + DLK EN+++ +   +KL D G+ +                 L      + TP ++APE
Sbjct: 205 YNDLKPENIML-TEEQLKLIDLGAVS----------RINSFGYL------YGTPGFQAPE 247

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 74.6 bits (184), Expect = 5e-17
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 20/126 (15%)

Query: 13  STPHGMHEYLILTELCTGGSLVDVLKERTSALPPN--IVCSILWQTCQAVKHMHGQNPPI 70
           S        + + E   GGSL  +L+ +   L  N   +     Q  + +K++H     I
Sbjct: 87  SFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--I 143

Query: 71  VHRDLKIENLLISSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT-TPMYR 128
           VHRD+K +N+LI++  G +K+ DFG++              + + +      FT T  Y 
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSK-------------RLAGINPCTETFTGTLQYM 190

Query: 129 APEMVD 134
           APE++D
Sbjct: 191 APEIID 196

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 74.7 bits (184), Expect = 6e-17
 Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 24/115 (20%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           I+ E   GGS +D+L+     L    + +IL +  + + ++H +    +HRD+K  N+L+
Sbjct: 97  IIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL 152

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA-RFT---TPMYRAPEMV 133
           S  G VKL DFG             + Q    L D    R T   TP + APE++
Sbjct: 153 SEHGEVKLADFGV------------AGQ----LTDTQIKRNTFVGTPFWMAPEVI 191

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 75.4 bits (186), Expect = 6e-17
 Identities = 42/137 (30%), Positives = 55/137 (40%), Gaps = 46/137 (33%)

Query: 21  YLILTELCTGGSLVDVLKERTS-----ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           YLI  +L TGG L + +  R       A         + Q  +AV H H     +VHR+L
Sbjct: 86  YLI-FDLVTGGELFEDIVAREYYSEADA------SHCIQQILEAVLHCHQMG--VVHRNL 136

Query: 76  KIENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TPMYR 128
           K ENLL++S      VKL DFG A                  +E E   +     TP Y 
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAI----------------EVEGEQQAWFGFAGTPGYL 180

Query: 129 APEM---------VDTW 136
           +PE+         VD W
Sbjct: 181 SPEVLRKDPYGKPVDLW 197

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 74.3 bits (183), Expect = 7e-17
 Identities = 32/115 (27%), Positives = 52/115 (45%), Gaps = 15/115 (13%)

Query: 4   LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKH 62
           +   + + ++    +    I+ E   GG L   +++R   A        I+    +A+++
Sbjct: 76  IVDVYENLYAGRKCLL---IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 63  MHGQNPPIVHRDLKIENLLISSAG---TVKLCDFGSATE---KVYSP--DNAWSA 109
           +H  N  I HRD+K ENLL +S      +KL DFG A E   + Y    D  WS 
Sbjct: 133 LHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCD-MWSL 184

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 74.7 bits (183), Expect = 8e-17
 Identities = 16/128 (12%), Positives = 36/128 (28%), Gaps = 25/128 (19%)

Query: 12  HSTPHGMHEYLILTELCTG--GSLVDVLKERTS---ALPPNIVCSILWQTCQAVKHMHGQ 66
                 +     L         +  +VL   +S   +L  +    +  Q  + +  +H  
Sbjct: 166 DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225

Query: 67  NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTP 125
              +VH  L+  ++++   G V L  F                      +        + 
Sbjct: 226 G--LVHTYLRPVDIVLDQRGGVFLTGFEHLVR-----------------DGARVVSSVSR 266

Query: 126 MYRAPEMV 133
            +  PE+ 
Sbjct: 267 GFEPPELE 274

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 74.3 bits (183), Expect = 1e-16
 Identities = 39/133 (29%), Positives = 53/133 (39%), Gaps = 39/133 (29%)

Query: 21  YLILTELCTGGSLVDVLKERTS-----ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
            L+  EL TGG L D + E+       A         + Q  +AV ++H     IVHRDL
Sbjct: 124 SLV-LELVTGGELFDRIVEKGYYSERDA------ADAVKQILEAVAYLHENG--IVHRDL 174

Query: 76  KIENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM 132
           K ENLL ++      +K+ DFG +  K+                       TP Y APE+
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLS--KIVEHQVLMK-----------TVCGTPGYCAPEI 221

Query: 133 ---------VDTW 136
                    VD W
Sbjct: 222 LRGCAYGPEVDMW 234

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 74.4 bits (183), Expect = 1e-16
 Identities = 34/119 (28%), Positives = 47/119 (39%), Gaps = 33/119 (27%)

Query: 21  YLILTELCTGGSLVDVLKERTS-----ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           +L+  +L   G L D L E+ +             SI+    +AV  +H  N  IVHRDL
Sbjct: 176 FLV-FDLMRKGELFDYLTEKVALSEKET------RSIMRSLLEAVSFLHANN--IVHRDL 226

Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPE 131
           K EN+L+     ++L DFG +      P                       TP Y APE
Sbjct: 227 KPENILLDDNMQIRLSDFGFS--CHLEPGEKLR--------------ELCGTPGYLAPE 269

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 73.9 bits (182), Expect = 1e-16
 Identities = 43/140 (30%), Positives = 60/140 (42%), Gaps = 38/140 (27%)

Query: 19  HEYLILTELCTGGSLVDVLKERTS-----ALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           H +L+  EL  GG L + +K++       A        I+ +   AV HMH     +VHR
Sbjct: 80  HTFLV-MELLNGGELFERIKKKKHFSETEA------SYIMRKLVSAVSHMHDVG--VVHR 130

Query: 74  DLKIENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
           DLK ENLL +       +K+ DFG A  ++  PDN         L+       T  Y AP
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFA--RLKPPDN-------QPLKT---PCFTLHYAAP 178

Query: 131 EM---------VDTWNNYVI 141
           E+          D W+  VI
Sbjct: 179 ELLNQNGYDESCDLWSLGVI 198

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 74.2 bits (182), Expect = 1e-16
 Identities = 23/112 (20%), Positives = 44/112 (39%), Gaps = 8/112 (7%)

Query: 23  ILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           ++T     GS  D++       +    +  IL    +A+ ++H      VHR +K  ++L
Sbjct: 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHIL 160

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           IS  G V L    S    +         +QR + +          + +PE++
Sbjct: 161 ISVDGKVYLSGLRSNLSMISH-----GQRQRVVHDFPKYSVKVLPWLSPEVL 207

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 73.5 bits (181), Expect = 1e-16
 Identities = 35/115 (30%), Positives = 57/115 (49%), Gaps = 24/115 (20%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E   GGSL DV+ E    +    + ++  +  QA++ +H     ++HRD+K +N+L+
Sbjct: 94  VVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL 149

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA-RFT---TPMYRAPEMV 133
              G+VKL DFG              AQ    +  E + R T   TP + APE+V
Sbjct: 150 GMDGSVKLTDFGF------------CAQ----ITPEQSKRSTMVGTPYWMAPEVV 188

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 73.5 bits (181), Expect = 2e-16
 Identities = 39/134 (29%), Positives = 55/134 (41%), Gaps = 38/134 (28%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y++L EL  GG L D +      L         +Q   AV+++H     I+HRDLK EN+
Sbjct: 90  YIVL-ELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENV 145

Query: 81  LISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM-- 132
           L+SS      +K+ DFG +  K+    +                 T   TP Y APE+  
Sbjct: 146 LLSSQEEDCLIKITDFGHS--KILGETSLMR--------------TLCGTPTYLAPEVLV 189

Query: 133 ----------VDTW 136
                     VD W
Sbjct: 190 SVGTAGYNRAVDCW 203

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.4 bits (181), Expect = 2e-16
 Identities = 33/126 (26%), Positives = 52/126 (41%), Gaps = 48/126 (38%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           L  ++K+ +  L P+ + + +  T Q ++++H     I+HRDLK  NLL+   G +KL D
Sbjct: 98  LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLAD 155

Query: 93  FGSATEKVYSPDNAWSAQQRSMLEDEMAR-FTTPM-----------YRAPEM-------- 132
           FG                        +A+ F +P            YRAPE+        
Sbjct: 156 FG------------------------LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 191

Query: 133 --VDTW 136
             VD W
Sbjct: 192 VGVDMW 197

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 72.7 bits (179), Expect = 3e-16
 Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 15  PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           P G   Y+++ E   G +L D++      + P     ++   CQA+   H     I+HRD
Sbjct: 86  PAGPLPYIVM-EYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRD 141

Query: 75  LKIENLLISSAGTVKLCDFGSA 96
           +K  N++IS+   VK+ DFG A
Sbjct: 142 VKPANIMISATNAVKVMDFGIA 163

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 73.2 bits (180), Expect = 3e-16
 Identities = 26/109 (23%), Positives = 47/109 (43%), Gaps = 11/109 (10%)

Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           R + L P     +++Q  + +K++H     ++HRD+K  N+L+++   VK+ DFG +   
Sbjct: 102 RANILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSF 159

Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPM---------YRAPEMVDTWNNY 139
           V       +         E      P+         YRAPE++     Y
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY 208

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 72.3 bits (178), Expect = 4e-16
 Identities = 30/118 (25%), Positives = 48/118 (40%), Gaps = 32/118 (27%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           L   L +  + +  + V   L+Q  + + + H Q   ++HRDLK +NLLI+  G +KL D
Sbjct: 86  LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLAD 143

Query: 93  FGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TPMYRAPEM----------VDTW 136
           FG A  +  S                   +     T  YR P++          +D W
Sbjct: 144 FGLA--RAKS--------------IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMW 185

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 72.4 bits (178), Expect = 4e-16
 Identities = 31/115 (26%), Positives = 58/115 (50%), Gaps = 24/115 (20%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           +L E   GG+L D++ +    L    + ++     QA+ ++H Q   ++HRD+K +++L+
Sbjct: 119 VLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILL 174

Query: 83  SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA-RFT---TPMYRAPEMV 133
           +  G VKL DFG            + AQ    +  ++  R +   TP + APE++
Sbjct: 175 TLDGRVKLSDFG------------FCAQ----ISKDVPKRKSLVGTPYWMAPEVI 213

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 72.3 bits (178), Expect = 4e-16
 Identities = 28/124 (22%), Positives = 56/124 (45%), Gaps = 23/124 (18%)

Query: 21  YLILTELCTGGS--LVD-VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
           Y+++ E C  G   ++D V ++R    P         Q    ++++H Q   IVH+D+K 
Sbjct: 84  YMVM-EYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKP 137

Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAPEMVDT 135
            NLL+++ GT+K+   G             +        D+  R +  +P ++ PE+ + 
Sbjct: 138 GNLLLTTGGTLKISALG------------VAEALHPFAADDTCRTSQGSPAFQPPEIANG 185

Query: 136 WNNY 139
            + +
Sbjct: 186 LDTF 189

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 72.3 bits (178), Expect = 4e-16
 Identities = 34/144 (23%), Positives = 49/144 (34%), Gaps = 36/144 (25%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            L+L        L D + E+   L          Q   A++H H +   +VHRD+K EN+
Sbjct: 114 MLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENI 170

Query: 81  LISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTT----PMYRAPEM--- 132
           LI    G  KL DFGS        D                 +T      +Y  PE    
Sbjct: 171 LIDLRRGCAKLIDFGSGA---LLHDEP---------------YTDFDGTRVYSPPEWISR 212

Query: 133 -------VDTWNNYVIGRSMLYGH 149
                     W+  ++   M+ G 
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGD 236

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 71.8 bits (177), Expect = 5e-16
 Identities = 39/135 (28%), Positives = 55/135 (40%), Gaps = 44/135 (32%)

Query: 21  YLILTELCTGGSLVDVLKERTS-----ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
           YL+  +L +GG L D + ER       A        ++ Q   AVK++H     IVHRDL
Sbjct: 82  YLV-MQLVSGGELFDRILERGVYTEKDA------SLVIQQVLSAVKYLHENG--IVHRDL 132

Query: 76  KIENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAP 130
           K ENLL  +      + + DFG +                 M ++ +      TP Y AP
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSK----------------MEQNGIMSTACGTPGYVAP 176

Query: 131 EM---------VDTW 136
           E+         VD W
Sbjct: 177 EVLAQKPYSKAVDCW 191

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 72.5 bits (178), Expect = 5e-16
 Identities = 36/152 (23%), Positives = 58/152 (38%), Gaps = 43/152 (28%)

Query: 4   LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTS-------ALPPNIVCSILWQT 56
           +   + + ++        ++  E   GG L   +++R         A        I+   
Sbjct: 120 IVDVYENLYAGRK--CLLIV-MECLDGGELFSRIQDRGDQAFTEREA------SEIMKSI 170

Query: 57  CQAVKHMHGQNPPIVHRDLKIENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRS 113
            +A++++H  N  I HRD+K ENLL +S      +KL DFG A  K  +  N+       
Sbjct: 171 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA--KETTSHNSL------ 220

Query: 114 MLEDEMARFTTPMYRAPEM---------VDTW 136
                     TP Y APE+          D W
Sbjct: 221 -----TTPCYTPYYVAPEVLGPEKYDKSCDMW 247

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 71.8 bits (177), Expect = 6e-16
 Identities = 33/122 (27%), Positives = 45/122 (36%), Gaps = 48/122 (39%)

Query: 37  LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA 96
           +      L  N+V    WQ  Q +   H     I+HRDLK +NLLI+  G +KL DFG  
Sbjct: 98  VGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFG-- 153

Query: 97  TEKVYSPDNAWSAQQRSMLEDEMAR-FTTPM-----------YRAPEM----------VD 134
                                 +AR F  P+           YRAP++          +D
Sbjct: 154 ----------------------LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSID 191

Query: 135 TW 136
            W
Sbjct: 192 IW 193

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 72.0 bits (177), Expect = 6e-16
 Identities = 43/146 (29%), Positives = 59/146 (40%), Gaps = 35/146 (23%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPI 70
            +  HG    LI+ E   GG L   ++ER   A        I+     A++ +H  N  I
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--I 149

Query: 71  VHRDLKIENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---T 124
            HRD+K ENLL +S      +KL DFG A E                 ++ +   T   T
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---------------TTQNAL--QTPCYT 192

Query: 125 PMYRAPEM---------VDTWNNYVI 141
           P Y APE+          D W+  VI
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVI 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 71.6 bits (176), Expect = 7e-16
 Identities = 35/116 (30%), Positives = 49/116 (42%), Gaps = 25/116 (21%)

Query: 23  ILTELCTGGSLVDVLKE----RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           I  EL    S     K         +P  I+  I   T +A+ H+  +N  I+HRD+K  
Sbjct: 98  ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK-ENLKIIHRDIKPS 155

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA-RFT--TPMYRAPE 131
           N+L+  +G +KLCDFG     +       S Q    L D +A         Y APE
Sbjct: 156 NILLDRSGNIKLCDFG-----I-------SGQ----LVDSIAKTRDAGCRPYMAPE 195

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 70.7 bits (174), Expect = 1e-15
 Identities = 36/132 (27%), Positives = 49/132 (37%), Gaps = 32/132 (24%)

Query: 19  HEYLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
            +YL L E C+GG L D          +P         Q    V ++HG    I HRD+K
Sbjct: 79  IQYLFL-EYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIK 132

Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAPEM-- 132
            ENLL+     +K+ DFG             +   R    + +      T  Y APE+  
Sbjct: 133 PENLLLDERDNLKISDFG------------LATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 133 --------VDTW 136
                   VD W
Sbjct: 181 RREFHAEPVDVW 192

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 70.7 bits (174), Expect = 1e-15
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 4/76 (5%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL++ E   G +L + ++     L  +   +   Q    +KH H     IVHRD+K +N+
Sbjct: 87  YLVM-EYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNI 142

Query: 81  LISSAGTVKLCDFGSA 96
           LI S  T+K+ DFG A
Sbjct: 143 LIDSNKTLKIFDFGIA 158

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 71.3 bits (175), Expect = 1e-15
 Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 3/76 (3%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E C  GS  D+L+     L    + ++     Q + ++H  N  ++HRD+K  N+L+
Sbjct: 131 LVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL 187

Query: 83  SSAGTVKLCDFGSATE 98
           S  G VKL DFGSA+ 
Sbjct: 188 SEPGLVKLGDFGSASI 203

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.4 bits (175), Expect = 1e-15
 Identities = 28/111 (25%), Positives = 44/111 (39%), Gaps = 17/111 (15%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA------- 96
           L    + ++L+     VK++H     I+HRDLK  N L++   +VK+CDFG A       
Sbjct: 153 LTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210

Query: 97  TEKVYSPDNAWSAQQRSMLEDEMARFTTPM--------YRAPEMVDTWNNY 139
                 P +        +           +        YRAPE++    NY
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY 261

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 70.4 bits (173), Expect = 2e-15
 Identities = 23/71 (32%), Positives = 33/71 (46%), Gaps = 3/71 (4%)

Query: 26  ELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA 85
            L  G  L  +L+ +   L P    +I+ Q   A+   H       HRD+K EN+L+S+ 
Sbjct: 114 RLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD 170

Query: 86  GTVKLCDFGSA 96
               L DFG A
Sbjct: 171 DFAYLVDFGIA 181

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.8 bits (174), Expect = 2e-15
 Identities = 31/133 (23%), Positives = 53/133 (39%), Gaps = 20/133 (15%)

Query: 9   IDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNP 68
           I  H     MH+  ++TEL     L  V+ ++   + P  +   ++     +  +H    
Sbjct: 97  IFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG- 154

Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLED-EMARF-TTPM 126
            +VHRDL   N+L++    + +CDF  A               R    D     + T   
Sbjct: 155 -VVHRDLHPGNILLADNNDITICDFNLA---------------REDTADANKTHYVTHRW 198

Query: 127 YRAPEMVDTWNNY 139
           YRAPE+V  +  +
Sbjct: 199 YRAPELVMQFKGF 211

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 70.2 bits (172), Expect = 3e-15
 Identities = 31/107 (28%), Positives = 45/107 (42%), Gaps = 25/107 (23%)

Query: 44  LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA----GTVKLCDFGSATEK 99
           LP  +V S+L+Q    + ++H     ++HRDLK  N+L+       G VK+ D G A   
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFAR-L 181

Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----------VDTW 136
             SP    +        D      T  YRAPE+          +D W
Sbjct: 182 FNSPLKPLA--------DLDPVVVTFWYRAPELLLGARHYTKAIDIW 220

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 70.0 bits (172), Expect = 3e-15
 Identities = 36/132 (27%), Positives = 49/132 (37%), Gaps = 32/132 (24%)

Query: 19  HEYLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
            +YL L E C+GG L D          +P         Q    V ++HG    I HRD+K
Sbjct: 79  IQYLFL-EYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIK 132

Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAPEM-- 132
            ENLL+     +K+ DFG             +   R    + +      T  Y APE+  
Sbjct: 133 PENLLLDERDNLKISDFG------------LATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 133 --------VDTW 136
                   VD W
Sbjct: 181 RREFHAEPVDVW 192

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.4 bits (170), Expect = 7e-15
 Identities = 25/101 (24%), Positives = 40/101 (39%), Gaps = 12/101 (11%)

Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA--TEKVYSPDNA 106
           + +IL+        +H     I+HRDLK  N L++   +VK+CDFG A         +  
Sbjct: 131 IKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 107 WSAQQRSMLEDEMARFTTPM--------YRAPEMVDTWNNY 139
              ++              +        YRAPE++    NY
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 69.4 bits (170), Expect = 7e-15
 Identities = 38/147 (25%), Positives = 62/147 (42%), Gaps = 36/147 (24%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL++ +   GG L+ +L +    LP  +    L +   A+  +H  +   VHRD+K +N+
Sbjct: 150 YLVM-DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNI 206

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TPMYRAPE----- 131
           L+   G ++L DFGS  +               ++ED   + +    TP Y +PE     
Sbjct: 207 LMDMNGHIRLADFGSCLK---------------LMEDGTVQSSVAVGTPDYISPEILQAM 251

Query: 132 ---------MVDTWNNYVIGRSMLYGH 149
                      D W+  V    MLYG 
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGE 278

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 68.8 bits (169), Expect = 8e-15
 Identities = 30/118 (25%), Positives = 49/118 (41%), Gaps = 28/118 (23%)

Query: 33  LVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD 92
           L  +L         + +  ++      + ++H     I+HRD+K  N+LI+  G +KL D
Sbjct: 110 LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLAD 167

Query: 93  FGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TPMYRAPEM----------VDTW 136
           FG A         A+S  + S    +  R+T    T  YR PE+          +D W
Sbjct: 168 FGLAR--------AFSLAKNS----QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 213

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.8 bits (169), Expect = 8e-15
 Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 11/100 (11%)

Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +T  L  + +C  L+Q  + +K++H  N  ++HRDLK  NLL+++   +K+CDFG A  +
Sbjct: 121 KTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA--R 176

Query: 100 VYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           V  PD+         L + +A   T  YRAPE++     Y
Sbjct: 177 VADPDH----DHTGFLTEYVA---TRWYRAPEIMLNSKGY 209

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 68.8 bits (169), Expect = 1e-14
 Identities = 39/101 (38%), Positives = 58/101 (57%), Gaps = 6/101 (5%)

Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA-TE 98
            T  L  + +   ++QT +AVK +HG N  ++HRDLK  NLLI+S   +K+CDFG A   
Sbjct: 105 STQMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162

Query: 99  KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
              + DN+    Q+S + + +A   T  YRAPE++ T   Y
Sbjct: 163 DESAADNSEPTGQQSGMVEFVA---TRWYRAPEVMLTSAKY 200

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 67.6 bits (166), Expect = 1e-14
 Identities = 38/143 (26%), Positives = 58/143 (40%), Gaps = 35/143 (24%)

Query: 21  YLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           ++++ E  +GG L D      R   +       +  Q   AV + H     +VHRDLK E
Sbjct: 87  FMVM-EYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPE 140

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAPEM---- 132
           N+L+ +    K+ DFG             S       + E  R +  +P Y APE+    
Sbjct: 141 NVLLDAHMNAKIADFG------------LSNMMS---DGEFLRTSCGSPNYAAPEVISGR 185

Query: 133 ------VDTWNNYVIGRSMLYGH 149
                 VD W+  VI  ++L G 
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGT 208

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 68.2 bits (167), Expect = 2e-14
 Identities = 36/145 (24%), Positives = 56/145 (38%), Gaps = 32/145 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           YL++ E   GG L+ +L +    +P  +    L +   A+  +H      VHRD+K +N+
Sbjct: 137 YLVM-EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNI 193

Query: 81  LISSAGTVKLCDFGSATE-KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE-------- 131
           L+   G ++L DFGS  + +      +  A              TP Y +PE        
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVRSLVA------------VGTPDYLSPEILQAVGGG 241

Query: 132 --------MVDTWNNYVIGRSMLYG 148
                     D W   V    M YG
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYG 266

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 67.7 bits (166), Expect = 2e-14
 Identities = 29/125 (23%), Positives = 45/125 (36%), Gaps = 53/125 (42%)

Query: 39  ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA-----GTVKLCDF 93
           ++   +   ++ S L+Q    V   H +    +HRDLK +NLL+S +       +K+ DF
Sbjct: 124 DKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDF 181

Query: 94  GSATEKVYSPDNAWSAQQRSMLEDEMAR-FTTPM-----------YRAPEM--------- 132
           G                        +AR F  P+           YR PE+         
Sbjct: 182 G------------------------LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYST 217

Query: 133 -VDTW 136
            VD W
Sbjct: 218 SVDIW 222

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 67.8 bits (166), Expect = 2e-14
 Identities = 28/112 (25%), Positives = 48/112 (42%), Gaps = 19/112 (16%)

Query: 23  ILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           ++ E+    +L D+L+      +  N+      Q C A+  +      I+H DLK EN+L
Sbjct: 133 LVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENIL 191

Query: 82  ISSAG--TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           + +     +K+ DFGS+          +   Q        +RF    YR+PE
Sbjct: 192 LCNPKRSAIKIVDFGSSC---QLGQRIYQYIQ--------SRF----YRSPE 228

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 67.5 bits (165), Expect = 2e-14
 Identities = 36/160 (22%), Positives = 52/160 (32%), Gaps = 59/160 (36%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVC---------------------------- 50
               ++ ELC GG L+D L                                         
Sbjct: 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRES 160

Query: 51  -----------SILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAG--TVKLCDFGSAT 97
                      +I+ Q   A+ ++H Q   I HRD+K EN L S+     +KL DFG + 
Sbjct: 161 LDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLS- 217

Query: 98  EKVYSPDNAWSAQQRSMLEDEMARFT----TPMYRAPEMV 133
            K +   N            E    T    TP + APE++
Sbjct: 218 -KEFYKLN----------NGEYYGMTTKAGTPYFVAPEVL 246

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 66.9 bits (164), Expect = 3e-14
 Identities = 32/141 (22%), Positives = 59/141 (41%), Gaps = 29/141 (20%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y  L      G L+  ++ +  +           +   A++++HG+   I+HRDLK EN+
Sbjct: 106 YFGL-SYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENI 161

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM----- 132
           L++    +++ DFG+A  KV SP++            +    +   T  Y +PE+     
Sbjct: 162 LLNEDMHIQITDFGTA--KVLSPES-----------KQARANSFVGTAQYVSPELLTEKS 208

Query: 133 ----VDTWNNYVIGRSMLYGH 149
                D W    I   ++ G 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGL 229

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 66.6 bits (163), Expect = 6e-14
 Identities = 33/143 (23%), Positives = 55/143 (38%), Gaps = 31/143 (21%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y+++ E   GG LV+++      +P         +   A+  +H      +HRD+K +N+
Sbjct: 145 YMVM-EYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNM 199

Query: 81  LISSAGTVKLCDFGSATE-KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE-------- 131
           L+  +G +KL DFG+  +          +A              TP Y +PE        
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV------------GTPDYISPEVLKSQGGD 247

Query: 132 -----MVDTWNNYVIGRSMLYGH 149
                  D W+  V    ML G 
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGD 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 66.7 bits (163), Expect = 6e-14
 Identities = 34/130 (26%), Positives = 50/130 (38%), Gaps = 35/130 (26%)

Query: 21  YLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           ++++ E  +GG L D      R   L       +  Q    V + H     +VHRDLK E
Sbjct: 92  FMVM-EYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPE 145

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAPEM---- 132
           N+L+ +    K+ DFG             S       + E  R +  +P Y APE+    
Sbjct: 146 NVLLDAHMNAKIADFG------------LSNMMS---DGEFLRTSCGSPNYAAPEVISGR 190

Query: 133 ------VDTW 136
                 VD W
Sbjct: 191 LYAGPEVDIW 200

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.1 bits (162), Expect = 8e-14
 Identities = 24/126 (19%), Positives = 51/126 (40%), Gaps = 21/126 (16%)

Query: 15  PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           P      L+   +    +  D  K+    L    +   +++  +A+ + H     I+HRD
Sbjct: 103 PVSRTPALVFEHV----NNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMG--IMHRD 155

Query: 75  LKIENLLISSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV 133
           +K  N++I      ++L D+G A  + Y P   ++            R  +  ++ PE++
Sbjct: 156 VKPHNVMIDHEHRKLRLIDWGLA--EFYHPGQEYN-----------VRVASRYFKGPELL 202

Query: 134 DTWNNY 139
             +  Y
Sbjct: 203 VDYQMY 208

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 66.3 bits (162), Expect = 9e-14
 Identities = 31/115 (26%), Positives = 51/115 (44%), Gaps = 27/115 (23%)

Query: 23  ILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +  EL    +L +++K+ +       +V        Q +  +H     I+H DLK EN+L
Sbjct: 176 MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENIL 232

Query: 82  ISSAG--TVKLCDFGSAT---EKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           +   G   +K+ DFGS+    ++VY+       Q         +RF    YRAPE
Sbjct: 233 LKQQGRSGIKVIDFGSSCYEHQRVYT-----YIQ---------SRF----YRAPE 269

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 66.2 bits (162), Expect = 9e-14
 Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 19/101 (18%)

Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +   L  + +  +++Q  + ++++H     I+HRDLK  NL ++    +K+ DFG A   
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA--- 175

Query: 100 VYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEMVDTWNNY 139
                       R   + EM  +  T  YRAPE++  W  Y
Sbjct: 176 ------------RQA-DSEMTGYVVTRWYRAPEVILNWMRY 203

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.4 bits (160), Expect = 1e-13
 Identities = 27/101 (26%), Positives = 48/101 (47%), Gaps = 12/101 (11%)

Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAG-TVKLCDFGSATE 98
               L        ++Q  + +K++H  N  ++HRDLK  NL I++    +K+ DFG A  
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLA-- 168

Query: 99  KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNY 139
           ++  P        +  L + +    T  YR+P ++ + NNY
Sbjct: 169 RIMDPHY----SHKGHLSEGLV---TKWYRSPRLLLSPNNY 202

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 65.4 bits (160), Expect = 1e-13
 Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 19/101 (18%)

Query: 40  RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK 99
           +   L  + V  +++Q  + +K++H  +  I+HRDLK  NL ++    +K+ DFG A   
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA--- 179

Query: 100 VYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEMVDTWNNY 139
                       R    DEM  +  T  YRAPE++  W +Y
Sbjct: 180 ------------RHT-ADEMTGYVATRWYRAPEIMLNWMHY 207

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 65.4 bits (160), Expect = 2e-13
 Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 19/92 (20%)

Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWS 108
           +  +++Q  + +K++H     +VHRDLK  NL ++    +K+ DFG A            
Sbjct: 128 IQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLA------------ 173

Query: 109 AQQRSMLEDEMARF-TTPMYRAPEMVDTWNNY 139
              R   + EM  +  T  YRAPE++ +W +Y
Sbjct: 174 ---RHA-DAEMTGYVVTRWYRAPEVILSWMHY 201

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.5 bits (160), Expect = 2e-13
 Identities = 37/132 (28%), Positives = 52/132 (39%), Gaps = 33/132 (25%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H  +I+ E  +GG L + +         +       Q    V + H     I HRDLK+E
Sbjct: 90  HLAIIM-EYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLE 145

Query: 79  NLLI--SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAPEM-- 132
           N L+  S A  +K+CDFG      YS         +S +     + T  TP Y APE+  
Sbjct: 146 NTLLDGSPAPRLKICDFG------YS---------KSSVLHSQPKSTVGTPAYIAPEVLL 190

Query: 133 --------VDTW 136
                    D W
Sbjct: 191 RQEYDGKIADVW 202

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 65.4 bits (160), Expect = 2e-13
 Identities = 17/74 (22%), Positives = 34/74 (45%), Gaps = 2/74 (2%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
             I+ EL  GG  +  L+   + L    +  ++      ++++  +    +HRDL   N 
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNC 244

Query: 81  LISSAGTVKLCDFG 94
           L++    +K+ DFG
Sbjct: 245 LVTEKNVLKISDFG 258

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 62.7 bits (153), Expect = 1e-12
 Identities = 39/143 (27%), Positives = 58/143 (40%), Gaps = 36/143 (25%)

Query: 21  YLILTELCTGGSLVD--VLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            +++ E   GG L D  V K+R   +  +       Q   A+++ H     IVHRDLK E
Sbjct: 85  VMVI-EYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPE 137

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT--TPMYRAPEM---- 132
           NLL+     VK+ DFG             S       +    + +  +P Y APE+    
Sbjct: 138 NLLLDDNLNVKIADFG------------LSNIMT---DGNFLKTSCGSPNYAAPEVINGK 182

Query: 133 ------VDTWNNYVIGRSMLYGH 149
                 VD W+  ++   ML G 
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGR 205

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 62.7 bits (153), Expect = 1e-12
 Identities = 34/139 (24%), Positives = 53/139 (38%), Gaps = 30/139 (21%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           Y+++ E   GG +   L+ R              Q     +++H  +  +++RDLK ENL
Sbjct: 117 YMVM-EYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENL 172

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF-TTPMYRAPEM------- 132
           LI   G +++ DFG A          W+                TP   APE+       
Sbjct: 173 LIDQQGYIQVTDFGFAKR---VKGRTWT-------------LCGTPEALAPEIILSKGYN 216

Query: 133 --VDTWNNYVIGRSMLYGH 149
             VD W   V+   M  G+
Sbjct: 217 KAVDWWALGVLIYEMAAGY 235

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 61.7 bits (150), Expect = 3e-12
 Identities = 31/141 (21%), Positives = 51/141 (36%), Gaps = 27/141 (19%)

Query: 21  YLILTELCTGGSL---VDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
            L++  +  GG +   +  + E               Q    ++H+H +N  I++RDLK 
Sbjct: 261 CLVM-TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKP 317

Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           EN+L+   G V++ D G A E                         TP + APE+     
Sbjct: 318 ENVLLDDDGNVRISDLGLAVELKAGQTKTKG------------YAGTPGFMAPELLLGEE 365

Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD +   V    M+   
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 61.3 bits (149), Expect = 4e-12
 Identities = 31/128 (24%), Positives = 57/128 (44%), Gaps = 25/128 (19%)

Query: 11  KHSTPHGMHEYLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPP 69
            H  P+G+H  +++ E+  G +L+ ++K+     +P   V  I  Q    + +MH +   
Sbjct: 96  NHKGPNGVH-VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG- 152

Query: 70  IVHRDLKIENLLIS------SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
           I+H D+K EN+L+       +   +K+ D G+A          W  +  +       R  
Sbjct: 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---------WYDEHYT--NSIQTRE- 200

Query: 124 TPMYRAPE 131
              YR+PE
Sbjct: 201 ---YRSPE 205

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 61.1 bits (149), Expect = 4e-12
 Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 29/103 (28%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ ++H +   I++RDLK++N+L+ S G +KL D+G   E               +   +
Sbjct: 122 ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--------------GLRPGD 165

Query: 119 MARFT---TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
               T   TP Y APE+         VD W   V+   M+ G 
Sbjct: 166 TTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 61.2 bits (149), Expect = 5e-12
 Identities = 23/78 (29%), Positives = 32/78 (41%), Gaps = 21/78 (26%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ ++  Q   I+HRD+K +N+L+   G V + DF  A                  L  E
Sbjct: 127 ALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAM----------------LPRE 168

Query: 119 MARFT---TPMYRAPEMV 133
               T   T  Y APEM 
Sbjct: 169 TQITTMAGTKPYMAPEMF 186

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 60.8 bits (148), Expect = 6e-12
 Identities = 33/132 (25%), Positives = 49/132 (37%), Gaps = 44/132 (33%)

Query: 23  ILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+ EL  G S  D +KE        + +  + +Q C++V  +H     + H DLK EN+L
Sbjct: 94  IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENIL 150

Query: 82  ISSAG-------------------TVKLCDFGSAT---EKVYSPDNAWSAQQRSMLEDEM 119
              +                     +K+ DFGSAT   E   +  +              
Sbjct: 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVS-------------- 196

Query: 120 ARFTTPMYRAPE 131
            R     YRAPE
Sbjct: 197 TRH----YRAPE 204

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 60.3 bits (147), Expect = 6e-12
 Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 2/75 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+TE  + G L++ L+     L P+ +  + +  C+ +  +       +HRDL   N L
Sbjct: 79  YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCL 136

Query: 82  ISSAGTVKLCDFGSA 96
           +     VK+ DFG  
Sbjct: 137 VDRDLCVKVSDFGMT 151

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 61.0 bits (148), Expect = 6e-12
 Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 24/104 (23%)

Query: 42  SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVY 101
             L    +  +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A     
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---- 212

Query: 102 SPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTW 136
                 +A    M+   +    T  YRAPE+         VD W
Sbjct: 213 ------TAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIW 247

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 61.1 bits (148), Expect = 6e-12
 Identities = 33/141 (23%), Positives = 51/141 (36%), Gaps = 32/141 (22%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
             IL +L  GG L   L  +        +     +    ++HMH +   +V+RDLK  N+
Sbjct: 268 SFIL-DLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANI 323

Query: 81  LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYV 140
           L+   G V++ D G A    +S     +               T  Y APE++     Y 
Sbjct: 324 LLDEHGHVRISDLGLA--CDFSKKKPHA------------SVGTHGYMAPEVLQKGVAY- 368

Query: 141 IGRS------------MLYGH 149
              S            +L GH
Sbjct: 369 -DSSADWFSLGCMLFKLLRGH 388

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 60.4 bits (147), Expect = 8e-12
 Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 29/103 (28%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ ++H +   I++RDLK++N+L+ S G +KL D+G   E               +   +
Sbjct: 165 ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--------------GLRPGD 208

Query: 119 MARFT---TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
               T   TP Y APE+         VD W   V+   M+ G 
Sbjct: 209 TTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 60.4 bits (147), Expect = 1e-11
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 8/93 (8%)

Query: 23  ILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD L+ R  S L  + +       C+A++++ G N   VHRDL   N+L
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVL 321

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNA-----WSA 109
           +S     K+ DFG   E   + D       W+A
Sbjct: 322 VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 354

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 60.0 bits (146), Expect = 1e-11
 Identities = 32/132 (24%), Positives = 48/132 (36%), Gaps = 44/132 (33%)

Query: 23  ILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I  EL  G +  + LKE      P   V  + +Q C A++ +H     + H DLK EN+L
Sbjct: 99  IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENIL 155

Query: 82  ISSAG-------------------TVKLCDFGSAT---EKVYSPDNAWSAQQRSMLEDEM 119
             ++                    ++++ DFGSAT   E   +                 
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVA-------------- 201

Query: 120 ARFTTPMYRAPE 131
            R     YR PE
Sbjct: 202 TRH----YRPPE 209

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 60.0 bits (146), Expect = 1e-11
 Identities = 33/101 (32%), Positives = 44/101 (43%), Gaps = 25/101 (24%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ ++H  N  IV+RDLK EN+L+ S G + L DFG   E +       +          
Sbjct: 151 ALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST---------- 198

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
              F  TP Y APE+         VD W    +   MLYG 
Sbjct: 199 ---FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 59.8 bits (145), Expect = 1e-11
 Identities = 13/72 (18%), Positives = 20/72 (27%), Gaps = 5/72 (6%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E   GGSL +V         P      +     A    H     +         + +
Sbjct: 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRV 162

Query: 83  SSAGTVKLCDFG 94
           S  G V L    
Sbjct: 163 SIDGDVVLAYPA 174

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 60.2 bits (146), Expect = 1e-11
 Identities = 22/76 (28%), Positives = 40/76 (52%), Gaps = 3/76 (3%)

Query: 22  LILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HR+L   N 
Sbjct: 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNC 349

Query: 81  LISSAGTVKLCDFGSA 96
           L+     VK+ DFG +
Sbjct: 350 LVGENHLVKVADFGLS 365

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 59.5 bits (145), Expect = 1e-11
 Identities = 17/75 (22%), Positives = 32/75 (42%), Gaps = 2/75 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            ++TE    G L D L+ +        +  +    C+ + ++      ++HRDL   N L
Sbjct: 79  CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCL 136

Query: 82  ISSAGTVKLCDFGSA 96
           +     +K+ DFG  
Sbjct: 137 VGENQVIKVSDFGMT 151

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 59.9 bits (146), Expect = 1e-11
 Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 28/101 (27%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A++++H ++  I++RDLK EN+L+   G +K+ DFG A      PD  ++          
Sbjct: 118 ALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY---VPDVTYT---------- 162

Query: 119 MARF-TTPMYRAPE---------MVDTWNNYVIGRSMLYGH 149
                 TP Y APE          +D W+  ++   ML G+
Sbjct: 163 ---LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.9 bits (146), Expect = 1e-11
 Identities = 31/103 (30%), Positives = 46/103 (44%), Gaps = 29/103 (28%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ H+H +   I++RDLK EN++++  G VKL DFG   E              S+ +  
Sbjct: 133 ALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKE--------------SIHDGT 176

Query: 119 MARFT---TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
           +   T   T  Y APE+         VD W+   +   ML G 
Sbjct: 177 VTH-TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 60.1 bits (146), Expect = 1e-11
 Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 24/101 (23%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ ++H +   +V+RDLK+ENL++   G +K+ DFG   E +       +          
Sbjct: 260 ALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---------- 308

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
              F  TP Y APE+         VD W   V+   M+ G 
Sbjct: 309 ---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 59.5 bits (145), Expect = 1e-11
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 8/93 (8%)

Query: 23  ILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           I+TE    GSLVD L+ R  S L  + +       C+A++++ G N   VHRDL   N+L
Sbjct: 92  IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVL 149

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNA-----WSA 109
           +S     K+ DFG   E   + D       W+A
Sbjct: 150 VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 182

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 59.5 bits (145), Expect = 2e-11
 Identities = 31/103 (30%), Positives = 46/103 (44%), Gaps = 29/103 (28%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+ H+H     I++RDLK EN+L+   G +KL DFG + E              S+  ++
Sbjct: 138 ALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKE--------------SIDHEK 181

Query: 119 MARFT---TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
            A  +   T  Y APE+          D W+  V+   ML G 
Sbjct: 182 KAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 59.2 bits (144), Expect = 2e-11
 Identities = 21/75 (28%), Positives = 38/75 (50%), Gaps = 2/75 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+TE    G L++ L+E         +  +    C+A++++  +    +HRDL   N L
Sbjct: 95  FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCL 152

Query: 82  ISSAGTVKLCDFGSA 96
           ++  G VK+ DFG +
Sbjct: 153 VNDQGVVKVSDFGLS 167

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 59.5 bits (145), Expect = 2e-11
 Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 25/101 (24%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
            ++ +H +   IV+RDLK++N+L+   G +K+ DFG   E +       +          
Sbjct: 130 GLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT---------- 177

Query: 119 MARFT-TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
              F  TP Y APE+         VD W+  V+   ML G 
Sbjct: 178 ---FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 59.8 bits (145), Expect = 2e-11
 Identities = 32/142 (22%), Positives = 52/142 (36%), Gaps = 32/142 (22%)

Query: 21  YLILTELCTGGSLVDVL-KERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
            L+L  L  GG L   +     +  P         + C  ++ +H +   IV+RDLK EN
Sbjct: 260 CLVL-TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPEN 316

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT---TPMYRAPEM---- 132
           +L+   G +++ D G A                 + E +  +     T  Y APE+    
Sbjct: 317 ILLDDHGHIRISDLGLAVH---------------VPEGQTIK-GRVGTVGYMAPEVVKNE 360

Query: 133 -----VDTWNNYVIGRSMLYGH 149
                 D W    +   M+ G 
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 59.1 bits (144), Expect = 2e-11
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 3/76 (3%)

Query: 22  LILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+  N+
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANI 140

Query: 81  LISSAGTVKLCDFGSA 96
           L+S   + K+ DFG A
Sbjct: 141 LVSDTLSCKIADFGLA 156

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 59.2 bits (144), Expect = 2e-11
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 29/103 (28%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A++++H ++  +V+RD+K+ENL++   G +K+ DFG   E               + +  
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKE--------------GISDGA 160

Query: 119 MARFT---TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
             + T   TP Y APE+         VD W   V+   M+ G 
Sbjct: 161 TMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 59.2 bits (144), Expect = 2e-11
 Identities = 27/103 (26%), Positives = 45/103 (43%), Gaps = 29/103 (28%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
            +  +  +   I++RDLK++N+++ S G +K+ DFG   E              ++ +  
Sbjct: 133 GLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE--------------NIWDGV 176

Query: 119 MARFT---TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
             + T   TP Y APE+         VD W   V+   ML G 
Sbjct: 177 TTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 58.8 bits (143), Expect = 3e-11
 Identities = 21/72 (29%), Positives = 37/72 (51%), Gaps = 2/72 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++TEL   GSL+D L++         +     Q  + + ++  +    +HRDL   NLL+
Sbjct: 97  MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL 154

Query: 83  SSAGTVKLCDFG 94
           ++   VK+ DFG
Sbjct: 155 ATRDLVKIGDFG 166

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 58.9 bits (143), Expect = 3e-11
 Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 15/89 (16%)

Query: 49  VCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWS 108
           +  +L+Q    +KH+H     I+HRDLK  N+++ S  T+K+ DFG A           +
Sbjct: 129 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR----------T 176

Query: 109 AQQRSMLEDEMARFTTPMYRAPEMVDTWN 137
           A    M+   +    T  YRAPE++    
Sbjct: 177 AGTSFMMTPYVV---TRYYRAPEVILGMG 202

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 59.1 bits (143), Expect = 3e-11
 Identities = 26/73 (35%), Positives = 38/73 (52%), Gaps = 2/73 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L
Sbjct: 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVL 523

Query: 82  ISSAGTVKLCDFG 94
           +SS   VKL DFG
Sbjct: 524 VSSNDCVKLGDFG 536

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.4 bits (142), Expect = 4e-11
 Identities = 31/103 (30%), Positives = 43/103 (41%), Gaps = 29/103 (28%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
           A+  +H +   I++RDLK++N+L+   G  KL DFG   E               +    
Sbjct: 136 ALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKE--------------GICNGV 179

Query: 119 MARFT---TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
               T   TP Y APE+         VD W   V+   ML GH
Sbjct: 180 TTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 58.6 bits (142), Expect = 4e-11
 Identities = 25/76 (32%), Positives = 39/76 (51%), Gaps = 3/76 (3%)

Query: 22  LILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            I+TE    GSL+D LK    S  P   +     Q  + +  +  +N   +HRDL+  N+
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANI 315

Query: 81  LISSAGTVKLCDFGSA 96
           L+S++   K+ DFG A
Sbjct: 316 LVSASLVCKIADFGLA 331

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 58.6 bits (142), Expect = 4e-11
 Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 3/76 (3%)

Query: 22  LILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            I+TE  + GSL+D LK  T   L    +  +  Q    + ++   N   VHRDL+  N+
Sbjct: 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANI 311

Query: 81  LISSAGTVKLCDFGSA 96
           L+      K+ DFG A
Sbjct: 312 LVGENLVCKVADFGLA 327

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 58.4 bits (141), Expect = 5e-11
 Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 3/76 (3%)

Query: 22  LILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            I+TE  + GSL+D LK  T   L    +  +  Q    + ++   N   VHRDL+  N+
Sbjct: 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANI 394

Query: 81  LISSAGTVKLCDFGSA 96
           L+      K+ DFG A
Sbjct: 395 LVGENLVCKVADFGLA 410

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 57.3 bits (139), Expect = 1e-10
 Identities = 23/76 (30%), Positives = 40/76 (52%), Gaps = 3/76 (3%)

Query: 22  LILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
            I+TE  T G+L+D L+E     +   ++  +  Q   A++++  +N   +HRDL   N 
Sbjct: 85  YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNC 142

Query: 81  LISSAGTVKLCDFGSA 96
           L+     VK+ DFG +
Sbjct: 143 LVGENHLVKVADFGLS 158

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 57.3 bits (138), Expect = 1e-10
 Identities = 21/73 (28%), Positives = 38/73 (52%), Gaps = 2/73 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +++ E+  GG L   L  +   +P + V  +L Q    +K++  +N   VHR+L   N+L
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVL 468

Query: 82  ISSAGTVKLCDFG 94
           + +    K+ DFG
Sbjct: 469 LVNRHYAKISDFG 481

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 56.9 bits (138), Expect = 1e-10
 Identities = 19/72 (26%), Positives = 38/72 (52%), Gaps = 2/72 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++T+L   G L+D ++E    +    + +   Q  + + ++  +   +VHRDL   N+L+
Sbjct: 93  LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV 150

Query: 83  SSAGTVKLCDFG 94
            +   VK+ DFG
Sbjct: 151 KTPQHVKITDFG 162

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 56.9 bits (138), Expect = 1e-10
 Identities = 19/72 (26%), Positives = 36/72 (50%), Gaps = 2/72 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E    GSL D L++    +    +     Q C+ ++++  +    +HRDL   N+L+
Sbjct: 90  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV 147

Query: 83  SSAGTVKLCDFG 94
            +   VK+ DFG
Sbjct: 148 ENENRVKIGDFG 159

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 56.9 bits (138), Expect = 1e-10
 Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 17/77 (22%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDN-AWSAQQRSMLED 117
           A++H+H     I++RD+K+EN+L+ S G V L DFG + E V      A+          
Sbjct: 171 ALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--------- 219

Query: 118 EMARFT-TPMYRAPEMV 133
               F  T  Y AP++V
Sbjct: 220 ----FCGTIEYMAPDIV 232

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 56.6 bits (137), Expect = 2e-10
 Identities = 27/138 (19%), Positives = 45/138 (32%), Gaps = 50/138 (36%)

Query: 23  ILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           ++ E   G SL +++     +      +     +  +A+ ++   +  + H DLK EN+L
Sbjct: 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENIL 169

Query: 82  ISSAG-------------------------TVKLCDFGSAT---EKVYSPDNAWSAQQRS 113
           +                              +KL DFG AT   +   S  N        
Sbjct: 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINT------- 222

Query: 114 MLEDEMARFTTPMYRAPE 131
                  R     YRAPE
Sbjct: 223 -------RQ----YRAPE 229

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 56.5 bits (137), Expect = 2e-10
 Identities = 26/73 (35%), Positives = 38/73 (52%), Gaps = 2/73 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+ ELCT G L   L+ R  +L    +    +Q   A+ ++  +    VHRD+   N+L
Sbjct: 91  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVL 148

Query: 82  ISSAGTVKLCDFG 94
           +SS   VKL DFG
Sbjct: 149 VSSNDCVKLGDFG 161

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 56.6 bits (137), Expect = 2e-10
 Identities = 19/72 (26%), Positives = 36/72 (50%), Gaps = 2/72 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E    GSL D L++    +    +     Q C+ ++++  +    +HRDL   N+L+
Sbjct: 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV 178

Query: 83  SSAGTVKLCDFG 94
            +   VK+ DFG
Sbjct: 179 ENENRVKIGDFG 190

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 57.0 bits (137), Expect = 2e-10
 Identities = 27/103 (26%), Positives = 45/103 (43%), Gaps = 29/103 (28%)

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDE 118
            +  +  +   I++RDLK++N+++ S G +K+ DFG   E              ++ +  
Sbjct: 454 GLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE--------------NIWDGV 497

Query: 119 MARFT---TPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
             + T   TP Y APE+         VD W   V+   ML G 
Sbjct: 498 TTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 56.5 bits (137), Expect = 2e-10
 Identities = 22/81 (27%), Positives = 37/81 (45%), Gaps = 2/81 (2%)

Query: 14  TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR 73
           T  G +   ++ E    GSL + L +  + +          Q C+ + ++  +    VHR
Sbjct: 93  TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHR 150

Query: 74  DLKIENLLISSAGTVKLCDFG 94
           DL   N+L+ S   VK+ DFG
Sbjct: 151 DLAARNVLVESEHQVKIGDFG 171

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 56.6 bits (137), Expect = 2e-10
 Identities = 20/73 (27%), Positives = 40/73 (54%), Gaps = 2/73 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            ++T+    GSL+D +++   AL P ++ +   Q  + + ++      +VHR+L   N+L
Sbjct: 90  QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVL 147

Query: 82  ISSAGTVKLCDFG 94
           + S   V++ DFG
Sbjct: 148 LKSPSQVQVADFG 160

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 56.1 bits (136), Expect = 2e-10
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 3/94 (3%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +++ E+  GG L   L  +   +P + V  +L Q    +K++  +N   VHRDL   N+L
Sbjct: 85  MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVL 142

Query: 82  ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSML 115
           + +    K+ DFG + + + + D+ ++A+     
Sbjct: 143 LVNRHYAKISDFGLS-KALGADDSYYTARSAGKW 175

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 56.2 bits (136), Expect = 2e-10
 Identities = 20/73 (27%), Positives = 32/73 (43%), Gaps = 2/73 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +I+TE    GSL   L+          +  +L      ++++       VHRDL   N+L
Sbjct: 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVL 183

Query: 82  ISSAGTVKLCDFG 94
           + S    K+ DFG
Sbjct: 184 VDSNLVCKVSDFG 196

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 56.2 bits (136), Expect = 2e-10
 Identities = 22/73 (30%), Positives = 35/73 (47%), Gaps = 2/73 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +I+TE    GSL   L++  +      +  +L      +K++       VHRDL   N+L
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNIL 179

Query: 82  ISSAGTVKLCDFG 94
           I+S    K+ DFG
Sbjct: 180 INSNLVCKVSDFG 192

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 56.2 bits (136), Expect = 3e-10
 Identities = 22/73 (30%), Positives = 36/73 (49%), Gaps = 2/73 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +I+TE    G+L   L+E+        +  +L      +K++   N   VHRDL   N+L
Sbjct: 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNIL 179

Query: 82  ISSAGTVKLCDFG 94
           ++S    K+ DFG
Sbjct: 180 VNSNLVCKVSDFG 192

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 55.7 bits (135), Expect = 3e-10
 Identities = 24/73 (32%), Positives = 38/73 (52%), Gaps = 2/73 (2%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            I+ EL   G L   L+   ++L    +     Q C+A+ ++   N   VHRD+ + N+L
Sbjct: 88  WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNIL 145

Query: 82  ISSAGTVKLCDFG 94
           ++S   VKL DFG
Sbjct: 146 VASPECVKLGDFG 158

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 55.8 bits (135), Expect = 3e-10
 Identities = 21/72 (29%), Positives = 36/72 (50%), Gaps = 2/72 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++ E    G L D L+   + L  + +     Q C+ ++++  +    VHRDL   N+L+
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV 160

Query: 83  SSAGTVKLCDFG 94
            S   VK+ DFG
Sbjct: 161 ESEAHVKIADFG 172

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 55.0 bits (133), Expect = 6e-10
 Identities = 19/72 (26%), Positives = 38/72 (52%), Gaps = 2/72 (2%)

Query: 23  ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI 82
           ++T+L   G L+D ++E    +    + +   Q  + + ++  +   +VHRDL   N+L+
Sbjct: 93  LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV 150

Query: 83  SSAGTVKLCDFG 94
            +   VK+ DFG
Sbjct: 151 KTPQHVKITDFG 162

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 54.2 bits (131), Expect = 1e-09
 Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 3/83 (3%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            +L      G L+  ++          + S   Q  + ++++  Q    VHRDL   N +
Sbjct: 99  HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCM 156

Query: 82  ISSAGTVKLCDFGSATEKVYSPD 104
           +  + TVK+ DFG A   +   +
Sbjct: 157 LDESFTVKVADFGLA-RDILDRE 178

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 54.2 bits (131), Expect = 1e-09
 Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 3/83 (3%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           L++      G L + ++  T       +     Q  + +K++  +    VHRDL   N +
Sbjct: 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCM 160

Query: 82  ISSAGTVKLCDFGSATEKVYSPD 104
           +    TVK+ DFG A   +Y  +
Sbjct: 161 LDEKFTVKVADFGLA-RDMYDKE 182

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 54.2 bits (131), Expect = 1e-09
 Identities = 18/73 (24%), Positives = 35/73 (47%), Gaps = 3/73 (4%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +++ E+   G L   L++    +    +  ++ Q    +K++   N   VHRDL   N+L
Sbjct: 93  MLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVL 149

Query: 82  ISSAGTVKLCDFG 94
           + +    K+ DFG
Sbjct: 150 LVTQHYAKISDFG 162

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 53.2 bits (128), Expect = 3e-09
 Identities = 20/83 (24%), Positives = 35/83 (42%), Gaps = 3/83 (3%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           L++      G L + ++  T       +     Q  + +K +  +    VHRDL   N +
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCM 224

Query: 82  ISSAGTVKLCDFGSATEKVYSPD 104
           +    TVK+ DFG A   +Y  +
Sbjct: 225 LDEKFTVKVADFGLA-RDMYDKE 246

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 52.3 bits (126), Expect = 5e-09
 Identities = 20/97 (20%), Positives = 41/97 (42%), Gaps = 8/97 (8%)

Query: 13  STPHGMHEYLILTELCTGGSLVDVLKER-----TSALPPNIVCSILWQTCQAVKHMHGQN 67
            +  G+ + +++      G L   L           +P   +   +      ++++  +N
Sbjct: 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167

Query: 68  PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD 104
              +HRDL   N ++    TV + DFG + +K+YS D
Sbjct: 168 --FLHRDLAARNCMLRDDMTVCVADFGLS-KKIYSGD 201

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 52.3 bits (126), Expect = 5e-09
 Identities = 21/73 (28%), Positives = 36/73 (49%), Gaps = 4/73 (5%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
            ++ E    GSL D L     ++    +     Q C+ + ++H Q+   +HRDL   N+L
Sbjct: 111 QLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVL 166

Query: 82  ISSAGTVKLCDFG 94
           + +   VK+ DFG
Sbjct: 167 LDNDRLVKIGDFG 179

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 50.7 bits (122), Expect = 2e-08
 Identities = 16/109 (14%), Positives = 39/109 (35%), Gaps = 25/109 (22%)

Query: 22  LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL 81
           +++ E    GSL   LK+  + +       +  Q   A+  +      ++H ++  +N+L
Sbjct: 88  ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNIL 145

Query: 82  ISSAGT--------VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF 122
           +             +KL D G +                ++L  ++ + 
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGIS---------------ITVLPKDILQE 179

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 50.0 bits (120), Expect = 4e-08
 Identities = 20/87 (22%), Positives = 37/87 (42%), Gaps = 15/87 (17%)

Query: 21  YLILTELCTGGSLVDVLKER-------------TSALPPNIVCSILWQTCQAVKHMHGQN 67
            L++TE C  G L++ L+ +              S      +     Q  Q +  +  +N
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184

Query: 68  PPIVHRDLKIENLLISSAGTVKLCDFG 94
              +HRD+   N+L+++    K+ DFG
Sbjct: 185 --CIHRDVAARNVLLTNGHVAKIGDFG 209

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 48.5 bits (116), Expect = 1e-07
 Identities = 20/88 (22%), Positives = 37/88 (42%), Gaps = 8/88 (9%)

Query: 22  LILTELCTGGSLVDVLKER-----TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
           +++      G L   L           LP   +   +      ++++  +N   +HRDL 
Sbjct: 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLA 164

Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPD 104
             N +++   TV + DFG +  K+YS D
Sbjct: 165 ARNCMLAEDMTVCVADFGLS-RKIYSGD 191

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.7 bits (115), Expect = 1e-07
 Identities = 19/76 (25%), Positives = 30/76 (39%), Gaps = 4/76 (5%)

Query: 21  YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL 80
           +++L E   GG   D+ + RT         SIL Q   ++      +    HRDL   N+
Sbjct: 138 FIVL-EFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHRDLHWGNV 193

Query: 81  LISSAGTVKLCDFGSA 96
           L+      KL    + 
Sbjct: 194 LLKKTSLKKLHYTLNG 209

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 47.7 bits (114), Expect = 2e-07
 Identities = 21/92 (22%), Positives = 38/92 (41%), Gaps = 12/92 (13%)

Query: 22  LILTELCTGGSLVDVLKER---------TSALPPNIVCSILWQTCQAVKHMHGQNPPIVH 72
           L++ EL T G L   L+            +    + +  +  +    + +++      VH
Sbjct: 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVH 161

Query: 73  RDLKIENLLISSAGTVKLCDFGSATEKVYSPD 104
           RDL   N +++   TVK+ DFG     +Y  D
Sbjct: 162 RDLAARNCMVAEDFTVKIGDFGMT-RDIYETD 192

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.8 bits (111), Expect = 5e-07
 Identities = 33/175 (18%), Positives = 55/175 (31%), Gaps = 47/175 (26%)

Query: 11  KHSTPHGMHEYLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPP 69
           K S  +G H  ++   L  G  L+  + +     LP   V  I+ Q  Q + ++H +   
Sbjct: 111 KISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR- 167

Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD-----------------NAWSAQQR 112
           I+H D+K EN+L+S            ATE   S                      +  + 
Sbjct: 168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEP 227

Query: 113 SMLEDEMARF-----------------TTPMYRAPEM---------VDTWNNYVI 141
              E    +                   T  YR+ E+          D W+   +
Sbjct: 228 KNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACM 282

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 46.6 bits (111), Expect = 5e-07
 Identities = 20/100 (20%), Positives = 42/100 (42%), Gaps = 18/100 (18%)

Query: 21  YLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHMHG 65
             ++ E  + G+L + L+ R                  L    + S  +Q  + ++++  
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 66  QNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDN 105
           +    +HRDL   N+L++    +K+ DFG A   ++  D 
Sbjct: 210 KK--CIHRDLAARNVLVTEDNVMKIADFGLA-RDIHHIDY 246

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 46.1 bits (110), Expect = 9e-07
 Identities = 22/100 (22%), Positives = 41/100 (41%), Gaps = 18/100 (18%)

Query: 21  YLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHMHG 65
            +++ E C  G+L   L+ +                  L    +    +Q  + ++ +  
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166

Query: 66  QNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDN 105
           +    +HRDL   N+L+S    VK+CDFG A   +Y   +
Sbjct: 167 RK--CIHRDLAARNILLSEKNVVKICDFGLA-RDIYKDPD 203

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 45.7 bits (109), Expect = 1e-06
 Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 19/91 (20%)

Query: 21  YLILTELCTGGSLVDVLKER-----------------TSALPPNIVCSILWQTCQAVKHM 63
            L++TE C  G L++ L+ +                   AL    + S  +Q  + +  +
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 64  HGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
             +N   +HRDL   N+L++     K+CDFG
Sbjct: 162 ASKN--CIHRDLAARNILLTHGRITKICDFG 190

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 45.1 bits (107), Expect = 2e-06
 Identities = 21/83 (25%), Positives = 34/83 (40%), Gaps = 11/83 (13%)

Query: 21  YLILTELCTGGSLVDVLKER------TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
             IL EL  GG L   L+E        S+L    +  +        +++   +   +HRD
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRD 206

Query: 75  LKIENLLISSAG---TVKLCDFG 94
           +   N L++  G     K+ DFG
Sbjct: 207 IAARNCLLTCPGPGRVAKIGDFG 229

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 45.0 bits (107), Expect = 2e-06
 Identities = 20/99 (20%), Positives = 42/99 (42%), Gaps = 18/99 (18%)

Query: 21  YLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHMHG 65
             ++ E  + G+L + L+ R                  +    + S  +Q  + ++++  
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 66  QNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD 104
           Q    +HRDL   N+L++    +K+ DFG A   + + D
Sbjct: 176 QK--CIHRDLAARNVLVTENNVMKIADFGLA-RDINNID 211

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 45.0 bits (107), Expect = 2e-06
 Identities = 21/83 (25%), Positives = 34/83 (40%), Gaps = 11/83 (13%)

Query: 21  YLILTELCTGGSLVDVLKER------TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
             IL EL  GG L   L+E        S+L    +  +        +++   +   +HRD
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRD 165

Query: 75  LKIENLLISSAG---TVKLCDFG 94
           +   N L++  G     K+ DFG
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFG 188

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 45.0 bits (107), Expect = 2e-06
 Identities = 17/89 (19%), Positives = 32/89 (35%), Gaps = 17/89 (19%)

Query: 21  YLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHMHG 65
             +  E    G+L+D L++                 S L    +        + + ++  
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160

Query: 66  QNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           +    +HRDL   N+L+      K+ DFG
Sbjct: 161 KQ--FIHRDLAARNILVGENYVAKIADFG 187

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 44.6 bits (106), Expect = 3e-06
 Identities = 20/88 (22%), Positives = 32/88 (36%), Gaps = 16/88 (18%)

Query: 21  YLILTELCTGGSLVDVLKER--------------TSALPPNIVCSILWQTCQAVKHMHGQ 66
            L++ E    G L   L+                   L    + ++  Q    + ++ G 
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177

Query: 67  NPPIVHRDLKIENLLISSAGTVKLCDFG 94
           +   VHRDL   N L+     VK+ DFG
Sbjct: 178 H--FVHRDLATRNCLVGQGLVVKIGDFG 203

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 44.5 bits (106), Expect = 3e-06
 Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 17/89 (19%)

Query: 21  YLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHMHG 65
            +++ E    G L   L+                    L  + +  I  Q    + ++  
Sbjct: 92  LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151

Query: 66  QNPPIVHRDLKIENLLISSAGTVKLCDFG 94
           Q+   VHRDL   N L+ +   VK+ DFG
Sbjct: 152 QH--FVHRDLATRNCLVGANLLVKIGDFG 178

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 44.7 bits (106), Expect = 3e-06
 Identities = 20/100 (20%), Positives = 42/100 (42%), Gaps = 18/100 (18%)

Query: 21  YLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHMHG 65
             ++ E  + G+L + L+ R                  +    + S  +Q  + ++++  
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221

Query: 66  QNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDN 105
           Q    +HRDL   N+L++    +K+ DFG A   + + D 
Sbjct: 222 QK--CIHRDLAARNVLVTENNVMKIADFGLA-RDINNIDY 258

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 44.3 bits (105), Expect = 4e-06
 Identities = 21/91 (23%), Positives = 40/91 (43%), Gaps = 7/91 (7%)

Query: 11  KHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPI 70
           +     G +  +++  L  G SL D+    +       V  +  Q    ++++H +N   
Sbjct: 71  RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--F 126

Query: 71  VHRDLKIENLLI---SSAGTVKLCDFGSATE 98
           +HRD+K +N L+        V + DFG A +
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 44.3 bits (105), Expect = 4e-06
 Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 9/89 (10%)

Query: 15  PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
           P G +  ++L  L  G SL D+            V  I  Q    ++++H +N  +++RD
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRD 130

Query: 75  LKIENLLI-----SSAGTVKLCDFGSATE 98
           +K EN LI      +   + + DF  A E
Sbjct: 131 VKPENFLIGRPGNKTQQVIHIIDFALAKE 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.0 bits (104), Expect = 4e-06
 Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 8/96 (8%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           H      + ++I+     G  L  + +          V  +  +    ++++H      V
Sbjct: 119 HDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YV 174

Query: 72  HRDLKIENLLIS--SAGTVKLCDFGSATEKVYSPDN 105
           H D+K  NLL++  +   V L D+G A    Y P+ 
Sbjct: 175 HGDIKASNLLLNYKNPDQVYLVDYGLA--YRYCPEG 208

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.9 bits (104), Expect = 4e-06
 Identities = 23/89 (25%), Positives = 38/89 (42%), Gaps = 9/89 (10%)

Query: 15  PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD 74
             G+H  L++  L  G SL D+L           V     Q    V+ +H ++  +V+RD
Sbjct: 76  QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRD 131

Query: 75  LKIENLLISSAGT-----VKLCDFGSATE 98
           +K +N LI    +     + + DFG    
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKF 160

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 44.2 bits (104), Expect = 4e-06
 Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 7/91 (7%)

Query: 11  KHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPI 70
           +     G +  L++  L  G SL D+    +  L    V  +  Q    V+ +H ++   
Sbjct: 69  RWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--F 124

Query: 71  VHRDLKIENLLISSAGT---VKLCDFGSATE 98
           +HRD+K +N L+        V + DFG A +
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 43.7 bits (104), Expect = 5e-06
 Identities = 20/88 (22%), Positives = 36/88 (40%), Gaps = 17/88 (19%)

Query: 22  LILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHMHGQ 66
            ++   C+ G L + L  R                SAL P     ++ Q    ++++   
Sbjct: 88  SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 147

Query: 67  NPPIVHRDLKIENLLISSAGTVKLCDFG 94
           +  +VH+DL   N+L+     VK+ D G
Sbjct: 148 H--VVHKDLATRNVLVYDKLNVKISDLG 173

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.9 bits (104), Expect = 5e-06
 Identities = 18/96 (18%), Positives = 38/96 (39%), Gaps = 9/96 (9%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
                  + ++++  L  G  L  +  +       + V  +  +    ++++H      V
Sbjct: 119 TEFKGRSYRFMVMERL--GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENE--YV 173

Query: 72  HRDLKIENLLI--SSAGTVKLCDFGSATEKVYSPDN 105
           H D+K  NLL+   +   V L D+G +    Y P+ 
Sbjct: 174 HGDIKAANLLLGYKNPDQVYLADYGLS--YRYCPNG 207

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 42.3 bits (100), Expect = 2e-05
 Identities = 20/96 (20%), Positives = 39/96 (40%), Gaps = 24/96 (25%)

Query: 21  YLILTELCTGGSLVDVLKER----------------------TSALPPNIVCSILWQTCQ 58
             ++ E C  G L++ L+ +                       + L    +    +Q  +
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183

Query: 59  AVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFG 94
            ++ +  ++   VHRDL   N+L++    VK+CDFG
Sbjct: 184 GMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFG 217

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 41.8 bits (99), Expect = 2e-05
 Identities = 27/108 (25%), Positives = 43/108 (39%), Gaps = 26/108 (24%)

Query: 21  YLILTELCTGGSLVDVLKER-----------------------TSALPPNIVCSILWQTC 57
            L++ E    GSL   L+E                          AL    + S  WQ  
Sbjct: 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160

Query: 58  QAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDN 105
           Q ++++      +VHRDL   N+L++    +K+ DFG +   VY  D+
Sbjct: 161 QGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLS-RDVYEEDS 205

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 41.3 bits (97), Expect = 4e-05
 Identities = 23/97 (23%), Positives = 37/97 (38%), Gaps = 13/97 (13%)

Query: 16  HGMHE----YLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPI 70
            G+H+    +L+L  L  G SL   L       L    V  +  +   A++ +H      
Sbjct: 125 FGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--Y 180

Query: 71  VHRDLKIENLLI--SSAGTVKLCDFGSATEKVYSPDN 105
           VH ++  EN+ +       V L  +G A    Y P  
Sbjct: 181 VHGNVTAENIFVDPEDQSQVTLAGYGFA--FRYCPSG 215

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 39.9 bits (93), Expect = 1e-04
 Identities = 17/67 (25%), Positives = 30/67 (44%), Gaps = 3/67 (4%)

Query: 39  ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
                L    +    +Q  + ++ +  +    +HRDL   N+L+S    VK+CDFG A  
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA-R 241

Query: 99  KVYSPDN 105
            +Y   +
Sbjct: 242 DIYKDPD 248

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 39.6 bits (93), Expect = 1e-04
 Identities = 23/107 (21%), Positives = 34/107 (31%), Gaps = 26/107 (24%)

Query: 21  YLILTELCTGGSLVDVLKER-----------------------TSALPPNIVCSILWQTC 57
             +L E    G L + L+                            L       I  Q  
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184

Query: 58  QAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD 104
             + ++  +    VHRDL   N L+     VK+ DFG +   +YS D
Sbjct: 185 AGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS-RNIYSAD 228

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 38.0 bits (89), Expect = 5e-04
 Identities = 13/39 (33%), Positives = 21/39 (53%), Gaps = 2/39 (5%)

Query: 67  NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDN 105
           +P I+HRD+K  N+L+       + DFG A  K+    +
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLA--KLMDYKD 188

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	150
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.98
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.95
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.95
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.95
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.95
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.95
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.95
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.95
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.95
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.95
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.94
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.94
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.94
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.94
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.94
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.94
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.94
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.94
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.94
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.94
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.94
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.94
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.94
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.93
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.93
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.93
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.93
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.93
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.93
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.93
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.93
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.93
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.93
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.93
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.93
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.93
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.93
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.93
3niz_A	311	Rhodanese family protein; structural genomics, str	99.93
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.93
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.93
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.93
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.93
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.93
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.93
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.93
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.93
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.93
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.93
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.93
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.93
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.93
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.93
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.93
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.93
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.93
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.93
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.92
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.92
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.92
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.92
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.92
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.92
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.92
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.92
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.92
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.92
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.92
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.92
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.92
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.92
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.92
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.92
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.92
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.92
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.92
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.92
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.92
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.92
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.92
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.92
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.92
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.92
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.92
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.92
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.92
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.92
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.92
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.92
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.92
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.92
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.92
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.92
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.92
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.92
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.92
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.92
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.92
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.92
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.92
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.92
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.92
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.92
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.92
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.92
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.91
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.91
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.91
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.91
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.91
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.91
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.91
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.91
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.91
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.91
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.91
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.91
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.91
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.91
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.91
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.91
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.91
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.91
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.91
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.91
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.91
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.91
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.91
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.91
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.91
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.91
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.91
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.91
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.91
3bhy_A	283	Death-associated protein kinase 3; death associate	99.91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.91
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.91
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.91
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.91
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.91
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.91
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.91
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.91
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.91
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.91
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.91
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.91
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.91
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.91
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.91
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.91
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.91
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.91
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.91
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.91
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.9
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.9
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.9
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.9
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.9
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.9
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.9
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.9
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.9
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.9
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.9
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.9
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.9
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.9
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.9
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.9
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.9
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.9
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.9
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.9
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.9
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.9
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.9
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.9
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.9
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.9
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.9
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.9
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.9
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.9
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.9
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.9
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.9
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.9
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.9
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.9
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.9
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.9
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.9
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.89
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.89
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.89
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.89
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.89
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.89
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.89
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.89
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.89
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.89
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.89
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.89
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.88
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.88
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.88
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.88
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.88
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.88
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.88
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.88
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.87
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.86
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.86
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.84
3uqc_A	286	Probable conserved transmembrane protein; structur	99.82
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.79
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.58
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.31
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.96
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.25
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.95
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.77
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.04
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	96.75
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	96.45
3ats_A	357	Putative uncharacterized protein; hypothetical pro	95.19
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	93.49
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	89.56
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	84.86
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	84.78
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	84.38
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	81.67

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.4e-38  Score=221.44  Aligned_cols=136  Identities=21%  Similarity=0.298  Sum_probs=118.7

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.+++++.+.+|||||||+||+|.+++++. +.+++..++.++.|++.|+.|+|+++  |+|||+||+||+
T Consensus        88 ~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNIL  164 (311)
T 4aw0_A           88 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENIL  164 (311)
T ss_dssp             TCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             hCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeE
Confidence            356899999999999999999999999999999999875 57999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeecC
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~~  150 (150)
                      ++.++.+|++|||+++.........          ...+.+||+.|||||++         |+||+||++++|++|..
T Consensus       165 l~~~g~vKl~DFGla~~~~~~~~~~----------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~  232 (311)
T 4aw0_A          165 LNEDMHIQITDFGTAKVLSPESKQA----------RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP  232 (311)
T ss_dssp             ECTTSCEEECCCTTCEECCTTTTCC----------CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred             EcCCCCEEEEEcCCceecCCCCCcc----------cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            9999999999999998542211110          11245799999999995         99999999999999863

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.7e-37  Score=221.36  Aligned_cols=133  Identities=26%  Similarity=0.430  Sum_probs=116.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+||++.++++..+.+|||||||+||+|.+++.... ..+++..+..++.|++.|+.|+|+++  |+|||+||+|||
T Consensus        80 l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NIL  157 (350)
T 4b9d_A           80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIF  157 (350)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEE
T ss_pred             CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEE
Confidence            458999999999999999999999999999999997643 45789999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.+||+|||+++....       .     .....+.+||+.|||||++         |+||+||++++|++|.
T Consensus       158 l~~~g~vKl~DFGla~~~~~-------~-----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~  222 (350)
T 4b9d_A          158 LTKDGTVQLGDFGIARVLNS-------T-----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK  222 (350)
T ss_dssp             ECTTCCEEECSTTEESCCCH-------H-----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCCEEEcccccceeecC-------C-----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            99999999999999975311       0     0112245799999999995         9999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.3e-37  Score=221.48  Aligned_cols=131  Identities=24%  Similarity=0.462  Sum_probs=116.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+||++.++++..+.+|||||||+||+|.+++..  ..+++..+..++.|++.|+.|+|+++  |+|||+||+|||+
T Consensus       128 l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl  203 (346)
T 4fih_A          128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILL  203 (346)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEE
Confidence            4589999999999999999999999999999999976  46999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+|++|||+++........            ..+.+||+.|||||++         |+||+||+++||++|.
T Consensus       204 ~~~g~vKl~DFGla~~~~~~~~~------------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~  267 (346)
T 4fih_A          204 THDGRVKLSDFGFCAQVSKEVPR------------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE  267 (346)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCC------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEecCcCceecCCCCCc------------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            99999999999999754322111            1245899999999995         9999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.9e-37  Score=220.23  Aligned_cols=138  Identities=29%  Similarity=0.335  Sum_probs=115.8

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+||++.++++..+.+|||||||+||+|.++++.. +.+++..+..++.|++.|+.|+|+++  |+|||+||+|||
T Consensus       106 ~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NIL  182 (336)
T 4g3f_A          106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVL  182 (336)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEE
T ss_pred             hCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEE
Confidence            356899999999999999999999999999999999875 57999999999999999999999999  999999999999


Q ss_pred             EcCCC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++ .+||+|||+++.........       ........+||+.|||||++         |+||+||++++|++|.
T Consensus       183 l~~~g~~vKl~DFGla~~~~~~~~~~-------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~  253 (336)
T 4g3f_A          183 LSSDGSRAALCDFGHALCLQPDGLGK-------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC  253 (336)
T ss_dssp             ECTTSCCEEECCCTTCEEC-------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EeCCCCEEEEeeCCCCeEccCCCccc-------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCc
Confidence            99987 69999999998543211100       00111234799999999995         9999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-37  Score=218.15  Aligned_cols=134  Identities=28%  Similarity=0.392  Sum_probs=117.0

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++++..+.+|||||||+||+|.+++++. ..+++..+..++.|++.|+.|+|+++  |+|||+||+||+
T Consensus        82 ~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NIL  158 (304)
T 3ubd_A           82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENIL  158 (304)
T ss_dssp             CCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEE
T ss_pred             HCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeE
Confidence            356899999999999999999999999999999999875 57999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeecC
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~~  150 (150)
                      ++.++.+|++|||+++.......            ...+.+||+.|||||++         |+||+||++++|++|..
T Consensus       159 l~~~g~vKl~DFGla~~~~~~~~------------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~  224 (304)
T 3ubd_A          159 LDEEGHIKLTDFGLSKESIDHEK------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL  224 (304)
T ss_dssp             ECTTSCEEEESSEEEEC-----C------------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             EcCCCCEEecccccceeccCCCc------------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCC
Confidence            99999999999999975322111            11245799999999995         99999999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.1e-37  Score=223.41  Aligned_cols=131  Identities=24%  Similarity=0.462  Sum_probs=116.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+||++.++++..+.+|||||||+||+|.++++.  ..+++..+..++.|++.|+.|||+++  |+|||+||+|||+
T Consensus       205 l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl  280 (423)
T 4fie_A          205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILL  280 (423)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEE
T ss_pred             CCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEE
Confidence            4589999999999999999999999999999999975  46999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+||+|||++.........            ..+.+||+.|||||++         |+||+||+++||++|.
T Consensus       281 ~~~g~vKl~DFGla~~~~~~~~~------------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~  344 (423)
T 4fie_A          281 THDGRVKLSDFGFCAQVSKEVPR------------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE  344 (423)
T ss_dssp             CTTCCEEECCCTTCEECCSSCCC------------BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEecCccceECCCCCcc------------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            99999999999999754322111            1245799999999995         9999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2e-36  Score=212.41  Aligned_cols=133  Identities=29%  Similarity=0.377  Sum_probs=114.1

Q ss_pred             cccchhhhcccCCCCC----ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           2 EYLSAAFIDKHSTPHG----MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      ++-||+||++.++++.    .+.+|||||||+||+|.+++++. ..+++..+..++.|++.|+.|+|+++++|+|||+||
T Consensus        81 ~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp  159 (290)
T 3fpq_A           81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC  159 (290)
T ss_dssp             TCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCG
T ss_pred             hCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccCh
Confidence            3568999999987653    56789999999999999999865 579999999999999999999999877799999999


Q ss_pred             CCEEEcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeee
Q psy1934          78 ENLLISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        78 ~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g  148 (150)
                      +|||++. ++.+|++|||+|+.....              ...+.+||+.|||||++        |+||+|+++++|++|
T Consensus       160 ~NILl~~~~g~vKl~DFGla~~~~~~--------------~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg  225 (290)
T 3fpq_A          160 DNIFITGPTGSVKIGDLGLATLKRAS--------------FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATS  225 (290)
T ss_dssp             GGEEESSTTSCEEECCTTGGGGCCTT--------------SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHS
T ss_pred             hheeEECCCCCEEEEeCcCCEeCCCC--------------ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence            9999975 689999999998642111              01245799999999995        999999999999998


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       226 ~  226 (290)
T 3fpq_A          226 E  226 (290)
T ss_dssp             S
T ss_pred             C
Confidence            6

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-36  Score=212.92  Aligned_cols=136  Identities=24%  Similarity=0.339  Sum_probs=113.4

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||||+++.++... +.++||||||+||+|.+++......+++..+..++.|++.|+.|+|+++  |+|||+||+|||
T Consensus        88 ~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NIL  164 (307)
T 3omv_A           88 KTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIF  164 (307)
T ss_dssp             TCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEE
T ss_pred             hCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEE
Confidence            4679999999987654 5789999999999999999876667999999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.+||+|||+++.......          .......+||+.|||||++            |+||+|+++|||++|.
T Consensus       165 l~~~~~~Ki~DFGla~~~~~~~~----------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~  234 (307)
T 3omv_A          165 LHEGLTVKIGDFGLATVKSRWSG----------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE  234 (307)
T ss_dssp             EETTEEEEECCCSSCBC----------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCcEEEeeccCceecccCCc----------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCC
Confidence            99999999999999975321110          0112245799999999974            9999999999999986


Q ss_pred             C
Q psy1934         150 V  150 (150)
Q Consensus       150 ~  150 (150)
                      .
T Consensus       235 ~  235 (307)
T 3omv_A          235 L  235 (307)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.3e-36  Score=208.42  Aligned_cols=131  Identities=29%  Similarity=0.389  Sum_probs=108.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+||||| +|+|.+++... ..+++..++.++.|++.|+.|+|+++  |+|||+||+||++
T Consensus        70 l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl  145 (275)
T 3hyh_A           70 LRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLL  145 (275)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEE
T ss_pred             CCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEE
Confidence            45899999999999999999999999 57999999764 57999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeecC
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~~  150 (150)
                      +.++.+|++|||+++.....             ....+.+||+.|||||++          |+||+|+++++|++|+.
T Consensus       146 ~~~~~vkl~DFGla~~~~~~-------------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~  210 (275)
T 3hyh_A          146 DEHLNVKIADFGLSNIMTDG-------------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL  210 (275)
T ss_dssp             CTTCCEEECCSSCC----------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCCEEEeecCCCeecCCC-------------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCC
Confidence            99999999999998743211             011245799999999985          99999999999999863

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1e-35  Score=209.85  Aligned_cols=136  Identities=19%  Similarity=0.237  Sum_probs=115.8

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      ++-||||+++.+++...+.++||||||++|+|.++++...            ..+++..+..++.|++.|+.|+|+++  
T Consensus        71 ~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--  148 (299)
T 4asz_A           71 NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--  148 (299)
T ss_dssp             TCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            4669999999999999999999999999999999997532            35899999999999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      |+|||+||+||+++.++.+|++|||+++........          .......||+.|||||++         |+||+|+
T Consensus       149 iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~----------~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gv  218 (299)
T 4asz_A          149 FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY----------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV  218 (299)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCE----------EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             cccCccCHhhEEECCCCcEEECCcccceecCCCCce----------eecCceecChhhcCHHHHcCCCCCchhhHHHHHH
Confidence            999999999999999999999999999743221110          011123589999999995         9999999


Q ss_pred             eEEEeee-ec
Q psy1934         141 IGRSMLY-GH  149 (150)
Q Consensus       141 ~~~~~~~-g~  149 (150)
                      ++|||++ |.
T Consensus       219 vl~Ellt~G~  228 (299)
T 4asz_A          219 VLWEIFTYGK  228 (299)
T ss_dssp             HHHHHHTTTC
T ss_pred             HHHHHHcCCC
Confidence            9999996 65

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.1e-35  Score=208.70  Aligned_cols=136  Identities=19%  Similarity=0.239  Sum_probs=110.7

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--------------CCCCHHHHHHHHHHHHHHHHHHhcCC
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--------------SALPPNIVCSILWQTCQAVKHMHGQN   67 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~l~~~~~~~~~~~i~~~l~~lh~~~   67 (150)
                      ++-|||||++.+++...+.+|||||||++|+|.++++...              .++++..+..++.|++.|+.|+|+++
T Consensus        99 ~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~  178 (329)
T 4aoj_A           99 MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH  178 (329)
T ss_dssp             TCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            4679999999999999999999999999999999997532              35889999999999999999999998


Q ss_pred             CCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccccc
Q psy1934          68 PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNN  138 (150)
Q Consensus        68 ~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~  138 (150)
                        |+|||+||+||+++.++.+||+|||+++.......          ........||+.|||||++         |+||+
T Consensus       179 --iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~----------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~  246 (329)
T 4aoj_A          179 --FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY----------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSF  246 (329)
T ss_dssp             --CCCSCCCGGGEEEETTTEEEECCCC--------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred             --eecccccHhhEEECCCCcEEEcccccceeccCCCc----------ceecCcccccccccChhhhcCCCCCccccccch
Confidence              99999999999999999999999999975322111          0111245789999999985         99999


Q ss_pred             ceeEEEeee-ec
Q psy1934         139 YVIGRSMLY-GH  149 (150)
Q Consensus       139 g~~~~~~~~-g~  149 (150)
                      |+++|||++ |.
T Consensus       247 Gvvl~Ellt~G~  258 (329)
T 4aoj_A          247 GVVLWEIFTYGK  258 (329)
T ss_dssp             HHHHHHHHTTSC
T ss_pred             HHHHHHHHcCCC
Confidence            999999996 65

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.1e-35  Score=221.81  Aligned_cols=129  Identities=24%  Similarity=0.287  Sum_probs=116.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+|+++.++++..+.+|||||||+||+|.+++... +.+++..++.++.|++.|+.|+|+++  |+|||+||+|||++
T Consensus       250 ~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld  326 (689)
T 3v5w_A          250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD  326 (689)
T ss_dssp             CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC
T ss_pred             CCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe
Confidence            4799999999999999999999999999999999875 57999999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      .++.+||+|||+|+......              ..+.+||+.|||||++          |+||+||++++|++|.
T Consensus       327 ~~G~vKL~DFGlA~~~~~~~--------------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~  388 (689)
T 3v5w_A          327 EHGHVRISDLGLACDFSKKK--------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH  388 (689)
T ss_dssp             TTSCEEECCCTTCEECSSCC--------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCEEecccceeeecCCCC--------------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999997542211              1245899999999985          9999999999999996

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.7e-35  Score=206.14  Aligned_cols=144  Identities=22%  Similarity=0.313  Sum_probs=103.1

Q ss_pred             cccchhhhcccCCCCCc------------eEEEEEEeccCCCCHHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHhcCC
Q psy1934           2 EYLSAAFIDKHSTPHGM------------HEYLILTELCTGGSLVDVLKERTS--ALPPNIVCSILWQTCQAVKHMHGQN   67 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~------------~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~   67 (150)
                      ++-||+|+++.+++...            ..+|+|||||++|+|.++++....  ..++..+..++.|++.|+.|+|+++
T Consensus        59 ~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~  138 (299)
T 4g31_A           59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG  138 (299)
T ss_dssp             TCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc
Confidence            45689999998876533            347999999999999999986431  2445667889999999999999999


Q ss_pred             CCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccccc
Q psy1934          68 PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNN  138 (150)
Q Consensus        68 ~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~  138 (150)
                        |+|||+||+||+++.++.+|++|||+++......................+.+||+.|||||++         |+||+
T Consensus       139 --IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl  216 (299)
T 4g31_A          139 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL  216 (299)
T ss_dssp             --CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHH
T ss_pred             --CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHH
Confidence              9999999999999999999999999998543221111100001111223456899999999985         99999


Q ss_pred             ceeEEEeee
Q psy1934         139 YVIGRSMLY  147 (150)
Q Consensus       139 g~~~~~~~~  147 (150)
                      ||+++||++
T Consensus       217 Gvilyell~  225 (299)
T 4g31_A          217 GLILFELLY  225 (299)
T ss_dssp             HHHHHHHHS
T ss_pred             HHHHHHHcc
Confidence            999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.6e-35  Score=206.14  Aligned_cols=136  Identities=21%  Similarity=0.274  Sum_probs=115.2

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcC
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQ   66 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~   66 (150)
                      ++-||||+++.+++...+.++||||||++|+|.++|....               ..+++..+..++.|++.|+.|+|++
T Consensus        85 ~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~  164 (308)
T 4gt4_A           85 RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH  164 (308)
T ss_dssp             HCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3569999999999999999999999999999999996431               3588999999999999999999999


Q ss_pred             CCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccc
Q psy1934          67 NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWN  137 (150)
Q Consensus        67 ~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~  137 (150)
                      +  ++|||+|++|||++.++.+|++|||+++........          .......||+.|||||++         |+||
T Consensus       165 ~--iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~----------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwS  232 (308)
T 4gt4_A          165 H--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS  232 (308)
T ss_dssp             T--CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCB----------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             C--CCCCCccccceEECCCCCEEECCcccceeccCCCce----------eEecccccCCcccCHHHHhCCCCCccchhhh
Confidence            8  999999999999999999999999998754221110          011234689999999985         9999


Q ss_pred             cceeEEEeee-ec
Q psy1934         138 NYVIGRSMLY-GH  149 (150)
Q Consensus       138 ~g~~~~~~~~-g~  149 (150)
                      +|+++|||++ |.
T Consensus       233 fGvvl~El~t~g~  245 (308)
T 4gt4_A          233 YGVVLWEVFSYGL  245 (308)
T ss_dssp             HHHHHHHHHTTTC
T ss_pred             HHHHHHHHHhCCC
Confidence            9999999986 64

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2e-34  Score=203.84  Aligned_cols=138  Identities=22%  Similarity=0.296  Sum_probs=110.6

Q ss_pred             cccchhhhcccCCCCCc----eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeE
Q psy1934           2 EYLSAAFIDKHSTPHGM----HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NPPIV   71 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~------~~~i~   71 (150)
                      ++-||||+++.+++...    ..+|||||||++|+|.++++.  ..++++.+..++.|++.|+.|+|++      .++|+
T Consensus        53 ~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~Ii  130 (303)
T 3hmm_A           53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA  130 (303)
T ss_dssp             TCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEE
T ss_pred             cCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEe
Confidence            45699999998876644    368999999999999999986  3688999999999999999999976      22399


Q ss_pred             EecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------ccc
Q psy1934          72 HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DTW  136 (150)
Q Consensus        72 h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~~  136 (150)
                      |||+||+|||++.++.+|++|||+++...........        .....+||+.|||||++               |+|
T Consensus       131 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~--------~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVw  202 (303)
T 3hmm_A          131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI--------APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY  202 (303)
T ss_dssp             CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESC--------C-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred             eccCCcccEEECCCCCEEEEeCCCCccccCCCCceee--------ecccccccccccCHHHhcccccccCCccChhHhhh
Confidence            9999999999999999999999999764332211100        11235799999999973               999


Q ss_pred             ccceeEEEeeeec
Q psy1934         137 NNYVIGRSMLYGH  149 (150)
Q Consensus       137 ~~g~~~~~~~~g~  149 (150)
                      |+|++++||++|.
T Consensus       203 S~Gvvl~El~tg~  215 (303)
T 3hmm_A          203 AMGLVFWEIARRC  215 (303)
T ss_dssp             HHHHHHHHHHHTB
T ss_pred             hHHHHHHHHHHCC
Confidence            9999999998873

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.98  E-value=1.2e-33  Score=204.03  Aligned_cols=139  Identities=27%  Similarity=0.302  Sum_probs=111.7

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+++.++++..+++|+|||||++|+|.++++    .+++..++.++.|++.|+.|+|+++  |+|||+||+||+++.
T Consensus        79 h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~  152 (361)
T 4f9c_A           79 QDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNR  152 (361)
T ss_dssp             BTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEET
T ss_pred             CCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeC
Confidence            7899999999999999999999999999999984    4899999999999999999999999  999999999999987


Q ss_pred             C-CcEEEeecCceeccccCCCcchhH----------------hhhhhhHHhhhcCCCCCccCcccc----------cccc
Q psy1934          85 A-GTVKLCDFGSATEKVYSPDNAWSA----------------QQRSMLEDEMARFTTPMYRAPEMV----------DTWN  137 (150)
Q Consensus        85 ~-~~~~l~dfg~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~  137 (150)
                      + +.+|++|||+|+............                ..........+.+||+.|||||++          |+||
T Consensus       153 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWS  232 (361)
T 4f9c_A          153 RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS  232 (361)
T ss_dssp             TTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred             CCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhh
Confidence            7 799999999997543221100000                000001122345899999999984          9999


Q ss_pred             cceeEEEeeeec
Q psy1934         138 NYVIGRSMLYGH  149 (150)
Q Consensus       138 ~g~~~~~~~~g~  149 (150)
                      +||++++|++|.
T Consensus       233 lG~il~ell~G~  244 (361)
T 4f9c_A          233 AGVIFLSLLSGR  244 (361)
T ss_dssp             HHHHHHHHHHTC
T ss_pred             hHHHHHHHHHCC
Confidence            999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=9.6e-34  Score=203.72  Aligned_cols=132  Identities=23%  Similarity=0.395  Sum_probs=109.8

Q ss_pred             hhhhcccCCCC-CceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           6 AAFIDKHSTPH-GMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         6 ~~~~~~~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      |+||++.+++. ..+.++||||||++|+|.++|+...               ..+++..+..++.|++.|+.|+|+++  
T Consensus       128 pnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--  205 (353)
T 4ase_A          128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--  205 (353)
T ss_dssp             TTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--
Confidence            68999998764 4567999999999999999997531               24788899999999999999999999  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|||+||+||+++.++.+||+|||+++.........          ......||+.|||||++         |+||+||
T Consensus       206 iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~----------~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv  275 (353)
T 4ase_A          206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV  275 (353)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSE----------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             eecCccCccceeeCCCCCEEECcchhhhhcccCCCce----------eeccccccccccCHHHHhcCCCCCcccEeehHH
Confidence            9999999999999999999999999997543221111          11234689999999985         9999999


Q ss_pred             eEEEeee-ec
Q psy1934         141 IGRSMLY-GH  149 (150)
Q Consensus       141 ~~~~~~~-g~  149 (150)
                      ++|||++ |.
T Consensus       276 ~l~El~t~G~  285 (353)
T 4ase_A          276 LLWEIFSLGA  285 (353)
T ss_dssp             HHHHHTTTSC
T ss_pred             HHHHHHhCCC
Confidence            9999986 65

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=1e-32  Score=209.21  Aligned_cols=132  Identities=25%  Similarity=0.436  Sum_probs=115.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|||||||+||+|.+++......+++..+..++.|++.|+.|||+++  |+|||+||+||++
T Consensus       211 l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill  288 (573)
T 3uto_A          211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMF  288 (573)
T ss_dssp             TCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccc
Confidence            45899999999999999999999999999999999765567999999999999999999999999  9999999999999


Q ss_pred             cCC--CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSA--GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.+  +.+|++|||+++.......             ....+||+.|||||++         |+||+||++++|++|.
T Consensus       289 ~~~~~~~vKl~DFG~a~~~~~~~~-------------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~  353 (573)
T 3uto_A          289 TTKRSNELKLIDFGLTAHLDPKQS-------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL  353 (573)
T ss_dssp             SSSSCCCEEECCCSSCEECCTTSE-------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred             cCCCCCCEEEeeccceeEccCCCc-------------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            864  7899999999985422110             1235799999999995         9999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.1e-32  Score=201.09  Aligned_cols=135  Identities=27%  Similarity=0.379  Sum_probs=110.6

Q ss_pred             ccchhhhcccCCCC------CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPH------GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~------~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||+|+++.++++      ..+.+|||||||+ |+|.+++... ..+++..++.++.|++.|+.|+|+++  |+|||+|
T Consensus       110 l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlK  185 (398)
T 4b99_A          110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLK  185 (398)
T ss_dssp             CCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCC
T ss_pred             cCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcC
Confidence            45899999887543      4578999999996 5899999754 57999999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.+|++|||+++........        ......+.+||+.|||||++          |+||+||+++||+
T Consensus       186 P~NIl~~~~~~~Ki~DFGla~~~~~~~~~--------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell  257 (398)
T 4b99_A          186 PSNLLVNENCELKIGDFGMARGLCTSPAE--------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML  257 (398)
T ss_dssp             GGGEEECTTCCEEECCCTTCBCC---------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccccCCCCCEEEeecceeeecccCccc--------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence            99999999999999999999753221100        00112245899999999984          9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       258 ~G~  260 (398)
T 4b99_A          258 ARR  260 (398)
T ss_dssp             HTS
T ss_pred             HCC
Confidence            986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.95  E-value=1e-29  Score=187.52  Aligned_cols=134  Identities=27%  Similarity=0.406  Sum_probs=116.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      .-|++|+++.+.++..+.+|+||||+++|+|.+++......+++..++.++.|++.|+.|+|+.+  ++|||+||+||++
T Consensus       131 ~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl  208 (437)
T 4aw2_A          131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILM  208 (437)
T ss_dssp             SCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeE
Confidence            34788999999999999999999999999999999875567999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g  148 (150)
                      +.++.+|++|||+++.........           ....+||+.|+|||++              |+||+|+++++|++|
T Consensus       209 ~~~g~vkL~DFGla~~~~~~~~~~-----------~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG  277 (437)
T 4aw2_A          209 DMNGHIRLADFGSCLKLMEDGTVQ-----------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG  277 (437)
T ss_dssp             CTTSCEEECCCTTCEECCTTSCEE-----------CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHS
T ss_pred             cCCCCEEEcchhhhhhcccCCCcc-----------cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhC
Confidence            999999999999987543221110           1134799999999973              999999999999998


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       278 ~  278 (437)
T 4aw2_A          278 E  278 (437)
T ss_dssp             S
T ss_pred             C
Confidence            6

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.95  E-value=9.2e-30  Score=183.32  Aligned_cols=130  Identities=25%  Similarity=0.382  Sum_probs=111.9

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+++.++++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|||+++  ++|||+||+||+++.
T Consensus        83 hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~  159 (353)
T 3txo_A           83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDH  159 (353)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECT
T ss_pred             CCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECC
Confidence            789999999999999999999999999999999765 56999999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++........            .....+||+.|+|||++         |+||+|+++++|++|.
T Consensus       160 ~g~ikL~DFG~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~  221 (353)
T 3txo_A          160 EGHCKLADFGMCKEGICNGV------------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH  221 (353)
T ss_dssp             TSCEEECCCTTCBCSCC---------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCEEEccccceeecccCCc------------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCC
Confidence            99999999999874321111            11245799999999984         9999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=1.7e-29  Score=182.36  Aligned_cols=134  Identities=20%  Similarity=0.339  Sum_probs=114.2

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER----TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      .|++++.+.+.....+..++||||+++|+|.+++...    ...+++..+..++.|++.|+.|+|+++  ++|||+||+|
T Consensus       125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~N  202 (365)
T 3e7e_A          125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDN  202 (365)
T ss_dssp             GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGG
T ss_pred             hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHH
Confidence            4788999999988889999999999999999999752    346899999999999999999999998  9999999999


Q ss_pred             EEEcC-----------CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccc
Q psy1934          80 LLISS-----------AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNY  139 (150)
Q Consensus        80 il~~~-----------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g  139 (150)
                      |+++.           .+.++++|||++..........          ......||+.|+|||++         |+||+|
T Consensus       203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  272 (365)
T 3e7e_A          203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT----------IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA  272 (365)
T ss_dssp             EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTE----------EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHH
T ss_pred             EEecccccCccccccccCCEEEeeCchhhhhhccCCCc----------eeeeecCCCCCCChHHhcCCCCCccccHHHHH
Confidence            99988           8999999999997532211111          11245689999999985         999999


Q ss_pred             eeEEEeeeec
Q psy1934         140 VIGRSMLYGH  149 (150)
Q Consensus       140 ~~~~~~~~g~  149 (150)
                      +++++|++|.
T Consensus       273 ~il~elltg~  282 (365)
T 3e7e_A          273 ATVYCMLFGT  282 (365)
T ss_dssp             HHHHHHHHSS
T ss_pred             HHHHHHHhCC
Confidence            9999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.95  E-value=1.4e-29  Score=184.68  Aligned_cols=131  Identities=27%  Similarity=0.416  Sum_probs=115.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+|+++.++++..+.+++||||+++|+|.+++... ..+++..++.++.|++.|+.|||+++  ++|||+||+||+++
T Consensus       111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~  187 (396)
T 4dc2_A          111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD  187 (396)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC
T ss_pred             CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC
Confidence            3789999999999999999999999999999999865 56999999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||+++........            ....+||+.|+|||++         |+||+|+++++|++|.
T Consensus       188 ~~g~ikL~DFGla~~~~~~~~~------------~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~  250 (396)
T 4dc2_A          188 SEGHIKLTDYGMCKEGLRPGDT------------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR  250 (396)
T ss_dssp             TTSCEEECCCTTCBCCCCTTCC------------BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCEEEeecceeeecccCCCc------------cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence            9999999999998743221111            1245789999999985         9999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.95  E-value=2.9e-29  Score=183.95  Aligned_cols=134  Identities=25%  Similarity=0.409  Sum_probs=115.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      .-|++|+++.+.++..+.+|+||||+++|+|.+++......+++..++.++.+++.|+.|+|+++  ++|||+||+||++
T Consensus       118 ~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl  195 (412)
T 2vd5_A          118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILL  195 (412)
T ss_dssp             SCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             cCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeee
Confidence            34788999999999999999999999999999999876557999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------------cccccceeEEEee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------------DTWNNYVIGRSML  146 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------------d~~~~g~~~~~~~  146 (150)
                      +.++.+|++|||++.........           .....+||+.|+|||++                |+||+|+++++|+
T Consensus       196 d~~g~vkL~DFGla~~~~~~~~~-----------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell  264 (412)
T 2vd5_A          196 DRCGHIRLADFGSCLKLRADGTV-----------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF  264 (412)
T ss_dssp             CTTSCEEECCCTTCEECCTTSCE-----------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred             cCCCCEEEeechhheeccCCCcc-----------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence            99999999999998754221110           01134799999999963                9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       265 tG~  267 (412)
T 2vd5_A          265 YGQ  267 (412)
T ss_dssp             HSS
T ss_pred             hCC
Confidence            986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.95  E-value=4.1e-29  Score=178.93  Aligned_cols=132  Identities=23%  Similarity=0.339  Sum_probs=114.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        62 l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll  138 (337)
T 1o6l_A           62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML  138 (337)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE
T ss_pred             CCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEE
Confidence            45889999999999999999999999999999999765 46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       139 ~~~g~vkL~DFG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  202 (337)
T 1o6l_A          139 DKDGHIKITDFGLCKEGISDGAT------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  202 (337)
T ss_dssp             CTTSCEEECCCTTCBCSCCTTCC------------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEeeccchhhcccCCCc------------ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCC
Confidence            99999999999998743221111            1134689999999985         9999999999999886

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.95  E-value=4.6e-29  Score=179.21  Aligned_cols=131  Identities=24%  Similarity=0.378  Sum_probs=114.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+|+++.++++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|||++|+||+++
T Consensus        76 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~  152 (345)
T 1xjd_A           76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD  152 (345)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC
T ss_pred             CCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC
Confidence            4789999999999999999999999999999999865 46899999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.........            ....+||+.|+|||++         |+||+|+++++|++|.
T Consensus       153 ~~g~vkL~DFG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  215 (345)
T 1xjd_A          153 KDGHIKIADFGMCKENMLGDAK------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ  215 (345)
T ss_dssp             TTSCEEECCCTTCBCCCCTTCC------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCEEEeEChhhhhcccCCCc------------ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCC
Confidence            9999999999998743221111            1235789999999984         9999999999999886

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=6.3e-29  Score=180.13  Aligned_cols=132  Identities=27%  Similarity=0.362  Sum_probs=114.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      .-||+|+++.+.++..+.+|+||||++||+|.+++... ..+++..++.++.+++.|+.|+|+++  ++|||+||+||++
T Consensus        96 ~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll  172 (373)
T 2r5t_A           96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL  172 (373)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred             CCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE
Confidence            45788999999999999999999999999999999765 46889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||+++........            ....+||+.|+|||++         |+||+|+++++|++|.
T Consensus       173 ~~~g~ikL~DFG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~  236 (373)
T 2r5t_A          173 DSQGHIVLTDFGLCKENIEHNST------------TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL  236 (373)
T ss_dssp             CTTSCEEECCCCBCGGGBCCCCC------------CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEeeCccccccccCCCc------------cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCC
Confidence            99999999999998753221111            1235799999999984         9999999999999885

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.95  E-value=5.7e-29  Score=179.20  Aligned_cols=131  Identities=24%  Similarity=0.395  Sum_probs=114.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+|+++.+.++..+.+|+||||++||+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|||++|+||+++
T Consensus        79 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~  155 (353)
T 2i0e_A           79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD  155 (353)
T ss_dssp             CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC
T ss_pred             CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc
Confidence            3788999999999999999999999999999999865 46899999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.........            ....+||+.|+|||++         |+||+|+++++|++|.
T Consensus       156 ~~g~vkL~DFG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~  218 (353)
T 2i0e_A          156 SEGHIKIADFGMCKENIWDGVT------------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ  218 (353)
T ss_dssp             TTSCEEECCCTTCBCCCCTTCC------------BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCcEEEEeCCcccccccCCcc------------cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCC
Confidence            9999999999998743221111            1134689999999984         9999999999999886

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.95  E-value=9.6e-29  Score=175.74  Aligned_cols=129  Identities=28%  Similarity=0.437  Sum_probs=114.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+++||||+++|+|.+++... ..+++..+..++.+++.|+.|+|+++  ++|+|++|+||++
T Consensus        63 l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll  139 (318)
T 1fot_A           63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILL  139 (318)
T ss_dssp             CCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE
T ss_pred             CCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEE
Confidence            45889999999999999999999999999999999764 46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++......               .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       140 ~~~g~~kL~Dfg~a~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  200 (318)
T 1fot_A          140 DKNGHIKITDFGFAKYVPDV---------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY  200 (318)
T ss_dssp             CTTSCEEECCCSSCEECSSC---------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEeecCcceecCCc---------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCC
Confidence            99999999999998753211               1134689999999984         9999999999999885

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.95  E-value=3.6e-29  Score=183.33  Aligned_cols=132  Identities=24%  Similarity=0.348  Sum_probs=114.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      .-||+|+++.++++..+.+|+||||++||+|.++++.  ..+++..+..++.+++.|+.|+|+++  ++|||+||+||++
T Consensus       126 l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl  201 (410)
T 3v8s_A          126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL  201 (410)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeE
Confidence            3478999999999999999999999999999999976  36899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-------------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........           ...+.+||+.|+|||++             |+||+|+++++|++|.
T Consensus       202 ~~~g~ikL~DFG~a~~~~~~~~~-----------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~  270 (410)
T 3v8s_A          202 DKSGHLKLADFGTCMKMNKEGMV-----------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD  270 (410)
T ss_dssp             CTTSCEEECCCTTCEECCTTSEE-----------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEeccceeEeeccCCcc-----------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCC
Confidence            99999999999998753211100           01245799999999973             9999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=1.9e-28  Score=188.98  Aligned_cols=130  Identities=25%  Similarity=0.404  Sum_probs=114.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      |++|+.+.+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|||+.+  |+|||+||+||+++.
T Consensus       401 ~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~  477 (674)
T 3pfq_A          401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDS  477 (674)
T ss_dssp             CTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECS
T ss_pred             CCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcC
Confidence            677888999999999999999999999999999875 46899999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++|+|||+++........            .....||+.|+|||++         |+||+|++++||++|.
T Consensus       478 ~g~ikL~DFGla~~~~~~~~~------------~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~  539 (674)
T 3pfq_A          478 EGHIKIADFGMCKENIWDGVT------------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ  539 (674)
T ss_dssp             SSCEEECCCTTCEECCCTTCC------------BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred             CCcEEEeecceeeccccCCcc------------cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCC
Confidence            999999999998753222111            1245799999999985         9999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.95  E-value=7e-29  Score=178.21  Aligned_cols=131  Identities=27%  Similarity=0.416  Sum_probs=114.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+|+++.++++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|||++|+||+++
T Consensus        68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~  144 (345)
T 3a8x_A           68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD  144 (345)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC
T ss_pred             CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC
Confidence            3789999999999999999999999999999999765 46899999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.........            ....+||+.|+|||++         |+||+|+++++|++|.
T Consensus       145 ~~g~~kL~DFG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  207 (345)
T 3a8x_A          145 SEGHIKLTDYGMCKEGLRPGDT------------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR  207 (345)
T ss_dssp             TTSCEEECCGGGCBCSCCTTCC------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCEEEEeccccccccCCCCc------------ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCC
Confidence            9999999999998743211111            1234789999999984         9999999999999885

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.95  E-value=7.7e-29  Score=176.90  Aligned_cols=131  Identities=28%  Similarity=0.395  Sum_probs=114.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++.+..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        71 l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll  147 (328)
T 3fe3_A           71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLL  147 (328)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             CCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEE
Confidence            45899999999999999999999999999999999765 56899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.......             ......||+.|+|||++          |+||+|+++++|++|.
T Consensus       148 ~~~~~~kl~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  211 (328)
T 3fe3_A          148 DADMNIKIADFGFSNEFTVGG-------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS  211 (328)
T ss_dssp             CTTSCEEECSTTCCGGGSSSC-------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEeeccCceecCCCC-------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCC
Confidence            999999999999986432111             11245799999999984          9999999999999886

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.95  E-value=1.8e-28  Score=178.32  Aligned_cols=131  Identities=24%  Similarity=0.348  Sum_probs=115.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+++||||+++|+|.+++... ..+++..+..++.+++.|+.|+|+++  ++|+|++|+||++
T Consensus        72 l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll  148 (384)
T 4fr4_A           72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILL  148 (384)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEE
Confidence            45889999999999999999999999999999999764 56899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........             .....||+.|+|||++            |+||+|+++++|++|.
T Consensus       149 ~~~g~vkL~DFG~a~~~~~~~~-------------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~  214 (384)
T 4fr4_A          149 DEHGHVHITDFNIAAMLPRETQ-------------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR  214 (384)
T ss_dssp             CTTSCEEECCCTTCEECCTTCC-------------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEeccceeeeccCCCc-------------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCC
Confidence            9999999999999875422111             1245689999999984            9999999999999885

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.94  E-value=1.9e-28  Score=176.29  Aligned_cols=129  Identities=23%  Similarity=0.274  Sum_probs=114.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        98 l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll  174 (350)
T 1rdq_E           98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLI  174 (350)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEE
Confidence            45788999999999999999999999999999999865 46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++......               .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       175 ~~~g~~kL~DFg~a~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  235 (350)
T 1rdq_E          175 DQQGYIQVTDFGFAKRVKGR---------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY  235 (350)
T ss_dssp             CTTSCEEECCCTTCEECSSC---------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEcccccceeccCC---------------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCC
Confidence            99999999999998753211               1134689999999984         9999999999999885

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.94  E-value=3.2e-28  Score=171.34  Aligned_cols=131  Identities=27%  Similarity=0.472  Sum_probs=114.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++||||+++|+|.+++...  .+++..+..++.+++.|+.|+|+++  ++|+|++|+||++
T Consensus        74 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~  149 (297)
T 3fxz_A           74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL  149 (297)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEE
Confidence            35789999999988889999999999999999999763  6899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  213 (297)
T 3fxz_A          150 GMDGSVKLTDFGFCAQITPEQSK------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE  213 (297)
T ss_dssp             CTTCCEEECCCTTCEECCSTTCC------------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEeeCCCceecCCcccc------------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999998754222111            1134689999999985         9999999999999885

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.94  E-value=3.4e-28  Score=175.64  Aligned_cols=132  Identities=32%  Similarity=0.471  Sum_probs=114.2

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus        71 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIl  147 (361)
T 2yab_A           71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIM  147 (361)
T ss_dssp             TCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred             hCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence            345899999999999999999999999999999999754 56899999999999999999999999  999999999999


Q ss_pred             EcCCC----cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          82 ISSAG----TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        82 ~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      ++..+    .++++|||++........             .....||+.|+|||++         |+||+|+++++|++|
T Consensus       148 l~~~~~~~~~vkl~DFG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g  214 (361)
T 2yab_A          148 LLDKNIPIPHIKLIDFGLAHEIEDGVE-------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  214 (361)
T ss_dssp             ESCTTSSSCCEEECCCSSCEECCTTCC-------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             EeCCCCCccCEEEEecCCceEcCCCCc-------------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhC
Confidence            98776    799999999875422111             1134689999999984         999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       215 ~  215 (361)
T 2yab_A          215 A  215 (361)
T ss_dssp             C
T ss_pred             C
Confidence            5

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.9e-28  Score=185.86  Aligned_cols=126  Identities=14%  Similarity=0.082  Sum_probs=97.5

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      |++++++.+++++.+.+||||||++|++|.+++... +.+++.   .++.||+.|+.|+|+++  |+|||+||+||+++.
T Consensus       301 ~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~  374 (569)
T 4azs_A          301 GFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDA  374 (569)
T ss_dssp             TCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECT
T ss_pred             CCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECC
Confidence            567999999999999999999999999999999864 456664   36889999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeee
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g  148 (150)
                      ++.+||+|||+++........            ..+.+||+.|||||++        |+|+.|+..+++..|
T Consensus       375 dg~vKL~DFGlAr~~~~~~~~------------~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          375 RQHARLIDFGSIVTTPQDCSW------------PTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             TSCEEECCCTTEESCC---CC------------SHHHHHHHHHHHHHHC-----------------CCCCTT
T ss_pred             CCCEEEeecccCeeCCCCCcc------------ccCceechhhccHHHhCCCCCCcccccccccchhhhccc
Confidence            999999999999854322111            1234689999999995        899999998887654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.94  E-value=4e-28  Score=170.62  Aligned_cols=134  Identities=25%  Similarity=0.342  Sum_probs=111.6

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.+.++..+.+++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus        67 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil  143 (294)
T 4eqm_A           67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNIL  143 (294)
T ss_dssp             TCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEE
T ss_pred             cCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence            345899999999999999999999999999999999875 46899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++........           .......||+.|+|||++         |+||+|+++++|++|.
T Consensus       144 ~~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~  209 (294)
T 4eqm_A          144 IDSNKTLKIFDFGIAKALSETSL-----------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE  209 (294)
T ss_dssp             ECTTSCEEECCCSSSTTC------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCCEEEEeCCCccccccccc-----------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence            99999999999999864321100           011234689999999984         9999999999999885

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.94  E-value=3.4e-28  Score=177.71  Aligned_cols=130  Identities=32%  Similarity=0.431  Sum_probs=105.5

Q ss_pred             chhhhcccCCCCC----ceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           5 SAAFIDKHSTPHG----MHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         5 ~~~~~~~~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      |++|+++.++++.    .+.+|+||||+++|+|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|+||+|
T Consensus       114 hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~N  191 (400)
T 1nxk_A          114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPEN  191 (400)
T ss_dssp             STTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred             CCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcce
Confidence            6888888876654    778999999999999999998643 35899999999999999999999999  9999999999


Q ss_pred             EEEcC---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          80 LLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        80 il~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+++.   ++.+|++|||++.......             ......||+.|+|||++         |+||+|+++++|++
T Consensus       192 ill~~~~~~~~~kl~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  258 (400)
T 1nxk_A          192 LLYTSKRPNAILKLTDFGFAKETTSHN-------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC  258 (400)
T ss_dssp             EEESSSSTTCCEEECCCTTCEECC------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH
T ss_pred             EEEecCCCCccEEEEecccccccCCCC-------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh
Confidence            99987   6889999999987532110             11234689999999985         99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       259 g~  260 (400)
T 1nxk_A          259 GY  260 (400)
T ss_dssp             SS
T ss_pred             CC
Confidence            85

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.94  E-value=5.6e-28  Score=170.73  Aligned_cols=146  Identities=21%  Similarity=0.242  Sum_probs=115.7

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.+++...+.+++||||+++++|.++++.....+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus        63 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil  140 (310)
T 3s95_A           63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCL  140 (310)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEE
T ss_pred             hCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEE
Confidence            345899999999999999999999999999999999876667999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhH--hhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSA--QQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++.............  .............||+.|+|||++         |+||+|++++++++|.
T Consensus       141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~  219 (310)
T 3s95_A          141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV  219 (310)
T ss_dssp             ECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             ECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCC
Confidence            9999999999999987543221110000  000001112245789999999984         9999999999998764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.94  E-value=5.4e-28  Score=183.03  Aligned_cols=132  Identities=24%  Similarity=0.319  Sum_probs=115.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.+.++..+.+|+||||++||+|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|||++|+||+
T Consensus       241 l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNIL  318 (576)
T 2acx_A          241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENIL  318 (576)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred             cCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEE
Confidence            357899999999999999999999999999999997643 34899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++........             ....+||+.|+|||++         |+||+|+++++|++|.
T Consensus       319 ld~~g~vKL~DFGla~~~~~~~~-------------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~  382 (576)
T 2acx_A          319 LDDHGHIRISDLGLAVHVPEGQT-------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ  382 (576)
T ss_dssp             ECTTSCEEECCCTTCEECCTTCC-------------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSS
T ss_pred             EeCCCCeEEEecccceecccCcc-------------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence            99999999999999875422111             1134799999999985         9999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.94  E-value=4e-28  Score=179.41  Aligned_cols=132  Identities=25%  Similarity=0.349  Sum_probs=113.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.+.++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|||+ .+  ++|+|++|+||+
T Consensus       205 l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIl  281 (446)
T 4ejn_A          205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLM  281 (446)
T ss_dssp             CSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEE
T ss_pred             CCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEE
Confidence            45889999999999999999999999999999999765 468999999999999999999998 88  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       282 l~~~~~~kl~DFG~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  346 (446)
T 4ejn_A          282 LDKDGHIKITDFGLCKEGIKDGA------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  346 (446)
T ss_dssp             ECSSSCEEECCCCCCCTTCC-----------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCCEEEccCCCceeccCCCc------------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCC
Confidence            99999999999999874221110            11245789999999985         9999999999999886

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=3.2e-28  Score=173.18  Aligned_cols=132  Identities=25%  Similarity=0.420  Sum_probs=114.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+++||||+++++|.+++......+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        58 l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~  135 (321)
T 1tki_A           58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIY  135 (321)
T ss_dssp             SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEE
Confidence            34789999999999999999999999999999999765557899999999999999999999999  9999999999999


Q ss_pred             cC--CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SS--AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.  ++.++++|||++........             .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       136 ~~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  200 (321)
T 1tki_A          136 QTRRSSTIKIIEFGQARQLKPGDN-------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI  200 (321)
T ss_dssp             SSSSCCCEEECCCTTCEECCTTCE-------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCCCEEEEECCCCeECCCCCc-------------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            87  68999999999875421110             1134689999999984         9999999999999885

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.94  E-value=1.1e-27  Score=180.55  Aligned_cols=133  Identities=22%  Similarity=0.276  Sum_probs=114.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-||+|+++.+.++..+.+|+||||++||+|.+++....   ..+++..+..++.|++.|+.|+|+++  ++|||+||+|
T Consensus       242 l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~N  319 (543)
T 3c4z_A          242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPEN  319 (543)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred             cCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHH
Confidence            347889999999999999999999999999999997542   35899999999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      |+++.++.++++|||++.........            .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       320 ILl~~~g~vkL~DFGla~~~~~~~~~------------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~  386 (543)
T 3c4z_A          320 VLLDDDGNVRISDLGLAVELKAGQTK------------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR  386 (543)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTCCC------------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             EEEeCCCCEEEeecceeeeccCCCcc------------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCC
Confidence            99999999999999999754221110            1134799999999985         9999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.94  E-value=6e-28  Score=172.08  Aligned_cols=132  Identities=27%  Similarity=0.379  Sum_probs=111.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+|+||||+++++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        78 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill  154 (327)
T 3a62_A           78 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIML  154 (327)
T ss_dssp             CCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEE
T ss_pred             CCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEE
Confidence            45889999999999999999999999999999999765 46888999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  218 (327)
T 3a62_A          155 NHQGHVKLTDFGLCKESIHDGT------------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA  218 (327)
T ss_dssp             CTTSCEEECCCSCC----------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCcEEEEeCCcccccccCCc------------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCC
Confidence            9999999999999864221110            11234689999999985         9999999999999885

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.94  E-value=1.6e-27  Score=172.55  Aligned_cols=134  Identities=20%  Similarity=0.295  Sum_probs=112.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNP   68 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~   68 (150)
                      -||+|+++.+.+...+.+|+||||+++|+|.+++....               ..+++..+..++.|++.|+.|+|+++ 
T Consensus       145 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-  223 (370)
T 2psq_A          145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-  223 (370)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             CCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            38999999999999999999999999999999998643               24788888999999999999999999 


Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccc
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNY  139 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g  139 (150)
                       ++|+|+||+||+++.++.+|++|||++..........          ......+++.|+|||++         |+||+|
T Consensus       224 -ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG  292 (370)
T 2psq_A          224 -CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK----------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG  292 (370)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTC----------TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHH
T ss_pred             -eeccccchhhEEECCCCCEEEccccCCcccCccccee----------cccCCCcccceECHhHhcCCCCCcHHHHHHHH
Confidence             9999999999999999999999999987532211100          01123467889999974         999999


Q ss_pred             eeEEEeee-ec
Q psy1934         140 VIGRSMLY-GH  149 (150)
Q Consensus       140 ~~~~~~~~-g~  149 (150)
                      +++++|++ |.
T Consensus       293 ~il~ellt~g~  303 (370)
T 2psq_A          293 VLMWEIFTLGG  303 (370)
T ss_dssp             HHHHHHHTTSC
T ss_pred             HHHHHHHcCCC
Confidence            99999987 64

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=1.6e-27  Score=171.00  Aligned_cols=130  Identities=28%  Similarity=0.434  Sum_probs=111.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+++.++++..+.+|+||||+++|+|.+++... ..+++..+..++.+++.|+.|+|+++  ++|+|++|+||++..
T Consensus        75 hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~  151 (342)
T 2qr7_A           75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVD  151 (342)
T ss_dssp             STTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESS
T ss_pred             CCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEec
Confidence            899999999999999999999999999999999764 46899999999999999999999999  999999999999844


Q ss_pred             C----CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 A----GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .    +.++++|||++.........            .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       152 ~~~~~~~~kl~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  217 (342)
T 2qr7_A          152 ESGNPESIRICDFGFAKQLRAENGL------------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY  217 (342)
T ss_dssp             SSCSGGGEEECCCTTCEECBCTTCC------------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCcCeEEEEECCCcccCcCCCCc------------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCC
Confidence            3    35999999998754322111            1134689999999985         9999999999999885

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.94  E-value=1.8e-27  Score=175.92  Aligned_cols=132  Identities=31%  Similarity=0.394  Sum_probs=113.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+++||||+++|+|.+.+... ..+++..+..++.|++.|+.|+|+++  ++|+|+||+||++
T Consensus        67 l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll  143 (444)
T 3soa_A           67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLL  143 (444)
T ss_dssp             CCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEE
T ss_pred             CCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE
Confidence            45899999999999999999999999999999999765 56899999999999999999999999  9999999999999


Q ss_pred             cC---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.   .+.++++|||++.........            .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       144 ~~~~~~~~vkL~DFG~a~~~~~~~~~------------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~  210 (444)
T 3soa_A          144 ASKLKGAAVKLADFGLAIEVEGEQQA------------WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGY  210 (444)
T ss_dssp             SBSSTTCCEEECCCSSCBCCCTTCCB------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             eccCCCCcEEEccCceeEEecCCCce------------eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCC
Confidence            84   578999999998654221110            1134689999999985         9999999999999885

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.94  E-value=1.2e-27  Score=170.45  Aligned_cols=136  Identities=24%  Similarity=0.319  Sum_probs=113.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+++...+.+++||||+++++|.++++.....+++..+..++.+++.|+.|+|+.+  ++|+|++|+||++
T Consensus       107 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll  184 (325)
T 3kul_A          107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLV  184 (325)
T ss_dssp             CCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             CCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEE
Confidence            45889999999999999999999999999999999876567999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++............         .....+|+.|+|||++         |+||+|+++++|++ |.
T Consensus       185 ~~~~~~kl~Dfg~a~~~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~  252 (325)
T 3kul_A          185 DSNLVCKVSDFGLSRVLEDDPDAAYT---------TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE  252 (325)
T ss_dssp             CTTCCEEECCCSSCEECC----CCEE---------CC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCCEEECCCCcccccccCccceee---------ccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence            99999999999998754322111100         0122357789999985         99999999999987 64

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.93  E-value=2e-27  Score=169.36  Aligned_cols=131  Identities=31%  Similarity=0.455  Sum_probs=113.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        71 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll  147 (326)
T 2y0a_A           71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIML  147 (326)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEE
Confidence            34899999999999999999999999999999999754 56899999999999999999999999  9999999999999


Q ss_pred             cCCC----cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAG----TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +..+    .++++|||++........             .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       148 ~~~~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  214 (326)
T 2y0a_A          148 LDRNVPKPRIKIIDFGLAHKIDFGNE-------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  214 (326)
T ss_dssp             SCSSSSSCCEEECCCTTCEECCTTSC-------------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCCCCEEEEECCCCeECCCCCc-------------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCc
Confidence            8876    799999999875422111             1134689999999984         9999999999999885

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.93  E-value=1.5e-27  Score=173.71  Aligned_cols=132  Identities=31%  Similarity=0.481  Sum_probs=113.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.++..+.+++||||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus       105 l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll  182 (387)
T 1kob_A          105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMC  182 (387)
T ss_dssp             CCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEE
Confidence            45889999999999999999999999999999999765557899999999999999999999999  9999999999999


Q ss_pred             cC--CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SS--AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.  .+.++++|||++........             .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       183 ~~~~~~~vkL~DFG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~  247 (387)
T 1kob_A          183 ETKKASSVKIIDFGLATKLNPDEI-------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL  247 (387)
T ss_dssp             SSTTCCCEEECCCTTCEECCTTSC-------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCceEEEecccceecCCCcc-------------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCC
Confidence            74  46799999999875422111             0123689999999985         9999999999999885

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.93  E-value=2.3e-27  Score=169.80  Aligned_cols=130  Identities=28%  Similarity=0.385  Sum_probs=112.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+++||||+ +|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        66 l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll  141 (336)
T 3h4j_B           66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLL  141 (336)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEE
T ss_pred             CCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEE
Confidence            45899999999999999999999999 67999988765 56899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........             .....||+.|+|||++          |+||+|+++++|++|.
T Consensus       142 ~~~~~~kl~DFG~s~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  205 (336)
T 3h4j_B          142 DDNLNVKIADFGLSNIMTDGNF-------------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR  205 (336)
T ss_dssp             CTTCCEEECCSSCTBTTTTSBT-------------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEEEeccceeccCCcc-------------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCC
Confidence            9999999999999864321110             1134689999999984          9999999999999885

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.93  E-value=1.9e-27  Score=171.70  Aligned_cols=131  Identities=31%  Similarity=0.377  Sum_probs=112.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        85 l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll  161 (362)
T 2bdw_A           85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLL  161 (362)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE
T ss_pred             CCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEE
Confidence            45899999999999999999999999999999999754 46899999999999999999999999  9999999999999


Q ss_pred             cCC---CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +..   +.++++|||++........             .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       162 ~~~~~~~~~kl~DfG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  227 (362)
T 2bdw_A          162 ASKAKGAAVKLADFGLAIEVNDSEA-------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY  227 (362)
T ss_dssp             SCSSTTCCEEECCCTTCBCCTTCCS-------------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCCCCEEEeecCcceEecCCcc-------------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCC
Confidence            765   4599999999875321110             1134689999999984         9999999999999885

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.93  E-value=2e-27  Score=168.21  Aligned_cols=130  Identities=26%  Similarity=0.320  Sum_probs=112.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++++++.++++..+.+++||||+ +++|.+++......+++..+..++.|++.|+.|+|+.+  ++|+|+||+||+++
T Consensus       115 ~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~  191 (311)
T 3p1a_A          115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG  191 (311)
T ss_dssp             CCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC
T ss_pred             CCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC
Confidence            4788999999999999999999999 56999999877667999999999999999999999998  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++.......             ......||+.|+|||++        |+||+|+++++|++|.
T Consensus       192 ~~~~~kl~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~  252 (311)
T 3p1a_A          192 PRGRCKLGDFGLLVELGTAG-------------AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNM  252 (311)
T ss_dssp             GGGCEEECCCTTCEECC-------------------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTC
T ss_pred             CCCCEEEccceeeeecccCC-------------CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999986532110             11234689999999985        9999999999998873

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.93  E-value=1.6e-27  Score=172.68  Aligned_cols=133  Identities=30%  Similarity=0.441  Sum_probs=113.5

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.+.++..+.+++||||+++++|.+++......+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+
T Consensus       142 ~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl  219 (373)
T 2x4f_A          142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENIL  219 (373)
T ss_dssp             TCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred             hCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEE
Confidence            345899999999999999999999999999999999765456899999999999999999999999  999999999999


Q ss_pred             E--cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 I--SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +  +..+.++++|||++........             .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       220 l~~~~~~~~kl~DFG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  285 (373)
T 2x4f_A          220 CVNRDAKQIKIIDFGLARRYKPREK-------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL  285 (373)
T ss_dssp             EEETTTTEEEECCCSSCEECCTTCB-------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSS
T ss_pred             EecCCCCcEEEEeCCCceecCCccc-------------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCC
Confidence            8  5567899999999875422111             0133689999999974         9999999999999885

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.93  E-value=1.5e-27  Score=172.19  Aligned_cols=131  Identities=27%  Similarity=0.408  Sum_probs=106.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+++...+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        73 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill  149 (361)
T 3uc3_A           73 LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLL  149 (361)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEE
T ss_pred             CCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE
Confidence            45899999999999999999999999999999999765 46899999999999999999999999  9999999999999


Q ss_pred             cCCCc--EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGT--VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +..+.  ++++|||+++.....             .......||+.|+|||++          |+||+|+++++|++|.
T Consensus       150 ~~~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  215 (361)
T 3uc3_A          150 DGSPAPRLKICDFGYSKSSVLH-------------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA  215 (361)
T ss_dssp             CSSSSCCEEECCCCCC----------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCceEEEeecCcccccccc-------------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCC
Confidence            87654  999999988632111             011234689999999984          9999999999999885

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.93  E-value=1.8e-27  Score=169.47  Aligned_cols=130  Identities=32%  Similarity=0.469  Sum_probs=99.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+++.++++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        65 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~  141 (325)
T 3kn6_A           65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTD  141 (325)
T ss_dssp             CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC
T ss_pred             CCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEec
Confidence            899999999999999999999999999999999864 56899999999999999999999999  999999999999976


Q ss_pred             CC---cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .+   .++++|||++........            ......+|+.|+|||++         |+||+|+++++|++|.
T Consensus       142 ~~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  206 (325)
T 3kn6_A          142 ENDNLEIKIIDFGFARLKPPDNQ------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ  206 (325)
T ss_dssp             ----CEEEECCCTTCEECCC----------------------------------CCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCcccEEEeccccceecCCCCC------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCC
Confidence            65   899999999875322111            11234578999999985         9999999999999885

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.93  E-value=9.8e-28  Score=173.09  Aligned_cols=138  Identities=15%  Similarity=0.117  Sum_probs=110.9

Q ss_pred             cchhhhcccCCCCCc----eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           4 LSAAFIDKHSTPHGM----HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      -|++|+++.+.+...    ...++||||+ +++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|+||+|
T Consensus       106 ~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~N  182 (364)
T 3op5_A          106 KYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASN  182 (364)
T ss_dssp             SCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred             cCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHH
Confidence            478888887765543    6689999999 88999999876567999999999999999999999998  9999999999


Q ss_pred             EEEc--CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          80 LLIS--SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        80 il~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      |+++  ..+.++++|||++............     .........||+.|+|||++         |+||+|+++++|++|
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g  257 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY-----AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG  257 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCS-----SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             EEEecCCCCeEEEEECCcceecccCCccccc-----ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence            9998  7899999999999754321110000     00001234589999999985         999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       258 ~  258 (364)
T 3op5_A          258 H  258 (364)
T ss_dssp             C
T ss_pred             C
Confidence            6

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.93  E-value=2.1e-27  Score=176.78  Aligned_cols=131  Identities=26%  Similarity=0.379  Sum_probs=114.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++.+..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        73 l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll  149 (476)
T 2y94_A           73 FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLL  149 (476)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEE
T ss_pred             CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEE
Confidence            45899999999999999999999999999999999753 56899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........             .....||+.|+|||++          |+||+|+++++|++|.
T Consensus       150 ~~~~~vkL~DFG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~  213 (476)
T 2y94_A          150 DAHMNAKIADFGLSNMMSDGEF-------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT  213 (476)
T ss_dssp             CTTCCEEECCCSSCEECCTTCC-------------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCeEEEeccchhhcccccc-------------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCC
Confidence            9999999999999875422110             1134689999999984          9999999999999886

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.93  E-value=2.9e-27  Score=168.10  Aligned_cols=133  Identities=23%  Similarity=0.298  Sum_probs=111.0

Q ss_pred             ccchhhhcccCCCCC----ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC----------CC
Q psy1934           3 YLSAAFIDKHSTPHG----MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ----------NP   68 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~----------~~   68 (150)
                      +-||+|+++.+++..    ...+++||||+++|+|.++++.  ..+++..+..++.|++.|+.|+|+.          + 
T Consensus        75 l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~-  151 (322)
T 3soc_A           75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-  151 (322)
T ss_dssp             CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE-
T ss_pred             CCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC-
Confidence            458899998887655    4458999999999999999976  3589999999999999999999998          8 


Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------c
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------D  134 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d  134 (150)
                       ++|+|+||+||+++.++.+|++|||++..........          ......||+.|+|||++              |
T Consensus       152 -ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D  220 (322)
T 3soc_A          152 -ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG----------DTHGQVGTRRYMAPEVLEGAINFQRDAFLRID  220 (322)
T ss_dssp             -EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCC----------CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHH
T ss_pred             -EEeCCCChHhEEECCCCeEEEccCCcccccccccCcc----------ccccCccCccccCHhhcccccccCcCCCccch
Confidence             9999999999999999999999999997543221110          01234689999999974              9


Q ss_pred             ccccceeEEEeeeec
Q psy1934         135 TWNNYVIGRSMLYGH  149 (150)
Q Consensus       135 ~~~~g~~~~~~~~g~  149 (150)
                      +||+|+++++|++|.
T Consensus       221 iwslG~il~el~tg~  235 (322)
T 3soc_A          221 MYAMGLVLWELASRC  235 (322)
T ss_dssp             HHHHHHHHHHHHTTB
T ss_pred             hHHHHHHHHHHHhCC
Confidence            999999999999884

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.93  E-value=1.9e-27  Score=170.99  Aligned_cols=133  Identities=27%  Similarity=0.325  Sum_probs=111.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-||+|+++.++++..+.+++||||+++++|.+.+....   ..+++..+..++.|++.|+.|+|+++  ++|+|++|+|
T Consensus        83 l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~N  160 (351)
T 3c0i_A           83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHC  160 (351)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred             CCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHH
Confidence            458999999999999999999999999999998886432   34889999999999999999999999  9999999999


Q ss_pred             EEEcCCCc---EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          80 LLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        80 il~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+++.++.   ++++|||++.........            .....||+.|+|||++         |+||+|+++++|++
T Consensus       161 Il~~~~~~~~~vkl~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  228 (351)
T 3c0i_A          161 VLLASKENSAPVKLGGFGVAIQLGESGLV------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS  228 (351)
T ss_dssp             EEECSSSTTCCEEECCCTTCEECCTTSCB------------CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred             eEEecCCCCCcEEEecCcceeEecCCCee------------ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH
Confidence            99976554   999999998754221110            1134689999999985         99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       229 g~  230 (351)
T 3c0i_A          229 GC  230 (351)
T ss_dssp             SS
T ss_pred             CC
Confidence            85

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.93  E-value=2.3e-27  Score=169.04  Aligned_cols=138  Identities=20%  Similarity=0.162  Sum_probs=114.2

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -|++|+++.+.+...+..++||||+ +++|.+++......+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++
T Consensus        63 ~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~  139 (330)
T 2izr_A           63 SGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIG  139 (330)
T ss_dssp             SCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC
T ss_pred             CCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec
Confidence            3788999988888889999999999 88999999876567999999999999999999999999  99999999999999


Q ss_pred             CCCc-----EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGT-----VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.     ++++|||++...........     ..........||+.|+|||++         |+||+|+++++|++|.
T Consensus       140 ~~~~~~~~~~kl~DFg~a~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~  214 (330)
T 2izr_A          140 RPGNKTQQVIHIIDFALAKEYIDPETKKH-----IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS  214 (330)
T ss_dssp             CGGGTCTTSEEECCCTTCEESBCTTTCCB-----CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCCCceEEEEEcccceeeecCCCCcc-----ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCC
Confidence            8876     99999999985432211100     000011245789999999985         9999999999999885

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=2.3e-27  Score=170.83  Aligned_cols=131  Identities=29%  Similarity=0.412  Sum_probs=112.7

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      |++|+++.+.++..+.+++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.
T Consensus       118 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~  194 (355)
T 1vzo_A          118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDS  194 (355)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT
T ss_pred             CCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC
Confidence            688999989888889999999999999999999865 46899999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++........           .......||+.|+|||++           |+||+|+++++|++|.
T Consensus       195 ~~~~kl~DfG~a~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~  259 (355)
T 1vzo_A          195 NGHVVLTDFGLSKEFVADET-----------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  259 (355)
T ss_dssp             TSCEEESCSSEEEECCGGGG-----------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             CCcEEEeeCCCCeecccCCC-----------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence            99999999999875321100           011234689999999984           9999999999999885

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.93  E-value=1.9e-27  Score=172.85  Aligned_cols=140  Identities=19%  Similarity=0.231  Sum_probs=115.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.+++...+.+++||||+++|+|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|+||+||+
T Consensus        83 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIl  160 (389)
T 3gni_B           83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHIL  160 (389)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred             CCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence            458999999999999999999999999999999998653 56899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||.+.............     ........||+.|+|||++           |+||+|+++++|++|.
T Consensus       161 l~~~~~~kl~dfg~~~~~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~  234 (389)
T 3gni_B          161 ISVDGKVYLSGLRSNLSMISHGQRQRVV-----HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH  234 (389)
T ss_dssp             ECTTCCEEECCGGGCEECEETTEECSCB-----CCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             EcCCCCEEEcccccceeecccccccccc-----ccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCC
Confidence            9999999999999876432221100000     0011134688999999984           9999999999999885

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.93  E-value=4.3e-27  Score=166.59  Aligned_cols=132  Identities=30%  Similarity=0.417  Sum_probs=113.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+++||||+++ ++.+.+......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        76 l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~  152 (311)
T 3niz_A           76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLI  152 (311)
T ss_dssp             CCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             cCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEE
Confidence            4588999999999999999999999986 899988776566999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+|+.|+|||++          |+||+|+++++|++|.
T Consensus       153 ~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  217 (311)
T 3niz_A          153 NSDGALKLADFGLARAFGIPVR------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK  217 (311)
T ss_dssp             CTTCCEEECCCTTCEETTSCCC---------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEccCcCceecCCCcc------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence            9999999999999875321111            11234689999999974          9999999999999885

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.93  E-value=8.7e-27  Score=165.35  Aligned_cols=133  Identities=30%  Similarity=0.433  Sum_probs=112.6

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-----SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      ++-||+|+++.++++..+.+++||||+++ +|.+++....     ..+++..+..++.|++.|+.|+|+++  ++|+|++
T Consensus        59 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlk  135 (317)
T 2pmi_A           59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLK  135 (317)
T ss_dssp             TCCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred             hcCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCC
Confidence            34589999999999999999999999985 9999987542     35888899999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.++++|||++.........            .....+|+.|+|||++          |+||+|+++++|+
T Consensus       136 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  203 (317)
T 2pmi_A          136 PQNLLINKRGQLKLGDFGLARAFGIPVNT------------FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI  203 (317)
T ss_dssp             GGGEEECTTCCEEECCCSSCEETTSCCCC------------CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             hHHeEEcCCCCEEECcCccceecCCCccc------------CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence            99999999999999999998753211110            0134689999999974          9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       204 ~g~  206 (317)
T 2pmi_A          204 TGK  206 (317)
T ss_dssp             HSS
T ss_pred             hCC
Confidence            885

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.93  E-value=1.1e-26  Score=165.54  Aligned_cols=139  Identities=22%  Similarity=0.268  Sum_probs=109.7

Q ss_pred             ccchhhhcccC-----CCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC---------CC
Q psy1934           3 YLSAAFIDKHS-----TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ---------NP   68 (150)
Q Consensus         3 ~~~~~~~~~~~-----~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---------~~   68 (150)
                      +-|++++++..     ...+...+++||||+++|+|.++++..  ..++..+..++.|++.|+.|+|+.         + 
T Consensus        64 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~-  140 (336)
T 3g2f_A           64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA-  140 (336)
T ss_dssp             CCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC-
T ss_pred             ccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc-
Confidence            45788888765     666677899999999999999999764  458888889999999999999998         7 


Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------  133 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------  133 (150)
                       ++|+|+||+||+++.++.++++|||++.............    .........||+.|+|||++               
T Consensus       141 -ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  215 (336)
T 3g2f_A          141 -ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE----EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ  215 (336)
T ss_dssp             -EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC-------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred             -eeecccccceEEEcCCCcEEEeeccceeecccccccCccc----cccccccCCCccceeCchhhcCCcccccccccccc
Confidence             9999999999999999999999999997543221110000    00112244689999999974               


Q ss_pred             -cccccceeEEEeeeec
Q psy1934         134 -DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       134 -d~~~~g~~~~~~~~g~  149 (150)
                       |+||+|+++++|++|.
T Consensus       216 ~DiwslG~il~ell~g~  232 (336)
T 3g2f_A          216 VDMYALGLIYWEIFMRC  232 (336)
T ss_dssp             HHHHHHHHHHHHHHTTB
T ss_pred             cchHHHHHHHHHHHhcC
Confidence             9999999999999873

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.93  E-value=3.5e-27  Score=170.96  Aligned_cols=137  Identities=22%  Similarity=0.337  Sum_probs=105.7

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.+++...+.+++||||+++|+|.++++.....+++..+..++.+++.|+.|+|+.+  ++|+|++|+||+
T Consensus       102 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl  179 (373)
T 2qol_A          102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNIL  179 (373)
T ss_dssp             TCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred             hCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEE
Confidence            356899999999999999999999999999999999876567899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||++...........         ......+++.|+|||++         |+||+|+++++++. |.
T Consensus       180 l~~~~~~kl~Dfg~a~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~  248 (373)
T 2qol_A          180 INSNLVCKVSDFGLGRVLEDDPEAAY---------TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE  248 (373)
T ss_dssp             ECTTCCEEECCC-------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-
T ss_pred             EcCCCCEEECcCccccccccCCccce---------eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCC
Confidence            99999999999999875422111000         00112346789999984         99999999999875 64

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.93  E-value=2.2e-27  Score=168.02  Aligned_cols=135  Identities=28%  Similarity=0.364  Sum_probs=107.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-||+|+++.+.+...+.+++||||+++|+|.+++....  ..+++..+..++.|++.|+.|+|+++++++|+|++|+||
T Consensus        91 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NI  170 (309)
T 3p86_A           91 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL  170 (309)
T ss_dssp             CCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGE
T ss_pred             CCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhE
Confidence            458899999999999999999999999999999997642  138889999999999999999999876699999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++.......            .......||+.|+|||++         |+||+|++++++++|.
T Consensus       171 ll~~~~~~kL~Dfg~a~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  236 (309)
T 3p86_A          171 LVDKKYTVKVCDFGLSRLKASTF------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ  236 (309)
T ss_dssp             EECTTCCEEECCCC-----------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCC
T ss_pred             EEeCCCcEEECCCCCCccccccc------------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999986422110            011234689999999984         9999999999999885

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=5.3e-27  Score=167.07  Aligned_cols=134  Identities=22%  Similarity=0.324  Sum_probs=109.3

Q ss_pred             ccchhhhcccCCCCCc----eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCe
Q psy1934           3 YLSAAFIDKHSTPHGM----HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ--------NPPI   70 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~--------~~~i   70 (150)
                      .-|++|+++.+.....    +.+++||||+++|+|.++++..  .+++..+..++.+++.|+.|+|+.        +  +
T Consensus        88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--i  163 (337)
T 3mdy_A           88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--I  163 (337)
T ss_dssp             CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--E
T ss_pred             hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--E
Confidence            3588898887765554    7899999999999999999763  689999999999999999999988        7  9


Q ss_pred             EEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------cc
Q psy1934          71 VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DT  135 (150)
Q Consensus        71 ~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~  135 (150)
                      +|+|+||+||+++.++.++++|||++..........        ........||+.|+|||++               |+
T Consensus       164 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di  235 (337)
T 3mdy_A          164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV--------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM  235 (337)
T ss_dssp             ECSCCCGGGEEECTTSCEEECCCTTCEECC-----------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHH
T ss_pred             EecccchHHEEECCCCCEEEEeCCCceeeccccccc--------cCCCCCCccCcceeChhhcccccCCccccCccccch
Confidence            999999999999999999999999986542211100        0001134689999999973               99


Q ss_pred             cccceeEEEeeee
Q psy1934         136 WNNYVIGRSMLYG  148 (150)
Q Consensus       136 ~~~g~~~~~~~~g  148 (150)
                      ||+|+++++|++|
T Consensus       236 wslG~il~el~tg  248 (337)
T 3mdy_A          236 YSFGLILWEVARR  248 (337)
T ss_dssp             HHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999999988

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.93  E-value=9.4e-28  Score=170.85  Aligned_cols=134  Identities=28%  Similarity=0.395  Sum_probs=114.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.+...+..++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        62 l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll  138 (323)
T 3tki_A           62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL  138 (323)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             CCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEE
Confidence            35789999999999999999999999999999998653 46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++..........          ......||+.|+|||++          |+||+|+++++|++|.
T Consensus       139 ~~~~~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  205 (323)
T 3tki_A          139 DERDNLKISDFGLATVFRYNNRER----------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE  205 (323)
T ss_dssp             CTTCCEEECCCTTCEECEETTEEC----------CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred             eCCCCEEEEEeeccceeccCCccc----------ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCC
Confidence            999999999999987532211100          01134689999999984          9999999999999885

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.93  E-value=7e-27  Score=166.18  Aligned_cols=132  Identities=26%  Similarity=0.446  Sum_probs=113.7

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-|++|++..+.+...+..++||||+++++|.+++..  ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+
T Consensus        98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIl  173 (321)
T 2c30_A           98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSIL  173 (321)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred             hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEE
Confidence            34588999999988888999999999999999999865  46899999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++.........            .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~  238 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVPK------------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE  238 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSCC------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCcEEEeeeeeeeecccCccc------------cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999999998754221111            1134689999999984         9999999999999885

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.93  E-value=9.1e-27  Score=165.46  Aligned_cols=134  Identities=22%  Similarity=0.258  Sum_probs=114.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcC---CCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQ---NPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~~~i~h~~l~   76 (150)
                      +-|++|+++.+.+...+..++||||+++|+|.+++....   ..+++..+..++.+++.|+.|+|+.   +  ++|+|++
T Consensus        84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlk  161 (326)
T 3uim_A           84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVK  161 (326)
T ss_dssp             CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCS
T ss_pred             ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCc
Confidence            458999999999999999999999999999999998643   2488999999999999999999998   8  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+||+++.++.++++|||++..........           .....||+.|+|||++         |+||+|+++++|++
T Consensus       162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  230 (326)
T 3uim_A          162 AANILLDEEFEAVVGDFGLAKLMDYKDTHV-----------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT  230 (326)
T ss_dssp             GGGEEECTTCCEEECCCSSCEECCSSSSCE-----------ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH
T ss_pred             hhhEEECCCCCEEeccCccccccCcccccc-----------cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh
Confidence            999999999999999999987543221111           1123589999999985         99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       231 g~  232 (326)
T 3uim_A          231 GQ  232 (326)
T ss_dssp             CC
T ss_pred             CC
Confidence            85

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.93  E-value=7.7e-27  Score=161.70  Aligned_cols=134  Identities=19%  Similarity=0.341  Sum_probs=114.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++......+++..+..++.|++.|+.++|+.+  ++|+|++|+||++
T Consensus        60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~  137 (268)
T 3sxs_A           60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLV  137 (268)
T ss_dssp             CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEE
T ss_pred             CCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEE
Confidence            45789999999999999999999999999999999876556999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++..........           .....+++.|+|||++         |+||+|++++++++ |.
T Consensus       138 ~~~~~~~l~Dfg~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~  203 (268)
T 3sxs_A          138 DRDLCVKVSDFGMTRYVLDDQYVS-----------SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK  203 (268)
T ss_dssp             CTTCCEEECCTTCEEECCTTCEEE-----------CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTC
T ss_pred             CCCCCEEEccCccceecchhhhhc-----------ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCC
Confidence            999999999999987542221100           1123456789999984         99999999999987 64

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.93  E-value=2.1e-27  Score=172.22  Aligned_cols=136  Identities=20%  Similarity=0.351  Sum_probs=112.6

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.+++...+.+++||||+++|+|.++++.....+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus       168 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil  245 (377)
T 3cbl_A          168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCL  245 (377)
T ss_dssp             TCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             hCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEE
Confidence            345899999999999889999999999999999999876556899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.+|++|||+++......   ....       .....+++.|+|||++         |+||+|++++|+++ |.
T Consensus       246 ~~~~~~~kl~DfG~s~~~~~~~---~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~  313 (377)
T 3cbl_A          246 VTEKNVLKISDFGMSREEADGV---YAAS-------GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGA  313 (377)
T ss_dssp             ECTTCCEEECCGGGCEECTTSE---EECC-------SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred             EcCCCcEEECcCCCceecCCCc---eeec-------CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999987432110   0000       0011235679999984         99999999999986 64

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.93  E-value=7.9e-27  Score=163.60  Aligned_cols=133  Identities=29%  Similarity=0.436  Sum_probs=112.4

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++++..+.+++||||+++ ++.+.+......+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus        57 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil  133 (292)
T 3o0g_A           57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLL  133 (292)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred             cCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence            34588999999999999999999999976 777777665567999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++.........            .....+|+.|+|||++          |+||+|+++++|++|.
T Consensus       134 ~~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~  199 (292)
T 3o0g_A          134 INRNGELKLANFGLARAFGIPVRC------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG  199 (292)
T ss_dssp             ECTTSCEEECCCTTCEECCSCCSC------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred             EcCCCCEEEeecccceecCCcccc------------ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcC
Confidence            999999999999998754211110            1134678999999974          9999999999998763

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.93  E-value=4.9e-27  Score=166.76  Aligned_cols=129  Identities=25%  Similarity=0.368  Sum_probs=96.6

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCce
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTS--ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSA   96 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~   96 (150)
                      ..+++||||+++++|.+++.....  ..++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.++.++++|||++
T Consensus       134 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a  211 (332)
T 3qd2_B          134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLV  211 (332)
T ss_dssp             CEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcc
Confidence            358999999999999999986432  2455567889999999999999999  999999999999999999999999998


Q ss_pred             eccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          97 TEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ..........................||+.|+|||++         |+||+|+++++|++|.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~  273 (332)
T 3qd2_B          212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF  273 (332)
T ss_dssp             EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCC
T ss_pred             cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcC
Confidence            8643322111000000001112234689999999984         9999999999998773

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.93  E-value=6.5e-27  Score=164.33  Aligned_cols=134  Identities=25%  Similarity=0.334  Sum_probs=110.0

Q ss_pred             ccchhhhcccCC----CCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCe
Q psy1934           3 YLSAAFIDKHST----PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMH--------GQNPPI   70 (150)
Q Consensus         3 ~~~~~~~~~~~~----~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~i   70 (150)
                      +-||+|+++.+.    .+..+.+++||||+++|+|.++++.  ..+++..+..++.|++.|+.|+|        +.+  +
T Consensus        59 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--i  134 (301)
T 3q4u_A           59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--I  134 (301)
T ss_dssp             CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--E
T ss_pred             ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--e
Confidence            568889988765    4556789999999999999999964  46899999999999999999999        877  9


Q ss_pred             EEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------------ccc
Q psy1934          71 VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------------VDT  135 (150)
Q Consensus        71 ~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------------~d~  135 (150)
                      +|+|+||+||+++.++.++++|||++...........        .......||+.|+|||+               .|+
T Consensus       135 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dv  206 (301)
T 3q4u_A          135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD--------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI  206 (301)
T ss_dssp             ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEE--------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHH
T ss_pred             ecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccc--------ccccccccccceeChhhhcCcCCCCcccCCchhhH
Confidence            9999999999999999999999999875432211100        00112368999999996               399


Q ss_pred             cccceeEEEeeee
Q psy1934         136 WNNYVIGRSMLYG  148 (150)
Q Consensus       136 ~~~g~~~~~~~~g  148 (150)
                      ||+|+++++|++|
T Consensus       207 wslG~il~el~tg  219 (301)
T 3q4u_A          207 WAFGLVLWEVARR  219 (301)
T ss_dssp             HHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhh
Confidence            9999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=5.7e-27  Score=162.53  Aligned_cols=134  Identities=16%  Similarity=0.293  Sum_probs=113.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++......+++..+..++.|++.|+.++|+.+  ++|+|++|+||++
T Consensus        62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~  139 (269)
T 4hcu_A           62 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV  139 (269)
T ss_dssp             CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             CCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEE
Confidence            45789999999999999999999999999999999876667899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++......           .........+++.|+|||++         |+||+|+++++|++ |.
T Consensus       140 ~~~~~~kl~Dfg~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~  205 (269)
T 4hcu_A          140 GENQVIKVSDFGMTRFVLDD-----------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK  205 (269)
T ss_dssp             CGGGCEEECCTTGGGGBCCH-----------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCCCCEEecccccccccccc-----------ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCC
Confidence            99999999999998643210           00111233467789999984         99999999999987 64

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.93  E-value=2.1e-27  Score=167.99  Aligned_cols=135  Identities=26%  Similarity=0.386  Sum_probs=105.3

Q ss_pred             ccchhhhcccCCCCCce----EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMH----EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      +-||+|+++.+.+...+    .+|+||||+++++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+
T Consensus        69 l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~  145 (311)
T 3ork_A           69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPA  145 (311)
T ss_dssp             CCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred             CCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHH
Confidence            45788998887665443    459999999999999999865 46899999999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ||+++.++.++++|||++.........         ........||+.|+|||++         |+||+|+++++|++|.
T Consensus       146 Nil~~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~  216 (311)
T 3ork_A          146 NIMISATNAVKVMDFGIARAIADSGNS---------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE  216 (311)
T ss_dssp             GEEEETTSCEEECCCSCC---------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             HEEEcCCCCEEEeeccCcccccccccc---------cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence            999999999999999998743221110         0111234689999999984         9999999999999885

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.93  E-value=1.4e-26  Score=166.61  Aligned_cols=128  Identities=23%  Similarity=0.319  Sum_probs=111.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|++|+++.+.+...+.+++||||+ +++|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|+||+||++
T Consensus        94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll  170 (360)
T 3llt_A           94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILL  170 (360)
T ss_dssp             TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEE
Confidence            3899999999999889999999999 889999998654 45899999999999999999999999  9999999999999


Q ss_pred             cC-------------------------CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----
Q psy1934          83 SS-------------------------AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----  133 (150)
Q Consensus        83 ~~-------------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----  133 (150)
                      +.                         .+.++++|||++.......               ....||+.|+|||++    
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~---------------~~~~gt~~y~aPE~~~~~~  235 (360)
T 3llt_A          171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH---------------GSIINTRQYRAPEVILNLG  235 (360)
T ss_dssp             SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC---------------CSCCSCGGGCCHHHHTTCC
T ss_pred             ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC---------------cCccCcccccCcHHHcCCC
Confidence            75                         6789999999987432110               134689999999985    


Q ss_pred             -----cccccceeEEEeeeec
Q psy1934         134 -----DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       134 -----d~~~~g~~~~~~~~g~  149 (150)
                           |+||+|+++++|++|.
T Consensus       236 ~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          236 WDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSS
T ss_pred             CCCccchHHHHHHHHHHHHCC
Confidence                 9999999999999885

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.93  E-value=6.3e-27  Score=166.50  Aligned_cols=134  Identities=22%  Similarity=0.257  Sum_probs=110.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.++ .+..++|+||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        72 l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~  148 (325)
T 3kex_A           72 LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLL  148 (325)
T ss_dssp             CCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEE
T ss_pred             CCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEE
Confidence            45889999988776 46789999999999999999865456888899999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++...........          .....++..|+|||++         |+||+|++++++++ |.
T Consensus       149 ~~~~~~kl~Dfg~a~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~  215 (325)
T 3kex_A          149 KSPSQVQVADFGVADLLPPDDKQLL----------YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA  215 (325)
T ss_dssp             SSSSCEEECSCSGGGGSCCCTTCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCeEEECCCCcccccCccccccc----------ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCC
Confidence            9999999999999875432211110          1123577899999984         99999999999987 75

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.93  E-value=4.7e-27  Score=164.52  Aligned_cols=132  Identities=26%  Similarity=0.356  Sum_probs=111.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+++||||+++ +|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~  133 (288)
T 1ob3_A           57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLI  133 (288)
T ss_dssp             CCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             cCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE
Confidence            4588999999999999999999999986 999999876567899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.......            .......+|+.|+|||++          |+||+|+++++|++|.
T Consensus       134 ~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  198 (288)
T 1ob3_A          134 NREGELKIADFGLARAFGIPV------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT  198 (288)
T ss_dssp             CTTSCEEECCTTHHHHHCC---------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEeECccccccCccc------------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999886431110            011234689999999974          9999999999999885

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.93  E-value=1.6e-26  Score=172.79  Aligned_cols=131  Identities=31%  Similarity=0.394  Sum_probs=112.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+||||+++|+|.+.+... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        93 l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~  169 (494)
T 3lij_A           93 LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLL  169 (494)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             CCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEE
Confidence            45899999999999999999999999999999988765 56899999999999999999999999  9999999999999


Q ss_pred             cCC---CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeeec
Q psy1934          83 SSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g~  149 (150)
                      +..   +.++++|||++........             .....||+.|+|||++        |+||+|+++++|++|.
T Consensus       170 ~~~~~~~~~kl~DfG~a~~~~~~~~-------------~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~  234 (494)
T 3lij_A          170 ESKEKDALIKIVDFGLSAVFENQKK-------------MKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGY  234 (494)
T ss_dssp             SCSSTTCCEEECCCTTCEECBTTBC-------------BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             eCCCCCCcEEEEECCCCeECCCCcc-------------ccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCC
Confidence            764   4599999999875321110             1134689999999985        9999999999999885

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.92  E-value=8.7e-27  Score=172.64  Aligned_cols=142  Identities=23%  Similarity=0.372  Sum_probs=107.3

Q ss_pred             ccchhhhcccCCC-----CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTP-----HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~-----~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-|++|+++.+++     +..+.+|+||||+. ++|.++++.. ..+++..++.++.|++.|+.|||+.+  ++|||+||
T Consensus       109 l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp  184 (458)
T 3rp9_A          109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKP  184 (458)
T ss_dssp             CCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCG
T ss_pred             CCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCCh
Confidence            3578899988876     55578999999985 5999999753 56899999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchh--------------H-hhhhhhHHhhhcCCCCCccCcccc---------
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWS--------------A-QQRSMLEDEMARFTTPMYRAPEMV---------  133 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~--------------~-~~~~~~~~~~~~~~~~~y~aPE~~---------  133 (150)
                      +||+++.++.+|++|||+++...........              . ............+||++|+|||++         
T Consensus       185 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  264 (458)
T 3rp9_A          185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA  264 (458)
T ss_dssp             GGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH
T ss_pred             hhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH
Confidence            9999999999999999999854321110000              0 000000123345789999999973         


Q ss_pred             -cccccceeEEEeeee
Q psy1934         134 -DTWNNYVIGRSMLYG  148 (150)
Q Consensus       134 -d~~~~g~~~~~~~~g  148 (150)
                       |+||+|++++||++|
T Consensus       265 ~DiwSlG~il~elltg  280 (458)
T 3rp9_A          265 IDVWSIGCIFAELLNM  280 (458)
T ss_dssp             HHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHHh
Confidence             999999999999863

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.92  E-value=1.9e-26  Score=164.92  Aligned_cols=131  Identities=25%  Similarity=0.295  Sum_probs=113.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCC-CHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGG-SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.++++..+.+++||||+.+| +|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus        86 l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIl  162 (335)
T 3dls_A           86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIV  162 (335)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             CCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEE
Confidence            45889999999999999999999999776 999999764 46899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++........             .....||+.|+|||++          |+||+|+++++|++|.
T Consensus       163 l~~~~~~kL~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  227 (335)
T 3dls_A          163 IAEDFTIKLIDFGSAAYLERGKL-------------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE  227 (335)
T ss_dssp             ECTTSCEEECCCTTCEECCTTCC-------------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred             EcCCCcEEEeecccceECCCCCc-------------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCC
Confidence            99999999999999875422111             1134689999999974          9999999999999885

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.92  E-value=2.4e-26  Score=172.15  Aligned_cols=131  Identities=27%  Similarity=0.402  Sum_probs=113.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+++|||||++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus       103 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~  179 (504)
T 3q5i_A          103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILL  179 (504)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             CCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEE
Confidence            34899999999999999999999999999999999765 56899999999999999999999999  9999999999999


Q ss_pred             cCCC---cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeeec
Q psy1934          83 SSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g~  149 (150)
                      +..+   .++++|||++........             .....||+.|+|||++        |+||+|+++++|++|.
T Consensus       180 ~~~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~  244 (504)
T 3q5i_A          180 ENKNSLLNIKIVDFGLSSFFSKDYK-------------LRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGY  244 (504)
T ss_dssp             SSTTCCSSEEECCCTTCEECCTTSC-------------BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCCccEEEEECCCCEEcCCCCc-------------cccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCC
Confidence            8775   699999999875422111             1134689999999985        9999999999999885

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1e-26  Score=168.48  Aligned_cols=137  Identities=18%  Similarity=0.234  Sum_probs=104.6

Q ss_pred             cccchhhhcccCC-CCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           2 EYLSAAFIDKHST-PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         2 ~~~~~~~~~~~~~-~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      ++-||+|+++.+. .+..+..++||||+++|+|.++++.....+++..+..++.|++.|+.|+|+++  ++|+|++|+||
T Consensus       146 ~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NI  223 (373)
T 3c1x_A          146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNC  223 (373)
T ss_dssp             TCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred             hCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheE
Confidence            3458999999886 55667889999999999999999876566888889999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +++.++.+|++|||+++........        .........+++.|+|||++         |+||+|+++++|++|
T Consensus       224 ll~~~~~~kL~DFG~a~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~  292 (373)
T 3c1x_A          224 MLDEKFTVKVADFGLARDMYDKEFD--------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR  292 (373)
T ss_dssp             EECTTCCEEECCC-----------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             EECCCCCEEEeeccccccccccccc--------cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999999999999998743211100        00111234567889999984         999999999999883

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.92  E-value=1.3e-26  Score=168.34  Aligned_cols=134  Identities=20%  Similarity=0.303  Sum_probs=112.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNP   68 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~   68 (150)
                      -||+|+++.+.+...+.+++||||+++|+|.+++....               ..+++..+..++.|++.|+.|+|+.+ 
T Consensus       133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-  211 (382)
T 3tt0_A          133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-  211 (382)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            48899999999999999999999999999999998653               24889999999999999999999999 


Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccc
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNY  139 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g  139 (150)
                       ++|+|+||+||+++.++.++++|||++..........          ......+|+.|+|||++         |+||+|
T Consensus       212 -ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG  280 (382)
T 3tt0_A          212 -CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK----------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG  280 (382)
T ss_dssp             -CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTC----------CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHH
T ss_pred             -EecCCCCcceEEEcCCCcEEEcccCcccccccccccc----------cccCCCCCcceeCHHHhcCCCCCchhHHHHHH
Confidence             9999999999999999999999999987542211100          01123467889999984         999999


Q ss_pred             eeEEEeee-ec
Q psy1934         140 VIGRSMLY-GH  149 (150)
Q Consensus       140 ~~~~~~~~-g~  149 (150)
                      +++++|++ |.
T Consensus       281 ~il~ellt~g~  291 (382)
T 3tt0_A          281 VLLWEIFTLGG  291 (382)
T ss_dssp             HHHHHHHTTSC
T ss_pred             HHHHHHHhCCC
Confidence            99999987 64

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.92  E-value=1.2e-26  Score=164.64  Aligned_cols=132  Identities=26%  Similarity=0.392  Sum_probs=109.0

Q ss_pred             ccchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           3 YLSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      +-||+|+++.+.+...  ..+++||||+++++|.+++....  ..+++..+..++.|++.|+.|+|+++  ++|+|++|+
T Consensus        64 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~  141 (319)
T 4euu_A           64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPG  141 (319)
T ss_dssp             CCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             cCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHH
Confidence            3478899887765543  48899999999999999998643  23899999999999999999999999  999999999


Q ss_pred             CEEE----cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc-----------------ccccc
Q psy1934          79 NLLI----SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM-----------------VDTWN  137 (150)
Q Consensus        79 nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~-----------------~d~~~  137 (150)
                      ||++    +..+.++++|||++........             .....||+.|+|||+                 .|+||
T Consensus       142 NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diws  208 (319)
T 4euu_A          142 NIMRVIGEDGQSVYKLTDFGAARELEDDEQ-------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS  208 (319)
T ss_dssp             GEEEEECTTSCEEEEECCCTTCEECCTTCC-------------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHH
T ss_pred             HEEEeccCCCCceEEEccCCCceecCCCCc-------------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHH
Confidence            9998    6777899999999875422111             113468999999996                 39999


Q ss_pred             cceeEEEeeeec
Q psy1934         138 NYVIGRSMLYGH  149 (150)
Q Consensus       138 ~g~~~~~~~~g~  149 (150)
                      +|+++++|++|.
T Consensus       209 lG~il~el~~g~  220 (319)
T 4euu_A          209 IGVTFYHAATGS  220 (319)
T ss_dssp             HHHHHHHHHHSS
T ss_pred             HHHHHHHHHhCC
Confidence            999999999885

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.92  E-value=1.4e-26  Score=161.18  Aligned_cols=133  Identities=24%  Similarity=0.419  Sum_probs=103.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+..++||||+++++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        68 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili  145 (278)
T 3cok_A           68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLL  145 (278)
T ss_dssp             BCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEE
T ss_pred             CCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE
Confidence            45789999999999999999999999999999999876567899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+++.|+|||++         |+||+|+++++|++|.
T Consensus       146 ~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  209 (278)
T 3cok_A          146 TRNMNIKIADFGLATQLKMPHE------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR  209 (278)
T ss_dssp             CTTCCEEECCCTTCEECC----------------------------------------CTHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEEeecceeeccCCCC------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999875321110            11134588999999974         9999999999999885

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.92  E-value=3.4e-27  Score=165.01  Aligned_cols=128  Identities=16%  Similarity=0.176  Sum_probs=110.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+++...+..++||||+++++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        69 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll  146 (289)
T 4fvq_A           69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILL  146 (289)
T ss_dssp             SCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred             CCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEE
Confidence            45889999999998889999999999999999999876555899999999999999999999999  9999999999999


Q ss_pred             cCCCc--------EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEE
Q psy1934          83 SSAGT--------VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRS  144 (150)
Q Consensus        83 ~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~  144 (150)
                      +.++.        ++++|||++.....                .....+++.|+|||++          |+||+|+++++
T Consensus       147 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e  210 (289)
T 4fvq_A          147 IREEDRKTGNPPFIKLSDPGISITVLP----------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWE  210 (289)
T ss_dssp             EECCBGGGTBCCEEEECCCCSCTTTSC----------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHH
T ss_pred             ecCCcccccccceeeeccCcccccccC----------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHH
Confidence            88876        99999998753210                0012367889999974          99999999999


Q ss_pred             eeee
Q psy1934         145 MLYG  148 (150)
Q Consensus       145 ~~~g  148 (150)
                      |++|
T Consensus       211 l~~g  214 (289)
T 4fvq_A          211 ICSG  214 (289)
T ss_dssp             HHTT
T ss_pred             HHcC
Confidence            9985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.92  E-value=1.1e-26  Score=164.41  Aligned_cols=137  Identities=24%  Similarity=0.368  Sum_probs=109.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+++.+.+...+.+++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        70 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~  146 (316)
T 2ac3_A           70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEH  146 (316)
T ss_dssp             CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESC
T ss_pred             CCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEcc
Confidence            899999999999999999999999999999999865 46899999999999999999999999  999999999999987


Q ss_pred             CCc---EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeee
Q psy1934          85 AGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLY  147 (150)
Q Consensus        85 ~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~  147 (150)
                      ++.   ++++|||++..........  .   ..........||+.|+|||++              |+||+|+++++|++
T Consensus       147 ~~~~~~~kl~Dfg~~~~~~~~~~~~--~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~  221 (316)
T 2ac3_A          147 PNQVSPVKICDFDLGSGIKLNGDCS--P---ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS  221 (316)
T ss_dssp             SSSSCSEEECCTTCCC------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHH
T ss_pred             CCCcCceEEEEccCccccccCCccc--c---ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHH
Confidence            765   9999999986432211100  0   000112234689999999974              99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       222 g~  223 (316)
T 2ac3_A          222 GY  223 (316)
T ss_dssp             SS
T ss_pred             CC
Confidence            85

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.92  E-value=3.8e-27  Score=170.36  Aligned_cols=135  Identities=21%  Similarity=0.304  Sum_probs=110.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||+|+++.+++...+..++||||+++|+|.++++...      ..+++..+..++.|++.|+.|+|+++  ++|+|+|
T Consensus       131 l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlk  208 (367)
T 3l9p_A          131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIA  208 (367)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             CCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCC
Confidence            458999999999999999999999999999999998653      34888899999999999999999999  9999999


Q ss_pred             CCCEEEcCCC---cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEE
Q psy1934          77 IENLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRS  144 (150)
Q Consensus        77 ~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~  144 (150)
                      |+||+++.++   .++++|||+++.......          ........+|+.|+|||++         |+||+|+++++
T Consensus       209 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~e  278 (367)
T 3l9p_A          209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGY----------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE  278 (367)
T ss_dssp             GGGEEESCSSTTCCEEECCCHHHHHHHHHSS----------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             hhhEEEecCCCCceEEECCCccccccccccc----------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHH
Confidence            9999998554   599999999864311100          0011123578899999985         99999999999


Q ss_pred             eee-ec
Q psy1934         145 MLY-GH  149 (150)
Q Consensus       145 ~~~-g~  149 (150)
                      |++ |.
T Consensus       279 llt~g~  284 (367)
T 3l9p_A          279 IFSLGY  284 (367)
T ss_dssp             HHTTSC
T ss_pred             HHhCCC
Confidence            986 64

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.92  E-value=8.4e-27  Score=167.54  Aligned_cols=131  Identities=31%  Similarity=0.388  Sum_probs=106.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus       105 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll  181 (349)
T 2w4o_A          105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLY  181 (349)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred             CCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEE
Confidence            45789999999999999999999999999999999754 46899999999999999999999999  9999999999999


Q ss_pred             cC---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.   ++.++++|||++.......             ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       182 ~~~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  247 (349)
T 2w4o_A          182 ATPAPDAPLKIADFGLSKIVEHQV-------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF  247 (349)
T ss_dssp             SSSSTTCCEEECCCC-----------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCCCCEEEccCccccccCccc-------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence            76   7899999999986432110             01134689999999984         9999999999999885

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.92  E-value=1.4e-26  Score=168.38  Aligned_cols=140  Identities=21%  Similarity=0.319  Sum_probs=108.1

Q ss_pred             chhhhcccCCCC--CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           5 SAAFIDKHSTPH--GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         5 ~~~~~~~~~~~~--~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      |++|+++.+++.  ....+|+||||+++ +|.++++.  ..+++..+..++.|++.|+.|+|+.+  ++|||+||+||++
T Consensus        68 h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll  142 (388)
T 3oz6_A           68 HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILL  142 (388)
T ss_dssp             CTTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEE
Confidence            789999888764  44579999999975 99999976  46888899999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchh---------HhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEE
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWS---------AQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGR  143 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~  143 (150)
                      +.++.++++|||+++...........         .............+||++|+|||++          |+||+|++++
T Consensus       143 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~  222 (388)
T 3oz6_A          143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG  222 (388)
T ss_dssp             CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred             cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHH
Confidence            99999999999999754221110000         0000001122345799999999974          9999999999


Q ss_pred             Eeeeec
Q psy1934         144 SMLYGH  149 (150)
Q Consensus       144 ~~~~g~  149 (150)
                      +|++|.
T Consensus       223 ell~g~  228 (388)
T 3oz6_A          223 EILCGK  228 (388)
T ss_dssp             HHHHSS
T ss_pred             HHHhCC
Confidence            999885

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.92  E-value=4.3e-26  Score=158.58  Aligned_cols=131  Identities=29%  Similarity=0.415  Sum_probs=112.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++... ..+++..+..++.+++.|+.++|+++  ++|+|++|+||++
T Consensus        63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~  139 (277)
T 3f3z_A           63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLF  139 (277)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEE
Confidence            45789999999999999999999999999999998765 46899999999999999999999999  9999999999999


Q ss_pred             ---cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeeec
Q psy1934          83 ---SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g~  149 (150)
                         +.++.++++|||++........             .....+|+.|+|||++        |+||+|+++++|++|.
T Consensus       140 ~~~~~~~~~~l~Dfg~~~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~  204 (277)
T 3f3z_A          140 LTDSPDSPLKLIDFGLAARFKPGKM-------------MRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGY  204 (277)
T ss_dssp             SSSSTTCCEEECCCTTCEECCTTSC-------------BCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCCCcEEEEecccceeccCccc-------------hhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCC
Confidence               7778999999999875322111             1134689999999984        9999999999999885

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.3e-26  Score=165.72  Aligned_cols=134  Identities=20%  Similarity=0.339  Sum_probs=111.6

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCC----------------------CCCHHHHHHHHHHHHHHHH
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTS----------------------ALPPNIVCSILWQTCQAVK   61 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------------~l~~~~~~~~~~~i~~~l~   61 (150)
                      -||+|+++.+.+...+.+++||||+++|+|.+++.....                      .+++..+..++.|++.|+.
T Consensus       107 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~  186 (344)
T 1rjb_A          107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME  186 (344)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred             CCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHH
Confidence            489999999999999999999999999999999976432                      2688888999999999999


Q ss_pred             HHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------
Q psy1934          62 HMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------  133 (150)
Q Consensus        62 ~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------  133 (150)
                      |+|+++  ++|+|++|+||+++.++.++++|||++..........          ......+|+.|+|||++        
T Consensus       187 ~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~  254 (344)
T 1rjb_A          187 FLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV----------VRGNARLPVKWMAPESLFEGIYTIK  254 (344)
T ss_dssp             HHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE----------EETTEEECGGGCCHHHHHHCCCCHH
T ss_pred             HHHhCC--cccCCCChhhEEEcCCCcEEeCCCccCcccccCccce----------eccCccCccCccCHHHhccCCCChh
Confidence            999999  9999999999999999999999999987542221110          01123467889999984        


Q ss_pred             -cccccceeEEEeee-ec
Q psy1934         134 -DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus       134 -d~~~~g~~~~~~~~-g~  149 (150)
                       |+||+|+++++|++ |.
T Consensus       255 ~Di~slG~il~el~t~g~  272 (344)
T 1rjb_A          255 SDVWSYGILLWEIFSLGV  272 (344)
T ss_dssp             HHHHHHHHHHHHHTTTSC
T ss_pred             HhHHHHHHHHHHHHcCCC
Confidence             99999999999996 64

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.92  E-value=1.9e-26  Score=171.99  Aligned_cols=131  Identities=32%  Similarity=0.451  Sum_probs=111.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+++||||+++|+|.+.+... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        78 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~  154 (486)
T 3mwu_A           78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILL  154 (486)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred             CCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEE
Confidence            45899999999999999999999999999999998765 46899999999999999999999999  9999999999999


Q ss_pred             cC---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeeec
Q psy1934          83 SS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g~  149 (150)
                      +.   .+.++++|||++.......             ......||+.|+|||++        |+||+|+++++|++|.
T Consensus       155 ~~~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~  219 (486)
T 3mwu_A          155 ESKEKDCDIKIIDFGLSTCFQQNT-------------KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGT  219 (486)
T ss_dssp             SSSSTTCCEEECSCSCTTTBCCC-----------------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCCCCEEEEECCcCeECCCCC-------------ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCC
Confidence            54   4579999999986432110             11234689999999985        9999999999999885

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.92  E-value=2.5e-26  Score=161.08  Aligned_cols=137  Identities=18%  Similarity=0.141  Sum_probs=111.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +++++.+.+..+..+..++||||+ +++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.
T Consensus        65 ~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~  141 (298)
T 1csn_A           65 CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGR  141 (298)
T ss_dssp             CTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECC
T ss_pred             CCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecc
Confidence            456777777788888999999999 88999999876567999999999999999999999998  999999999999987


Q ss_pred             CCc-----EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 AGT-----VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.     ++++|||++...........     ..........||+.|+|||++         |+||+|+++++|++|.
T Consensus       142 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  215 (298)
T 1csn_A          142 PNSKNANMIYVVDFGMVKFYRDPVTKQH-----IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS  215 (298)
T ss_dssp             SSSTTTTCEEECCCTTCEESBCTTTCCB-----CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCCCeEEEEECcccccccccccccc-----ccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCC
Confidence            665     99999999875432211100     000011234689999999984         9999999999999886

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.92  E-value=2e-26  Score=163.97  Aligned_cols=132  Identities=28%  Similarity=0.382  Sum_probs=109.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.+...+.+++||||+++ +|.+++......+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~  133 (324)
T 3mtl_A           57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLI  133 (324)
T ss_dssp             CCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEE
T ss_pred             cCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEE
Confidence            4578999999999999999999999975 999999876667899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.......            .......+|+.|+|||++          |+||+|+++++|++|.
T Consensus       134 ~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  198 (324)
T 3mtl_A          134 NERGELKLADFGLARAKSIPT------------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR  198 (324)
T ss_dssp             CTTCCEEECSSSEEECC------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEccCcccccccCCc------------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999987432110            011134678999999974          9999999999999885

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.92  E-value=1e-26  Score=166.04  Aligned_cols=135  Identities=19%  Similarity=0.239  Sum_probs=112.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-----------------------CCCCHHHHHHHHHHHHHH
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-----------------------SALPPNIVCSILWQTCQA   59 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~~~~~i~~~   59 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++....                       ..+++..+..++.|++.|
T Consensus       107 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~  186 (343)
T 1luf_A          107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG  186 (343)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHH
T ss_pred             CCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHH
Confidence            458999999999999999999999999999999997642                       458888999999999999


Q ss_pred             HHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------
Q psy1934          60 VKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------  133 (150)
Q Consensus        60 l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------  133 (150)
                      +.|+|+++  ++|+|++|+||+++.++.++++|||++........          ........+++.|+|||++      
T Consensus       187 l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~~  254 (343)
T 1luf_A          187 MAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY----------YKADGNDAIPIRWMPPESIFYNRYT  254 (343)
T ss_dssp             HHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC----------BC----CCBCGGGCCHHHHHHCCCC
T ss_pred             HHHHHhCC--eecCCCCcceEEECCCCeEEEeecCCCcccccCcc----------ccccCCCcccceecChhhhccCCcC
Confidence            99999999  99999999999999999999999999864321100          0011234578889999974      


Q ss_pred             ---cccccceeEEEeee-ec
Q psy1934         134 ---DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus       134 ---d~~~~g~~~~~~~~-g~  149 (150)
                         |+||+|+++++|++ |.
T Consensus       255 ~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          255 TESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             HHHHHHHHHHHHHHHHTTTC
T ss_pred             cccccHHHHHHHHHHHhcCC
Confidence               99999999999997 64

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.92  E-value=2.1e-26  Score=163.52  Aligned_cols=131  Identities=32%  Similarity=0.465  Sum_probs=113.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        72 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~  148 (321)
T 2a2a_A           72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIML  148 (321)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEE
Confidence            45889999999999999999999999999999999764 46889999999999999999999999  9999999999999


Q ss_pred             cCCC----cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAG----TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++    .++++|||++........             .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       149 ~~~~~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  215 (321)
T 2a2a_A          149 LDKNIPIPHIKLIDFGLAHEIEDGVE-------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  215 (321)
T ss_dssp             SCTTSSSCCEEECCCTTCEECCTTCC-------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCcCCEEEccCccceecCcccc-------------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCC
Confidence            8887    799999999875422111             0134689999999984         9999999999999885

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.92  E-value=2.1e-26  Score=161.83  Aligned_cols=136  Identities=21%  Similarity=0.259  Sum_probs=111.9

Q ss_pred             ccchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|++++++.+.+...  +.+++||||+++++|.+++......+++..+..++.|++.|+.++|+++  ++|+|++|+||
T Consensus        80 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Ni  157 (302)
T 4e5w_A           80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNV  157 (302)
T ss_dssp             CCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred             CCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheE
Confidence            4578899988876655  6789999999999999999776667999999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++...........         ......+|..|+|||++         |+||+|+++++|++|.
T Consensus       158 l~~~~~~~kl~Dfg~~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  226 (302)
T 4e5w_A          158 LVESEHQVKIGDFGLTKAIETDKEYYT---------VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC  226 (302)
T ss_dssp             EEEETTEEEECCCTTCEECCTTCCEEE---------CCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred             EEcCCCCEEECcccccccccCCCccee---------ccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHcc
Confidence            999999999999999875432211100         01123577889999974         9999999999998864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.92  E-value=1.9e-26  Score=172.47  Aligned_cols=134  Identities=22%  Similarity=0.287  Sum_probs=112.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.+++...+.+++||||+++|+|.++++... ..+++..+..++.|++.|+.|||+++  ++|+|++|+||+
T Consensus       273 l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIl  350 (495)
T 1opk_A          273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCL  350 (495)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             cCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEE
Confidence            458999999999999899999999999999999998643 45888899999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.+|++|||+++........           ......++..|+|||++         |+||+|+++++|++ |.
T Consensus       351 l~~~~~~kl~DFG~a~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~  417 (495)
T 1opk_A          351 VGENHLVKVADFGLSRLMTGDTYT-----------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM  417 (495)
T ss_dssp             ECGGGCEEECCTTCEECCTTCCEE-----------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             ECCCCcEEEeecccceeccCCcee-----------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCC
Confidence            999999999999998754211100           01123456789999984         99999999999987 64

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=2.3e-26  Score=164.25  Aligned_cols=136  Identities=22%  Similarity=0.338  Sum_probs=109.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.....+.+++||||+++++|.+++......+++..+..++.|++.|+.++|+.+  ++|+|++|+||++
T Consensus       103 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~  180 (333)
T 1mqb_A          103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV  180 (333)
T ss_dssp             CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             CCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEE
Confidence            45789999999999999999999999999999999876567999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++..........         .......+++.|+|||++         |+||+|++++++++ |.
T Consensus       181 ~~~~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  248 (333)
T 1mqb_A          181 NSNLVCKVSDFGLSRVLEDDPEAT---------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE  248 (333)
T ss_dssp             CTTCCEEECCCCC--------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCcEEECCCCcchhhccccccc---------cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC
Confidence            999999999999987542211100         011123457789999984         99999999999886 64

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.92  E-value=9.9e-27  Score=163.52  Aligned_cols=131  Identities=24%  Similarity=0.352  Sum_probs=109.7

Q ss_pred             ccchhhhcccCCCCC--ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHG--MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-||+|+++.+.+..  .+.+++||||+++++|.+++..  ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNL  168 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHE
Confidence            457889998887654  6789999999999998876543  46899999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeee
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g  148 (150)
                      +++.++.++++|||++.........            .....||+.|+|||++            |+||+|+++++|++|
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDAL------------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCE------------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             EECCCCCEEEecCCCcccccccccc------------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            9999999999999998754221110            0134689999999974            999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       237 ~  237 (298)
T 2zv2_A          237 Q  237 (298)
T ss_dssp             S
T ss_pred             C
Confidence            5

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.92  E-value=1.7e-26  Score=161.11  Aligned_cols=134  Identities=20%  Similarity=0.352  Sum_probs=113.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.+...+.+++||||+++++|.+++......+++..+..++.|++.|+.++|+++  ++|+|++|+||++
T Consensus        76 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili  153 (283)
T 3gen_A           76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV  153 (283)
T ss_dssp             CCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEE
T ss_pred             CCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEE
Confidence            45789999999999999999999999999999999875567999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++......           .........+++.|+|||++         |+||+|++++++++ |.
T Consensus       154 ~~~~~~kl~Dfg~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~  219 (283)
T 3gen_A          154 NDQGVVKVSDFGLSRYVLDD-----------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK  219 (283)
T ss_dssp             CTTSCEEECSTTGGGGBCCH-----------HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTC
T ss_pred             cCCCCEEEcccccccccccc-----------ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999998643210           00111233467789999984         99999999999986 64

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.92  E-value=4.3e-26  Score=164.76  Aligned_cols=129  Identities=33%  Similarity=0.423  Sum_probs=112.7

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+...+.++..+..++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++.
T Consensus       159 hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~  235 (365)
T 2y7j_A          159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDD  235 (365)
T ss_dssp             CTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECT
T ss_pred             CCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence            788999999888899999999999999999999865 46899999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------------ccccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------------VDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------------~d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++........             .....||+.|+|||+               .|+||+|+++++|++|.
T Consensus       236 ~~~ikl~DfG~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~  302 (365)
T 2y7j_A          236 NMQIRLSDFGFSCHLEPGEK-------------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS  302 (365)
T ss_dssp             TCCEEECCCTTCEECCTTCC-------------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             CCCEEEEecCcccccCCCcc-------------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC
Confidence            99999999998875422111             113468999999996               39999999999999885

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.92  E-value=2.4e-26  Score=161.35  Aligned_cols=136  Identities=18%  Similarity=0.218  Sum_probs=111.3

Q ss_pred             ccchhhhcccCC-CCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHST-PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~-~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.+. .+..+..+++|||+++|+|.++++.....+++..+..++.|++.|+.++|+++  ++|+|++|+||+
T Consensus        83 l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil  160 (298)
T 3f66_A           83 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCM  160 (298)
T ss_dssp             CCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             CCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEE
Confidence            457899999886 66777899999999999999999876566889999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      ++.++.++++|||++........        ..........+++.|+|||++         |+||+|++++++++|
T Consensus       161 ~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~  228 (298)
T 3f66_A          161 LDEKFTVKVADFGLARDMYDKEY--------YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR  228 (298)
T ss_dssp             ECTTCCEEECSCGGGCCCSCGGG--------CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ECCCCCEEECcccccccccccch--------hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence            99999999999999874321110        001112234577889999985         999999999999884

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.92  E-value=1.1e-26  Score=164.95  Aligned_cols=135  Identities=18%  Similarity=0.195  Sum_probs=112.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-||+|+++.+.+...+.+++||||+++|+|.+++....   ..+++..+..++.|++.|+.|+|+++  ++|+|++|+|
T Consensus        92 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~N  169 (321)
T 2qkw_B           92 CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSIN  169 (321)
T ss_dssp             CCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTT
T ss_pred             CCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHH
Confidence            458899999999999999999999999999999986532   24888999999999999999999998  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      |+++.++.++++|||++...........          .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       170 il~~~~~~~kl~Dfg~~~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~  238 (321)
T 2qkw_B          170 ILLDENFVPKITDFGISKKGTELDQTHL----------STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR  238 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECSSSSCCCC----------BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCC
T ss_pred             EEECCCCCEEEeeccccccccccccccc----------ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCC
Confidence            9999999999999999875322111100          0123478899999984         9999999999999885

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.92  E-value=3.5e-26  Score=168.50  Aligned_cols=142  Identities=26%  Similarity=0.364  Sum_probs=107.8

Q ss_pred             ccchhhhcccCCCCCc-----eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPHGM-----HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-|++|+++.+.+...     +.+|+||||+++ +|.++++.. ..+++..++.++.|++.|+.|+|+++  ++|||+||
T Consensus        82 l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp  157 (432)
T 3n9x_A           82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKP  157 (432)
T ss_dssp             CCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             cCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCH
Confidence            3478899988776554     679999999975 999999763 56899999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchh----------HhhhhhhHHhhhcCCCCCccCcccc----------cccc
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWS----------AQQRSMLEDEMARFTTPMYRAPEMV----------DTWN  137 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~  137 (150)
                      +||+++.++.+|++|||+++...........          .............+||++|+|||++          |+||
T Consensus       158 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwS  237 (432)
T 3n9x_A          158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS  237 (432)
T ss_dssp             GGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred             HHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccch
Confidence            9999999999999999999864322110000          0000000112456899999999974          9999


Q ss_pred             cceeEEEeeee
Q psy1934         138 NYVIGRSMLYG  148 (150)
Q Consensus       138 ~g~~~~~~~~g  148 (150)
                      +|+++++|++|
T Consensus       238 lG~il~ell~g  248 (432)
T 3n9x_A          238 TGCIFAELLNM  248 (432)
T ss_dssp             HHHHHHHHHTT
T ss_pred             HHHHHHHHHhc
Confidence            99999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.92  E-value=6.6e-26  Score=161.91  Aligned_cols=132  Identities=30%  Similarity=0.431  Sum_probs=114.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.++..+.+++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++++||++
T Consensus        98 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~  174 (335)
T 2owb_A           98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFL  174 (335)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE
T ss_pred             CCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEE
Confidence            45889999999999999999999999999999998765 46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....|++.|+|||++         |+|++|+++++|++|.
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  238 (335)
T 2owb_A          175 NEDLEVKIGDFGLATKVEYDGER------------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK  238 (335)
T ss_dssp             CTTCCEEECCCTTCEECCSTTCC------------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEeeccCceecccCccc------------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCc
Confidence            99999999999998754221111            1134689999999984         9999999999999885

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.92  E-value=5.6e-26  Score=160.35  Aligned_cols=129  Identities=29%  Similarity=0.409  Sum_probs=107.7

Q ss_pred             chhhhcccCCCCCce-----EEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           5 SAAFIDKHSTPHGMH-----EYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      ||+|+++.+.+...+     .++++|||+++ +|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+
T Consensus        73 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~  149 (308)
T 3g33_A           73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPE  149 (308)
T ss_dssp             CTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTT
T ss_pred             CCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHH
Confidence            788998887654433     68999999975 9999998654 33899999999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ||+++.++.++++|||++........             .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       150 Nil~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  216 (308)
T 3g33_A          150 NILVTSGGTVKLADFGLARIYSYQMA-------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK  216 (308)
T ss_dssp             TEEECTTSCEEECSCSCTTTSTTCCC-------------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSS
T ss_pred             HEEEcCCCCEEEeeCccccccCCCcc-------------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCC
Confidence            99999999999999999864321111             1134689999999985         9999999999999885

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.92  E-value=1.4e-26  Score=172.56  Aligned_cols=132  Identities=30%  Similarity=0.414  Sum_probs=113.3

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++++..+.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus        82 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil  158 (484)
T 3nyv_A           82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLL  158 (484)
T ss_dssp             TCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred             hCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEE
Confidence            345899999999999999999999999999999999764 56899999999999999999999999  999999999999


Q ss_pred             E---cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeeec
Q psy1934          82 I---SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g~  149 (150)
                      +   +..+.++++|||++........             .....||+.|+|||++        |+||+|+++++|++|.
T Consensus       159 ~~~~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~  224 (484)
T 3nyv_A          159 LESKSKDANIRIIDFGLSTHFEASKK-------------MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGC  224 (484)
T ss_dssp             ESSSSTTCCEEECCTTHHHHBCCCCS-------------HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EecCCCCCcEEEEeeeeeEEcccccc-------------cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCC
Confidence            9   4568899999999864321110             1134689999999984        9999999999999885

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.92  E-value=8.9e-27  Score=167.38  Aligned_cols=133  Identities=23%  Similarity=0.396  Sum_probs=108.1

Q ss_pred             chhhhcccCCCCCc-eEEEEEEeccCCCCHHHHHHhhCC-----------------------------------------
Q psy1934           5 SAAFIDKHSTPHGM-HEYLILTELCTGGSLVDVLKERTS-----------------------------------------   42 (150)
Q Consensus         5 ~~~~~~~~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~-----------------------------------------   42 (150)
                      ||+|+++.+.+... +.+++||||+++|+|.+++.....                                         
T Consensus        85 hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (359)
T 3vhe_A           85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS  164 (359)
T ss_dssp             CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred             CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence            68999998876654 458999999999999999976422                                         


Q ss_pred             ------------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          43 ------------------------ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        43 ------------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                                              .+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.++.++++|||++..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  242 (359)
T 3vhe_A          165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARD  242 (359)
T ss_dssp             -------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred             cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceee
Confidence                                    1788889999999999999999999  99999999999999999999999999874


Q ss_pred             cccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          99 KVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ........          ......+|+.|+|||++         |+||+|+++++|++ |.
T Consensus       243 ~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  293 (359)
T 3vhe_A          243 IYKDPDYV----------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  293 (359)
T ss_dssp             TTSCTTCE----------EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             ecccccch----------hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCC
Confidence            32221110          11133578889999974         99999999999996 64

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.92  E-value=4.2e-26  Score=158.92  Aligned_cols=128  Identities=23%  Similarity=0.276  Sum_probs=109.3

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      -||+|+++.+.+...+.+++||||+++++|.+++....   ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||
T Consensus        69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NI  146 (289)
T 1x8b_A           69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNI  146 (289)
T ss_dssp             SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred             CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHE
Confidence            47899999999998999999999999999999997542   46899999999999999999999999  99999999999


Q ss_pred             EEcCC-------------------CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------
Q psy1934          81 LISSA-------------------GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------  133 (150)
Q Consensus        81 l~~~~-------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------  133 (150)
                      +++..                   ..++++|||.+......                ....||+.|+|||++        
T Consensus       147 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~  210 (289)
T 1x8b_A          147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----------------QVEEGDSRFLANEVLQENYTHLP  210 (289)
T ss_dssp             EEC--------------------CCCEEECCCTTCEETTCS----------------CCCCCCGGGCCHHHHTTCCTTHH
T ss_pred             EEcCCCCCcccccccccccccCCceEEEEcccccccccCCc----------------cccCCCccccChhHhcCCCCCCc
Confidence            99843                   47899999988753211                123588999999974        


Q ss_pred             --cccccceeEEEeeeec
Q psy1934         134 --DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       134 --d~~~~g~~~~~~~~g~  149 (150)
                        |+||+|+++++++.|.
T Consensus       211 ~~Di~slG~il~~l~~~~  228 (289)
T 1x8b_A          211 KADIFALALTVVCAAGAE  228 (289)
T ss_dssp             HHHHHHHHHHHHHHTTCC
T ss_pred             hhhHHHHHHHHHHHhcCC
Confidence              9999999999998774

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.92  E-value=5e-26  Score=168.45  Aligned_cols=131  Identities=26%  Similarity=0.403  Sum_probs=108.8

Q ss_pred             cccchhhhcccCCCC-CceEEEEEEeccCCCCHHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           2 EYLSAAFIDKHSTPH-GMHEYLILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      ++-||+|+++.++.. ..+.+++||||+++|+|.++++.... .+++..+..++.|++.|+.|+|+++  ++|+|++|+|
T Consensus       242 ~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~N  319 (450)
T 1k9a_A          242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARN  319 (450)
T ss_dssp             TCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGG
T ss_pred             hccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhh
Confidence            345889999888743 44579999999999999999987643 3788899999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      |+++.++.+|++|||+++.....               .....++..|+|||++         |+||+|+++++|++ |.
T Consensus       320 ill~~~~~~kl~DfG~a~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~  384 (450)
T 1k9a_A          320 VLVSEDNVAKVSDFGLTKEASST---------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR  384 (450)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             EEECCCCCEEEeeCCCccccccc---------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999998743211               0112467889999985         99999999999986 65

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.92  E-value=2.4e-26  Score=165.14  Aligned_cols=128  Identities=27%  Similarity=0.406  Sum_probs=112.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+++...+..++||||++ |++.+++......+++..+..++.+++.|+.|+|+++  ++|+|++|+||++
T Consensus       111 l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll  187 (348)
T 1u5q_A          111 LRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL  187 (348)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE
T ss_pred             CCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE
Confidence            457899999999888899999999997 5899988766667999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++......                ....||+.|+|||++            |+||+|+++++|++|.
T Consensus       188 ~~~~~~kL~DfG~a~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~  250 (348)
T 1u5q_A          188 SEPGLVKLGDFGSASIMAPA----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  250 (348)
T ss_dssp             ETTTEEEECCCTTCBSSSSB----------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEeeccCceecCCC----------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999998643211                134689999999974            9999999999999885

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.92  E-value=3.9e-26  Score=161.19  Aligned_cols=135  Identities=23%  Similarity=0.301  Sum_probs=112.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-----------------------CCCCHHHHHHHHHHHHHH
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-----------------------SALPPNIVCSILWQTCQA   59 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~~~~~i~~~   59 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++....                       ..+++..+..++.|++.|
T Consensus        83 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  162 (314)
T 2ivs_A           83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG  162 (314)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHH
T ss_pred             CCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHH
Confidence            458999999999999999999999999999999998642                       137888899999999999


Q ss_pred             HHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------
Q psy1934          60 VKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------  133 (150)
Q Consensus        60 l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------  133 (150)
                      +.|+|+++  ++|+|++|+||+++.++.++++|||++..........          ......+++.|+|||++      
T Consensus       163 l~~lH~~~--ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~  230 (314)
T 2ivs_A          163 MQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV----------KRSQGRIPVKWMAIESLFDHIYT  230 (314)
T ss_dssp             HHHHHHTT--EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE----------CSSCCCSCGGGCCHHHHHHCEEC
T ss_pred             HHHHHHCC--CcccccchheEEEcCCCCEEEccccccccccccccce----------eccCCCCcccccChhhhcCCCcC
Confidence            99999999  9999999999999999999999999987542211100          01123467889999974      


Q ss_pred             ---cccccceeEEEeee-ec
Q psy1934         134 ---DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus       134 ---d~~~~g~~~~~~~~-g~  149 (150)
                         |+||+|+++++|++ |.
T Consensus       231 ~~~Di~slG~il~el~t~g~  250 (314)
T 2ivs_A          231 TQSDVWSFGVLLWEIVTLGG  250 (314)
T ss_dssp             HHHHHHHHHHHHHHHHTTSC
T ss_pred             chhhHHHHHHHHHHHHhCCC
Confidence               99999999999987 64

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.92  E-value=8.1e-27  Score=163.67  Aligned_cols=136  Identities=18%  Similarity=0.252  Sum_probs=107.6

Q ss_pred             ccchhhhcccCCCCC--ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHG--MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-||+|+++.+.+..  .+.+++||||+++++|.+++......+++..+..++.|++.|+.|+|+.+  ++|+|++|+||
T Consensus        68 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Ni  145 (295)
T 3ugc_A           68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNI  145 (295)
T ss_dssp             CCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             CCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhE
Confidence            457889998876543  34589999999999999999876556899999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++.........         ........++..|+|||++         |+||+|++++++++|.
T Consensus       146 l~~~~~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  214 (295)
T 3ugc_A          146 LVENENRVKIGDFGLTKVLPQDKEF---------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI  214 (295)
T ss_dssp             EEEETTEEEECCCCSCC----------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred             EEcCCCeEEEccCcccccccCCcce---------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcc
Confidence            9999999999999998753221110         0111123467789999984         9999999999998863

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.92  E-value=4.7e-26  Score=158.64  Aligned_cols=130  Identities=25%  Similarity=0.370  Sum_probs=111.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++... ..+++..+..++.+++.|+.|+|+.+  ++|+|++|+||++
T Consensus        66 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili  142 (279)
T 3fdn_A           66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL  142 (279)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEE
T ss_pred             CCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEE
Confidence            45789999999999999999999999999999999765 46899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++......              ......+++.|+|||++         |+||+|+++++|++|.
T Consensus       143 ~~~~~~~l~Dfg~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  204 (279)
T 3fdn_A          143 GSAGELKIADFGWSVHAPSS--------------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK  204 (279)
T ss_dssp             CTTSCEEECSCCEESCC----------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEEeccccccCCcc--------------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCC
Confidence            99999999999987532211              11234689999999974         9999999999999885

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.92  E-value=3.7e-26  Score=159.84  Aligned_cols=132  Identities=30%  Similarity=0.439  Sum_probs=109.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++...   ...+++..+..++.|++.|+.|+|+++  ++|+|++|+|
T Consensus        77 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~N  154 (285)
T 3is5_A           77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPEN  154 (285)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGG
T ss_pred             CCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHH
Confidence            45789999999999999999999999999999988643   356899999999999999999999999  9999999999


Q ss_pred             EEE---cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeee
Q psy1934          80 LLI---SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        80 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g  148 (150)
                      |++   +..+.++++|||++.......             ......+++.|+|||++        |+||+|+++++|++|
T Consensus       155 Il~~~~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g  221 (285)
T 3is5_A          155 ILFQDTSPHSPIKIIDFGLAELFKSDE-------------HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTG  221 (285)
T ss_dssp             EEESSSSTTCCEEECCCCCCCC-----------------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHS
T ss_pred             EEEecCCCCCCEEEEeeecceecCCcc-------------cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhC
Confidence            999   445789999999986432110             11234689999999974        999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       222 ~  222 (285)
T 3is5_A          222 C  222 (285)
T ss_dssp             S
T ss_pred             C
Confidence            5

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.92  E-value=1.7e-26  Score=161.09  Aligned_cols=133  Identities=26%  Similarity=0.306  Sum_probs=102.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.... +.+++||||+++++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        73 l~h~~iv~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~  149 (281)
T 1mp8_A           73 FDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV  149 (281)
T ss_dssp             CCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred             CCCCccceEEEEEcc-CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEE
Confidence            457899998887754 6789999999999999999876557899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++........           .......+++.|+|||++         |+||+|++++++++ |.
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~  215 (281)
T 1mp8_A          150 SSNDCVKLGDFGLSRYMEDSTY-----------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV  215 (281)
T ss_dssp             EETTEEEECC------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCCEEECccccccccCcccc-----------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCC
Confidence            9999999999999875321110           011123467789999984         99999999999985 64

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.92  E-value=2e-26  Score=176.18  Aligned_cols=136  Identities=22%  Similarity=0.323  Sum_probs=109.3

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-|++|+++.++++. +.+++||||+++|+|.+++......+++..+..++.|++.|+.|||+++  ++|+|++|+||+
T Consensus       392 ~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIL  468 (613)
T 2ozo_A          392 QLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVL  468 (613)
T ss_dssp             TCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             hCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEE
Confidence            3558899999988776 5699999999999999999765566899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.+|++|||+++........         ........+++.|+|||++         |+||+|++++||+. |.
T Consensus       469 l~~~~~vkL~DFGla~~~~~~~~~---------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~  537 (613)
T 2ozo_A          469 LVNRHYAKISDFGLSKALGADDSY---------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ  537 (613)
T ss_dssp             EEETTEEEECCCSTTTTCC-----------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             EcCCCcEEEeeccCcccccCCCce---------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            999999999999998753211100         0011122356889999985         99999999999996 75

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.92  E-value=2.6e-26  Score=163.51  Aligned_cols=134  Identities=19%  Similarity=0.236  Sum_probs=110.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+... ..++++||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|+||+||++
T Consensus        74 l~h~~iv~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll  150 (327)
T 3poz_A           74 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV  150 (327)
T ss_dssp             CCBTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             CCCCCEeEEEEEEecC-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEE
Confidence            4578899988887764 478999999999999999876667999999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||+++........          .......+|+.|+|||++         |+||+|++++++++ |.
T Consensus       151 ~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  217 (327)
T 3poz_A          151 KTPQHVKITDFGLAKLLGAEEKE----------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS  217 (327)
T ss_dssp             EETTEEEECCTTHHHHHTTTCC-----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCCEEEccCcceeEccCCccc----------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCC
Confidence            99999999999998753221111          011123467889999984         99999999999987 64

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.92  E-value=4.8e-26  Score=169.15  Aligned_cols=128  Identities=28%  Similarity=0.396  Sum_probs=102.5

Q ss_pred             ccchhhhcccCCCC------CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPH------GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~------~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||+|+++.+++.      ..+.+|+||||+++ ++.+.+..   .+++..+..++.|++.|+.|+|+.+  ++|||+|
T Consensus       118 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlk  191 (464)
T 3ttj_A          118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK  191 (464)
T ss_dssp             CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCC
T ss_pred             CCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCC
Confidence            35788999888664      34678999999976 57776643   4889999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+||+++.++.+|++|||+++......             .....+||+.|+|||++         |+||+|+++++|++
T Consensus       192 p~NIll~~~~~~kl~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~  258 (464)
T 3ttj_A          192 PSNIVVKSDCTLKILDFGLARTAGTSF-------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR  258 (464)
T ss_dssp             GGGEEECTTSCEEECCCCCC-----CC-------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             hHhEEEeCCCCEEEEEEEeeeecCCCc-------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHh
Confidence            999999999999999999987432110             01234789999999984         99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       259 g~  260 (464)
T 3ttj_A          259 HK  260 (464)
T ss_dssp             SS
T ss_pred             CC
Confidence            85

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=6.8e-26  Score=163.83  Aligned_cols=127  Identities=24%  Similarity=0.390  Sum_probs=108.4

Q ss_pred             ccchhhhcccCCCCCc------eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGM------HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-|++|+++.+++...      ..+|+||||+ +++|.++++.  ..+++..+..++.|++.|+.|+|+++  ++|+|++
T Consensus        81 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk  155 (367)
T 1cm8_A           81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLK  155 (367)
T ss_dssp             CCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred             CCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcC
Confidence            3478899988866554      4579999999 7799999976  46899999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.+|++|||+++.....               ....++|++|+|||++          |+||+|+++++|+
T Consensus       156 p~NIll~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  220 (367)
T 1cm8_A          156 PGNLAVNEDCELKILDFGLARQADSE---------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI  220 (367)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSS---------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred             HHHEEEcCCCCEEEEeeecccccccc---------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence            99999999999999999998753211               1134689999999974          9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       221 ~g~  223 (367)
T 1cm8_A          221 TGK  223 (367)
T ss_dssp             HSS
T ss_pred             hCC
Confidence            885

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.92  E-value=1.4e-26  Score=165.91  Aligned_cols=137  Identities=15%  Similarity=0.063  Sum_probs=110.5

Q ss_pred             cchhhhcccCCCCC----ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           4 LSAAFIDKHSTPHG----MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         4 ~~~~~~~~~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      -|++|+++.+.+..    .+.+++||||+ +++|.+++.... .+++..+..++.|++.|+.|+|+++  ++|+|++|+|
T Consensus       106 ~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~N  181 (345)
T 2v62_A          106 DYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAAN  181 (345)
T ss_dssp             SCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred             cccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHH
Confidence            46788888776655    78999999999 889999997653 7899999999999999999999998  9999999999


Q ss_pred             EEEcCCC--cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          80 LLISSAG--TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        80 il~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      |+++.++  .++++|||+++..........     ..........||+.|+|||++         |+||+|+++++|++|
T Consensus       182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g  256 (345)
T 2v62_A          182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQ-----YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG  256 (345)
T ss_dssp             EEEESSSTTSEEECCCTTCEESSGGGCCCC-----CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             EEEccCCCCcEEEEeCCCceeccccccccc-----chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            9998877  999999999975432111000     000011245789999999984         999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       257 ~  257 (345)
T 2v62_A          257 K  257 (345)
T ss_dssp             S
T ss_pred             C
Confidence            6

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.92  E-value=1.5e-25  Score=157.20  Aligned_cols=132  Identities=30%  Similarity=0.431  Sum_probs=113.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.+...+..++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        72 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~  148 (294)
T 2rku_A           72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFL  148 (294)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEE
Confidence            45789999999999999999999999999999998765 46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....|++.|+|||++         |+|++|+++++|++|.
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  212 (294)
T 2rku_A          149 NEDLEVKIGDFGLATKVEYDGER------------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK  212 (294)
T ss_dssp             CTTCCEEECCCTTCEECCSTTCC------------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEEeccCceecccCccc------------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999998754221111            1124588999999984         9999999999999885

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.92  E-value=5.6e-26  Score=161.57  Aligned_cols=144  Identities=49%  Similarity=0.858  Sum_probs=97.8

Q ss_pred             chhhhcccCCC--------CCceEEEEEEeccCCCCHHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEec
Q psy1934           5 SAAFIDKHSTP--------HGMHEYLILTELCTGGSLVDVLKER--TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD   74 (150)
Q Consensus         5 ~~~~~~~~~~~--------~~~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~   74 (150)
                      |++|+++.+.+        ...+.+++++||++ |+|.+++...  ...+++..+..++.|++.|+.|+|+.+++++|+|
T Consensus        85 h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~D  163 (337)
T 3ll6_A           85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD  163 (337)
T ss_dssp             STTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCC
T ss_pred             CCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEcc
Confidence            78888876544        67788999999996 5999988752  3468999999999999999999998766699999


Q ss_pred             CCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeE
Q psy1934          75 LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIG  142 (150)
Q Consensus        75 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~  142 (150)
                      ++|+||+++.++.++++|||++..........................+|+.|+|||++            |+||+|+++
T Consensus       164 ikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il  243 (337)
T 3ll6_A          164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL  243 (337)
T ss_dssp             CCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHH
T ss_pred             CCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHH
Confidence            99999999999999999999987543322211111111111122345689999999975            999999999


Q ss_pred             EEeeeec
Q psy1934         143 RSMLYGH  149 (150)
Q Consensus       143 ~~~~~g~  149 (150)
                      ++|++|.
T Consensus       244 ~el~~g~  250 (337)
T 3ll6_A          244 YLLCFRQ  250 (337)
T ss_dssp             HHHHHSS
T ss_pred             HHHHhCC
Confidence            9999885

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.92  E-value=5.5e-26  Score=161.66  Aligned_cols=131  Identities=18%  Similarity=0.261  Sum_probs=110.4

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNP   68 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~   68 (150)
                      -||+|+++.+.++..+.+++||||+++++|.+++....               ..+++..+..++.|++.|+.|+|+++ 
T Consensus        84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-  162 (327)
T 1fvr_A           84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-  162 (327)
T ss_dssp             CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             CCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            47899999999999999999999999999999997542               35889999999999999999999999 


Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccc
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNY  139 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g  139 (150)
                       ++|+|++|+||+++.++.++++|||++........             .....+++.|+|||++         |+||+|
T Consensus       163 -ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  228 (327)
T 1fvr_A          163 -FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYG  228 (327)
T ss_dssp             -EECSCCSGGGEEECGGGCEEECCTTCEESSCEECC-------------C----CCTTTCCHHHHHHCEECHHHHHHHHH
T ss_pred             -ccCCCCccceEEEcCCCeEEEcccCcCcccccccc-------------ccCCCCCccccChhhhccccCCchhcchHHH
Confidence             99999999999999999999999999874221111             0122467889999984         999999


Q ss_pred             eeEEEeee-ec
Q psy1934         140 VIGRSMLY-GH  149 (150)
Q Consensus       140 ~~~~~~~~-g~  149 (150)
                      +++++|++ |.
T Consensus       229 ~il~ellt~g~  239 (327)
T 1fvr_A          229 VLLWEIVSLGG  239 (327)
T ss_dssp             HHHHHHHTTSC
T ss_pred             HHHHHHHcCCC
Confidence            99999986 64

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.91  E-value=8.2e-26  Score=157.79  Aligned_cols=130  Identities=23%  Similarity=0.359  Sum_probs=112.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++||||+++++|.+++... ..+++..+..++.|++.|+.++|+++  ++|+|++|+||++
T Consensus        71 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~  147 (284)
T 2vgo_A           71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLM  147 (284)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE
T ss_pred             CCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE
Confidence            35789999999998899999999999999999999865 46899999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.......              .....|++.|+|||++         |+||+|++++++++|.
T Consensus       148 ~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  209 (284)
T 2vgo_A          148 GYKGELKIADFGWSVHAPSLR--------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM  209 (284)
T ss_dssp             CTTCCEEECCCTTCEECSSSC--------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEecccccccCcccc--------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCC
Confidence            999999999999886432111              0134588999999984         9999999999999885

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.91  E-value=5.5e-26  Score=157.22  Aligned_cols=130  Identities=17%  Similarity=0.225  Sum_probs=111.0

Q ss_pred             ccchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-||+|+++.++....  +.+++||||+++|+|.+++..... .+++..+..++.|++.|+.|+|+++.+++|+|++|+|
T Consensus        64 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~N  143 (271)
T 3kmu_A           64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS  143 (271)
T ss_dssp             CSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGG
T ss_pred             cCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccce
Confidence            4588999998887665  788999999999999999986543 4899999999999999999999887679999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc------------ccccccceeEEEeee
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------------VDTWNNYVIGRSMLY  147 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~------------~d~~~~g~~~~~~~~  147 (150)
                      |+++.++.+++.+|+++.....                 ....+|+.|+|||+            .|+||+|+++++|++
T Consensus       144 il~~~~~~~~l~~~~~~~~~~~-----------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  206 (271)
T 3kmu_A          144 VMIDEDMTARISMADVKFSFQS-----------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT  206 (271)
T ss_dssp             EEECTTSCEEEEGGGSCCTTSC-----------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCcceeEEeccceeeecc-----------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999887653211                 12357899999997            399999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       207 g~  208 (271)
T 3kmu_A          207 RE  208 (271)
T ss_dssp             CS
T ss_pred             CC
Confidence            85

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.91  E-value=8.5e-26  Score=159.18  Aligned_cols=135  Identities=22%  Similarity=0.301  Sum_probs=113.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-||+|++..+.+...+..+++|||+++++|.+++....  ..+++..+..++.+++.|+.|+|+.+  ++|+|++|+||
T Consensus        87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Ni  164 (307)
T 2nru_A           87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANI  164 (307)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred             cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHE
Confidence            357899999999999999999999999999999997432  45889999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++..........          ......|++.|+|||++        |+||+|+++++|++|.
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~  231 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTV----------MTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGL  231 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCE----------ECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCC
T ss_pred             EEcCCCcEEEeecccccccccccccc----------cccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCC
Confidence            99999999999999987542211110          00123689999999984        9999999999999885

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.91  E-value=4.5e-26  Score=157.57  Aligned_cols=134  Identities=17%  Similarity=0.305  Sum_probs=113.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||++++..+.+...+.++++|||+++++|.+++......+++..+..++.+++.|+.++|+.+  ++|+|++|+||++
T Consensus        60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili  137 (267)
T 3t9t_A           60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV  137 (267)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE
T ss_pred             CCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEE
Confidence            45789999999988889999999999999999999876567899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++......           .........+++.|+|||++         |+||+|+++++|++ |.
T Consensus       138 ~~~~~~kl~dfg~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~  203 (267)
T 3t9t_A          138 GENQVIKVSDFGMTRFVLDD-----------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK  203 (267)
T ss_dssp             CGGGCEEECCTTGGGGBCCH-----------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCCEEEcccccccccccc-----------cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCC
Confidence            99999999999988643210           00111233467789999984         99999999999987 54

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.91  E-value=1.6e-25  Score=156.43  Aligned_cols=130  Identities=25%  Similarity=0.380  Sum_probs=109.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+..+...  ++||||+++++|.+.+......+++..+..++.|++.|+.|+|+++.+++|+|++|+||++
T Consensus        80 l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~  157 (287)
T 4f0f_A           80 LNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL  157 (287)
T ss_dssp             CCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEE
T ss_pred             CCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEE
Confidence            45788999888777654  6999999999999999776667999999999999999999999987669999999999999


Q ss_pred             cCCCc-----EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEee
Q psy1934          83 SSAGT-----VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSML  146 (150)
Q Consensus        83 ~~~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~  146 (150)
                      +..+.     ++++|||++......               .....||+.|+|||++           |+||+|+++++|+
T Consensus       158 ~~~~~~~~~~~kl~Dfg~~~~~~~~---------------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~  222 (287)
T 4f0f_A          158 QSLDENAPVCAKVADFGLSQQSVHS---------------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL  222 (287)
T ss_dssp             SCCCTTCSCCEEECCCTTCBCCSSC---------------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred             eccCCCCceeEEeCCCCcccccccc---------------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence            87765     999999998642210               1134689999999984           9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       223 ~g~  225 (287)
T 4f0f_A          223 TGE  225 (287)
T ss_dssp             HSS
T ss_pred             cCC
Confidence            885

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.91  E-value=1.2e-25  Score=156.59  Aligned_cols=132  Identities=21%  Similarity=0.290  Sum_probs=109.0

Q ss_pred             ccchhhhcccCCCC----------------CceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhc
Q psy1934           3 YLSAAFIDKHSTPH----------------GMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHG   65 (150)
Q Consensus         3 ~~~~~~~~~~~~~~----------------~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~   65 (150)
                      +-||+++++.+.++                ..+.+++||||+++++|.+++.... ..+++..+..++.|++.|+.|+|+
T Consensus        61 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  140 (284)
T 2a19_B           61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS  140 (284)
T ss_dssp             CCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34677877766543                3567899999999999999997643 568899999999999999999999


Q ss_pred             CCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccc
Q psy1934          66 QNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTW  136 (150)
Q Consensus        66 ~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~  136 (150)
                      .+  ++|+|++|+||+++.++.++++|||++........             .....+++.|+|||++         |+|
T Consensus       141 ~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~  205 (284)
T 2a19_B          141 KK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-------------RTRSKGTLRYMSPEQISSQDYGKEVDLY  205 (284)
T ss_dssp             TT--EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC-------------CCCCCSCCTTSCHHHHHCSCCCTHHHHH
T ss_pred             CC--eeeccCCHHHEEEcCCCCEEECcchhheecccccc-------------ccccCCcccccChhhhccCCCcchhhhH
Confidence            99  99999999999999999999999999875432111             1123588999999984         999


Q ss_pred             ccceeEEEeeeec
Q psy1934         137 NNYVIGRSMLYGH  149 (150)
Q Consensus       137 ~~g~~~~~~~~g~  149 (150)
                      |+|+++++|++|.
T Consensus       206 slG~il~~l~~~~  218 (284)
T 2a19_B          206 ALGLILAELLHVC  218 (284)
T ss_dssp             HHHHHHHHHHSCC
T ss_pred             HHHHHHHHHHhcC
Confidence            9999999998774

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.91  E-value=3.1e-26  Score=161.60  Aligned_cols=134  Identities=22%  Similarity=0.368  Sum_probs=111.7

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCC-----------------CCCHHHHHHHHHHHHHHHHHHhcC
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTS-----------------ALPPNIVCSILWQTCQAVKHMHGQ   66 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-----------------~l~~~~~~~~~~~i~~~l~~lh~~   66 (150)
                      -||+|+++.+.+...+..++||||+++|+|.+++.....                 .+++..+..++.|++.|+.|+|++
T Consensus        85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  164 (313)
T 1t46_A           85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK  164 (313)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence            388999999999999999999999999999999986432                 388899999999999999999999


Q ss_pred             CCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccc
Q psy1934          67 NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWN  137 (150)
Q Consensus        67 ~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~  137 (150)
                      +  ++|+|++|+||+++.++.++++|||++..........          ......+++.|+|||++         |+||
T Consensus       165 ~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  232 (313)
T 1t46_A          165 N--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV----------VKGNARLPVKWMAPESIFNCVYTFESDVWS  232 (313)
T ss_dssp             T--CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSE----------ECSSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             C--eecCCCccceEEEcCCCCEEEccccccccccccccce----------eccCCCCcceeeChHHhcCCCCChHHHHHH
Confidence            9  9999999999999999999999999987542221100          00122457789999974         9999


Q ss_pred             cceeEEEeee-ec
Q psy1934         138 NYVIGRSMLY-GH  149 (150)
Q Consensus       138 ~g~~~~~~~~-g~  149 (150)
                      +|+++++|++ |.
T Consensus       233 lG~il~ellt~g~  245 (313)
T 1t46_A          233 YGIFLWELFSLGS  245 (313)
T ss_dssp             HHHHHHHHHTTTC
T ss_pred             HHHHHHHHHhCCC
Confidence            9999999987 64

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=3.6e-26  Score=163.92  Aligned_cols=132  Identities=26%  Similarity=0.353  Sum_probs=112.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+++...+.+++||||+++ +|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        69 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~  145 (346)
T 1ua2_A           69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLL  145 (346)
T ss_dssp             CCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred             CCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEE
Confidence            3478999999999999999999999987 899998765556888899999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....+|+.|+|||++          |+||+|+++++|++|.
T Consensus       146 ~~~~~~kl~Dfg~a~~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  210 (346)
T 1ua2_A          146 DENGVLKLADFGLAKSFGSPNRA------------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV  210 (346)
T ss_dssp             CTTCCEEECCCGGGSTTTSCCCC------------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEEecccceeccCCccc------------CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCC
Confidence            99999999999998753211110            1134689999999974          9999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.91  E-value=1.7e-25  Score=157.02  Aligned_cols=129  Identities=30%  Similarity=0.431  Sum_probs=112.6

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+++.+.++..+.+++||||+++++|.+++... ..+++..+..++.+++.|+.++|+.+  ++|+|++|+||+++.
T Consensus        83 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~  159 (298)
T 1phk_A           83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDD  159 (298)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECT
T ss_pred             CCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcC
Confidence            899999999999999999999999999999999865 46899999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++++|||++........             .....+++.|+|||++               |+|++|+++++|++|.
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  226 (298)
T 1phk_A          160 DMNIKLTDFGFSCQLDPGEK-------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS  226 (298)
T ss_dssp             TCCEEECCCTTCEECCTTCC-------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCcEEEecccchhhcCCCcc-------------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence            99999999999875322111             0134588999999964               9999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.91  E-value=2.9e-26  Score=169.84  Aligned_cols=134  Identities=24%  Similarity=0.352  Sum_probs=109.9

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      ++-||+|+++.++.. .+.+++||||+++|+|.++++... ..+++..+..++.|++.|+.|||+++  ++|+|++|+||
T Consensus       239 ~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Ni  315 (454)
T 1qcf_A          239 TLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANI  315 (454)
T ss_dssp             TCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGE
T ss_pred             hCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHE
Confidence            356889999888776 467899999999999999997542 35888888999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +++.++.+|++|||+++.....   .        ........++..|+|||++         |+||+|+++++|++ |.
T Consensus       316 ll~~~~~~kl~DFG~a~~~~~~---~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~  383 (454)
T 1qcf_A          316 LVSASLVCKIADFGLARVIEDN---E--------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR  383 (454)
T ss_dssp             EECTTCCEEECSTTGGGGBCCH---H--------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             EECCCCcEEEeeCCCceEcCCC---c--------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCC
Confidence            9999999999999998743210   0        0111123456789999985         99999999999997 65

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.91  E-value=5.5e-26  Score=159.62  Aligned_cols=138  Identities=22%  Similarity=0.401  Sum_probs=110.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHh-------hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKE-------RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++..       ....+++..+..++.|++.|+.|+|+++  ++|+|+
T Consensus        70 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl  147 (303)
T 2vwi_A           70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDV  147 (303)
T ss_dssp             CCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCC
T ss_pred             cCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCC
Confidence            4589999999988888999999999999999999974       1245889999999999999999999998  999999


Q ss_pred             CCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEe
Q psy1934          76 KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSM  145 (150)
Q Consensus        76 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~  145 (150)
                      +|+||+++.++.++++|||++..........       .........||+.|+|||++          |+||+|+++++|
T Consensus       148 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  220 (303)
T 2vwi_A          148 KAGNILLGEDGSVQIADFGVSAFLATGGDIT-------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL  220 (303)
T ss_dssp             SGGGEEECTTCCEEECCCHHHHHCC----------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHH
T ss_pred             ChhhEEEcCCCCEEEEeccchheeccCCCcc-------chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHH
Confidence            9999999999999999999876432211100       00111234689999999974          999999999999


Q ss_pred             eeec
Q psy1934         146 LYGH  149 (150)
Q Consensus       146 ~~g~  149 (150)
                      ++|.
T Consensus       221 ~~g~  224 (303)
T 2vwi_A          221 ATGA  224 (303)
T ss_dssp             HHSS
T ss_pred             HhCC
Confidence            9885

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.91  E-value=7.4e-26  Score=159.99  Aligned_cols=133  Identities=24%  Similarity=0.274  Sum_probs=108.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++++||+++++|.+++... ..+++..+..++.+++.|+.|+|+.+  ++|+|++|+||++
T Consensus        91 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~  167 (309)
T 2h34_A           91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILV  167 (309)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             cCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEE
Confidence            45789999999988889999999999999999999865 46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........           .......+++.|+|||++         |+||+|+++++|++|.
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  232 (309)
T 2h34_A          168 SADDFAYLVDFGIASATTDEKL-----------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS  232 (309)
T ss_dssp             CTTSCEEECSCCC---------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEecCccCcccccccc-----------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCC
Confidence            9999999999998864321110           011234688999999985         9999999999999885

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.91  E-value=3e-26  Score=167.12  Aligned_cols=132  Identities=25%  Similarity=0.381  Sum_probs=109.0

Q ss_pred             ccchhhhcccCCCCCc--eEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           3 YLSAAFIDKHSTPHGM--HEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      +-||+|+++.++....  ..+++||||+++|+|.++++...  ..+++..+..++.|++.|+.|+|+++  ++|+|++|+
T Consensus        64 l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~  141 (396)
T 4eut_A           64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPG  141 (396)
T ss_dssp             CCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred             cCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHH
Confidence            3478899988765543  47899999999999999997643  23899999999999999999999999  999999999


Q ss_pred             CEEE----cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------------cccc
Q psy1934          79 NLLI----SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------------DTWN  137 (150)
Q Consensus        79 nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------------d~~~  137 (150)
                      ||++    +..+.++++|||++.......             ......||+.|+|||++                 |+||
T Consensus       142 NIll~~~~~~~~~~kL~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwS  208 (396)
T 4eut_A          142 NIMRVIGEDGQSVYKLTDFGAARELEDDE-------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS  208 (396)
T ss_dssp             GEEEEECTTSCEEEEECCGGGCEECCCGG-------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHH
T ss_pred             HEEEeecCCCceeEEEecCCCceEccCCC-------------ccccccCCccccCHHHhhccccccccccCCCcHHHHHH
Confidence            9998    667789999999987532110             11234689999999963                 9999


Q ss_pred             cceeEEEeeeec
Q psy1934         138 NYVIGRSMLYGH  149 (150)
Q Consensus       138 ~g~~~~~~~~g~  149 (150)
                      +|+++++|++|.
T Consensus       209 lG~il~el~tg~  220 (396)
T 4eut_A          209 IGVTFYHAATGS  220 (396)
T ss_dssp             HHHHHHHHHHSS
T ss_pred             HHHHHHHHHHCC
Confidence            999999999885

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.91  E-value=7.8e-26  Score=166.53  Aligned_cols=127  Identities=25%  Similarity=0.374  Sum_probs=109.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      +++++++.+.+...+.+++||||+. ++|.+++.... ..+++..+..++.|++.|+.|||+.+  ++|+|+||+||+++
T Consensus       158 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~  234 (429)
T 3kvw_A          158 TMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLK  234 (429)
T ss_dssp             CSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEES
T ss_pred             CcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc
Confidence            5678888888888899999999996 59999998654 45899999999999999999999998  99999999999999


Q ss_pred             CCCc--EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 SAGT--VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .++.  ++++|||++......               .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       235 ~~~~~~vkL~DFG~a~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~  296 (429)
T 3kvw_A          235 QQGRSGIKVIDFGSSCYEHQR---------------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY  296 (429)
T ss_dssp             STTSCCEEECCCTTCEETTCC---------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCcceEEeecccceecCCc---------------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCC
Confidence            9876  999999998643211               1134689999999984         9999999999999885

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.91  E-value=1.1e-25  Score=159.00  Aligned_cols=133  Identities=26%  Similarity=0.439  Sum_probs=114.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+++++.+.....+.+++||||+++++|.+++......+++..+..++.+++.|+.++|+.+  ++|+|++|+||++
T Consensus        81 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~  158 (314)
T 3com_A           81 CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILL  158 (314)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEE
Confidence            45788999999888889999999999999999999866667999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+++.|+|||++         |+||+|+++++|++|.
T Consensus       159 ~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  222 (314)
T 3com_A          159 NTEGHAKLADFGVAGQLTDTMA------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK  222 (314)
T ss_dssp             CTTCCEEECCCTTCEECBTTBS------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEeecccchhhhhhcc------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCC
Confidence            9999999999999875322111            01134688999999984         9999999999999885

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.91  E-value=1.2e-25  Score=160.36  Aligned_cols=134  Identities=20%  Similarity=0.295  Sum_probs=111.2

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNP   68 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~   68 (150)
                      -||+|+++.+.+...+.+++||||+++|+|.+++....               ..+++..+..++.|++.|+.|+|+++ 
T Consensus        99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-  177 (334)
T 2pvf_A           99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-  177 (334)
T ss_dssp             CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            37899999999999999999999999999999998643               13788889999999999999999999 


Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccc
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNY  139 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g  139 (150)
                       ++|+|++|+||+++.++.++++|||++..........          ......+++.|+|||++         |+||+|
T Consensus       178 -ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  246 (334)
T 2pvf_A          178 -CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK----------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG  246 (334)
T ss_dssp             -EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEE----------CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHH
T ss_pred             -eeCCCCccceEEEcCCCCEEEcccccccccccccccc----------ccCCCCcccceeChHHhcCCCcChHHHHHHHH
Confidence             9999999999999999999999999987532211100          01123467789999974         999999


Q ss_pred             eeEEEeee-ec
Q psy1934         140 VIGRSMLY-GH  149 (150)
Q Consensus       140 ~~~~~~~~-g~  149 (150)
                      +++++|++ |.
T Consensus       247 ~il~ellt~g~  257 (334)
T 2pvf_A          247 VLMWEIFTLGG  257 (334)
T ss_dssp             HHHHHHHTTSC
T ss_pred             HHHHHHHhCCC
Confidence            99999987 64

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.91  E-value=7.1e-26  Score=161.07  Aligned_cols=136  Identities=23%  Similarity=0.303  Sum_probs=111.3

Q ss_pred             ccchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|++|+++.+..  ...+.+++||||+++++|.+++......+++..+..++.+++.|+.|+|+.+  ++|+|++|+||
T Consensus        81 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NI  158 (327)
T 3lxl_A           81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNI  158 (327)
T ss_dssp             CCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred             cCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhE
Confidence            3467888877644  4667899999999999999999875556899999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++...........         ......+++.|+|||++         |+||+|+++++|++|.
T Consensus       159 l~~~~~~~kl~Dfg~~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~  227 (327)
T 3lxl_A          159 LVESEAHVKIADFGLAKLLPLDKDYYV---------VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC  227 (327)
T ss_dssp             EEEETTEEEECCGGGCEECCTTCSEEE---------CSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred             EECCCCCEEEcccccceecccCCccce---------eeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCC
Confidence            999999999999999875432211100         01123577889999974         9999999999998874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.91  E-value=6.2e-26  Score=165.22  Aligned_cols=130  Identities=28%  Similarity=0.342  Sum_probs=107.0

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +++|+++.++....+.+++||| +.+++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|||++|+||+++ 
T Consensus       115 ~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-  189 (390)
T 2zmd_A          115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-  189 (390)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-
T ss_pred             CCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-
Confidence            5889999988888899999999 5677999999865 46888888999999999999999999  99999999999995 


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------------cccccceeEEE
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------------DTWNNYVIGRS  144 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------------d~~~~g~~~~~  144 (150)
                      ++.+|++|||++.........          .......||+.|+|||++                    |+||+|+++++
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~e  259 (390)
T 2zmd_A          190 DGMLKLIDFGIANQMQPDTTS----------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY  259 (390)
T ss_dssp             SSCEEECCCSSSCCC-------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHH
T ss_pred             CCeEEEEecCccccccCCCcc----------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHH
Confidence            588999999998753211100          011234699999999973                    99999999999


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      |++|.
T Consensus       260 ll~G~  264 (390)
T 2zmd_A          260 MTYGK  264 (390)
T ss_dssp             HHHSS
T ss_pred             HHHCC
Confidence            99885

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.91  E-value=5.7e-26  Score=161.03  Aligned_cols=135  Identities=18%  Similarity=0.237  Sum_probs=111.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHR   73 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~   73 (150)
                      +-|++|+++.+.....+..++||||+++|+|.+++....         ..+++..+..++.|++.|+.|+|+++  ++|+
T Consensus        85 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~  162 (322)
T 1p4o_A           85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHR  162 (322)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCS
T ss_pred             cCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccC
Confidence            457899999999998899999999999999999997532         34688889999999999999999999  9999


Q ss_pred             cCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEE
Q psy1934          74 DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRS  144 (150)
Q Consensus        74 ~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~  144 (150)
                      |++|+||+++.++.++++|||++........          ........+++.|+|||++         |+||+|+++++
T Consensus       163 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  232 (322)
T 1p4o_A          163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDY----------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE  232 (322)
T ss_dssp             CCSGGGEEECTTCCEEECCTTCCCGGGGGGC----------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             CCccceEEEcCCCeEEECcCccccccccccc----------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHH
Confidence            9999999999999999999999864321110          0011223467889999984         99999999999


Q ss_pred             eee-ec
Q psy1934         145 MLY-GH  149 (150)
Q Consensus       145 ~~~-g~  149 (150)
                      |++ |.
T Consensus       233 l~~~g~  238 (322)
T 1p4o_A          233 IATLAE  238 (322)
T ss_dssp             HHHTSC
T ss_pred             HHhcCC
Confidence            987 53

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.91  E-value=6.3e-26  Score=163.23  Aligned_cols=130  Identities=28%  Similarity=0.384  Sum_probs=111.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~nil   81 (150)
                      +-|++|+++.+++...+.+++||||+++++|.+++... ..+++..+..++.+++.|+.|+|+. +  ++|+|++|+||+
T Consensus        88 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil  164 (360)
T 3eqc_A           88 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNIL  164 (360)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEE
T ss_pred             CCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEE
Confidence            45788999999988899999999999999999999865 4688999999999999999999985 7  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++.....              .......||+.|+|||++         |+||+|+++++|++|.
T Consensus       165 ~~~~~~~kl~Dfg~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  227 (360)
T 3eqc_A          165 VNSRGEIKLCDFGVSGQLID--------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR  227 (360)
T ss_dssp             ECTTCCEEECCCCCCHHHHH--------------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTS
T ss_pred             ECCCCCEEEEECCCCccccc--------------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999998753210              011234689999999984         9999999999999885

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.91  E-value=6.8e-26  Score=162.57  Aligned_cols=135  Identities=21%  Similarity=0.332  Sum_probs=108.5

Q ss_pred             cchhhhcccCCCCC--------ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           4 LSAAFIDKHSTPHG--------MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         4 ~~~~~~~~~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      -|++|+++.+.+..        .+.+++||||+++ ++.+.+......+++..+..++.|++.|+.|+|+++  ++|+|+
T Consensus        74 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dl  150 (351)
T 3mi9_A           74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDM  150 (351)
T ss_dssp             CCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred             cCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCC
Confidence            46778887765543        5679999999986 888888766567999999999999999999999999  999999


Q ss_pred             CCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEe
Q psy1934          76 KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSM  145 (150)
Q Consensus        76 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~  145 (150)
                      +|+||+++.++.++++|||++...........        .......||+.|+|||++          |+||+|+++++|
T Consensus       151 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  222 (351)
T 3mi9_A          151 KAANVLITRDGVLKLADFGLARAFSLAKNSQP--------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM  222 (351)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEECCCCSSSSC--------CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCCEEEccchhcccccccccccc--------cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHH
Confidence            99999999999999999999875422111100        011234689999999974          999999999999


Q ss_pred             eeec
Q psy1934         146 LYGH  149 (150)
Q Consensus       146 ~~g~  149 (150)
                      ++|.
T Consensus       223 l~g~  226 (351)
T 3mi9_A          223 WTRS  226 (351)
T ss_dssp             HHSS
T ss_pred             HhCC
Confidence            9875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.91  E-value=2.4e-25  Score=157.46  Aligned_cols=142  Identities=25%  Similarity=0.403  Sum_probs=113.1

Q ss_pred             ccchhhhcccCCCC----CceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           3 YLSAAFIDKHSTPH----GMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         3 ~~~~~~~~~~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      +-||+|+++.+.+.    ..+..++|+||+++|+|.+++...   ...+++..+..++.|++.|+.|+|+++  ++|+|+
T Consensus        83 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dl  160 (317)
T 2buj_A           83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDL  160 (317)
T ss_dssp             CCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred             cCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCC
Confidence            45788999888764    567889999999999999999763   356899999999999999999999999  999999


Q ss_pred             CCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEE
Q psy1934          76 KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGR  143 (150)
Q Consensus        76 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~  143 (150)
                      +|+||+++.++.++++|||++.........   ..............||+.|+|||++            |+||+|++++
T Consensus       161 kp~NIl~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~  237 (317)
T 2buj_A          161 KPTNILLGDEGQPVLMDLGSMNQACIHVEG---SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY  237 (317)
T ss_dssp             CGGGEEECTTSCEEECCCSSCEESCEEEES---HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCCEEEEecCcchhccccccc---ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHH
Confidence            999999999999999999987653221111   0111111222344679999999973            9999999999


Q ss_pred             Eeeeec
Q psy1934         144 SMLYGH  149 (150)
Q Consensus       144 ~~~~g~  149 (150)
                      +|++|.
T Consensus       238 el~~g~  243 (317)
T 2buj_A          238 AMMFGE  243 (317)
T ss_dssp             HHHHSS
T ss_pred             HHHhCC
Confidence            999885

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.91  E-value=1.7e-25  Score=156.02  Aligned_cols=131  Identities=31%  Similarity=0.376  Sum_probs=111.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.+...+..+++|||+++++|.+.+... ..+++..+..++.+++.|+.|+|+++  ++|+|++|+||++
T Consensus        62 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~  138 (284)
T 3kk8_A           62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLL  138 (284)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE
T ss_pred             cCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEE
Confidence            45789999999999999999999999999999988765 56899999999999999999999999  9999999999999


Q ss_pred             cCCCc---EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.   ++++|||++........             .....|++.|+|||++         |+||+|+++++|++|.
T Consensus       139 ~~~~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  204 (284)
T 3kk8_A          139 ASKAKGAAVKLADFGLAIEVNDSEA-------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY  204 (284)
T ss_dssp             SSSSTTCCEEECCCTTCEECCSSCB-------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCCCcEEEeeceeeEEcccCcc-------------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCC
Confidence            76654   99999999865422111             0124688999999984         9999999999999885

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.91  E-value=2.2e-25  Score=156.05  Aligned_cols=132  Identities=30%  Similarity=0.399  Sum_probs=109.8

Q ss_pred             ccchhhhcccCCCC----CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           3 YLSAAFIDKHSTPH----GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         3 ~~~~~~~~~~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      +-||+|+++.+.+.    ..+.+++||||+++++|.+++... ..+++..+..++.+++.|+.|+|+.+.+++|+|++|+
T Consensus        82 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~  160 (290)
T 1t4h_A           82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD  160 (290)
T ss_dssp             CCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGG
T ss_pred             CCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHH
Confidence            45788888877443    467799999999999999999865 4688999999999999999999988666999999999


Q ss_pred             CEEEc-CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeeec
Q psy1934          79 NLLIS-SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        79 nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g~  149 (150)
                      ||+++ ..+.++++|||++.......              .....|++.|+|||++        |+||+|+++++|++|.
T Consensus       161 Nil~~~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~  226 (290)
T 1t4h_A          161 NIFITGPTGSVKIGDLGLATLKRASF--------------AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSE  226 (290)
T ss_dssp             GEEESSTTSCEEECCTTGGGGCCTTS--------------BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             HEEEECCCCCEEEeeCCCcccccccc--------------cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCC
Confidence            99997 67899999999885322110              1134689999999985        9999999999999885

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.91  E-value=1.1e-25  Score=160.36  Aligned_cols=134  Identities=19%  Similarity=0.236  Sum_probs=106.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+... ..++++||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        74 l~hp~iv~~~~~~~~~-~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~  150 (327)
T 3lzb_A           74 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV  150 (327)
T ss_dssp             CCBTTBCCCCEEEESS-SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             CCCCCeeEEEEEEecC-CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEE
Confidence            4578899988887764 488999999999999999876667999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++.........          .......+++.|+|||++         |+||+|++++++++ |.
T Consensus       151 ~~~~~~kL~DfG~a~~~~~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~  217 (327)
T 3lzb_A          151 KTPQHVKITDFGLAKLLGAEEKE----------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS  217 (327)
T ss_dssp             EETTEEEECCTTC--------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCCCCEEEccCcceeEccCcccc----------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCC
Confidence            99999999999998753211110          011123467789999984         99999999999987 64

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.91  E-value=3e-26  Score=163.26  Aligned_cols=134  Identities=20%  Similarity=0.325  Sum_probs=111.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-------------TSALPPNIVCSILWQTCQAVKHMHGQNPPI   70 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i   70 (150)
                      -||+|+++.+.+...+.+++||||+++|+|.+++...             ...+++..+..++.|++.|+.|+|+++  +
T Consensus       108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i  185 (333)
T 2i1m_A          108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--C  185 (333)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred             CCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--c
Confidence            3899999999999999999999999999999999753             234788899999999999999999998  9


Q ss_pred             EEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccccccee
Q psy1934          71 VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVI  141 (150)
Q Consensus        71 ~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~  141 (150)
                      +|+|++|+||+++.++.++++|||++..........          ......+++.|+|||++         |+||+|++
T Consensus       186 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  255 (333)
T 2i1m_A          186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI----------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL  255 (333)
T ss_dssp             ECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSE----------ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             ccCCcccceEEECCCCeEEECcccccccccccccee----------ecCCCCCCccccCHHHhccCCCChHHHHHHHHHH
Confidence            999999999999999999999999987432211100          01122457789999974         99999999


Q ss_pred             EEEeee-ec
Q psy1934         142 GRSMLY-GH  149 (150)
Q Consensus       142 ~~~~~~-g~  149 (150)
                      +++|++ |.
T Consensus       256 l~el~t~g~  264 (333)
T 2i1m_A          256 LWEIFSLGL  264 (333)
T ss_dssp             HHHHTTTSC
T ss_pred             HHHHHcCCC
Confidence            999987 64

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.91  E-value=5.2e-26  Score=166.20  Aligned_cols=135  Identities=27%  Similarity=0.374  Sum_probs=104.5

Q ss_pred             ccchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHhhC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q psy1934           3 YLSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKERT--------SALPPNIVCSILWQTCQAVKHMHGQNPPIVH   72 (150)
Q Consensus         3 ~~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h   72 (150)
                      +-||+|+++.+++  +....+++||||+++ +|.+++....        ..+++..+..++.|++.|+.|||+++  ++|
T Consensus        75 l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH  151 (405)
T 3rgf_A           75 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLH  151 (405)
T ss_dssp             CCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             cCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeC
Confidence            3478999998887  667899999999975 8888886321        24889999999999999999999999  999


Q ss_pred             ecCCCCCEEE----cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------ccccc
Q psy1934          73 RDLKIENLLI----SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNN  138 (150)
Q Consensus        73 ~~l~~~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~  138 (150)
                      +|++|+||++    +..+.++++|||++.........         ........||+.|+|||++          |+||+
T Consensus       152 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  222 (405)
T 3rgf_A          152 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP---------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI  222 (405)
T ss_dssp             CCCCGGGEEECCSSTTTTCEEECCTTCCC-------------------------CCCTTCCHHHHTTCCSCCHHHHHHHH
T ss_pred             CCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcc---------cccCCCceecCcccCchhhcCCCcccchhhhHHH
Confidence            9999999999    66789999999998753211100         0112245789999999974          99999


Q ss_pred             ceeEEEeeeec
Q psy1934         139 YVIGRSMLYGH  149 (150)
Q Consensus       139 g~~~~~~~~g~  149 (150)
                      |+++++|++|.
T Consensus       223 G~il~ell~g~  233 (405)
T 3rgf_A          223 GCIFAELLTSE  233 (405)
T ss_dssp             HHHHHHHHHSS
T ss_pred             HHHHHHHHhCC
Confidence            99999999885

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.91  E-value=8.7e-26  Score=161.75  Aligned_cols=129  Identities=28%  Similarity=0.310  Sum_probs=106.0

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSA   85 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~   85 (150)
                      ++|+++.++....+.+++|||+ .+++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++ +
T Consensus        69 ~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~  143 (343)
T 3dbq_A           69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D  143 (343)
T ss_dssp             TTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-T
T ss_pred             CceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-C
Confidence            7899999999999999999995 577999999864 56889999999999999999999999  99999999999996 6


Q ss_pred             CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------------cccccceeEEEe
Q psy1934          86 GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------------DTWNNYVIGRSM  145 (150)
Q Consensus        86 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------------d~~~~g~~~~~~  145 (150)
                      +.++++|||++.........          .......||+.|+|||++                    |+||+|+++++|
T Consensus       144 ~~~kl~DFG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~el  213 (343)
T 3dbq_A          144 GMLKLIDFGIANQMQPDTTS----------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM  213 (343)
T ss_dssp             TEEEECCCSSSCCC----------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHH
T ss_pred             CcEEEeecccccccCccccc----------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHH
Confidence            78999999998753211110          011244799999999984                    999999999999


Q ss_pred             eeec
Q psy1934         146 LYGH  149 (150)
Q Consensus       146 ~~g~  149 (150)
                      ++|.
T Consensus       214 l~g~  217 (343)
T 3dbq_A          214 TYGK  217 (343)
T ss_dssp             HHSS
T ss_pred             HhCC
Confidence            9885

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.91  E-value=6.5e-26  Score=163.95  Aligned_cols=113  Identities=15%  Similarity=0.127  Sum_probs=93.3

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEee
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIV------CSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD   92 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~------~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~d   92 (150)
                      +.+|+||||++ |+|.+++......+++...      ..++.|++.|+.|+|+++  ++|+|+||+||+++.++.+|++|
T Consensus       161 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~D  237 (371)
T 3q60_A          161 ANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGD  237 (371)
T ss_dssp             EEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEECTTSCEEECC
T ss_pred             eeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCHHHEEECCCCCEEEEe
Confidence            56899999998 7999999865434555555      566799999999999999  99999999999999999999999


Q ss_pred             cCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeeec
Q psy1934          93 FGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        93 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~  149 (150)
                      ||++......   .            ....+|+.|+|||++           |+||+|+++++|++|.
T Consensus       238 FG~a~~~~~~---~------------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          238 VSALWKVGTR---G------------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             GGGEEETTCE---E------------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             cceeeecCCC---c------------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            9998743210   0            023466899999984           9999999999999885

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.91  E-value=3.5e-26  Score=162.88  Aligned_cols=130  Identities=29%  Similarity=0.441  Sum_probs=109.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      ||+|+++.+.++..+.+++||||+++|+|.+++... ...+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++
T Consensus        88 ~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~  165 (327)
T 3lm5_A           88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLS  165 (327)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEES
T ss_pred             CCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEe
Confidence            488999999999999999999999999999988543 256899999999999999999999999  99999999999998


Q ss_pred             C---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 S---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .   .+.++++|||++.......             ......||+.|+|||++         |+||+|+++++|++|.
T Consensus       166 ~~~~~~~~kL~Dfg~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  230 (327)
T 3lm5_A          166 SIYPLGDIKIVDFGMSRKIGHAC-------------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT  230 (327)
T ss_dssp             CBTTBCCEEECCGGGCEEC----------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCCcEEEeeCccccccCCcc-------------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCC
Confidence            7   6899999999987532110             11234689999999984         9999999999999885

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.91  E-value=2e-25  Score=155.60  Aligned_cols=131  Identities=31%  Similarity=0.459  Sum_probs=110.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++... ..+++..+..++.+++.|+.++|+++  ++|+|++|+||++
T Consensus        65 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~  141 (283)
T 3bhy_A           65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIML  141 (283)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             CCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEE
Confidence            34789999999999999999999999999999999764 46899999999999999999999999  9999999999999


Q ss_pred             cCCC----cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAG----TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++    .++++|||++.......             ......+++.|+|||++         |+||+|++++++++|.
T Consensus       142 ~~~~~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  208 (283)
T 3bhy_A          142 LDKNVPNPRIKLIDFGIAHKIEAGN-------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  208 (283)
T ss_dssp             SCSSSSSCCEEECCCTTCEECC---------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCCCCceEEEecccceeccCCC-------------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCC
Confidence            8776    79999999987532110             01134688999999984         9999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.91  E-value=5.4e-26  Score=166.93  Aligned_cols=130  Identities=32%  Similarity=0.400  Sum_probs=103.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++. +.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus       197 l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll  272 (419)
T 3i6u_A          197 LNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLL  272 (419)
T ss_dssp             CCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             CCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEE
Confidence            458899999888765 5689999999999999988653 56899999999999999999999999  9999999999999


Q ss_pred             cCCC---cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeee
Q psy1934          83 SSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLY  147 (150)
Q Consensus        83 ~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~  147 (150)
                      +..+   .++++|||++......             .......||+.|+|||++            |+||+|+++++|++
T Consensus       273 ~~~~~~~~~kl~DFG~a~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt  339 (419)
T 3i6u_A          273 SSQEEDCLIKITDFGHSKILGET-------------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS  339 (419)
T ss_dssp             SSSSSSCCEEECCSSTTTSCC------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCcceEEEeecccceecCCC-------------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH
Confidence            7544   5999999998743211             011234689999999974            99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       340 g~  341 (419)
T 3i6u_A          340 GY  341 (419)
T ss_dssp             SS
T ss_pred             CC
Confidence            85

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.91  E-value=4.9e-26  Score=159.44  Aligned_cols=135  Identities=24%  Similarity=0.353  Sum_probs=102.9

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-|++++.+.+.. ..+.+++||||+++++|.+++......+++..+..++.|++.|+.|+|+.+  ++|+|++|+||+
T Consensus        76 ~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil  152 (289)
T 3og7_A           76 KTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIF  152 (289)
T ss_dssp             TCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred             hCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEE
Confidence            34578888887754 446789999999999999999765567899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.++++|||++.........          .......||+.|+|||++            |+||+|+++++|++|.
T Consensus       153 ~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  222 (289)
T 3og7_A          153 LHEDNTVKIGDFGLATEKSRWSGS----------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ  222 (289)
T ss_dssp             EETTTEEEECCCC----------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCCEEEccceecccccccccc----------ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCC
Confidence            999999999999998643211110          011234689999999974            9999999999999885

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.91  E-value=1.5e-25  Score=162.58  Aligned_cols=127  Identities=24%  Similarity=0.338  Sum_probs=105.4

Q ss_pred             chhhhcccCCCC----CceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCC
Q psy1934           5 SAAFIDKHSTPH----GMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIE   78 (150)
Q Consensus         5 ~~~~~~~~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~   78 (150)
                      |++++++.+.+.    ....+|+||||+ ++++.+.+.... ..+++..+..++.|++.|+.|+|++ +  ++|+|+||+
T Consensus       100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~  176 (397)
T 1wak_A          100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPE  176 (397)
T ss_dssp             GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGG
T ss_pred             cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHH
Confidence            667888888766    677999999999 457777665433 5689999999999999999999998 8  999999999


Q ss_pred             CEEEcCCC-------------------------------------------------cEEEeecCceeccccCCCcchhH
Q psy1934          79 NLLISSAG-------------------------------------------------TVKLCDFGSATEKVYSPDNAWSA  109 (150)
Q Consensus        79 nil~~~~~-------------------------------------------------~~~l~dfg~~~~~~~~~~~~~~~  109 (150)
                      ||+++.++                                                 .++++|||++......       
T Consensus       177 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------  249 (397)
T 1wak_A          177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------  249 (397)
T ss_dssp             GEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------
T ss_pred             HeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------
Confidence            99998765                                                 7999999998753211       


Q ss_pred             hhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934         110 QQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       110 ~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                              .....||+.|+|||++         |+||+|+++++|++|.
T Consensus       250 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  290 (397)
T 1wak_A          250 --------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD  290 (397)
T ss_dssp             --------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             --------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCC
Confidence                    1134689999999984         9999999999999885

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.91  E-value=7.8e-26  Score=158.97  Aligned_cols=133  Identities=25%  Similarity=0.400  Sum_probs=110.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++......+++..+..++.+++.|+.|+|+.+  ++|+|++|+||++
T Consensus        73 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~  150 (302)
T 2j7t_A           73 CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLM  150 (302)
T ss_dssp             CCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE
T ss_pred             CCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEE
Confidence            35789999999888889999999999999999999876667999999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g  148 (150)
                      +.++.++++|||++.....            .........|++.|+|||++              |+||+|+++++|++|
T Consensus       151 ~~~~~~kl~Dfg~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  218 (302)
T 2j7t_A          151 TLEGDIRLADFGVSAKNLK------------TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI  218 (302)
T ss_dssp             CTTSCEEECCCHHHHHHHH------------HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS
T ss_pred             CCCCCEEEEECCCCccccc------------cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC
Confidence            9999999999998642110            00111234689999999974              999999999999887


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       219 ~  219 (302)
T 2j7t_A          219 E  219 (302)
T ss_dssp             S
T ss_pred             C
Confidence            5

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.91  E-value=1.7e-25  Score=157.67  Aligned_cols=130  Identities=30%  Similarity=0.437  Sum_probs=111.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+||++
T Consensus        63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~  139 (304)
T 2jam_A           63 IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLY  139 (304)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEE
T ss_pred             CCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE
Confidence            45789999999999999999999999999999999765 46899999999999999999999999  9999999999999


Q ss_pred             ---cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 ---SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                         +..+.++++|||++......   .           .....|++.|+|||++         |+||+|+++++|++|.
T Consensus       140 ~~~~~~~~~kl~Dfg~~~~~~~~---~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  204 (304)
T 2jam_A          140 LTPEENSKIMITDFGLSKMEQNG---I-----------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY  204 (304)
T ss_dssp             SSSSTTCCEEBCSCSTTCCCCCB---T-----------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCCCCEEEccCCcceecCCC---c-----------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence               67789999999987642111   0           0123488999999984         9999999999999885

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.91  E-value=1.4e-25  Score=159.10  Aligned_cols=135  Identities=17%  Similarity=0.223  Sum_probs=102.5

Q ss_pred             ccchhhhcccCCCCCceEE------EEEEeccCCCCHHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q psy1934           3 YLSAAFIDKHSTPHGMHEY------LILTELCTGGSLVDVLKERT-----SALPPNIVCSILWQTCQAVKHMHGQNPPIV   71 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~------~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~   71 (150)
                      +-||+|+++.+.....+..      ++++||+++|+|.+++....     ..+++..+..++.|++.|+.|+|+++  ++
T Consensus        82 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--iv  159 (323)
T 3qup_A           82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FI  159 (323)
T ss_dssp             CCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             CCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cc
Confidence            4578899988876655554      99999999999999996532     14889999999999999999999999  99


Q ss_pred             EecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeE
Q psy1934          72 HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIG  142 (150)
Q Consensus        72 h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~  142 (150)
                      |+|++|+||+++.++.++++|||++........          ........+++.|+|||++         |+||+|+++
T Consensus       160 H~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  229 (323)
T 3qup_A          160 HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY----------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM  229 (323)
T ss_dssp             CSCCSGGGEEECTTSCEEECCCCC---------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             cCCCCcceEEEcCCCCEEEeecccccccccccc----------ccccccccCcccccCchhhcCCCCCCccchhhHHHHH
Confidence            999999999999999999999999874321110          0111233467789999984         999999999


Q ss_pred             EEeee-ec
Q psy1934         143 RSMLY-GH  149 (150)
Q Consensus       143 ~~~~~-g~  149 (150)
                      ++|++ |.
T Consensus       230 ~ell~~g~  237 (323)
T 3qup_A          230 WEIMTRGQ  237 (323)
T ss_dssp             HHHHTTSC
T ss_pred             HHHHhCCC
Confidence            99988 54

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=4.2e-26  Score=163.07  Aligned_cols=137  Identities=28%  Similarity=0.426  Sum_probs=107.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---------------------------------------CCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---------------------------------------TSA   43 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---------------------------------------~~~   43 (150)
                      +-||+|+++.++++..+.+++||||+++|+|.+++...                                       ...
T Consensus        85 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (345)
T 3hko_A           85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV  164 (345)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHH
T ss_pred             CCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence            34789999999999999999999999999999998521                                       001


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC--cEEEeecCceeccccCCCcchhHhhhhhhHHhhhc
Q psy1934          44 LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAG--TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR  121 (150)
Q Consensus        44 l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (150)
                      +++..+..++.|++.|+.|+|+.+  ++|+|++|+||+++.++  .++++|||++...........        ......
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~--------~~~~~~  234 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY--------YGMTTK  234 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----------------
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCcccc--------cccccc
Confidence            245667788999999999999999  99999999999998766  899999999875432211110        111244


Q ss_pred             CCCCCccCcccc-----------cccccceeEEEeeeec
Q psy1934         122 FTTPMYRAPEMV-----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       122 ~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~  149 (150)
                      .||+.|+|||++           |+||+|+++++|++|.
T Consensus       235 ~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~  273 (345)
T 3hko_A          235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA  273 (345)
T ss_dssp             CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            689999999974           9999999999999885

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.91  E-value=8.2e-26  Score=159.52  Aligned_cols=132  Identities=30%  Similarity=0.465  Sum_probs=108.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+++...+.+++||||+++++|.+++... ..+++..+..++.+++.|+.|+|+++  ++|+|++|+||++
T Consensus        59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~  135 (311)
T 4agu_A           59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILI  135 (311)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEE
Confidence            34789999999999999999999999998998887653 56899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+|+.|+|||++          |+||+|++++++++|.
T Consensus       136 ~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  200 (311)
T 4agu_A          136 TKHSVIKLCDFGFARLLTGPSD------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV  200 (311)
T ss_dssp             CTTSCEEECCCTTCEECC------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEeeCCCchhccCccc------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence            9999999999999875321110            01133678999999974          9999999999999885

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.91  E-value=8.4e-26  Score=161.02  Aligned_cols=131  Identities=27%  Similarity=0.384  Sum_probs=106.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+++||||+++ +|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        90 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll  165 (329)
T 3gbz_A           90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLL  165 (329)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             cCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEE
Confidence            4578999999999999999999999985 999999764 46899999999999999999999999  9999999999999


Q ss_pred             c-----CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeee
Q psy1934          83 S-----SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLY  147 (150)
Q Consensus        83 ~-----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~  147 (150)
                      +     ..+.++++|||++.......            .......+|+.|+|||++          |+||+|+++++|++
T Consensus       166 ~~~~~~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  233 (329)
T 3gbz_A          166 SVSDASETPVLKIGDFGLARAFGIPI------------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM  233 (329)
T ss_dssp             EC-----CCEEEECCTTHHHHHC-----------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCccceEEECcCCCccccCCcc------------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH
Confidence            4     44569999999886432110            111234679999999984          99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       234 g~  235 (329)
T 3gbz_A          234 KT  235 (329)
T ss_dssp             SS
T ss_pred             CC
Confidence            75

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.91  E-value=3.9e-25  Score=162.40  Aligned_cols=131  Identities=24%  Similarity=0.412  Sum_probs=105.0

Q ss_pred             ccchhhhcccCCC------CCceEEEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q psy1934           3 YLSAAFIDKHSTP------HGMHEYLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR   73 (150)
Q Consensus         3 ~~~~~~~~~~~~~------~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~   73 (150)
                      +-|++|+++.+++      .....+++||||+++ ++.+.+..   ....+++..+..++.|++.|+.|+|+++  ++||
T Consensus       104 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHr  180 (420)
T 1j1b_A          104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHR  180 (420)
T ss_dssp             CCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECS
T ss_pred             cCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence            4578898886655      334457899999986 77776653   2356899999999999999999999999  9999


Q ss_pred             cCCCCCEEEcCC-CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeE
Q psy1934          74 DLKIENLLISSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIG  142 (150)
Q Consensus        74 ~l~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~  142 (150)
                      |+||+||+++.+ +.+|++|||+++.......             .....+|+.|+|||++          |+||+|+++
T Consensus       181 Dlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il  247 (420)
T 1j1b_A          181 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL  247 (420)
T ss_dssp             CCSGGGEEEETTTTEEEECCCTTCEECCTTCC-------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             CCChhhEEEeCCCCeEEeccchhhhhcccCCC-------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHH
Confidence            999999999965 6789999999975422111             1134689999999984          999999999


Q ss_pred             EEeeeec
Q psy1934         143 RSMLYGH  149 (150)
Q Consensus       143 ~~~~~g~  149 (150)
                      ++|++|.
T Consensus       248 ~ell~G~  254 (420)
T 1j1b_A          248 AELLLGQ  254 (420)
T ss_dssp             HHHHHSS
T ss_pred             HHHHhCC
Confidence            9999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.91  E-value=2e-25  Score=155.11  Aligned_cols=131  Identities=26%  Similarity=0.382  Sum_probs=106.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.+.....+.+++||||+++++|.+++... ..+++..+..++.|++.|+.++|+++  ++|+|++|+||++
T Consensus        68 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~  144 (276)
T 2h6d_A           68 FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLL  144 (276)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEE
T ss_pred             CCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEE
Confidence            45789999999988899999999999999999999765 46889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.......             ......+++.|+|||++          |+||+|+++++|++|.
T Consensus       145 ~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  208 (276)
T 2h6d_A          145 DAHMNAKIADFGLSNMMSDGE-------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT  208 (276)
T ss_dssp             CTTSCEEECCCCGGGCCCC--------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEeecccccccCCCc-------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCC
Confidence            999999999999886432110             01123578899999984          9999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=9.7e-26  Score=157.69  Aligned_cols=135  Identities=23%  Similarity=0.310  Sum_probs=110.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+..+ .+.+++||||+++++|.+++......+++..+..++.|++.|+.++|+.+  ++|+|++|+||++
T Consensus        67 l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili  143 (287)
T 1u59_A           67 LDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL  143 (287)
T ss_dssp             CCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCEeEEEEEec-CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEE
Confidence            34788999888874 46799999999999999999765567999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++...........         ......+++.|+|||++         |+||+|+++++|++ |.
T Consensus       144 ~~~~~~kl~Dfg~~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  211 (287)
T 1u59_A          144 VNRHYAKISDFGLSKALGADDSYYT---------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ  211 (287)
T ss_dssp             EETTEEEECCCTTCEECTTCSCEEC---------CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCCCCEEECcccceeeeccCcceee---------ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            9999999999999875422211000         01123467889999984         99999999999996 75

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.91  E-value=1.5e-25  Score=165.17  Aligned_cols=134  Identities=26%  Similarity=0.302  Sum_probs=105.2

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+|+++.+..+..+.+|+||||+++ +|.+++........+..+..++.|++.|+.|+|+++  ++|||+||+||+++
T Consensus        76 ~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~  152 (432)
T 3p23_A           76 EHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILIS  152 (432)
T ss_dssp             CCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEEC
T ss_pred             CCCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEe
Confidence            389999999999999999999999975 999999876545555566788999999999999999  99999999999995


Q ss_pred             C-----CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEee
Q psy1934          84 S-----AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSML  146 (150)
Q Consensus        84 ~-----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~  146 (150)
                      .     ...++++|||++........         .........||+.|+|||++            |+||+|+++++|+
T Consensus       153 ~~~~~~~~~~kL~DFG~a~~~~~~~~---------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell  223 (432)
T 3p23_A          153 MPNAHGKIKAMISDFGLCKKLAVGRH---------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI  223 (432)
T ss_dssp             CCBTTTBCCEEECCTTEEECC---------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred             cCCCCCceeEEEecccceeeccCCCc---------ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence            3     23588999999875422111         00112345799999999984            9999999999998


Q ss_pred             e-ec
Q psy1934         147 Y-GH  149 (150)
Q Consensus       147 ~-g~  149 (150)
                      + |.
T Consensus       224 t~g~  227 (432)
T 3p23_A          224 SEGS  227 (432)
T ss_dssp             TTSC
T ss_pred             cCCC
Confidence            8 53

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.91  E-value=6.7e-26  Score=173.84  Aligned_cols=134  Identities=19%  Similarity=0.293  Sum_probs=107.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|+++.++.+. +.+++||||+++|+|.+++... ..+++..+..++.|++.|+.|||+++  ++|+|+||+||++
T Consensus       427 l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl  502 (635)
T 4fl3_A          427 LDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL  502 (635)
T ss_dssp             CCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred             CCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEE
Confidence            458899999888765 5689999999999999999754 56899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.+|++|||+++........         ........+++.|+|||++         |+||+|+++++|+. |.
T Consensus       503 ~~~~~~kL~DFGla~~~~~~~~~---------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~  570 (635)
T 4fl3_A          503 VTQHYAKISDFGLSKALRADENY---------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ  570 (635)
T ss_dssp             EETTEEEECCTTHHHHTTC----------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eCCCCEEEEEcCCccccccCccc---------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999998754221110         0111223467889999985         99999999999996 75

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.91  E-value=7.8e-26  Score=167.48  Aligned_cols=133  Identities=23%  Similarity=0.281  Sum_probs=106.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.++... +.+++||||+++|+|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus       236 l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nil  312 (452)
T 1fmk_A          236 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANIL  312 (452)
T ss_dssp             CCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             CCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEE
Confidence            458899998887766 67899999999999999997532 45889999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.+|++|||+++.......           .......++..|+|||++         |+||+|++++++++ |.
T Consensus       313 l~~~~~~kl~DfG~a~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~  379 (452)
T 1fmk_A          313 VGENLVCKVADFGLARLIEDNEY-----------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR  379 (452)
T ss_dssp             ECGGGCEEECCCCTTC-------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ECCCCCEEECCCccceecCCCce-----------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCC
Confidence            99999999999999874321100           011123467789999984         99999999999997 64

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.91  E-value=3.7e-25  Score=161.29  Aligned_cols=131  Identities=22%  Similarity=0.389  Sum_probs=104.8

Q ss_pred             ccchhhhcccCCC------CCceEEEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q psy1934           3 YLSAAFIDKHSTP------HGMHEYLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR   73 (150)
Q Consensus         3 ~~~~~~~~~~~~~------~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~   73 (150)
                      +-|++|+++.+++      .....+++||||+++ ++.+.+..   ....+++..+..++.|++.|+.|+|+++  ++|+
T Consensus        89 l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHr  165 (394)
T 4e7w_A           89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHR  165 (394)
T ss_dssp             CCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred             CCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCC
Confidence            4478888887765      344458999999987 55444432   2356899999999999999999999999  9999


Q ss_pred             cCCCCCEEEc-CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeE
Q psy1934          74 DLKIENLLIS-SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIG  142 (150)
Q Consensus        74 ~l~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~  142 (150)
                      |+||+||+++ .++.+|++|||+++.......             .....+|+.|+|||++          |+||+|+++
T Consensus       166 Dlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il  232 (394)
T 4e7w_A          166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-------------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM  232 (394)
T ss_dssp             CCSGGGEEEETTTTEEEECCCTTCEECCTTCC-------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCcEEEeeCCCcccccCCCC-------------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHH
Confidence            9999999998 789999999999875422211             1134688999999974          999999999


Q ss_pred             EEeeeec
Q psy1934         143 RSMLYGH  149 (150)
Q Consensus       143 ~~~~~g~  149 (150)
                      ++|++|.
T Consensus       233 ~ell~g~  239 (394)
T 4e7w_A          233 AELMQGQ  239 (394)
T ss_dssp             HHHHHSS
T ss_pred             HHHHhCC
Confidence            9999885

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.91  E-value=2e-25  Score=159.25  Aligned_cols=134  Identities=22%  Similarity=0.289  Sum_probs=110.5

Q ss_pred             ccchhhhcccCCCCCce----EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCe
Q psy1934           3 YLSAAFIDKHSTPHGMH----EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMH--------GQNPPI   70 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~i   70 (150)
                      +-||+|+++.+.....+    .+++||||+++|+|.++++.  ..+++..+..++.+++.|+.|+|        +.+  +
T Consensus        93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--i  168 (342)
T 1b6c_B           93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--I  168 (342)
T ss_dssp             CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--E
T ss_pred             cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--e
Confidence            46889999888766655    89999999999999999976  36889999999999999999999        777  9


Q ss_pred             EEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc---------------ccc
Q psy1934          71 VHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---------------VDT  135 (150)
Q Consensus        71 ~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---------------~d~  135 (150)
                      +|+|++|+||+++.++.++++|||++...........        .......||+.|+|||+               .|+
T Consensus       169 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di  240 (342)
T 1b6c_B          169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID--------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI  240 (342)
T ss_dssp             ECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEE--------ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHH
T ss_pred             eeCCCCHHHEEECCCCCEEEEECCCceeccccccccc--------cccccCCcCcccCCHhhhcccccccccccCCcccH
Confidence            9999999999999999999999999875432211000        00113468999999996               399


Q ss_pred             cccceeEEEeeee
Q psy1934         136 WNNYVIGRSMLYG  148 (150)
Q Consensus       136 ~~~g~~~~~~~~g  148 (150)
                      ||+|+++++|++|
T Consensus       241 ~slG~il~el~tg  253 (342)
T 1b6c_B          241 YAMGLVFWEIARR  253 (342)
T ss_dssp             HHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=5.4e-25  Score=159.77  Aligned_cols=118  Identities=32%  Similarity=0.553  Sum_probs=96.5

Q ss_pred             CCceEEEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-CCCcEEEe
Q psy1934          16 HGMHEYLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-SAGTVKLC   91 (150)
Q Consensus        16 ~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~-~~~~~~l~   91 (150)
                      .....+++||||+++ +|.+.+..   ....+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++ .++.++++
T Consensus       108 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~  184 (383)
T 3eb0_A          108 SQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLC  184 (383)
T ss_dssp             --CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEEC
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEE
Confidence            444568999999985 88887764   2356899999999999999999999999  99999999999997 57899999


Q ss_pred             ecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          92 DFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        92 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      |||++........             .....+|+.|+|||++          |+||+|+++++|++|.
T Consensus       185 Dfg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  239 (383)
T 3eb0_A          185 DFGSAKKLIPSEP-------------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK  239 (383)
T ss_dssp             CCTTCEECCTTSC-------------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCcccCCCCC-------------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence            9999875422111             1134688999999974          9999999999999885

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.90  E-value=2.8e-25  Score=154.86  Aligned_cols=133  Identities=23%  Similarity=0.271  Sum_probs=108.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+++++.+..+. +..++||||+++++|.+++......+++..+..++.+++.|+.++|+++  ++|+|++|+||++
T Consensus        70 l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~  146 (281)
T 3cc6_A           70 LDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV  146 (281)
T ss_dssp             HCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE
T ss_pred             CCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEE
Confidence            347889998887765 4568999999999999999876667899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++........           .......+++.|+|||++         |+||+|+++++|+. |.
T Consensus       147 ~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~  212 (281)
T 3cc6_A          147 ASPECVKLGDFGLSRYIEDEDY-----------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK  212 (281)
T ss_dssp             EETTEEEECCCCGGGCC--------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCCcEEeCccCCCcccccccc-----------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCC
Confidence            9999999999998864321100           011123467789999984         99999999999986 65

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.90  E-value=2.6e-25  Score=160.02  Aligned_cols=131  Identities=24%  Similarity=0.470  Sum_probs=104.2

Q ss_pred             ccchhhhcccCCC-----CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTP-----HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~-----~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-||+|+++.+.+     ...+.+++||||++ |+|.+.+......+++..+..++.|++.|+.|+|+++  ++|+|++|
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp  162 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHP  162 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCCh
Confidence            3478888887765     56678999999998 4999988866567899999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLY  147 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~  147 (150)
                      +||+++.++.++++|||++.......             ......+|+.|+|||++          |+||+|++++++++
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~  229 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTADA-------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN  229 (362)
T ss_dssp             GGEEECTTCCEEECCTTC----------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred             HHEEEcCCCCEEEEecCccccccccc-------------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh
Confidence            99999999999999999986321110             11234688999999973          99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       230 g~  231 (362)
T 3pg1_A          230 RK  231 (362)
T ss_dssp             SS
T ss_pred             CC
Confidence            85

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.90  E-value=1.5e-25  Score=159.67  Aligned_cols=132  Identities=28%  Similarity=0.427  Sum_probs=109.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.++.... ..+++..+..++.+++.|+.++|+.+  ++|+|++|+||++
T Consensus        81 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~  157 (331)
T 4aaa_A           81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILV  157 (331)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred             CCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEE
Confidence            44789999999999999999999999998888876543 56899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++........            ......+++.|+|||++          |+||+|+++++|++|.
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  222 (331)
T 4aaa_A          158 SQSGVVKLCDFGFARTLAAPGE------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE  222 (331)
T ss_dssp             CTTSCEEECCCTTC------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCcEEEEeCCCceeecCCcc------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCC
Confidence            9999999999999864321110            11234689999999974          9999999999999885

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.90  E-value=2e-25  Score=171.74  Aligned_cols=133  Identities=26%  Similarity=0.304  Sum_probs=108.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.... +.+++||||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus       448 l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl  524 (656)
T 2j0j_A          448 FDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV  524 (656)
T ss_dssp             CCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred             CCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEE
Confidence            458899999888754 6789999999999999999876556899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++........           .......+++.|+|||++         |+||+|+++++|++ |.
T Consensus       525 ~~~~~vkL~DFG~a~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~  590 (656)
T 2j0j_A          525 SSNDCVKLGDFGLSRYMEDSTY-----------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV  590 (656)
T ss_dssp             EETTEEEECCCCCCCSCCC---------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             eCCCCEEEEecCCCeecCCCcc-----------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCC
Confidence            9999999999999875321110           001123467889999984         99999999999986 64

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.90  E-value=1.2e-25  Score=157.13  Aligned_cols=131  Identities=25%  Similarity=0.349  Sum_probs=104.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIE   78 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~   78 (150)
                      .-||+++++.+.+...+.+++||||+++ +|.+++..   ....+++..+..++.|++.|+.|+|++ +  ++|+|++|+
T Consensus        63 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~  139 (290)
T 3fme_A           63 VDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPS  139 (290)
T ss_dssp             CCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGG
T ss_pred             CCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHH
Confidence            4578899999998888999999999975 88888764   235689999999999999999999997 8  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-------------cccccceeEEEe
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-------------DTWNNYVIGRSM  145 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------d~~~~g~~~~~~  145 (150)
                      ||+++.++.++++|||++.......             ......||+.|+|||++             |+||+|+++++|
T Consensus       140 Nil~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l  206 (290)
T 3fme_A          140 NVLINALGQVKMCDFGISGYLVDDV-------------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL  206 (290)
T ss_dssp             GCEECTTCCEEBCCC----------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHH
T ss_pred             HEEECCCCCEEEeecCCcccccccc-------------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHH
Confidence            9999999999999999986432110             11123689999999984             999999999999


Q ss_pred             eeec
Q psy1934         146 LYGH  149 (150)
Q Consensus       146 ~~g~  149 (150)
                      ++|.
T Consensus       207 ~~g~  210 (290)
T 3fme_A          207 AILR  210 (290)
T ss_dssp             HHTS
T ss_pred             HHCC
Confidence            8875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.90  E-value=2.3e-25  Score=159.26  Aligned_cols=129  Identities=33%  Similarity=0.461  Sum_probs=94.7

Q ss_pred             chhhhcccCCCCC----ceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           5 SAAFIDKHSTPHG----MHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         5 ~~~~~~~~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      |++++++.+.+..    .+.+++||||+++|+|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+|
T Consensus        81 h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~N  158 (336)
T 3fhr_A           81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPEN  158 (336)
T ss_dssp             STTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred             CCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence            5778887776654    567899999999999999998653 36899999999999999999999999  9999999999


Q ss_pred             EEEcC---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          80 LLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        80 il~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+++.   .+.++++|||++......              ......+|+.|+|||++         |+||+|+++++|++
T Consensus       159 Ill~~~~~~~~~kl~Dfg~~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  224 (336)
T 3fhr_A          159 LLYTSKEKDAVLKLTDFGFAKETTQN--------------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC  224 (336)
T ss_dssp             EEESCSSTTCCEEECCCTTCEEC------------------------------------CHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCCceEEEeccccceecccc--------------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHH
Confidence            99976   455999999998743211              01134578999999986         99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       225 g~  226 (336)
T 3fhr_A          225 GF  226 (336)
T ss_dssp             SS
T ss_pred             CC
Confidence            75

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=1.5e-25  Score=157.11  Aligned_cols=136  Identities=18%  Similarity=0.191  Sum_probs=110.5

Q ss_pred             ccchhhhcccCCCCCceEE-EEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEY-LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~-~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.+.+...+.. ++++||+.+++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus        79 l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil  156 (298)
T 3pls_A           79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCM  156 (298)
T ss_dssp             CCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             CCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEE
Confidence            4588999998887655555 9999999999999999876567889999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      ++.++.++++|||++.........        .........+++.|+|||++         |+||+|+++++|++|
T Consensus       157 i~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  224 (298)
T 3pls_A          157 LDESFTVKVADFGLARDILDREYY--------SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR  224 (298)
T ss_dssp             ECTTCCEEECCTTSSCTTTTGGGG--------CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHT
T ss_pred             EcCCCcEEeCcCCCcccccCCccc--------ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhC
Confidence            999999999999998643211000        00011123567889999984         999999999999885

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.90  E-value=1.1e-25  Score=157.27  Aligned_cols=134  Identities=23%  Similarity=0.300  Sum_probs=112.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|++|+++.+.+...+.+++||||+++++|.+++.... ..+++..+..++.+++.|+.++|+++  ++|+|++|+||+
T Consensus        66 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil  143 (288)
T 3kfa_A           66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCL  143 (288)
T ss_dssp             CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEE
T ss_pred             CCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEE
Confidence            347899999999999999999999999999999998643 45889999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||++..........           .....+++.|+|||++         |+||+|+++++|++ |.
T Consensus       144 ~~~~~~~~l~Dfg~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~  210 (288)
T 3kfa_A          144 VGENHLVKVADFGLSRLMTGDTYTA-----------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM  210 (288)
T ss_dssp             ECGGGCEEECCCCGGGTSCSSSSEE-----------ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             EcCCCCEEEccCccceeccCCcccc-----------ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999987532211100           1123457789999974         99999999999987 64

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.90  E-value=3e-25  Score=155.12  Aligned_cols=135  Identities=24%  Similarity=0.279  Sum_probs=109.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++|++..+.....+ .++|+||+++++|.+++......+++..+..++.+++.|+.++|+++  ++|+|++|+||++
T Consensus        78 l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili  154 (291)
T 1u46_A           78 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL  154 (291)
T ss_dssp             CCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE
T ss_pred             CCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEE
Confidence            34788999888877754 89999999999999999876566899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++...........         ......+++.|+|||++         |+||+|+++++|++ |.
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~  222 (291)
T 1u46_A          155 ATRDLVKIGDFGLMRALPQNDDHYV---------MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ  222 (291)
T ss_dssp             EETTEEEECCCTTCEECCC-CCEEE---------C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCCCCEEEccccccccccccccchh---------hhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999875432221110         01123467789999984         99999999999987 64

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.90  E-value=3.1e-25  Score=157.37  Aligned_cols=134  Identities=22%  Similarity=0.278  Sum_probs=110.0

Q ss_pred             ccchhhhcccCCCCC--ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHG--MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-||+|+++.+++..  ...+++||||+++++|.+++...  .+++..+..++.+++.|+.++|+.+  ++|+|++|+||
T Consensus        90 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Ni  165 (318)
T 3lxp_A           90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNV  165 (318)
T ss_dssp             CCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred             CCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheE
Confidence            347888888887654  57899999999999999999763  5899999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++..........         .......++..|+|||++         |+||+|+++++|++|.
T Consensus       166 l~~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~  234 (318)
T 3lxp_A          166 LLDNDRLVKIGDFGLAKAVPEGHEYY---------RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC  234 (318)
T ss_dssp             EECTTCCEEECCGGGCEECCTTCSEE---------EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred             EEcCCCCEEECCcccccccccccccc---------ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999999987543221110         001133578889999985         9999999999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.90  E-value=9.7e-26  Score=156.57  Aligned_cols=134  Identities=28%  Similarity=0.395  Sum_probs=112.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++++++.+.....+..++|+||+++++|.+++... ..+++..+..++.|++.|+.++|+++  ++|+|++|+||++
T Consensus        62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~  138 (276)
T 2yex_A           62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL  138 (276)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             cCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEE
Confidence            45788999999888889999999999999999988653 46889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||.+..........          ......|++.|+|||++          |+||+|+++++|++|.
T Consensus       139 ~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  205 (276)
T 2yex_A          139 DERDNLKISDFGLATVFRYNNRER----------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE  205 (276)
T ss_dssp             CTTCCEEECCCTTCEECEETTEEC----------CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCEEEeeCCCccccCCCcchh----------cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCC
Confidence            999999999999987532211100          01134588999999984          9999999999999885

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.90  E-value=6.4e-25  Score=156.13  Aligned_cols=125  Identities=29%  Similarity=0.399  Sum_probs=105.9

Q ss_pred             hhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-
Q psy1934           7 AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS-   84 (150)
Q Consensus         7 ~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~-   84 (150)
                      ++++..+.++..+.+++||||+ +++|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++. 
T Consensus        78 ~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQS  154 (339)
T ss_dssp             CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCC
T ss_pred             eeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEecc
Confidence            3677777788888999999999 779999998654 35889999999999999999999999  999999999999987 


Q ss_pred             ------------------CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccc
Q psy1934          85 ------------------AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWN  137 (150)
Q Consensus        85 ------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~  137 (150)
                                        ++.++++|||++......               .....||+.|+|||++         |+||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~s  219 (339)
T 1z57_A          155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---------------HSTLVSTRHYRAPEVILALGWSQPCDVWS  219 (339)
T ss_dssp             CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC---------------CCSSCSCGGGCCHHHHTTSCCCTHHHHHH
T ss_pred             ccccccCCccccccccccCCCceEeeCcccccCccc---------------cccccCCccccChHHhhCCCCCcchhhHH
Confidence                              567999999998743211               1134689999999984         9999


Q ss_pred             cceeEEEeeeec
Q psy1934         138 NYVIGRSMLYGH  149 (150)
Q Consensus       138 ~g~~~~~~~~g~  149 (150)
                      +|+++++|++|.
T Consensus       220 lG~il~el~~g~  231 (339)
T 1z57_A          220 IGCILIEYYLGF  231 (339)
T ss_dssp             HHHHHHHHHHSS
T ss_pred             HHHHHHHHHhCC
Confidence            999999999885

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.90  E-value=4e-25  Score=154.77  Aligned_cols=128  Identities=20%  Similarity=0.185  Sum_probs=103.4

Q ss_pred             CCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE---cCCCcEEE
Q psy1934          14 TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI---SSAGTVKL   90 (150)
Q Consensus        14 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~---~~~~~~~l   90 (150)
                      .....+..++||||+ +++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++   +..+.+++
T Consensus        73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL  149 (296)
T 4hgt_A           73 CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEE
T ss_pred             ecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEE
Confidence            445667889999999 88999999866567999999999999999999999999  9999999999999   78889999


Q ss_pred             eecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          91 CDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        91 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +|||++...........     ..........||+.|+|||++         |+||+|+++++|++|.
T Consensus       150 ~Dfg~a~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  212 (296)
T 4hgt_A          150 IDFGLAKKYRDARTHQH-----IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS  212 (296)
T ss_dssp             CCCTTCEECBCTTTCCB-----CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ecCccceeccCcccCcc-----CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCC
Confidence            99999875432211000     000011234689999999984         9999999999999885

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.90  E-value=3.5e-25  Score=157.48  Aligned_cols=136  Identities=18%  Similarity=0.235  Sum_probs=109.3

Q ss_pred             ccchhhhcccCCCCC--ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHG--MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-|++|++..+....  .+.+++||||+++++|.+++......+++..+..++.+++.|+.++|+.+  ++|+|++|+||
T Consensus        99 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NI  176 (326)
T 2w1i_A           99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNI  176 (326)
T ss_dssp             CCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred             CCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceE
Confidence            347888888775544  34789999999999999999876566899999999999999999999998  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.++++|||++...........         ......++..|+|||++         |+||+|+++++|++|.
T Consensus       177 li~~~~~~kL~Dfg~~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~  245 (326)
T 2w1i_A          177 LVENENRVKIGDFGLTKVLPQDKEYYK---------VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI  245 (326)
T ss_dssp             EEEETTEEEECCCTTCEECCSSCSEEE---------CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTT
T ss_pred             EEcCCCcEEEecCcchhhccccccccc---------cccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcC
Confidence            999999999999999875432211000         00123467789999984         9999999999998873

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.90  E-value=4.2e-25  Score=155.48  Aligned_cols=131  Identities=27%  Similarity=0.407  Sum_probs=112.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|+++++..+.+...+.+++||||+++++|.+++..  ..+++..+..++.+++.|+.++|+.+  ++|+|++|+||++
T Consensus        77 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~  152 (303)
T 3a7i_A           77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL  152 (303)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEE
Confidence            3478899998888888999999999999999999965  46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||++.........            .....|++.|+|||++         |+||+|+++++|++|.
T Consensus       153 ~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  216 (303)
T 3a7i_A          153 SEHGEVKLADFGVAGQLTDTQIK------------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE  216 (303)
T ss_dssp             CTTSCEEECCCTTCEECBTTBCC------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEeecccceecCccccc------------cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCC
Confidence            99999999999998754221110            1134688999999985         9999999999999885

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.90  E-value=9.8e-25  Score=158.36  Aligned_cols=128  Identities=23%  Similarity=0.347  Sum_probs=105.7

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS-   83 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~-   83 (150)
                      ++++++.+.+...+.+|+||||+++ +|.+++.... ..+++..+..++.|++.|+.|+|.+..+++|+|+||+||++. 
T Consensus       116 ~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~  194 (382)
T 2vx3_A          116 YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN  194 (382)
T ss_dssp             GGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS
T ss_pred             eeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec
Confidence            3477777778888899999999965 9999998754 458999999999999999999995322399999999999995 


Q ss_pred             -CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 -SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 -~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                       ..+.++++|||++......               .....+|+.|+|||++         |+||+|+++++|++|.
T Consensus       195 ~~~~~~kL~DFG~a~~~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~  255 (382)
T 2vx3_A          195 PKRSAIKIVDFGSSCQLGQR---------------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE  255 (382)
T ss_dssp             TTSCCEEECCCTTCEETTCC---------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCcEEEEeccCceecccc---------------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence             4678999999998753211               1134689999999984         9999999999999885

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.90  E-value=3.9e-25  Score=159.97  Aligned_cols=128  Identities=30%  Similarity=0.408  Sum_probs=99.8

Q ss_pred             ccchhhhcccCCCCCc------eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGM------HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||+|+++.+++...      +.+++||||+++ +|.+.+.   ..+++..+..++.|++.|+.|+|+++  ++|+|++
T Consensus        81 l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlk  154 (371)
T 2xrw_A           81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK  154 (371)
T ss_dssp             CCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             cCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCC
Confidence            3478888888766544      388999999976 8888885   35889999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+||+++.++.++++|||++......             .......||+.|+|||++         |+||+|+++++|++
T Consensus       155 p~NIl~~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  221 (371)
T 2xrw_A          155 PSNIVVKSDCTLKILDFGLARTAGTS-------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK  221 (371)
T ss_dssp             GGGEEECTTSCEEECCCCC-----------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             HHHEEEcCCCCEEEEEeecccccccc-------------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHh
Confidence            99999999999999999998643211             011234689999999984         99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       222 g~  223 (371)
T 2xrw_A          222 GG  223 (371)
T ss_dssp             SS
T ss_pred             CC
Confidence            85

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.90  E-value=3.7e-25  Score=155.18  Aligned_cols=143  Identities=24%  Similarity=0.313  Sum_probs=102.4

Q ss_pred             ccchhhhcccCC-------------CCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           3 YLSAAFIDKHST-------------PHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         3 ~~~~~~~~~~~~-------------~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      +-||++++..+.             ....+.+++||||+++++|.+++......+++..+..++.|++.|+.|+|+++  
T Consensus        59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--  136 (303)
T 1zy4_A           59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--  136 (303)
T ss_dssp             CCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--
Confidence            346777776543             34578899999999999999999875555788888899999999999999999  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHh--hhhhhHHhhhcCCCCCccCcccc----------cccc
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQ--QRSMLEDEMARFTTPMYRAPEMV----------DTWN  137 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~y~aPE~~----------d~~~  137 (150)
                      ++|+|++|+||+++.++.++++|||++..............  ............|++.|+|||++          |+||
T Consensus       137 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s  216 (303)
T 1zy4_A          137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS  216 (303)
T ss_dssp             CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHH
T ss_pred             eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHH
Confidence            99999999999999999999999999875321110000000  00001112244689999999974          9999


Q ss_pred             cceeEEEeee
Q psy1934         138 NYVIGRSMLY  147 (150)
Q Consensus       138 ~g~~~~~~~~  147 (150)
                      +|+++++|++
T Consensus       217 lG~il~~l~~  226 (303)
T 1zy4_A          217 LGIIFFEMIY  226 (303)
T ss_dssp             HHHHHHHHHS
T ss_pred             HHHHHHHHHh
Confidence            9999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.90  E-value=6e-25  Score=156.25  Aligned_cols=126  Identities=18%  Similarity=0.304  Sum_probs=106.5

Q ss_pred             chhhhcccCCCCC--ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           5 SAAFIDKHSTPHG--MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         5 ~~~~~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      |++|+++.+....  ....++||||+++++|.++++.    +++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        90 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~  163 (330)
T 3nsz_A           90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMI  163 (330)
T ss_dssp             STTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE
Confidence            7888888887665  6788999999999999998853    788889999999999999999999  9999999999999


Q ss_pred             cCCC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++ .++++|||++........             .....+++.|+|||++          |+||+|+++++|++|.
T Consensus       164 ~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  228 (330)
T 3nsz_A          164 DHEHRKLRLIDWGLAEFYHPGQE-------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK  228 (330)
T ss_dssp             ETTTTEEEECCCTTCEECCTTCC-------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             cCCCCEEEEEeCCCceEcCCCCc-------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCC
Confidence            9776 899999999875322111             1134688899999974          9999999999999885

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.90  E-value=2e-25  Score=160.33  Aligned_cols=124  Identities=17%  Similarity=0.169  Sum_probs=100.4

Q ss_pred             ceEEEEEEeccCCCCHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC--cEEEeecC
Q psy1934          18 MHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAG--TVKLCDFG   94 (150)
Q Consensus        18 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~--~~~l~dfg   94 (150)
                      .+.+++||||+ +++|.+++... ...+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++.++  .++++|||
T Consensus       130 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~~~~~~~~kl~Dfg  206 (352)
T 2jii_A          130 DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYG  206 (352)
T ss_dssp             TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEETTEEEEEEECCGG
T ss_pred             CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEcCCCCceEEEecCc
Confidence            57889999999 88999999864 256999999999999999999999998  99999999999999987  89999999


Q ss_pred             ceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          95 SATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++............     .........||+.|+|||++         |+||+|+++++|++|.
T Consensus       207 ~a~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  265 (352)
T 2jii_A          207 FAFRYCPSGKHVAY-----VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF  265 (352)
T ss_dssp             GCBCSSGGGCCCCC-----CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             ceeeccCCCccccc-----cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            98754321110000     00011234689999999984         9999999999999886

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.90  E-value=9.4e-26  Score=159.35  Aligned_cols=133  Identities=23%  Similarity=0.399  Sum_probs=107.7

Q ss_pred             chhhhcccCCCCC-ceEEEEEEeccCCCCHHHHHHhhCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCC
Q psy1934           5 SAAFIDKHSTPHG-MHEYLILTELCTGGSLVDVLKERTSA---------------LPPNIVCSILWQTCQAVKHMHGQNP   68 (150)
Q Consensus         5 ~~~~~~~~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~---------------l~~~~~~~~~~~i~~~l~~lh~~~~   68 (150)
                      ||+|+++.+.+.. .+.++++|||+++++|.+++......               +++..+..++.|++.|+.|+|+++ 
T Consensus        90 hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-  168 (316)
T 2xir_A           90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-  168 (316)
T ss_dssp             CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             CCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            6889998887554 34589999999999999999864321               788889999999999999999998 


Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccc
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNY  139 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g  139 (150)
                       ++|+|++|+||+++.++.++++|||++..........          ......+|+.|+|||++         |+||+|
T Consensus       169 -i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG  237 (316)
T 2xir_A          169 -CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFG  237 (316)
T ss_dssp             -CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSE----------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             -cccccCccceEEECCCCCEEECCCccccccccCccce----------eccCCCcceeecCchhhccccccchhHHHHHH
Confidence             9999999999999999999999999987432211110          01123467889999974         999999


Q ss_pred             eeEEEeee-ec
Q psy1934         140 VIGRSMLY-GH  149 (150)
Q Consensus       140 ~~~~~~~~-g~  149 (150)
                      +++++|++ |.
T Consensus       238 ~il~~l~t~g~  248 (316)
T 2xir_A          238 VLLWEIFSLGA  248 (316)
T ss_dssp             HHHHHHHTTSC
T ss_pred             HHHHHHHhCCC
Confidence            99999986 64

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.90  E-value=1.1e-25  Score=159.27  Aligned_cols=138  Identities=20%  Similarity=0.214  Sum_probs=109.0

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-|+++++..+.....+.+++++||+++++|.+++......+++..+..++.+++.|+.|+|+++  ++|+|++|+||+
T Consensus        85 ~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl  162 (319)
T 2y4i_B           85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVF  162 (319)
T ss_dssp             TCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEE
T ss_pred             cCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEE
Confidence            345889999999988889999999999999999999875556899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------------cccccceeEE
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------------DTWNNYVIGR  143 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------------d~~~~g~~~~  143 (150)
                      ++ ++.++++|||++..........       .........|++.|+|||++                  |+||+|++++
T Consensus       163 ~~-~~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~  234 (319)
T 2y4i_B          163 YD-NGKVVITDFGLFSISGVLQAGR-------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY  234 (319)
T ss_dssp             EC---CCEECCCSCCC-----------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred             Ee-CCCEEEeecCCccccccccccc-------cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence            98 6789999999876431110000       00011123478889999973                  9999999999


Q ss_pred             Eeeeec
Q psy1934         144 SMLYGH  149 (150)
Q Consensus       144 ~~~~g~  149 (150)
                      +|++|.
T Consensus       235 el~~g~  240 (319)
T 2y4i_B          235 ELHARE  240 (319)
T ss_dssp             HHHHSS
T ss_pred             HHHhCC
Confidence            999885

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.90  E-value=4.7e-25  Score=154.51  Aligned_cols=134  Identities=19%  Similarity=0.270  Sum_probs=109.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|++..+.. ..+.+++||||+++++|.+++... ..+++..+..++.|++.|+.++|+.+  ++|+|++|+||++
T Consensus        75 l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~  150 (291)
T 1xbb_A           75 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL  150 (291)
T ss_dssp             CCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             CCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEE
Confidence            4578899988877 456789999999999999999864 46899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.++++|||++...........         ......+++.|+|||++         |+||+|+++++|++ |.
T Consensus       151 ~~~~~~kl~Dfg~~~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~  218 (291)
T 1xbb_A          151 VTQHYAKISDFGLSKALRADENYYK---------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ  218 (291)
T ss_dssp             EETTEEEECCCTTCEECCTTCSEEE---------C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred             eCCCcEEEccCCcceeeccCCCccc---------ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCC
Confidence            9999999999999875432211100         01122467889999984         99999999999987 65

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.90  E-value=6.5e-25  Score=163.69  Aligned_cols=131  Identities=21%  Similarity=0.191  Sum_probs=105.2

Q ss_pred             ccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE---cCCCc
Q psy1934          11 KHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI---SSAGT   87 (150)
Q Consensus        11 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~---~~~~~   87 (150)
                      +.......+..++||||+ +++|.+++......+++..+..++.|++.|+.|||+++  ++|+|+||+||++   +..+.
T Consensus        68 i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~  144 (483)
T 3sv0_A           68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQ  144 (483)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTC
T ss_pred             EEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCe
Confidence            334445667889999999 88999999876667999999999999999999999999  9999999999999   57889


Q ss_pred             EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          88 VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        88 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++|+|||++...........     ..........||+.|+|||++         |+||+|+++++|++|.
T Consensus       145 vkL~DFGla~~~~~~~~~~~-----~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~  210 (483)
T 3sv0_A          145 VYIIDFGLAKKYRDTSTHQH-----IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS  210 (483)
T ss_dssp             EEECCCTTCEECBCTTTCCB-----CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             EEEEeCCcceeccCCccccc-----cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence            99999999986432211100     000111245689999999985         9999999999999885

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.90  E-value=1.8e-25  Score=158.95  Aligned_cols=135  Identities=21%  Similarity=0.293  Sum_probs=109.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT------SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++....      ..+++..+..++.+++.|+.|+|+++  ++|+|++
T Consensus        90 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlk  167 (327)
T 2yfx_A           90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIA  167 (327)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             CCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCC
Confidence            458899999999999899999999999999999998653      24788889999999999999999999  9999999


Q ss_pred             CCCEEEcC---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEE
Q psy1934          77 IENLLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRS  144 (150)
Q Consensus        77 ~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~  144 (150)
                      |+||+++.   ...++++|||++........          ........+++.|+|||++         |+||+|+++++
T Consensus       168 p~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  237 (327)
T 2yfx_A          168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASY----------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE  237 (327)
T ss_dssp             GGGEEESCSSTTCCEEECCCHHHHHHHC----------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             HhHEEEecCCCcceEEECccccccccccccc----------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHH
Confidence            99999984   44699999998864321110          0111133578899999984         99999999999


Q ss_pred             eee-ec
Q psy1934         145 MLY-GH  149 (150)
Q Consensus       145 ~~~-g~  149 (150)
                      |++ |.
T Consensus       238 llt~g~  243 (327)
T 2yfx_A          238 IFSLGY  243 (327)
T ss_dssp             HHTTSC
T ss_pred             HHcCCC
Confidence            986 64

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.90  E-value=1.1e-25  Score=169.80  Aligned_cols=133  Identities=23%  Similarity=0.289  Sum_probs=109.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|++|+++.++... +.+++||||+++|+|.++++... ..+++..+..++.|++.|+.|||+++  ++|+|++++||+
T Consensus       319 l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIl  395 (535)
T 2h8h_A          319 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANIL  395 (535)
T ss_dssp             CCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             CCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEE
Confidence            458899998887766 67899999999999999997532 45889999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.+||+|||+++.....   .        ........++..|+|||++         |+||+|+++++|++ |.
T Consensus       396 l~~~~~~kl~DFG~a~~~~~~---~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~  462 (535)
T 2h8h_A          396 VGENLVCKVADFGLARLIEDN---E--------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR  462 (535)
T ss_dssp             ECGGGCEEECCTTSTTTCCCH---H--------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTC
T ss_pred             EcCCCcEEEcccccceecCCC---c--------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999998643210   0        0111123456789999984         99999999999997 64

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.90  E-value=3.1e-25  Score=153.71  Aligned_cols=131  Identities=27%  Similarity=0.418  Sum_probs=104.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-eEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPP-IVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~-i~h~~l~~~nil   81 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.++++.  ..+++..+..++.|++.|+.|+|+++.. ++|+|++|+||+
T Consensus        63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil  140 (271)
T 3dtc_A           63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL  140 (271)
T ss_dssp             CCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEE
T ss_pred             cCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEE
Confidence            3478999999999999999999999999999999864  4689999999999999999999988632 889999999999


Q ss_pred             EcC--------CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEE
Q psy1934          82 ISS--------AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRS  144 (150)
Q Consensus        82 ~~~--------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~  144 (150)
                      ++.        .+.++++|||++......              ......|++.|+|||++         |+||+|+++++
T Consensus       141 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~  206 (271)
T 3dtc_A          141 ILQKVENGDLSNKILKITDFGLAREWHRT--------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWE  206 (271)
T ss_dssp             ESSCCSSSCCSSCCEEECCCCC---------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHH
T ss_pred             EecccccccccCcceEEccCCcccccccc--------------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHH
Confidence            986        678999999998643211              01134589999999984         99999999999


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      +++|.
T Consensus       207 l~~g~  211 (271)
T 3dtc_A          207 LLTGE  211 (271)
T ss_dssp             HHHCC
T ss_pred             HHhCC
Confidence            99885

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.90  E-value=4.9e-25  Score=156.43  Aligned_cols=130  Identities=32%  Similarity=0.390  Sum_probs=107.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+..+..+ +++||||+++++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++
T Consensus        72 l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~  147 (322)
T 2ycf_A           72 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLL  147 (322)
T ss_dssp             CCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE
Confidence            34788999888776654 89999999999999998753 56899999999999999999999999  9999999999999


Q ss_pred             cCCC---cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeee
Q psy1934          83 SSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLY  147 (150)
Q Consensus        83 ~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~  147 (150)
                      +..+   .++++|||++......   .          ......||+.|+|||++            |+||+|+++++|++
T Consensus       148 ~~~~~~~~~kl~Dfg~~~~~~~~---~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~  214 (322)
T 2ycf_A          148 SSQEEDCLIKITDFGHSKILGET---S----------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS  214 (322)
T ss_dssp             SSSSSSCCEEECCCTTCEECCCC---H----------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCeEEEccCccceecccc---c----------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh
Confidence            8765   4999999998753211   0          01123589999999973            99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       215 g~  216 (322)
T 2ycf_A          215 GY  216 (322)
T ss_dssp             SS
T ss_pred             CC
Confidence            85

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.90  E-value=7e-26  Score=161.71  Aligned_cols=116  Identities=15%  Similarity=0.163  Sum_probs=96.5

Q ss_pred             chhhhcccCCCCC-------------ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCe
Q psy1934           5 SAAFIDKHSTPHG-------------MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMH-GQNPPI   70 (150)
Q Consensus         5 ~~~~~~~~~~~~~-------------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~i   70 (150)
                      ||+|+++.++++.             .+.+|+||||+++|++.+.+..  ..+++..++.++.|++.|+.|+| +++  +
T Consensus       108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~--i  183 (336)
T 2vuw_A          108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLR--F  183 (336)
T ss_dssp             CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHC--C
T ss_pred             cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCC--E
Confidence            6778777766553             7899999999999976666643  46899999999999999999999 898  9


Q ss_pred             EEecCCCCCEEEcCCC--------------------cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCc
Q psy1934          71 VHRDLKIENLLISSAG--------------------TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP  130 (150)
Q Consensus        71 ~h~~l~~~nil~~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  130 (150)
                      +|||+||+||+++.++                    .+|++|||+++....                 ...+||+.|+||
T Consensus       184 vHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----------------~~~~gt~~y~aP  246 (336)
T 2vuw_A          184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----------------GIVVFCDVSMDE  246 (336)
T ss_dssp             BCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------------TEEECCCCTTCS
T ss_pred             eECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------------CcEEEeecccCh
Confidence            9999999999999887                    899999999975321                 123689999999


Q ss_pred             ccc--------ccccccee
Q psy1934         131 EMV--------DTWNNYVI  141 (150)
Q Consensus       131 E~~--------d~~~~g~~  141 (150)
                      |++        |+||++.+
T Consensus       247 E~~~g~~~~~~Diwsl~~~  265 (336)
T 2vuw_A          247 DLFTGDGDYQFDIYRLMKK  265 (336)
T ss_dssp             GGGCCCSSHHHHHHHHHHH
T ss_pred             hhhcCCCccceehhhhhCC
Confidence            996        99997554

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.90  E-value=2.5e-25  Score=161.19  Aligned_cols=109  Identities=14%  Similarity=0.171  Sum_probs=90.9

Q ss_pred             EEEEEeccCCCCHHHHHHhhCCCCC-------HHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeec
Q psy1934          21 YLILTELCTGGSLVDVLKERTSALP-------PNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDF   93 (150)
Q Consensus        21 ~~lv~E~~~~g~L~~~l~~~~~~l~-------~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~df   93 (150)
                      .+++|||+ +|+|.+++.... .++       +..+..++.|++.|+.|+|+++  ++|+|+||+||+++.++.+|++||
T Consensus       175 ~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DF  250 (377)
T 3byv_A          175 RFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGF  250 (377)
T ss_dssp             EEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCG
T ss_pred             EEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEec
Confidence            79999999 579999998642 233       4677789999999999999999  999999999999999999999999


Q ss_pred             CceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------------cccccceeEEEeeeec
Q psy1934          94 GSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        94 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------------d~~~~g~~~~~~~~g~  149 (150)
                      |++.....               ......| +.|+|||++                    |+||+|+++++|++|.
T Consensus       251 G~a~~~~~---------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~  310 (377)
T 3byv_A          251 EHLVRDGA---------------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD  310 (377)
T ss_dssp             GGCEETTC---------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             hhheecCC---------------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence            99874211               0113457 899999972                    9999999999999885

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.90  E-value=9.2e-25  Score=153.01  Aligned_cols=128  Identities=20%  Similarity=0.185  Sum_probs=102.7

Q ss_pred             CCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE---cCCCcEEE
Q psy1934          14 TPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI---SSAGTVKL   90 (150)
Q Consensus        14 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~---~~~~~~~l   90 (150)
                      .....+..++||||+ +++|.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||++   +..+.+++
T Consensus        73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl  149 (296)
T 3uzp_A           73 CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEE
T ss_pred             ccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEE
Confidence            335567889999999 88999999865567999999999999999999999999  9999999999999   47789999


Q ss_pred             eecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          91 CDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        91 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +|||++...........     ..........||+.|+|||++         |+||+|+++++|++|.
T Consensus       150 ~Dfg~~~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  212 (296)
T 3uzp_A          150 IDFGLAKKYRDARTHQH-----IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS  212 (296)
T ss_dssp             CCCTTCEECBCTTTCCB-----CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             eeCCCcccccccccccc-----cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence            99999875432211000     000011234689999999985         9999999999999885

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.90  E-value=7e-25  Score=153.55  Aligned_cols=133  Identities=25%  Similarity=0.300  Sum_probs=111.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTS--ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-||+|+++.+.+...+.+++||||+++++|.+++.....  .+++..+..++.+++.|+.|+|+.+  ++|+|++|+||
T Consensus        76 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Ni  153 (295)
T 2clq_A           76 LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNV  153 (295)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred             CCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhE
Confidence            4578999999999888999999999999999999986532  3567888889999999999999998  99999999999


Q ss_pred             EEcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeee
Q psy1934          81 LISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        81 l~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g  148 (150)
                      +++. ++.++++|||++........            ......|++.|+|||++           |+||+|+++++|++|
T Consensus       154 l~~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  221 (295)
T 2clq_A          154 LINTYSGVLKISDFGTSKRLAGINP------------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG  221 (295)
T ss_dssp             EEETTTCCEEECCTTTCEESCC-----------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT
T ss_pred             EEECCCCCEEEeecccccccCCCCC------------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            9987 78999999999875321100            01134688999999973           999999999999987


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       222 ~  222 (295)
T 2clq_A          222 K  222 (295)
T ss_dssp             S
T ss_pred             C
Confidence            5

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.90  E-value=9.8e-25  Score=154.81  Aligned_cols=130  Identities=25%  Similarity=0.401  Sum_probs=109.7

Q ss_pred             cchhhhcccCCCC-----CceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           4 LSAAFIDKHSTPH-----GMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         4 ~~~~~~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      -||+|+++.+.+.     ..+.+++||||++ |+|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|
T Consensus        72 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp  148 (326)
T 1blx_A           72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKP  148 (326)
T ss_dssp             CCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred             CCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCH
Confidence            4889999888765     6788999999998 59999998653 34899999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +||+++.++.++++|||++......             .......+++.|+|||++         |+||+|+++++|++|
T Consensus       149 ~Nili~~~~~~kl~Dfg~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  215 (326)
T 1blx_A          149 QNILVTSSGQIKLADFGLARIYSFQ-------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR  215 (326)
T ss_dssp             GGEEECTTCCEEECSCCSCCCCCGG-------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             HHeEEcCCCCEEEecCcccccccCC-------------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence            9999999999999999998643210             011234689999999984         999999999999987


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       216 ~  216 (326)
T 1blx_A          216 K  216 (326)
T ss_dssp             S
T ss_pred             C
Confidence            5

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.90  E-value=8.5e-25  Score=154.47  Aligned_cols=128  Identities=26%  Similarity=0.363  Sum_probs=102.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHhc---CCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTS--ALPPNIVCSILWQTCQAVKHMHG---QNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~~~~~i~~~l~~lh~---~~~~i~h~~l~~   77 (150)
                      +-||+|+++.+...+  ..++||||+++++|.+++.....  .+++..+..++.|++.|+.|+|+   ++  ++|+|++|
T Consensus        58 l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp  133 (307)
T 2eva_A           58 VNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKP  133 (307)
T ss_dssp             CCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSG
T ss_pred             CCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCCh
Confidence            357899998887764  47999999999999999986432  36788888999999999999999   66  99999999


Q ss_pred             CCEEEcCCCc-EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          78 ENLLISSAGT-VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        78 ~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      +||+++.++. ++++|||++......               .....||+.|+|||++         |+||+|+++++|++
T Consensus       134 ~NIll~~~~~~~kl~Dfg~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  198 (307)
T 2eva_A          134 PNLLLVAGGTVLKICDFGTACDIQTH---------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT  198 (307)
T ss_dssp             GGEEEETTTTEEEECCCCC---------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             hHEEEeCCCCEEEEcccccccccccc---------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHH
Confidence            9999988876 799999988632110               1123589999999984         99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       199 g~  200 (307)
T 2eva_A          199 RR  200 (307)
T ss_dssp             TC
T ss_pred             CC
Confidence            85

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.90  E-value=1e-24  Score=157.28  Aligned_cols=133  Identities=30%  Similarity=0.487  Sum_probs=108.4

Q ss_pred             ccchhhhcccCCCCC-----ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPHG-----MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-||+|+++.+.+..     ...+++|+||+++ +|.++++.  ..+++..+..++.|++.|+.|+|+++  ++|+|++|
T Consensus        82 l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp  156 (364)
T 3qyz_A           82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKP  156 (364)
T ss_dssp             CCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             cCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCh
Confidence            447888888775543     3578999999975 99999976  46899999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLY  147 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~  147 (150)
                      +||+++.++.++++|||++..........         .......||+.|+|||++          |+||+|+++++|++
T Consensus       157 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  227 (364)
T 3qyz_A          157 SNLLLNTTCDLKICDFGLARVADPDHDHT---------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS  227 (364)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCGGGCBC---------CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred             HhEEECCCCCEEEEeCcceEecCCCCCcc---------ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH
Confidence            99999999999999999987543211100         001234689999999973          99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       228 g~  229 (364)
T 3qyz_A          228 NR  229 (364)
T ss_dssp             SS
T ss_pred             CC
Confidence            85

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.90  E-value=4.3e-25  Score=156.77  Aligned_cols=131  Identities=24%  Similarity=0.417  Sum_probs=105.8

Q ss_pred             chhhhcccCCCCC------ceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           5 SAAFIDKHSTPHG------MHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         5 ~~~~~~~~~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      |++|+++.+.+..      .+.+++||||+++++|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|
T Consensus        80 h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp  157 (326)
T 2x7f_A           80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKG  157 (326)
T ss_dssp             STTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSG
T ss_pred             CCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcH
Confidence            7788887776544      568999999999999999998643 46889999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEE
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGR  143 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~  143 (150)
                      +||+++.++.++++|||++.......            .......|++.|+|||++              |+||+|++++
T Consensus       158 ~NIl~~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~  225 (326)
T 2x7f_A          158 QNVLLTENAEVKLVDFGVSAQLDRTV------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI  225 (326)
T ss_dssp             GGEEECTTCCEEECCCTTTC-------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHH
T ss_pred             HHEEEcCCCCEEEeeCcCceecCcCc------------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHH
Confidence            99999999999999999876432110            011234689999999974              9999999999


Q ss_pred             Eeeeec
Q psy1934         144 SMLYGH  149 (150)
Q Consensus       144 ~~~~g~  149 (150)
                      +|++|.
T Consensus       226 ~l~~g~  231 (326)
T 2x7f_A          226 EMAEGA  231 (326)
T ss_dssp             HHHHSS
T ss_pred             HHHhCC
Confidence            999885

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.90  E-value=9.5e-25  Score=154.08  Aligned_cols=133  Identities=27%  Similarity=0.386  Sum_probs=105.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-|++|+++.+.+...+.+++||||+++++|.+++...   ...+++..+..++.+++.|+.++|+.+  ++|+|++|+|
T Consensus        89 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~N  166 (310)
T 2wqm_A           89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPAN  166 (310)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGG
T ss_pred             CCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHH
Confidence            45788999999888889999999999999999999752   355889999999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      |+++.++.++++|||++........            ......+++.|+|||++         |+||+|+++++|++|.
T Consensus       167 Il~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~  233 (310)
T 2wqm_A          167 VFITATGVVKLGDLGLGRFFSSKTT------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ  233 (310)
T ss_dssp             EEECTTSCEEECCC------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             EEEcCCCCEEEEeccceeeecCCCc------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999998764321100            11133588999999974         9999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.90  E-value=1e-24  Score=154.92  Aligned_cols=128  Identities=29%  Similarity=0.431  Sum_probs=110.3

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCC-CCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTG-GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      +++++++.+.+...+.+++++|++.+ ++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++
T Consensus       107 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~  183 (320)
T 3a99_A          107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILID  183 (320)
T ss_dssp             SCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE
T ss_pred             CCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEe
Confidence            47899999999999999999999986 7999999865 56899999999999999999999999  99999999999998


Q ss_pred             -CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          84 -SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 -~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                       .++.++++|||++.......              .....||+.|+|||++          |+||+|+++++|++|.
T Consensus       184 ~~~~~~kL~Dfg~~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~  246 (320)
T 3a99_A          184 LNRGELKLIDFGSGALLKDTV--------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD  246 (320)
T ss_dssp             TTTTEEEECCCTTCEECCSSC--------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEeeCcccccccccc--------------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC
Confidence             67899999999987542111              0123588999999973          9999999999999885

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.90  E-value=5.6e-25  Score=153.11  Aligned_cols=133  Identities=25%  Similarity=0.340  Sum_probs=108.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-|+++++..+.... +..++||||+++++|.+++.... ..+++..+..++.|++.|+.++|+++  ++|+|++|+||+
T Consensus        65 l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil  141 (279)
T 1qpc_A           65 LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL  141 (279)
T ss_dssp             CCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             CCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEE
Confidence            357888888887664 56899999999999999997532 25889999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||++..........           .....+++.|+|||++         |+||+|+++++|++ |.
T Consensus       142 ~~~~~~~kl~Dfg~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~  208 (279)
T 1qpc_A          142 VSDTLSCKIADFGLARLIEDNEYTA-----------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR  208 (279)
T ss_dssp             ECTTSCEEECCCTTCEECSSSCEEC-----------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTC
T ss_pred             EcCCCCEEECCCcccccccCccccc-----------ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCC
Confidence            9999999999999987543211100           0123467789999984         99999999999987 64

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.89  E-value=1.4e-24  Score=153.38  Aligned_cols=135  Identities=17%  Similarity=0.198  Sum_probs=103.4

Q ss_pred             ccchhhhcccCCCCCce-----EEEEEEeccCCCCHHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q psy1934           3 YLSAAFIDKHSTPHGMH-----EYLILTELCTGGSLVDVLKER-----TSALPPNIVCSILWQTCQAVKHMHGQNPPIVH   72 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h   72 (150)
                      +-||+|+++.++....+     ..+++|||+++++|.+++...     ...+++..+..++.+++.|+.|+|+++  ++|
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH  170 (313)
T 3brb_A           93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLH  170 (313)
T ss_dssp             CCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCC
T ss_pred             CCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence            45788998887655443     459999999999999999532     245889999999999999999999998  999


Q ss_pred             ecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEE
Q psy1934          73 RDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGR  143 (150)
Q Consensus        73 ~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~  143 (150)
                      +|++|+||+++.++.++++|||++........          ........+++.|+|||++         |+||+|++++
T Consensus       171 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  240 (313)
T 3brb_A          171 RDLAARNCMLRDDMTVCVADFGLSKKIYSGDY----------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW  240 (313)
T ss_dssp             CCCSGGGEEECTTSCEEECSCSCC--------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred             CCCCcceEEEcCCCcEEEeecCcceecccccc----------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHH
Confidence            99999999999999999999999864321110          0111233567889999985         9999999999


Q ss_pred             Eeee-ec
Q psy1934         144 SMLY-GH  149 (150)
Q Consensus       144 ~~~~-g~  149 (150)
                      +|++ |.
T Consensus       241 el~~~g~  247 (313)
T 3brb_A          241 EIATRGM  247 (313)
T ss_dssp             HHHTTSC
T ss_pred             HHHhcCC
Confidence            9998 54

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.89  E-value=3.4e-25  Score=160.23  Aligned_cols=127  Identities=28%  Similarity=0.428  Sum_probs=95.9

Q ss_pred             ccchhhhcccCCCCCc------eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGM------HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-|++|+++.+.+...      +.+++++|++ +++|.++++.  ..+++..+..++.|++.|+.|+|+.+  ++|+|++
T Consensus        85 l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlk  159 (367)
T 2fst_X           85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLK  159 (367)
T ss_dssp             CCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCC
T ss_pred             CCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCC
Confidence            3478888888765433      6789999999 6799998875  46899999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.++++|||+++....               ......+|+.|+|||++          |+||+|+++++|+
T Consensus       160 p~NIll~~~~~~kL~DFG~a~~~~~---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  224 (367)
T 2fst_X          160 PSNLAVNEDCELKILDFGLARHTAD---------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  224 (367)
T ss_dssp             GGGEEECTTCCEEECC------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHH
T ss_pred             HhhEEECCCCCEEEeeccccccccc---------------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999999999999864211               11234689999999973          9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       225 ~g~  227 (367)
T 2fst_X          225 TGR  227 (367)
T ss_dssp             HSS
T ss_pred             hCC
Confidence            885

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.89  E-value=5.4e-25  Score=153.21  Aligned_cols=130  Identities=27%  Similarity=0.416  Sum_probs=103.0

Q ss_pred             ccchhhhcccCC-CCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           3 YLSAAFIDKHST-PHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         3 ~~~~~~~~~~~~-~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      +-||++++..+. .+..+.+++||||+++++|.+++.... ..+++..+..++.+++.|+.++|+++  ++|+|++|+||
T Consensus        71 l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Ni  148 (278)
T 1byg_A           71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNV  148 (278)
T ss_dssp             CCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             CCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceE
Confidence            457889998886 445567899999999999999997643 23788889999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +++.++.++++|||++......               .....+++.|+|||++         |+||+|+++++|++ |.
T Consensus       149 l~~~~~~~~l~Dfg~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~  212 (278)
T 1byg_A          149 LVSEDNVAKVSDFGLTKEASST---------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR  212 (278)
T ss_dssp             EECTTSCEEECCCCC---------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             EEeCCCcEEEeecccccccccc---------------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCC
Confidence            9999999999999987642111               0122467889999984         99999999999986 64

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.89  E-value=1.1e-24  Score=153.90  Aligned_cols=129  Identities=26%  Similarity=0.366  Sum_probs=107.5

Q ss_pred             cchhhhcccCCCCCceEEEEEEec-cCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTEL-CTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      -|++|+++.+++...+.+++|+|+ +++++|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|+|++++||++
T Consensus        96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~  172 (312)
T 2iwi_A           96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILI  172 (312)
T ss_dssp             CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEE
T ss_pred             CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEE
Confidence            489999999999999999999999 7889999999875 46899999999999999999999998  9999999999999


Q ss_pred             c-CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 S-SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      + .++.++++|||++.......              .....|++.|+|||++          |+||+|++++++++|.
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  236 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEP--------------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD  236 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSC--------------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred             eCCCCeEEEEEcchhhhcccCc--------------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCC
Confidence            8 78899999999987542211              0134588999999973          9999999999999885

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.89  E-value=2.1e-24  Score=151.83  Aligned_cols=134  Identities=22%  Similarity=0.359  Sum_probs=107.2

Q ss_pred             ccchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           3 YLSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         3 ~~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      +-|++|+++.+..  +..+.+++||||++++ +.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+|
T Consensus        63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~N  139 (305)
T 2wtk_C           63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGN  139 (305)
T ss_dssp             CCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred             cCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCccc
Confidence            4578899988876  5667899999999875 777776532 46889999999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeee
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g  148 (150)
                      |+++.++.++++|||++..........          ......|++.|+|||++           |+||+|+++++|++|
T Consensus       140 Il~~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  209 (305)
T 2wtk_C          140 LLLTTGGTLKISALGVAEALHPFAADD----------TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG  209 (305)
T ss_dssp             EEECTTCCEEECCCTTCEECCTTCSSC----------EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHS
T ss_pred             EEEcCCCcEEeeccccccccCcccccc----------ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhC
Confidence            999999999999999987542211110          01134588999999973           999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       210 ~  210 (305)
T 2wtk_C          210 L  210 (305)
T ss_dssp             S
T ss_pred             C
Confidence            5

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.89  E-value=2.1e-24  Score=154.69  Aligned_cols=140  Identities=30%  Similarity=0.445  Sum_probs=107.1

Q ss_pred             ccchhhhcccCCCC-----CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPH-----GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-|++|+++.+...     ..+..+++|||+++ +|.+++..  ..+++..+..++.|++.|+.|+|+++  ++|+|++|
T Consensus        66 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp  140 (353)
T 2b9h_A           66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKP  140 (353)
T ss_dssp             CCCTTBCCEEEECCCSCSTTCCCEEEEECCCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred             CcCCCcCCeeeeecccccCccceEEEEEeccCc-cHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            34788888776444     34789999999975 99999876  46899999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLY  147 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~  147 (150)
                      +||+++.++.++++|||++............  ............||+.|+|||++          |+||+|+++++|++
T Consensus       141 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  218 (353)
T 2b9h_A          141 SNLLINSNCDLKVCDFGLARIIDESAADNSE--PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL  218 (353)
T ss_dssp             GGEEECTTCCEEECCCTTCEECC------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHeEEcCCCcEEEEecccccccccccccccC--ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHh
Confidence            9999999999999999998754322111000  00000112234689999999973          99999999999998


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       219 g~  220 (353)
T 2b9h_A          219 RR  220 (353)
T ss_dssp             SS
T ss_pred             CC
Confidence            85

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.89  E-value=2.2e-24  Score=154.31  Aligned_cols=124  Identities=28%  Similarity=0.396  Sum_probs=103.2

Q ss_pred             hhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE----
Q psy1934           8 FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI----   82 (150)
Q Consensus         8 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~----   82 (150)
                      ++...+.++..+.+++||||+ ++++.+.+.... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||++    
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~  160 (355)
T 2eu9_A           84 CVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSE  160 (355)
T ss_dssp             BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCC
T ss_pred             EEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccc
Confidence            556666677778999999999 557888776543 46899999999999999999999998  9999999999999    


Q ss_pred             ---------------cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccccc
Q psy1934          83 ---------------SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNN  138 (150)
Q Consensus        83 ---------------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~  138 (150)
                                     +..+.++++|||++......               .....||+.|+|||++         |+||+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  225 (355)
T 2eu9_A          161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---------------HTTIVATRHYRPPEVILELGWAQPCDVWSI  225 (355)
T ss_dssp             EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             ccccccccccccccccCCCcEEEeecCcccccccc---------------ccCCcCCCcccCCeeeecCCCCCccchHHH
Confidence                           56788999999998743211               1134689999999984         99999


Q ss_pred             ceeEEEeeeec
Q psy1934         139 YVIGRSMLYGH  149 (150)
Q Consensus       139 g~~~~~~~~g~  149 (150)
                      |+++++|++|.
T Consensus       226 G~il~el~~g~  236 (355)
T 2eu9_A          226 GCILFEYYRGF  236 (355)
T ss_dssp             HHHHHHHHHSS
T ss_pred             HHHHHHHHhCC
Confidence            99999999885

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.89  E-value=5.6e-25  Score=157.40  Aligned_cols=131  Identities=24%  Similarity=0.357  Sum_probs=112.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHH------HHhh-CCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEec
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDV------LKER-TSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRD   74 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~   74 (150)
                      +-||++++..+++...+.+++||||+++++|.++      +... ...+++..+..++.|++.|+.|+|+ ++  ++|+|
T Consensus       100 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~d  177 (348)
T 2pml_X          100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRD  177 (348)
T ss_dssp             CCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCC
T ss_pred             CCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecC
Confidence            4588999999999999999999999999999998      5542 3568999999999999999999998 88  99999


Q ss_pred             CCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEE
Q psy1934          75 LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGR  143 (150)
Q Consensus        75 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~  143 (150)
                      ++|+||+++.++.++++|||.+......              ......+++.|+|||++           |+||+|++++
T Consensus       178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~  243 (348)
T 2pml_X          178 VKPSNILMDKNGRVKLSDFGESEYMVDK--------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY  243 (348)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECBTT--------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred             CChHhEEEcCCCcEEEeccccccccccc--------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence            9999999999999999999998753211              01134688999999974           9999999999


Q ss_pred             Eeeeec
Q psy1934         144 SMLYGH  149 (150)
Q Consensus       144 ~~~~g~  149 (150)
                      +|++|.
T Consensus       244 ~l~~g~  249 (348)
T 2pml_X          244 VMFYNV  249 (348)
T ss_dssp             HHHHSS
T ss_pred             HHHhCC
Confidence            999885

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.89  E-value=1.6e-24  Score=156.19  Aligned_cols=127  Identities=23%  Similarity=0.331  Sum_probs=105.5

Q ss_pred             chhhhcccCCCCCce----EEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCC
Q psy1934           5 SAAFIDKHSTPHGMH----EYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIE   78 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~   78 (150)
                      |++|+++.+.+...+    .++++|||+ +++|.+++.... ..+++..+..++.|++.|+.|+|++ +  ++|+|++|+
T Consensus        85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~  161 (373)
T 1q8y_A           85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPE  161 (373)
T ss_dssp             HTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGG
T ss_pred             cchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChH
Confidence            577888888766544    899999999 789999998643 4589999999999999999999998 8  999999999


Q ss_pred             CEEEcC------CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEE
Q psy1934          79 NLLISS------AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGR  143 (150)
Q Consensus        79 nil~~~------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~  143 (150)
                      ||+++.      .+.++++|||++......               .....+|+.|+|||++         |+||+|++++
T Consensus       162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~  226 (373)
T 1q8y_A          162 NVLMEIVDSPENLIQIKIADLGNACWYDEH---------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF  226 (373)
T ss_dssp             GEEEEEEETTTTEEEEEECCCTTCEETTBC---------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHH
T ss_pred             HeEEeccCCCcCcceEEEcccccccccCCC---------------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHH
Confidence            999943      347999999998753211               1133689999999984         9999999999


Q ss_pred             Eeeeec
Q psy1934         144 SMLYGH  149 (150)
Q Consensus       144 ~~~~g~  149 (150)
                      +|++|.
T Consensus       227 el~~g~  232 (373)
T 1q8y_A          227 ELITGD  232 (373)
T ss_dssp             HHHHSS
T ss_pred             HHHhCC
Confidence            999885

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.89  E-value=1.1e-24  Score=168.31  Aligned_cols=125  Identities=22%  Similarity=0.271  Sum_probs=103.8

Q ss_pred             ccchhhhcccCCCCCceE-----EEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHE-----YLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~-----~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-||+|+++.+++...+.     .|+||||++|++|.+++..   .+++..+..++.|++.|+.|+|+++  ++|+|+||
T Consensus       136 l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp  210 (681)
T 2pzi_A          136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKP  210 (681)
T ss_dssp             CCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             cCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCh
Confidence            458899998887665544     7999999999999987754   6899999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeeec
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g~  149 (150)
                      +||+++.+ .+|++|||++......                ....||+.|+|||++        |+||+|+++++|++|.
T Consensus       211 ~NIll~~~-~~kl~DFG~a~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~  273 (681)
T 2pzi_A          211 ENIMLTEE-QLKLIDLGAVSRINSF----------------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDL  273 (681)
T ss_dssp             GGEEECSS-CEEECCCTTCEETTCC----------------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCC
T ss_pred             HHeEEeCC-cEEEEecccchhcccC----------------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCC
Confidence            99999875 8999999998753211                134689999999984        9999999999998774

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.89  E-value=3.1e-24  Score=154.15  Aligned_cols=130  Identities=30%  Similarity=0.477  Sum_probs=103.1

Q ss_pred             cchhhhcccCCCCC-------ceEEEEEEeccCCCCHHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCeE
Q psy1934           4 LSAAFIDKHSTPHG-------MHEYLILTELCTGGSLVDVLKE---RTSALPPNIVCSILWQTCQAVKHMH--GQNPPIV   71 (150)
Q Consensus         4 ~~~~~~~~~~~~~~-------~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~~~~~i~~~l~~lh--~~~~~i~   71 (150)
                      -||+|+++.+++..       ...+++||||+++ ++.+.+..   ....+++..+..++.+++.|+.|+|  +.+  ++
T Consensus        77 ~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--iv  153 (360)
T 3e3p_A           77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VC  153 (360)
T ss_dssp             CCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CB
T ss_pred             CCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--ee
Confidence            47888888776533       3348999999987 66655543   2356888888999999999999999  877  99


Q ss_pred             EecCCCCCEEEcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccce
Q psy1934          72 HRDLKIENLLISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYV  140 (150)
Q Consensus        72 h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~  140 (150)
                      |+|++|+||+++. ++.++++|||++........             .....||+.|+|||++          |+||+|+
T Consensus       154 H~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~  220 (360)
T 3e3p_A          154 HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP-------------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGC  220 (360)
T ss_dssp             CSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC-------------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             cCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC-------------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHH
Confidence            9999999999987 79999999999875422111             1133578999999974          9999999


Q ss_pred             eEEEeeeec
Q psy1934         141 IGRSMLYGH  149 (150)
Q Consensus       141 ~~~~~~~g~  149 (150)
                      ++++|++|.
T Consensus       221 il~ell~g~  229 (360)
T 3e3p_A          221 IFAEMMLGE  229 (360)
T ss_dssp             HHHHHHHSS
T ss_pred             HHHHHHhCC
Confidence            999999885

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.88  E-value=2.5e-24  Score=152.16  Aligned_cols=130  Identities=23%  Similarity=0.350  Sum_probs=104.9

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCCCEEE
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKIENLLI   82 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~~nil~   82 (150)
                      -|++|+++.+++...+.+++||||+ ++.+..+.......+++..+..++.+++.|+.|+|+. +  ++|+|++|+||++
T Consensus        82 ~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~  158 (318)
T 2dyl_A           82 DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILL  158 (318)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEE
T ss_pred             CCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEE
Confidence            4788999999998899999999999 5577777665556799999999999999999999985 8  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g  148 (150)
                      +.++.++++|||++.......             ......+++.|+|||++              |+||+|+++++|++|
T Consensus       159 ~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  225 (318)
T 2dyl_A          159 DERGQIKLCDFGISGRLVDDK-------------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG  225 (318)
T ss_dssp             CTTSCEEECCCTTC---------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCCCEEEEECCCchhccCCc-------------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhC
Confidence            999999999999886432110             01133588999999985              999999999999988


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       226 ~  226 (318)
T 2dyl_A          226 Q  226 (318)
T ss_dssp             S
T ss_pred             C
Confidence            5

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.88  E-value=1.2e-24  Score=151.38  Aligned_cols=135  Identities=25%  Similarity=0.333  Sum_probs=107.7

Q ss_pred             ccchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHhcCC---CCeEEec
Q psy1934           3 YLSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKERT---SALPPNIVCSILWQTCQAVKHMHGQN---PPIVHRD   74 (150)
Q Consensus         3 ~~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---~~i~h~~   74 (150)
                      +-||+|+++.+..  +..+.+++||||+++++|.+++....   ..+++..+..++.|++.|+.++|+.+   .+++|+|
T Consensus        62 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~d  141 (279)
T 2w5a_A           62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD  141 (279)
T ss_dssp             CCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCC
T ss_pred             cCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEec
Confidence            3478899988755  55678999999999999999997532   34899999999999999999999865   2399999


Q ss_pred             CCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEe
Q psy1934          75 LKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSM  145 (150)
Q Consensus        75 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~  145 (150)
                      ++|+||+++.++.++++|||++.......            .......+++.|+|||++         |+||+|+++++|
T Consensus       142 l~p~NIl~~~~~~~kl~dfg~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  209 (279)
T 2w5a_A          142 LKPANVFLDGKQNVKLGDFGLARILNHDT------------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL  209 (279)
T ss_dssp             CSGGGEEECSSSCEEECCCCHHHHC---C------------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHH
T ss_pred             cchhhEEEcCCCCEEEecCchheeecccc------------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHH
Confidence            99999999999999999999886432110            001123588999999984         999999999999


Q ss_pred             eeec
Q psy1934         146 LYGH  149 (150)
Q Consensus       146 ~~g~  149 (150)
                      ++|.
T Consensus       210 ~~g~  213 (279)
T 2w5a_A          210 CALM  213 (279)
T ss_dssp             HHSS
T ss_pred             HHCC
Confidence            9875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.88  E-value=2.1e-24  Score=159.06  Aligned_cols=135  Identities=24%  Similarity=0.305  Sum_probs=100.1

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSA------LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~------l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      -||+|+++.+..+..+.+++||||++ |+|.+++......      .++..+..++.|++.|+.|+|+++  ++|+|++|
T Consensus        67 ~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp  143 (434)
T 2rio_A           67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKP  143 (434)
T ss_dssp             TSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             CCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCCh
Confidence            38999999999999999999999996 5999999764211      122234678999999999999999  99999999


Q ss_pred             CCEEEcCC-------------CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCccc------------
Q psy1934          78 ENLLISSA-------------GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------------  132 (150)
Q Consensus        78 ~nil~~~~-------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~------------  132 (150)
                      +||+++..             ..++++|||++..........        ........||+.|+|||+            
T Consensus       144 ~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  215 (434)
T 2rio_A          144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF--------RTNLNNPSGTSGWRAPELLEESNNLQTKRR  215 (434)
T ss_dssp             GGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC----------------------CCTTSCHHHHSCCCTTSCCCC
T ss_pred             HhEEEecCcccccccccCCCceEEEEcccccceecCCCCccc--------eeeecCCCCCCCccCHHHhccccccccccC
Confidence            99999654             479999999987543211100        001123468999999996            


Q ss_pred             ----ccccccceeEEEeee-ec
Q psy1934         133 ----VDTWNNYVIGRSMLY-GH  149 (150)
Q Consensus       133 ----~d~~~~g~~~~~~~~-g~  149 (150)
                          .|+||+|+++++|++ |.
T Consensus       216 ~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          216 LTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cchhhhhHhHHHHHHHHHhCCC
Confidence                399999999999997 64

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.88  E-value=2.5e-24  Score=153.04  Aligned_cols=131  Identities=26%  Similarity=0.379  Sum_probs=97.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKE----RTSALPPNIVCSILWQTCQAVKHMHGQ-NPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~i~h~~l~~   77 (150)
                      .-||+|+++.+.+...+..++||||+++ +|.+++..    ....+++..+..++.+++.|+.|+|+. +  ++|+|++|
T Consensus        78 ~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp  154 (327)
T 3aln_A           78 SDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKP  154 (327)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCG
T ss_pred             CCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCH
Confidence            3478999999988888999999999986 88887763    135688999999999999999999998 8  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-------------cccccceeEEE
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-------------DTWNNYVIGRS  144 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------d~~~~g~~~~~  144 (150)
                      +||+++.++.++++|||++.......             ......|++.|+|||++             |+||+|+++++
T Consensus       155 ~NIll~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~  221 (327)
T 3aln_A          155 SNILLDRSGNIKLCDFGISGQLVDSI-------------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE  221 (327)
T ss_dssp             GGEEEETTTEEEECCCSSSCC-------------------------------------------CCSHHHHHHHHHHHHH
T ss_pred             HHEEEcCCCCEEEccCCCceeccccc-------------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHH
Confidence            99999999999999999986432110             01123588999999985             99999999999


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      |++|.
T Consensus       222 l~~g~  226 (327)
T 3aln_A          222 LATGR  226 (327)
T ss_dssp             HHHSC
T ss_pred             HHHCC
Confidence            99885

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.88  E-value=1.2e-23  Score=161.34  Aligned_cols=132  Identities=26%  Similarity=0.383  Sum_probs=109.2

Q ss_pred             ccchhhhcccCCCCC------ceEEEEEEeccCCCCHHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEec
Q psy1934           3 YLSAAFIDKHSTPHG------MHEYLILTELCTGGSLVDVLKERT--SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRD   74 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~   74 (150)
                      +-||+|+++.+....      .+..++||||+++|+|.+++....  ..+++..+..++.+++.|+.|+|+.+  ++|+|
T Consensus        69 L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrD  146 (676)
T 3qa8_A           69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRD  146 (676)
T ss_dssp             CCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCC
T ss_pred             CCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCC
Confidence            347888888776554      778899999999999999998643  25888899999999999999999999  99999


Q ss_pred             CCCCCEEEcCCCc---EEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeE
Q psy1934          75 LKIENLLISSAGT---VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIG  142 (150)
Q Consensus        75 l~~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~  142 (150)
                      ++|+||+++.++.   ++++|||++........             .....|++.|+|||++         |+||+|+++
T Consensus       147 LKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~-------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviL  213 (676)
T 3qa8_A          147 LKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-------------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA  213 (676)
T ss_dssp             CCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC-------------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHH
T ss_pred             CCHHHeEeecCCCceeEEEcccccccccccccc-------------cccccCCcccCChHHhccCCCCchhHHHHHHHHH
Confidence            9999999986654   89999999875422111             0134689999999985         999999999


Q ss_pred             EEeeeec
Q psy1934         143 RSMLYGH  149 (150)
Q Consensus       143 ~~~~~g~  149 (150)
                      +++++|.
T Consensus       214 yeLltG~  220 (676)
T 3qa8_A          214 FECITGF  220 (676)
T ss_dssp             HHHHSSC
T ss_pred             HHHHHCC
Confidence            9999885

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.88  E-value=3.7e-24  Score=154.85  Aligned_cols=126  Identities=24%  Similarity=0.361  Sum_probs=103.9

Q ss_pred             ccchhhhcccCCCCCceEE------EEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGMHEY------LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~------~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||+|+++.+++...+..      ++||||+++ +|.+.+.   ..+++..+..++.|++.|+.|+|+++  ++|+|++
T Consensus        98 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dik  171 (371)
T 4exu_A           98 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLK  171 (371)
T ss_dssp             CCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCE-EHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             cCCCCchhhhhheeccCCcccceeEEEEEccccc-cHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcC
Confidence            3478899988877766554      999999974 8888774   35899999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.++++|||++.....               ......+|+.|+|||++          |+||+|+++++|+
T Consensus       172 p~NIll~~~~~~kL~Dfg~a~~~~~---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  236 (371)
T 4exu_A          172 PGNLAVNEDCELKILDFGLARHADA---------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML  236 (371)
T ss_dssp             GGGEEECTTCCEEECSTTCC-----------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred             HHHeEECCCCCEEEEecCccccccc---------------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHH
Confidence            9999999999999999999864311               11234689999999974          9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       237 ~g~  239 (371)
T 4exu_A          237 TGK  239 (371)
T ss_dssp             HSS
T ss_pred             hCC
Confidence            885

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.88  E-value=6.7e-24  Score=149.89  Aligned_cols=133  Identities=25%  Similarity=0.350  Sum_probs=104.2

Q ss_pred             ccchhhhcccCCC--------------CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy1934           3 YLSAAFIDKHSTP--------------HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNP   68 (150)
Q Consensus         3 ~~~~~~~~~~~~~--------------~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~   68 (150)
                      +-||++++..+..              ...+.+++||||++ |+|.++++.  ..+++..+..++.|++.|+.|+|+++ 
T Consensus        65 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-  140 (320)
T 2i6l_A           65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN-  140 (320)
T ss_dssp             CCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             cCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC-
Confidence            3477888775533              45678999999998 499999965  46889999999999999999999999 


Q ss_pred             CeEEecCCCCCEEEcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccc
Q psy1934          69 PIVHRDLKIENLLISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWN  137 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~  137 (150)
                       ++|+|++|+||+++. ++.++++|||++.........         ........+++.|+|||++          |+||
T Consensus       141 -i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s  210 (320)
T 2i6l_A          141 -VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH---------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA  210 (320)
T ss_dssp             -CBCCCCSGGGEEEETTTTEEEECCCTTCBCC-----------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHH
T ss_pred             -EecCCCCHHHEEEcCCCCeEEEccCccccccCCCccc---------ccccccccccccccCcHHhcCcccCCchhhhHh
Confidence             999999999999974 578999999998753211000         0011123578899999974          9999


Q ss_pred             cceeEEEeeeec
Q psy1934         138 NYVIGRSMLYGH  149 (150)
Q Consensus       138 ~g~~~~~~~~g~  149 (150)
                      +|+++++|++|.
T Consensus       211 lG~il~el~~g~  222 (320)
T 2i6l_A          211 AGCIFAEMLTGK  222 (320)
T ss_dssp             HHHHHHHHHHSS
T ss_pred             HHHHHHHHHhCC
Confidence            999999999885

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.88  E-value=3.9e-24  Score=149.55  Aligned_cols=131  Identities=32%  Similarity=0.453  Sum_probs=109.1

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.....+.+++|+||+++++|.+.+... ..+++..+..++.+++.|+.++|+++  ++|+|++|+||++
T Consensus        78 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv  154 (287)
T 2wei_A           78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILL  154 (287)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             ccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEE
Confidence            45788999999888899999999999999999988764 46899999999999999999999999  9999999999999


Q ss_pred             cCC---CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeeec
Q psy1934          83 SSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g~  149 (150)
                      +..   ..++++|||++..........             ...+++.|+|||++        |+||+|+++++|++|.
T Consensus       155 ~~~~~~~~~kL~Dfg~~~~~~~~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~  219 (287)
T 2wei_A          155 ESKEKDCDIKIIDFGLSTCFQQNTKMK-------------DRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGT  219 (287)
T ss_dssp             SCSSTTCCEEECSTTGGGTBCCCSSCS-------------CHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCcccEEEeccCcceeecCCCccc-------------cccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCC
Confidence            654   469999999886432211100             11356789999984        9999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.87  E-value=1.1e-23  Score=148.98  Aligned_cols=130  Identities=29%  Similarity=0.347  Sum_probs=104.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      +++++++.+.....+.++++|| +.+++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+||+++ 
T Consensus        87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-  161 (313)
T 3cek_A           87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-  161 (313)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-
T ss_pred             CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE-
Confidence            4789999988888899999999 5577999999864 46888899999999999999999999  99999999999996 


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------------cccccceeEEE
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------------DTWNNYVIGRS  144 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------------d~~~~g~~~~~  144 (150)
                      ++.++++|||++.........          .......|++.|+|||++                    |+||+|+++++
T Consensus       162 ~~~~kL~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~e  231 (313)
T 3cek_A          162 DGMLKLIDFGIANQMQPDTTS----------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY  231 (313)
T ss_dssp             TTEEEECCCSSSCC------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHH
T ss_pred             CCeEEEeeccccccccCcccc----------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHH
Confidence            488999999998743211110          011234689999999973                    99999999999


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      |++|.
T Consensus       232 l~~g~  236 (313)
T 3cek_A          232 MTYGK  236 (313)
T ss_dssp             HHHSS
T ss_pred             HHhCC
Confidence            99885

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.86  E-value=6.8e-24  Score=152.32  Aligned_cols=126  Identities=24%  Similarity=0.378  Sum_probs=103.1

Q ss_pred             ccchhhhcccCCCCCce------EEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGMH------EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||+|+++.+.+...+      .+++||||+++ +|.+++.   ..+++..+..++.|++.|+.|+|+++  ++|+|++
T Consensus        80 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlk  153 (353)
T 3coi_A           80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLK  153 (353)
T ss_dssp             CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSE-EGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCC
T ss_pred             cCCCCcccHhheEecccccccceeEEEEeccccC-CHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCC
Confidence            34788999888776554      35999999975 8877664   35899999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.++++|||++.....               ......+|+.|+|||++          |+||+|+++++|+
T Consensus       154 p~NIl~~~~~~~kl~Dfg~~~~~~~---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~  218 (353)
T 3coi_A          154 PGNLAVNEDCELKILDFGLARHADA---------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML  218 (353)
T ss_dssp             GGGEEECTTCCEEECSTTCTTC-----------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred             HHHEeECCCCcEEEeecccccCCCC---------------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHH
Confidence            9999999999999999998864211               01234689999999973          9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       219 ~g~  221 (353)
T 3coi_A          219 TGK  221 (353)
T ss_dssp             HSS
T ss_pred             hCC
Confidence            885

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.86  E-value=9.9e-23  Score=143.28  Aligned_cols=119  Identities=30%  Similarity=0.402  Sum_probs=99.9

Q ss_pred             cchhhhcccCCCCC----ceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           4 LSAAFIDKHSTPHG----MHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         4 ~~~~~~~~~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      -||+|+++.+.+..    .+.+++||||+++|+|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|+|++|+
T Consensus        69 ~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~  146 (299)
T 3m2w_A           69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPE  146 (299)
T ss_dssp             TSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             cCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHH
Confidence            36888888877665    788999999999999999998753 36899999999999999999999999  999999999


Q ss_pred             CEEEcC---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccccccccceeEEEeeeec
Q psy1934          79 NLLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        79 nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~d~~~~g~~~~~~~~g~  149 (150)
                      ||+++.   ++.++++|||++.....                       ..|  ....|+||+|+++++|++|.
T Consensus       147 Nil~~~~~~~~~~kl~Dfg~a~~~~~-----------------------~~~--~~~~DiwslG~il~el~tg~  195 (299)
T 3m2w_A          147 NLLYTSKRPNAILKLTDFGFAKETTG-----------------------EKY--DKSCDMWSLGVIMYILLCGY  195 (299)
T ss_dssp             GEEESSSSTTCCEEECCCTTCEECTT-----------------------CGG--GGHHHHHHHHHHHHHHHHSS
T ss_pred             HEEEecCCCCCcEEEecccccccccc-----------------------ccC--CchhhHHHHHHHHHHHHHCC
Confidence            999998   78899999999864311                       001  11259999999999999885

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.84  E-value=2.2e-22  Score=147.47  Aligned_cols=111  Identities=16%  Similarity=0.178  Sum_probs=91.1

Q ss_pred             EEEEEEeccCCCCHHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeec
Q psy1934          20 EYLILTELCTGGSLVDVLKER------TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDF   93 (150)
Q Consensus        20 ~~~lv~E~~~~g~L~~~l~~~------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~df   93 (150)
                      .++++|+.+ +++|.++++..      ...+++..+..++.|++.|+.|+|+++  ++|||+||+||+++.++.+|++||
T Consensus       179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~~~~~~kL~DF  255 (413)
T 3dzo_A          179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGF  255 (413)
T ss_dssp             SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCG
T ss_pred             ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEecCCeEEEEec
Confidence            467888876 56999988521      233667778888899999999999999  999999999999999999999999


Q ss_pred             CceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-------------------cccccceeEEEeeeec
Q psy1934          94 GSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-------------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        94 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------------------d~~~~g~~~~~~~~g~  149 (150)
                      |+++.....               .....| +.|+|||++                   |+||+|+++++|++|.
T Consensus       256 G~a~~~~~~---------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~  314 (413)
T 3dzo_A          256 EHLVRDGAS---------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD  314 (413)
T ss_dssp             GGCEETTEE---------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred             cceeecCCc---------------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence            998743211               123467 899999976                   9999999999999885

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.82  E-value=1e-21  Score=137.58  Aligned_cols=113  Identities=16%  Similarity=0.075  Sum_probs=94.5

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-|++|+++.+.++..+.+|+||||++|++|.++++.   ......+..++.|++.|+.|+|+++  ++|+|+||+||+
T Consensus        87 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIl  161 (286)
T 3uqc_A           87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVR  161 (286)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEE
T ss_pred             cCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEE
Confidence            35688999999999999999999999999999999964   2455567788999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccccccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.+++.+++....                              .....|+||+|+++++|++|.
T Consensus       162 l~~~g~~kl~~~~~~~~------------------------------~~~~~Di~slG~il~elltg~  199 (286)
T 3uqc_A          162 VSIDGDVVLAYPATMPD------------------------------ANPQDDIRGIGASLYALLVNR  199 (286)
T ss_dssp             EETTSCEEECSCCCCTT------------------------------CCHHHHHHHHHHHHHHHHHSE
T ss_pred             EcCCCCEEEEeccccCC------------------------------CCchhHHHHHHHHHHHHHHCC
Confidence            99999999875542210                              012249999999999999885

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.79  E-value=1.4e-20  Score=142.14  Aligned_cols=113  Identities=15%  Similarity=0.207  Sum_probs=84.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+.........+..|+||||+++++|.++++.         +..++.|++.++.|+|+++  ++|||+||+||++
T Consensus       396 l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl  464 (540)
T 3en9_A          396 VKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIF  464 (540)
T ss_dssp             GGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEE
T ss_pred             cCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEE
Confidence            4577888443333345567999999999999999864         4467899999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV  133 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  133 (150)
                      +.  .+|++|||+++......     ..............||+.|||||++
T Consensus       465 ~~--~~kL~DFGla~~~~~~~-----~~~~~~~~~~~~~~GT~~y~APEv~  508 (540)
T 3en9_A          465 DK--DLYIIDFGLGKISNLDE-----DKAVDLIVFKKAVLSTHHEKFDEIW  508 (540)
T ss_dssp             SS--SEEECCCTTCEECCCHH-----HHHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred             CC--eEEEEECccCEECCCcc-----ccccchhhhhhhhcCCCCcCCHHHH
Confidence            98  99999999998642110     0000001112345689999999996

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.58  E-value=3.7e-16  Score=109.26  Aligned_cols=69  Identities=25%  Similarity=0.300  Sum_probs=59.9

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      +..|+||||++|++|.+ +.     .  .....++.|++.|+.++|+.+  ++|+|++|+||+++ ++.++++|||++..
T Consensus       173 ~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          173 EGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             ETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             cceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            56799999999999987 42     1  223468899999999999999  99999999999999 99999999999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.31  E-value=6e-13  Score=91.77  Aligned_cols=73  Identities=26%  Similarity=0.325  Sum_probs=59.0

Q ss_pred             eEEEEEEeccCC-C----CHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEcCCCcEEEee
Q psy1934          19 HEYLILTELCTG-G----SLVDVLKERTSALPPNIVCSILWQTCQAVKHMH-GQNPPIVHRDLKIENLLISSAGTVKLCD   92 (150)
Q Consensus        19 ~~~~lv~E~~~~-g----~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~i~h~~l~~~nil~~~~~~~~l~d   92 (150)
                      +..+|||||+.+ |    +|.+....    .++..+..++.|++.++.++| +.+  ++|+|++|.||+++.  .++++|
T Consensus       141 ~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~NILl~~--~~~liD  212 (258)
T 1zth_A          141 MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYID--KVYFID  212 (258)
T ss_dssp             ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCSTTSEEESS--SEEECC
T ss_pred             CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEcC--cEEEEE
Confidence            345899999942 3    67665432    234456678899999999999 988  999999999999988  899999


Q ss_pred             cCceecc
Q psy1934          93 FGSATEK   99 (150)
Q Consensus        93 fg~~~~~   99 (150)
                      ||++...
T Consensus       213 FG~a~~~  219 (258)
T 1zth_A          213 MGQAVTL  219 (258)
T ss_dssp             CTTCEET
T ss_pred             CcccccC
Confidence            9998754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.96  E-value=2.3e-10  Score=83.08  Aligned_cols=67  Identities=16%  Similarity=0.186  Sum_probs=53.4

Q ss_pred             EEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC----------cEEEe
Q psy1934          22 LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAG----------TVKLC   91 (150)
Q Consensus        22 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~----------~~~l~   91 (150)
                      +|||||++|++|.++..     .  +....++.|++.++.++|+++  ++|+|+||.||+++.++          .+.++
T Consensus       187 ~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iI  257 (397)
T 4gyi_A          187 TIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDAEDPSSITLTPIII  257 (397)
T ss_dssp             EEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECSSCTTSEEEEEEEC
T ss_pred             eEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCcccccccccceEEE
Confidence            69999999887754321     2  223456789999999999998  99999999999998765          37899


Q ss_pred             ecCcee
Q psy1934          92 DFGSAT   97 (150)
Q Consensus        92 dfg~~~   97 (150)
                      ||+=+-
T Consensus       258 D~~Q~V  263 (397)
T 4gyi_A          258 XFPQMV  263 (397)
T ss_dssp             CCTTCE
T ss_pred             EeCCcc
Confidence            998544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.25  E-value=6.4e-07  Score=61.31  Aligned_cols=82  Identities=12%  Similarity=0.082  Sum_probs=57.2

Q ss_pred             ccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------
Q psy1934          11 KHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQN-----------------------   67 (150)
Q Consensus        11 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----------------------   67 (150)
                      ........+..|+|||+++|.++.+.+.      +......++.++..++..+|+..                       
T Consensus        75 v~~~~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T 3tm0_A           75 VLHFERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             EEEEEEETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             EEEEEecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhc
Confidence            3334445578899999999988877531      11112245567777788888610                       


Q ss_pred             ----------------------------------CCeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          68 ----------------------------------PPIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        68 ----------------------------------~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                                                        ..++|+|+++.||+++..+...+.||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                              2389999999999997655567999997764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.95  E-value=1e-05  Score=57.85  Aligned_cols=77  Identities=21%  Similarity=0.314  Sum_probs=56.5

Q ss_pred             eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q psy1934          19 HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ--------------------------------   66 (150)
Q Consensus        19 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~--------------------------------   66 (150)
                      +..++||||++|..+.+..   ...++......+..++...+..+|+.                                
T Consensus       114 g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             SSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             CCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            4578999999987664311   12356666667777888888888852                                


Q ss_pred             ------------------------CCCeEEecCCCCCEEEcCCC--cEEEeecCceec
Q psy1934          67 ------------------------NPPIVHRDLKIENLLISSAG--TVKLCDFGSATE   98 (150)
Q Consensus        67 ------------------------~~~i~h~~l~~~nil~~~~~--~~~l~dfg~~~~   98 (150)
                                              ...++|+|+++.||+++.++  .+.+.||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    13499999999999998764  368999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.77  E-value=6.9e-06  Score=55.78  Aligned_cols=30  Identities=17%  Similarity=0.296  Sum_probs=25.5

Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceecc
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEK   99 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   99 (150)
                      ++|+|+++.||+++..+...+.||+.+...
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence            999999999999977665679999987643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.11  E-value=0.00058  Score=47.62  Aligned_cols=30  Identities=23%  Similarity=0.506  Sum_probs=25.4

Q ss_pred             CeEEecCCCCCEEEcC--CCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISS--AGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~--~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++.  .....+.||+.+..
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence            3899999999999987  45678999988764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=96.75  E-value=0.0018  Score=44.17  Aligned_cols=29  Identities=21%  Similarity=0.434  Sum_probs=25.0

Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      ++|+|+.+.|++++..+..-+.||+.+..
T Consensus       195 l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            79999999999998776667999988764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=96.45  E-value=0.011  Score=41.40  Aligned_cols=31  Identities=26%  Similarity=0.462  Sum_probs=25.0

Q ss_pred             CeEEecCCCCCEEEcC---CCc-EEEeecCceecc
Q psy1934          69 PIVHRDLKIENLLISS---AGT-VKLCDFGSATEK   99 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~---~~~-~~l~dfg~~~~~   99 (150)
                      .++|+|+.+.|++++.   .+. ..+.||+.+...
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence            3899999999999987   344 579999877643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=95.19  E-value=0.015  Score=41.26  Aligned_cols=30  Identities=17%  Similarity=0.255  Sum_probs=25.0

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++..+.+.+.||..+..
T Consensus       223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          223 VLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             EEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             eEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            499999999999998544578999988764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=93.49  E-value=0.13  Score=35.93  Aligned_cols=30  Identities=17%  Similarity=0.298  Sum_probs=26.5

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++.++.+.+.||+.+..
T Consensus       223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             ceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            499999999999998778899999998753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=89.56  E-value=0.51  Score=34.26  Aligned_cols=29  Identities=14%  Similarity=0.291  Sum_probs=25.6

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++..+ +.+.||+.+..
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            399999999999998776 89999988774

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=84.86  E-value=0.38  Score=33.38  Aligned_cols=30  Identities=27%  Similarity=0.326  Sum_probs=25.2

Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++.++...+.||+.+..
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            389999999999998766567999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=84.38  E-value=3.8  Score=27.44  Aligned_cols=60  Identities=17%  Similarity=0.288  Sum_probs=44.0

Q ss_pred             CHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEee
Q psy1934          32 SLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCD   92 (150)
Q Consensus        32 ~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~d   92 (150)
                      +|.+.|+....++++.+++.++.|.+.++.-.-.+.. -..+=..+..+++..+|.+...+
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~   93 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP   93 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc
Confidence            7999999888999999999999999888776622110 11223446788888888887653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=81.67  E-value=0.72  Score=32.21  Aligned_cols=30  Identities=37%  Similarity=0.490  Sum_probs=25.8

Q ss_pred             CeEEecCCCCCEEEcCC----CcEEEeecCceec
Q psy1934          69 PIVHRDLKIENLLISSA----GTVKLCDFGSATE   98 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~----~~~~l~dfg~~~~   98 (150)
                      .++|+|+.+.|++++.+    +.+.+.||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            49999999999999764    6789999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	150
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-22
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-21
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-21
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-20
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-20
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-20
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-20
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-19
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-19
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-18
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-18
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-18
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-18
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-17
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-16
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-16
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-16
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-16
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-15
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-15
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-15
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-15
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-14
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-14
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-14
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-14
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-14
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-14
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-14
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-13
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-13
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-13
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-13
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-13
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-13
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-13
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-13
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-13
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-12
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-12
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-12
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-12
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-12
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-12
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-12
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-12
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-12
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-12
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-12
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-11
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-11
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-11
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-11
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-11
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-10
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-10
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-10
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-09
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-09
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-08
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-08
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-07
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-07

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.4 bits (216), Expect = 2e-22
 Identities = 40/147 (27%), Positives = 63/147 (42%), Gaps = 24/147 (16%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
            ST  G    +++TEL T G+L   LK     +   ++ S   Q  + ++ +H + PPI+
Sbjct: 78  ESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPII 136

Query: 72  HRDLKIENLLISSA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP 130
           HRDLK +N+ I+   G+VK+ D G A   +     A +               TP + AP
Sbjct: 137 HRDLKCDNIFITGPTGSVKIGDLGLA--TLKRASFAKAVIG------------TPEFMAP 182

Query: 131 EM--------VDTWNNYVIGRSMLYGH 149
           EM        VD +   +    M    
Sbjct: 183 EMYEEKYDESVDVYAFGMCMLEMATSE 209

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.4 bits (211), Expect = 2e-21
 Identities = 36/145 (24%), Positives = 57/145 (39%), Gaps = 28/145 (19%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           +   IL E C GG++  V+ E    L  + +  +  QT  A+ ++H     I+HRDLK  
Sbjct: 82  NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAG 139

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           N+L +  G +KL DFG + +   +     S               TP + APE+      
Sbjct: 140 NILFTLDGDIKLADFGVSAKNTRTIQRRDS------------FIGTPYWMAPEVVMCETS 187

Query: 133 --------VDTWNNYVIGRSMLYGH 149
                    D W+  +    M    
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIE 212

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.9 bits (207), Expect = 5e-21
 Identities = 31/126 (24%), Positives = 54/126 (42%), Gaps = 12/126 (9%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            +  I+T+ C G SL   L    +      +  I  QT Q + ++H ++  I+HRDLK  
Sbjct: 76  PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSN 133

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           N+ +    TVK+ DFG A   V S  +     ++           + ++ APE++   + 
Sbjct: 134 NIFLHEDLTVKIGDFGLA--TVKSRWSGSHQFEQLSG--------SILWMAPEVIRMQDK 183

Query: 139 YVIGRS 144
                 
Sbjct: 184 NPYSFQ 189

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.8 bits (204), Expect = 2e-20
 Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 16/117 (13%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            E  I  E   GGSL  VLK+    +P  I+  +     + + ++  ++  I+HRD+K  
Sbjct: 77  GEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPS 134

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDT 135
           N+L++S G +KLCDFG + + + S  N++                T  Y +PE +  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDSMANSFVG--------------TRSYMSPERLQG 177

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.2 bits (200), Expect = 4e-20
 Identities = 33/140 (23%), Positives = 54/140 (38%), Gaps = 26/140 (18%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
               ++ E    G++   L+ + S        + + +   A+ + H +   ++HRD+K E
Sbjct: 79  TRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPE 135

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           NLL+ SAG +K+ DFG +     S                     T  Y  PEM      
Sbjct: 136 NLLLGSAGELKIADFGWSVHAPSSRR--------------TTLCGTLDYLPPEMIEGRMH 181

Query: 133 ---VDTWNNYVIGRSMLYGH 149
              VD W+  V+    L G 
Sbjct: 182 DEKVDLWSLGVLCYEFLVGK 201

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 82.4 bits (203), Expect = 5e-20
 Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 26/142 (18%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           +E +++ E  +GG L D +      +    V + + Q C+ +KHMH  +  IVH D+K E
Sbjct: 99  YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPE 156

Query: 79  NLLISS--AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--- 133
           N++  +  A +VK+ DFG A     +PD           E       T  + APE+V   
Sbjct: 157 NIMCETKKASSVKIIDFGLA--TKLNPD-----------EIVKVTTATAEFAAPEIVDRE 203

Query: 134 ------DTWNNYVIGRSMLYGH 149
                 D W   V+G  +L G 
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGL 225

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.8 bits (199), Expect = 7e-20
 Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 23/138 (16%)

Query: 4   LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTS---ALPPNIVCSILWQTCQAV 60
                ID+ +T        I+ E C GG L  V+ + T     L    V  ++ Q   A+
Sbjct: 68  YYDRIIDRTNTT-----LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 61  KHMHGQN---PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLED 117
           K  H ++     ++HRDLK  N+ +     VKL DFG A  ++ + D +++         
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA--RILNHDTSFA--------- 171

Query: 118 EMARFTTPMYRAPEMVDT 135
             A   TP Y +PE ++ 
Sbjct: 172 -KAFVGTPYYMSPEQMNR 188

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 80.5 bits (198), Expect = 2e-19
 Identities = 33/142 (23%), Positives = 59/142 (41%), Gaps = 26/142 (18%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           +E +++ E  +GG L + + +  + +  +     + Q C+ + HMH  N   VH DLK E
Sbjct: 96  NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPE 153

Query: 79  NLLISS--AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---- 132
           N++ ++  +  +KL DFG        P  +                 T  + APE+    
Sbjct: 154 NIMFTTKRSNELKLIDFGLT--AHLDPKQSVKVTTG-----------TAEFAAPEVAEGK 200

Query: 133 -----VDTWNNYVIGRSMLYGH 149
                 D W+  V+   +L G 
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGL 222

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 80.0 bits (197), Expect = 2e-19
 Identities = 29/120 (24%), Positives = 53/120 (44%), Gaps = 19/120 (15%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           H   ++ E C G +   +   +   L    + ++     Q + ++H  N  ++HRD+K  
Sbjct: 88  HTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAG 144

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           N+L+S  G VKL DFGSA+                ++    +   TP + APE++   + 
Sbjct: 145 NILLSEPGLVKLGDFGSAS----------------IMAPANSFVGTPYWMAPEVILAMDE 188

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.4 bits (190), Expect = 1e-18
 Identities = 38/141 (26%), Positives = 57/141 (40%), Gaps = 23/141 (16%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           +   +  E C+GG L D ++     +P         Q    V ++HG    I HRD+K E
Sbjct: 76  NIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPE 132

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           NLL+     +K+ DFG AT   Y+       +             T  Y APE+      
Sbjct: 133 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG----------TLPYVAPELLKRREF 182

Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W+  ++  +ML G 
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGE 203

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.8 bits (191), Expect = 2e-18
 Identities = 37/131 (28%), Positives = 58/131 (44%), Gaps = 20/131 (15%)

Query: 8   FIDKHSTPHGMHEYL-ILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHG 65
            +D +   +   + L I+ E   GG L   +++R   A        I+    +A++++H 
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 66  QNPPIVHRDLKIENLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARF 122
            N  I HRD+K ENLL +S      +KL DFG A  K  +  N+                
Sbjct: 130 IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA--KETTSHNSL-----------TTPC 174

Query: 123 TTPMYRAPEMV 133
            TP Y APE++
Sbjct: 175 YTPYYVAPEVL 185

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 76.6 bits (188), Expect = 3e-18
 Identities = 35/136 (25%), Positives = 56/136 (41%), Gaps = 5/136 (3%)

Query: 16  HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL 75
                + ++ +L   G L D L E+ + L       I+    + +  +H  N  IVHRDL
Sbjct: 80  ETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALHKLN--IVHRDL 136

Query: 76  KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAP--EMV 133
           K EN+L+     +KL DFG + +              S L  E+   +         + V
Sbjct: 137 KPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196

Query: 134 DTWNNYVIGRSMLYGH 149
           D W+  VI  ++L G 
Sbjct: 197 DMWSTGVIMYTLLAGS 212

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.6 bits (185), Expect = 8e-18
 Identities = 37/144 (25%), Positives = 57/144 (39%), Gaps = 17/144 (11%)

Query: 8   FIDKHSTPHGMHEYL-ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ 66
           FI   +  +G    L ++++    GSL D L   T  +    +  +   T   + H+H +
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHME 119

Query: 67  ------NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
                  P I HRDLK +N+L+   GT  + D G A     + D    A    +      
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV------ 173

Query: 121 RFTTPMYRAPEMVDTWNNYVIGRS 144
              T  Y APE++D   N     S
Sbjct: 174 --GTKRYMAPEVLDDSINMKHFES 195

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.1 bits (179), Expect = 6e-17
 Identities = 25/140 (17%), Positives = 49/140 (35%), Gaps = 22/140 (15%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            +          G L+  ++ +  +           +   A++++H     I+HRDLK E
Sbjct: 81  EKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPE 137

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           N+L++    +++ DFG+A         A +                  Y +PE+      
Sbjct: 138 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT----------AQYVSPELLTEKSA 187

Query: 133 ---VDTWNNYVIGRSMLYGH 149
               D W    I   ++ G 
Sbjct: 188 CKSSDLWALGCIIYQLVAGL 207

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.7 bits (175), Expect = 2e-16
 Identities = 31/138 (22%), Positives = 55/138 (39%), Gaps = 20/138 (14%)

Query: 18  MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
               +++ E+  GG L   L  +   +P + V  +L Q    +K++  +N   VHRDL  
Sbjct: 80  AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAA 137

Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
            N+L+ +    K+ DFG +  K    D+++   + +             + APE      
Sbjct: 138 RNVLLVNRHYAKISDFGLS--KALGADDSYYTARSAGK-------WPLKWYAPECINFRK 188

Query: 133 ----VDTWNNYVIGRSML 146
                D W+  V     L
Sbjct: 189 FSSRSDVWSYGVTMWEAL 206

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.0 bits (176), Expect = 2e-16
 Identities = 32/142 (22%), Positives = 60/142 (42%), Gaps = 26/142 (18%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            E +++ E  +G  + + +      L    + S + Q C+A++ +H  N  I H D++ E
Sbjct: 74  EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPE 131

Query: 79  NLLISS--AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM---- 132
           N++  +  + T+K+ +FG A              Q    ++    FT P Y APE+    
Sbjct: 132 NIIYQTRRSSTIKIIEFGQAR-------------QLKPGDNFRLLFTAPEYYAPEVHQHD 178

Query: 133 -----VDTWNNYVIGRSMLYGH 149
                 D W+   +   +L G 
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGI 200

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.4 bits (172), Expect = 7e-16
 Identities = 35/140 (25%), Positives = 60/140 (42%), Gaps = 25/140 (17%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            E  ++ E   GGSL DV+ E         + ++  +  QA++ +H     ++HRD+K +
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSD 145

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           N+L+   G+VKL DFG   +         +               TP + APE+      
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRST------------MVGTPYWMAPEVVTRKAY 193

Query: 133 ---VDTWNNYVIGRSMLYGH 149
              VD W+  ++   M+ G 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGE 213

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.0 bits (171), Expect = 7e-16
 Identities = 31/118 (26%), Positives = 47/118 (39%), Gaps = 18/118 (15%)

Query: 19  HEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
               I+TE    GSLVD L+ R  S L  + +       C+A++++ G N   VHRDL  
Sbjct: 74  GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAA 131

Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDT 135
            N+L+S     K+ DFG                 +     +        + APE +  
Sbjct: 132 RNVLVSEDNVAKVSDFGLT---------------KEASSTQDTGKLPVKWTAPEALRE 174

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 69.4 bits (169), Expect = 2e-15
 Identities = 30/140 (21%), Positives = 53/140 (37%), Gaps = 27/140 (19%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
           +   + +L  GG L   L +       ++      +    ++HMH +   +V+RDLK  N
Sbjct: 81  KLSFILDLMNGGDLHYHLSQHGVFSEADM-RFYAAEIILGLEHMHNRF--VVYRDLKPAN 137

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
           +L+   G V++ D G A +      +A                 T  Y APE+       
Sbjct: 138 ILLDEHGHVRISDLGLACDFSKKKPHAS--------------VGTHGYMAPEVLQKGVAY 183

Query: 133 ---VDTWNNYVIGRSMLYGH 149
               D ++   +   +L GH
Sbjct: 184 DSSADWFSLGCMLFKLLRGH 203

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.5 bits (169), Expect = 2e-15
 Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 13/128 (10%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
            +      + + L     G  L  +LK +   L  + +C  L+Q  + +K++H  N  ++
Sbjct: 76  RAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN--VL 131

Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           HRDLK  NLL+++   +K+CDFG A  +V  PD+  +      +        T  YRAPE
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLA--RVADPDHDHTGFLTEYV-------ATRWYRAPE 182

Query: 132 MVDTWNNY 139
           ++     Y
Sbjct: 183 IMLNSKGY 190

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 69.0 bits (168), Expect = 2e-15
 Identities = 28/127 (22%), Positives = 51/127 (40%), Gaps = 8/127 (6%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
              +I+TE    GSL   L++         +  +L      +K++   N   VHRDL   
Sbjct: 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAAR 157

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMY----RAPEMVD 134
           N+L++S    K+ DFG +  +    D +      ++      R+T P      +     D
Sbjct: 158 NILVNSNLVCKVSDFGLS--RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASD 215

Query: 135 TWNNYVI 141
            W+  ++
Sbjct: 216 VWSYGIV 222

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.5 bits (164), Expect = 8e-15
 Identities = 32/140 (22%), Positives = 54/140 (38%), Gaps = 24/140 (17%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
                + E   GG L+  ++        +       +    ++ +H +   IV+RDLK++
Sbjct: 76  ENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLD 132

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           N+L+   G +K+ DFG   E +       +               TP Y APE+      
Sbjct: 133 NILLDKDGHIKIADFGMCKENMLGDAKTNT------------FCGTPDYIAPEILLGQKY 180

Query: 133 ---VDTWNNYVIGRSMLYGH 149
              VD W+  V+   ML G 
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQ 200

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.5 bits (164), Expect = 1e-14
 Identities = 27/154 (17%), Positives = 55/154 (35%), Gaps = 34/154 (22%)

Query: 19  HEYLILTELCTGGSLVDVLKER----------------------TSALPPNIVCSILWQT 56
               ++ E C  G L++ L+ +                       + L    +    +Q 
Sbjct: 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173

Query: 57  CQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLE 116
            + ++ +  ++   VHRDL   N+L++    VK+CDFG A  +    D+ +  +  +   
Sbjct: 174 AKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLA--RDIMSDSNYVVRGNAR-- 227

Query: 117 DEMARFTTPMYRAPEMVDTWNNYVIGRSMLYGHV 150
                     + APE +      +      YG +
Sbjct: 228 ------LPVKWMAPESLFEGIYTIKSDVWSYGIL 255

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.7 bits (162), Expect = 1e-14
 Identities = 27/139 (19%), Positives = 50/139 (35%), Gaps = 21/139 (15%)

Query: 18  MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
              ++++ E+   G L   L++    +    +  ++ Q    +K++   N   VHRDL  
Sbjct: 79  AESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAA 135

Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
            N+L+ +    K+ DFG +  K    D  +   Q               + APE      
Sbjct: 136 RNVLLVTQHYAKISDFGLS--KALRADENYYKAQTHGK-------WPVKWYAPECINYYK 186

Query: 133 ----VDTWNNYVIGRSMLY 147
                D W+  V+      
Sbjct: 187 FSSKSDVWSFGVLMWEAFS 205

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.8 bits (162), Expect = 1e-14
 Identities = 32/154 (20%), Positives = 54/154 (35%), Gaps = 22/154 (14%)

Query: 7   AFIDKHSTPHGMHEYL-ILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG 65
               K S  +     + ++ + C       +          + +  ++      + ++H 
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHR 135

Query: 66  QNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTP 125
               I+HRD+K  N+LI+  G +KL DFG A         A+S  + S       R  T 
Sbjct: 136 NK--ILHRDMKAANVLITRDGVLKLADFGLAR--------AFSLAKNSQPNRYTNRVVTL 185

Query: 126 MYRAPEM----------VDTWNNYVIGRSMLYGH 149
            YR PE+          +D W    I   M    
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.1 bits (158), Expect = 4e-14
 Identities = 33/142 (23%), Positives = 54/142 (38%), Gaps = 27/142 (19%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
             ++++ E       +        AL   +  S  WQ  +AV+H H     ++HRD+K E
Sbjct: 82  DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDE 139

Query: 79  NLLIS-SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM----- 132
           N+LI  + G +KL DFGS        D  ++               T +Y  PE      
Sbjct: 140 NILIDLNRGELKLIDFGSG---ALLKDTVYTDFD-----------GTRVYSPPEWIRYHR 185

Query: 133 -----VDTWNNYVIGRSMLYGH 149
                   W+  ++   M+ G 
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGD 207

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.2 bits (158), Expect = 6e-14
 Identities = 27/149 (18%), Positives = 51/149 (34%), Gaps = 5/149 (3%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           ++     F+         H+ L        G  +     R              +   A+
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           +++H  +  +V+RD+K+ENL++   G +K+ DFG   E +       +          +A
Sbjct: 119 EYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE---YLA 173

Query: 121 RFTTPMYRAPEMVDTWNNYVIGRSMLYGH 149
                       VD W   V+   M+ G 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 64.9 bits (157), Expect = 6e-14
 Identities = 25/174 (14%), Positives = 43/174 (24%), Gaps = 44/174 (25%)

Query: 8   FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTS-----------------------AL 44
            +             +L E    G L + L+  +                         L
Sbjct: 78  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137

Query: 45  PPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPD 104
                  I  Q    + ++  +    VHRDL   N L+     VK+ DFG          
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFG---------- 185

Query: 105 NAWSAQQRSMLEDEMARFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
            + +       + +        +  PE           D W   V+   +    
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.3 bits (156), Expect = 8e-14
 Identities = 27/121 (22%), Positives = 49/121 (40%), Gaps = 21/121 (17%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
               I+TE    G L++ L+E         +  +    C+A++++   +   +HRDL   
Sbjct: 72  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAAR 129

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT----TPMYRAPEMVD 134
           N L++  G VK+ DFG +               R +L+DE            +  PE++ 
Sbjct: 130 NCLVNDQGVVKVSDFGLS---------------RYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 135 T 135
            
Sbjct: 175 Y 175

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.9 bits (155), Expect = 1e-13
 Identities = 29/131 (22%), Positives = 53/131 (40%), Gaps = 5/131 (3%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSA-LPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
               I+TE    GSLVD LK  +   L  N +  +  Q  + +  +  +N   +HRDL+ 
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRA 137

Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWN 137
            N+L+S   + K+ DFG A  ++   +   + +         A             D W+
Sbjct: 138 ANILVSDTLSCKIADFGLA--RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195

Query: 138 NYVIGRSMLYG 148
             ++   ++  
Sbjct: 196 FGILLTEIVTH 206

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.2 bits (153), Expect = 2e-13
 Identities = 31/137 (22%), Positives = 51/137 (37%), Gaps = 20/137 (14%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
               ++TEL   GSL+D L++         +     Q  + + ++   +   +HRDL   
Sbjct: 83  PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAAR 140

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           NLL+++   VK+ DFG       + D+    + R              + APE       
Sbjct: 141 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK---------VPFAWCAPESLKTRTF 191

Query: 133 ---VDTWNNYVIGRSML 146
               DTW   V    M 
Sbjct: 192 SHASDTWMFGVTLWEMF 208

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (152), Expect = 3e-13
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 4/128 (3%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           +   I+ ELCT G L   L+ R  +L    +    +Q   A+ ++   +   VHRD+   
Sbjct: 80  NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAAR 137

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           N+L+SS   VKL DFG +  +       + A +  +    MA  +    R     D W  
Sbjct: 138 NVLVSSNDCVKLGDFGLS--RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 195

Query: 139 YVIGRSML 146
            V    +L
Sbjct: 196 GVCMWEIL 203

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (152), Expect = 4e-13
 Identities = 23/116 (19%), Positives = 47/116 (40%), Gaps = 12/116 (10%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
              ++T+L   G L+D ++E    +    + +   Q  + + ++  +   +VHRDL   N
Sbjct: 84  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARN 141

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDT 135
           +L+ +   VK+ DFG A  K+   +      +               + A E +  
Sbjct: 142 VLVKTPQHVKITDFGLA--KLLGAEEKEYHAEGGK--------VPIKWMALESILH 187

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.0 bits (150), Expect = 5e-13
 Identities = 21/138 (15%), Positives = 42/138 (30%), Gaps = 22/138 (15%)

Query: 20  EYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN 79
              ++ E    G L D L+ +        +  +    C+ + ++      ++HRDL   N
Sbjct: 74  PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARN 131

Query: 80  LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------- 132
            L+     +K+ DFG                                + +PE+       
Sbjct: 132 CLVGENQVIKVSDFG-----------MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 133 --VDTWNNYVIGRSMLYG 148
              D W+  V+   +   
Sbjct: 181 SKSDVWSFGVLMWEVFSE 198

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.5 bits (151), Expect = 6e-13
 Identities = 23/121 (19%), Positives = 43/121 (35%), Gaps = 10/121 (8%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
              L++      G L + ++  T       +     Q  + +K +   +   VHRDL   
Sbjct: 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAAR 159

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           N ++    TVK+ DFG A +      ++   +  + L           + A E + T   
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL--------PVKWMALESLQTQKF 211

Query: 139 Y 139
            
Sbjct: 212 T 212

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.2 bits (150), Expect = 6e-13
 Identities = 36/147 (24%), Positives = 60/147 (40%), Gaps = 24/147 (16%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
            S      +  ++ E         + K     +P   +  +++Q  + +  +H     +V
Sbjct: 81  VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VV 138

Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           HRDLK +N+L++S+G +KL DFG A  ++YS   A             +   T  YRAPE
Sbjct: 139 HRDLKPQNILVTSSGQIKLADFGLA--RIYSFQMAL-----------TSVVVTLWYRAPE 185

Query: 132 M---------VDTWNNYVIGRSMLYGH 149
           +         VD W+   I   M    
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 61.7 bits (149), Expect = 8e-13
 Identities = 27/131 (20%), Positives = 52/131 (39%), Gaps = 5/131 (3%)

Query: 19  HEYLILTELCTGGSLVDVLKERTS-ALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI 77
             + I+TE  T G+L+D L+E     +   ++  +  Q   A++++       +HRDL  
Sbjct: 86  PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAA 143

Query: 78  ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWN 137
            N L+     VK+ DFG +  ++ + D   +           A  +    +     D W 
Sbjct: 144 RNCLVGENHLVKVADFGLS--RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 201

Query: 138 NYVIGRSMLYG 148
             V+   +   
Sbjct: 202 FGVLLWEIATY 212

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.8 bits (149), Expect = 9e-13
 Identities = 33/141 (23%), Positives = 55/141 (39%), Gaps = 25/141 (17%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
               ++ +         ++K+ +  L P+ + + +  T Q ++++H     I+HRDLK  
Sbjct: 73  SNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPN 129

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           NLL+   G +KL DFG             +    S       +  T  YRAPE+      
Sbjct: 130 NLLLDENGVLKLADFG------------LAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W    I   +L   
Sbjct: 178 YGVGVDMWAVGCILAELLLRV 198

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.4 bits (148), Expect = 1e-12
 Identities = 27/131 (20%), Positives = 48/131 (36%), Gaps = 11/131 (8%)

Query: 9   IDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNP 68
           I            +I+TE    G+L   L+E+        +  +L      +K++   N 
Sbjct: 72  IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--NM 129

Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYR 128
             VHRDL   N+L++S    K+ DFG +      P+  ++     +            + 
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI---------PIRWT 180

Query: 129 APEMVDTWNNY 139
           APE +      
Sbjct: 181 APEAISYRKFT 191

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 60.5 bits (146), Expect = 2e-12
 Identities = 36/147 (24%), Positives = 59/147 (40%), Gaps = 22/147 (14%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
             TP G   Y+++ E   G +L D++      + P     ++   CQA+   H     I+
Sbjct: 78  AETPAGPLPYIVM-EYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNG--II 133

Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           HRD+K  N++IS+   VK+ DFG A            A   + +    A   T  Y +PE
Sbjct: 134 HRDVKPANIMISATNAVKVMDFGIA---------RAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 132 M---------VDTWNNYVIGRSMLYGH 149
                      D ++   +   +L G 
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.0 bits (147), Expect = 2e-12
 Identities = 31/131 (23%), Positives = 55/131 (41%), Gaps = 3/131 (2%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            +  ++ +   GG L   L +R      + V   + +   A++H+H     I++RD+K+E
Sbjct: 102 TKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLE 158

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTWNN 138
           N+L+ S G V L DFG + E V            ++                + VD W+ 
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218

Query: 139 YVIGRSMLYGH 149
            V+   +L G 
Sbjct: 219 GVLMYELLTGA 229

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.0 bits (147), Expect = 2e-12
 Identities = 31/149 (20%), Positives = 51/149 (34%), Gaps = 9/149 (6%)

Query: 4   LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLK--ERTSALPPNIVCSILWQTCQAVK 61
           L   F         ++  L+L +                   LP   V   ++Q  +++ 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 62  HMHGQNPPIVHRDLKIENLLISSAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           ++H     I HRD+K +NLL+      +KLCDFGSA  K         +   S       
Sbjct: 137 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA--KQLVRGEPNVSYICSRYYRAPE 192

Query: 121 RFTTPMYRAPEMVDTWNNYVIGRSMLYGH 149
                       +D W+   +   +L G 
Sbjct: 193 LIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.6 bits (146), Expect = 3e-12
 Identities = 22/154 (14%), Positives = 46/154 (29%), Gaps = 39/154 (25%)

Query: 19  HEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHM 63
               +  E    G+L+D L++                 S L    +        + + ++
Sbjct: 84  GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143

Query: 64  HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
                  +HRDL   N+L+      K+ DFG              ++ + +   +     
Sbjct: 144 S--QKQFIHRDLAARNILVGENYVAKIADFG-------------LSRGQEVYVKKTMGRL 188

Query: 124 TPMYRAPEM---------VDTWNNYVIGRSMLYG 148
              + A E           D W+  V+   ++  
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.1 bits (145), Expect = 3e-12
 Identities = 28/132 (21%), Positives = 48/132 (36%), Gaps = 5/132 (3%)

Query: 18  MHEYLILTELCTGGSLVDV-LKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK 76
                I+TE  + GSL+D    E    L    +  +  Q    + ++   N   VHRDL+
Sbjct: 83  EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLR 140

Query: 77  IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMVDTW 136
             N+L+      K+ DFG A  ++   +   + Q         A       R     D W
Sbjct: 141 AANILVGENLVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 198

Query: 137 NNYVIGRSMLYG 148
           +  ++   +   
Sbjct: 199 SFGILLTELTTK 210

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 60.2 bits (145), Expect = 3e-12
 Identities = 27/145 (18%), Positives = 44/145 (30%), Gaps = 21/145 (14%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
             + +L     G SL D+L           V     Q    V+ +H ++  +V+RD+K +
Sbjct: 73  GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPD 130

Query: 79  NLLISS-----AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM- 132
           N LI       A  + + DFG                Q     ++     T  Y +    
Sbjct: 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK-----QHIPYREKKNLSGTARYMSINTH 185

Query: 133 --------VDTWNNYVIGRSMLYGH 149
                    D      +    L G 
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGS 210

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.2 bits (145), Expect = 3e-12
 Identities = 30/149 (20%), Positives = 51/149 (34%), Gaps = 29/149 (19%)

Query: 19  HEYLILTELCTGGSLVDVLKERTS-----------------ALPPNIVCSILWQTCQAVK 61
              L++TE C  G L++ L+ +                   AL    + S  +Q  + + 
Sbjct: 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159

Query: 62  HMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMAR 121
            +  +N   +HRDL   N+L++     K+CDFG A +     +       R         
Sbjct: 160 FLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR--------- 208

Query: 122 FTTPMYRAPEMVDTWNNYVIGRSMLYGHV 150
                + APE +             YG  
Sbjct: 209 -LPVKWMAPESIFNCVYTFESDVWSYGIF 236

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 59.9 bits (144), Expect = 4e-12
 Identities = 24/133 (18%), Positives = 49/133 (36%), Gaps = 21/133 (15%)

Query: 8   FIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQN 67
             D    P      L+  E         + +     L    +   +++  +A+ + H   
Sbjct: 95  LADIVKDPVSRTPALVF-EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG 149

Query: 68  PPIVHRDLKIENLLISSAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPM 126
             I+HRD+K  N++I      ++L D+G A  + Y P   +             R  +  
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYHPGQEY-----------NVRVASRY 194

Query: 127 YRAPEMVDTWNNY 139
           ++ PE++  +  Y
Sbjct: 195 FKGPELLVDYQMY 207

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 59.7 bits (144), Expect = 6e-12
 Identities = 42/143 (29%), Positives = 63/143 (44%), Gaps = 28/143 (19%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
               ++ +L +GG L D + E+           +++Q   AVK++H  +  IVHRDLK E
Sbjct: 80  GHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPE 136

Query: 79  NLLISSA---GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           NLL  S      + + DFG +  K+  P +  S               TP Y APE+   
Sbjct: 137 NLLYYSLDEDSKIMISDFGLS--KMEDPGSVLS-----------TACGTPGYVAPEVLAQ 183

Query: 133 ------VDTWNNYVIGRSMLYGH 149
                 VD W+  VI   +L G+
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGY 206

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 59.5 bits (143), Expect = 6e-12
 Identities = 33/149 (22%), Positives = 52/149 (34%), Gaps = 4/149 (2%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           ++ L  + I K        + L+L        L  +L      L      S L Q    +
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
            + H +   ++HRDLK +NLLI+  G +K+ DFG A                        
Sbjct: 114 AYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 121 RFTTPMYRAPEMVDTWNNYVIGRSMLYGH 149
              +  Y     +D W+   I   M+ G 
Sbjct: 172 LMGSKKY--STTIDIWSVGCIFAEMVNGT 198

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 57.9 bits (139), Expect = 3e-11
 Identities = 32/158 (20%), Positives = 55/158 (34%), Gaps = 26/158 (16%)

Query: 1   MEYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAV 60
           ++ ++  F+ K       +  L +      G  +     R              Q     
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 61  KHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMA 120
           +++H  +  +++RDLK ENLLI   G +++ DFG A               + +      
Sbjct: 155 EYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA---------------KRVKGRTWT 197

Query: 121 RFTTPMYRAPEM---------VDTWNNYVIGRSMLYGH 149
              TP   APE+         VD W   V+   M  G+
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 57.2 bits (137), Expect = 4e-11
 Identities = 25/143 (17%), Positives = 49/143 (34%), Gaps = 20/143 (13%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
              +++ EL  G SL D+    +       V  +  Q    ++++H +N   +HRD+K +
Sbjct: 76  DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPD 132

Query: 79  NLLISSAG---TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM--- 132
           N L+        V + DFG A +   +  +     + +          T  Y +      
Sbjct: 133 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN-----KNLTGTARYASINTHLG 187

Query: 133 ------VDTWNNYVIGRSMLYGH 149
                  D  +   +      G 
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGS 210

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.8 bits (136), Expect = 6e-11
 Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 24/141 (17%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
           ++  ++ E         +     + +P  ++ S L+Q  Q +   H  +  ++HRDLK +
Sbjct: 74  NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQ 131

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           NLLI++ G +KL DFG A  + +                      T  YRAPE+      
Sbjct: 132 NLLINTEGAIKLADFGLA--RAFGVPVRT----------YTHEVVTLWYRAPEILLGCKY 179

Query: 133 ----VDTWNNYVIGRSMLYGH 149
               VD W+   I   M+   
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRR 200

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 56.6 bits (136), Expect = 6e-11
 Identities = 33/140 (23%), Positives = 62/140 (44%), Gaps = 27/140 (19%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            +  ++ +   GG L  +L++     P  +      + C A++++H  +  I++RDLK E
Sbjct: 77  QQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPE 133

Query: 79  NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEM------ 132
           N+L+   G +K+ DFG A               + + +       TP Y APE+      
Sbjct: 134 NILLDKNGHIKITDFGFA---------------KYVPDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 133 ---VDTWNNYVIGRSMLYGH 149
              +D W+  ++   ML G+
Sbjct: 179 NKSIDWWSFGILIYEMLAGY 198

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.4 bits (135), Expect = 8e-11
 Identities = 24/133 (18%), Positives = 48/133 (36%), Gaps = 18/133 (13%)

Query: 19  HEYLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHM 63
               ++ E  + G+L + L+ R                  L    + S  +Q  + ++++
Sbjct: 92  GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 151

Query: 64  HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
              +   +HRDL   N+L++    +K+ DFG A + ++  D         +    MA   
Sbjct: 152 A--SKKCIHRDLAARNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEA 208

Query: 124 TPMYRAPEMVDTW 136
                     D W
Sbjct: 209 LFDRIYTHQSDVW 221

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.6 bits (133), Expect = 1e-10
 Identities = 23/141 (16%), Positives = 44/141 (31%), Gaps = 21/141 (14%)

Query: 19  HEYLILTELCTGGSLVDVLK---------ERTSALPPNIVCSILWQTCQAVKHMHGQNPP 69
              L++ EL T G L   L+            +    + +  +  +    + +++     
Sbjct: 96  QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANK 153

Query: 70  IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRA 129
            VHRDL   N +++   TVK+ DFG                +               + +
Sbjct: 154 FVHRDLAARNCMVAEDFTVKIGDFG----------MTRDIYETDYYRKGGKGLLPVRWMS 203

Query: 130 PEMVDTWNNYVIGRSMLYGHV 150
           PE +             +G V
Sbjct: 204 PESLKDGVFTTYSDVWSFGVV 224

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.7 bits (133), Expect = 2e-10
 Identities = 31/146 (21%), Positives = 53/146 (36%), Gaps = 18/146 (12%)

Query: 19  HEYLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHM 63
              +++ E C  G+L   L+ +                  L    +    +Q  + ++ +
Sbjct: 91  GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 150

Query: 64  HGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFT 123
             +    +HRDL   N+L+S    VK+CDFG A +    PD       R  L+  MA  T
Sbjct: 151 ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK-WMAPET 207

Query: 124 TPMYRAPEMVDTWNNYVIGRSMLYGH 149
                     D W+  V+   +    
Sbjct: 208 IFDRVYTIQSDVWSFGVLLWEIFSLG 233

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (131), Expect = 2e-10
 Identities = 32/142 (22%), Positives = 51/142 (35%), Gaps = 5/142 (3%)

Query: 9   IDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNP 68
           +  H   H   +  ++ E C                 P IV S L+Q  + +   H +N 
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN- 121

Query: 69  PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYR 128
            ++HRDLK +NLLI+  G +KL +FG A           +             F   +Y 
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY- 179

Query: 129 APEMVDTWNNYVIGRSMLYGHV 150
               +D W+   I   +     
Sbjct: 180 -STSIDMWSAGCIFAELANAGR 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.2 bits (127), Expect = 1e-09
 Identities = 38/144 (26%), Positives = 57/144 (39%), Gaps = 29/144 (20%)

Query: 19  HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE 78
            + +++ EL  GG L D L E+ S L        L Q    V ++H  +  I H DLK E
Sbjct: 86  TDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPE 142

Query: 79  NLLISSAGT----VKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE--- 131
           N+++         +K+ DFG A +  +  +                 F TP + APE   
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-------------IFGTPEFVAPEIVN 189

Query: 132 ------MVDTWNNYVIGRSMLYGH 149
                   D W+  VI   +L G 
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGA 213

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.0 bits (126), Expect = 1e-09
 Identities = 33/144 (22%), Positives = 53/144 (36%), Gaps = 11/144 (7%)

Query: 7   AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ 66
            F  + +       YL+  EL        +  E         +  +L+Q    +KH+H  
Sbjct: 84  VFTPQKTLEEFQDVYLV-MELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH-- 136

Query: 67  NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPM 126
           +  I+HRDLK  N+++ S  T+K+ DFG A     S         R     E+       
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196

Query: 127 YRAPEMVDTWNNYVIGRSMLYGHV 150
                 VD W+   I   M+   +
Sbjct: 197 EN----VDIWSVGCIMGEMVRHKI 216

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.4 bits (117), Expect = 2e-08
 Identities = 29/133 (21%), Positives = 52/133 (39%), Gaps = 21/133 (15%)

Query: 7   AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ 66
            F    +       YL++      G+ +  L +    L  + +  +++Q  + ++++H  
Sbjct: 85  VFTPDETLDDFTDFYLVM-PFM--GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHAA 140

Query: 67  NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPM 126
                HRDLK  NL ++    +K+ DFG A               R    +      T  
Sbjct: 141 GII--HRDLKPGNLAVNEDCELKILDFGLA---------------RQADSEMTGYVVTRW 183

Query: 127 YRAPEMVDTWNNY 139
           YRAPE++  W  Y
Sbjct: 184 YRAPEVILNWMRY 196

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.3 bits (114), Expect = 4e-08
 Identities = 37/153 (24%), Positives = 59/153 (38%), Gaps = 31/153 (20%)

Query: 7   AFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ 66
            F    S       YL+      G  L +++K +   L  + V  +++Q  + +K++H  
Sbjct: 85  VFTPARSLEEFNDVYLV--THLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSA 140

Query: 67  NPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPM 126
           +  I+HRDLK  NL ++    +K+ DFG A                           T  
Sbjct: 141 D--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---------------ATRW 183

Query: 127 YRAPEM----------VDTWNNYVIGRSMLYGH 149
           YRAPE+          VD W+   I   +L G 
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 46.7 bits (110), Expect = 1e-07
 Identities = 14/47 (29%), Positives = 23/47 (48%), Gaps = 3/47 (6%)

Query: 52  ILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATE 98
           +L    + V   +  +  IVH DL   N+L+S  G + + DF  + E
Sbjct: 108 VLDMILEEVAKFY--HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVE 151

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 45.0 bits (105), Expect = 7e-07
 Identities = 31/147 (21%), Positives = 53/147 (36%), Gaps = 20/147 (13%)

Query: 12  HSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIV 71
           H  P+G+H  ++  E+     L  + K     +P   V  I  Q    + +MH +   I+
Sbjct: 91  HKGPNGVHVVMV-FEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-RRCGII 148

Query: 72  HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPE 131
           H D+K EN+L+    +          E +     A         E       T  YR+PE
Sbjct: 149 HTDIKPENVLMEIVDS---------PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPE 199

Query: 132 M---------VDTWNNYVIGRSMLYGH 149
           +          D W+   +   ++ G 
Sbjct: 200 VLLGAPWGCGADIWSTACLIFELITGD 226

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	150
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.98
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.97
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.97
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.96
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.96
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.96
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.96
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.96
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.96
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.96
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.95
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.95
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.95
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.95
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.95
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.95
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.95
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.95
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.95
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.95
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.94
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.94
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.94
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.94
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.94
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.93
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.93
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.93
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.93
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.92
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.92
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.92
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.91
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.91
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.79
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.33
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	96.29
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	90.72
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	83.62

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-36  Score=207.38  Aligned_cols=134  Identities=28%  Similarity=0.395  Sum_probs=116.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.++..+.+|+|||||++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        60 l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl  136 (271)
T d1nvra_          60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL  136 (271)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE
T ss_pred             CCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEE
Confidence            46899999999999999999999999999999998653 56999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+|++|||+++.........          .....+||+.|||||++          |+||+|+++++|++|+
T Consensus       137 ~~~~~~KL~DFG~a~~~~~~~~~~----------~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~  203 (271)
T d1nvra_         137 DERDNLKISDFGLATVFRYNNRER----------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE  203 (271)
T ss_dssp             CTTCCEEECCCTTCEECEETTEEC----------CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCEEEccchhheeeccCCccc----------cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCC
Confidence            999999999999998543221110          11245799999999984          9999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-35  Score=204.14  Aligned_cols=133  Identities=27%  Similarity=0.398  Sum_probs=117.3

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+|||||++|+|.+++.+....+++..+..++.|++.|+.|+|+++  |+|||+||+||++
T Consensus        66 l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll  143 (288)
T d2jfla1          66 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILF  143 (288)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeE
Confidence            45899999999999999999999999999999998776667999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------------cccccceeEEEeeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------------d~~~~g~~~~~~~~g  148 (150)
                      +.++.+|++|||++.....            ......+..||+.|+|||++              |+||+|+++++|++|
T Consensus       144 ~~~~~~Kl~DFG~a~~~~~------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg  211 (288)
T d2jfla1         144 TLDGDIKLADFGVSAKNTR------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI  211 (288)
T ss_dssp             CTTSCEEECCCTTCEECHH------------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHS
T ss_pred             CCCCCEEEEechhhhccCC------------CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhC
Confidence            9999999999999864310            01122356799999999984              999999999999998


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      .
T Consensus       212 ~  212 (288)
T d2jfla1         212 E  212 (288)
T ss_dssp             S
T ss_pred             C
Confidence            6

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-35  Score=201.46  Aligned_cols=130  Identities=25%  Similarity=0.369  Sum_probs=115.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+|||||++|+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        63 l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill  139 (263)
T d2j4za1          63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL  139 (263)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred             cCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeecccccee
Confidence            45899999999999999999999999999999999865 56999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+|++|||++........              ....||+.|||||++         |+||+|+++++|++|.
T Consensus       140 ~~~~~~kl~DFG~a~~~~~~~~--------------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~  201 (263)
T d2j4za1         140 GSAGELKIADFGWSVHAPSSRR--------------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK  201 (263)
T ss_dssp             CTTSCEEECCCCSCSCCCCCCC--------------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEeecccceeeecCCCcc--------------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCC
Confidence            9999999999999875322111              134689999999995         9999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-34  Score=201.88  Aligned_cols=131  Identities=27%  Similarity=0.476  Sum_probs=115.4

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+|||||+||+|.+++..  ..+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        74 l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl  149 (293)
T d1yhwa1          74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL  149 (293)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEE
Confidence            4589999999999999999999999999999998865  46999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+|++|||++.........            ....+||+.|+|||++         |+||+|+++++|++|+
T Consensus       150 ~~~~~vkl~DFG~a~~~~~~~~~------------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~  213 (293)
T d1yhwa1         150 GMDGSVKLTDFGFCAQITPEQSK------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE  213 (293)
T ss_dssp             CTTCCEEECCCTTCEECCSTTCC------------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCcEeeccchhheeecccccc------------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCC
Confidence            99999999999999754221111            1234799999999985         9999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-35  Score=206.24  Aligned_cols=130  Identities=28%  Similarity=0.383  Sum_probs=113.9

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.++++..+++|+||||+++|+|.+++.+. ..+++..++.++.|++.|+.|+|+ ++  |+|||+||+||+
T Consensus        61 l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NIL  137 (322)
T d1s9ja_          61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNIL  137 (322)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEE
T ss_pred             CCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHee
Confidence            45899999999999999999999999999999999765 469999999999999999999997 47  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.+|++|||+|.....              ....+.+||+.|||||++         |+||+||+++||++|+
T Consensus       138 l~~~~~vkl~DFGla~~~~~--------------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~  200 (322)
T d1s9ja_         138 VNSRGEIKLCDFGVSGQLID--------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR  200 (322)
T ss_dssp             ECTTCCEEECCCCCCHHHHH--------------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCCEEEeeCCCccccCC--------------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            99999999999999874311              112245899999999995         9999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=202.01  Aligned_cols=134  Identities=21%  Similarity=0.299  Sum_probs=115.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+|||||++|+|.+++... +.+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        65 l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll  141 (288)
T d1uu3a_          65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILL  141 (288)
T ss_dssp             CCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred             cCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCcccccc
Confidence            45899999999999999999999999999999998765 57999999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.++++|||+++........          .......||+.|+|||++         |+||+|+++++|++|.
T Consensus       142 ~~~~~vkl~DFG~a~~~~~~~~~----------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~  207 (288)
T d1uu3a_         142 NEDMHIQITDFGTAKVLSPESKQ----------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL  207 (288)
T ss_dssp             CTTSCEEECCCTTCEECC--------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCceEEecccccceecccCCcc----------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCC
Confidence            99999999999999754221110          112245799999999995         9999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-34  Score=203.35  Aligned_cols=132  Identities=23%  Similarity=0.339  Sum_probs=116.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+|||||+||+|.+++... ..+++..++.++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        62 l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl  138 (337)
T d1o6la_          62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML  138 (337)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE
T ss_pred             CCCCCEEEEEeeeccccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEe
Confidence            45899999999999999999999999999999999865 57899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+|++|||+++........            ....+||+.|+|||++         |+||+||++++|++|.
T Consensus       139 ~~~g~vkl~DFG~a~~~~~~~~~------------~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~  202 (337)
T d1o6la_         139 DKDGHIKITDFGLCKEGISDGAT------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  202 (337)
T ss_dssp             CTTSCEEECCCTTCBCSCCTTCC------------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEeecccccccccCCcc------------cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCC
Confidence            99999999999999754322111            1135689999999995         9999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=6.4e-34  Score=196.60  Aligned_cols=133  Identities=30%  Similarity=0.393  Sum_probs=113.0

Q ss_pred             cccchhhhcccCCCC----CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           2 EYLSAAFIDKHSTPH----GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      ++-||+|+++.++++    +.+.+|+||||+++|+|.+++++. ..+++..+..++.|++.|+.|+|+++++++|||+||
T Consensus        64 ~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp  142 (270)
T d1t4ha_          64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC  142 (270)
T ss_dssp             TCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG
T ss_pred             hCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcCh
Confidence            456899999988654    457899999999999999999865 568999999999999999999999877799999999


Q ss_pred             CCEEEcC-CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------cccccceeEEEeeee
Q psy1934          78 ENLLISS-AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        78 ~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------d~~~~g~~~~~~~~g  148 (150)
                      +||+++. ++.+|++|||+++.....              ...+.+||+.|||||++        |+||+|+++++|++|
T Consensus       143 ~NILl~~~~~~~Kl~DFGla~~~~~~--------------~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g  208 (270)
T d1t4ha_         143 DNIFITGPTGSVKIGDLGLATLKRAS--------------FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATS  208 (270)
T ss_dssp             GGEEESSTTSCEEECCTTGGGGCCTT--------------SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHS
T ss_pred             hhceeeCCCCCEEEeecCcceeccCC--------------ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHC
Confidence            9999964 689999999998642111              01245799999999996        999999999999998


Q ss_pred             c
Q psy1934         149 H  149 (150)
Q Consensus       149 ~  149 (150)
                      +
T Consensus       209 ~  209 (270)
T d1t4ha_         209 E  209 (270)
T ss_dssp             S
T ss_pred             C
Confidence            6

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.2e-34  Score=198.74  Aligned_cols=135  Identities=24%  Similarity=0.307  Sum_probs=111.8

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++... +.+++|||||++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        60 ~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiL  136 (276)
T d1uwha_          60 KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIF  136 (276)
T ss_dssp             TCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred             hCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEE
Confidence            4568999998887654 5789999999999999999876667999999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.+|++|||+++.......          ........||+.|||||++            |+||+|++++||++|.
T Consensus       137 l~~~~~~Kl~DFGla~~~~~~~~----------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~  206 (276)
T d1uwha_         137 LHEDLTVKIGDFGLATVKSRWSG----------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ  206 (276)
T ss_dssp             EETTSSEEECCCCCSCC----------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             EcCCCCEEEccccceeeccccCC----------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence            99999999999999875321111          0112245789999999984            9999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=9.7e-34  Score=202.00  Aligned_cols=133  Identities=25%  Similarity=0.434  Sum_probs=115.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+|||||+||+|.+++.+....+++..+..++.|++.|+.|||+++  ++|||+||+||++
T Consensus        80 l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll  157 (350)
T d1koaa2          80 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMF  157 (350)
T ss_dssp             TCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeee
Confidence            45899999999999999999999999999999999765567999999999999999999999999  9999999999999


Q ss_pred             cC--CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeecC
Q psy1934          83 SS--AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        83 ~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~~  150 (150)
                      ..  ++.+|++|||++........             .....||+.|||||++         |+||+|+++++|++|+.
T Consensus       158 ~~~~~~~vkL~DFG~a~~~~~~~~-------------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~  223 (350)
T d1koaa2         158 TTKRSNELKLIDFGLTAHLDPKQS-------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS  223 (350)
T ss_dssp             SSTTSCCEEECCCTTCEECCTTSC-------------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCCCCeEEEeecchheecccccc-------------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCC
Confidence            64  57899999999875422111             1235789999999985         99999999999999863

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=8.8e-34  Score=199.12  Aligned_cols=132  Identities=28%  Similarity=0.399  Sum_probs=105.8

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++++..+.+|+|||||+||+|.+++.+. ..+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        63 ~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil  139 (307)
T d1a06a_          63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLL  139 (307)
T ss_dssp             TCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred             hCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEeccccee
Confidence            346899999999999999999999999999999999764 57999999999999999999999999  999999999999


Q ss_pred             Ec---CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 IS---SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.   .++.+|++|||+++......             ...+.+||+.|||||++         |+||+|+++++|++|.
T Consensus       140 ~~~~~~~~~vkl~DFG~a~~~~~~~-------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~  206 (307)
T d1a06a_         140 YYSLDEDSKIMISDFGLSKMEDPGS-------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY  206 (307)
T ss_dssp             ESSSSTTCCEEECCC-------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecccCCCceEEEeccceeEEccCCC-------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCC
Confidence            95   36789999999987432110             11245799999999995         9999999999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=2.6e-33  Score=197.43  Aligned_cols=129  Identities=28%  Similarity=0.437  Sum_probs=115.6

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+|||||+||++.+++... ..+++..++.++.|++.|+.|+|+++  |+|||+||+||++
T Consensus        61 l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl  137 (316)
T d1fota_          61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILL  137 (316)
T ss_dssp             CCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE
T ss_pred             ccCcChhheeeeEeeCCeeeeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeE
Confidence            56899999999999999999999999999999988764 56888888899999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+|++|||+++.....               ..+..||+.|||||++         |+||+|+++++|++|+
T Consensus       138 ~~~g~vkL~DFG~a~~~~~~---------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~  198 (316)
T d1fota_         138 DKNGHIKITDFGFAKYVPDV---------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY  198 (316)
T ss_dssp             CTTSCEEECCCSSCEECSSC---------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCEEEecCccceEeccc---------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCC
Confidence            99999999999999754211               1245799999999995         9999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=1.9e-33  Score=201.45  Aligned_cols=129  Identities=24%  Similarity=0.287  Sum_probs=115.2

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      -||+|+++.++++..+.+|+|||||+||+|.+++... ..+++..+..++.|++.|+.|+|+++  ++|||+||+||+++
T Consensus        65 ~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~  141 (364)
T d1omwa3          65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD  141 (364)
T ss_dssp             CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC
T ss_pred             CCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc
Confidence            3899999999999999999999999999999999875 56889999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      ..+.+|++|||++.......              .....||+.|+|||++          |+||+||++++|++|+
T Consensus       142 ~~g~iKl~DFGla~~~~~~~--------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~  203 (364)
T d1omwa3         142 EHGHVRISDLGLACDFSKKK--------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH  203 (364)
T ss_dssp             SSSCEEECCCTTCEECSSSC--------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCcEEEeeeceeeecCCCc--------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCC
Confidence            99999999999987542211              1134699999999984          9999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=2.4e-33  Score=200.10  Aligned_cols=133  Identities=31%  Similarity=0.478  Sum_probs=116.1

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++++..+.+|+|||||+||+|.+.+......+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        82 ~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NIL  159 (352)
T d1koba_          82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIM  159 (352)
T ss_dssp             TCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred             hCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccccccccc
Confidence            355899999999999999999999999999999988766567999999999999999999999999  999999999999


Q ss_pred             Ec--CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 IS--SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++  ..+.+|++|||++........             .....||+.|+|||++         |+||+|+++++|++|+
T Consensus       160 l~~~~~~~vkL~DFGla~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~  225 (352)
T d1koba_         160 CETKKASSVKIIDFGLATKLNPDEI-------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL  225 (352)
T ss_dssp             ESSTTCCCEEECCCTTCEECCTTSC-------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred             ccccCCCeEEEeecccceecCCCCc-------------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCC
Confidence            97  458899999999975432111             1134689999999995         9999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=1.5e-33  Score=197.24  Aligned_cols=139  Identities=21%  Similarity=0.320  Sum_probs=108.4

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.+++...+.+++|||||++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        83 ~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NIL  160 (299)
T d1jpaa_          83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNIL  160 (299)
T ss_dssp             TCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred             hCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEE
Confidence            456899999999999999999999999999999999876567999999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.+|++|||+++........       ..........+|+.|||||++         |+||+|++++||++ |.
T Consensus       161 l~~~~~~Kl~DFGla~~~~~~~~~-------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~  231 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFLEDDTSD-------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE  231 (299)
T ss_dssp             ECTTCCEEECCC------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ECCCCcEEECCcccceEccCCCCc-------ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCC
Confidence            999999999999998754221110       001111233578999999984         99999999999985 65

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=2.3e-33  Score=197.06  Aligned_cols=129  Identities=25%  Similarity=0.361  Sum_probs=113.8

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.+++...+.+|+|||||++|++..++... ..+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        71 ~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NIL  147 (309)
T d1u5ra_          71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNIL  147 (309)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEE
T ss_pred             HCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEE
Confidence            456899999999999999999999999998887666543 57999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.+|++|||++......                ....||+.|||||++            |+||+|+++++|++|.
T Consensus       148 l~~~~~~Kl~DFG~a~~~~~~----------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~  211 (309)
T d1u5ra_         148 LSEPGLVKLGDFGSASIMAPA----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  211 (309)
T ss_dssp             EETTTEEEECCCTTCBSSSSB----------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCCEEEeecccccccCCC----------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCC
Confidence            999999999999998743211                134699999999973            9999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.1e-33  Score=197.74  Aligned_cols=134  Identities=20%  Similarity=0.341  Sum_probs=113.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC----------------------CCCCHHHHHHHHHHHHHHHH
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT----------------------SALPPNIVCSILWQTCQAVK   61 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~l~~~~~~~~~~~i~~~l~   61 (150)
                      -||+|+++.++++..+.+++|||||++|+|.+++++..                      ..+++..+..++.|++.|+.
T Consensus        99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~  178 (325)
T d1rjba_          99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME  178 (325)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred             CCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence            37999999999999999999999999999999997542                      24788889999999999999


Q ss_pred             HHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc--------
Q psy1934          62 HMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV--------  133 (150)
Q Consensus        62 ~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--------  133 (150)
                      |||+++  |+|||+||+||+++.++.+|++|||+++.........          ...+..||+.|||||++        
T Consensus       179 yLH~~~--IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~  246 (325)
T d1rjba_         179 FLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV----------VRGNARLPVKWMAPESLFEGIYTIK  246 (325)
T ss_dssp             HHHHTT--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE----------EETTEEECGGGCCHHHHHHCCCCHH
T ss_pred             HHHhCC--eeeccCchhccccccCCeEEEeeccccccccCCCcee----------eeccccCCCccCChHHHcCCCCCcc
Confidence            999999  9999999999999999999999999997543221110          01134578999999985        


Q ss_pred             -cccccceeEEEeee-ec
Q psy1934         134 -DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus       134 -d~~~~g~~~~~~~~-g~  149 (150)
                       |+||+|++++||++ |.
T Consensus       247 ~DiwS~Gvil~emlt~g~  264 (325)
T d1rjba_         247 SDVWSYGILLWEIFSLGV  264 (325)
T ss_dssp             HHHHHHHHHHHHHTTTSC
T ss_pred             eeccchhHHHHHHHhCCC
Confidence             99999999999985 65

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-33  Score=194.07  Aligned_cols=136  Identities=26%  Similarity=0.337  Sum_probs=102.3

Q ss_pred             cccchhhhcccCCC--CCceEEEEEEeccCCCCHHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHhcCC---CCeEEe
Q psy1934           2 EYLSAAFIDKHSTP--HGMHEYLILTELCTGGSLVDVLKER---TSALPPNIVCSILWQTCQAVKHMHGQN---PPIVHR   73 (150)
Q Consensus         2 ~~~~~~~~~~~~~~--~~~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---~~i~h~   73 (150)
                      ++-||+|+++.+++  +..+.+|+|||||++|+|.+++...   ...+++..+..++.|++.|+.|+|+++   .+|+||
T Consensus        59 ~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHr  138 (269)
T d2java1          59 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR  138 (269)
T ss_dssp             SCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC--------
T ss_pred             HCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeC
Confidence            45689999998866  4457799999999999999998642   356999999999999999999999753   239999


Q ss_pred             cCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEE
Q psy1934          74 DLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRS  144 (150)
Q Consensus        74 ~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~  144 (150)
                      |+||+||+++.++.+|++|||+++......            .......||+.|||||++         |+||+|+++++
T Consensus       139 DiKp~NIll~~~~~vkl~DFG~a~~~~~~~------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilye  206 (269)
T d2java1         139 DLKPANVFLDGKQNVKLGDFGLARILNHDT------------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE  206 (269)
T ss_dssp             -CCGGGEEECTTSCEEECCHHHHHHC-----------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCchhhcCcCCCCcEEEeeccceeecccCC------------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHH
Confidence            999999999999999999999987532111            011235789999999985         99999999999


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      |++|+
T Consensus       207 l~tg~  211 (269)
T d2java1         207 LCALM  211 (269)
T ss_dssp             HHHSS
T ss_pred             HhhCC
Confidence            99986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.3e-33  Score=196.47  Aligned_cols=130  Identities=32%  Similarity=0.431  Sum_probs=111.6

Q ss_pred             chhhhcccCCCCC----ceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           5 SAAFIDKHSTPHG----MHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         5 ~~~~~~~~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      ||+|+++.++++.    .+.+|+|||||+||+|.+++.... ..+++..+..++.|++.|+.|||+++  ++|||+||+|
T Consensus        64 hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~N  141 (335)
T d2ozaa1          64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPEN  141 (335)
T ss_dssp             STTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred             CCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccc
Confidence            7899999887754    678999999999999999998653 46899999999999999999999999  9999999999


Q ss_pred             EEEcC---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          80 LLISS---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        80 il~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+++.   .+.+|++|||+++.......             .....||+.|||||++         |+||+|+++++|++
T Consensus       142 Ill~~~~~~~~~Kl~DFG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt  208 (335)
T d2ozaa1         142 LLYTSKRPNAILKLTDFGFAKETTSHNS-------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC  208 (335)
T ss_dssp             EEESCSSTTCCEEECCCTTCEECCCCCC-------------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccccccceeeeccCCCc-------------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh
Confidence            99976   45799999999975432211             1134799999999995         99999999999999


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |.
T Consensus       209 g~  210 (335)
T d2ozaa1         209 GY  210 (335)
T ss_dssp             SS
T ss_pred             CC
Confidence            86

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-32  Score=193.82  Aligned_cols=133  Identities=24%  Similarity=0.380  Sum_probs=117.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+||||+++|+|.++++.. ..+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        60 ~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~  136 (320)
T d1xjda_          60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILL  136 (320)
T ss_dssp             TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE
T ss_pred             CCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceee
Confidence            46899999999999999999999999999999999865 56899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeecC
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~~  150 (150)
                      +..+.+|++|||+++........            .....||+.|+|||++         |+||+||++++|++|+.
T Consensus       137 ~~~~~~kl~DFG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~  201 (320)
T d1xjda_         137 DKDGHIKIADFGMCKENMLGDAK------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS  201 (320)
T ss_dssp             CTTSCEEECCCTTCBCCCCTTCC------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCceeccccchhhhccccccc------------ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCC
Confidence            99999999999998753221111            1234789999999995         99999999999999863

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.5e-33  Score=191.74  Aligned_cols=133  Identities=16%  Similarity=0.270  Sum_probs=108.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+++...+.+++||||+++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        57 l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill  134 (263)
T d1sm2a_          57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV  134 (263)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEE
T ss_pred             cCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheee
Confidence            56899999999999899999999999999999999876667899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +.++.+|++|||+++.......           .......||+.|+|||++         |+||+|++++||++|
T Consensus       135 ~~~~~~Kl~DFGla~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~  198 (263)
T d1sm2a_         135 GENQVIKVSDFGMTRFVLDDQY-----------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE  198 (263)
T ss_dssp             CGGGCEEECSCC-----------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCCeEecccchheeccCCCc-----------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHC
Confidence            9999999999999874321111           011234689999999985         999999999999874

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=1.5e-32  Score=195.82  Aligned_cols=130  Identities=23%  Similarity=0.272  Sum_probs=116.2

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++++..+.+++||||+.+|+|.+++... ..+++..++.++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        97 ~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NIL  173 (350)
T d1rdqe_          97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLL  173 (350)
T ss_dssp             TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred             HcCCCcEeecccccccccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcc
Confidence            356899999999999999999999999999999999765 47999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ++.++.+||+|||+++.....               .....||+.|||||++         |+||+||++++|++|.
T Consensus       174 l~~~g~ikL~DFG~a~~~~~~---------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~  235 (350)
T d1rdqe_         174 IDQQGYIQVTDFGFAKRVKGR---------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY  235 (350)
T ss_dssp             ECTTSCEEECCCTTCEECSSC---------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCCEEeeeceeeeecccc---------------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCC
Confidence            999999999999999754211               1134689999999995         9999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=2.7e-32  Score=189.07  Aligned_cols=130  Identities=30%  Similarity=0.423  Sum_probs=115.5

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS   84 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~   84 (150)
                      ||+|+++.+.+++.+.+|||||||++|+|.++++.. ..+++..+..++.|++.|+.|+|+++  ++|||++|+||+++.
T Consensus        69 hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~  145 (277)
T d1phka_          69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDD  145 (277)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECT
T ss_pred             CCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcC
Confidence            789999999999999999999999999999999865 57999999999999999999999999  999999999999999


Q ss_pred             CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------cccccceeEEEeeeec
Q psy1934          85 AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~~~~g~~~~~~~~g~  149 (150)
                      ++.+|++|||++........             .....||+.|+|||++               |+||+|+++++|++|+
T Consensus       146 ~~~~kl~DFG~a~~~~~~~~-------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~  212 (277)
T d1phka_         146 DMNIKLTDFGFSCQLDPGEK-------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS  212 (277)
T ss_dssp             TCCEEECCCTTCEECCTTCC-------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCeEEccchheeEccCCCc-------------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence            99999999999975432211             1134689999999974               8999999999999986


Q ss_pred             C
Q psy1934         150 V  150 (150)
Q Consensus       150 ~  150 (150)
                      .
T Consensus       213 ~  213 (277)
T d1phka_         213 P  213 (277)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-32  Score=191.74  Aligned_cols=136  Identities=23%  Similarity=0.323  Sum_probs=113.7

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++.+. +.+|+|||||++|+|.+++......+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        65 ~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nil  141 (285)
T d1u59a_          65 QLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVL  141 (285)
T ss_dssp             HCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred             hCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhhee
Confidence            3568999999998765 5689999999999999998765567999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.+|++|||+++.........         .......||+.|+|||++         |+||+|++++||++ |.
T Consensus       142 l~~~~~~Kl~DFGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~  210 (285)
T d1u59a_         142 LVNRHYAKISDFGLSKALGADDSYY---------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ  210 (285)
T ss_dssp             EEETTEEEECCCTTCEECTTCSCEE---------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             eccCCceeeccchhhhccccccccc---------ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCC
Confidence            9999999999999998643221111         011134578999999985         99999999999885 65

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.2e-32  Score=190.07  Aligned_cols=131  Identities=31%  Similarity=0.455  Sum_probs=114.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+|||||++|+|.+++... ..+++..+..++.|++.|+.|||+++  ++|||+||+||++
T Consensus        70 l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill  146 (293)
T d1jksa_          70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIML  146 (293)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEE
Confidence            45899999999999999999999999999999999865 47999999999999999999999999  9999999999999


Q ss_pred             cCCC----cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSAG----TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +..+    .+|++|||++........             .....||+.|+|||++         |+||+|+++++|++|+
T Consensus       147 ~~~~~~~~~vkl~DfG~a~~~~~~~~-------------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~  213 (293)
T d1jksa_         147 LDRNVPKPRIKIIDFGLAHKIDFGNE-------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  213 (293)
T ss_dssp             SCSSSSSCCEEECCCTTCEECTTSCB-------------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCcccceEecchhhhhhcCCCcc-------------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCC
Confidence            8765    599999999875422111             1234689999999985         9999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.9e-32  Score=189.80  Aligned_cols=135  Identities=19%  Similarity=0.278  Sum_probs=112.0

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++.+. +.++||||||++|+|.+++.+. ..+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        64 ~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nil  139 (277)
T d1xbba_          64 QLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVL  139 (277)
T ss_dssp             TCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             hCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhc
Confidence            4568999999998765 4678999999999999999764 56999999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.++++|||+++..........         ......||+.|||||++         |+||+|++++||++ |.
T Consensus       140 l~~~~~~kl~DFGla~~~~~~~~~~~---------~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~  208 (277)
T d1xbba_         140 LVTQHYAKISDFGLSKALRADENYYK---------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ  208 (277)
T ss_dssp             EEETTEEEECCCTTCEECCTTCSEEE---------C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred             ccccCcccccchhhhhhccccccccc---------cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCC
Confidence            99999999999999975432211110         11234688999999985         99999999999985 65

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=1.2e-32  Score=191.69  Aligned_cols=133  Identities=23%  Similarity=0.279  Sum_probs=114.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.+++...+.+++|||||++|+|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        70 l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NIL  147 (287)
T d1opja_          70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCL  147 (287)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             CCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEE
Confidence            468999999999999999999999999999999997643 56899999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      ++.++.+|++|||+++.........           .....|++.|+|||++         |+||+|++++||++|
T Consensus       148 l~~~~~~Kl~DFG~a~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~  212 (287)
T d1opja_         148 VGENHLVKVADFGLSRLMTGDTYTA-----------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY  212 (287)
T ss_dssp             ECGGGCEEECCCCCTTTCCSSSSEE-----------ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred             ECCCCcEEEccccceeecCCCCcee-----------eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhC
Confidence            9999999999999987543221111           1123478899999984         999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.6e-32  Score=187.32  Aligned_cols=136  Identities=21%  Similarity=0.315  Sum_probs=110.9

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++....+..+++|||+.++++.+.+......+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        65 ~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NIL  142 (283)
T d1mqba_          65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNIL  142 (283)
T ss_dssp             TCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred             hcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEE
Confidence            346899999999999999999999999999999998876677999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      ++.++.+|++|||+++.........         .......||+.|||||++         |+||+|++++||++|
T Consensus       143 l~~~~~~Kl~DFGla~~~~~~~~~~---------~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~  209 (283)
T d1mqba_         143 VNSNLVCKVSDFGLSRVLEDDPEAT---------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY  209 (283)
T ss_dssp             ECTTCCEEECCCCC--------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ECCCCeEEEcccchhhcccCCCccc---------eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhC
Confidence            9999999999999997542221111         011234588999999984         999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.6e-32  Score=190.57  Aligned_cols=132  Identities=25%  Similarity=0.416  Sum_probs=114.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+|||||+||+|.+++......+++..+..++.|++.|+.|||+.+  ++|||+||+||++
T Consensus        58 l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll  135 (321)
T d1tkia_          58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIY  135 (321)
T ss_dssp             SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceee
Confidence            45899999999999999999999999999999999876557999999999999999999999999  9999999999999


Q ss_pred             cCC--CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          83 SSA--GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +.+  ..++++|||++........             .....+|+.|+|||+.         |+||+|+++++|++|.
T Consensus       136 ~~~~~~~ikl~DFG~~~~~~~~~~-------------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~  200 (321)
T d1tkia_         136 QTRRSSTIKIIEFGQARQLKPGDN-------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI  200 (321)
T ss_dssp             SSSSCCCEEECCCTTCEECCTTCE-------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCceEEEEcccchhhccccCCc-------------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCC
Confidence            754  4799999999875422111             1134688999999984         9999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.1e-32  Score=186.22  Aligned_cols=132  Identities=23%  Similarity=0.314  Sum_probs=110.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      +-||+|+++.++... +.+++||||+++|+|.+++.... ..+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        65 l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIl  141 (272)
T d1qpca_          65 LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANIL  141 (272)
T ss_dssp             CCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             CCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhhee
Confidence            458999999987655 56799999999999999875432 35899999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      ++.++.+|++|||+++........           ......||+.|||||++         |+||+|++++||++|
T Consensus       142 l~~~~~~Kl~DFGla~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~  206 (272)
T d1qpca_         142 VSDTLSCKIADFGLARLIEDNEYT-----------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH  206 (272)
T ss_dssp             ECTTSCEEECCCTTCEECSSSCEE-----------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             eecccceeeccccceEEccCCccc-----------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhC
Confidence            999999999999999854322110           11234688999999985         999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-31  Score=186.59  Aligned_cols=132  Identities=25%  Similarity=0.321  Sum_probs=112.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++++..+.+|+||||++++++..+. .....+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        57 l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli  133 (299)
T d1ua2a_          57 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLL  133 (299)
T ss_dssp             CCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred             CCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEe
Confidence            45899999999999999999999999886665544 33456889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+|++|||++.........            ....+||+.|+|||++          |+||+|+++++|++|+
T Consensus       134 ~~~~~~KL~DFG~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~  198 (299)
T d1ua2a_         134 DENGVLKLADFGLAKSFGSPNRA------------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV  198 (299)
T ss_dssp             CTTCCEEECCCGGGSTTTSCCCC------------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCccccccCccccccCCCccc------------ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCc
Confidence            99999999999998754322111            1134689999999984          9999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.3e-31  Score=185.25  Aligned_cols=132  Identities=22%  Similarity=0.371  Sum_probs=101.9

Q ss_pred             chhhhcccCCC-CCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy1934           5 SAAFIDKHSTP-HGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNP   68 (150)
Q Consensus         5 ~~~~~~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~   68 (150)
                      |++|+...+.. +..+.+++|||||++|+|.++++...               ..+++..+..++.|++.|+.|+|+++ 
T Consensus        76 h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-  154 (299)
T d1ywna1          76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-  154 (299)
T ss_dssp             CTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             CCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            45677766653 44567899999999999999997532               24788899999999999999999999 


Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccc
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNY  139 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g  139 (150)
                       ++|||+||+||+++.++.+||+|||+++.........          ......||+.|+|||++         |+||+|
T Consensus       155 -ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~G  223 (299)
T d1ywna1         155 -CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFG  223 (299)
T ss_dssp             -CCCSCCCGGGEEECGGGCEEECC------CCSCTTSC----------CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             -CcCCcCCccceeECCCCcEEEccCcchhhcccccccc----------ccCceeeCccccchhHhhcCCCCcccceeehH
Confidence             9999999999999999999999999997543221111          11234689999999985         999999


Q ss_pred             eeEEEeeee
Q psy1934         140 VIGRSMLYG  148 (150)
Q Consensus       140 ~~~~~~~~g  148 (150)
                      ++++||++|
T Consensus       224 vil~ellt~  232 (299)
T d1ywna1         224 VLLWEIFSL  232 (299)
T ss_dssp             HHHHHHHTT
T ss_pred             HHHHHHHhC
Confidence            999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.4e-31  Score=180.09  Aligned_cols=135  Identities=20%  Similarity=0.351  Sum_probs=115.9

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.+++...+.+++||||+++|++.+++......+++..+..++.|++.|+.|+|+++  ++|+|++|+||+
T Consensus        55 ~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nil  132 (258)
T d1k2pa_          55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCL  132 (258)
T ss_dssp             TCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEE
T ss_pred             hcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEE
Confidence            346899999999999999999999999999999998766667899999999999999999999998  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.+|++|||+++.........           .....+|+.|+|||++         |+||+|++++||++ |+
T Consensus       133 l~~~~~~kl~DfG~a~~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~  199 (258)
T d1k2pa_         133 VNDQGVVKVSDFGLSRYVLDDEYTS-----------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK  199 (258)
T ss_dssp             ECTTCCEEECCCSSCCBCSSSSCCC-----------CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             EcCCCcEEECcchhheeccCCCcee-----------ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCC
Confidence            9999999999999987532221110           1134688999999995         99999999999986 65

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.9e-31  Score=182.82  Aligned_cols=134  Identities=26%  Similarity=0.308  Sum_probs=105.3

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLL   81 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil   81 (150)
                      ++-||+|+++.++++. +.+++||||+++|++.+++......+++..+..++.|++.|+.|+|+++  ++|||+||+||+
T Consensus        64 ~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIl  140 (273)
T d1mp8a_          64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVL  140 (273)
T ss_dssp             TCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             hCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhhee
Confidence            3468999999998864 6789999999999999998776667999999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          82 ISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        82 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      ++.++.+|++|||+++.......           .......||+.|+|||++         |+||+|++++||++ |.
T Consensus       141 l~~~~~~Kl~DfG~a~~~~~~~~-----------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~  207 (273)
T d1mp8a_         141 VSSNDCVKLGDFGLSRYMEDSTY-----------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV  207 (273)
T ss_dssp             EEETTEEEECC------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred             ecCCCcEEEccchhheeccCCcc-----------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCC
Confidence            99999999999999874321111           111234578999999995         99999999999986 64

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.96  E-value=4.5e-31  Score=182.82  Aligned_cols=135  Identities=26%  Similarity=0.384  Sum_probs=106.3

Q ss_pred             ccchhhhcccCCCCCc----eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           3 YLSAAFIDKHSTPHGM----HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      +-||+|++..++++..    ..+|+||||++|++|.+++... ..+++..+..++.|++.|+.|+|+++  ++|||+||+
T Consensus        64 ~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~  140 (277)
T d1o6ya_          64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPA  140 (277)
T ss_dssp             CCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred             cCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCc
Confidence            4578999988876543    4589999999999999988765 57999999999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ||+++.++..++.|||.+.........         .......+||+.|+|||++         |+||+|+++++|++|+
T Consensus       141 NIll~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~  211 (277)
T d1o6ya_         141 NIMISATNAVKVMDFGIARAIADSGNS---------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE  211 (277)
T ss_dssp             GEEEETTSCEEECCCTTCEECC-------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccccCccccceeehhhhhhhhcccccc---------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCC
Confidence            999999999999999987643221110         0122345799999999995         9999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-30  Score=182.46  Aligned_cols=138  Identities=22%  Similarity=0.297  Sum_probs=111.4

Q ss_pred             cccchhhhcccCCCCCc----eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeE
Q psy1934           2 EYLSAAFIDKHSTPHGM----HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQ------NPPIV   71 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~------~~~i~   71 (150)
                      ++-||+|+++.++....    ..+|+||||+++|+|.+++++.  .+++..+..++.+++.|+.|+|+.      ..+|+
T Consensus        53 ~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~Iv  130 (303)
T d1vjya_          53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA  130 (303)
T ss_dssp             TCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEE
T ss_pred             hCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCee
Confidence            45689999988876543    4789999999999999999863  688999899999999999999963      12399


Q ss_pred             EecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------------ccc
Q psy1934          72 HRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------------DTW  136 (150)
Q Consensus        72 h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------------d~~  136 (150)
                      |||+||+||+++.++.+|++|||++............        ......||+.|+|||++               |+|
T Consensus       131 HrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~  202 (303)
T d1vjya_         131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI--------APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY  202 (303)
T ss_dssp             CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC------------CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred             ccccCccceEEcCCCCeEEEecCccccccCCCcceec--------cccceecccCcCChhhccccccccCCCcCcchhhh
Confidence            9999999999999999999999999865433221110        11245799999999983               999


Q ss_pred             ccceeEEEeeeec
Q psy1934         137 NNYVIGRSMLYGH  149 (150)
Q Consensus       137 ~~g~~~~~~~~g~  149 (150)
                      |+|++++||++|.
T Consensus       203 S~Gvvl~el~tg~  215 (303)
T d1vjya_         203 AMGLVFWEIARRC  215 (303)
T ss_dssp             HHHHHHHHHHHTB
T ss_pred             hhHHHHHHHhhCC
Confidence            9999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-30  Score=180.36  Aligned_cols=128  Identities=29%  Similarity=0.424  Sum_probs=111.4

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCC-CCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTG-GSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      ||+|+++.++++..+.+++||||+.+ +++.+++... ..+++..++.++.|++.|+.|+|+++  ++|||+||+||+++
T Consensus        68 h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~  144 (273)
T d1xwsa_          68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILID  144 (273)
T ss_dssp             SCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE
T ss_pred             CCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEe
Confidence            68899999999999999999999975 5888888765 57999999999999999999999999  99999999999998


Q ss_pred             CC-CcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          84 SA-GTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      .+ +.+|++|||++.......              ..+..||+.|+|||++          |+||+|+++++|++|.
T Consensus       145 ~~~~~vkl~DFG~a~~~~~~~--------------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~  207 (273)
T d1xwsa_         145 LNRGELKLIDFGSGALLKDTV--------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD  207 (273)
T ss_dssp             TTTTEEEECCCTTCEECCSSC--------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCeEEECccccceeccccc--------------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCC
Confidence            55 799999999987532211              1235699999999984          9999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.8e-30  Score=179.26  Aligned_cols=131  Identities=24%  Similarity=0.361  Sum_probs=109.6

Q ss_pred             cchhhhcccCCC-----CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q psy1934           4 LSAAFIDKHSTP-----HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIE   78 (150)
Q Consensus         4 ~~~~~~~~~~~~-----~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~   78 (150)
                      -||+|+++.+++     +....+++++||++++++..........+++..++.++.|++.|+.|+|+++  ++|||+||+
T Consensus        68 ~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~  145 (305)
T d1blxa_          68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQ  145 (305)
T ss_dssp             CCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred             CCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCcc
Confidence            378999988765     4567899999999987666555544466899999999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          79 NLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        79 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      ||+++..+.+|++|||++......             .......||+.|+|||++         |+||+|+++++|++|+
T Consensus       146 NILi~~~~~~kl~dfg~~~~~~~~-------------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~  212 (305)
T d1blxa_         146 NILVTSSGQIKLADFGLARIYSFQ-------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK  212 (305)
T ss_dssp             GEEECTTCCEEECSCCSCCCCCGG-------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EEEEcCCCCeeecchhhhhhhccc-------------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCC
Confidence            999999999999999998643211             112345799999999985         9999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.6e-30  Score=180.63  Aligned_cols=133  Identities=27%  Similarity=0.400  Sum_probs=112.1

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKE-RTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      ++-||+|+++.+.++..+.+|+||||+.+ ++.+++.. ....+++..+..++.|++.|+.|+|+++  |+|||+||+||
T Consensus        57 ~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNI  133 (298)
T d1gz8a_          57 ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNL  133 (298)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred             hCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchhe
Confidence            34589999999999999999999999976 55555543 3456999999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.+|++|||+++.......            ......||+.|+|||++          |+||+|+++++|++|.
T Consensus       134 l~~~~~~~kl~DFG~a~~~~~~~~------------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~  200 (298)
T d1gz8a_         134 LINTEGAIKLADFGLARAFGVPVR------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR  200 (298)
T ss_dssp             EECTTSCEEECSTTHHHHHCCCSB------------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             eecccCcceeccCCcceeccCCcc------------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCC
Confidence            999999999999999875422111            11234789999999973          9999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.8e-30  Score=180.27  Aligned_cols=134  Identities=19%  Similarity=0.239  Sum_probs=110.7

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.++... +..++++||+.+|+|.+.+......+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        68 l~HpnIv~l~g~~~~-~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll  144 (317)
T d1xkka_          68 VDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV  144 (317)
T ss_dssp             CCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             CCCCCEeeEEEEEec-CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhccee
Confidence            468999999988776 4677889999999999999877678999999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.+|++|||+++........          .......||+.|+|||++         |+||+|++++||++ |.
T Consensus       145 ~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~  211 (317)
T d1xkka_         145 KTPQHVKITDFGLAKLLGAEEKE----------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS  211 (317)
T ss_dssp             EETTEEEECCCSHHHHTTTTCC------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCCeEeeccccceeccccccc----------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCC
Confidence            99999999999998754322111          011133589999999985         99999999999986 54

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.4e-30  Score=179.75  Aligned_cols=133  Identities=22%  Similarity=0.254  Sum_probs=107.6

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      ++-|++|+++.+.... +.+++||||+++|++..++... ...+++..+..++.+++.|+.|+|+++  ++|+|+||+||
T Consensus        68 ~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NI  144 (285)
T d1fmka3          68 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANI  144 (285)
T ss_dssp             HCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             hcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEE
Confidence            3568999999988765 5689999999999999988653 256899999999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeee
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYG  148 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g  148 (150)
                      +++.++.+|++|||+++.......           .......||+.|+|||++         |+||+|++++||++|
T Consensus       145 ll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~  210 (285)
T d1fmka3         145 LVGENLVCKVADFGLARLIEDNEY-----------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK  210 (285)
T ss_dssp             EECGGGCEEECCCCTTC-------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             EECCCCcEEEcccchhhhccCCCc-----------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhC
Confidence            999999999999999874321111           111234689999999985         999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.9e-30  Score=176.53  Aligned_cols=135  Identities=24%  Similarity=0.287  Sum_probs=111.8

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+++.. +.+++||||+++|++.+++......+++..+..++.|++.|+.|+|+++  ++|||+||+||++
T Consensus        68 l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll  144 (273)
T d1u46a_          68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL  144 (273)
T ss_dssp             CCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE
T ss_pred             CCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhcc
Confidence            458999999998876 4678999999999999998876667999999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      +.++.+|++|||+++...........         .....|+..|+|||++         |+||+|++++||++ |.
T Consensus       145 ~~~~~vkl~DfGl~~~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~  212 (273)
T d1u46a_         145 ATRDLVKIGDFGLMRALPQNDDHYVM---------QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ  212 (273)
T ss_dssp             EETTEEEECCCTTCEECCC-CCEEEC--------------CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred             ccccceeeccchhhhhcccCCCccee---------cCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCC
Confidence            99999999999999864332221111         1123577889999984         99999999999985 65

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.1e-30  Score=178.72  Aligned_cols=130  Identities=18%  Similarity=0.241  Sum_probs=111.8

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhh---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKER---------------TSALPPNIVCSILWQTCQAVKHMHGQNPP   69 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~   69 (150)
                      ||+|+++.+++..++.+++||||+++|+|.+++...               ...+++..+..++.|++.|+.|+|+++  
T Consensus        70 HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--  147 (309)
T d1fvra_          70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--  147 (309)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--
Confidence            899999999999999999999999999999999643               246899999999999999999999998  


Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccce
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYV  140 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~  140 (150)
                      ++|||++|+||+++.++.+|++|||+++........             ....||..|+|||.+         |+||+|+
T Consensus       148 iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~-------------~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGv  214 (309)
T d1fvra_         148 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-------------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGV  214 (309)
T ss_dssp             EECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC-----------------CCTTTCCHHHHHHCEECHHHHHHHHHH
T ss_pred             ccccccccceEEEcCCCceEEccccccccccccccc-------------cceecCCcccchHHhccCCCCccceeehhHH
Confidence            999999999999999999999999998753222111             123588999999995         9999999


Q ss_pred             eEEEeeeec
Q psy1934         141 IGRSMLYGH  149 (150)
Q Consensus       141 ~~~~~~~g~  149 (150)
                      +++||++|.
T Consensus       215 il~ell~~~  223 (309)
T d1fvra_         215 LLWEIVSLG  223 (309)
T ss_dssp             HHHHHHTTS
T ss_pred             HHHHHHhcC
Confidence            999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1e-29  Score=177.72  Aligned_cols=134  Identities=20%  Similarity=0.303  Sum_probs=114.0

Q ss_pred             cchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q psy1934           4 LSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------------SALPPNIVCSILWQTCQAVKHMHGQNP   68 (150)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~~l~~lh~~~~   68 (150)
                      -||+|+++.+++...+.+++||||+++|+|.+++....               ..+++..+..++.|++.|+.|+|+++ 
T Consensus        77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-  155 (299)
T d1fgka_          77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-  155 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-
Confidence            38999999999999999999999999999999997542               24789999999999999999999999 


Q ss_pred             CeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccc
Q psy1934          69 PIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNY  139 (150)
Q Consensus        69 ~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g  139 (150)
                       ++|||+||+||+++.++.+|++|||++..........          ......+++.|+|||++         |+||+|
T Consensus       156 -ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~G  224 (299)
T d1fgka_         156 -CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK----------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG  224 (299)
T ss_dssp             -CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTC----------CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred             -EEeeeecccceeecCCCCeEeccchhhcccccccccc----------ccccCCCChhhhhhhHhcCCCCCchhhhHHhH
Confidence             9999999999999999999999999987543221111          11234678899999985         999999


Q ss_pred             eeEEEeee-ec
Q psy1934         140 VIGRSMLY-GH  149 (150)
Q Consensus       140 ~~~~~~~~-g~  149 (150)
                      ++++||++ |+
T Consensus       225 vvl~ell~~g~  235 (299)
T d1fgka_         225 VLLWEIFTLGG  235 (299)
T ss_dssp             HHHHHHHTTSC
T ss_pred             HHHHHhccCCC
Confidence            99999986 54

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.7e-30  Score=175.33  Aligned_cols=131  Identities=27%  Similarity=0.415  Sum_probs=105.6

Q ss_pred             cccchhhhcccCCC-CCceEEEEEEeccCCCCHHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q psy1934           2 EYLSAAFIDKHSTP-HGMHEYLILTELCTGGSLVDVLKERT-SALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIEN   79 (150)
Q Consensus         2 ~~~~~~~~~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~n   79 (150)
                      ++-||+|+++.+.+ +..+.+|+||||+++|+|.+++.... ..+++..+..++.|++.|+.|+|+.+  ++|+|++|+|
T Consensus        56 ~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~N  133 (262)
T d1byga_          56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARN  133 (262)
T ss_dssp             TCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred             hCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHh
Confidence            45689999999865 55677999999999999999996542 35899999999999999999999998  9999999999


Q ss_pred             EEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee-ec
Q psy1934          80 LLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY-GH  149 (150)
Q Consensus        80 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~-g~  149 (150)
                      |+++.++.++++|||+++.....               .....++..|+|||++         |+||+|++++||++ |+
T Consensus       134 il~~~~~~~kl~dfg~s~~~~~~---------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~  198 (262)
T d1byga_         134 VLVSEDNVAKVSDFGLTKEASST---------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR  198 (262)
T ss_dssp             EEECTTSCEEECCCCC---------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             heecCCCCEeecccccceecCCC---------------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCC
Confidence            99999999999999998743111               1123578899999985         99999999999986 55

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.5e-29  Score=175.85  Aligned_cols=138  Identities=17%  Similarity=0.222  Sum_probs=113.8

Q ss_pred             cccchhhhcccCCC-CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q psy1934           2 EYLSAAFIDKHSTP-HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENL   80 (150)
Q Consensus         2 ~~~~~~~~~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~ni   80 (150)
                      ++-||+|+++.++. +..+.+++|||||++|+|.+++......+++..+..++.|++.|+.|+|+.+  ++|||+||+||
T Consensus        84 ~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NI  161 (311)
T d1r0pa_          84 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNC  161 (311)
T ss_dssp             TCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             hCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhE
Confidence            45689999998864 4567899999999999999999876566788888899999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          81 LISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        81 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      +++.++.+|++|||+++..........        .......||+.|+|||++         |+||+|++++||++|.
T Consensus       162 Ll~~~~~~kL~DFG~~~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~  231 (311)
T d1r0pa_         162 MLDEKFTVKVADFGLARDMYDKEFDSV--------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG  231 (311)
T ss_dssp             EECTTCCEEECSSGGGCCTTTTTCCCT--------TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             eECCCCCEEEecccchhhccccccccc--------eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCC
Confidence            999999999999999975433221110        111234688999999985         9999999999998753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=1.6e-29  Score=176.83  Aligned_cols=135  Identities=19%  Similarity=0.214  Sum_probs=112.2

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-----------------------CCCCHHHHHHHHHHHHHH
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-----------------------SALPPNIVCSILWQTCQA   59 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~~~~~i~~~   59 (150)
                      +-||++++..++....+..++++||+++|+|.+++....                       ..+++..+..++.|++.|
T Consensus        73 l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~g  152 (301)
T d1lufa_          73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG  152 (301)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHH
T ss_pred             cCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHH
Confidence            458999999999999999999999999999999996421                       237788899999999999


Q ss_pred             HHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc------
Q psy1934          60 VKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV------  133 (150)
Q Consensus        60 l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~------  133 (150)
                      +.|+|+++  ++|||+||+||+++.++.+|++|||+++.......          .....+..+++.|+|||++      
T Consensus       153 l~ylH~~~--ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~t  220 (301)
T d1lufa_         153 MAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY----------YKADGNDAIPIRWMPPESIFYNRYT  220 (301)
T ss_dssp             HHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC----------BC----CCBCGGGCCHHHHHHCCCC
T ss_pred             hhhcccCC--eEeeEEcccceEECCCCcEEEccchhheeccCCcc----------ccccCCCCcCcCcCCHHHHccCCCC
Confidence            99999999  99999999999999999999999999874322111          0112245688999999985      


Q ss_pred             ---cccccceeEEEeeeec
Q psy1934         134 ---DTWNNYVIGRSMLYGH  149 (150)
Q Consensus       134 ---d~~~~g~~~~~~~~g~  149 (150)
                         |+||+|++++||++|.
T Consensus       221 ~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         221 TESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             HHHHHHHHHHHHHHHHTTT
T ss_pred             hhhhhccchhhHHHHHccC
Confidence               9999999999998874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.5e-29  Score=176.63  Aligned_cols=131  Identities=22%  Similarity=0.362  Sum_probs=112.2

Q ss_pred             chhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCC
Q psy1934           5 SAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT-----------------SALPPNIVCSILWQTCQAVKHMHGQN   67 (150)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------~~l~~~~~~~~~~~i~~~l~~lh~~~   67 (150)
                      ||+|+++.+..+..+.++++||||++|+|.+++....                 ..+++..+..++.|++.|+.|||+++
T Consensus        86 HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~  165 (311)
T d1t46a_          86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN  165 (311)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            8999999999999999999999999999999997532                 24788899999999999999999999


Q ss_pred             CCeEEecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------ccccc
Q psy1934          68 PPIVHRDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNN  138 (150)
Q Consensus        68 ~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~  138 (150)
                        ++|||+||+||+++..+.++++|||.++.........          ......||+.|+|||++         |+||+
T Consensus       166 --ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~  233 (311)
T d1t46a_         166 --CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV----------VKGNARLPVKWMAPESIFNCVYTFESDVWSY  233 (311)
T ss_dssp             --CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSE----------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             --eeecccccccccccccCcccccccchheeccCCCcce----------EeeecccChHHcCHHHhcCCCCCCcccccch
Confidence              9999999999999999999999999987543221111          11134678999999985         99999


Q ss_pred             ceeEEEeee
Q psy1934         139 YVIGRSMLY  147 (150)
Q Consensus       139 g~~~~~~~~  147 (150)
                      |++++||++
T Consensus       234 G~~l~ellt  242 (311)
T d1t46a_         234 GIFLWELFS  242 (311)
T ss_dssp             HHHHHHHHT
T ss_pred             HHHHHHHHh
Confidence            999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.94  E-value=1.4e-28  Score=171.52  Aligned_cols=136  Identities=19%  Similarity=0.142  Sum_probs=110.5

Q ss_pred             hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-
Q psy1934           6 AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISS-   84 (150)
Q Consensus         6 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~-   84 (150)
                      ++++.+.+.++..+..++||||+ +++|.+++......++...+..++.|++.|+.|+|+++  ++|||+||+||+++. 
T Consensus        61 ~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~  137 (293)
T d1csna_          61 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRP  137 (293)
T ss_dssp             TTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCS
T ss_pred             CCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCc
Confidence            56667777888889999999999 67999999876667999999999999999999999999  999999999999974 


Q ss_pred             ----CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          85 ----AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        85 ----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                          .+.++++|||+++...........     .........||+.|||||++         |+||+|+++++|++|.
T Consensus       138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~-----~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~  210 (293)
T d1csna_         138 NSKNANMIYVVDFGMVKFYRDPVTKQHI-----PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS  210 (293)
T ss_dssp             SSTTTTCEEECCCTTCEESBCTTTCCBC-----CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccccCCceEEcccceeEEcccCccccce-----eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCC
Confidence                467999999999864332211100     00112245799999999985         9999999999999886

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.4e-28  Score=173.25  Aligned_cols=131  Identities=24%  Similarity=0.401  Sum_probs=104.2

Q ss_pred             ccchhhhcccCCC------CCceEEEEEEeccCCCCHHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q psy1934           3 YLSAAFIDKHSTP------HGMHEYLILTELCTGGSLVDVLK---ERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHR   73 (150)
Q Consensus         3 ~~~~~~~~~~~~~------~~~~~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~   73 (150)
                      +-|++|+++.+.+      .....+|+|||||+++ +.+.+.   .....+++..++.++.|++.|+.|+|+++  |+||
T Consensus        70 l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHr  146 (350)
T d1q5ka_          70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHR  146 (350)
T ss_dssp             CCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECC
T ss_pred             cCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--Cccc
Confidence            4578888877654      3445689999999875 444342   22356999999999999999999999999  9999


Q ss_pred             cCCCCCEEEcCCC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeE
Q psy1934          74 DLKIENLLISSAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIG  142 (150)
Q Consensus        74 ~l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~  142 (150)
                      |+||+||+++.++ .+|++|||++........             ..+..||+.|+|||++          |+||+|+++
T Consensus       147 DiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il  213 (350)
T d1q5ka_         147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL  213 (350)
T ss_dssp             CCCGGGEEECTTTCCEEECCCTTCEECCTTSC-------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             CCCcceEEEecCCCceeEecccchhhccCCcc-------------cccccccccccChHHhhcccCCCcceeecccceEE
Confidence            9999999999875 899999999875422111             1134789999999974          999999999


Q ss_pred             EEeeeec
Q psy1934         143 RSMLYGH  149 (150)
Q Consensus       143 ~~~~~g~  149 (150)
                      +||++|+
T Consensus       214 ~el~~g~  220 (350)
T d1q5ka_         214 AELLLGQ  220 (350)
T ss_dssp             HHHHHTS
T ss_pred             EehhhCC
Confidence            9999885

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.3e-28  Score=172.38  Aligned_cols=131  Identities=28%  Similarity=0.406  Sum_probs=112.9

Q ss_pred             c-hhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 S-AAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~-~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      | |+|+++.+..+..+.+++++||+.+|+|.+++... ..+++..+..++.|++.|+.|+|+.+  ++|||++|+||+++
T Consensus        87 h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~  163 (322)
T d1vzoa_          87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD  163 (322)
T ss_dssp             TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred             CCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeec
Confidence            5 67999999999999999999999999999999875 46788888899999999999999999  99999999999999


Q ss_pred             CCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc-----------cccccceeEEEeeeec
Q psy1934          84 SAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV-----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----------d~~~~g~~~~~~~~g~  149 (150)
                      .++.++++|||++........           .......|++.|++||++           |+||+|+++++|++|.
T Consensus       164 ~~~~vkL~DFG~a~~~~~~~~-----------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~  229 (322)
T d1vzoa_         164 SNGHVVLTDFGLSKEFVADET-----------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  229 (322)
T ss_dssp             TTSCEEESCSSEEEECCGGGG-----------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCEEEeeccchhhhccccc-----------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCC
Confidence            999999999999875422111           112245689999999974           9999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.8e-28  Score=171.95  Aligned_cols=135  Identities=19%  Similarity=0.233  Sum_probs=113.0

Q ss_pred             cccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q psy1934           2 EYLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERT---------SALPPNIVCSILWQTCQAVKHMHGQNPPIVH   72 (150)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h   72 (150)
                      ++-||+|+++.+.....+.+++||||+++|+|.+++....         ..+++..+..++.+++.|+.|+|+++  ++|
T Consensus        79 ~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivH  156 (308)
T d1p4oa_          79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVH  156 (308)
T ss_dssp             GCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBC
T ss_pred             HcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eee
Confidence            3558999999999999999999999999999999986431         23678888899999999999999998  999


Q ss_pred             ecCCCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEE
Q psy1934          73 RDLKIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGR  143 (150)
Q Consensus        73 ~~l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~  143 (150)
                      ||+|++||+++.++.+||+|||+++.......          ........+|+.|+|||.+         |+||+|++++
T Consensus       157 rDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~----------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~  226 (308)
T d1p4oa_         157 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDY----------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW  226 (308)
T ss_dssp             SCCSGGGEEECTTCCEEECCTTCCCGGGGGGC----------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             ceEcCCceeecCCceEEEeecccceeccCCcc----------eeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence            99999999999999999999999875422111          0112234688999999984         9999999999


Q ss_pred             Eeeee
Q psy1934         144 SMLYG  148 (150)
Q Consensus       144 ~~~~g  148 (150)
                      ||++|
T Consensus       227 El~t~  231 (308)
T d1p4oa_         227 EIATL  231 (308)
T ss_dssp             HHHHT
T ss_pred             HHHhC
Confidence            99876

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.4e-28  Score=170.91  Aligned_cols=127  Identities=24%  Similarity=0.390  Sum_probs=107.9

Q ss_pred             ccchhhhcccCCCCCc------eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPHGM------HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||+++++.+++...      ..+|+||||+ +.+|..+.+.  ..+++..++.++.|++.|+.|||+++  |+|||+|
T Consensus        74 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiK  148 (346)
T d1cm8a_          74 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLK  148 (346)
T ss_dssp             CCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred             cCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccC
Confidence            4578899988765543      4679999999 5588888765  46999999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSML  146 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~  146 (150)
                      |+||+++.++.++++|||++......               .+...||+.|+|||++          |+||+|+++++|+
T Consensus       149 p~NIL~~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell  213 (346)
T d1cm8a_         149 PGNLAVNEDCELKILDFGLARQADSE---------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI  213 (346)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSS---------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred             cchhhcccccccccccccceeccCCc---------------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHH
Confidence            99999999999999999999754211               1245789999999984          9999999999999


Q ss_pred             eec
Q psy1934         147 YGH  149 (150)
Q Consensus       147 ~g~  149 (150)
                      +|.
T Consensus       214 ~g~  216 (346)
T d1cm8a_         214 TGK  216 (346)
T ss_dssp             HSS
T ss_pred             HCc
Confidence            985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.93  E-value=4.2e-28  Score=168.42  Aligned_cols=133  Identities=24%  Similarity=0.295  Sum_probs=109.5

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-||+|+++.+.+...+..++++|++.++.+..+. .....+++..+..++.|++.|+.|+|+.+  |+|||+||+||++
T Consensus        57 l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll  133 (286)
T d1ob3a_          57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLI  133 (286)
T ss_dssp             CCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             CCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeE
Confidence            45899999999999999999999999875555554 44467999999999999999999999998  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeecC
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGHV  150 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~~  150 (150)
                      +.++.+|++|||.+.......            .......+++.|+|||++          |+||+|+++++|++|+.
T Consensus       134 ~~~~~~kl~DfG~a~~~~~~~------------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~  199 (286)
T d1ob3a_         134 NREGELKIADFGLARAFGIPV------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP  199 (286)
T ss_dssp             CTTSCEEECCTTHHHHHCC---------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCCEEecccccceecccCc------------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCC
Confidence            999999999999986432110            111234688999999984          99999999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.1e-27  Score=170.27  Aligned_cols=133  Identities=29%  Similarity=0.463  Sum_probs=105.6

Q ss_pred             ccchhhhcccCCCCCc-----eEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPHGM-----HEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-||+++++.+.....     ..++++ ||+.+|+|.+++..  ..+++..++.++.|++.|+.|+|+++  ++|||+||
T Consensus        63 l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp  137 (345)
T d1pmea_          63 FRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKP  137 (345)
T ss_dssp             CCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred             cCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCc
Confidence            3467888877655432     335555 55668899999976  36999999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLY  147 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~  147 (150)
                      +||+++.++.+|++|||++..........         ......+||+.|+|||++          |+||+|+++++|++
T Consensus       138 ~NILl~~~~~~kl~DfG~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~  208 (345)
T d1pmea_         138 SNLLLNTTCDLKICDFGLARVADPDHDHT---------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS  208 (345)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCGGGCBC---------CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred             ceEEECCCCCEEEcccCceeeccCCCccc---------eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh
Confidence            99999999999999999987542221110         011245689999999984          99999999999999


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |+
T Consensus       209 g~  210 (345)
T d1pmea_         209 NR  210 (345)
T ss_dssp             SS
T ss_pred             CC
Confidence            86

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.93  E-value=1.8e-27  Score=166.14  Aligned_cols=137  Identities=18%  Similarity=0.138  Sum_probs=106.3

Q ss_pred             chhhh-cccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q psy1934           5 SAAFI-DKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLIS   83 (150)
Q Consensus         5 ~~~~~-~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~   83 (150)
                      |++++ .........+.+++||||+. +++.+.+......+++..+..++.|++.|+.|+|+++  ++|||+||+||++.
T Consensus        61 ~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~  137 (299)
T d1ckia_          61 GGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMG  137 (299)
T ss_dssp             TSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC
T ss_pred             CCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhcccc
Confidence            45544 34556677788999999995 5788877766677999999999999999999999999  99999999999876


Q ss_pred             C---CCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeeeec
Q psy1934          84 S---AGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        84 ~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~g~  149 (150)
                      .   ...++++|||+++...........     .........||+.|||||++         |+||+|++++||++|.
T Consensus       138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~  210 (299)
T d1ckia_         138 LGKKGNLVYIIDFGLAKKYRDARTHQHI-----PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS  210 (299)
T ss_dssp             CGGGTTCEEECCCSSCEECBCTTTCCBC-----CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCceeeeeccCcceeccccccccce-----eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCC
Confidence            4   457999999999865332211100     00111245799999999985         9999999999999886

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.92  E-value=1.9e-27  Score=167.94  Aligned_cols=126  Identities=18%  Similarity=0.293  Sum_probs=105.0

Q ss_pred             chhhhcccCCCC--CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           5 SAAFIDKHSTPH--GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         5 ~~~~~~~~~~~~--~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      ||+|+++.+.++  ..+.+++|||||++++|.+..    ..+++..++.++.|++.|+.|||+++  |+|||+||+||++
T Consensus        89 hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi  162 (328)
T d3bqca1          89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMI  162 (328)
T ss_dssp             STTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             CCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEE
Confidence            788999888764  456799999999999987653    35899999999999999999999999  9999999999999


Q ss_pred             cCCC-cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAG-TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++ .++++|||++........             .....+|+.|+|||++          |+||+|++++++++|+
T Consensus       163 ~~~~~~vkl~DFG~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~  227 (328)
T d3bqca1         163 DHEHRKLRLIDWGLAEFYHPGQE-------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK  227 (328)
T ss_dssp             ETTTTEEEECCGGGCEECCTTCC-------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             cCCCCeeeecccccceeccCCCc-------------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCC
Confidence            8764 689999999875422211             1134689999999984          9999999999998875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=4.3e-27  Score=165.44  Aligned_cols=135  Identities=21%  Similarity=0.309  Sum_probs=102.4

Q ss_pred             cchhhhcccCCC--------CCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q psy1934           4 LSAAFIDKHSTP--------HGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDL   75 (150)
Q Consensus         4 ~~~~~~~~~~~~--------~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l   75 (150)
                      -|+++++..+.+        ...+.+|++|||++++.+. ........+++..++.++.|++.|+.|+|+++  ++|||+
T Consensus        67 ~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDl  143 (318)
T d3blha1          67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDM  143 (318)
T ss_dssp             CCTTBCCEEEEEEC----------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred             cCCCccceEeeeecccccccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCc
Confidence            467777765543        3356789999999875544 44444456889999999999999999999999  999999


Q ss_pred             CCCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEe
Q psy1934          76 KIENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSM  145 (150)
Q Consensus        76 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~  145 (150)
                      ||+||+++.++.++++|||++..........        .....+..||+.|+|||++          |+||+|+++++|
T Consensus       144 Kp~NILl~~~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el  215 (318)
T d3blha1         144 KAANVLITRDGVLKLADFGLARAFSLAKNSQ--------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM  215 (318)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECCC-------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             CchheeecCCCcEEeeecceeeecccccccc--------cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeH
Confidence            9999999999999999999987532211100        0111234689999999984          999999999999


Q ss_pred             eeec
Q psy1934         146 LYGH  149 (150)
Q Consensus       146 ~~g~  149 (150)
                      ++|+
T Consensus       216 ~~g~  219 (318)
T d3blha1         216 WTRS  219 (318)
T ss_dssp             HHSS
T ss_pred             hhCC
Confidence            9885

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.8e-26  Score=159.30  Aligned_cols=132  Identities=27%  Similarity=0.386  Sum_probs=112.0

Q ss_pred             ccchhhhcccCCCCCceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q psy1934           3 YLSAAFIDKHSTPHGMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLI   82 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~   82 (150)
                      +-|++++++..++...+.+++++|++.++++..++... ..+++..+..++.|++.|+.|+|+++  |+|||+||+||++
T Consensus        58 l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli  134 (292)
T d1unla_          58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLI  134 (292)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred             cCcCCEEeeccccccccceeEEeeeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCccccc
Confidence            45789999999999999999999999998888777643 57889999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeeeec
Q psy1934          83 SSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLYGH  149 (150)
Q Consensus        83 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~g~  149 (150)
                      +.++.+|++|||.+..........            ....+++.|+|||++          |+||+|+++++|++|.
T Consensus       135 ~~~~~~kl~DFG~a~~~~~~~~~~------------~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~  199 (292)
T d1unla_         135 NRNGELKLANFGLARAFGIPVRCY------------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG  199 (292)
T ss_dssp             CTTCCEEECCCTTCEECCSCCSCC------------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred             ccCCceeeeecchhhcccCCCccc------------eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCC
Confidence            999999999999998643221111            123467788999873          9999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=5.3e-26  Score=162.10  Aligned_cols=129  Identities=28%  Similarity=0.402  Sum_probs=100.4

Q ss_pred             ccchhhhcccCCCC------CceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q psy1934           3 YLSAAFIDKHSTPH------GMHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLK   76 (150)
Q Consensus         3 ~~~~~~~~~~~~~~------~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~   76 (150)
                      +-||+|+++.+++.      ..+.+|+|||||.+ ++.+.+.   ..+++..++.++.|++.|+.|+|+.+  ++|||+|
T Consensus        73 l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlK  146 (355)
T d2b1pa1          73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK  146 (355)
T ss_dssp             CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             cCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCC
Confidence            45788999887663      55899999999976 5555453   45899999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEEeee
Q psy1934          77 IENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRSMLY  147 (150)
Q Consensus        77 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~~~~  147 (150)
                      |+||+++.++..+++|||+++.....             .......+|+.|+|||++         |+||+|+++++|+.
T Consensus       147 P~Nil~~~~~~~kl~df~~~~~~~~~-------------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~  213 (355)
T d2b1pa1         147 PSNIVVKSDCTLKILDFGLARTAGTS-------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR  213 (355)
T ss_dssp             GGGEEECTTCCEEECCCCC----------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccccccccccceeeechhhhhccccc-------------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhh
Confidence            99999999999999999987643211             111244689999999995         99999999999999


Q ss_pred             ecC
Q psy1934         148 GHV  150 (150)
Q Consensus       148 g~~  150 (150)
                      |+.
T Consensus       214 g~~  216 (355)
T d2b1pa1         214 HKI  216 (355)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.8e-26  Score=164.01  Aligned_cols=128  Identities=27%  Similarity=0.376  Sum_probs=101.0

Q ss_pred             ccchhhhcccCCCCC-----ceEEEEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q psy1934           3 YLSAAFIDKHSTPHG-----MHEYLILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKI   77 (150)
Q Consensus         3 ~~~~~~~~~~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~   77 (150)
                      +-|++++++.+++..     ....++++||+.+|+|.+++..  ..+++..++.++.|++.|+.|||+++  ++|||+||
T Consensus        74 l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp  149 (348)
T d2gfsa1          74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKP  149 (348)
T ss_dssp             CCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCG
T ss_pred             cCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCC
Confidence            457888887776532     2233555677778999999964  46999999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc----------cccccceeEEEeee
Q psy1934          78 ENLLISSAGTVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV----------DTWNNYVIGRSMLY  147 (150)
Q Consensus        78 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------d~~~~g~~~~~~~~  147 (150)
                      +||+++.++.++++|||++.....               ...+..|++.|+|||+.          |+||+|+++++|++
T Consensus       150 ~NILi~~~~~~kl~dfg~a~~~~~---------------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~  214 (348)
T d2gfsa1         150 SNLAVNEDCELKILDFGLARHTDD---------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT  214 (348)
T ss_dssp             GGEEECTTCCEEECCC----CCTG---------------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccchhcccCc---------------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHh
Confidence            999999999999999998864311               11234578889999973          99999999999999


Q ss_pred             ec
Q psy1934         148 GH  149 (150)
Q Consensus       148 g~  149 (150)
                      |+
T Consensus       215 g~  216 (348)
T d2gfsa1         215 GR  216 (348)
T ss_dssp             SS
T ss_pred             CC
Confidence            86

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.79  E-value=4.8e-21  Score=136.27  Aligned_cols=128  Identities=22%  Similarity=0.303  Sum_probs=96.3

Q ss_pred             chhhhcccCCCCC--ceEEEEEEeccCCC-CHHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCC
Q psy1934           5 SAAFIDKHSTPHG--MHEYLILTELCTGG-SLVDVLKER-TSALPPNIVCSILWQTCQAVKHMHG-QNPPIVHRDLKIEN   79 (150)
Q Consensus         5 ~~~~~~~~~~~~~--~~~~~lv~E~~~~g-~L~~~l~~~-~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~i~h~~l~~~n   79 (150)
                      +++++++.++.+.  ....+++++++..+ +........ ...+++..++.++.|++.|+.|+|+ .+  |+|||+||+|
T Consensus        79 ~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~N  156 (362)
T d1q8ya_          79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPEN  156 (362)
T ss_dssp             HTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGG
T ss_pred             cCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhH
Confidence            5677777766543  34556666666544 344434332 2468888999999999999999997 77  9999999999


Q ss_pred             EEEcCCC------cEEEeecCceeccccCCCcchhHhhhhhhHHhhhcCCCCCccCcccc---------cccccceeEEE
Q psy1934          80 LLISSAG------TVKLCDFGSATEKVYSPDNAWSAQQRSMLEDEMARFTTPMYRAPEMV---------DTWNNYVIGRS  144 (150)
Q Consensus        80 il~~~~~------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---------d~~~~g~~~~~  144 (150)
                      |+++..+      .++++|||.+.......               ....||+.|+|||++         |+||+|+++++
T Consensus       157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  221 (362)
T d1q8ya_         157 VLMEIVDSPENLIQIKIADLGNACWYDEHY---------------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE  221 (362)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTBCC---------------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHH
T ss_pred             eeeeccCcccccceeeEeeccccccccccc---------------ccccccccccChhhccccCCCccccccchHHHHHH
Confidence            9997654      38999999987432111               134689999999984         99999999999


Q ss_pred             eeeec
Q psy1934         145 MLYGH  149 (150)
Q Consensus       145 ~~~g~  149 (150)
                      |+.|.
T Consensus       222 l~~g~  226 (362)
T d1q8ya_         222 LITGD  226 (362)
T ss_dssp             HHHSS
T ss_pred             HHHCC
Confidence            99885

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.33  E-value=4.5e-13  Score=86.89  Aligned_cols=67  Identities=25%  Similarity=0.277  Sum_probs=55.0

Q ss_pred             EEEEeccCCCCHHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCcEEEeecCceecc
Q psy1934          22 LILTELCTGGSLVDVLKERTSALPPNIVCSILWQTCQAVKHMHGQNPPIVHRDLKIENLLISSAGTVKLCDFGSATEK   99 (150)
Q Consensus        22 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~i~h~~l~~~nil~~~~~~~~l~dfg~~~~~   99 (150)
                      +++|||++++.+.        .++...+..++.|++.++.++|+++  ++|+|+||+||+++.. .++++|||.+...
T Consensus        86 ~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDFG~a~~~  152 (191)
T d1zara2          86 AVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDFPQSVEV  152 (191)
T ss_dssp             EEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCCTTCEET
T ss_pred             EEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEECCCcccC
Confidence            7999999875432        2444555678899999999999999  9999999999999865 5889999988653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=96.29  E-value=0.0018  Score=42.30  Aligned_cols=29  Identities=21%  Similarity=0.381  Sum_probs=24.7

Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      ++|+|+.+.|++++..+...+.||+.+..
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEeeccCcceeecCCceEEEeechhccc
Confidence            79999999999998766667999987764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=90.72  E-value=0.039  Score=36.77  Aligned_cols=29  Identities=28%  Similarity=0.355  Sum_probs=26.4

Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      ++|.|+.++|++++.+....+.||+.+..
T Consensus       185 iIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         185 VIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCcchhhhhcccccceeEeccccccc
Confidence            99999999999999887778999998874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=83.62  E-value=0.22  Score=31.60  Aligned_cols=29  Identities=17%  Similarity=0.311  Sum_probs=25.1

Q ss_pred             eEEecCCCCCEEEcCCCcEEEeecCceec
Q psy1934          70 IVHRDLKIENLLISSAGTVKLCDFGSATE   98 (150)
Q Consensus        70 i~h~~l~~~nil~~~~~~~~l~dfg~~~~   98 (150)
                      ++|+|+.+.|+++...+...+.||+.+..
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            79999999999998776677999987764